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Donald Everett Axinn
(1929–2009)
Donald Everett Axinn was one of the quiet Long Islanders who had a major impact on the well-
being of the communities and institutions that make up much of what Long Island is about. Cold
Spring Harbor Laboratory was fortunate to have him as a dear friend and benefactor and suffered
a great loss when he lost his battle with cancer at the age of 80. From the day he was introduced
to the Laboratory via our President’s Council and as an early indirect investor in some of our spin-
off companies, Don displayed a keen interest in our science and its relationship to people’s lives.
He also fostered the mingling of literature and science via his passion for writing.
Founder and chairman of the Donald E. Axinn Companies, an investment and real estate devel-
opment firm, he served on the CSHL Board of Trustees since 2006. Don was active in the building,
finance, and nominating committees, where he shared his finely tuned business and real estate devel-
opment skills and experiences to benefit CSHL. Don was also generous in sharing his friends with
CSHL, and along with his wife Joan, he enriched our connections to many new supporters. Most
importantly, he helped our chief facilities officer Art Brings with the completion of the new Hillside
Laboratories, one of the largest projects ever completed on our main campus. Don appreciated the
integration of artistic and functional elements of design that are clearly visible in the six buildings that
collectively formed the heart of the project. Hard-hat on, he patrolled the construction site reviewing
plans, questioning craftsmen, negotiating with vendors. He took it personally, and through his
involvement became ever more integrated into the CSHL family. We were honored by the pride that
he took in the successes of this institution, which he publicly proclaimed to all who would listen. 
Don’s pride in the institution and these new laboratories was such that he very generously financial-
ly supported The Donald Everett Axinn Laboratory, one of the six research buildings that constitute the
visually elegant complex. Adjacent to the Axinn Laboratory is the Laurie and Leo Guthart Discovery
Tower, honoring Don’s long-time friend, business associate and fellow Laboratory Trustee Leo Guthart.
Don and Leo together supported a major cancer research effort in Greg Hannon’s laboratory.
It was particularly pleasing to see Don and Joan, joined by family and friends on June 12, 2009,
for the Hillside Laboratories dedication and that he was able to celebrate this monumental achieve-
ment with all of us. We captured his zest for adventure in the sky in a beautiful portrait of Don and
his 1944 Boeing N253 Navy Stearman painted by local artist David Peikon. A passionate airman and
strong supporter of the Long Island Cradle of Aviation Museum, Don helped to envision the eight
exhibit galleries housed in the Donald Everett Axinn Air and Space Museum Hall.
Born of Russian émigré parents, Don graduated from Middlebury College where he later received
an honorary Doctor of Letters, one of five such degrees that honored his major accomplishments. He
maintained a strong association with Middlebury, as a writer in residence and supporter of the col-
lege’s Donald E. Axinn '51 Center for Literary and Cultural Studies at the Starr Library. 
Don served on Long Island’s Hofstra University Board of Trustees from 1970 to 1979, including
terms as Secretary and Vice Chair. He did an amazing thing in 1971–1972 when he assumed, on a
pro-bono basis, the Associate Deanship of the Hofstra College of Liberal Arts and Sciences. He
rejoined the Board at Hofstra as an active trustee in 1984, serving until 1990 when he became a Trustee
Emeritus. In 1988, the Hofstra University Library was named the Joan and Donald E. Axinn Library
in recognition of his many accomplishments and his service as a valued advisor to the University.
Don was known as the quintessential 20th-century renaissance man, pursuing three distinct
careers. In addition to his accomplishments as a successful real estate developer, he was an accom-
plished writer and made a lifelong commitment to public service via philanthropy.
Altogether, Don wrote eight volumes of poetry and three novels. One of them caused Don to
become a film producer when his novel Spin was made into a movie by director James Redford,
winning a Crystal Heart Award at the Heartland Film Festival. Don was a Tennessee Williams
Fellow at the Bread Loaf Writers’ Conference, and we were proud to host poetry readings by Don
as part of the annual CSHL Cultural Series. He generously donated the proceeds of his latest novel
Allan, Burning to CSHL. In reviewing this latest novel, Nelson DeMille wrote, “Donald Axinn
brings his renowned poetry to this beautifully written story of a man in crisis... . [T]his is a novel
that will make you think and compel us all into re-examining our ordinary lives.”
In addition to supporting research at CSHL, Don and Joan devoted themselves to environmen-
tal and humanitarian causes. Don was one of the founders of the Interfaith Nutrition Network,
which provides shelter and kitchens for the homeless on Long Island. He also served as a director
and/or trustee for numerous public organizations, among them The Nature Conservancy, Poets &
Writers, The Academy of American Poets, and Friends for Long Island’s Heritage. 
Don Axinn continues to fly high above us.
Bruce Stillman
A poem that Don wrote for us hangs in the Axinn Laboratory building. 
THE COLORS OF INFINITY
beyond cold and comprehension
past stashed universes
where god contemplates
the shapes of cosmic islands where the
dead have escaped
old bones and cacophony
where I almost remember
the tingle of the first kisses
my children’s uncorrupted faces
slipstreams and winging
into the white mystery of clouds
the musty smells of august’s forest floors
smoke and wildflowers
there in that wondrous place 
where night and day
are always the same
where the end or beginning
never matter
there I would bathe in the strong
rich colors of infinity
Donald Everett Axinn      ix
John Cleary
(1933–2009)
John Cleary’s death from a heart attack while on a skiing holiday in Colorado was a grievous blow
not only to his family but also to Cold Spring Harbor Laboratory and to his many close friends
on Long Island. His calming, intelligent personality made us increasingly dependent on his skills
as a consummate lawyer and counsel. He helped to steer me in the new world of biotechnology
and later into the world of high-powered publishing and entertainment. The coming of the 50th
anniversary of the double helix had created a potential need for a well-crafted TV series and atten-
dant book that would let the general public appreciate the ever-increasing relevance of DNA to
our daily lives.
John understood all too well the importance of genetics in the diagnosis and treatment of
human disease. Too soon after the birth of his and Rita’s youngest son, Jimmy, weakness in his leg
muscles had led to the diagnosis of Duchesne muscular dystrophy (DMD), an affliction due to
mutational changes in the gene coding for vital muscle protein dystrophin. After arrival of recom-
binant DNA technologies made possible the cloning of disease genes, John became hopeful that
some clever gene therapy technique would cure his son. Unfortunately then and even today, the
problem of how to deliver good dystrophin genes to diseased muscle cells remains beyond human
capability.
Temporarily I held out hope to John and Rita that Jimmy’s disease might be curable if one
could find drugs that would greatly increase the synthesis in muscles of eutrophin, a relative of dys-
trophin just discovered in Oxford by Kay Davies. With monies provided by the farsighted head of
the French Muscular Dystrophy Society, Long Island’s new biotech start-up Oncogene Sciences
(now OSI Pharmaceuticals) screened its own proprietary chemical libraries for compounds that
would turn on eutrophin synthesis. Unfortunately, no such molecules were found. 
John became the first investor for Mirus Bio, of Madison, Wisconsin, founded on the princi-
ple that nonviral (i.e., plasmid-DNA-based) methods offer distinct advantages over viral methods
of gene transfer. Following this path, Mirus has pioneered the development of a wide range of non-
viral delivery technologies using proteins, polymers, and lipids in conjunction with novel
chemistries that provide unique nucleic acid delivery capabilities. John served on its board until its
growing success led to its acquisition by Roche Pharmaceuticals in 2008.
Increasingly aware of recombinant DNA’s unique potential for producing much needed new
drugs, John became committed to the nurturing of a cluster of biotech companies in the center of
Long Island. Without John’s leadership, the Broadhollow Bioscience Park at SUNY Farmingdale
would not exist. He was personally involved in securing local and statewide support from the New
York State Legislature, the State University of New York, and key state employees. Most appropri-
x
ately as the first chairman of its board, he worked to bring Cold Spring Harbor Laboratory and
SUNY Farmingdale together to encourage biotech start-ups.
John’s formal involvement with Cold Spring Harbor Laboratory began as a Director of the
CSHL Association in 1988, serving as its President from 1994 to 1997 and at the same time also
serving on the CSHL Board of Trustees. From 2001 to his untimely death on February 1, 2009,
he was appointed an Honorary Trustee, regularly attending its meetings and remaining a sage
source of common sense. While on the board, he served on the Executive Committee, the
Building Committee, the Development Committee, and the Community Relations Committee.
Always aware of the Lab’s need for new monies to expand into new frontiers, John with Rita made
significant gifts to the Double Helix Medals dinner, the Women’s Partnership lunch, the Mary
Lindsay Child Care Center, and the Watson School of Biological Sciences through establishing the
John P. Cleary Visiting Lectureship. Their gift to the Campaign for the Hillside Laboratories let
us recently dedicate the John P. and Rita M. Cleary Lounge in the Les and Jean Quick Laboratory
for Cancer Research.
After graduating from Yale University in 1954 with a B.A. in Economics, he earned his law
degree from New York University Law School in 1961. John was a founding partner of Farrell,
Fritz, Caemmerer, Cleary, Barnosky and Armentano in Uniondale, where he is remembered as a
man of his word with ethics beyond reproach. A trustee of Molloy College from 1979 to 1997,
he served as its Chairman from 1985 to 1998. His long service to Molloy was recognized in 1998
when the college awarded him an honorary LLD.
Through his passing, the Cold Spring Harbor Laboratory lost a passionate voice for biomed-
ical research. We will very much miss his reassuring presence.
James D. Watson
John Cleary      xi
As the year covered by this report came to a close, we reached the end of the new century’s opening
decade. In the brief interval of 10 years, the American economy soared, crashed, and then soared and
crashed again. And yet here at Cold Spring Harbor Laboratory, we remained on a remarkably even keel,
blazing a trail forward on multiple fronts. One of the virtues of scientific research is that it does not come
to an abrupt halt in hard times. Without a doubt, we are able to do more when all of the economic arrows
are pointing upward. But it is a measure of the strength of our institutions that progress in science does
not correlate, at least over the short-run, with the condition of the economy.
The challenges posed by the current recession have been by no means trivial. We have made a con-
certed effort to husband our resources and reduce costs while keeping at full strength the superb faculty
and staff that has put us at the leading edge of discovery. Our base of private donors has risen to the
occasion, as has the federal government, which wisely set aside additional funds for scientific research
as part of a broad economic recovery and revitalization package. Our scientists performed admirably
in the ensuring competition for one-time special funding.
The Laboratory has not simply weathered the storm—it has flourished. Our campus has not contracted
along with the economy during the last year but rather has grown with our burgeoning research capabil-
ities. The magnificently designed Hillside Laboratory buildings opened in June and provided our faculty
with ~40% more space in which to perform their work. We will be adding faculty as funding permits,
thereby enhancing our already world-class programs in cancer, neuroscience, and plant genetics research,
as well as building a new center of expertise in the field of quantitative biology.
All of this is possible because of groundwork we laid in the first years of the decade. Extensive plan-
ning, coupled with both public and private generosity, enabled a plan made in boom times to come to
fruition during a trough. Although I am fond of pointing out that science moves inexorably forward,
it is important to qualify that science of the caliber performed at Cold Spring Harbor Laboratory is
possible only because of careful forethought, periodic assessment of trends in research, and philanthropy
that drives innovation.
As I survey the road ahead, I would be remiss if I did not offer some cautionary words. Although ac-
ademic science has flourished during the past decade, as powerful new technologies have enabled us to
reap the fruits of the many genome sequences that have been determined, the private sector has lagged
behind. Ever since the technology bubble broke at the beginning of the decade, funds for value-added
science have all but disappeared, and in the last few years, venture capital investment in the biomedical
sciences has dropped precipitously. By value-added science, I mean the kind of research and development
activity that adds commercial value to discoveries made by scientists engaged in basic research. Value-
added science was once the purview of early-stage biotechnology companies. In the current environment,
however, such companies are not being formed. Compounding the problem, pharmaceutical investment
in research has also dropped, owing to the recessionary economy and a reduction in corporate income
as major pharmaceuticals have gone off patent. 
During the past decade, scientists at Cold Spring Harbor Laboratory have developed a rich collection
of technologies for discovery and validation of new therapeutic targets, particularly for cancer. This
followed from a deliberate expansion of our research into areas that are closer to the clinic, yet still
strongly rooted in basic discovery. In the coming years, we shall increasingly be contributing to knowl-
edge that is of great potential value to projects of national and global import, particularly in health-re-
lated sciences. But there are other areas in which biology can make a major impact.
This past year, the National Academy of Sciences Board on Life Sciences, of which I am a member, is-
sued a report from a committee cochaired by Thomas Connelly of DuPont Company and Phillip A.
Sharp, CSHL alumnus, MIT professor, and Nobel laureate. The report identified four grand challenges
to which 21st-century biology might contribute in major ways: cultivation of food plants that will sustain
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the growing global population, development of methods with which to sustain ecosystem function and
biodiversity, creation of sustainable and economical alternatives to fossil fuels, and continued progress to-
ward medicines that are increasingly coupled to individual experience and genetics.*
If what the National Academy committee calls the “new biology”—collaborative, multi- and cross-
disciplinary science—is to rise to these challenges, I believe we who perform basic science and guide it
at the institutional level will have to address one internal challenge and advocate for action on a related,
but external, front.
The problem we must address within basic science concerns our relationships, individually and col-
lectively, with private industry. The ability of academia and industry to collaborate has become clouded
by controversy arising from recent disclosures of unreported financial arrangements made between pri-
vate-sector companies, notably large pharmaceutical firms, and a small number of scientists and physi-
cians. What can only be regarded as the undeclared greed of a tiny minority of academic scientists now
imperils the health of the research establishment as a whole. Following the uncovering of a few cases in
which clinicians received large sums of money from industry, sums deliberately hidden from their aca-
demic institutions, and later, from a Congressional investigation of certain medical schools, the entire
academic community was tarred with the same brush. Some members of Congress have now caused the
National Institutes of Health (NIH) to introduce regulatory reforms that are adding more detailed layers
of reporting of conflict of interest. Remarkably, those that violated the previous and reasonable institu-
tional policies have, as far as I know, retained their academic positions. Clearly if the few clinicians who
blatantly violated their intuitional policies had been appropriately disciplined, we might have avoided
the now more burdensome regulations and scrutiny that have been imposed. It is now the situation that
if an academic scientist has a relationship with a company, motives are immediately suspect.
The solution is obvious. Full disclosure must be made by research scientists (and immediate family
members) of all external financial arrangements directly pertinent to their work, including ownership
of company shares, as well as fees from speaking engagements, board service, and the like. This was the
situation in all leading research centers before the recent abuses came to light. Now, reports must be
made to the federal government, with clarifying follow-up questions that seem to me to be feeding a
bureaucracy and not achieving any real purpose. For example, in advising the National Cancer Institute,
I have found the level of disclosure and documentation of personal information required before every
meeting to be excessive. I know of senior scientists who have been counseled not to join such advisory
committees because of the potential criminal liability that is coupled with the requirements for accuracy
of such detailed disclosures. The process has gone too far, as such measures now stand as a disincentive
for well-meaning people to provide advice to the scientific community. The mere fact of disclosure—
publication over the Internet and in publications—will serve to curtail abuses. Beyond the humiliation
that will be visited upon any faculty transgressor, I believe properly documented abuses should be pun-
ished by dismissal or by preventing transgressors from applying for public research funds.
At the same time, it is vital that regulators not choke off the vitality of research activity. Overreaction
would almost certainly have a harmful impact upon discovery and innovation nationwide. Indeed, there
is nothing wrong if basic scientists who make significant discoveries to which commercial value is subse-
quently added, in the process of translation or commercialization, are able to benefit from their contri-
butions. Appropriately, as is now the case, most of the financial benefits that may derive from commercial
research in academia do not go to individual scientists but to the institutions in which they work, so that
it can be plowed back into more research. The public interest will in fact be damaged if scientists and in-
stitutions are discouraged from thinking about practical applications of their own research. 
Those who make discoveries in basic science ought not be prevented or scared away from entering
into partnerships with industry. Rather, they should be encouraged to do so, particularly if we are to ac-
complish the grand challenges that the National Academies report has identified for biology. Collaboration
between academia and industry is also needed if we are to fulfill the promise of basic research under way
2 President’s Report
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today at Cold Spring Harbor Laboratory: cataloging genes and tracing pathways involved in major mental
illnesses, as prelude to the development of diagnostics and next-generation treatments; acquiring a much
deeper understanding of metastasis in cancer and the means of predicting and circumventing resistance
to chemotherapy as a means to identify new therapeutic strategies; laying the groundwork for the thera-
peutic use of gene-regulating RNA interference; and applying results from experimentation in plant de-
velopment to processes such as increasing food production and generating biofuels.
We must also advocate for a solution on a second and related front, equally important to ensure the vitality
of basic science and its translation to value-added research. Since the steep stock market decline of 2002–2003,
private financing for new science-based companies has virtually dried up. Venture capital is not being risked
as much as it was in the past, and the market for initial public offerings for companies that do get started has
essentially ground to a halt. Such an economic climate has greatly reduced a major source of funding that
supported value-added science. One mechanism to overcome the steep decline in small-company formation
is for industry and academic interactions to be made more seamless than they are now. It is important that
publication of basic research results upon which applied science is necessarily based not be delayed by discus-
sions about intellectual property even before such property has been developed. I suggest that improved in-
teractions between academia and industry may be the only way to benefit from the sizable public funding of
research in the United States. Industry must find new ways to develop research interactions with academia
that are more open and collaborative, and academic institutions must limit their appetite for financial benefit,
a concern that often drives them to extended negotiations about intellectual property and financial reward. 
If we are to spur translation of basic biological discoveries, we need to identify better models for aca-
demic–industry collaboration. Such measures could include venture capital investment in research within
academic institutions so that venture capital does not have to bear the substantial costs associated with
establishing a completely independent entity until it is obvious that the research warrants it. Perhaps a re-
view of policies concerning the Small Business Innovation Research (SBIR) grants provided by NIH at
the request of Congress will provide funds for new modes of collaboration. These might enable venture
capital and government to better collaborate in seeding early-stage value-added research within academia
before companies exist. 
Alternatively, large existing corporations and academia should discover new ways of interacting. Cold
Spring Harbor Laboratory now has an interesting partnership between our plant geneticists and the Pi-
oneer Hi-Bred division of the DuPont Company. This entirely above-board relationship represents the
best of two worlds: our basic research and Pioneer’s product development engine. Laboratory scientists
collaborate with company scientists on research of mutual interest. Our scientists benefit from access to
resources that only could be provided within a large corporation, such as the rapid mapping of gene mu-
tations in plants, and company scientists become involved in exciting early-stage research that normally
would not be possible if they were left to work on their own within a corporate development environment.
Early access to new discoveries should enable Pioneer to capitalize on those ideas, ensuring that there is a
path to commercialization for our basic research. We both benefit, as will society, if, for instance, new
methods of boosting crop yields are the result. Such arrangements should not be frowned upon as bene-
fiting industry with taxpayer funds, because the United States economy depends on the success of such
advancements. Otherwise, we will find that published research from United States–based academic insti-
tutions will be commercialized in other countries.
To sum up, scientists must fully and publicly disclose all arrangements from which they stand to
benefit, transgressors should lose their jobs or their ability to seek taxpayer-supported research funds,
scientists should be able to profit from their inventions, and academia and industry must be encouraged
to invent new ways to interact that will ultimately serve the public good.
It would be a supreme irony if Americans regulated themselves out of a world-leadership position
in the sciences. Responsibly managed, basic science can and should provide fuel for entrepreneurialism
in America, a signature attribute of the nation that links scientific discovery with public benefit.
     Bruce Stillman, Ph.D., F.R.S.
     President
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Research
Good scientists know how to judge the relative contributions of their colleagues, peers, and institu-
tions, mostly via a subjective assessment of research. Indeed, it is part of the process of recruiting
new faculty; early-career scientists are judged on their potential for an outstanding research career,
and Cold Spring Harbor Laboratory (CSHL) is known as a place in which such young people excel.
There are, however, some objective criteria, such as the number of times research papers are cited
by colleagues, indicating on average a relatively high impact.
This year, Thompson Reuters, a science publisher well known for its Essential Science Indicators,
again placed CSHL atop a list of 20 “heavy hitters” in molecular biology and genetics selected from
a database comprising more than 42,000 research institutions worldwide.
This particular measure of impact, covering the last 10 years, was based
on the number of times, on average, papers written by a given institution’s
faculty were cited by their peers. Other institutions in the top 20 were
Massachusetts Institute of Technology, Salk Institute for Biological Studies,
Memorial Sloan-Kettering Cancer Center, The Rockefeller University, and
Harvard University. Other rating organizations also place CSHL at the
very top of research institutions worldwide, and CSHL has consistently
been placed as number one in these ratings for the past three decades.
These ratings are not the only measure of research impact, of course, and
we do not use such information when assessing the progress and promo-
tion of our individual scientists. But in general, the rating does reflect the
view I have long held of our institution, based on intimate first-hand
knowledge. An exciting research agenda is part of what makes CSHL a
great place to work. In 2009, our scientists were as productive as ever, a
fact reflected in the highlights of some of the research that appear below.
Mouse Models of Leukemia That Predict Human Response to Chemotherapy
This past year, Scott Lowe and colleagues developed new mouse models for human acute myeloid
leukemia (AML), a devastating cancer of white blood cells. Most patients with AML receive intense
chemotherapy followed by additional chemotherapy cycles or bone marrow transplantation; only a
quarter of patients are cured and most die within a few months. The range in treatment response is
due to AML’s genetic heterogeneity, meaning that the 100 or so mutations associated with this form
of cancer occur in different combinations in each patient and influence therapeutic outcomes in dif-
ferent ways. Scott’s group identified the most commonly occurring mutations in a sample of 111 chil-
dren with AML and then engineered these mutations into mice, which soon developed leukemia. Of
the two most common mutations they observed, one, in an oncogene called AML1/ETO, previously
had been associated with a favorable therapeutic outcome in people; the other, in an oncogene
called MLL, was associated with an adverse outcome. To design an animal model that predicts
these outcomes, the team introduced each mutation individually into stem and progenitor
cells along with another oncogene, called Nras, which also appears frequently in human AML
and is commonly found in concert with AML1/ETO and MLL oncogenes. These altered
stem cells were transplanted into mice pretreated with radiation to destroy existing bone mar-
row cells. The altered stem cells then took over the “host” bone marrow and promoted the
development of leukemia, which, within weeks, showed the same genetic and pathological
features as human AML. Just as in humans, leukemias in mice that received the AML1/ETO
oncogene were also sensitive to chemotherapy and soon regressed, whereas MLL-triggeredS. Lowe
CSHL ranked number one for worldwide impact in
molecular biology and genetics
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leukemias remained resistant and eventually killed their hosts. These findings suggest that such models
can predict how human cancers will respond to therapy and help to identify genes promoting resistance
or sensitivity to any cancer drug. The mouse models also serve as an effective test system for new drugs
and treatment strategies. Indeed, CSHL Fellow Chris Vakoc, in collaboration with Scott’s laboratory,
is now searching for new therapeutic targets for the MLL form of leukemia.
A Protein That Blocks Progression of Malignant p53-deficient Tumors 
More than half of all human cancers have mutations that disable a protein called p53. The product
of a master tumor-suppressor gene by the same name, p53 is central in several cancer-fighting oper-
ations within cells. When cells lose p53, tumors grow aggressively and often cannot be
treated. But this past year Alea Mills and colleagues demonstrated that there is a chink in
the armor of p53-deficient tumors—a protein called TAp63, the product of a gene called
p63, which Alea discovered as a postdoctoral student a decade ago. The p63 gene is usually
intact and not mutated in most cancers. Mills and her team succeeded in shutting off growth
in tumors in which p53 is missing by turning up the production of TAp63 proteins; it com-
pletely blocked tumor initiation by inducing senescence, a state of growth arrest in which
tumor cells are still metabolically alive but fail to divide. More importantly, turning up the
levels of TAp63 in p53-deficient cells blocked the progression of established tumors in mice.
As Alea suggests, this means that we now have a model of how to attack refractory human
cancers that have damaged p53.
A Drug Candidate for Treating Spinal Muscular Atrophy
Spinal muscular atrophy, or SMA, is a devastating illness, and although quite rare, it is nevertheless the
leading genetic cause of death in infants. It is caused by mutations in a gene called Survival of Motor
Neuron 1 (SMN1), which cause levels of SMN protein in the motor nerve cells of the spinal cord to
diminish. These nerve cells, or neurons, are the cells that control muscle activity, and without the pro-
tein, they degenerate. Infants born with SNM1 mutations progressively lose the ability to move, swallow,
and breathe. There are no approved therapies for SMA. This year, we were excited to learn that Adrian
Krainer’s lab, in collaboration with colleagues at Paratek Pharmaceuticals and Rosalind Franklin Uni-
versity of Medicine and Science, has identified a tetracycline-like compound that stimulates SMN pro-
duction by altering RNA splicing. Called PTK-SMA1, it is the only small molecule known
to specifically alter RNA splicing by directly and solely targeting the splicing reaction. The
team confirmed that the effect of PTK-SMA1 on RNA splicing and exon inclusion ultimately
results in increased levels of full-length and functional SMN protein. The compound boosted
protein levels in cells isolated from SMA patients and cultured in lab dishes. The team also
proved its ability to work in vivo by injecting it into mice carrying a human SMN2 gene. The
mice showed a more than fivefold increase in human SMN protein levels within a week of
treatment. Adrian and colleagues will next tackle the questions of how PTK-SMA1 redirects
RNA splicing and will seek a way of getting it across the blood-brain barrier and into affected
neurons in the spinal cord. His laboratory is also working on other therapeutic strategies for
SMA that look very promising
Small RNAs That Protect the Germline
CSHL is at the forefront of research on small RNAs. Two fascinating studies published by our fac-
ulty this past year reveal the vital role played by these tiny bits of nucleic acid in the defense of the
germline, in very different species. Rob Martienssen led a team that looked at sperm cells in plant
pollen grains. In this setting, sperm are cocooned within larger “companion” cells, called pollen
vegetative cells. It has long been known that the companion cells provide sperm with energy and
help move them to their targets during fertilization. Rob’s team determined that they also provide
sperm with instructions that protect their DNA from damage and thus help pass on a stable genome
A. Mills
A. Krainer
to the next generation. The instructions offered to sperm specifically come in the form of
small RNA molecules that companion cells pass on to sperm. These small RNAs can inac-
tivate, or “silence,” specific DNA sequences. In this way, they help set up gene expression
patterns in sperm, providing the next generation with instructions that specify which re-
gions of the genome should be turned on and which should be switched off and protect
the sperm from expressing genes that might be detrimental when the pollen fertilizes cells
for the next generation.
A separate study by Greg Hannon and colleagues examined how the germline in fruit
flies is protected from genetic parasites called transposons. These bits of DNA sequence
have infiltrated host genomes over the eons and can cause damage by copying and inserting
themselves in random fashion across genomes, disrupting genes and regulatory sequences.
To protect themselves from transposons, animal germline cells have developed a molecular
immune system, operated by an army of small RNA molecules called Piwi-interacting
RNAs (piRNAs) and a set of proteins belonging to the Piwi family. Greg’s team discovered
that in the ovaries of fruit flies, nongermline, or “somatic cells,” that surround germline
cells have also developed an antitransposon defense system. Over the years, fruit fly re-
searchers have uncovered genomic mutations that lead to sterility and abnormal develop-
ment. Because these defects could have been caused by unchecked transposon activity,
mutant flies are a good experimental resource to uncover exactly how piRNA pathways
work and how they might get disrupted. Hannon’s team analyzed eight such mutants,
showing how the genes disrupted in each mutant impact the piRNA pathway and how it
alters the type and number of piRNAs that cells are able to generate. These studies help us
understand the broad picture of how the piRNA pathway has been genetically stitched together to
perform its vital role in protecting the germline and genetic information that will be passed from
parents to the next generation.
Mobile Small RNAs That Set Up Leaf Patterning in Plants 
Anyone who has taken the time to carefully inspect a plant leaf knows that the top and bottom sur-
faces are not quite the same. In fact, this difference is the product of a developmental program that
establishes an asymmetry crucial for the leaf’s function: It ensures that the leaf develops a flattened
blade optimized for energy production by photosynthesis, with a top surface specialized for light
harvesting and a bottom surface containing tiny pores that serve as locales for gas exchange. Plant
scientists have known that the top/bottom axis is established by a signal derived from the meristem,
the stem cell-rich growing tip of the plant from which all new leaves arise. Other signals
that traffic between the upper and lower sides of the leaf are thought to stably maintain
this polar axis. In 2009, Marja Timmermans and her team were the first group to uncover
the identity of one such positional signal—a family of mobile small RNAs generated on
the upper surface of young leaves but which traffic to form a concentration gradient across
each leaf.  This graded distribution pattern of small RNA molecules creates discrete regions
of gene activity so that cells in each half of a leaf develop a distinct “top” or “bottom” iden-
tity. Besides providing a remarkable example of a morphogen-like small RNA signal, Marja
and her team have also shown that the location of the various biochemical ingredients re-
quired for small RNA activity can impact pattern formation. Together, their discoveries
explain how mobile small RNAs can generate leaf patterns during development.
Identification of a Protein That Enhances Long-term Memory
by Controlling Rest Periods
Students everywhere—those who study, at any rate—know from experience that studying improves
memory, but only under certain conditions. Facts are preserved longer in memory if a student spaces
out learning sessions between rest intervals. This past year, Yi Zhong and his team discovered how
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this so-called “spacing effect” is controlled in the brain at the level of individual molecules.
Yi has long been interested in genes that when mutated trigger learning and memory disor-
ders such as Noonan’s syndrome, a rare genetically inherited disease. More than half of Noo-
nan’s patients have mutations in a gene called PTP11, which encodes the SHP-2 phosphatase
protein. In contrast to many disease-related mutations that shut off protein production or
impair protein activity, these PTP11 mutations do the opposite—they boost the activity
levels of SHP-2 phosphatase. To understand how this change impedes long-term memory,
Zhong’s team engineered these mutations into a gene in fruit flies called corkscrew that is
the functional equivalent of PTP11 in humans. The team found that normally, as each learn-
ing period ends, SHP-2 phosphatase activity inside stimulated neurons triggers a wave of
biochemical signals, which have to peak and decay before the next learning session can begin.
They discovered that the repeated formation and decay of the biochemical signal during each rest
interval induces long-term memory.  In normal flies, these signal waves took 15 minutes to peak and
decay. In the mutants that had excess protein activity, however, the signaling wave took 40 minutes
to decay. This research shows it is crucial that the period of rest should last as long as it takes for a
signal wave to form and reset. Yi’s team succeeded in reversing memory deficits in mutant flies, by
reducing the activity of mutated SHP-2 phosphatase to normal levels with drugs or simply altering
training regimens to include 40-minute rest intervals instead of the normal 15 minutes. These results
suggest a potential means with which to address memory impairments in an illness such as Noonan’s
syndrome.
Structure of the NMDA Subunit Reveals Target for Drugs Against 
Neurological Diseases 
Hiro Furukawa and colleagues obtained crystal structures this year for one of several subunits of the
NMDA (N-methyl-D-aspartate) receptor.  This receptor type is one of a family that mediates exci-
tatory transmission in nerve cells in the brain. One theory of causation in Alzheimer’s, Parkinson’s,
and multiple sclerosis posits that excessive amounts of the excitatory neurotransmitter glu-
tamate can cause an overstimulation of glutamate receptors, including the NMDA recep-
tor. Such excitotoxicity, the theory holds, can cause nerve cell death and subsequent
neurological dysfunction. The search is well under way for molecules that can shut down
the NMDA receptor. To do so in a highly specific manner—one that would potentially
carry lower risk of unwanted side effects—we need a precise map of the receptor and its ac-
tive sites at the level of individual atoms. Hiro’s team focused on a portion of the extracel-
lular domain of the receptor, a subunit called NR2B. It includes a domain of particular
interest called the ATD (the amino terminal domain), whose structural distinctiveness makes
it a potentially attractive target for future drugs. Hence, the importance of the team’s
achievement: A crystal structure revealed by the powerful light source at nearby Brookhaven
National Laboratory that shows the ATD to have a clamshell-like appearance that proves to be im-
portant for its function.  Work can now proceed on rational design of a drug that can precisely bind
the ATD within what Hiro and colleagues call its “clamshell cleft,” based on the crystal structure
they have obtained.
Roles of a Key Protein, Associated with Mental Retardation, 
on Both Sides of the Synapse 
This past year, Linda Van Aelst and colleagues demonstrated the mechanism by which a signaling
protein found throughout the brain controls the maturation and strength of excitatory synapses, the
tiny gaps across which the majority of neurons communicate. The discovery is important, in part,
because deficits of the signaling protein in question, called oligophrenin-1 (OPHN1), have previously
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been associated with X-linked mental retardation. Indeed, problems at the synapse—in their
formation and in the mechanisms through which the strength, or plasticity, of their con-
nections are regulated—are thought to contribute to numerous mental and neurological
disorders. Linda points out that at least 280 genes have already been implicated in metal re-
tardation. But what we have not done, to date, is connect the genetic abnormalities to bio-
logical processes that establish and modify the function of neuronal circuits. Previously,
Linda had shown that dendritic spines—knoblike structures that protrude from a neuron’s
branch-like dendrites and receive signals across synapses from the axons of other neurons—
are short and misshapen when expression of the OPHN1 gene is acutely reduced.  Her
team’s new experiments showed that the OPHN protein is not essential for the formation
of dendritic spines, but it is needed for the proper maintenance of their structure. Impor-
tantly, in this maintenance function, the OPHN1 protein was found to have a key role both in the
maturation of excitatory synapses and in their plasticity, or ability to vary in strength. In related ex-
periments, focusing on the presynaptic side of the gap between nerve cells, they found that OPHN1
also helps neurons to transmit messages, by controlling the recycling of synaptic vesicles in presynaptic
terminals. This suggests that symptoms of X-linked mental retardation could stem not only from
having both immature and deformed dendritic spines, but also from inefficient neuronal vesicle re-
trieval and recycling.
A Reference Genome for Maize
In late 2009, a 4-year, multi-institutional effort co-led by three CSHL scientists culminated in pub-
lication of a landmark series of papers in the journal Science revealing in unprecedented detail the
DNA sequence of the maize plant. Maize, or corn, as it is commonly called in North America, is
one of the world’s most important plants and the most valuable agricultural crop grown in the United
States, representing $47 billion in annual value. The sequence spans 2.3 billion DNA base-pairs and
contains ~32,500 genes, or about one-third more than the human genome. This version of the maize
genome—taken from a variant called B73—is regarded by the scientific and agricultural communities
as a reference version. Doreen Ware, one of the CSHL coprincipal investigators, contributed impor-
tant annotation and evolutionary analysis. In a parallel effort, Doreen’s CSHL team also helped gen-
erate a draft haplotype map of maize, in collaboration with the USDA. As in humans, the maize
HapMap gauges genomic diversity by comparing distinct individuals—in this case, 27 maize lines—
with the reference version. Dick McCombie and Rob Martienssen were the other CSHL coprincipal
investigators on this important project. Having the sequence and a HapMap of this critical plant
will enable scientists to find genes associated with quantitative traits—genes that affect traits of im-
portance to agriculture, everything from the size of the seeds to when the plant flowers to whether it
can tolerate drought or dampness. This may help plant scientists develop maize varieties that will
thrive as the planet warms in the period ahead.
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Likely Origin of Facial Cancer Decimating the Tasmanian Devil Population
An international team led by Greg Hannon and his former student, Elizabeth Murchison, of CSHL
and the Australian National University, succeeded in identifying the likely point of origin for the
deadly facial tumors decimating Australia’s Tasmanian devil population: Schwann cells, cells of the
nervous system which form a tissue type that cushions and protects nerve fibers. The discovery stems
from the team’s effort to carry out a genetic analysis of tumor cells in devil tumor facial disease.
DFTD is a unique type of cancer transmitted from animal to animal via biting or other physical
contact. Tumors in the canine-sized devils are mostly found on the face and mouth, but they often
spread to internal organs. With no diagnostic tests, treatments, or vaccines currently available, the
aggressive disease could wipe out the Tasmanian devil species, which is found only on that island-
state of Australia, in 25 to 35 years. The largest surviving marsupial carnivores, the devils have become
a cause célèbre for conservationists worldwide. Greg and his team determined the identity of the
originating cell by using advanced sequencing technology to uncover the tumors’ transcriptome—
the complete set of genes that are turned on in tumor cells. Comparing this readout to that from
other tissues, they found that the tumors’ genetic signature best matched that of Schwann cells.
Armed with the tumors’ genetic profile, researchers now can start hunting for genes and pathways
involved in tumor formation. A catalog of devil genes compiled by the Hannon–Murchison team
should be useful in designing vaccines and other therapeutic strategies.
Cold Spring Harbor Laboratory Board of Trustees
The Board of Trustees elected three new members this year: Michael R. Botchan, Ph.D., Goldman
Professor and Chair of the Department of Molecular and Cell Biology, University of California,
Berkeley, and a former faculty member at CSHL; Thomas Quick, President of First Palm Beach
Properties, Inc., who begins a second period as Trustee; and Samuel L. Stanley, Jr., M.D., the fifth
president of Stony Brook University. 
In addition, the Board named Nancy Marks as an Honorary Trustee. Nancy served on the board
as a Trustee from 2004 to 2009 and participated in the Development Committee (2004–2006),
the Capital Campaign Committee (2006–2008), and the Building Committee (2000–2009).
Congratulations to CSHL Scientific Trustee Charles L. Sawyers, M.D., chair of the Human On-
cology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, who in September
received the 2009 Lasker-DeBakey Clinical Medical Research Award for groundbreaking work on
the treatment of chronic myeloid leukemia. 
CSHL mourned the passing of Honorary Trustee John P. Cleary, Honorary Trustee, early in the
year. John and his wife Rita made significant philanthropic contributions toward the research and ed-
ucation mission of the Laboratory, recently supporting the expansion of CSHL’s research infrastructure
and the creation of the Broad Hollow Bioscience Park to promote biotechnology research on Long Is-
land. 
The CSHL community also grieved for Trustee Donald Everett Axinn who died in November
2009. The Donald Everett Axinn Laboratory opened this year as part of the largest construction
project ever undertaken by CSHL. The successful completion of this building project was in large
part due to Don’s support and guidance. 
I thank the CSHL Board of Trustees for its leadership and generosity in the successful completion
of the Capital Campaign, which began in 2005 with a goal to raise $200 million to realize a 40% ex-
pansion of the Laboratory’s research capacity. With significant contributions from our Trustees, we
surpassed the original goal and raised $340 million over the period of the Capital Campaign. In June
2009, we celebrated the dedication of the six new buildings that make up the new Hillside Laboratories. 
The Cold Spring Harbor Laboratory Association, under the leadership of president Tim Broad-
bent, had a successful year, raising $4.8 million of critical unrestricted funds to support early-career
scientists at CSHL. Events that contributed to this achievement included the Double Helix Medals
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Dinner, which alone raised more than $3 million; the President’s Council, which raised over
$375,000; and the Women’s Partnership for Science luncheon, which raised close to $50,000. The
balance was contributed by CSHL Association members.
On behalf of CSHL, our Board of Trustees, and our Development Department, I thank all those
who helped us achieve our goals. Private philanthropy is the engine of innovative research, and your
contributions are pushing the boundaries of science forward. Please refer to the back of this Annual
Report for a complete list of our generous supporters.
Research and Education Management
Our research and education management teams performed exceedingly well in the face of the chal-
lenges that the world financial crisis presented. CSHL’s investigators and administrators worked
closely to effectively manage existing programs under conditions where we had to cut our budget
mid year. In an unprecedented team effort, CSHL secured more than $22 million in federal stimulus
grants issued under the American Recovery and Reinvestment Act (ARRA). These 2-year funds will
support research in cancer, neuroscience, epigenetics, and plant biology, as well as research training
and laboratory enhancements. 
In applying for research grants, applicants were encouraged to develop innovative and bold ideas in
relatively short grant proposals. CSHL scientists had a 30% success rate in securing ARRA grants, much
higher than the national average. I suspect that this is because much of our innovative science is sup-
ported by philanthropy or by internal endowment funds, and our scientists are used to proposing bold
ideas. If such proposals were submitted in normal individual research grant proposals (the so-called
RO1 mechanism), such ideas would invariably be shot down and not funded. Perhaps this is a lesson
of how the National Institutes of Health (NIH) should consider funding some science in the future. 
True to CSHL’s legacy as a breeding ground for the latest technologies and approaches to solving
biological questions, CSHL secured special 5-year grants for “transformative” research projects. Our
researchers Josh Dubnau, Ph.D., and Partha Mitra, Ph.D., received these grants for neuroscience
projects that the NIH deemed “exceptionally innovative, high-risk, original, and/or unconven-
tional… [with] the potential to create new or challenge existing scientific paradigms.” 
We were also encouraged by a pledge of continued support to stem cell research from New York Gov-
ernor David A. Paterson, who visited CSHL in October with State Health Commissioner Richard F.
Daines, M.D., in order to be briefed on stem cell research projects by CSHL investigators Drs. Linda
Van Aelst, Grigori Enikolopov, Marja Timmermans, and CSHL Clinical Fellow Dr. Johannes Zuber.
The CSHL Scientific Advisory Council (SAC) met for the first time this year in March, lending
third-party scientific expertise to help CSHL continue to maintain its global leadership position in
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research and education. To provide the SAC with requisite background, the CSHL leadership de-
voted a number of sessions to a broad overview of the research, environment, and philosophy of
CSHL. Several other sessions were devoted to discussions of specific questions and topics that CSHL
senior administration had provided in advance of the meeting. In addition, SAC members met with
both postdoctoral fellows and graduate students and held a session open to all CSHL faculty. The
meeting ended with the SAC members providing helpful recommendations and feedback on specific
issues related to research at CSHL. I thank the SAC Chair Fred Alt and all the members of the com-
mittee who provided very valuable advice.
CSHL Education Programs
CSHL’s Watson School of Biological Sciences (WSBS) marked its first decade on April 26, graduating
five new Ph.D.s: Allison Blum, Daniel Chitwood, Shu-Ling Chiu, Keisha John, and Jeremy Wilusz.
SarahJane Locke received the Master of Science degree. This year brings the total number of WSBS grad-
uates thriving in the outside world to 35. I am particularly pleased that even in its short history, six grad-
uates of the school already have faculty positions at major universities or research
institutes, supporting our thesis that the path to scientific independence need not
be long.
The 2009 Commencement Convocation ceremony
also conferred honorary degrees upon individuals who
have made remarkable contributions to CSHL’s wide-
ranging and innovative education programs, including
the Dolan DNA Learning Center, the Undergraduate
Research Program, the CSHL Press and our advanced
courses, and the Watson School of Biological Sciences:
David Micklos, Alfred Goldberg, Jeffrey Miller, and
Winship Herr, each of whom has made remarkable
contributions to educational programs at CSHL. 
CSHL’s advanced scientific course offerings ex-
panded into new facilities that were supported by the Howard Hughes Med-
ical Institute. This new laboratory enables our advanced courses to expand
teaching on brain anatomy and neural networks, cognition and behavior. 
The 74th CSHL Symposium, “Evolution: The Molecular Landscape,” cel-
ebrated Charles Darwin’s 200th birthday and the 150th anniversary of his
revolutionary work, On the Origin of Species. Approximately 400 scientists
gathered at this 6-day-long conference to discuss a wide range of evolution-
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themed topics, ranging from the origins of life on a molecular scale to the emergence of species both
simple and complex over the last three billion years. 
The reputation of CSHL’s Meetings and Courses Program continues to grow, as evidenced not
only by attendance, which reached a record of 6500 this year, but also by external, independent rat-
ings. The September 2009 edition of the magazine Genome Technology ranked CSHL’s “Biology of
Genomes” meeting as “the most recommended” among general genomics meetings. Another CSHL
meeting called “Genome Informatics” was the “most recommended” in the Bioinformatics/ Infor-
mation Technology category.
Cold Spring Harbor Laboratory Conferences Asia convened its first meeting in Suzhou, China
in November. This invitation-only Banbury-style meeting was held in temporary facilities while our
purpose-built conference center was being completed. The meeting focused on transgenic crops and
served as a prelude to the opening of a complete program of large-scale meetings on a wide range
of topics in the biological sciences in 2010. The $70-million 600,000-square-foot conference center
can accommodate up to 500 participants.
The Dolan DNA Learning continues to blaze new trails in web-based educational experiences.
This year, DNALC’s BioMedia Group launched “Genes to Cognition Online” (www.g2conline.
org), which is distinguished by both its content and its presentation on the web. The site uses a
unique approach to depict the complex and interlocking relationships between different aspects of
brain anatomy and function. Just as the brain itself is composed of interconnected networks
of cells, the site graphically represents information about these components as members of a
vast network, whose nodes are interconnected. 
The BioMedia Group also produced an exciting iPhone application that can be download
for quick and easy access to a three-dimensional model of the brain and its functions. Rapidly,
this application became one of the top educational tools downloaded to iPhones.
The CSHL Press published Cold Spring Harbor Perspectives in Biology, a new online publication
spanning the complete spectrum of the molecular life sciences. Each issue includes reviews cov-
ering a wide variety of topics in molecular, cell, and developmental biology, genetics, neuroscience,
immunology, cancer biology, and molecular pathology. Contributions are written by leading re-
searchers in each field and commissioned by a board of eminent academic editors.
Awards and Honors
Many of CSHL’s younger researchers received prestigious awards this year, recognizing their early-
career accomplishments. Adam Kepecs was made a Klingenstein Fellow in Neurosciences and was
also named an Alfred P. Sloan Research Fellow. Adam’s laboratory is combining its behavioral ex-
pertise with molecular and optical techniques to monitor and manipulate genetically identified cir-
cuit elements in behaving mice. Bo Li received a Dana Foundation Award to investigate how
hyperactive brain synapses may be key to understanding depression and formulating a treatment.
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Zach Lippman won a Human Frontier Science Program Career Development Award to continue
his work in understanding the molecular dynamics that underlie altered developmental fates of cer-
tain plant meristems. Pavel Osten received the McKnight Technological Innovations in Neuroscience
Award for his use of novel imaging technology to map changes in neural circuits in mice that carry
genetic mutations linked to autism and schizophrenia. Grisha Enikopolov was the recipient of the
Ellison Foundation Senior Scholar Award. 
Lin He, a former CSHL postdoctoral fellow was named a MacArthur Fellow by the John D. and
Catherine T. MacArthur Foundation. She was honored for advancing our understanding of
the role of microRNAs in the development of cancer and laying the groundwork for future
cancer treatments. 
Former CSHL Fellow and Faculty member Carol Greider, along with her colleagues Eliz-
abeth Blackburn and Jack Szostak, won the 2009 Nobel Prize for Physiology or Medicine
for discovering how chromosomes are protected during cell division by telomeres and the
enzyme telomerase. During her fellowship from 1988 to 1990, Dr. Greider identified the
RNA component of the enzyme telomerase that adds DNA to the ends of chromosomes.
She continued her research career as a member of the CSHL faculty from 1990 to 1997 and
is currently Daniel Nathans Professor and Director of Molecular Biology and Genetics at
the Institute for Basic Biomedical Sciences at Johns Hopkins School of Medicine. 
Development
For the eighth consecutive year, CSHL earned a four-star rating for sound financial practices from
the philanthropic evaluator Charity Navigator. Only 1% of the approximately 5000 nonprofit or-
ganizations analyzed by Charity Navigator have achieved this milestone.
Building Projects
Congratulations to the entire team of CSHL Facilities Department staff and the many Long Island
craftsmen and women who were part of the Hillside Laboratories complex project. The construction
of the largest building project in CSHL history was completed this year—on schedule and within
Highlights of the Year      13
P. OstenZ. LippmanA. Kepecs B. Li
C. Greider, winner of the
2009 Nobel Prize for Physiol-
ogy or Medicine
CSHL received Charity Navigator’s highest rank for the eighth consecutive year
budget. Commissioning of the Hillside Laboratory buildings was accomplished, with the new Si-
mons Center for Quantitative Biology and the relocated operations of the CSHL Cancer Center
occupying finished space. The Hillside Laboratories complex also contains an additional animal fa-
cility that was brought on line in 2009. The CSHL Information Technology Department and an
updated and expanded datacenter were relocated to the Hillside complex. This is the new home of
the High Performance Computing Center (HPCC)—CSHL’s very own supercomputer. 
For 120 years, CSHL has been a proud steward of the Long Island shoreline and local ecosystem.
The design and construction of the Hillside Laboratories demonstrates our continued commitment
to the environment. The new facilities were designed to be 30% more efficient than standards set
by the American Society of Heating, Refrigeration, and Air-Conditioning Engineers (ASHRAE).
With help from the Long Island Power Authority (LIPA), CSHL successfully reduced the environ-
mental footprint of the new facilities and reduced energy costs associated with facility operations.
The total cost of electrical energy efficient measures incorporated into the project was $1,057,022,
which was offset by a $224,940 Commercial Construction rebate from LIPA.
The Hillside Laboratory complex also breaks ground architecturally. The project won the Plat-
inum Award from the American Council of Engineering Companies of New York for Excellence in
Engineering for outstanding design. The awards ceremonies were held in March 2010 at the Waldorf
Astoria Hotel in New York City.
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Campus view from Cold Spring Harbor Village
In addition to the new construction on the upper campus, we completed scheduled improve-
ments to the ca. 1927 Delbruck Laboratory building’s historic teaching lab space. The project,
which was made possible by funds from the Howard Hughes Medical Institute, included recon-
struction of the top floor and roof of the building and the renovation and expansion of an existing
conference room. 
Across the harbor at the Banbury Conference Center in Lloyd Harbor, we also completed the
interior renovations to the ca. 1937 Robertson House, which provides lodging for visiting scientists
who attend Banbury meetings and participate in CSHL’s advanced courses on the latest scientific
technologies and techniques. Installation of modern HVAC, electrical, and data systems now make
the manor house comfortable for guests throughout the entire year. 
The reconstruction and addition to the Carnegie Building, which is home to the CSHL Library
and Archives and The Genentech Center for the History of Molecular Biology, was largely complete
by the end of the year. We look forward to the official reopening of the building in the spring of 2010.
At the Genome Center in nearby Woodbury we constructed a new, state-of-the-art greenhouse
to allow for an expansion of our plant biology program that is being led by a new faculty member,
Zachary Lippman, Ph.D., who studies varieties of tomato plants to understand the mechanisms
that control flower, fruit, and seed production. 
To increase operational efficiency across the expanding Laboratory, we are leasing a facility in
Syosset that allows us to centralize receiving, storage, and fulfillment operations. This facility also
provides needed office and administrative space.
Special Events
• Gavin Borden Visiting Fellows. The 15th Annual Gavin Borden Visiting Fellow Lecture, in
memory of the publisher of Molecular Biology of the Cell, was held on March 24. The lecture was
presented by Ralph J. Greenspan, Senior Fellow in Experimental Neurobiology, Lewis B. and
Dorothy Cullman Senior Fellow, The Neurosciences Institute, San Diego, California.
• Symposium. During the 74th Symposium, “Evolution: The Molecular Landscape,” the tradi-
tional Dorcas Cummings Memorial Lecture for scientists and guests from the community was
delivered by Kevin Padian, Professor of Evolutionary Biology and Paleontology, University of
California, Berkeley. The title of the lecture was “Darwin, Dover, and Intelligent Design.”
• Women’s Partnership for Science. On June 14 at Peacock Point, at the Lattingtown home of
Mr. and Mrs. Daniel P. Davison, nearly 140 women lunched and learned about the link between
viruses and cancer, specifically human papillomavirus (HPV), a prime cause of cervical cancer.
The speakers included the Dean of the Watson School of Biological Sciences and Howard Hughes
Highlights of the Year      15
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Medical Institute Investigator, Leemor Joshua-Tor, Ph.D., and Felicia
Callan, M.D., obstetrician/gynecologist at the Mount Sinai School of Med-
icine/North Shore Medical Group. Money raised at this event supports
women who pursue careers in biomedical research at CSHL.
• Hillside Laboratories Opening. On June 12, CSHL dedicated the Hillside
Laboratories, with remarks from Chairman of the CSHL Board of Trustees
Eduardo Mestre; Chancellor Emeritus Jim Watson, Ph.D.; Bill Grover,
FAIA, founding partner of Centerbrook Architects and Planners; and myself.
The keynote address, “Thoughts on the Future of Biological Sciences,” was
delivered by Philip A. Sharp, Ph.D., Nobel laureate, University Professor,
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology.
• The President’s Council. CSHL Board Chairman Eduardo Mestre and his wife Dr. Gillian Shep-
herd hosted an April 16 reception to announce the theme of the members-only 2009 President’s
Council program: “Personal Genomes.” Special guests at this Manhattan event were Linda Avey
and Anne Wojcicki, co-founders of the genome sequencing company 23andMe. The annual fall
President’s Council retreat was held on October 16-17 and featured Peter Neufeld, co-founder
and -director of The Innocence Project. Other speakers that weekend included: David Botstein,
a geneticist and CSHL Scientific Trustee; Esther Dyson, whose own genome was among the first
sequenced in the Personal Genome Project; Elaine Mardis, Co-Director of The Genome Center,
Washington University School of Medicine; Dr. Philip Marshal of WebMD Health Services; and
CSHL Assistant Professor Gurinder “Mickey” Atwal. 
• The Double Helix Medals Dinner. The 4th Double Helix Medals Dinner was held at the Man-
darin Oriental Hotel in Manhattan on November 10. Medals for Scientific Research were
presented to Herbert W. Boyer, Ph.D. and Stanley N. Cohen, M.D., who co-discovered re-
combinant DNA. Life-long philanthropist and advocate for research Kathryn W. Davis,
Ph.D., was honored for Humanitarianism. In recognition for his unprecedented support of
biomedical research, Maurice “Hank” Greenberg was presented with the medal for Corporate
Philanthropy. Violin virtuoso Joshua Bell performed with accompaniment by pianist Frederic
Chiu. The event was cochaired by Mr. and Mrs. Eli Broad, Mr. and Mrs. Christopher Davis,
Ms. Florence A. Davis, Mr. and Mrs. Edward E. Matthews, and Dr. Richard H. Scheller.
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President’s Council members Thomas Lehrman, Kristina Perkin Davison, Judy Car-
many, and George Carmany (front row, left to right) discuss personal genomes
Double Helix Medal
• The Lorraine Grace Lectureship on Societal Issues of Biomedical Research. On November 29,
science journalist Nicholas Wade, Ph.D., presented the first annual lecture, introducing his newly
published book, The Faith Instinct—How Religion Evolved and Why It Endures.
CSHL Public Lectures
March 23—William C. Mobley, M.D., Ph.D.: The Future of Down
Syndrome: Improving Memory and Cognition, sponsored by the Na-
tional Down Syndrome Society and the Down Syndrome Connec-
tion of Long Island.
April 27—Josh Dubnau, Ph.D., CSHL Assistant Professor: Memo-
ries of a Fly: What a Fly’s Brain Can Teach Us About Our Own.
May 26—Darwin Commemorative Lecture: Sean Carroll, Ph.D.,
Professor of Molecular Biology, Genetics and Medical Genetics, Uni-
versity of Wisconsin, Madison: Remarkable Creatures: Epic Adventures
in the Search for the Origin of Species.
September 17—Rob Martienssen, Ph.D., CSHL Professor: Designing
Bioenergy Crops: Developmental Problems and Genetic Solutions.
October 13—Scott Lowe, Ph.D., CSHL Professor and HHMI In-
vestigator: Cancer Research at Cold Spring Harbor Laboratory: Our
Latest Successes and the Road Ahead.
October 22—Senthil Muthuswamy, Ph.D., CSHL Assistant Pro-
fessor: Breast Cancer Research in 3-D: A New Way of Looking at How
Tumors Develop.
CSHL Public Concerts
April 17—Irina Muresanu and Dana Ciocarlie, violinist and pianist
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Sean Carroll, author of Remarkable Crea-
tures, presented the Darwin Commemo-
rative Lecture at CSHL
May 1—Michelle Cann, pianist
May 15—Frederic Chiu, pianist
September 4—Margarita Shevchencko, pianist
September 11—Steven Beck, pianist
September 25—Ken Noda and Tamara Mumford, pianist and mezzo soprano
October 2—Inbal Segev, Dmitri Berlinsky, and Elena Baksht, cellist, violinist, and pianist
October 9—Daria Rabotkina, pianist
Laboratory Employees
New Staff 
This year, we welcomed two new Assistant Professors: Stephen Shea and
Mikala Egeblad. Stephen Shea received his Ph.D. from University of
Chicago in 2004 and completed his postdoctoral fellowship at Duke Uni-
versity. Stephen studies the neural circuitry of social communication and
decisions. His laboratory’s efforts are directed at answering a number of re-
lated questions such as: What are the neural mechanisms for interpreting
social information and selecting appropriate behaviors? How do we discrim-
inate and remember familiar individuals? How do emotion and social con-
text shape our attention and memories? And how are social cues
from our various senses integrated to shape behavioral decisions?
Stephen directly addresses these questions using natural social com-
munication behavior in mice. 
Mikala Egeblad joins us from University of California, San Francisco, where she was an
Assistant Researcher. Mikala received her Ph.D. from the University of Copenhagen and
the Danish Cancer Society in 2000. Her work addresses the challenge of separating func-
tions and behaviors of the different stromal components of the tumor. In her lab, she uses
mouse models of breast cancer and powerful real-time imaging of cells in tumors in live
mice. This enables her to follow the behaviors of and the interactions between cancer and
stromal cells in tumors during progression or treatment.
Promotions 
Congratulations to Marja Timmermans, Ph.D., who was promoted this year
to full professor, and to Alexander Krasnitz, Ph.D., who was promoted to
assistant professor.
Departures
In 2009, several faculty members left CSHL for appointments in other parts
of the country. Jacek Skowronski is now a professor at Case Western Reserve
University, School of Medicine. William Tansey is a professor at Vanderbilt
University. Tim Tully is Chief Science Officer at Dart Neuroscience. 
Community Outreach
In addition to the Cultural Series of concerts and lectures for the public that we organize each year
in cooperation with local organizations, CSHL continues to be an active participant in the com-
munity here on Long Island. We are also becoming an increasingly visible part of science-related
action in New York City. 
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Last year, our campus welcomed 30 community-based groups as part of a program that is staffed
by a very energetic team of CSHL students and postdocs. Thanks to them, attendance in our reg-
ularly scheduled Saturday morning walking tours for the public had a waiting list! The Dolan
DNA Learning Center’s hands-on Saturday programs and summer camp sessions continue to sell
out. 
Seven Long Island high school seniors recommended by their school’s science chairs were selected
for this year’s Partners for the Future program at CSHL. These promising young people worked
hand-in-hand throughout the school year on real experiments with some of CSHL’s top scientists:
Drs. Tony Zador, Josh Huang, Michael Zhang, Alea Mills, Doreen Ware, and David Jackson. In
close collaboration with the Cold Spring Harbor School District, CSHL participated in this com-
munity’s first American Cancer Society “Relay for Life” event, with remarks from CSHL Director
of Research David Spector and Dr. Michael Wigler. CSHL students, postdocs, and researchers vol-
unteered at several science fairs judging the projects of middle and high school students across Long
Island. CSHL students and postdocs also hosted local elementary school students, teachers, and
parents for a field trip. 
Spearheaded by Harlem DNA Lab instructor Ileana Rios, CSHL participated in the second an-
nual World Science Festival (WSF) in Manhattan, serving as a laboratory workshop for high school
kids participating in the festival’s “Pioneers in Science” Program. Highlights of the event included
a demonstration of banana DNA extraction at a street fair in Washington
Square that drew a total crowd of 100,000 New Yorkers! Jim Watson was
also involved in the WSF this year, as part of the gala and as a central fig-
ure in a performance by artist Anna Deavere Smith in “Watching Watson
and Wilson,” a one-woman show composed of vignettes that portray Jim
and E.O. Wilson. 
Community Support
Each year, our employees demonstrate their commitment to the local
community in so many ways. We held three blood drives on campus this
year in February, August, and October. This effort set a record, collecting
20% more blood in 2009 than in 2008.
We continue to participate in the Secure the Call Foundation’s effort
to convert used cell phones to 911 emergency-use phones for those in
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2009–2020 Partners for the Future with CSHL faculty
CSHL employees volunteer at local science fairs
need. CSHL volunteers prepared and served dinner at the Ronald McDonald house to 40 families
of seriously ill children. We also collected 300 pounds of food in support of the Long Island Cares
Harry Chapin Food Bank. 
Looking Forward
The financial and economic setbacks in 2008–2009 will most likely cause a major change in the
long-term prospects for both philanthropic and federal support of science. We can be secure that
our science continues to be world leading and hence will attract support, but increasingly in tight
times, we must be aware that both members of Congress and taxpayers are increasingly looking at
the outcomes of basic research. The economic impact of research is obvious, but changing how we
interact with industry is going to be necessary if we are to achieve these goals. More fundamentally,
we must increase the applied value of our research internally. Finding a mechanism of funding to
do this will create a major challenge in the future.
    Bruce Stillman, Ph.D., F.R.S.
    President
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DNALC instructor Ileana Rios at the World Science Festival Street Fair in Manhattan
CHIEF OPERATING OFFICER’S REPORT
In a recent New York Times op-ed column entitled “The Big Zero,” Nobel
Prize–winning economist Paul Krugman presented his assessment of the perform-
ance of the U.S. economy during the first decade of the new millennium. Lament-
ing the fact that during the 10 years, there was zero growth in stock and home
values after inflation, and observing that the dot-com bubble was quickly followed
by the housing bubble, he dryly concluded that this was “the decade in which we
achieved nothing and learned nothing.” 
    Happily, the same cannot be said for Cold Spring Harbor Laboratory. In the last
10 years, we have built the Freeman Building, the Marks Laboratory, and the Hillside
Laboratory complex as well as acquired and renovated the Woodbury Genome Cen-
ter and the Syosset Center, thereby adding 170,000 square feet of research space
and 40,000 square feet of support space. Major renovations and additions to many
facilities have taken place including the Dolan DNA Learning Center, James Lab-
oratory, Harris Research Support Facility, Robertson House, and Carnegie Library. An elite and highly
successful graduate school with a student body of 50 Ph.D. students was founded and built. The Meet-
ings & Courses and Dolan DNA Learning Center educational programs have developed overseas op-
erations. Our faculty has expanded in number from 35 to 50 while the overall employee population
has grown from 700 to more than 1000. At the same time, our operating income and total assets have
doubled to $129 million and $650 million, respectively. In addition to a steady annual fund-raising
program, two major campaigns were initiated and completed: the $30 million Watson School endow-
ment campaign in 2000 and the $200 million campaign to support the Hillside Laboratories in 2008.
As testament to the fact that the growth in both program and plant did not come at the expense of
academic excellence and fiscal prudence, the Laboratory has been rated the number-one research in-
stitution in the country for productivity over the decade and its credit rating has been upgraded to a
very solid AA– status. 
    All of this is not to suggest that the recent financial crisis and recession have not inflicted insti-
tutional pain. As was reported last year, although our endowment fund outperformed that of the
average university, it nevertheless declined 24% during the 2008 calendar year. The year 2009 began
just as poorly with the S&P 500 Index down 6% in the first quarter. Fortunately, the market began
to recover in March and along with it, the value of the Laboratory endowment. The portfolio re-
turned 20% for the calendar year—a relatively strong performance given that 30% of the fund was
conservatively allocated to fixed-income investments. Total market value at year end increased to
approximately $250 million, although still well short of its high-water mark. To position the port-
folio to achieve solid growth while reducing volatility, the Investment Committee of the Board of
Trustees has reduced exposure to “long only” equity managers while increasing the allocation to al-
ternative and hedged managers who are less closely correlated to market indexes. 
    For the fiscal year ended 12/31/09, the Laboratory operating budget reached approximately $129
million—a 4% increase over the prior year. Due to the practice of calculating annual endowment
spending as a percentage of a moving average of market value over the previous 12 calendar quarters,
we knew that the steep decline in the fund value in 2008 would put substantial pressure on our
2009 operating budget. In fact, the endowment spending draw in 2009 was nearly $3 million less
than in 2008. Consequently, we fell somewhat short of our goal of achieving cash-neutral operating
results after netting depreciation expense against expenditures on capital improvements. 
Looking forward to 2010, there is reason for both optimism and caution. The Laboratory’s in-
vestigators have been extremely successful in securing new grants that became available as part of
the American Recovery and Reinvestment Act—driving a substantial increase in projected program
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revenue. However, many of these are temporary “stimulus” awards, are mostly limited to 2 years in
duration, and the revenue will need to be replaced in 2012. Expenses continue to be diligently man-
aged and we are encouraged by an opportunity to significantly reduce energy costs in the coming
years. Finally, we continue to get strong support from our private donor base despite the trying eco-
nomic times. This is critical because the future of the institution is dependent on rebuilding and
growing our endowment funds. 
We are profoundly grateful to our loyal supporters and to our talented and dedicated staff. 
    Dill Ayres
    Chief Operating Officer
Long-term Service
(Back row) Drew Mendelsohn, Danny Miller, Jennifer Troge, Dill Ayres, Jan Eisenman, James Watson, Bruce Stillman, Dessie Carter, Spencer
Teplin, David Spector, Yuri Lazebnik, Jim Hope; (middle row) Idee Mallardi, Carmelita Bautista, Maureen Berejka, Alison Mc Dermott, Mary Ellen
Goldstein; (front row) Jim Bense, Sharon Bense, Carol DuPree, Susan De Angelo, Janet Argentine, Judy Cuddihy, Jamie Bonilla, Leigh Johnson,
Diane Esposito, Rob Gensel, John Meyer
The following employees celebrated milestone anniversaries in 2009:
35 Years Lane Smith
30 Years Maureen Berejka, Judy Cuddihy, Jim Hope, John Meyer, Bruce Stillman
25 Years Carmelita Bautista, Dessie Carter, Rob Gensel, Mary Ellen Goldstein, 
Danny Miller, Steven Tang
20 Years Jim Bense, Sharon Bense, Charlene De Poto, Jan Eisenman, Leigh Johnson,
Rob Martienssen, Jackie Matura, Alison Mc Dermott, Spencer Teplin
15 Years Leslie Allen, Janet Argentine, Jaime Bonilla, Susan De Angelo, Carol DuPree, 
Diane Esposito, Yuri Lazebnik, Philip Lembo, Rob Lucito, Idee Mallardi, 
Drew Mendelsohn, Sharon Story, Jennifer Troge, Tracy Woolfson
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See previous page for photos of the following scientific staff:
Row 1: G. Atwal (Atwal Lab); E. Vernersson Lindahl (Mills Lab); H. Oviedo (Zador Lab); 
A. Campbell (Turner Lab)
Row 2: C. Ruse (Pappin Lab); D. Albeanu, A. Dhawale (Albeanu Lab); Y.-T. Yang (Van 
Aelst Lab); T. Caulfield (McCombie Lab)
Row 3: Z. Lippman, S. Park (Lippman Lab); L. Joshua-Tor, R. Prakash (Joshua-Tor Lab); 
W. Li, J. Dubnau (Dubnau Lab); K. Revill (Powers Lab)
Row 4: J. Taranda, P. Osten (Osten Lab); N. Cutter (Lucito Lab); A. Krainer, M.A. Jensen 
(Krainer Lab); R. Burgess (Hannon Lab)
Row 5: E. Karakas, N. Simorowski, H. Furukawa (Furukawa Lab); A.M. Naguib, C. Pratt, 
L. Trotman (Trotman Lab); L. Lintault, L. Dow (Lowe Lab); A. Goldschmidt 
(Jackson Lab)
Gene expression and proliferation focuses on the regulation of gene expression, cell-division cycle con-
trol, and chromosome structure in normal and cancer cells.
Thomas Gingeras and colleagues study where and how functional information is stored in
genomes. These efforts help us to understand the biological and clinical effects of disease-causing
gene mutations in humans and other organisms. Gingeras is a leader of the ENCODE (ENCyclo-
pedia of DNA Elements) and modENCODE (model genome ENCODE) projects of the National
Institutes of Health. His research has revealed that almost the entire lengths of genomes in organisms
ranging from bacteria to humans, contrary to expectations, can be transcribed into RNA and that
most RNA products are not destined to be translated into proteins. Rather, noncoding RNAs (ncR-
NAs) are proving to be involved in a variety of other important biological functions, only a small
fraction of which are known. Some ncRNAs have been shown to be critical components in the pre-
and posttranscriptional and translational processes. Others serve as scaffolds upon which large pro-
tein complexes are assembled. This year in a collaboration with Greg Hannon, Gingeras and col-
leagues discovered a new posttranscriptional processing pathway culminating in the generation of
capped short RNAs, which provide a record of transcribed regions and some spliced RNA sequences. 
Gregory Hannon is a pioneer in the study of RNA interference (RNAi) in mammalian systems.
In RNAi, double-stranded RNA molecules induce gene silencing. In addition to elucidating key el-
ements of the RNAi machinery, Hannon and colleagues have led the way in using RNAi to study
cancer biology and genetics, generating a library of short hairpin RNAs that researchers at CSHL
and elsewhere apply broadly in gene-silencing studies. This year, the laboratory reported results in
a number of concurrent projects. They announced their discovery in fruit flies of an antitransposon
defense system in somatic cells that is entirely distinct from that previously seen in germline cells. The
system, they found, guards against a particular class of transposon called gypsy elements. In a col-
laboration with Thomas Gingeras, Hannon discovered a new posttranscriptional processing pathway
leading to the formation of a new class of small RNAs, called non-PSARs, which, clipped from ma-
ture protein-coding RNAs, can regulate gene expression. The lab introduced a method of harnessing
the logic of Sudoku math puzzles to vastly enhance genome-sequencing capability; it is being used
to analyze the genomes of large populations to identify individuals who carry mutations that cause
genetic diseases. The lab also had a critical role in the work of an international team which discovered
that Schwann cells are the probable cellular origin of the deadly transmissible facial tumors deci-
mating Australia’s Tasmanian devil population.
The laboratory of Leemor Joshua-Tor focuses on protein complexes involved in nucleic acid reg-
ulatory processes. They use X-ray crystallography to obtain three-dimensional structures of individual
proteins and atomic-level views of their interactions with other molecules. Joshua-Tor is well known
for her work on the helicase enzyme, which acts to unwind DNA strands during the DNA self-repli-
cation process, and for revealing structures that help explain the gene-silencing mechanisms of RNA
interference. This year, Joshua-Tor and colleagues helped to explain the mechanism by which hete-
rochromatin is assembled. Heterochromatin is a highly compressed bundling of chromosomal ma-
terial such that genes in these areas are rendered inaccessible and therefore “silent.” Joshua-Tor’s team
demonstrated that heterochromatin assembly depends on the strength with which a protein called
Chp1 binds to a specific target site located on a histone protein attached to the double helix.
Adrian Krainer’s lab studies mechanisms of RNA splicing, ways in which they go awry in disease,
and the means by which faulty splicing can be corrected. Their approach has borne fruit in the
study of spinal muscular atrophy (SMA), a neuromuscular disease that is the leading genetic cause
of death in infants. Their ability to correct a messenger RNA (mRNA) splicing defect in SMA that
makes a gene called SMN2 only partially functional forms the basis of a potentially powerful ther-
apeutic approach. This year, Krainer and colleagues demonstrated that PTK-SMA1, a tetracycline-
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like small molecule, stimulates production of SMN protein by directly targeting the splicing reaction
in mouse models of SMA and in cells isolated from SMA patients. Further collaborative research
will focus on preclinical drug development. Krainer’s team has also uncovered important new details
about how a mutation in a gene called RARS2 causes a cellular editing error that results in a devas-
tating brain disease called pontocerebellar hypoplasia (PCH). 
David L. Spector’s lab studies the spatial organization and regulation of gene expression. Their
in vivo approach is exemplified in a live-cell gene expression system that has made possible exami-
nation in real time of the recruitment of members of the gene expression and silencing machineries.
A current research focus is the distribution and dynamics of nuclear polycomb complex proteins,
known to keep genes in a silent state. The team seeks to target them to segments of DNA as a means
of selectively silencing specific genes. Another focus is the study of long noncoding RNAs (ncRNAs)
retained in the nucleus, whose functions are still mostly unknown. This year, Spector and colleagues
revealed a unique structure-building role for two ncRNA molecules. Called MENε and MENβ,
they organize and maintain the structure of paraspeckles, a compartment within the cell’s nucleus.
Papillomaviruses, a large viral family that induces cell proliferation at the site of infection, usually
give rise to benign tumors. But certain types of human papillomaviruses (HPVs) generate tumors
that progress toward malignancy. Among these are HPVs that cause most cervical cancers. Arne
Stenlund and colleagues have obtained a detailed understanding of processes required for initiation
of DNA replication from the papillomavirus, using this system to gain a general biochemical un-
derstanding applicable in other systems. Members of the Stenlund lab also pursue studies aimed at
developing an effective small-molecule inhibitor of HPVs that might someday be used by women
who do not receive the preventive anti-HPV vaccine now available, or those already infected with
HPV who would not be helped by the vaccine.
Bruce Stillman’s lab studies the process by which DNA is copied within cells before they divide
in two. Working with yeast and human cells, Stillman and colleagues have identified many of the
cellular proteins that function at the DNA replication fork during the S phase, the portion of the
cell division cycle when DNA synthesis occurs. Among these proteins are those that facilitate the
assembly of chromatin, the protein–DNA complexes that form the chromosomes. The prime focus
of current research, however, is the mechanism that initiates the entire process of DNA replication
in eukaryotic cells. At the heart of this mechanism is a protein that binds to “start” sites on the chro-
mosomes, called the origin recognition complex (ORC). Stillman’s research has demonstrated that
ORC is also involved in the process of segregating the duplicated chromosomes in mitosis. The
team has found ORC at centrosomes and centromeres, structures that orchestrate chromosome sep-
aration in mitosis. This past year, they identified a protein, Orc1, that controls the copying of the
centrosome in human cells and prevents it from being reduplicated. Orc1, which is one of six pro-
teins that comprise the ORC, was also found by the lab to control the number of centriole pairs in
a cell.
How is the very first step in the life of a protein functionally related to proteolysis, the very last
step—the protein’s destruction by the proteosome? The key link, William Tansey has demonstrated,
is ubiquitin, a molecule with which proteins must be tagged before they can enter the proteosome
for destruction. Having linked ubiquitin and proteolysis to the activity of transcription factors,
Tansey and colleagues have focused on the broader question of how other components of the ubiq-
uitin–proteasome system affect transcription. Recently, among other things, they have discovered
that the proteasome itself interacts—likely in its entirety—with active genes, using its proteolytic
functions to promote multiple steps in the transcription process. They are currently exploring the
precise mechanism through which the proteasome is involved in gene activation and probing how
this large protein complex is recruited to chromatin.
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ENCODE Project
C. Davis, A. Dobin, J. Drenkow, W. Lin, J. Schlesinger, 
H. Wang , C. Xue, C. Zaleski
A sizable fraction of our group is involved in the
NHGRI-sponsored encyclopedia of DNA elements
(ENCODE) project. Our group leads a consortium of
five other international laboratories to identify and
characterize the human transcriptome. Characterization
of the transcriptome is divided into four parts. Long
(>200 nucleotides) and short (<200 nucleotides) RNAs
are being identified and characterized by our group and
the Hannon group at CSHL, respectively. The 5′ tran-
scription start sites (TSS) for nonpolyadenylated
(poly(A)–) and the 5′ and 3′ termini for polyadenylated
(poly(A)+) RNAs are being characterized by groups at
RIKEN, Japan, and GIS, Singapore, respectively. Fi-
nally, cross-data-set integration analyses and full-length
isolation and sequencing of novel RNAs are being ad-
dressed by CRG, Spain, and the Universities of Geneva
and Lausanne, respectively.
Sites of transcription have been mapped using both
high-density tiling arrays and deep RNA sequencing.
The production of genome-wide transcriptome maps
by the consortium has exceeded what was originally
proposed as milestones for the first 2 years of the proj-
ect. A total of 66 data sets have been submitted for the
scientific community to use as a collective resource. The
data sets that have been submitted are summarized in
Table 1.
ORGANIZATION AND REGULATION OF TRANSCRIPTOMES
T.R. Gingeras P. Batut J. Drenkow J. Schlesinger
K. Bell D. Fagegaltier L.-H. See
S. Chakrabortty S. Jha H. Wang
C. Davis I. Lasa C. Xue
A. Dobin W. Lin C. Zaleski
The sources of the long and short RNAs mapped in
these experiments include eight primary and trans-
formed cell lines. Long and short RNAs for all cell lines
have been independently isolated from the nuclei and
cytosol of each cell line. Additionally, for K562 cell
lines, four other subcellular compartments have been
analyzed for the RNA complement present. These com-
partments include nuclear chromatin, nucleoplasm and
nucleoli, and cytosolic polysomes. Cross-subcompart-
ment analyses of the maps are currently in progress.
ModENCODE Project
C. Davis, A. Dobin, D. Fagegaltier, S. Jha, C. Xue
A second transcriptome mapping project is also under
way in our group. The NHGRI-sponsored model
genome ENCODE (modENCODE) project is focused
on defining the transcriptome mapping of two model
genetic organisms: Drosophila melanogaster and Caenor-
habditis elegans. Our group is one of seven laboratories
that form a consortium seeking to identify and charac-
terize the transcriptome of D. melanogaster. Our aim is
to generate a comprehensive set of developmentally
staged and tissue- and cell-specific RNAs for expression
profiling using high-density genome tiling microarrays
and deep RNA sequencing. As with the ENCODE proj-
ect, these maps include long and short RNAs and se-
quences derived from the 5′ TSS. 
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Table 1. Summary of Production for Years 2001 and 2002
Map type Year 2001 Year 2002 Total submitted/
Group or output proposed submitted proposed submitted proposed
Gingeras long RNAs 6 11 12 17 30/18
Hannon short RNAs 3 3 6 6 9/9
RIP/CLIP 3 0 3 0 0/6
Carninci-RIKEN CAGE 3 2 6 9 11/9
Ruan-GIS PET 3 1 6 15 16/9
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phosphate libraries and absent from capped libraries;
in turn, species known to be capped such as small nu-
clear RNAs (snRNAs), are mostly restricted to capped
libraries. The analysis of unique mappers from the re-
spective libraries also reveals several populations of both
known and unknown classes of small RNAs: (1) Abun-
dant capped small RNAs such as PASRs (Fig. 1, panel
1) and TASRs (Fig. 1, panel 2) present the same features
as in human cell lines; one advantage of the protocol
developed is that it is designed for paired-end stranded
sequencing, allowing us to examine the size of these
RNA classes. (2) New species of capped small RNAs
are found at the 5′ and 3′ ends of specific families of
transposable elements, whereas characterized somatic
endoribonuclease-prepared siRNAs (esiRNAs) (5′-
mono-P small RNAs) cover the internal regions of
transposable elements. (3) Another interesting popula-
tion of small RNAs emerged as 5′-mono-P small RNAs
whose 3′ end aligns with the transcription termination
(Fig. 1, panel 4; not present in panel 3). 
Role of Short RNAs in Dosage 
Compensation
D. Fagegaltier
Our analysis of short RNAs in Drosophila has also
prompted us to investigate the role of short RNA in sex
differentiation. The X chromosome carries hundreds of
genes, but few have anything to do directly with gene-
specific expression. Thus, to function in both sexes, X-
linked genes must be expressed at similar levels from a
single copy in the heterogametic sex or two copies in the
homogametic sex. To solve this conundrum, males (XY)
and females (XX) equalize the level of X-linked tran-
scripts through a process called dosage compensation. In
Drosophila, at least six proteins (MSL-1, MSL-2, MSL-
3, MLE, MOF, JIL-1) and two long noncoding RNAs
(roX1 and roX2) form a ribonucleoprotein complex
whose association at hundreds of sites along the X chro-
mosome exclusively in males enables doubling of the ex-
pression of X-linked genes. Hence, males generate from
a single X chromosome transcripts equal in amount to
their female counterparts. In females, the key player in
sex determination, Sex-lethal (Sxl), represses MSL-2 ex-
pression, therefore preventing dosage compensation.
In flies, miRNAs are likely candidates for controlling
the expression of genes involved in dosage compensation
and in sex determination. Many of the annotated genes
involved in these processes represent predicted targets of
miRNAs in databases, but they require further in vivo
validation. Eight to 27 predicted miRNA target sites are
In the current year of this project, we generated 3.5
billion 75-bp reads (single and paired ends) from 30
developmental time points using the Illumina GAIIx
platform. Alignment of the data to combined genome
and splice junction databases yielded ~2 billion
uniquely mapped sequence reads. These data have been
submitted for use by the scientific community and the
underlying data sets have been submitted to GEO
(Gene Expression Omnibus) and Short Read Archive.
Analysis of the ~3.5 billion RNA-Seq reads from the
developmental time course has identified ~29,000
unannotated splice junctions. Many of these junctions
are supported by expressed sequence tag (EST) or
cDNA sequences that are not incorporated into the cur-
rent annotations. Moreover, 1746 of these junctions
have been targeted for validation by directed experi-
ments (see below). The paired-end RNA-Seq data pro-
vide important connectivity information, in some cases
confirming up to four exons in a single read-pair. 
FUNCTIONAL SHORT RNAS
Identification of Two Types of Short RNAs at
the 3′ Ends of Genes
D. Fagegaltier, A. Dobin, C. Xue
Early in 2009, we reported a new posttranscriptional
processing pathway leading to cleaved and capped long
RNAs (>200 nucleotides) and capped small RNAs
(<200 nucleotides). The capped short RNAs include
those found at the 5′ and 3′ ends of most protein-coding
and noncoding genes, namely, promoter-associated
small RNAs (PASRs) and termination-associated small
RNAs (TASRs) (Fejes-Toth et al. 2009). A third class of
capped small RNAs spans across internal exons. Initially
identified in humans and mice, it is now clear that such
small RNAs derived from processed transcripts also exist
in flies. However, their exact role in Drosophila transcrip-
tion regulation is yet to be demonstrated. 
One of the modENCODE consortium goals is to
profile all capped small RNAs expressed in flies. To ac-
complish this goal, the development of a working pro-
tocol to clone enriched populations of capped small
RNAs (<200 nucleotides) was required. Using A-tailing
and anchored primers for reverse transcription, libraries
were made and sequenced from S2 cell capped small
RNAs, mixed capped and uncapped small RNAs, and
5′-monophosphate small RNAs. Sequences were
mapped using Galaxy/Nexalign and the STAR algo-
rithm developed in the laboratory (see below). As ex-
pected, microRNAs (miRNAs) are cloned in mono-
found in the 3′ untranslated region (3′UTR) of dosage
compensation complex (DCC) components. MSL-3 is
the only exception, as the predicted target of three 
miRNAs. Interestingly, the analysis of predicted miRNA
targets points to four components of the DCC being
targeted by a common miRNA (miR-985). The same
applies to components of the sex determination hierar-
chy, whose 3′UTR contains 10–29 predicted miRNA
target sites: miR-1000 has predicted target sites in dsx,
fru, tra, and sxl 3′UTRs. In addition, two of these genes
are predicted targets of the same four miRNAs.
One simple way of achieving sex-specific expression
is to restrict expression of their miRNA repressors to the
opposite sex. Recent studies in worms have identified
miRNAs with sex-preferential expression. To determine
the levels of expression of miRNAs predicted to target
DCC and sex determination components, the popula-
tions of small RNAs in Drosophila male and female so-
matic tissues, respectively, have been surveyed. These
include larval salivary glands, young adult heads and
bodies, and somatic S2 cells derived from late embryos,
an established male model for dosage compensation
studies. Comparing the relative miRNA populations in
sexed tissues using high-throughput sequencing revealed
miRNA differentially or exclusively expressed in one sex.
The widest set of miRNAs (all annotated 155 miRNAs)
is detected in the fly body. More than 38 miRNAs show
a strong bias toward male expression in body for 51 pref-
erentially expressed in female (24 strongly biased). In sali-
vary glands, 57 miRNAs present at least 50 reads across
male and female libraries; ~110 miRNAs are detected in
salivary glands when adding the numerous miRNAs with
very few reads. Sixty are enriched preferentially in males,
versus 47 in females. In heads, 71 miRNAs are preferen-
tially expressed in males and 63 are preferentially ex-
pressed in females, out of 148 miRNAs detected; of
these, two of the most abundant miRNAs show a strong
male preference, and four abundant miRNAs show a fe-
male preference. In addition to sex biases, some miRNAs
appear to be strongly enriched in specific tissues. Heads
present a high number of expressed miRNAs, some of
which are strongly enriched compared to young adult
bodies. Fewer miRNAs are found in salivary glands com-
pared to body samples covering a complex range of tissue
types.
An important finding is that miRNAs expressed in
bodies whose expression is the most strongly biased to-
ward male are enriched on the X chromosome (13 of 38).
Although the number of miRNAs found on the X chro-
mosome is comparable to other chromosomes, dosage
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Figure 1. Density plots of RNASeq reads. (A) The capped short (s) RNAs found at the 5′ ends of fly genes are cen-
tered at the TSS of the gene and appear both on sense strands (above reference lane) and on antisense strands
(below reference lane). (B) Capped sRNAs at the TSS are observed after the termination of the gene. (C) Uncapped
sRNAs that are 10 times less exist at the TSS and (D) uncapped sRNAs map within the gene boundary before the
TSS.
compensation may provide a means of tuning miRNA
expression on the X chromosome. A lower yet significant
proportion of miRNAs whose expression is biased toward
female is also found on the X chromosome (6 of 24).
miRNAs found at similar levels in male and female bod-
ies tend to be located elsewhere in the genome.
DEVELOPMENT OF ANALYSIS 
ALGORITHMS AND DATABASE
Development of RNA Mapping Algorithm
A. Dobin
The recent advances in sequencing technology made it
an attractive tool for the studies of the transcriptome at
single-nucleotide resolutions. The analysis of the tens
of millions of relatively short (36-mer) and medium
(100-mer) reads produced by sequencing of cellular
transcriptomes comprising spliced and unspliced RNAs
presents unique challenges. Two main tasks make these
analyses extremely computationally intensive: The first
task is the accurate alignment of increasingly longer
reads that display growing numbers of mismatches
caused by sequencing errors, single-nucleotide poly-
morphisms (SNPs), RNA editing, etc. The second task
is the mapping of reads derived from noncontiguous
regions of the genome, for example, splice junctions
and chimeric RNAs. Although the first task is shared
with DNA resequencing efforts, the second task is spe-
cific and crucial to the RNA sequencing because it pro-
vides the connectivity information and allows the
reconstruction of the RNA molecules.
Various sequence alignment algorithms have been ap-
plied to these problems, including existing general-pur-
pose approaches (e.g., BLAT) or more recent tools
designed for high-throughput sequencing reads (e.g.,
Bowtie/Tophat). The latter strategies rely upon either
previously annotated splice junctions, the sequence char-
acteristics of annotated junctions (e.g., canonical introns
motifs and maximum exon/intron size), and/or the con-
struction of a reference database of junction sites. We use
the splice transcripts alignment and reconstruction
(STAR) tool. Its novel alignment strategy for de novo de-
tection of the splice junctions does not require any pre-
vious knowledge of splice junctions’ loci and does not
use a priori properties of the junctions. This unbiased
splice junction mapping is imperative for discovery of
novel (unannotated, noncanonical) splice junctions and
isoforms, as well as other increasingly important RNA
species such as interchromosomal chimeric RNAs. The
key algorithm of our alignment strategy is the search for
the maximum mappable length of a read, implemented as
a speed-efficient suffix array search. Another important
novelty of our approach is the split/search/extend algo-
rithm driven by the sequencing quality scores, which al-
lows a confident alignment of reads comprising a large
number of sequencing errors. The STAR’s penalty system
is highly user-configurable and assigns probabilistic
meaning to the alignment scores.
The following are some other important advantages
of the STAR: STAR is capable of finding the multiple
loci to which a read can be mapped, providing estimates
of the relative probabilities of these alignments. STAR
can align reads of any length, working accurately and
efficiently for both long and short RNA molecules.
STAR can align reads containing any number of splice
junctions, indels, and/or mismatches, which is impor-
tant as the length of the reads continues to increase rap-
idly with the advances of the sequencing technology.
STAR can deal with arbitrarily large intron length (im-
portant, e.g., for distal exons and chimeric RNA), as
well as with extremely short exons (microexons). STAR
performs an “auto”-trimming of the poor-quality read
ends, which are a common occurrence as the read
length is pushed to the limit. STAR can detect the non-
templated poly(A) tails, thus providing a means to de-
termine the transcription termination site for poly(A+)
mRNAs. STAR treats the paired-end sequencing in a
most straightforward way by incorporating naturally
the paired-end information into the mapping process.
Although the STAR algorithm is heuristic and
nonexhaustive (i.e., it does not find all the possible
alignments, unlike, e.g., the Smith–Waterman local
search), we showed that it can recover almost all highly
probable alignments for almost all reads. STAR is very
fast: On a modern but not overly expensive server, it
can align 75 million per hour of 76-mer reads to the
human genome, including the splice junctions, multi-
ple mappers, and numerous (about seven) mismatches. 
In the following example, we use STAR to map
270M 76-mer reads from a human cell line (K562)
total RNA samples. Table 2 compares STAR’s results
with those of an exhaustive mapping with up to two
mismatches allowed. One can see that for these li-
braries, STAR maps twice as many reads as the full-
length (76 nucleotides) exhaustive search, or 50% more
reads than the exhaustive search with the reads trimmed
to 50 nucleotides, illustrating STAR’s ability to auto-
trim the poor-quality tails.
We found 3.75M reads that cross splice junctions,
from those 96% crossing canonical junctions (GT/AG
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introns) and 4% noncanonical. We found 87K unique
junctions in the genome, of which 90% are annotated
canonical junctions, 7% unannotated canonical, and
3% noncanonical mostly unannotated junctions. This
illustrates STAR’s ability to correctly detect annotated
junctions, as well as predict a large number of unanno-
tated canonical and noncanonical sites. 
Novel Exon Detection by Hierarchical 
RNA-Seq Clustering
F. Schlesinger
Large-scale RNA sequencing projects, such as those
done as part of the ENCODE project, allow the dis-
covery of previously unknown transcripts or novel
exons within known transcripts. Millions of short se-
quence reads derived from cDNA are independently
mapped to the genome. Highly expressed regions are
fully covered with reads, so that transcripts can easily
be detected. However, many biologically relevant tran-
scripts are only expressed at low levels of a few mole-
cules per cell. Shotgun cDNA libraries are unlikely to
completely cover such transcripts given current limita-
tions to sequencing depth. Instead, the observed reads
must be treated as a statistical sample of a much larger
true population of RNA fragments.
Exons in low-abundance transcripts can still be seen
as several reads mapping closer together in genomic
space than would be expected by pure chance if they
were evenly dispersed through the genome. To detect
loci where such significant read clusters are observed
and to distinguish them from nonspecific background
events, we developed software to apply a hierarchical
clustering algorithm based on a statistical sampling
model and maximum likelihood model comparison. 
This algorithm scans along a chromosome to find a
large region with a higher density of mapped reads than
the local background level. This region is then recur-
sively split again into subregions according to read den-
sity until all such clusters are found. The benefit of this
approach is that clusters of any length or strength can
be detected independent of any predefined cutoffs
while considering nonspecific background noise. This
is important because we do not know a priori how long
the novel transcripts of unknown type (spliced/un-
spliced, A+/A–) will be. 
The largest clusters represent gene islands, whereas
the lowest level detects individual exons. These blocks
can be linked to form transcript models by split reads.
These are short sequences derived from spliced tran-
scripts, which span an exon–exon boundary. Detecting
them at novel, possibly noncanonical splice sites re-
quires the new STAR genome mapping software.
Results of this approach on total cellular RNA li-
braries show many novel transcribed loci, antisense
transcripts, or extended 3′UTRs in agreement with pre-
vious tilling array analysis. RNA data from a single cell
line sample included 20,000 intergenic clusters and
more than 15,000 in antisense to genes, representing
potential exons of novel transcripts present at levels cor-
responding to ~1.5 molecules per cell on average. We
also observed more than 80,000 cases of RNA-Seq sig-
nal in introns of annotated transcripts. Further statisti-
cal analysis of their distribution and split-read mapping
will help differentiate unspliced pre-mRNAs found in
the total RNA library from novel exons. 
Development of Genomic Data Manager
Database and Pipeline
C. Zaleski
Next-generation genomics technologies such as microar-
rays and high-throughput sequencing are becoming
more common among biologists. Although these tech-
nologies are extremely powerful, the information they
generate introduces many difficulties. Among these are
(1) analysis of the data, often requiring complex algo-
rithms and tremendous computing resources, (2) visu-
alization of the data, requiring powerful application
interfaces and time-consuming study, and (3) storage
and management of the data, requiring nontraditional
approaches due to the size and complexity of the data.
Although many tools have addressed the first two
points—analysis and visualization—we feel that storage
and management of the data are an equally important,
yet overlooked, part of the process. Traditional methods
for handling this requirement could include files organ-
ized in a directory structure on a network drive, shared
spreadsheets, and simple database solutions such as Access
or Filemaker. However, these solutions often do not scale
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Table 2. STAR Performance Compared to Exhaustive Mapping 
Approach
Uniquely Mean mapped 
mapped reads length (bases)
0–2MMa 51Mb 76
0–2MM & trim to 50 72M 50
STAR 106M 64.8
aMismatch.
bMillion.
to the needs of next-generation technologies due to
•   Number of files: Easily reaches tens or hundreds of
thousands.
•   Files sizes: Up to many gigabytes for a single file.
•   Metadata: A tremendous amount of information
needs to be associated with the data at many levels
of organization.
To address these storage and management issues, we
created Genomic Data Manager (GDM). GDM is a
web-based database system designed to solve the prob-
lems specific to storage and management of genomics
data. It allows for the following:
•   Robust storage: Data files are kept on a storage system
that provides high-speed access, redundancy, and
managed backups.
•   Organization and structure: Experiment results (files)
are organized into logical groups (aka “DataSets”) that
form hierarchical relationships. Each DataSet has an
associated “Process” that created it.
•   Extensive metadata: Detailed information can be as-
sociated with the data at multiple levels—Processes,
DataSets, and Files—through the use of predefined
attributes and user-defined annotation. 
•   Security: Multiple levels of access rights are enforced,
and users can only view or manipulate data for the
particular “projects” with which they are associated.
•   Easy search and retrieval: Users can browse through
data using a top-down hierarchy of biological attrib-
utes (e.g., species, cell line, and nucleic acid). Search
features are also provided to quickly target a DataSet
of interest. Requested data can be viewed simulta-
neously with all associated information, and data
files can be downloaded with a single click.
•   Easy integration with analysis tools: Although analysis
of data is left to other existing tools, easy integration
with these tools is vital. GDM has been integrated
with a Galaxy (http://galaxy.psu.edu/) server and al-
lows for seamless import/export while maintaining
a homogeneous interface. Similarly, Galaxy itself can
then be used to easily integrate almost any analysis
tool that is required.
Integration with Galaxy is accomplished by using
Galaxy’s built-in facilities for external data sources. The
Galaxy interface is divided into frames or sections that
provide different information to the user—Menu, His-
tory, etc. When the user chooses to import data from
an external source, the actual website of the source can
be placed directly inside the Galaxy window. This is ex-
actly how GDM works, and it allows for a seamless ex-
perience for the user. Once GDM was made aware of
Galaxy and the appropriate configuration files were cre-
ated, adding the GDM “tool” as a Galaxy data source
is a plug-and-play procedure.
GDM was created with common tools and technolo-
gies allowing for easy maintenance. The database is im-
plemented in MySQL 5.1, business logic is implemented
with PHP 5.1 served via Apache 2, and the interface is
created with HTML and Javascript, using widgets and
Ajax from dhtmlx (http://www.dhtmlx.com/).
PROKARYOTIC TRANSCRIPTOMES
Transcriptional Profiles of 
Staphylococcus aureus
I. Lasa, A. Dobin
Due to their small size (on average between 2 and 5 Mb),
bacterial genomes were the first free-living organisms to
be sequenced. Almost immediately, the development of
microarray techniques combined with the genome infor-
mation allowed the characterization of what at that time
was called “whole bacterial transcriptome.” However,
those initial studies were limited to the characterization
of the transcription products of annotated genes. During
the past few years, the development of high-resolution
tiling arrays and RNA deep sequencing has allowed the
study of transcriptomes without bias from previous
genome annotations. These techniques, first imple-
mented for eukaryotic organisms, have demonstrated that
the collection of RNA molecules produced by eukaryotic
cells (transcriptome) is highly more complex than ex-
pected. Although prokaryotic cells do not posses the elab-
orate RNA maturation machinery of eukaryotic cells, it
seems likely that the bacterial transcriptome is going to
be also more complex than expected. 
This project is aimed at determining the transcrip-
tome map of the pathogenic bacteria Staphylococcus au-
reus, combining tiling arrays and deep-sequencing
technologies. S. aureus is a human pathogen that causes
both nosocomial and community-acquired infections
that can range from minor skin infections to life-threat-
ening illnesses such as endocarditis, osteomyelitis, and
toxic shock syndrome. From the analysis of the S. aureus
transcriptome, we expect to (1) identify putative new
families of ncRNA, (2) determine the frequency of RNA
regulatory mechanism such as 5′ and 3′ overlapping
UTR, antisense RNAs, (3) identify enzymatic activities
linked to new RNA regulatory mechanisms that might
be susceptible for the design of new antibiotics, and (4)
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define a new map of operons that will pave the path for
all future genetic studies with this bacterium.
For tiling array studies, total RNA from three genet-
ically unrelated S. aureus strains and selected isogenic
mutants from one of these strains were hybridized with
custom-made Affymetrix arrays. Analysis of the data
was based in Bioconductor R package.
For RNA deep-sequencing, RNA was size-selected
in two fractions, one containing RNA molecules
shorter than 75 nucleotides and the other one contain-
ing total RNA. Two libraries using standard laboratory
protocols have been constructed and sequenced.
Overall, the results show a very good correlation on a
gene-by-gene comparison between the deep sequencing
and the tiling arrays. Figure 2 shows 5′ and 3′ overlapping
UTRs of convergent genes or noncoding RNA (ncRNA). 
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Figure 2. Array: The plots show the normalized hybridization intensities (y axis) and genome position (x axis).
Each dot corresponds to the average intensity of intensity signals from independent biological repetitions. 
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We study the molecular basis of nucleic acid regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystallog-
raphy enables us to obtain the three-dimensional
structures of these molecular machines. Biochemistry
and molecular biology allow us to study properties that
can be correlated with protein structure and function. 
Mechanisms of RNAi
T. Schalch, C. Faehnle, C. Kuhn, C. Kuscu, J. Calarco, 
S. Goldsmith, S. Lin [in collaboration with G.J. Hannon, 
R.A. Martienssen, Cold Spring Harbor Laboratory, and 
J. Partridge, St. Jude Children’s Research Hospital]
RNA interference (RNAi) has made an enormous im-
pact on biology in a very short period of time. Not only
are we still discovering new cellular pathways for the
regulation of gene expression that use these pathways,
but RNAi became an extraordinary useful and simple
tool for gene silencing. Almost from its beginnings,
people have used genetics, biochemistry, molecular bi-
ology and bioinformatics to study the mechanism of
RNAi and related pathways. We argued, however, that
in order to get a true mechanistic understanding of
these pathways, we must understand how the compo-
nents of the RNAi machinery work at a molecular level.
Therefore, we embarked on structural and biochemical
studies of key proteins in the RNAi pathway.
During RNAi, long double-stranded RNA is
processed to yield short (~19–31 nucleotides) double-
stranded RNAs that trigger the RNAi response. These
short RNAs get incorporated into effector complexes
called the RNA-induced silencing complex (RISC),
where in the mature complexes, a single-stranded RNA,
the antisense strand of the original double-stranded
RNA, is retained in the complex. This short RNA—
short interfering RNAs (siRNAs) or microRNAs 
(miRNAs)—then acts to guide the RISC complex to
its target through base complementarity. The best-char-
STRUCTURAL BIOLOGY OF NUCLEIC ACID REGULATORY PROCESSES
L. Joshua-Tor C. Ashar C. Kuhn S.-J. Lee
J. Calarco P.R. Kumar S. Lin
E. Elkayam C. Kuscu T. Schalch
C. Faehnle T. Lavy A. Tocilj
S. Goldsmith
acterized pathway, and the one that is predominantly
used for gene knockdown technology, is a posttran-
scriptional silencing (PTGS) pathway called “Slicing.”
Here, the RISC complex is targeted to the mRNA and
produces an endonucleolytic cut in the mRNA target,
thus preventing gene expression from proceeding.
Other RNAi silencing pathways such as translational
inhibition and transcriptional gene silencing (TGS) are
also mediated through RISC complexes. In all cases,
these complexes contain a small single-stranded RNA
and an Argonaute protein, features that serve to define
the RISC complex. In the past few years we have been
studying Argonaute family proteins, their complexes,
and their roles in various RNAi silencing pathways. 
In the fission yeast Schizosaccharomyces pombe, assem-
bly of centrometic heterochromatin requires the RITS
complex, which consists of Ago1, Tas3, Chp1, and siR-
NAs derived from centromeric repeats. In the past year,
we have shown from our crystal structure of Chp1’s
chromodomain in complex with a trimethylated lysine-
9 H3 peptide (H3K9me) extensive sites of contact that
contribute to Chp1’s high-affinity binding (Fig. 1). We
found that this high-affinity binding is critical for the
efficient establishment of centromeric heterochromatin,
but preassembled heterochromatin can be maintained
when Chp1’s affinity for H3K9me is greatly reduced.
The Different Faces of E1: A Replicative
Hexameric Helicase
E.J. Enemark (now at St. Jude Children’s Research Hospital,
Memphis, TN), S.-J. Lee
During DNA replication, two complementary DNA
strands are separated and each becomes a template for
the synthesis of a new complementary strand. Strand
separation is mediated by a helicase enzyme, a molecu-
lar machine that uses the energy derived from ATP hy-
drolysis to separate DNA strands while moving along
the DNA. Recently, we determined a crystal structure
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multiple configurations are observed within the hexa-
mer. These have been assigned as ATP type, ADP type,
and apo type. The configuration of the site for a given
subunit correlates with the relative height of its DNA-
binding hairpin in the staircase arrangement. The sub-
units that adopt an ATP-type configuration place their
hairpins at the top of the staircase while the hairpins of
apo-type subunits occupy the bottom positions of the
staircase. The hairpins of the ADP-type subunits are
placed at intermediate positions.
A straightforward “coordinated escort” DNA translo-
cation mechanism is inferred from the staircased DNA
binding and its correlation with the configuration at the
ATP-binding sites. Each DNA-binding hairpin main-
tains continuous contact with one unique nucleotide of
single-stranded DNA and migrates downward via ATP
hydrolysis and subsequent ADP release at the subunit
interfaces. ATP hydrolysis occurs between subunits lo-
cated toward the top of the staircase, whereas ADP re-
lease occurs between subunits located toward the
bottom of the staircase. The hairpin at the bottom of
the staircase releases its associated single-stranded DNA
phosphate to conclude its voyage through the hexameric
channel. Upon binding a new ATP molecule, this sub-
unit moves to the top of the staircase to pick up the next
available single-stranded DNA phosphate, initiating its
escorted journey through the channel and repeating the
process. For one full cycle of the hexamer, each subunit
hydrolyzes one ATP molecule, releases one ADP mole-
cule, and translocates one nucleotide of DNA through
the interior channel. A full cycle therefore translocates
six nucleotides with associated hydrolysis of six ATPs
and release of six ADPs. A detailed comparison with
other multimeric ATPase motors that highlighted the
roles of individual site residues in the ATPase activity
was also performed. We continue to study this helicase
and the role other domains of the protein might have
in helicase assembly and activity.
NADP Regulates the Yeast GAL
Induction System 
P.R. Kumar and T. Lavy [in collaboration with 
R. Sternglanz, Stony Brook University, and 
S.A. Johnston, Arizona State University]
Transcriptional regulation of the galactose metabolizing
genes in Saccharomyces cerevisiae depends on three core
proteins: Gal4p, the transcriptional activator that binds
to upstream activating DNA sequences (UASGAL);
Gal80p, a repressor that binds to the carboxyl terminus
of the replicative helicase E1 from papillomavirus
bound to single-stranded DNA and nucleotide mole-
cules at the ATP-binding sites.
Papillomaviruses are tumor viruses that cause be-
nign and cancerous lesions in their host. Replication of
papillomaviral DNA within a host cell requires the viral
E1 protein, a multifunctional protein. E1 initially par-
ticipates in recognizing a specific replication origin
DNA sequence as a dimer with E2, another viral pro-
tein. Subsequently, further E1 molecules are assembled
at the replication origin until two hexamers are estab-
lished. These hexamers are the active helicases that op-
erate bidirectionally in the replication of the viral DNA.
To unwind DNA, helicases must separate the two
strands while moving along, or translocating, on the
DNA. On the basis of structures of the DNA-binding
domain of E1 bound to DNA that we determined a few
years ago in collaboration with Arne Stenlund’s lab, we
suggested a mechanism for DNA strand separation.
However, the mechanism that couples the ATP cycle to
DNA translocation has been unclear.
The E1 hexameric helicase adopts a ring shape with
a prominent central channel. ATP-binding (and hy-
drolysis) sites are located at the subunit interfaces, and
Figure 1. Crystal structure of the Chp1 chromodomain bound to
H3K9me3 peptide. (Top) Cartoon representation of the Chp1
chromodomain is shown in a ribbon representation, and the H3
peptide is shown in a stick representation. The Chp1 “aromatic
cage” residues and zinc-binding aspartates are also shown with
sticks. Zinc ions are shown as gray spheres. (Bottom) Side-by-
side comparison of HP1 and Chp1 cocrystal structures with
H3K9me3 peptides. H3K9me3 peptide is shown with sticks.
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of Gal4p and inhibits transcription; and Gal3p, a cyto-
plasmic transducer which upon binding galactose and
ATP relieves Gal80p repression. The current model of
induction relies on Gal3p sequestering Gal80p in the
cytoplasm. However, the rapid induction of this system
implies that there is a missing factor. To understand the
molecular mechanism of the GAL regulatory system,
we have determined the structure of S. cerevisiae Gal80p
with the activation domain of Gal4p. 
The crystal structures of Gal80p reveal a three-do-
main architecture with an amino-terminal domain con-
sisting of a Rossmann fold, normally associated with
binding of NAD(P) cofactors. The carboxy-terminal do-
main consists of a large β-sheet that forms an extensive
dimer interface with another monomer (Fig. 1). A large
cleft is apparent between these two domains. A smaller
third domain, located between the amino- and carboxy-
terminal domains, consists of three small β strands and
a helix that resemble a set of fingers at the entrance of
the cleft. Gal80p dimers form tetramers in both crystal
forms. When we soaked a crystal of Gal80pS0:P21 (a 21-
amino-acid peptide that contains the conserved region
of the carboxy-terminal activation domain [AD] of
Gal4p) with the dinucleotide NAD (nicotinamide ade-
nine dinucleotide), the structure revealed that NAD
binds to both monomers of Gal80p in the cleft formed
by the Rossmann fold. We were also able to observe extra
density corresponding to the P21 peptide. The peptide
appears to interact with the nicotinamide portion of the
dinucleotide. NAD nestles between Gal80p and Gal4p,
making several key interactions with Gal80p. 
In vitro pull-down assays of Gal80p with purified re-
combinant GST-Gal4p containing the acidic AD in the
presence of NAD and NADH showed no change in
binding for either of these two dinucleotides. However,
when NADP and NADPH were used, a clear reduction
in binding was observed with increasing concentrations
of NADP. Alterations in the NAD(P)-binding site af-
fects the initial rate of GAL induction in vivo, but not
overall final expression levels. It appears that NAD
might facilitate Gal80p binding to Gal4p, because we
could only identify Gal4p-AD with NAD bound, and
NADP destabilizes this interaction. The mutations, af-
fecting both NAD and NADP binding, would therefore
disrupt both the stabilizing effect of NAD and destabi-
lizing effect of NADP with a net result of faster induc-
tion for the mutants compared to wild type.
Although we do not understand precisely how this
trigger for GAL regulation functions, nor the involve-
ment of NADP versus NAD, we speculate that switch-
ing the cell to a fermentable galactose medium causes a
change in NADP/NADPH or NADP/NAD ratios in
the cell, and Gal80p effectively senses the metabolic
state of the cell. NADP might be acting as a “second
messenger” in triggering the system. Alternatively,
Gal80p may function as an oxidoreductase enzyme, ac-
tively converting NADPH to NADP in the presence of
a substrate causing it to disassociate from Gal4p. 
We are now examining possible enzymatic activities
as well as other complexes involved in this classic tran-
scriptional switch. 
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Mechanisms of Constitutive 
and Alternative Pre-mRNA Splicing
RNA splicing is required for correct expression of most
eukaryotic protein-coding genes. The spliceosome se-
lects authentic splice sites with very high fidelity, relying
on limited sequence information present throughout
introns and exons. In humans, >75% of genes are ex-
pressed via alternative splicing, giving rise to multiple
protein isoforms. The choice of alternative splice sites
is commonly regulated to alter gene expression, either
tissue-specifically or in response to a developmental
program or to signaling pathways. The fact that multi-
ple protein isoforms can be expressed from individual
genes demonstrates that the classical “one gene–one en-
zyme” paradigm is no longer valid and provides an ex-
planation for the unexpectedly small number of genes
uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well
as RNA components that are part of small nuclear 
ribonucleoprotein (snRNP) particles. The work in our
lab focuses on the identification and molecular char-
acterization of protein factors and sequence elements
that are necessary for the catalysis and fidelity of splic-
ing and/or for the regulation of alternative splice-site
selection. We are interested in how the spliceosome
correctly identifies the exons on pre-mRNA, and how
certain point mutations in either exon or intron se-
quences cause aberrant splicing, leading to various
human genetic diseases. Related areas of interest in-
clude the remodeling of mRNP architecture as a con-
sequence of splicing, which influences downstream
events, such as nonsense-mediated mRNA decay
(NMD), the role of alternative splicing misregulation
in cancer, and the development of effective methods
to correct defective splicing or modulate alternative
splicing, especially in a disease context. A summary of
some of our recently published studies is provided
below.
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Studies of Splicing Factors 
SF2/ASF and hnRNP A1
SF2/ASF is a prototypical serine- and arginine-rich pro-
tein, with important roles in splicing and other aspects
of mRNA metabolism. SFRS1, the gene encoding
SF2/ASF, is a potent proto-oncogene with abnormal
expression in many tumors. We found that SF2/ASF
negatively autoregulates its expression to maintain
homeostatic levels. We characterized six alternatively
spliced SF2/ASF mRNA isoforms: the major isoform
encodes full-length protein, whereas the others are ei-
ther retained in the nucleus or degraded by nonsense-
mediated mRNA decay. Unproductive splicing
accounts for only part of the autoregulation, which oc-
curs primarily at the translational level. The effect is
specific to SF2/ASF and requires RNA recognition
motif 2 (RRM2). The ultraconserved 3′-untranslated
region (UTR) is necessary and sufficient for down-reg-
ulation. SF2/ASF overexpression shifts the distribution
of target mRNA toward monoribosomes, and transla-
tional repression is partly independent of Dicer and a
5′ cap. Thus, multiple posttranscriptional and transla-
tional mechanisms are involved in fine-tuning the ex-
pression of SF2/ASF.
Alternative splicing and posttranslational modifica-
tions (PTMs) are major sources of protein diversity in
eukaryotic proteomes.Functional studies of SR protein
PTMs have exclusively focused on reversible phospho-
rylation of serine residues in their carboxy-terminal RS
domain. We confirmed that humanSF2/ASF is methy-
lated at residues R93, R97, and R109, which were first
identified in a global proteomic analysis of arginine
methylation. We further investigated whether these
methylated residues regulate the properties of SF2/ASF,
which normally shuttles between the nucleus and the
cytoplasm. We found that the three arginines additively
control the subcellular localization of SF2/ASF, and
both the positive charge and the methylation state are
important. Mutations that block methylation and re-
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pressed in differentiated cells, and it confers a prolifer-
ative advantage to tumor cells. The M1 and M2 pyru-
vate kinase isozymes are expressed from a single gene
through alternative splicing of a pair of mutually exclu-
sive exons. In collaboration with Lewis Cantley (Har-
vard Medical School), we measured the expression of
M1 and M2 mRNA and protein isoforms in mouse tis-
sues, tumor cell lines, and during terminal differentia-
tion of muscle cells and showed that alternative splicing
regulation is sufficient to account for the levels of ex-
pressed protein isoforms. We further showed that the
M1-specific exon is actively repressed in cancer cell
lines—although some M1 mRNA is expressed in cell
lines derived from brain tumors—and demonstrated
that the related splicing repressors hnRNP A1 and A2,
as well as the polypyrimidine-tract-binding protein
PTB, contribute to this control. Down-regulation of
these splicing repressors in cancer cell lines using short
hairpin RNAs (shRNAs) rescued M1 isoform expres-
sion and decreased the extent of lactate production.
These findings extended the links between alternative
splicing and cancer and identified some of the factors
responsible for the switch to aerobic glycolysis.
Spinal Muscular Atrophy: Genetics, 
Splicing Mechanisms, and 
Therapeutics Development
Spinal muscular atrophy (SMA) is a common, autoso-
mal-recessive motor neuron disorder caused by ho-
mozygous deletion or mutation of the survival-of-
motor-neuron gene, SMN1. A closely related SMN1
paralog, SMN2, is present in all patients and differs
from SMN1 by a C to T transition in exon 7 that causes
substantial skipping of this exon, such that SMN2 ex-
presses only low levels of functional protein. SMN2 de-
creases the severity of SMA in a copy-number-
dependent manner. However, SMN2 is not the sole
phenotypic modifier, because there are discordant SMA
cases in which the SMN2 copy number does not ex-
plain the clinical phenotype. In collaboration with Tom
Prior (Ohio State University), we reported three unre-
lated SMA patients with low SMN2 copy numbers that
did not correlate with their mild clinical phenotypes. 
A single base substitution in SMN2, c.859G>C, was
identified in exon 7 in the patients’ DNA. We showed
that the nucleotide change creates a putative exonic
splicing enhancer motif and increases the amount of
full-length transcript, thus resulting in the less severe
phenotypes. This finding demonstrated that the
c.859G>C substitution is a positive modifier of the
move the positive charge result in cytoplasmic accumu-
lation of SF2/ASF. The consequent decrease in nuclear
SF2/ASF levels prevents it from modulating alternative
splicing of target genes, results in higher splicing-en-
hancer-dependent translation stimulation, and abro-
gates the enhancement of nonsense-mediated mRNA
decay.
Heterogeneous nuclear RNP (hnRNP) A1 is a ubiq-
uitous splicing repressor that binds to RNA in a coop-
erative manner. Initial hnRNP A1 binding to an exonic
splicing silencer at the 3′ end of human immunodefi-
ciency virus type 1 (HIV-1) tat exon 3, which is a high-
affinity site, is followed by cooperative spreading in a
3′ to 5′ direction. As hnRNP A1 propagates toward the
5′ end of the exon, it antagonizes binding of SF2/ASF
to an exonic splicing enhancer, thereby inhibiting splic-
ing at that exon’s alternative 3′ splice site. tat exon 3
and the preceding intron of HIV-1 pre-mRNA can fold
into an elaborate RNA secondary structure in solution,
which could potentially influence hnRNP A1 binding.
We found that hnRNP A1 binding and splicing repres-
sion can occur on an unstructured RNA. Moreover,
hnRNP A1 can effectively unwind an RNA hairpin
upon binding, displacing a bound protein. We further
showed that hnRNP A1 can also spread in a 5′ to 3′ di-
rection, although when initial binding takes place in
the middle of an RNA, spreading preferentially pro-
ceeds in a 3′ to 5′ direction. Finally, when two distant
high-affinity sites are present on the same RNA, they
facilitate cooperative spreading of hnRNP A1 between
the two sites. These cooperative RNA-binding proper-
ties shed light into hnRNP A1’s splicing repression ac-
tivity, which controls alternative splicing of many
pre-mRNAs.
Alternative Splicing and Cancer 
Cell Metabolism
Alternative splicing has an important role in cancer,
partly by modulating the expression of many oncogenes
and tumor suppressors and also because inactivating
mutations that affect alternative splicing of various
tumor suppressor genes account for some of the inher-
ited and sporadic susceptibility to cancer. In addition,
alternative splicing controls a metabolic switch charac-
teristic of all cancer cells, which is known as the War-
burg effect. Cancer cells preferentially metabolize
glucose by aerobic glycolysis, characterized by increased
lactate production. This distinctive metabolism involves
expression of the embryonic M2 isozyme of pyruvate
kinase, in contrast to the M1 isozyme normally ex-
SMA phenotype and that SMN2 sequence variations
can affect the disease severity.
We continue to explore strategies to increase the ex-
tent of exon 7 inclusion during splicing of SMN2 tran-
scripts, for eventual therapeutic use in SMA. One of
our strategies involves the use of tetracycline derivatives,
in collaboration with Paratek Pharmaceuticals. This
work was initiated by Michelle Hastings, who is now
at Roslind Franklin University, Chicago. We identified
a tetracycline-like compound, PTK-SMA1, which
stimulates exon-7 splicing and increases SMN protein
levels in SMA patient fibroblasts and in mice transgenic
for human SMN2. Unlike previously identified small
molecules that stimulate SMN production via SMN2
promoter activation or undefined mechanisms, PTK-
SMA1 is a unique therapeutic candidate in that it acts
by directly stimulating splicing of exon 7, as shown by
in vitro splicing experiments in cell-free extracts. Struc-
ture-activity relationship studies are in progress to de-
velop more potent derivatives, as well as compounds
that efficiently penetrate the blood-brain barrier.
Splice-Site Recognition 
and Human Genetics
We continued to analyze the specificity of splice-site
recognition and the relationship between splice site mu-
tations and genetic diseases. The 5′ splice site—the
highly diverse element at the 5′ end of introns—is ini-
tially recognized via base pairing to the 5′ end of the U1
small nuclear RNA (snRNA). However, many natural
5′ splice sites have a poor match to the consensus se-
quence and are predicted to be weak. Using genetic sup-
pression experiments in human cells, we demonstrated
that some atypical 5′ splice sites are actually efficiently
recognized by U1, in an alternative base-pairing register
that is shifted by one nucleotide relative to the canonical
one. These atypical 5′ splice sites are phylogenetically
widespread, and many of them are conserved. The un-
expected flexibility in 5′ splice site/U1 base pairing chal-
lenges an established paradigm and has broad impli-
cations for splice site prediction algorithms and gene an-
notation efforts in genome projects.
In addition, shifted base pairing provides an expla-
nation for the effect of a 5′ splice site mutation in in-
tron 2 of RARS2, associated with a genetic disorder,
pontocerebellar hypoplasia. This mutation was known
to cause defective splicing, which was paradoxical be-
cause the mutation changes a nonconsensus nucleotide
to a consensus one. However, because this atypical 5′
splice site base pairs with U1 in a shifted register, the
mutation weakens this interaction, accounting for the
splicing defect. 
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Most cellular processes can trace their beginnings to the
nucleus where a gene is activated, resulting in the pro-
duction of an RNA molecule that must get processed
and transported to the cytoplasm. Although much bio-
chemical information is available regarding many of the
factors involved in gene expression, the spatial and tem-
poral aspects of gene expression and the dynamics of
the nuclear domains that the gene expression machin-
ery occupies are less well understood. During the past
year, we have focused on two main areas: (1) examining
the dynamics of gene expression/repression and DNA
repair in living cells and (2) characterizing the dynamics
of a long nuclear-retained noncoding RNA. 
The Dynamics of Gene Expression/
Repression and DNA Repair
M. Hübner, R. Zhao, R.I. Kumaran, J. Li
Our research during the past year has focused on the
spatial and temporal aspects of gene expression. During
the cell cycle, development, and differentiation, the
gene expression program of cells changes. These
changes in gene expression are carried out in part by
changes in chromatin-associated histone modifications.
The JMJD3/KDM6B protein has recently been iden-
tified to act as a demethylase for dimethylated and
trimethylated H3K27. Its action would thereby have a
role in activating a gene that was silenced by the
H3K27 trimethyl mark. During the past year, we have
been interested in studying the nuclear organization
and dynamics of the JMJD3 protein. In addition to a
diffuse nuclear pool, endogenous JMJD3 protein de-
tected by a specific antibody, or in a stable cell line ex-
pressing yellow fluorescence protein (YFP)-tagged
JMJD3, localized to 20–40 nuclear foci that are 0.2–
0.5 µm in diameter in human U2OS osteosarcoma
cells. These foci are relatively static structures and do
not change their position relative to each other over sev-
eral hours in interphase cells. The foci break up in
prophase of mitosis and form once again in the G1
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phase of the cell cycle. Deletion analysis has shown that
the nuclear localization of the JMJD3 protein requires
the amino-terminal portion of the protein, whereas lo-
calization to nuclear foci depends on an intact zinc fin-
ger domain close to the carboxyl terminus. Conversely,
the catalytic JmjC domain, or an intact Fe(II)-binding
site in the catalytic domain, is dispensable for localiza-
tion to JMJD3 foci. An examination of the dynamics
of the JMJD3 protein by fluorescence recovery after
photobleaching (FRAP) has shown that the population
of the JMJD3 protein residing in foci has a relatively
slow exchange rate, with a half-recovery time of 12 sec
(+/– 1.9) and an immobile fraction of 20%. In contrast,
the diffuse pool of JMJD3 has a fast half-recovery time
of ~1 sec and no immobile fraction. Interestingly, the
slow recovery of JMJD3 within foci depends on the
presence of its catalytic domain, and removal of this do-
main leads to faster recovery (5.2 sec +/– 0.8) and the
loss of the immobile fraction. These data suggest that
it is the functional pool of the protein that is localized
to JMJD3 foci. The JMJD3 foci do not show signifi-
cant colocalization with sites of ongoing transcription
(RNA polymerase II Ser-2-P, H3K4me3, AcH3). How-
ever, they colocalize with marks of heterochromatin
(HP1α, HP1γ, H3K9me3). Similarly, the JMJD3 pro-
tein shows a low level of colocalization with a 200-copy
transgene array stably integrated on human chromo-
some 1p36 in U2OS 2-6-3 cells (Janicki et al., Cell 116:
683–698 [2004]). Importantly, upon transcriptional
induction of this locus by doxycycline, JMJD3 becomes
rapidly (within 3 min) and transiently recruited to the
locus. This recruitment precedes the detection of RNA
transcripts by ~10 min, indicating that JMJD3 might
have a role in the early events of transcriptional induc-
tion. In accordance with the live cell imaging data,
chromatin immunoprecipitation experiments revealed
that JMJD3 shows a low level of binding to the unin-
duced locus. Importantly, upon transcriptional induc-
tion, JMJD3 becomes recruited primarily to the
boundary between the promoter and the coding region
where it shows a threefold enrichment compared to the
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duction observed in interphase, RNA pol II reached its
maximal signal intensity at the locus in only 2–4 min
postmitosis, with mRNA production peaking at 15–30
min. This observation suggested that the cell is somehow
able to remember, or “bookmark,” the locus as one need-
ing to be transcribed such that the transcription machin-
ery can be rapidly recruited to the locus when cellular
transcription is reactivated after mitosis. Interestingly, we
detected a rapid recruitment of the chromatin remodel-
ing protein Brd4 in early G1, which occurs ~2–4 min 
earlier than RNA pol II and positive transcription elon-
gation factor b (P-TEFb). Next, we examined whether
specific histone modifications were also associated with
the loci during mitosis. Chromosome immunoprecipi-
tation (ChIP) experiments showed about fourfold en-
richment of histone H4 lysine-5 acetylation (H4K5Ac),
a mark recognized by Brd4, at the locus upon induction
in interphase. These data suggest that both Brd4 and the
histone modification are part of a “bookmarking” com-
plex at the locus. Interestingly, when transcription elon-
gation is inhibited prior to mitosis by treating cells with
5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)
and then releasing them and allowing the cells to proceed
through mitosis, RNA pol II is still rapidly recruited to
the locus after mitosis, although mRNA synthesis occurs
more slowly. These results imply that transcriptional ini-
tiation and transcriptional elongation are separately
bookmarked. This study has provided a real-time view
of interphase transcriptional induction and postmitotic
reactivation at a single genetic locus and provides a sys-
tem in which we will continue to study how gene expres-
sion patterns are transmitted to daughter cells post-
mitosis.
In addition to examining the dynamics of transcrip-
tion, we have also been interested in examining the as-
sembly of the DNA-repair nanomachinery at sites of
DNA damage. Current methodologies, to specifically
correct mutations both reproducibly and robustly at a
given site in the genome of mammalian cells, are lim-
ited. This is because of the high frequency of nonho-
mologous end joining (NHEJ) compared to the
homologous recombination (HR) mechanism. How-
ever, engineered chimeric zinc finger nucleases (ZFNs)
that combine the nonspecific cleavage domain of the
FokI restriction endonuclease, with custom-designed
zinc finger domains, specific to unique DNA se-
quences, represent a very promising approach because
inducing a DNA break by ZFNs increases the fre-
quency of HR. To visualize the repair process at high
resolution, and in living cells, we have used U2OS 2-
6-3 cells and a microscope platform called OMX.
uninduced state within 1 h of induction. In compari-
son, recruitment to the body of the coding region is
slightly less (2.5-fold) and is weak within the 3′ un-
translated region (3′UTR; 1.5-fold). Upon prolonged
induction, JMJD3 levels at the locus decline, and after
4 h of induction, JMJD3 binding to the locus is
twofold below the initial level of the uninduced locus.
Next, we examined a second cell type to determine
whether JMJD3 shows a localization to nuclear foci
similar to that observed in U2OS cells and whether
JMJD3 changes its localization upon transcriptional in-
duction of endogenous genes by a ligand-activated
stimulus. To this end, we used MCF7 human breast
cancer cells, in which a number of well-characterized
endogenous genes are induced by the steroid hormone
estradiol. Similar to that observed in U2OS cells,
JMJD3 localized to nuclear foci, albeit with a larger dif-
fuse pool as compared to U2OS cells. Importantly,
upon administration of 10 nM estradiol, these foci be-
come more prominent transiently. Interestingly, upon
short hairpin RNA (shRNA)-induced knockdown of
JMJD3, the inducibility of estradiol-inducible genes is
reduced, indicating that JMJD3 has a role in estrogen-
receptor-mediated gene transcription. Experiments are
under way to study the role of JMJD3 on estradiol-in-
duced genes on a genome-wide level and to determine
if estradiol-induced genes localize to JMJD3 foci in
MCF7 cells. 
A second major focus of our efforts during the past
year has been a comparative study of the kinetics of tran-
scriptional induction of the same genetic locus in inter-
phase and postmitotic U2OS 2-6-3 cells. This cell system
allows us to directly visualize gene expression (DNA,
RNA, protein) within the context of a living cell. In in-
terphase, after transcriptional induction, we observed de-
condensation of the locus from a heterochromatic to a
euchromatic state, followed by the accumulation of RNA
polymerase II (RNA pol II) at the locus and the produc-
tion of nascent transcripts. By plotting the relative fluo-
rescence intensity of the locus over time, we found that
RNA pol II levels and mRNA production gradually in-
creased over time, taking ~180 min to reach a maximal
signal intensity. We similarly studied the kinetics of tran-
scriptional initiation of this genetic locus upon exit from
mitosis. In this case, we kept the locus in a transcription-
ally active state and allowed it to naturally shut down
upon entry into mitosis. Upon exit from mitosis, in the
presence of doxycycline, RNA pol II was recruited to the
locus after nuclear envelope reformation in telophase,
and mRNA synthesis was first detected ~3–5 min later.
In contrast to the relatively slow, gradual kinetics of in-
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OMX (optical microscope experimental) is a new
microscope platform (Fig. 1) with unprecedented me-
chanical and thermal stability, coupled with high sen-
sitivity and increased signal:noise ratio for
photon-limited bioimaging. We are currently one of
seven laboratories in the world to have implemented
this microscope system. In the structured illumination
mode (SIM), OMX allows for imaging at super resolu-
tion of ~100 nm (beyond the diffraction limit). In the
live cell imaging mode, the microscope allows for rapid
image acquisition in four channels using EMCCD
cameras. Thus, OMX is ideal for rapid/fast live cell im-
aging and super-resolution imaging. The OMX system
is equipped with five laser lines (405, 457, 488, 514,
and 594 nm). The twofold increase in resolution (X, Y,
and Z) will provide a major advantage to our studies
aimed at understanding the assembly of the DNA-re-
pair machinary at the site of a single double-strand
break (DSB) in our newly developed one-to-few copy
DSB reporter cell lines. During the past year, we have
optimized the three-dimensional (3D)-SIM imaging for
the recruitment of the DNA-repair nanomachinary
(mCherry-53BP1, EYFP-Rad51) to ZFN-induced
DSB break sites marked by LacI-ECFP. Ongoing stud-
ies are aimed at elucidating the kinetics of assembly and
disassembly of the DNA-repair machinery. 
Identification and Characterization 
of Nuclear-retained Noncoding RNAs
Y. Mao, H. Sunwoo, B. Zhang
Although it has been generally assumed that most ge-
netic information is expressed as and transacted by pro-
teins, recent evidence from genomic tiling arrays and
large-scale cDNA-cloning projects suggests that the
majority of the transcriptional output of the mam-
malian genome represents RNA that does not code for
proteins. These noncoding RNAs (ncRNAs) include
microRNAs, Piwi-interacting RNAs (piRNAs), and
small nucleolar RNAs (snoRNAs), as well as a signifi-
cant number of longer transcripts, most of whose func-
tions are unknown. These longer transcripts probably
do not simply represent transcriptional “noise” because
many have been shown to exhibit cell-type-specific ex-
pression, localization to specific subcellular compart-
ments, and association with human diseases. Therefore,
the big and largely unanswered question that we are
Figure 1. The OMX microscope is optimized for rapid live cell imaging and super-resolution (100 nm) imaging of fixed cells.
trying to address is: What are the functions of these
long ncRNAs? 
Using microarray analysis in collaboration with J.
Mattick’s laboratory (Institute for Molecular Bio-
science, University of Queensland, St Lucia, Australia),
we have examined ncRNAs whose expression levels
change after mouse C2C12 myoblasts differentiate into
myotubes. RNA FISH (fluorescence in situ hybridiza-
tion) analysis of candidate clones revealed one clone,
corresponding to the MEN ε/β locus, that is up-regu-
lated 3.3-fold upon myoblast differentiation to my-
otubes. Two ncRNA isoforms are produced from a
single RNA pol II promoter, differing in the location
of their 3′ ends. MEN ε is a 3.2-kb polyadenylated
RNA, whereas MEN β is a ~20-kb transcript contain-
ing a genomically encoded poly(A)-rich tract at its 3′
end. These RNA transcripts are broadly expressed in
adult mouse tissues and conserved among mammals.
The MEN ε/β transcripts are localized to nuclear para-
speckles and directly interact with p54/nrb. Knock
down of MEN ε/β expression results in the disruption
of nuclear paraspeckles. Furthermore, the formation of
paraspeckles, after release from transcriptional inhibi-
tion by DRB treatment, was suppressed in MEN ε/β
depleted cells. Our findings indicate that the MENε/β
ncRNAs are essential structural/organizational compo-
nents of paraspeckles. Ongoing studies are examining
the mechanism by which these ncRNAs are retained in
the nucleus and their potential function in myoblast
differentiation.
In addition, during the past year, we have developed
a stable mouse myoblast cell line in which we can in-
ducibly express MEN ε RNA containing an MS2-con-
jugated fluorescent tag. Using this system, we have been
able to demonstrate that paraspeckles are formed at the
MEN ε transcription site. In addition, we have been
able to characterize the dynamics of the MEN ε RNP
with respect to its transcription site and other nuclear
domains. We find several categories of dynamic events.
In ~25% of the cells, the MEN ε RNPs form stable
clusters, in 15% of the cells, they are highly dynamic,
and in 60% of the cells, they are released from the tran-
scription site and then move to other nuclear locations
including existing paraspeckles. Ongoing studies are ex-
amining the function of MEN ε/β RNAs in differenti-
ation.
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The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifer-
ation of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usually
regress after some time, but certain types of human pa-
pillomaviruses (HPVs) give rise to tumors that are
prone to progress toward malignancy. This is frequently
the case, especially for cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive cer-
vical carcinoma and thus represents one of the few
firmly established links between viral infections and the
development of cancer. 
An impediment to the study of papillomaviruses has
been the inability to define simple in vitro cell culture
systems for analysis of the viral life cycle. These viruses
normally require specialized differentiating cells that only
with difficulty can be generated in cell culture. However,
for a bovine papillomavirus (BPV-1), a convenient cell
culture system exists where viral gene expression, onco-
genic transformation, and viral DNA replication can be
studied. Thus, BPV has become a useful model for these
aspects of the viral life cycle. The DNA replication prop-
erties of the papillomaviruses show some unique and in-
teresting characteristics. As part of their normal life cycle,
these viruses can exist in a state of latency, which is char-
acterized by maintenance of the viral DNA as a multi-
copy plasmid in infected cells. The copy number of the
viral DNA is tightly controlled, and the viral DNA is sta-
bly inherited under these conditions. Papillomaviruses
therefore provide a unique opportunity to study plasmid
replication in mammalian cells. In addition, the viral
DNA replication (ori) machinery represents one of the
most promising targets for antiviral therapy. 
In previous years, we have reported the characteriza-
tion of the papillomavirus replicon and the identification
of the viral components that are required for viral DNA
replication. In recent years, we have directed our atten-
tion toward the biochemical events that are associated
with initiation of DNA replication. We are studying the
biochemical properties of the viral E1 and E2 proteins
and how these two proteins interact with the viral origin
of DNA replication (ori) and with the cellular replication
machinery to generate initiation complexes. Our studies
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demonstrate that the E1 protein has all of the character-
istics of an initiator protein, including ori recognition,
DNA-dependent ATPase activity, and DNA helicase ac-
tivity. The transcription factor E2, whose precise func-
tion has remained more elusive, appears to serve largely
as a loading factor for E1. Through direct physical inter-
actions with both E1 and the ori, E2 provides sequence
specificity for the formation of the initiation complex. 
We are currently attempting to elucidate how the E1
and E2 proteins orchestrate the precise biochemical
events that precede initiation of DNA replication at the
viral ori. These events include binding of the initiator
to the ori, the initial opening of the DNA duplex (melt-
ing), and the assembly and loading of the E1 replicative
helicase at the replication fork. Our studies so far indi-
cate that these activities are generated in an ordered
process that involves the sequential assembly of E1 mol-
ecules on the ori. This sequential assembly generates
different complexes with different properties that in
turn recognize ori, destabilize the double helix, and
function as the replicative DNA helicase. 
ATP Binding and Hydrolysis 
by the E1 Initiator Protein
The E1 protein is a member of the AAA+ family of pro-
teins and can bind and hydrolyze ATP. The ATP-bind-
ing pocket is formed between two adjacent subunits in
E1 oligomers. Analysis of the structure of the E1 helicase
and oligomerization domain has revealed that a total of
10 residues are likely to be involved in ATP binding and
hydrolysis. To determine the precise function of these
residues in ATP binding and hydrolysis, we mutated
them to alanine, purified the mutant proteins, and ana-
lyzed them for the ability to bind and hydrolyze ATP. 
All mutant proteins were structurally intact based on
their ability to form the E12E22–ori complex whose for-
mation does not require ATP. As expected, all the mu-
tants, with one exception (Y534A), showed severe defects
for ATPase activity, demonstrating a defect in either
binding or hydrolysis of ATP. To distinguish between 
the ability to bind and to hydrolyze ATP, we tested the
mutants for E1 trimer and double trimer (DT) forma-
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sively, resides in the E1 DBD. This DNA-binding ac-
tivity is required for tethering of the E1 protein to the
viral origin of DNA replication, which contains four
E1-binding sites (E1 BS). A poorly characterized DNA-
binding activity is present in the helicase and oligomer-
ization domain. This activity binds to double-stranded
DNA without sequence specificity and is required for
attachment of the E1 helicase domain to the sequences
flanking the E1 BS to form an E1 DT complex on the
ori DNA. The DT is required for local melting of the
ori DNA and serves as a direct precursor for the E1
double hexamer, which is the replicative DNA helicase. 
We have previously demonstrated that two residues
(K506 and H507) in a β-hairpin structure present in
the E1 helicase domain are required for this nonspecific
DNA-binding activity. To further identify residues that
might be involved in the nonsequence-specific DNA
binding by the E1 helicase domain, we extracted a
monomer of the E1 helicase and oligomerization do-
main from the hexameric structure and placed it on
DNA such that the β-hairpin residues K506 and H507
were in contact with the DNA. On the basis of this
model, we identified 14 residues in the helicase and
oligomerization domains that might contact DNA. We
mutated these residues to alanine and expressed and pu-
rified the mutant proteins from Escherichia coli. We
screened the mutant proteins for E1 trimer and DT for-
mation and identified three residues that in addition to
the previously identified K506 and H507 affected the
ability of E1 to form the E1 trimer and DT. These
residues are present in three elements in the E1 helicase
domain. The β-hairpin contains three residues (R505,
K506, and H507) that are involved in nonspecific
DNA binding. A hydrophobic loop contains F464 and
in close proximity, a charged loop contains K461. To
directly test whether these mutants affected the non-
specific DNA-binding activity of the E1, we used a
competition assay where we challenged sequence-spe-
cific DNA binding of E1 to E1 BS with nonspecific
competitor DNA. Due to the presence of the nonspe-
cific DNA-binding activity in the helicase domain,
binding of wild-type E1 is very sensitive to competitor
DNA. Mutations that reduce the nonspecific DNA-
binding activity show resistance to competitor DNA.
The five mutants that were defective for trimer and DT
formation all showed increased resistance to competitor
DNA, indicating that these mutations specifically af-
fected nonspecific DNA-binding activity. As expected,
all of the mutations that affected nonspecific DNA
binding were also defective for DNA replication in vitro
and in vivo. These results identify a novel DNA-bind-
tion, which require ATP binding, but not hydrolysis. Six
of the mutants—K425A, K439A, S440A, D497A,
Y499A, and R538A—were defective for trimer forma-
tion, demonstrating that these mutants are defective for
ATP binding. The remaining four mutants—D478A,
D479A, N523A, and Y534A—were active for trimer
formation. Interestingly, two of these mutants, D478A
and N523A, showed significant trimer formation even
in the absence of nucleotide. This result indicated that
these two mutations might generate a conformational
change that mimics the nucleotide-bound state. How-
ever, when we tested the mutants for DT formation in
the absence of nucleotide, these mutants did not form
DT but instead formed ladders. Upon addition of nu-
cleotide, the DT was formed, demonstrating that these
mutants are able to bind nucleotide. One interpretation
of these results is that nucleotide binding serves two dif-
ferent functions for E1 DNA binding. The first function
could be a general activation of DNA binding, which is
mimicked by the mutants at residues 478 and 523. The
second function could be a direct dependence on bound
nucleotide for formation of the DT complex, which the
mutations at 478 and 523 cannot mimic. The general
lack of DNA-binding activity of E1 in the absence of nu-
cleotide presents an obvious possibility. The E1 DNA-
binding domain (DBD) may be regulated by the
interaction with other parts of the E1 protein. To deter-
mine whether this was the case, we performed pull-down
experiments using the E1 DBD and other parts of E1.
Interestingly, the E1 DBD interacted strongly with a
fragment containing the oligomerization and helicase do-
main fragments, and furthermore, this interaction was
significantly weakened by the presence of nucleotide.
These results indicate that the natural state of the E1
DBD in the absence of nucleotide is in a complex with
the E1 helicase domain, where the DNA-binding surface
of the E1 DBD is hidden. Upon addition of nucleotide,
binding of the nucleotide to its binding site in the E1
helicase domain releases the E1 DBD from its interaction
with the helicase domain and exposes the DNA-binding
surface. These data for the first time provide a molecular
explanation for how nucleotide binding activates DNA
binding by replication initiator proteins.
Structure-based Mapping 
of the Nonspecific DNA-binding 
Activity in the E1 Helicase Domain
The E1 initiator protein contains at least two distinct
DNA-binding activities. A sequence-specific DNA-
binding activity, which we have characterized exten-
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ing activity in the helicase domain of the E1 initiator
proteins, which likely is conserved also for the T anti-
gens of the polyomaviruses. 
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Approximately 15 years ago, we successfully reconsti-
tuted the complete replication of the small simian virus
40 (SV40) genome with purified human cell proteins
and the essential virus-encoded T antigen, which is the
protein that serves multiple functions as an origin recog-
nition protein, a DNA helicase, and a DNA primase and
polymerase loading protein. That significant achieve-
ment allowed us to investigate how those proteins copied
both strands of the double helix to produce two identical
genomes and set the stage for understanding how cellular
chromosomes duplicate. Just 2 years before this work was
published, we reported the structure of the first eukary-
otic cell origin of DNA replication to be characterized in
detail and also identified the origin recognition complex
(ORC), a six-subunit protein that binds to origins of
DNA replication, thereby beginning the complex process
of initiation of DNA replication throughout the entire
cell genome. The discovery of ORC facilitated the rapid
identification of other initiation proteins, such as Cdc6,
Cdt1, and the MCM2–7 hexamer of proteins that com-
bined to form a prereplicative complex (pre-RC) that
renders chromosomes competent for subsequent initia-
tion of DNA replication that occurs in S phase of the cell
division cycle. Moreover, these studies resulted in a de-
tailed description of how the initiation of DNA replica-
tion in eukaryotic cells is regulated throughout the cell
division cycle and how DNA replication occurs only
once before the execution mitosis. This year, we, in col-
laboration with former postdoctoral fellow Christian
Speck, who now has his own laboratory at the MRC in
London, reported the reconstitution of pre-RC assembly
in vitro with purified proteins. John Diffely’s laboratory
at Clare Hall near London also reported in 2009 the re-
constitution of pre-RC assembly in vitro with highly pu-
rified proteins. These two studies have now set the stage
for understanding of how DNA replication forks are es-
tablished in eukaryotic cells. 
Mechanism of Pre-RC Assembly
A major goal of our studies on DNA replication was to
identify the molecular mechanisms of pre-RC assembly, 
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a process involving ORC, Cdc6, Cdt1, and the MCM2–7
proteins that are thought to be the essential core of the
replicative helicase complex. The pre-RC is formed at each
origin of DNA replication as cells exit mitosis or as cells
progress though G1 phase. Pre-RC assembly defines a state
in which all chromosomes are licensed for a new round
of initiation of DNA replication that occurs later in S
phase, after cells commit to cell division. Thus, the mo-
lecular nature of the pre-RC and which proteins are both
necessary and sufficient for its assembly have been of con-
siderable interest. The ORC, Cdc6, Cdt1, and the
MCM2–7 proteins were identified as essential for pre-RC
assembly in vivo using a combination of genetics and bio-
chemistry, but we did not know if they were sufficient.
Other proteins, such as Noc3, have been implicated as es-
sential for pre-RC assembly, but the role of these proteins
has remained controversial.
In prior years, we have characterized the interactions
between ORC and Cdc6 and have shown that Cdc6
binds to ORC and activates the ORC ATPase activity
that it inhibited when ORC binds to origins of DNA
replication. Furthermore, we have shown that addition
of Cdc6 to ORC that is bound to the origins DNA
greatly extends the nuclease protection footprint of the
origin from 48 bp to more than 80 bp. The extended
footprint of the ORC–Cdc6 complex requires the ac-
tivity of the Cdc6 ATPase and specific nucleotides
within the origin DNA. The assembly of the ORC–
Cdc6 complex was thought to be a precursor for load-
ing of the MCM2–7 complex onto DNA by the Cdt1
chaperone. In the past year or two, we have focused on
the loading of the MCM2–7 complex.
A protein complex consisting of Cdt1 bound to
MCM2–7 was purified from yeast cells that had been ar-
rested in G1 phase. This complex did not exist in S- or
G2-phase cells. We were able to express Cdt1 in Es-
cherichia coli, and Christian Speck, when he moved to
his own lab at the MRC in London, was able to over-
express and purify the MCM2–7 complex from G1-phase
yeast cells. When combined with ORC and Cdc6, the
Cdt1 and MCM2–7 complex were active in loading the
MCM2–7 proteins onto DNA in a highly efficient man-
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is the amino terminus of the Mcm4 protein. We also
demonstrated that the Mcm4 amino terminus contains
both inhibitory and activating regions for the initiation
of DNA replication after formation of the pre-RC, a
process that requires both DDK and the S-phase-
specific cyclin-dependent protein kinase CDK. We re-
ported that deletion of the inhibitory sequences from
the Mcm4 amino terminus was sufficient to bypass the
dependence on DDK for cell viability and initiation of
DNA replication. This argued that the Mcm4 amino
terminus was the critical and essential target for regu-
lation by DDK, but it did not mean that this was the
only target.
In an effort to identify other DDK targets, we col-
laborated with Mike Snyder and Ben Turk at Yale who
had devised a high-throughput method for analysis of
large number of peptides that each had a carboxy-ter-
minal biotin tag as substrates for various protein ki-
nases. The phosphorylated peptides were identified by
printing the peptides on a streptavidin-coated array and
detecting the phosphorylation. Using this method, they
applied DDK along with 60 other protein kinases from
yeast, and based on the peptide sequence, the DDK was
found to have a remarkably relaxed requirement for
amino acid sequence at the site of phosphorylation. The
study linked DDK to the acidophilic protein kinases
that included Polo-like kinase (Cdc5), casein kinases 1
and 2 (CK1 and CK2), and glycogen synthase kinase 3
(GSK3). Thus, the specificity of the kinase was not em-
bedded in the substrate, but most likely how the kinase
binds to its substrate. We have shown that DDK binds
to a docking site in Mcm4 that is adjacent to the phos-
phorylation site. This opens the door to perform a
screen for DDK-binding proteins as potential sub-
strates.
Role of ORC in Human Cells in the
Maintenance of Heterochromatin
The ORC is generally known as a DNA replication ini-
tiator protein, but during recent years, we and other
investigators have shown that it is involved in diverse
cellular functions including gene silencing, sister-chro-
matid cohesion, telomere biology, heterochromatin lo-
calization, centromere and centrosome activity, and
cytokinesis. Recent studies of ORC in human cells
have revealed that multiple ORC subunits associate
with HP1α and HP1β containing heterochromatic
foci. By investigating the recovery of fluorescently la-
beled ORC subunits that were photobleached in vivo
by lasers, we have shown that multiple subcomplexes
ner. MCM2–7 complex loading was dependent on ORC,
Cdc6, and Cdt1, and in the presence of competitor
DNA, the loading occurred specifically at the geneti-
cally defined origin of DNA replication. In the absence
of competitor DNA, efficient MCM2–7 complex load-
ing was achieved on nonorigin DNA. Other proteins
such as Noc3 were not required. The loading was ATP-
hydrolysis dependent.
The MCM2–7 complex purified from yeast cells was
a hexamer consisting of one of each of the Mcm2,
Mcm3, Mcm4, Mcm5, Mcm6, and Mcm7 proteins;
however, after loading, the MCM2–7 proteins were now
present in a double hexamer (dodecamer) structure.
Moreover, the dodecamer of MCM2–7 was able to slide
along the DNA because it was stably associated with
circular DNA, but slid off linear DNA. When the linear
DNA was blocked with a streptavidin protein bound
to a biotinylated nucleotide at the ends of the linear
DNA, sliding off the DNA was prevented. We con-
cluded that the MCM2–7 dodecamer complex was topo-
logically linked to the double-stranded DNA and that
it could slide, but dissociate from, the double-stranded
DNA unless a double-strand break occurred in the
DNA.
These results were very similar to results published
at about the same time from John Diffley’s laboratory
(Remus et al., Cell 139: 719 [2009]), and combined,
they represent a major advance in understanding the
mechanism of initiation of DNA replication. We now
know that for loading of MCM2–7 complex, ORC,
Cdc6, and Cdt1 are sufficient, but the results raise
many interesting questions, particularly how is a double
hexamer of MCM2–7 loaded onto DNA by an apparent
single ORC and Cdc6 complex and how can the dou-
ble hexamer be activated to become a DNA helicase?
We are investigating these and other questions.
To facilitate the biochemical characterization of pre-
RC assembly and subsequent steps in the initiation of
DNA replication, we have expressed the MCM2–7 pro-
teins in baculovirus-infected insect cells and have puri-
fied the MCM2–7 complex using Cdt1 protein affinity
chromatography. In this manner, a highly purified
Cdt1–MCM2–7 complex can be obtained, and it also
supports pre-RC assembly in vitro with purified ORC
and Cdc6.
Control of the Initiation of DNA
Replication by the Kinase DDK
In the last year, we have reported that the major and es-
sential target of the Cdc7-Dbf4 (DDK) protein kinase
of ORC exist at heterochromatin, with Orc1 stably as-
sociated with heterochromatin in G1 phase, and other
ORC subunits having more transient interactions
throughout the cell division cycle. Both Orc1 and
Orc3 directly bound to HP1α and two domains of
Orc3—a coiled coil domain and a MIR domain—can
independently bind to HP1α; however, both are es-
sential for in vivo localization of Orc3 to heterochro-
matic foci. Direct binding of both Orc1 and Orc3 to
HP1 suggests that following the degradation of Orc1
at the G1/S boundary, Orc3 facilitates assembly of
ORC/HP1 proteins to chromatin. Although depletion
of Orc2 and Orc3 subunits by small interfering
(siRNA) caused loss of HP1α association to hete-
rochromatin, loss of Orc1 and Orc5 caused aberrant
HP1α distribution only to pericentric heterochro-
matin surrounding nucleoli. Depletion of HP1α from
human cells also shows loss of Orc2 binding to hete-
rochromatin, suggesting that ORC and HP1 proteins
are mutually required for each other to bind to hete-
rochromatin. Similar to HP1α-depleted cells, Orc2
and Orc3 siRNA-treated cells also show loss of com-
paction at satellite repeats, suggesting that ORC to-
gether with HP1 proteins may be involved in
organizing higher-order chromatin structure.
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The maintenance of normal cellular homeostasis re-
quires that cells synthesize proteins when they are
needed and destroy them when their function is no
longer appropriate. These two “bookends” that define
the life of any protein are, respectively, transcriptional
regulation and ubiquitin (Ub)-mediated proteolysis.
Despite the apparent dissimilarity of these processes, a
growing body of evidence suggests that components of
the Ub–proteasome system are intimately involved in
regulating gene activity. Work in our laboratory takes
advantage of the connection between the transcription
and Ub–proteasome systems to achieve two objectives:
To gain new insight into the actions of the oncoprotein
transcription factor Myc and to probe the depth with
which the factors normally associated with protein de-
struction are involved in regulating gene activity. 
Regulation of Myc by Ub-mediated
Proteolysis 
The c-Myc oncogene encodes a basic helix-loop-helix
leucine zipper transcription factor that can act as both
a transcriptional activator and a repressor. First identi-
fied as a cellular counterpart of the transforming gene
from the avian myelocytomatosis virus MC29, Myc has
been shown to have an extensive role in cancer: It can
collaborate with other oncogenes to induce cellular
transformation, and aberrant Myc expression is ob-
served in many human malignancies, including adeno-
carcinoma, colon, breast, and lung cancer, as well as a
variety of leukemias and lymphomas. Indeed, it has
been estimated that one-third of all human cancers dis-
play deregulated Myc activity and that one American
dies every 7 minutes as a result of ectopic Myc expres-
sion or activity.
The majority of evidence indicates that Myc exerts
its biological effects by controlling transcription. Acti-
vation of Myc target genes depends on the association
of Myc with its partner protein, Max, and is mediated
via the actions of an amino-terminal transcriptional ac-
tivation domain (TAD) that interacts with components
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of the transcriptional machinery. A large number
(~1700) of Myc target genes have been identified, in-
cluding an impressive assortment of cell-cycle regulators,
metabolic enzymes, and components of the translational
machinery. The ability of Myc to regulate so many genes
important for cell proliferation and growth undoubtedly
underlies its ability to promote ectopic S-phase entry,
apoptosis, and cellular transformation.
Because of its potent growth-promoting properties,
cells have evolved a number of mechanisms to limit Myc
accumulation and activity. One of the most prominent
of these mechanisms is Ub-mediated proteolysis, which
typically destroys Myc within minutes of its synthesis.
The rapid and controlled destruction of Myc keeps its
levels low and has a major role in restraining Myc’s func-
tion, a notion supported by the fact that tumor-derived
mutations within Myc block its rapid destruction and
are aggressively oncogenic. Our laboratory is interested
in the mechanisms and consequences of Myc destruc-
tion by the Ub–proteasome system. During the years
that we have studied this process, we have defined the
elements in Myc that control its stability, identified pro-
teins that interact with these elements, and probed how
the turnover of Myc impacts its activity as an transcrip-
tion factor and oncoprotein.
In the last year, we have pursued three main avenues
of research on Myc. First, we have probed the role that
a conserved region known as “Myc box III” (MbIII) has
in the function of Myc. Our previous studies have re-
vealed that this element is important for signaling Myc
proteolysis and that in the absence of this conserved se-
quence, Myc becomes “hyperapoptotic” and hence less
able to drive cellular transformation. In the last year, we
identified a number of protein factors that interact with
this region of Myc and are in the process of asking how
these factors influence Myc stability and activity. 
Second, we revisited the issue of whether the Ub-
mediated proteolysis of Myc is subverted in cancer. Our
work on this topic goes back to the early days of the
laboratory, when we found that a commonly occurring
tumor-derived mutation in Myc, threonine 58 to ala-
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ries, including our own, has revealed that these two
processes come together to control gene activity. Our
efforts in this area began with the observation that,
within Myc, the element that signals Myc ubiquityla-
tion overlaps precisely with the domain that activates
transcription. Subsequent studies have revealed that the
overlap of TADs and degrons occurs in most unstable
transcription factors, that the relationship between
these elements is intimate, and that, in some cases, the
ability of an activator to engage the Ub–proteasome sys-
tem is essential for transcription activation. Together
with other findings demonstrating that Ub-ligases can
function as transcriptional co-activators, that some gen-
eral transcription factors have Ub-ligase activity, and
that components of the proteasome have a nonprote-
olytic role in transcriptional elongation and chromatin
modifications, these observations suggest a deep and
mechanistic connection between the transcription and
ubiquitin systems that we are anxious to explore.
Our research in this area uses the yeast Saccharomyces
cerevisiae to probe the basic connections between the
transcription and ubiquitin systems. Two areas of re-
search have been particularly productive in the last year.
First, we have continued our studies of the prototypical
yeast activator Gal4. We have found that Gal4 is un-
stable when it activates transcription, that it is destroyed
by the Dsg1 Ub-ligase, and that ubiquitylation and/or
destruction of Gal4 is important for its ability to pro-
ductively activate transcription. Recently, this notion
was challenged when a competing group reported that
when Gal4 activates transcription, it stably associates
with chromatin and locks in to a solid complex that
cannot be competed off DNA. The notion that Gal4–
promoter complexes are static is incompatible with any
model in which proteolysis of the activator has an es-
sential role in transcriptional regulation. Using a variety
of assays, we have found that Gal4 associates with chro-
matin in a highly dynamic way and that reports to the
contrary are influenced by an artifact in experimental
design. These data support the idea that protein com-
plexes involved in transcription are dynamic structures
that depend on newly synthesized activators for contin-
ual activity.
Second, we examined carefully whether the prote-
olytic activity of the proteasome is required for GAL
gene activation in yeast. This is an area of considerable
controversy. To resolve this issue, we took two parallel
approaches. First, we combined chemical and genetic
inhibition of the protease activity of the proteasome
and found that GAL gene activation is severely attenu-
ated when proteasome function is impaired. Second,
nine (T58A), blocks its rapid destruction by the ub–
proteasome system. Subsequently, in collaboration with
the laboratory of Dr. Scott Lowe at CSHL, we found
that this mutation also enhanced the oncogenic poten-
tial of Myc and allowed Myc to drive tumorigenesis in
vivo without triggering p53-dependent tumor surveil-
lance mechanisms. Although we did not explore at the
time the extent to which tumor-derived mutations af-
fect Myc, we have addressed this topic in the last year.
Analysis of the literature reveals that in ~50% of cases
where the Myc gene is rearranged, there is some change
to the Myc coding sequence. Interestingly, these
changes cluster to just five regions of the Myc protein.
We examined the consequences of these changes and
found, remarkably, that mutations in four out of the
five “hot spots” stabilized Myc and (where examined)
activated its oncogenicity. These results demonstrate
that stabilization of Myc is a common—but not uni-
versal—consequence of tumor-derived mutations and
strongly implies that these mutations select for a process
that facilitates tumor formation. 
Finally, in an atypical set of experiments for us, we
collaborated with the Muthuswamy laboratory at CSHL
to examine how these mutants impact the ability of Myc
to function in a three-dimensional (3D) tissue culture
model of breast cancer. These experiments were spurred
on by our finding that some tumor-associated mutations
in Myc alter its ability to signal apoptosis and by reports
from other laboratories that epithelial cell polarity temper
Myc’s pro-apoptotic capabilities. During the course of
these studies, we found that Myc and the Myc mutants
behave very similarly in 2D and 3D tissue culture sys-
tems. We also found that the reported ineffectiveness of
Myc in 3D cultures is due to activation of a transcrip-
tional program in 3D that results in the near-complete
shutdown of Myc and Myc target gene expression. Thus,
although we can show that shutdown of Myc expression
is important for the development of normal polarized
epithelia, polarity itself does not attenuate Myc activity.
These results demonstrate that mechanisms to control
Myc expression—be they at the level of transcription or
of proteolysis—are critically important for protecting
cells against oncogenic insult by Myc and that cell po-
larity per se is not sufficient to keep Myc at bay. 
Control of Transcription by
the Ub–Proteasome System
Although transcriptional activation and Ub-mediated
proteolysis are two processes that have apparently very
little in common, research from a number of laborato-
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we developed highly selective monoclonal antibodies
against 19S and 20S subunits of the proteasome and
used chromatin immunoprecipitation and found that
when GAL genes are activated, both 19S and 20S sub-
units associate quickly with the active chromatin and
coat active genes as if they are moving with polymerase.
We also found that both 19S and 20S subunits disso-
ciate from chromatin within seconds of shutting down
GAL transcription. Together, these studies strongly sug-
gest that both the proteolytic and nonproteolytic ac-
tivities of the proteasome are important for gene
activation in yeast. We suggest that recruitment of pro-
teasomes to chromatin brings in a myriad of biochem-
ical properties to facilitate multiple steps in the
transcription process.
PUBLICATIONS
Chakraborty AA, Tansey WP. 2009. Adenoviral function through E1A.
Oncogene 69: 6–9.
Chakraborty AA, Tansey WP. 2009. Inference of cell cycle-dependent
proteolysis by laser scanning cytometry. Exp Cell Res 315: 1772–
1778.
Collins GA, Lipford JR, Deshaies RJ, Tansey WP. 2009. Gal4 turnover
and transcription activation. Nature 461: E7.
Daulny A, Tansey WP. 2009. Damage control: DNA repair, transcrip-
tion, and the ubiquitin–proteasome system. DNA Repair 8: 444–
448.
In Press
Wang X, Muratani M, Tansey WP, Ptashne M. 2010. Proteolytic insta-
bility and the action of non-classical activators. Curr Biol 20: 868–
871.
54 Research
Cancer Genetics focuses on understanding the genetic basis of cancer, cancer progression, and devel-
opment of resistance to chemotherapy.
Gurinder S. “Mickey” Atwal and colleagues are applying insights from the physical sciences to the
study of biological phenomena. Specifically, they develop and use mathematical and computational
tools to address quantitative principles governing the behavior of correlated “many-body” biological
systems. Such systems range from molecular interactions in a single cell to the evolution of Homo sapi-
ens. They are now seeking to understand evolutionary forces acting on the genome in the context of
human diseases. In collaborations with colleagues at the Institute for Advanced Study, Princeton, Atwal
has modeled the process by which genetic variants, or alleles, evolve. This has recently led to surprising
insights about the role in reproduction played by p53, a master tumor suppressor gene. This work also
bears on the question of demonstrating recent selective pressures acting on our genomes.
Alexander Krasnitz and colleagues use mathematical and statistical tools to discover key genetic
elements involved in cancer and to understand how cancer cells evolve. Array-based comparative
genome hybridization, a technique developed in the Wigler lab, and, more recently, sequencing ex-
periments, have revealed subtle patterns of frequent and widespread aberration in cancer genomes.
Krasnitz hypothesizes that aberrant genomic loci observed to recur in a range of cancer types are
under selection and therefore are enriched in important cancer genes. He has developed a novel,
comprehensive methodology to study such “epicenters” and has used it to analyze multiple-genome
data sets in breast, lung, colon and liver cancer. The results have been shared with cancer biology
labs across CSHL and have been a key enabling agent of functional studies using mouse models
and RNA interference. Krasnitz has begun to apply advanced statistical methods to the latest gen-
eration of experimental data, which have characterized tumor samples down to the level of single
cells. With such data he and colleagues seek to learn how specific cancer types evolve and how cancer
cells migrate in metastasis. 
Scott Lowe’s laboratory studies cancer gene networks and determines how genetic lesions affecting
these networks contribute to tumor development and resistance to therapy. This year, his team suc-
ceeded in developing mouse models of leukemia that accurately predict human responses to drug
resistance. In addition, Lowe has adapted RNA interference (RNAi) technology to produce animal
models in which genes can be switched on and off in a spatial, temporal, and reversible manner,
and he has used this to identify and characterize new genes that modulate tumor cell responses to
chemotherapy. Lowe also has spearheaded a collaborative effort involving four other CSHL labs to
identify novel tumor suppressor genes. He combined his earlier integrated oncogenomics approach
on human liver cancers with RNAi-based screening in a mouse model. This brought to light nearly
two dozen previously unknown tumor suppressor genes. Lowe and colleagues also continue to study
cellular senescence, a potentially powerful mechanism for suppressing tumor formation. They have
demonstrated that senescence helps limit wound-healing responses in liver disease, a finding that
suggests senescence has functional relevance, in addition to cancer, in the maintenance of tissue
homeostasis following damage.
Robert Lucito has had an important role along with Michael Wigler in developing innovative
technologies, including RDA, ROMA, MOMA and CGH, that have proven valuable to cancer re-
searchers worldwide. As an experimentalist, Lucito conducts studies using these techniques to detect
copy-number changes in large sets of human ovarian and pancreatic cancer tissue samples. His lab
also has turned its attention to epigenetics, specifically to the study of methylation throughout the
genome. When methyl groups in sufficient numbers attach to cytosine bases in DNA, the packing
of DNA into the chromosomes can be altered, reducing the levels at which the methylated genes
are expressed. Under circumstances that Lucito is exploring, this may be a means by which normally
protective tumor suppressor genes are turned off, rendering cells tumorigenic.
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Alea Mills is studying genetic pathways important in cancer and aging, identifying the genetic
players and determining how aberrations in their functions culminate in human disease. Through
innovative use of a technique called chromosome engineering, the Mills group identified a tumor
suppressor gene that had eluded investigators for three decades. The gene, called Chd5, was shown
by Mills to regulate an extensive cancer-preventing network. The epigenetic role of Chd5 in devel-
opment, cancer, and stem cell maintenance is currently being investigated. The Mills lab is also
studying p63 proteins, which regulate development, tumorigenesis, cellular senescence, and aging,
in vivo. This year, in model mice, they succeeded in halting the growth of malignant tumors in
which p53, a master tumor suppressor, was missing. The key was increasing production of one of
the proteins encoded by the p63 gene, called TAp63. This could point to new ways of treating ma-
lignancies with p53 deficiencies, which tend to be very aggressive and refractory to treatment.
Scott Powers’ work focuses on gene mutations that cause cancer and factors that influence re-
sponses to specific anticancer drugs. His lab uses technologies that probe the entire genome to iden-
tify candidate cancer genes and evaluate their functional role in cell transformation and tumor
biology. They also use whole-genome technologies to guide development of novel cancer diagnostics
and therapeutics. Using DNA copy-number analysis, the Powers group pinpoints novel amplified
oncogenes and then applies functional studies to address the validity of candidate genes and the
mechanisms by which they are implicated in oncogenesis. They have successfully applied this ap-
proach in liver, colon, and lung cancer. Powers has had an important role, along with Scott Lowe
and other investigators, in the development of a distinctive CSHL approach to functional study of
cancer genes. Called integrative oncogenomics, it is a rapid, large-scale screen for genes that are
deleted in human cancers and suspected of being tumor suppressors. An initial demonstration of
the approach, which worked with a list of 360 candidate human liver cancer genes identified by
Powers, culminated in the discovery, in mice, of 13 previously unknown tumor suppressors whose
deletion resulted in aggressive cancers. 
Michael Wigler’s group uses methods for comparative genome analysis to study cancer and other
human genetic diseases. These methods (called ROMA and MOMA) evolved from an earlier tech-
nique called RDA, used to find tumor suppressors, oncogenes, and pathogenic viruses. Current mi-
croarray-based techniques, including comparative genome hybridization (CGH), reveal changes in
the numbers of copies of sections of the genome and regions of deletion and duplication, mutations
that may underlie the evolution of cancers. Wigler’s group focuses on breast cancer and leukemias
and are engaged in clinical studies with major research hospitals to discover mutation patterns pre-
dicting treatment response and outcome. In this connection, they are also developing methods for
the analysis of the genomes of single cells. In collaboration with Jim Hicks and Gregory Hannon,
the lab has applied microarray techniques and hybrid selection to explore the role of epigenetics in
cancer. With Jonathan Sebat, they have made headway in the discovery of the causative mutations
in autism. Their results show that spontaneous mutation has a far greater role in autism than pre-
viously suspected. They have developed a new theory of autism’s genetic basis that explains otherwise
bewildering patterns of inheritance and are testing the new genetic model in other disabling genetic
disorders. Wigler also has spearheaded the development of a Center for Quantitative Biology at
CSHL, with initial funding from the Simons and Starr Foundations.
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During the past year, Marcela Monaco, a former postdoc
with Lincoln Stein, was hired as a consultant from July
to October. Suyash Shringapure, a summer research in-
tern, returned to Carnegie Mellon University to resume
his graduate studies at the Computer Science depart-
ment, but he continues to collaborate with Bud Mishra
and myself on a project we initiated at CSHL. Felix
Schlesinger, who worked as a graduate rotation student,
has accepted a position in the lab of Thomas Gingeras.
Ying Cai completed a graduate rotation and has since ac-
cepted a position in my lab. Bernard Fendler, having re-
cently been awarded a doctorate in theoretical physics,
was hired at the end of the year as a postdoctoral re-
searcher. Joshua Weiss started work as a volunteer as part
of the Partners for the Future program. Alexandra Sharpe
worked as a volunteer in the lab from July to October.
Cancer Risk and Haplotype Structure
of the MDM4 Gene
A large body of evidence strongly suggests that the p53
tumor suppressor pathway is central in reducing cancer
frequency in vertebrates. The protein product of the
haploinsufficient mouse double minute 2 (MDM2)
oncogene binds to and inhibits the p53 protein. Recent
studies of human genetic variants in p53 and MDM2
by our lab have shown that single-nucleotide polymor-
phisms (SNPs) can affect p53 signaling and confer can-
cer risk, and they suggest that the pathway is under
evolutionary selective pressure. We recently analyzed
the haplotype structure of MDM4, a structural ho-
molog of MDM2, in several different human popula-
tions. Unusual patterns of linkage disequilibrium (LD)
in the haplotype distribution of MDM4 indicated the
presence of candidate SNPs that may also modify the
efficacy of the p53 pathway. Association studies in five
different patient populations revealed that these SNPs
in MDM4 confer an increased risk for, or early onset
of, human breast and ovarian cancers in Ashkenazi Jew-
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ish and European cohorts, respectively. This not only
implicates MDM4 as a key regulator of tumorigenesis
in the human breast, but also exploits for the first time
evolutionary-driven linkage disequilibrium as a means
to select SNPs of p53 pathway genes that might be clin-
ically relevant.
Regulation of Human Fertility by SNPs
in the p53 Pathway
The tumor suppressor protein p53 has an important
role in maternal reproduction in mice through tran-
scriptional regulation of leukemia inhibitory factor
(LIF), a cytokine crucial for blastocyst implantation.
To determine whether these observations could be ex-
tended to humans, a list of SNPs in the p53 pathway
that can modify the function of p53 was assembled
and used to study their impact on human fertility. The
p53 allele encoding proline at codon 72 (P72) was
found to be significantly enriched over the allele en-
coding arginine (R72) among in vitro fertilization
(IVF) patients. The P72 allele serves as a risk factor for
implantation failure. LIF levels were significantly lower
in cells with the P72 allele than in cells with the R72
allele, which may have contributed to the decreased
implantation and fertility associated with the P72 al-
lele. Selected alleles in SNPs in LIF, Mdm2, Mdm4,
and Hausp genes, each of which regulates p53 levels in
cells, were also enriched in IVF patients. Interestingly,
the role of these SNPs on fertility was much reduced
or absent in patients older than 35 years of age, indi-
cating that other functions may have a more important
role in infertility in older women. The association of
SNPs in the p53 pathway with human fertility suggests
that p53 regulates the efficiency of human reproduc-
tion. These results also provide a plausible explanation
for the evolutionary-positive selection of some alleles
in the p53 pathway and demonstrate the alleles in the
p53 pathway as a good example of antagonistic
pleiotropy.
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eases. The novel entropy framework would be of value
for deciphering recent evolutionary histories of humans.
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Fine-scale Detection of Recent Selection
Signatures Using Haplotype Entropy
Creation of a coherent genomic map of recent selection
is one of the greatest challenges for a better understand-
ing of human evolution. Various methods have provided
the means for genome-wide linkage disequilibrium
analysis; however, there is still a gap for scanning with
short-intermediate resolution. Entropy, a measure of dis-
order in physics, has been proposed as a new concept to
measure genetic diversity and strength of linkage dise-
quilibrium of sequences. We produced a fine-scale ge-
nomic scan using haplotype entropy. The analysis with a
median resolution size of ~23 kb for HapMap SNPs data
of African and Caucasian populations depicted new re-
cent selection signatures, as well as known signatures.
Gene-enrichment analysis on the signatures showed as-
sociations with diverse diseases such as cardiovascular,
immunological, neurological, skeletal, and muscular dis-
Gurinder “Mickey” Atwal
Our lab focuses on three major areas of biology. For the
past decade, we have sought to understand the biological
roles of small RNAs and the underlying mechanisms by
which they operate. We have identified and character-
ized many of the major biogenesis and effector com-
plexes for small interfering RNAs (siRNAs) and
microRNAs (miRNAs), including Dicer, RISC (RNA-
induced silencing complex), and elements of the micro-
processor. During the past several years, we have focused
on the roles of small RNAs in germ cells, which tend to
have the most elaborate set of small RNA pathways of
any cell type. This led to the discovery of an essential
role for pseudogenes in producing small RNAs that are
critical for proper oocyte development and to the dis-
covery of an elegant small-RNA-based immune system
that guards the genome against transposable elements.
The latter system incorporates another small RNA class,
Piwi-interacting RNAs (piRNAs), into an adaptive cycle
that both responds to transposon challenge and can
communicate epigenetic information about that chal-
lenge from parent to progeny. The Hannon lab also
strives to understand the biology of cancer cells, with a
focus on breast and pancreatic cancer. Here, we are in-
terested in the roles of small RNAs as oncogenes and
tumor suppressors and in exploiting the RNA interfer-
ence (RNAi) libraries that we have developed to identify
new therapeutic targets for specific disease subtypes. Fi-
nally, we are taking genetic approaches to understand
the biology of resistance to currently used targeted ther-
apies. The third component of the laboratory exploits
the power of next-generation sequencing to understand
the biology of the mammalian genome. Our efforts
range from the identification of new classes of small
RNAs to understanding human evolution and diversity.
Most recently, we have placed a major emphasis on the
evolution of the epigenome and its role in driving cell-
fate specification. Highlights of scientific progress dur-
ing the last year are given below.
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The past year has seen a number of changes in the
members of the Hannon lab. Ingrid Ibarra, Xingyue He,
Colin Malone, Oliver Tam, Ikuko Hotta, and Yaniv Er-
lich successfully defended their theses and were awarded
Ph.D. degrees. Yaniv was recognized by the coveted
Weintraub Award for his thesis work. Kata Fejes-Toth
and Alexei Aravin both departed for faculty positions at
the California Institute of Technology. Michelle Rooks
departed to begin her Ph.D. studies. Angelique Girard
left for a postdoctoral fellowship at Harvard, and Monica
Dus for New York University. Vihra Sotirova left follow-
ing the birth of her first child, and Nobu Hiramatsu de-
parted to return to studies on ER stress. We were joined
by several students—Elvin Wagenblast, Antoine Molaro,
Felix Muerdter, Ben Czech, and Dario Bressan—and by
several postdoctoral fellows—Adam Rosebrock, Sun
Wook Chi, Jon Preall, and Yang Yu. Pramod Theekat,
Amy Valentine, and John Colagiola also joined the lab.
Elena Tonin also came as a visitor from the lab of a for-
mer CSHL colleague, Roberta Maestro, and Debbie
Goodman and Jacqueline Cortes spent brief stints in the
lab as undergraduate researchers.
The Search for Genes Involved in piRNA
Biogenesis and Function
A.D. Haase, P. Guzzardo, F. Muerdter, B. Czech 
piRNAs together with Piwi-clade Argonaute proteins
constitute an evolutionary conserved germline-specifc
small RNA silencing system that is implicated in gene
silencing, particularly of repetitive elements, germline
differentiation, and maintenance of germline stem cells;
mutations in Piwi almost universally lead to sterility
and germ cell loss.
We are working to identify and characterize genes in-
volved in piRNA biogenesis and function in a Drosophila
ovary somatic sheet (OSS) cell line. OSS cells, like ovar-
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mRNA in a spacially and temporally controlled man-
ner. The majority of miRNA–mRNA interactions do
not lead to Argonaute-directed cleavage but instead lead
to to destablilzation of the mRNA in a way that does
not depend on Ago catalysis. Nevertheless, the catalytic
potential of Ago2 is deeply conserved. In an effort to
understand the pressure for this conservation, we
searched for miRNA-directed Ago cleavage targets by
global RACE (rapid amplification of cDNA ends) of
mRNAs in wild-type and Ago2 mutant embryonic
stem (ES) cells. We identified a number of previously
unknown miRNA cleavage targets, but we also saw a
wide array of mRNA processing sites that could not be
explained by Ago. Another RNAi pathway component,
Drosha, had previously been implicated in the regula-
tion of one gene, DGCR8, by cleaving a site that resem-
bles a miRNA precursor. We found a number of other
Drosha cleavage sites within mRNAs, a subset of which
can be demonstrated to regulate mRNA levels. Even
after we accounted for all Drosha and Ago2 cleavage
sites, a large number of processing sites remained, and
many of these were evolutionarily conserved in othol-
ogous mouse mRNAs. Considered as a whole, our find-
ings not only reveal a previously unappreciated breadth
in the roles of RNAi family enzymes in mRNA cleav-
age, but also suggest that mRNAs are subject to a sur-
prising diversity of endonucleolytic, posttranscriptional
processing events. The path toward understanding the
precise biological impact of these processing events will
likely require our linking individual cleavage sites with
the nucleolytic complexes that generate them.
The Biogenesis of “Amir,” a Blood-specific
miRNA, Requires Argonaute 2 Cleavage 
Activity Independently of Dicer
S. Cheloufi
In mammals, Argonaute 2 is the only endonuclease that
loads small RNAs (miRNAs or siRNAs) and uses them
as complementary guides to slice target mRNAs. The
couple of miRNAs that have been demonstrated to
cleave perfect complementary targets, together with the
discovery of endogenous siRNAs in the female germline,
hints to the important role of the slicer activity during
development. However, the direct biological role of Arg-
onaute catalysis has not been studied in the whole organ-
ism. Here, we show that mice harboring a catalytically
inactive Argonaute survive to term but manifest anemia
and die shortly after birth. This is the first demonstration
of the essential role of Argonaute catalysis somatically
during development. The maturation of the small RNA–
ian somatic stem cells and follicle cells, express Piwi and
its associated piRNAs. To screen for genes involved in
piRNA biogenesis and effector steps, we are establishing
direct and indirect sensor systems. These sensor systems
are based on direct detection of piRNAs and transcripts
of transposable elements by real-time polymerase chain
reaction (PCR), and sensor transgenes, respectively. We
aim to perform a genome-wide RNAi screen. In addition
to this genome-wide study, we are pursuing two inde-
pendent approaches to determine sets of genes for a
smaller, more targeted screen. To this end, we have com-
pared the transcriptome of OSS cells to that of S2 cells,
which do not express Piwi proteins or piRNAs, and are
analyzing Piwi protein complexes by mass spectrometry.
Overall, our study aims to advance our understand-
ing of how genome integrity is guarded by small RNAs
in the germline.
Arginine Methylation as a Molecular
Signature of the Piwi Small RNA Pathway
V. Vagin, A. Aravin
In animals, members of the Argonaute protein family are
subdivided into two clades, Ago and Piwi, based on their
sequence and expression pattern. We comprehensively
characterized Piwi-associated proteins in mouse germline
cells and found that Piwi associates with the
PRMT5/WDR77 complex, which is known to methy-
late arginine residues in numerous proteins. Piwi com-
plexes also contain several proteins with Tudor domains;
these domains bind to symmetrically methylated argi-
nine. Piwi proteins harbor several methylated arginines,
and these residues are critical for interaction with Tudor
proteins. Methylated arginines are clustered at the amino
termini of Piwi proteins and are absent in Ago members,
providing a molecular mechanism that differentiates be-
tween members of the two clades. Indeed, Piwi, but not
Ago, members faithfully interact with Tudor proteins in
a heterologous cell culture system, and several Tudor do-
main proteins localize to nuage granules together with
Piwi in germ cells. Tudor proteins might therefore pro-
vide the platform necessary for assembly of numerous
proteins that function as a complex in the Piwi pathway. 
Conserved Endonucleolytic Processing
Events in Mammalian mRNAs
F. Karginov
Argonaute proteins are guided by their miRNA part-
ners to mRNA targets, leading to regulation of the
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Argonaute gene-silencing complex is orchestrated
through a series of enzymatic steps acting on precursor
RNA molecules. miRNAs depend on Drosha and Dicer
for maturation, and siRNAs depend on dicer only. Here,
We demonstrate that mammalian Argonaute 2 is loaded
with the precursor of a well-conserved blood-specific
miRNA following Drosha processing of its primary tran-
script, bypassing the dicer step. We further show that its
slicer activity is required for the maturation of this
miRNA. This is the first demonstration of the require-
ment of Argonaute catalysis in miRNA biogenesis, a no-
tion that can be exploited to generate potent silencing
complexes. The function of this small RNA has been re-
ported to be essential for erythropoiesis in the mouse and
zebrafish, similar to the mouse model described here.
Further genetic and biochemical studies will help unravel
other specific developmental processes that lead to the
conservation of the catalytic function of the Argonaute
protein in mammals.
Hierarchical Rules for Argonaute
Loading in Drosophila
B. Czech [in collaboration with R. Zhou, Harvard Medical
School]
Animal miRNAs are derived from structured RNA pre-
cursors, which are processed through the sequential ac-
tion of two RNase III family enzymes, Drosha and
Dicer, to yield double-stranded RNA duplexes of 21–
23 nucleotides in length. The vast majority of miRNA
duplexes are intrinsically asymmetric in character, with
one strand, called the miR strand, differentially entering
RISC to recognize and regulate the expression of target
mRNAs. The other strand, called miR*, has generally
been viewed as a mere by-product of miRNA biogene-
sis. In Drosophila, miRNAs preferentially occupy one
of its two Argonaute family members, Argonaute-1
(AGO1), whereas siRNAs, either derived from endoge-
nous double-stranded RNAs or exogenous RNAi trig-
gers, enter Argonaute-2 (AGO2).
By deeply sequencing AGO1- and AGO2-associated
small RNAs, we observed that miR* strands are among
the most abundant individual species in AGO2 RISC.
This is supported by many miR*s bearing 2′-O-methyl
modifications that mark AGO2-associated species.
Through this association, miR* strands can repress tar-
get mRNAs carrying perfectly complementary sites
both in cultured cells and in animals. Although both
miRs and miR*s are Dcr-1 products, loading of miR*s
into AGO2 depends additionally on canonical siRNA
loading factors, Dcr-2 and R2D2.
These results suggest that a single miRNA precursor
can produce two potentially functional small RNAs,
with each strand having distinct intrinsic loading sig-
nals. By examining the loading patterns of manipulated
miRNA and siRNA duplexes, we infer a set of hierar-
chical rules for AGO loading that incorporate both pre-
viously proposed structural determinants and thermo-
dynamic asymmetry.
miRNAs in Normal and Cancer Stem Cells
I. Ibarra [in collaboration with the Wicha lab at the Univer-
sity of Michigan]
The elucidation of the stem and progenitor cell com-
partments in the mammary epithelium, and uncovering
their potential role in tumorigenic processes, has been
the focus of my research. The mammary gland is a dy-
namic tissue that undergoes various morphological
transitions during puberty, pregnancy, lactation, and
involution in response to ovarian-secreted hormones.
Although there is evidence for the existence of stem cells
within the mammary epithelium, the location of these
cells during mammary gland development remains elu-
sive. The expression of a highly conserved miRNA, let-
7, in differentiated cell types provides a way to isolate
less-committed cell types. We have generated a let-7
sensor mouse model that allows in vivo tracking of
primitive compartments in the mammary gland, intes-
tinal crypts, and bone marrow. miR sensor technology
has allowed us to access the temporal and cell-type-
specific expression pattern of a single miRNA that has
a key role in stem cell biology. 
In parallel, we have worked with the Wicha lab at
the University of Michigan to test the relevance of
miRNA in human cancer stem cells. We found that
transiently expressing either of two miRNAs, let-7 or
miR-93, whose levels are strongly reduced in stem cells,
negates the ability of human breast cancer cell lines to
form tumors in mice. This provides strong evidence in
favor of the cancer stem cell hypothesis and suggests
potential strategies for addressing this compartment in
human cancer.
miRNAs as Therapeutic Targets
in Breast Cancer
C. Dos Santos
Since November 2008, we have been testing the delivery
of a new type of molecule that blocks miRNA function
to murine breast tumors. Mice bearing breast tumors
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were treated with locked nucleic acid (LNA) antagonists
or control LNAs via intravenous injection. Live-image
analysis of tumors, which express a fluorescent protein
under the control of target miRNA, were quantified
after treatment. Preliminary data suggest that there was
efficient LNA delivery to breast tumors, and experi-
ments to further test effects on tumor prevention are
being performed.
Moreover, we are interested in identifying novel
mechanisms regulating mammary gland stem cell biol-
ogy. First, we are using unbiased gene knockdown
screens to identify essential factors that control stem cell
self-renewal. Second, we are searching for modifications
occurring at the DNA level in different stages of mam-
mary development—menarche, early age pregnancy,
and late age pregnancy—and their correlation with
breast cancer predisposition.
Tumor-associated Macrophage in Breast
Cancer
C. Rebbeck
Macrophage cells are a key component of the body’s
immune system. They are frequently found in tumor
tissue, and in breast tumors, for example, these cells can
comprise up to 80% of the tumor mass. These tumor-
associated macrophages (TAMs) are considered to be
in an altered state of activation and are thought to ac-
tually aid tumor growth, development, and metastasis.
Our research has involved identifying and isolating
these TAMs from breast tumors in order to create a
miRNA profile to look for differences between these
and other activated macrophages in the hope of better
understanding what makes these TAMs behave in a
tumor-promoting manner. 
In addition, we have been designing a construct to
allow labeling of individual cells with various color
combinations to use in the study of tumor seeding,
metastasis, and development. 
Pathways Affecting the Effectiveness of the
EGFR Blockade in Lung Cancer Therapy
F. Rollins [in collaboration with R. Sordella, Cold Spring
Harbor Laboratory]
During the past year, we have been focusing on eluci-
dating the mechanisms underlying resistance to spe-
cific, FDA-approved, chemotherapeutics. Using a cell
culture model of non-small-cell lung cancer, we have
screened a sparse representation of the genome, includ-
ing a selected set of genes believed to be involved in
cancer. Currently, we are in the validation stages, hav-
ing identified multiple targets that could significantly
contribute to drug sensitivity and perhaps be used as
combination therapy to treat even resistant patients.
Structural Variation in Human Cancer
A. Canela
During the past year, we have been developing a
methodology to characterize structural variations in can-
cer cells at a single-base resolution level by next-genera-
tion sequencing. First, we focused on regions containing
chromosomal rearrangements identified by comparative
genomic hybridization (CGH) analysis (in collaboration
with the Wigler lab at CSHL) in breast cancer, to eval-
uate the use of copy-number variations as landmarks of
complex chromosomal rearrangements. These regions
are purified from tumor genomes by array capture, and
the nature of chromosomal rearrangement is identified
by sequencing. Second, we used large-insert genomic li-
braries as an unbiased strategy. Next-generation paired-
end sequencing maps both ends of each fragment of the
library, allowing the study of chromosomal rearrange-
ments and copy-number variation (structural variation)
in the tumor genome. This methodology will allow us
to build a structural variation map of tumor genomes
and study the repercussion of chromosomal rearrange-
ments in the tumorigenesis.
Finding the Causative Mutation of Joubert
Syndrome Type 2 in Ashkenazi Jews by
Whole-exome Sequencing
Y. Erlich, E. Hodges
Joubert syndrome type 2 is a devastating disease that is
characterized by cerebellum malformation, ataxia, oc-
ular problems, and kidney insufficiency. We studied
several Ashkenazi families that suffer from Joubert syn-
drome in collaboration with Dor-Yeshorim, a Brook-
lyn-based foundation that focuses on prevention of
genetic diseases in the ultra-orthodox Jewish commu-
nity. Although there are nine genes that are linked to
Joubert in other populations, none of these genes were
mutated in our samples. We used whole-exome se-
quencing of a mother and affected daughter to identify
possible variations that may cause the disease. On the
basis of the profile of the incidents, our working as-
sumption was that the disease is recessive and that there
is a single founder mutation. According to this assump-
Cancer: Genetics     63
tion, we narrowed 20,000 mutual variations in the
mother and daughter to a list of 39 potential variations.
We further narrowed down the region by autozygosity
mapping to a 3-Mb area on chromosome 11. We found
only a single possible variation in a gene called
TMEM216 that encodes a small transmembrane pro-
tein with 88 amino acids. We found that a single-nu-
cleotide polymorphism (SNP) causes arginine to be
replaced by leucine in position 12 in both copies of the
affected daughter. In collaboration with the Hadsa
Medical Center (Israel), we performed tests on other
Ashkenazi patients, which indicated that this is the
causative mutation of the syndrome. This is one of the
first studies that uses whole-exome sequencing to iden-
tify causative mutation of Mendelian disorders. The
Dor-Yeshorim Foundation routinely tests this mutation
in their carrier screening program.
DNA Sudoku
Y. Erlich, K. Chang, A. Gordon, R. Ronen, O. Navon,
M. Rooks
Although next-generation sequencing technologies have
greatly increased sequencing capacity, multiplexing li-
braries composed of a large number of specimens is still
challenging. Current multiplexing schemes encode the
specimen identity by appending unique DNA bar
codes to each one. These approaches scale poorly be-
cause bar-code synthesis and library preparations for a
large number of specimens are cumbersome and expen-
sive. 
We devised a different approach, which is based on
combinatorial pooling: Tens of thousands of specimens
are first grouped into mere hundreds of pools according
to a designated mathematical pattern. Then, the pools,
instead of the individual specimens, are bar-coded. This
strategy, which is deeply rooted in information theory
(and solving Sudoku puzzles), is applied to “needle in
a haystack” sequencing scenarios, such as carrier screens
and finding rare mutations. 
In the past year, we used this strategy to genotype
500,000 bacterial colonies, and we showed that with
only a single Illumina GAII run, and 384 bar codes,
one could genotype a batch composed of 40,000 bac-
terial colonies. Recently, we began a collaboration with
the Dor-Yeshorim Foundation, one of the largest carrier
screen programs in North America, to test the method
for high-throughput carrier screen for rare Mendelian
diseases. On the basis of extensive simulations, we en-
vision an ultrafast, inexpensive, and scalable carrier
screen strategy using our approach.
Mechanisms Driving Human
Variation and Evolution
R. Burgess
Eukaryotic germline cells undergo meiotic recombina-
tion, in which homologous pairs of parental chromo-
somes are broken and rejoined to form the single-
composite chromosomes that are passed through egg or
sperm to progeny. By this means, alleles at physically
linked loci on the same chromosome may be “reshuf-
fled” in a population, allowing combinations of novel
genes that arose in different ancestors to be brought to-
gether in one individual. This critical evolutionary
process remains poorly understood—in particular the
molecular specification of recombination hot spots, places
in the genomic DNA where the breaks preferentially
occur. Working initially with mouse models, we have
been developing assays to measure the distribution of
recombination events across the mammalian genome,
using sperm cells to obtain a large sample of meiotic
outcomes in a single individual. These assays will pro-
vide the first experimental platform to analyze the spec-
ification of meiotic recombination events in living
mammals. 
Comparative Analysis of the Modern Human
and Neandertal Proteomes
E. Hodges [in collaboration with the Pääbo lab at the
Max-Planck Institute]
During the past several years, we have developed and
refined methods for purifying specific genomic regions
by in situ array capture. Despite the increasing power
of next-generation sequencing technologies, determin-
ing the sequences of extinct organisms from ancient
DNA samples remains a daunting task, in part because
these samples are invariably contaminated with large
amounts of bacterial and fungal DNA. Working with
Svante Pääbo at the Max-Planck Institute in Leipzig,
we demonstrated that we could purify hominid DNA
from libraries made from ~40,000-year-old Neandertal
bones, with an enrichment of up to 50,000-fold for
areas of interest. Using this procedure, we essentially re-
constructed the protein sequences of Neandertal and
compared them with those of modern humans. This
process focused on sites at which chimp and human dif-
fered (~5 million years of divergence) and where mod-
ern humans had a different coding variant from the
ancestral chimp allele. Using this approach, we have se-
quenced ~14,000 protein-coding positions that have
been inferred to have changed on the human lineage
64 Research
since the last common ancestor shared with chim-
panzees. We identified 88 amino-acid substitutions that
have become fixed in all humans since the divergence
from the Neandertals.
Genome-wide Analysis of DNA 
Methylation during Stem Cell 
Differentiation and Development
E. Hodges, A. Molaro, O. Tam [in collaboration with the
Smith lab at the University of Southern California, and 
the Raffii lab at Cornell]
The publishing of several mammalian genomes in recent
years has advanced our understanding of the underlying
genetic programs that govern growth and development.
However, it is increasingly clear that additional layers of
information, broadly known as epigenetics, are crucial to
the establishment and maintenance of these genetic pro-
grams throughout the life of the organism. An example
of this is DNA methylation, where cytosine nucleotides
of a gene promoter are methylated enzymatically. This
nucleotide modification has been associated with the for-
mation of heterochromatin and the subsequent repres-
sion of the surrounding gene. Although there have been
hints of dramatic changes to DNA methylation during
growth and development, genome-wide analyses of these
epigenetic marks have begun to appear only in recent
times. We present three projects here that aim to charac-
terize the epigenetic landscape (DNA methylation state)
of mammalian cells during the differentiation of the
hematopoietic lineage, maturation of male germ cells,
and in the early developing mouse embryo.
Self-renewal is essential for the homeostasis and life-
time maintenance of many organ systems. This process
is dependent on rare populations of adult stem cells,
whose key features include multilineage potential and re-
populating capacity. Blood cell development is driven by
the successive restriction of cell fate as multipotent
hematopoietic stem cells (HSCs) give rise to all mature
red and white blood cell types. We have generated
genome-wide, single-base resolution maps of DNA
methylation in purified cell populations derived from
human and chimpanzee peripheral blood. Specifically,
using whole-genome shotgun bisulfite sequencing, we
are comparing methylation states in long-term HSCs
(the self-renewing cells), mature B lymphocytes, and
neutrophils, representing terminally differentiated lym-
phoid and myeloid cells, respectively. These data will pro-
vide insight into differential methylation patterns that
influence lineage restrictions while also revealing epige-
netic relationships between two closely related primates.
During mammalian development, DNA methyla-
tion is erased and reestablished in germ cell develop-
ment. To achieve this, we successfully generated and
sequenced bisulfite-treated genome-wide libraries of
murine male germ cells. These cells show 60%–70%
methylated CpGs, indicating that de novo methylation
acts almost upon the entire genome. When the analysis
is extended earlier in development, we found that DNA
methylation is drastically reduced to a level of 4% in
primordial germ cells. We are also analyzing DNA
methylation in the germ cells of humans and chim-
panzees to uncover conserved CpG islands and investi-
gate their evolutionary dynamics. 
One of our current focal points is to uncover the pat-
terns of remethylation, especially in repetitive sequences,
that are epigenetically silenced in the germline. We are
also further investigating the role of the piRNA pathway
in the targeting of de novo methylation of various trans-
posons by comparing and contrasting the methylation
profiles of germ cells between MILI mutant (piRNA-
deficient) and wild-type animals.
Early (preimplantation) embryo development is an-
other stage where DNA methylation states are dramat-
ically altered in the mouse. Previous low-resolution
studies revealed a global decrease in DNA methylation
following fertilization until the eight-cell embryonic
stage. This is then followed by a global remethylation
of cytosine to levels comparable to those of adult or-
ganisms. Although informative, these earlier studies fail
to combine a nucleotide-level resolution with a
genome-wide approach. To address this shortcoming,
we will perform deep sequencing (using the Illumina
Genome Analyzer platform) on bisulfite-treated DNA
samples from preimplantation embryos to assess their
genome-wide DNA methylation status. In collabora-
tion with the Jackson Laboratory in Bar Harbor, Maine,
we have collected more than 1000 embryos from the
blastocyst and morula stages of embryonic develop-
ment, which will be converted into Illumina-compati-
ble bisulfite-treated libraries for deep sequencing. The
results will be processed through the bioinformatics
pipeline developed by Andrew Smith, which will allow
us to identify and characterize the DNA methylation
during these critical stages of development. This project
would provide valuable insights into the role of DNA
mehtylation during early embryonic development, and
hints at their possible roles in specifying and regulating
pluripotency and differentiation.
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Cancer arises through an evolutionary process whereby
normal cells acquire mutations that erode growth con-
trols, leading to the inappropriate expansion of aber-
rantly proliferating cells. Such mutations can involve
activation of oncogenes or inactivation of tumor-sup-
pressor genes, each contributing one or more new capa-
bilities to the developing cancer cell. However, cancer is
not an inevitable consequence of oncogenic mutations;
instead, cells acquiring such mutations can be elimi-
nated or kept in check by innate tumor-suppressor pro-
grams that can be activated in these damaged cells. Our
laboratory studies tumor-suppressor networks control-
ling apoptosis and senescence and how their disruption
influences malignant behavior. We previously showed
that apoptosis and cellular senescence are potent barriers
to oncogene-driven tumorigenesis and that each con-
tributes to the antitumor action of many chemothera-
peutic drugs. Thus, not only do mutations that disrupt
apoptosis and senescence promote tumor progression,
but, depending on the particular lesion, they can also
reduce the efficacy of cancer therapy. 
To facilitate our research, we are combining advanced
genetic and genomic tools that enable us to explore var-
ious aspects of cancer biology in a comprehensive way.
For example, we have recently developed new mouse
cancer models based on the genetic manipulation of stem
and progenitor cells ex vivo followed by transplantation
of the altered cells into the appropriate organ of syn-
geneic recipient mice. This approach allows us to rapidly
study the impact of many genes and gene combinations
on tumorigenesis in a “mosaic” setting where tumor-ini-
tiating cells are embedded in normal tissues. Further-
more, we have developed powerful methods for using
RNA interference (RNAi) to suppress gene function in
vivo in either a stable or reversible manner. Current ef-
forts in the laboratory strive to integrate mosaic mouse
models, RNAi, and cancer genomics to identify new
components of tumor-suppressor gene networks and
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characterize their impact on tumorigenesis and treatment
response. In addition, we are developing new RNAi
methods to explore the role of tumor-suppressor genes
in tumor maintenance and the cell death mechanisms
involved in tumor regression.
Control of Cell Survival
C. Bialucha, Y. Chien, C. Miething, C. Scuoppo, J. Simon 
[in collaboration G. Hannon, Cold Spring Harbor 
Laboratory, J. Pelletier, McGill University, and 
former laboratory member A. Bric]
Normal cells possess intrinsic tumor-suppressor mech-
anisms that limit the consequences of aberrant prolif-
eration. For example, deregulated expression of c-Myc
or disruption of the retinoblastoma (Rb) pathway in
normal cells can force aberrant S-phase entry and pre-
dispose cells to apoptotic cell death. Conversely, many
oncogenic pathways promote cell survival by counter-
ing apoptosis. We have previously shown that onco-
genes can engage the ARF-p53 tumor-suppressor
pathway to promote apoptosis and that disruption of
this pathway through loss of tumor suppressors or en-
forced expression of prosurvival genes cooperates with
oncogenes to transform normal cells in vitro and pro-
mote tumorigenesis in vivo. We are currently interested
in identifying additional components of these programs
and in understanding how they function in a “tumor-
suppressor network.”
Much of our current work on apoptosis and survival
signaling exploits the Eµ-myc transgenic mouse model.
This model of B-cell lymphoma, where disruption of the
ARF-p53 pathway, or overexpression of the prosurvival
gene Bcl-2, cooperates with Myc to dramatically acceler-
ate lymphomagenesis. Similarly, prosurvival signaling
through the phosphoinositol-3 kinase (PI3K)/Akt path-
way can also promote lymphomagenesis. Using a variety
of approaches, we have produced a large number of lym-
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tured human fibroblasts and is characterized by a series
of poorly understood markers. Senescent cells remain
metabolically active, but they are unable to proliferate
and display changes in gene expression that could alter
tissue physiology. Although “replicative” senescence is
triggered by telomere attrition and can be prevented by
telomerase, an identical endpoint can be produced
acutely in response to activated oncogenes, DNA dam-
age, oxidative stress, and suboptimal cell culture con-
ditions. These observations have led us to propose that
senescence acts in parallel to apoptosis as a cellular re-
sponse to stress and acts in a similar way to suppress tu-
morigenesis and mediate responses to chemotherapy. 
Our laboratory was the first to demonstrate that
deregulated mitogenic oncogenes could drive cells into
a senescent state thereby preventing transformation and
that senescence could contribute to the outcome of
chemotherapy in vivo. On the basis of the hypothesis
that senescence is an important tumor-suppressive
mechanism in vivo, we continue to study the roles and
regulation of senescence. On the one hand, we continue
to explore how the p53 tumor suppressor pathway ac-
tivates a gene expression program to trigger senescence;
on the other hand, we are interested in how the Rb
tumor suppressor represses gene expression in senescent
cells. This year, we collaborated with the Mills lab to
study the role of the p53 family member, p63, in senes-
cence (Guo et al. 2009). We also performed large gene
expression and chromatin-binding experiments to iden-
tify Rb-regulated genes that are unique to the senescent
state (Chicas et al., in press). We showed that Rb pref-
erentially associates with E2F target genes involved in
DNA replication and is uniquely required to repress
these genes during senescence but not other growth
states. Consequently, Rb loss leads to inappropriate
DNA synthesis following a senescence trigger and, to-
gether with disruption of a p53-mediated cell cycle
checkpoint, enables extensive proliferation and rampant
genomic instability. Our results identify a nonredun-
dant Rb effector function that may contribute to tumor
suppression and reveal how loss of Rb and p53 cooper-
ate to bypass senescence. 
We also continue to be interested in the biology of
senescence and the impact and fate of senescent cells in
tissues. Our interest stems from the observations that (1)
cells triggered to senesce undergo dramatic changes in
gene expression that lead to a “senescence-associated se-
cretory phenotype” involving the up-regulation of in-
flammatory cytokines and immune modulators, (2)
components of the innate immune system are recruited
to senescent cells in tissues leading to their clearance, and
phoma genotypes in which cell survival is disrupted in
various ways and used this to identify and characterize
how cancer genotype influences tumor cell responses to
cytotoxic and targeted anticancer drugs. Recently, we
have collaborated with Ricky Johnstone (Peter McCal-
lum Cancer Center) and Jerry Pelletier (McGill Univer-
sity) to study the impact of histone deacetylase and
translation elogation inhibitors on treatment outcome
(Ellis et al. 2009; Robert et al. 2009). With Dr. Pelletier,
we continue to use the Eµ-myc system to study the im-
pact of translational regulators on oncogenesis and trans-
lational inhibitors on tumor regression. 
We previously used the Eµ-myc model to demon-
strate that p53 gene suppression by RNAi, like p53 mu-
tations, could promote Myc-induced lymphomagenesis,
providing the first evidence that RNAi could be used to
mimic the effects of tumor-suppressor gene loss. These
studies involved isolation of hematopoietic stem and
progenitor cells from Eµ-myc mice, introducing short
hairpin RNAs (shRNAs) that suppressed p53 protein
and monitoring tumorigenesis following retransplanta-
tion into the hematopoietic compartment of recipient
mice. This year, by introducing pools of shRNAs into
the same system, we performed a positive-selection-
based RNAi screen to identify a series of new tumor sup-
pressors that accelerated Eµ-myc tumorigenesis (see
below). One gene we identified as a potent tumor sup-
pressor was RAD17, which acts to mediate DNA-dam-
age responses to replicative stress (Bric et al. 2009). We
showed that shRNAs suppressing RAD17 can attenuate
Myc-induced apoptosis and enable Myc-expressing cells
to proliferate more rapidly. Remarkably, only partial
RAD17 suppression produced a proliferation and sur-
vival advantage, whereas complete RAD17 suppression
was lethal to the cell. Thus, RAD17 is a haploinsufficient
tumor suppressor that appears to mediate hyperprolif-
erative signaling to Myc. Additional screens are currently
in progress to identify other tumor suppressors in lym-
phoma and to identify candidate drug targets whose in-
hibition may reverse the effects of prosurvival mutations
during lymphomagenesis. 
Roles and Regulation of Cellular Senescence 
J. Bolden, A. Chicas, Y. Chien, V. Krizhanovsky, A. Lujambio,
B. Ma, O. Mert, J. Simon [in collaboration with A. Mills, 
X. Wang, C. Zhang, and M. Zhang, Cold Spring Harbor 
Laboratory, and M. Narita, Cancer Research United 
Kingdom, Cambridge]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in cul-
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(3) prevention of this inflammatory response leads to the
retention of senescent cells in tissues and impacts tumor
regression or wound-healing responses. These observa-
tions suggest that senescence can act as both a tumor
suppressive mechanism and one that can promote cer-
tain wound-healing responses, and it does so through
both cell-autonomous and non-cell-autonomous mech-
anisms (Krizhanovsky et al. 2009). We continue to ex-
plore the interplay between the immune system and
senescence in order to provide insights into this previ-
ously uncharacterized form of immune surveillance.
Such studies provide our first foray into investigating fac-
tors that influence the tumor microenvironment.
Mouse Models of Human Cancer
C. Bialucha, J. Cappellani, S. Ebbesen, D. Grace, 
A. Rappaport, M. Saborowski, C. Scuoppo, J. Simon,
M. Taylor, S.J. White, Z. Zhao, J. Zuber [in collaboration 
with S. Kogan, University of California, San Francisco, 
and C. Cordon-Cardo, Columbia University]
In cancer patients, tumors arise in the context of nor-
mal and diseased tissue, and it has become overwhelm-
ingly apparent that not all processes relevant to cancer
progression and therapy response can be understood
from the behavior of cells in a Petri dish. For this rea-
son, our laboratory has continually moved toward
studying factors that impact cancer biology and therapy
using genetically engineered mouse models, where
tumor behavior can be studied in the context of its nat-
ural microenvironment. These studies have revealed
many new insights into the nature and complexity of
the genes and processes that contribute to tumor initi-
ation and progression. 
One substantial obstacle limiting the use of mouse
models is that their production is time-consuming and
expensive. To address this issue, we have incorporated a
“mosaic” approach to modeling cancer in mice, whereby
genes or shRNAs are introduced ex vivo into stem and
progenitor cells derived from different tissues, and the
genetically modified populations are retransplanted into
recipient mice. Using this approach, one can readily vary
the target cell population and the nature of the intro-
duced transgene, enabling the production of tumors
with a broad range of genotypes. Moreover, because the
cells are transplanted into normal recipients, the animals
are mosaics where the developing tumor arises in a nor-
mal tissue microenvironment. Such models are ex-
tremely flexible, and dramatically reduce the time and
cost of producing similar models by intercrossing
germline transgenic or knockout strains. 
Our first mosaic model, described above, was based
on the Eµ-myc mouse model of lymphoma, which re-
mains a mainstay of research in our laboratory. This
year, we established a variety of new leukemia models
based on the same fundamental concepts. We observed
that mutations commonly found in concert in human
patients cooperate in mouse models to promote acute
myeloid leukemia (AML). For example, activating mu-
tations in Ras signaling pathways—one of the most
common lesions in human AML—are associated and
functionally cooperate with AML1/ETO and MLL fu-
sion proteins as well as loss of p53. We showed that
these mosaic models mimic the pathophysiological and
molecular features of human malignancies to the best
level currently available. We are using these models to
provide tractable experimental systems to identify can-
cer-related genes and novel drug targets and to evaluate
new compounds and combinatorial therapies preclini-
cally. Other mosaic mouse models in use or under de-
velopment include those involving epithelial cancers
such as liver, breast, lung, and pancreas. Our goal is to
use these for cancer gene discovery and validation ef-
forts (see below).
Integrated Approaches to Cancer
Gene Discovery
C. Bialucha, S. Ebbesen, S. He, T. Kitzing, B. Ma, C. Miething,
A. Rappaport, M. Saborowski, C. Scuoppo, J. Simon, M.
Spector, M. Taylor, S.Z. Zhao, J. Zuber [in collaboration 
with A. Kraznitz, M. Wigler, J. Hicks, G. Hannon, and 
S. Powers, Cold Spring Harbor Laboratory]
Based on the premise that a complete understanding of
the genetic alterations that occur in human cancers will
enable more effective use of existing drugs and facilitate
the development of improved therapies, genomic tech-
nologies are being used on a large scale in efforts to
identify all of the recurrent genetic alterations that
occur in human tumors. However, because cancers are
inherently genomically unstable, it is often difficult to
distinguish between “driver” mutations that contribute
to the malignancy and those that are “passengers” with
no phenotypic effect from this information alone. To
address this issue and speed up the pace at which new
cancer genes are identified, we are using our mosaic
mouse models to filter through human genomic data
and rapidly identify the genes and gene combinations
that contribute to tumorigenesis. By combining these
models with genomic information from human can-
cers, we are systematically identifying genes that con-
tribute to the development of several tumor types.
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Our efforts at identifying cancer genes were initiated
in 2005, when we used mosaic models to functionally
characterize oncogenes in a region amplified in human
and mouse liver carcinomas. Next, we performed an in
vivo RNAi screen to identify new tumor suppressors in
liver cancer, leading to the identification of 12 new
tumor suppressors. This year, continuing our ongoing
collaborations with Drs. Hannon, Kraznitz, Hicks,
Wigler, and Powers, we used our Eµ-myc mosaic model
to screen pools of shRNAs targeting a focused set of can-
cer-relevant genes for their ability to promote tumori-
genesis following transduction into stem and progenitor
cells and engraftment into syngeneic recipients. More
than 20 candidate tumor-promoting shRNAs were iso-
lated, including those targeting established tumor sup-
pressors (Bric et al. 2009). New tumor suppressors
included the DNA-damage-response protein Rad17 (see
above), molecules that may have pro-oncogenic activities
in other contexts (e.g., Mek1), and others that encode
secreted proteins (e.g., Sfrp1). 
We also continued to perform follow-up studies on
cancer genes that we previously identified, as well as
worked with collaborators to implement our mouse sys-
tems to characterize new cancer genes. Among these in-
clude collaborative studies to explore the function of
apoptosis regulators such as cIAP1 (Laska et al. 2009;
Ma et al. 2009), the hippo pathway effector YAP (Xu
et al. 2009), and mir17-92 in tumorigenesis (Olive et
al. 2009). In addition, we worked together with Anne
DeJean (Pasteur institute) and John Luk (Hong Kong
University) to characterize miR221 and cadherin-17 as
potential oncogenes in hepatocellular carinoma (Liu et
al. 2009; Pineau et al. 2009). Finally, we worked to-
gether with David Largaespada (at the University of
Minnesota) to characterize potential liver cancer onco-
genes identified by insertional mutagenesis in mice
(Keng et al. 2009).
Our results establish the feasibility of in vivo RNAi
screens and illustrate how combining cancer genomics,
RNAi, and mosaic mouse models can facilitate the
functional annotation of the cancer genome. Although
our studies used mouse models of hepatocellular carci-
noma and lymphoma and focused only on focal dele-
tions, we are currently extending this relatively
high-throughput approach to other mouse models and
are screening shRNA pools targeting genes affected by
larger deletions, promoter methylation, and point mu-
tations. Moreover, through exploitation of the emerging
libraries of full-length cDNAs, we are performing par-
allel screens for oncogenes involved in genomic ampli-
fications. 
Whereas our cancer gene discovery efforts can use ge-
nomic data generated by other investigators, we have de-
veloped the in-house capability to identify and
characterize copy-number changes in various human
cancers and, more recently, are incorporating next-gen-
eration sequencing to characterize genes of interest in
human cancers. These efforts are producing new hy-
potheses that can be functionally validated in our mouse
models. We believe that such integrative approaches will
provide a cost-effective strategy for functional annota-
tion of the cancer genome.
Molecular Genetics of Drug Sensitivity
and Resistance
C. Miething, A. Rappaport, J. Simon, M. Spector, M. Taylor,
Z. Zhao, J. Zuber [in collaboration with S. Kogan, 
University of California, San Francisco, and E. Dolan,
University of Chicago] 
Our laboratory has a longstanding interest in under-
standing genetic determinants that influence the cellu-
lar response to conventional chemotherapy with the
long-term goal of identifying mechanisms of drug re-
sistance and developing new drug targets. These efforts
involve a combination of experiments using RNAi to
characterize drug sensitivity and resistance genes, ge-
nomic approaches designed to identify genes that are
linked to poor treatment responses in patients, and an-
imal-modeling studies to test new drugs and drug com-
binations that might circumvent drug resistance. 
Last year, we used our new mosaic mouse models of
AML (see above) to demonstrate that a subtype of
leukemia linked to poor treatment response in the clinic
(harboring genetic translocations of the MLL gene) re-
sponds poorly to chemotherapy in mice and that this
results, surprisingly, from an attenuated p53 response
(Zuber et al. 2009). Our studies provide insights into
the differential response patterns of human leukemia,
suggest strategies for improving the use of conventional
chemotherapy, and produce tractable preclinical sys-
tems for testing new therapeutic strategies. They also
indicate that p53 action is central to the response of
leukemia to conventional chemotherapy. 
Developing rational strategies to target these other-
wise refractory leukemias is a major goal of current re-
search. We are attacking this problem through both
systematic and global approaches using RNAi to iden-
tify genes that are required for the maintenance of
these leukemias. We also are using the mouse models
as preclinical test systems for new drugs and drug com-
binations.
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Modulation of Gene Expression
In Vivo Using RNAi
J. Bolden, J. Cappellani, L. Dow, C. Fellmann, D. Grace, 
S. Guo, B. Ma, K. McJunkin, C. Miething, Y. Park, 
P. Premsrirut, M. Saborowski, J. Simon, V. Sridhar,
S.J. White, A. Yu, J. Zuber [in collaboration with 
G. Hannon, Cold Spring Harbor Laboratory, and 
C. Cordon-Cardo, Columbia University] 
Together with Gregory Hannon, we continue to de-
velop improvements in RNAi technology with a spe-
cific interest in using this approach to probe various
aspects of cancer biology. Using shRNAs based on the
mir30 microRNA (miRNA) scaffold, we have devel-
oped improved vectors for expressing miRNA-based
shRNAs in stable and conditional systems, thereby fa-
cilitating their use in genetic screens and to study the
role of particular genes in the maintenance of malignant
progression. We also have initiated studies to develop
shRNAs with optimal potency. These efforts, if success-
ful, have the potential to revolutionize RNAi technol-
ogy by enabling the production of genome-wide
shRNA libraries with validated gene knockdown. 
One of our most aggressive areas of technology devel-
opment involves the production of transgenic mice. We
have previously shown that it is possible to produce trans-
genic mice based on pronuclear injection of a linear frag-
ment encoding a miR30-based shRNA downstream from
the tet-responsive element (TRE). To improve upon this,
we produced a second generation of transgenic technol-
ogy that rapidly generates fully transgenic founders with
a defined genomic integration. Using the KH2 embry-
onic stem (ES) cell system from the laboratory of
Rudolph Jaenisch (Whitehead Institute), an improved
TRE-shRNA expression cassette was recombined into a
docking site at the collagen-A1 locus. In this generation
of mice, the miR-shRNA is separated from the TRE by
a green fluorescent protein (GFP) cDNA, conferring bet-
ter shRNA processing as well as a simple marker for spa-
tial and temporal induction of the TRE cassette. This
improved system also obviates the need for screening of
different founder mice because the integration site is con-
stant. Together, these advances have drastically improved
consistency, cost, and speed of generating inducible
RNAi transgenic mice. We are using these systems to pro-
duce animals capable of tissue-specific and reversible sup-
pression of tumor suppressors, drug targets, and essential
genes.
In addition to using this system to study shRNAs,
we have launched efforts to generate a collection of ES
cells expressing tet-regulatable miRNAs using an estab-
lished Flp/Frt recombinase-mediated cassette exchange
system that utilizes our own custom-designed Flp-in tar-
geting vector. All known mouse miRNAs at the time of
construction have been inserted downstream from GFP
of the “tet-on”–Flp-in targeting vectors, which will
eventually allow for regulatable expression of miRNAs
in ES cells. Additionally, two different kinds of miRNAs
are being targeted: One involves expressing the miRNA
in its natural context and the other involves expressing
the miRNAs embedded in a mir30 context, which ex-
presses particularly well in this system. This collection
of ES cell lines will be made available to the community
via the NCI Mouse Models of Human Cancer reposi-
tory. We anticipate that this resource will serve as a pow-
erful tool for the research community at large.
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In addition to genetic mutations such as amplification
and deletion, epigenetic aberrations are frequent events
that can have far-reaching effects in the phenotype of a
cancer cell. A common epigenetic modification is the
methylation of cytosine residues that are next to guanine
residues. It has been shown that methylation present in
the DNA of the transcriptional control region has been
involved in the silencing of gene expression of tumor
suppressors in cancer. We have previously adapted
ROMA (representational oligonucleotide microarray
analysis) to methylation detection oligonucleotide mi-
croarray analysis (MOMA). This methodology was use-
ful and allowed us to identify genes that were methylated
in the tumor cells, but it only gave us a general idea of
where in the CpG island the methylation had occurred.
In addition, after performing the analysis, sequencing
validation was required to determine which of the array
measurements accurately identified methylated frag-
ments. With the development of next-generation se-
quencing technologies, it is now possible to identify the
methylation status for the vast majority of CpG islands.
Our approach is to sequence MspI representations of
the genome. We have developed several different ap-
proaches to generate the libraries for sequencing and
have decided to prepare Illumina libraries from bisul-
fite-treated MspI representations. 
We are presently sequencing three tumors and two
cell lines. We have determined the coverage and the
number of sequences required to obtain appropriate
coverage of many of the CpG islands and have devel-
oped methods to carry out the analysis on the sequenc-
ing data. Mapping the reads to the genome is not trivial
because the bisulfite treatment essentially changes the
genome sequence to only three bases due to the con-
version of most cytosines to thymine. We have used a
program developed by Andrew Smith, formerly of
CSHL, to map the reads to an in silico bisulfite-treated
human genome. After mapping the reads, the se-
quences that map to CpG islands are separated from
other sequences; this represents ~20% of the reads.
These reads are contigged using the program Velvet to
form larger regions for analysis. The data can now be
REPRESENTATION METHYLATION SEQUENCING ANALYSIS
R. Lucito J. Byrnes S. Kamalakaran
E. Cutter E. Lum
M. Joinnides
analyzed to determine gene-specific methylation states.
Thus far, we have used the data to identify which genes
are methylated in the tumor samples. More impor-
tantly, we have expression data for these samples and
will use these data to determine which region of the
CpG island is methylated for genes that have suppres-
sion of transcription. It will also be interesting to de-
termine the effect of methylation of island sequences
within the coding region of the gene. We plan on in-
creasing the number of samples for two reasons. We
will be analyzing a new set of ovarian tumor samples
from our collaborator Dr. Douglas Levine from Me-
morial Sloan-Kettering Cancer Center. The data from
these samples will serve as an independent validation
of the genes we have found to be methylated from our
MOMA results (see below). These data will also give
us a much more accurate view of the regions methy-
lated and the purpose of this methylation with respect
to gene expression. 
Methylome Analysis of Ovarian Cancer
K. Wrzeszczynski [in collaboration with M. Zheng] 
This year in the United States alone, more than 25,500
women will be diagnosed with ovarian cancer, and more
than 16,000 women will die of this disease. Five-year
survival rates for women diagnosed with stage I or II
ovarian cancer are 90% and 70%, respectively. Unfortu-
nately, there is no reliable screening test for the early de-
tection of ovarian cancer, and less than 35% of women
are diagnosed before stage III, with 5-year survival for
stage III or IV being less than 25%. Ovarian cancer is
the leading cause of death from gynecologic cancer and
the fifth most frequent cause of cancer-related death for
women in the United States. Despite significant advances
in surgical management and chemotherapy in the past
few decades, the survival rate has not improved signifi-
cantly. Currently, the 5-year survival rate for patients
with advanced disease is less than 30%. A major imped-
iment to successful treatment is the lack of therapeutic
strategies that are effective against resistant tumors. Com-
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shRNA insert for sequence identification. From the
original 30 genes, we identified four genes that can af-
fect platinum sensitivity when expression is knocked
down. For one of these genes (CHD3), we have moved
on to functional analysis. One interesting phenotype is
that the suppression of this gene causes the cells to cycle
slower. This would be in line with the theory of how
many chemotherapies including Carboplatin target
faster-growing cells, which would be tumor cells and a
number of specialized normal cells in the individual.
Interestingly, we have noticed that some of the genes
that we found to be methylated in the sample set were
actually oncogenes. We found this at first very difficult
to explain. However, in light of our findings, it is pos-
sible that this is a mechanism that tumor cells use to es-
cape the blanket chemotherapies that are more toxins
than molecules that target specific genes or classes of
genes. We are continuing this investigation and are now
screening all of the candidate genes that we have iden-
tified.
Analysis of the PAK4 Genes Involved
in Pancreatic Cancer
Of an estimated 30,000 cases of pancreatic cancer this
year, 29,700 patients will succumb to the disease. Al-
though the number of cases is low compared to several
other cancers such as colon, lung, or breast cancer, the
survival rate for pancreatic cancer is one of the lowest.
Treatments can extend survival or alleviate pain, but
they seldom cure the patient. In fact, the mean survival
time is ~6 months. We performed ROMA and identi-
fied copy-number alterations in 82 tumor samples and
used these data to identify new alterations. One ampli-
fied region on chromosome 19q12 is interesting be-
cause there has been confusion in the literature as to
which gene in the region is the oncogene with respect
to pancreatic cancer. Although this region is amplified
in a number of tumors and cell lines, two primary tu-
mors are the most informative for defining the epicen-
ter or common region of mutation. We have previously
shown that the p21-activated kinase-4 (PAK4) gene was
overexpressed at the RNA level, overproduced at the
protein level, and overactivated as a kinase in cells with
genomic amplification. This protein was also shown by
other investigators to transform cells when activated. 
To elucidate the function of PAK4 in the tumor, we
have used shRNA constructs to knock down the level
of PAK4 in cells with the amplicon to determine the ef-
fect on tumorigenicity. After knocking down the level
mon and important genetic aberrations in ovarian car-
cinoma are poorly understood. Approximately 25% of
patients will present with primary platinum-resistant dis-
ease and will have very poor outcomes. Additionally, all
patients who relapse will ultimately develop acquired
platinum resistance.
We hypothesize that the tumors have taken advan-
tage of epigenetic mechanisms to become resistant to
therapy and/or increase their ability to survive. Epige-
netic modification such as CG dinucleotide methylation
can have far-reaching affects on cellular phenotypes. We
have used MOMA to analyze two sets of ovarian tu-
mors, 55 from Dr. Douglas Levine of Memorial Sloan-
Kettering Cancer Center and 75 from Dr. Anne-Lise
Borresen-Dale from the Norwegian Radium Hospital.
Both sample sets have associated expression and copy-
number data. After performing MOMA on these sam-
ples, the data were associated with clinical data.
Statistical analysis was performed to identify the methy-
lation differences that are present. These differences can
segregate patients on the basis of the clinical variable
platinum-free interval (PFI), which is the time from the
end of chemotherapy treatment to the recurrence of
tumor progression. For gene candidates that are able to
segregate the patients on the basis of PFI, expression
data were associated to identify those genes whose ex-
pression was suppressed presumably by methylation.
Thus far, we have identified ~600 genes that we are now
subjecting to methylation validation with the gold stan-
dard bisulfite sequencing. 
A small set of 30 genes was selected for functional
validation experiments based on literature analysis for
genes that were found methylated. We have developed
a culture-based system to screen for genes that affect
platinum resistance when expression is suppressed. We
have characterized the platinum sensitivity for 14 ovar-
ian tumor cell lines and two normal immortalized ovar-
ian cell lines. Four of these cell lines—one normal, two
tumor cell lines with varied sensitivities, and one resist-
ant cell line—were selected. To mimic the transcription
suppression caused by promoter methylation, we have
used short hairpin RNA (shRNA) clones for the gene
candidates. Up to three clones for each gene were used,
and to increase throughput, pools of 30 shRNAs each
were prepared. Retroviruses for each pool were prepared
and used to infect the four cell lines and selected. After
regrowth of the cells, they were challenged with Car-
boplatin for 3 days at the IC50 (half-maximal inhibitory
concentration). After selection, the cells were harvested,
and genomic DNA was prepared and used as a template
for polymerase chain reaction (PCR) to amplify the
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of PAK4 in the cells, we collected RNA and performed
both expression analysis and pathway analysis to deter-
mine whether any pathways were significantly altered in
the cells with PAK4 compared to the cells with the PAK4
suppressed. We were surprised to find that of the path-
ways altered by the knockdown of PAK4, the most ob-
vious one involving cellular movement or migration was
not greatly affected. This may be due to the fact that
PAK4 is actually more important to other pathways that
have yet to be discovered. We did find several interesting
pathways that were statistically significant, including in-
tracellular transport, regulation of transcription, blood
vessel development, and cell cycle regulation. We already
know that when PAK4 is activated, cells undergo trans-
formation, and so the pathways affected by PAK4 must
be more complex, involving others in addition to those
involved in cellular movement. We will be using path-
way analysis to identify candidate genes that can be stud-
ied to identify how PAK4 is onvolved in transformation.
We plan on taking advantage of the fact that a portion
of signaling through K-ras goes through PAK4. We are
presently carrying out expression analysis of cells with
shRNAs to K-ras so that we can determine the overlap
between cells with activated PAK4 and those with acti-
vated K-ras. 
Genomic Alterations of Phosphatases
F. Chaudhary [in collaboration with N. Tonks, Cold Spring
Harbor Laboratory] 
The goal of this collaborative study is to integrate gene
discovery technology with experimental strategies devel-
oped in Dr. Tonks’ lab for the characterization of the pro-
tein tyrosine phosphatase (PTP) family of enzymes, to
investigate how tyrosine-phosphorylation-dependent sig-
naling pathways are disrupted in cancer. We have taken
advantage of several different forms of genomic data to
determine which PTPs are affected in cancer cells. 
We have used genomic copy-number data, expres-
sion data, and now epigenetic DNA methylation data
to determine which PTPs are altered in ovarian cancer.
We have also expanded our extension of analysis of
PTPs in cancer into the proteins with which PTPs in-
teract. An interesting gene in this class encodes the
MTSS1 protein which interacts with a PTP, the recep-
tor-like PTP RPTPδ, and regulates cytoskeletal organ-
ization. It is known to be preferentially methylated in
several cancers, including breast cancer, and its expres-
sion is markedly decreased in ovarian cancer.
We first generated shRNAs to suppress expression
of the MTSS1 gene in cell culture assays, which would
mimic the transcriptional repression caused by pro-
moter methylation. Because this gene was selected
based only on the comparison of tumor to normal, we
did not have a selection for assay development. We sur-
mised that because MTSS1 possessed an actin-binding
domain, the protein might have a role in cytoskeletal
rearrangement, cell movement, and invasion. There-
fore, we performed an invasion assay with MCF10A
mammary epithelial cells, which are used typically as a
normal line. We observed that very few cells migrate
without the addition of the attractant epidermal growth
factor (EGF). Furthermore, RNA interference (RNAi)-
mediated suppression of MTSS1 enhanced migration
in the presence of EGF. There is evidence in the litera-
ture that in ERBB2-positive breast cancer, there is loss
of MTSS1 transcription. To determine whether ERBB2
overexpression synergizes with loss of MTSS1, we per-
formed an invasion assay in MCF10AN cells. These
cells express a chimeric ERBB2 gene in which the ac-
tivity of the cytoplasmic PTK domain of ERBB2 is
acutely regulated by a small-molecule dimerizing agent.
We noted that the level of invasion is highest in the cells
in which MTSS1 was suppressed and ERBB2 activated,
demonstrating cooperation between these two gene
products. Our current data indicate that these effects
are mediated via changes in tyrosine phosphorylation
regulated by RPTPδ.
PUBLICATIONS
Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M,
Cruz C, Beck A, Webb C, et al. 2009. Genomic events associated
with progression of pleural malignant mesothelioma. Int J Cancer
124: 589–599.
Lucito R, Byrnes J. 2009. Comparative genomic hybridization by rep-
resentational oligonucleotide microarray analysis. Methods Mol Biol
556: 33–46.
In Press
Kamalakaran S, Kendall J, Zhao X, Tang C, Khan S, Ravi K, Auletta T,
Riggs M, Wang Y, Helland A, et al. 2010. Methylation detection
oligonucleotide microarray analysis: A high-resolution method for
detection of CpG island methylation. Nucleic Acids Res (in press).
The Mills laboratory is focused on mammalian genet-
ics, specifically on identifying and characterizing genes
that contribute to human diseases such as those affect-
ing development, aging, and cancer. Research areas in-
clude (1) determining the role of the chromatin
remodeler CHD5 in cancer and stem cell function and
(2) investigating the role of the p53-related protein p63
in development, cancer, and aging.
CHD5 is a Tumor Suppressor 
Mapping to 1p36
CHD5 maps within 1p36, a region of the genome that
has a three-decade history as being deleted in a wide va-
riety of human cancers. Despite the rich body of evidence
indicating that one or more tumor suppressors reside in
this region, the causative gene had remained a mystery.
We identified CHD5 as a potent tumor suppressor by
(1) establishing that deletions encompassing Chd5 pre-
dispose to a variety of spontaneous cancers, (2) determin-
ing that specific deficiency of Chd5 enhances
tumorigenesis in vivo, and (3) demonstrating that CHD5
is frequently deleted in human glioma. In addition to
these loss-of-function studies, we found that mouse mod-
els with gain of the interval encompassing Chd5 have ex-
cessive tumor suppression. The finding that CHD5 is a
tumor suppressor was further corroborated by other in-
vestigators in subsequent work showing that CHD5 is
deleted in neuroblastoma and T-cell acute lymphoblas-
tomic leukemia or mutated in neuroblastoma and breast
cancer. The discovery that CHD5 is a tumor suppressor
is also consistent with an extensive body of literature in-
dicating that CHD5 maps within a genomic region com-
monly deleted in diverse types of human cancer. 
The reciprocal gain and loss models that we gener-
ated using chromosome engineering were invaluable for
determining the mechanism by which CHD5 functions
as a tumor suppressor. We found that CHD5 is a master
switch for a tumor suppressive network. Chd5 posi-
tively regulates the Ink4/Arf locus, thereby facilitating
expression of p16 and p19—two important tumor sup-
pressors. Compromised Chd5 activity, either by engi-
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neered heterozygous deletion of the interval encompass-
ing Chd5 or by specific depletion of Chd5 using RNA
interference (RNAi), cripples the tumor suppressive
network, compromising p16/Rb- and p19/p53-medi-
ated pathways, predisposing to cancer. Intriguingly,
Chd5 is a predicted chromatin remodeling protein,
consistent with our view that it regulates Ink4/Arf by
maintaining this locus in a transcriptionally competent
chromatin state. Indeed, gain of Chd5 dosage enhances
expression of p16, p19, and p53, causing compromised
proliferation and senescence in cultured cells as well as
excessive apoptosis in vivo.
We are currently (1) assessing the spectrum of tu-
mors that develop in mice with compromised Chd5
and extending these findings to human cancers, (2) in-
vestigating the role of CHD5 in stem cells, and (3) de-
termining the mechanism whereby Chd5 regulates
chromatin dynamics. Having identified CHD5 as a
novel tumor suppressor, we now strive to more fully un-
derstand the mechanism whereby CHD5 protects from
cancer so that more effective anticancer therapies can
be designed in the future.
Function of the p53 Homolog p63
p63 is essential for development. The discovery that the
p53 tumor suppressor is a member of a multigene family
that also includes p63 and p73 revolutionized the p53
field. p63 is a transcription factor that is structurally
quite similar to p53. We previously identified the p63
gene and generated a number of p63-deficient mouse
models, which allowed us to determine that despite their
similarities, p63 and p53 perform very different func-
tions in vivo: p63 is essential for development of strati-
fied epithelia, whereas p53 is dispensable during
embryogenesis but functions as a powerful tumor sup-
pressor in the adult. To explore whether compromised
p63 function leads to cancer, we monitored p63+/– mice
for spontaneous cancers over a 2-year period. This study
demonstrated that mice with reduced p63 are not prone
to cancer, further demonstrating the unique roles of
p53-related proteins.
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neering to create mice that are specifically depleted of
TAp63 proteins, yet still express ∆Np63 proteins, we
discovered that senescence in response to oncogenic in-
sults did not occur when TAp63 was absent. This indi-
cates that TAp63 proteins are essential for cellular
senescence. TAp63’s ability to induce senescence com-
pletely blocked the initiation of tumors. Even more
strikingly, when we used an inducible expression system
to turn on TAp63 in tumors that were already estab-
lished, senescence was induced, p21 was expressed, and
the tumors stopped growing. Importantly, TAp63-me-
diated senescence could even occur in tumors that did
not have p53. Because p53 is absent in the majority of
human cancers, this finding suggests that strategies that
turn up TAp63 levels could provide a new way to treat
human malignancies.
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p63 links cellular senescence and aging. During the
course of the tumor study described above, we realized
that p63+/– mice had a significant reduction in life span
and developed age-related pathology. By generating a
new model that allowed us to turn off p63 specifically
in proliferating cells of stratified epithelia such as the
skin, we discovered an unanticipated link among p63,
cellular senescence, and aging. Remarkably, p63 defi-
ciency triggers cellular senescence and leads to aging in
vivo. This suggested a mechanism for the low tumor in-
cidence of p63+/– mice: Cellular senescence effectively
removes aberrantly proliferating cells, thereby protect-
ing from cancer. 
TAp63 induces cellular senescence and shuts down
tumor growth. A fascinating feature of the p63 gene (as
well as the p53 and p73 genes) is that it encodes multi-
ple proteins that fall into the TAp63 and the ∆Np63
classes. This year, we asked which p63 protein class was
responsible for senescence. We found that TAp63 was
able to trigger senescence that was dependent on the
cell cycle regulator p21. By using chromosome engi-
Emma Vernersson-Lindahl
Despite the considerable progress in cancer research and
treatment during the last decade, fundamental ques-
tions still exist regarding clinically important cancers
including liver cancer and ovarian cancer. Breast cancer
to a first approximation is driven by aberrant estrogen,
HER2, and phosphoinositol-3 kinase (PI3K) signaling,
but what factor has a similar role in liver cancer or ovar-
ian cancer? What are these tumors dependent on that
can be exploited by targeted therapeutics? To help an-
swer these questions, this year we became part of a
newly formed National Cancer Institute (NCI)-funded
network of Cancer Target Discovery & Development
Centers. Below, we describe this new project along with
our ongoing work in hepatocellular carcinoma (HCC). 
Integrative Genomic Discovery of Driver
Genes and Oncogenic Dependencies
E. Sawey, C. Cai, M. Costanza, B. Gerdes, J. Marchica 
[in collaboration with S. Lowe, A. Krasnitz, L. Stein, 
S. Guo, P. Premisrut, G. Wu, Cold Spring Harbor 
Laboratory; D. French (Genentech); and R. Finn 
and S. Orsulic, University of California, Los Angeles] 
Cancer genome projects have revealed a tremendous
amount of information about structural alterations in
specific cancers, but they have provided surprisingly lit-
tle knowledge about what drives the formation of these
cancers. To identify driver genes from the mountain of
genomic data, we have been collaborating with Scott
Lowe’s lab at CSHL to develop relatively high-through-
put functional screening methods that use an appropri-
ate mouse model to test the oncogenicity of candidate
drivers. Our lab’s focus has been on using cDNAs to
discover oncogenic driver genes from human amplicons. 
Last year, we reported that we were using this ap-
proach to discover several new amplified driver genes in
human HCC. This year, we completed our genome-
wide functional screen in which we identified oncogenic
driver genes from recurrent amplified regions in HCC
and a follow-up study to determine whether human
HCC cells containing these amplified genes show evi-
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dence of oncogene dependence. We identified eight
completely novel oncogenes that provide new insights
into the cellular processes that can drive malignant trans-
formation. One interesting example is POLR1C, which
encodes the highly conserved RPA40 subunit of both
RNA polymerases I and III (RNA pol I and pol III). Its
function can be characterized as “housekeeping,” mak-
ing it problematic to reconcile with known cancer path-
ways. However, it has long been known that there is an
increase in RNA pol I and III transcription in cancer
cells. Curiously, RPA40 was shown recently to be tyro-
sine phosphorylated, and taken together with its role as
an amplified oncogene, this suggests that it is a central
player in the mechanism driving increased RNA pol I
and III transcription in cancer. These results indicate
that increased RNA pol I and III transcription can ac-
tively drive cancer progression and that these are not
merely passive secondary events. 
RNA interference (RNAi) has proven to be an ex-
tremely effective tool for determining whether a gene
commonly altered in cancer still has an important
oncogenic role in the fully mature tumor cell. The an-
swer to this question more or less determines whether
it is a good therapeutic target. For three of the amplified
oncogenes we identified, we performed in-depth analy-
ses using multiple independent RNAi designs to test
the effects of silencing these driver genes. In all three
cases, RNAi silencing of the target genes inhibited both
tumorigenicity and clonal growth of human HCC cells,
and this oncogene dependence was only observed in
cells harboring the amplified gene. In collaboration
with Dorothy French at Genentech and Richard Finn
at UCLA, we extended our findings to a candidate can-
cer drug by demonstrating that FGF19 amplification is
a predictive biomarker of growth inhibition by a neu-
tralizing monoclonal antibody directed against FGF19.
These results establish that the amplified oncogenome
is a valuable resource for systematic functional identi-
fication of therapeutic targets. 
This discovery of FGF19 as a driver gene for a sig-
nificant subset of HCC validates the utility of our func-
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halt. This year, we have started to screen cancer cells for
sensitizers to what turns out to be a much more prom-
ising candidate cancer drug, an inhibitor to PI3K, which
is an important driver gene in breast cancer. We have
also discovered some promising new sensitizers to the
standard-of-care drug for treating inoperable melanoma,
temozolomide (TMZ). Next year, we hope to report on
a clinical trial based on these findings.
Genome-wide Analysis of DNA 
Methylation Alterations in HCC
K. Revill, T. Wang
As more and more large-scale cancer genome projects
take hold, there is less and less for individual laborato-
ries to discover. However, the cancer epigenome is rel-
atively unexplored and likely to be the source of
interesting investigations for years to come. We have
started to investigate changes that occur in the DNA
methylation patterns of HCC using genome-wide tech-
nologies. These changes could be just as important as
the DNA copy-number changes that we previously
characterized. Although this analysis is just beginning,
our preliminary findings show that the scope of alter-
ations in HCC differs markedly from that in colorectal
cancer, which was not the case for DNA copy-number
alterations. In addition to the anticipated increase in
CpG-island methylation, we also found that some
genes in liver cancer appear to have their CpG islands
demethylated instead (Fig. 1). 
tional genomics approach to driver gene discovery. As
a result of NCI funding, we expanded our study to
ovarian cancer and have begun functional genomic
analysis of genes and pathways altered in human ovar-
ian cancer (identified in collaboration with A. Krasnitz
and L. Stein, CSHL) using ovarian epithelial progenitor
cells provided by Sandra Orsulic’s laboratory at UCLA.
Our goal in both of these projects is to understand
more about the cellular processes that are critical to liver
and ovarian cancer and most importantly to discover
new strategies for treatment and diagnosis.
RNAi Screens to Discover Tumor 
Cell Dependencies and Combination 
Therapy Strategies
A. Mofunanya , C. Eifert,  J. Zhang [in collaboration with 
K. Chang and G. Hannon, Cold Spring Harbor Laboratory;
G. Schwartz, Memorial Sloan-Kettering Cancer Center; 
and K. Bachman and R. Wooster, GlaxoSmithKline] 
This year, we continued to use the powerful RNAi
screening methodology developed by Greg Hannon here
at CSHL to look for combination therapy strategies for
cancer drugs, and we also began screening human HCC
cell lines to look for tumor cell dependencies. Last year,
we reported on a screen for sensitizers to a Polo-kinase
inhibitor, a candidate cancer drug, and the discovery that
retinoic acid synergized with this compound to kill can-
cer cells. Unfortunately, an unexpected side effect of that
candidate cancer drug caused its clinical development to
Figure 1. Heat map of the most variant CpG-methylation al-
terations amongst a set of 12 HCC specimens with matching
non-tumorous liver samples.  There are two  major classes of
genes (rows):  those that are hypermethylated in a subpopula-
tion of tumors (left-most columns), which form the top group
of rows, and those that are hypomethylated in that same set of
tumors, which form the bottom rows. Surprisingly, these groups
are different than those found altered in colorectal cancer.
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How Does the Newly Discovered 
Oncoprotein FNDC3B Transform 
Liver Epithelial Cells?
C. Cai
A postdoc in the lab, Chunlin Cai, took on the ambi-
tious goal of determining the mechanism by which a
newly discovered oncoprotein, FNDC3B, transforms
cells. FNDC3B was discovered in the functional ge-
nomic screen for driver genes in HCC described above.
For a little more than 2 years, Cai steadfastly attacked
this problem using a variety of approaches. Very little
was (or still is) known about the normal function of
FNDC3B, so he was really starting from scratch. One
fact that he managed to establish, with the expert help
of Stephen Hearn in the Microscopy Facility, is that
FNDC3B localizes to the Golgi apparatus, a rather un-
usual subcellular localization for oncoproteins. This lo-
calization assignment was carefully controlled with
independent antibodies to FNDC3B along with the use
of green fluorescent protein (GFP) fusions. Mutations
that caused mislocalization also destroyed oncogenic
function, suggesting that its localization to the Golgi
may be essential for its transforming activity. But how?
Chunlin tried to obtain a clue to the biochemical mech-
anisms through identification of interacting proteins by
proteomic analysis. This analysis indicated that
FNDC3B seems to interact with a bewildering array of
proteins, including heat-shock protein 70-kDa protein
1B, lysosomal phospholipase A2, heterogeneous nuclear
ribonucleoprotein K, and a protein ignominiously called
C20orf70. However, we did not follow up on these pro-
teins because none of them provided compelling clues
to the biochemical function of FNDC3B and their in-
teraction seemed potentially nonphysiological. The
other approach to find the biochemical mechanism was
to start with the oncogenic pathways modulated by
FNDC3B. Here, the idea was to survey the cancer path-
ways for FNDC3B modulation and then to dissect the
point at which FNDC3B intervened with the specific
pathways. This approach yielded more solid results,
which nevertheless were very surprising in that several
independent signaling pathways were activated, includ-
ing Rb1, Akt, PKC, and TGF-β. The latter pathway was
examined in detail, and we found that the activation oc-
curred at the level of receptor activation, but not
through the production or stimulation of ligand. Al-
though these results were interesting, we did not solve
the problem, and the results point out the potential dif-
ficulty in determining oncogenic mechanisms. We have
learned a lesson from this and will reserve future explo-
rations of the oncogenic mechanism for when it can
help move forward a truly promising therapeutic target.
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Mammalian Genetics
We study variations in the human genome and their as-
sociation with disease and genetic disorders. The varia-
tions we study arise when a large segment of the
genome is duplicated or deleted (Lucito et al., Genome
Res 13: 2291 [2003]; Sebat et al., Science 305: 525
[2004]). Such “copy-number” variations, or CNVs, can
arise somatically or in the germline. Somatic variations
are often seen in cancer and distinguish cancer cells
from the normal cells of the body. They provide clues
for the origin and behavior of the cancer (Hicks et al.,
Genome Res 16: 1465 [2006]) and possibly its early de-
tection. Analysis of cancer genomes at the single-cell
level will enable us to better study how cancers evolve
(Navin et al., Genome Res 20: 68 [2010]) and provide
new tools for clinical evaluations of many sorts.
Germline variations distinguish individuals from each
other and may be inherited, in which case, they are
known as copy-number polymorphisms, or CNPs, or
they may arise spontaneously, in which case, they serve
as engines of human diversity and can sometimes cause
devastating genetic disorders, such as autism (Sebat et
al., Science 316: 445 [2007]). We have formulated a hy-
pothesis unifying spontaneous and inherited mutation
in the etiology of autism (Zhao et al., Proc Natl Acad
Sci 104: 12831 [2007]). Much of the lab is dedicated
to devising methods for data interpretation and build-
ing quantitative genetic models.
Cancer and Leukemia
We use copy-number data and DNA-methylation sta-
tus to study breast cancer (Hicks et al., Genome Res 16:
1465 [2006]) and B-cell chronic leukemia (Grubor et
al., Blood 113: 1294 [2008]). We seek to identify the
loci most frequently mutated in cancers and leukemias,
and among them to determine which might be
causative (Zender et al., Cell 125: 1253 [2006]; Xue et
al., Genes Dev 22: 1439 [2008]; Zender et al., Cell 135:
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852 [2008]; Bric et al. 2009), and to determine if ge-
nomic data can be used to predict the outcome of the
disease (Hicks et al., Genome Res 16: 1465 [2006]), its
response to therapy (McArthur et al. 2009), and the
early detection of its recurrence. In addition to assessing
the role of copy-number mutation in cancer etiology
and outcome, we have developed methods to assess the
role of DNA methylation changes (Hodges et al. 2009;
Kamalakaran et al. 2009; S Kamalakaran et al., in
prep.). A particular emphasis is using copy-number data
to assess the population substructure of tumors (Navin
et al., Genome Res 20: 68 [2010]). We have had success
with single-cell genome sequence analysis, a tool that
shows extensive promise for applications in clinical and
basic cancer biology (N Navin et al., in prep.). All of
the above studies are collaborations with scientists at
CSHL (Powers, Lowe, McCombie, and Hannon labs)
and at other institutions.
Genetic Disorders
After our discovery that copy-number variation is com-
mon in the human gene pool (Sebat et al., Science 305:
525 [2004]), we studied the role of CNVs in human
disease and, in particular, the role of spontaneous (or
de novo) germline CNVs. Our findings established that
germline mutation is a more significant risk factor for
autism spectrum disorders (ASD) than previously rec-
ognized (Sebat et al., Science 316: 445 [2007]) and es-
tablished a new approach for the further study of the
genetic basis of this and other genetic disorders. We also
study the role of spontaneous mutation in congenital
heart disease (a collaboration with Dorothy Warburton
at Columbia University), rheumatoid arthritis (with
Peter Gregersen at North Shore University Hospital),
and pediatric cancers (with Ken Offit at Memorial
Sloan-Kettering Cancer Center).
One of the de novo events we identified in autism
was a deletion on 16p (Sebat et al., Science 316: 445
[2007]). This event has now been shown by two other
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males minus the incidence in females) divided by the
incidence in males.
Our study based on copy number does not pinpoint
the genes that cause autism, because even the narrow
events typically contain multiple genes. Pathway analy-
sis, performed in collaboration with Ivan Iossifov at
CSHL, does suggest a plausible set of interrelated genes.
We are now pursuing our leads by sequence analysis of
trios (mother, father, and child) from the Simons col-
lection (a collaboration with the McCombie Lab at
CSHL). We are conducting a search for de novo point
mutations that disrupt function in our candidate genes.
From our unified hypothesis, knowledge of the rate of
de novo mutation in the germline, and the rate of
autism in males, we estimate that there are on the order
of 300–500 autism genes. In the 1000+ trios we expect
to sequence, we predict to see a signal in the form of
recurrent mutations only in the actual autism genes. 
Data Generation, Analysis, and
Quantitative Modeling of Genetic Process
A major part of our group’s effort centers on the gen-
eration, analysis, and interpretation of high-volume
data. This includes developing protocols for handling
microarray copy-number data, determining quality
control, probe evaluation, signal extraction, and seg-
mentation (the method of “observing” copy-number
variation); comparisons of sets of experiments, includ-
ing new statistical measures, data reduction, and data
summary; as well as construction of databases so that
we can communicate our results to others. Our novel
contributions include methods to attenuate system
noise in array hybridizations, parameterize hybridiza-
tion performance, detect and correctly call regions of
genetic polymorphism, detect de novo events, classify
cancers for outcome, and define the epicenters of ge-
netic change in cancers and leukemias. We are now also
using high-throughput DNA sequence data to measure
mutation rates. This entails becoming familiar with and
developing new methods for data analysis. Our first
“product” in this line is a method to correctly call copy
number from the DNA sequence read density of sin-
gle-cell genomes.
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groups to explain perhaps as much as 1% of autism. We
assisted Alea Mills at CSHL to engineer mice with the
orthologous deletion on mouse chromosome 7, and she
has continued to search for phenotypic consequences.
We are hopeful that these mice will provide animal
models suitable for understanding the underlying neu-
ropathology of the condition and the search for pallia-
tive treatments.
Analysis of autism incidence in families, a collabora-
tion with Kenny Ye at the Albert Einstein School of
Medicine, provided evidence for a unified theory of the
genetic basis for the disorder (Zhao et al., Proc Natl Acad
Sci 104: 12831 [2007]). Autism families are divided into
simplex (only one affected child) and multiplex (multi-
ply affected children). By inspecting the records from
the AGRE consortium, we found that the risk to a male
newborn in an established multiplex family is nearly
50%, the frequency expected of a dominant disorder.
Autism incidence and sibling concurrence rates are con-
sistent with a model in which new or recent mutations
with strong penetrance explain the majority of autism
in males and are consistent with a one-hit event. 
We are now in the midst of a larger study of sponta-
neous mutation in autism, based on a population of
simplex families collected by the Simons Foundation.
This collection is of high-functioning children, and it
has a 7:1 bias of males to females. Early initial results
confirm our previous findings, and we observe de novo
(copy-number) mutation more frequently in children
with autism than in their unaffected siblings. The sta-
tistical evidence is strong for deletion events, but much
weaker for amplifications, an assessment that was not
possible before because of lack of statistical power. Be-
cause our new studies are performed with higher-reso-
lution microarrays, we also see many more examples of
narrow new mutations (altering only a few genes), thus
expanding our list of good candidate genes involved in
the disorder. There is a male bias to the detection of
narrow mutations, but we see little gender bias for
broad mutations (altering many genes). Because there
should be no gender bias in the incidence of new mu-
tation, the detection biases suggest to us that at least
two contributory genes are targeted in the broad le-
sions, equalizing susceptibility in males and females.
The data deepen the mystery of the male bias in
autism. We are developing testable theories, including
the possibility that the pattern of monoallelic expression
is different in males and females during early develop-
ment. Regardless of the model, if females require two-
hit events, it enables us to estimate the proportion of
autism that is one-hit in males. It is (the incidence in
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Signal Transduction focuses on signaling pathways and cell architecture in normal and cancer cells.
Mikala Egeblad and colleagues study tumors and in particular the microenvironment in which
tumors arise and live. Solid tumors are abnormally organized tissues that contain cancer cells, stromal
cells, and the extracellular matrix. Communications between the different components of the tumor
influence its progression, for example, by regulating metastasis, the immune response to tumors, or
the response to therapy. The lab seeks to separate functions and behaviors of the different stromal
components of tumors, using mouse models of breast cancer and real-time imaging of cells in tumors
in live mice. This enables them to follow the behaviors of and the interactions between cancer and
stromal cells in tumors during progression or treatment. Among the tumor-associated stromal cells,
their main focus is on myeloid-derived immune cells, a diverse group of cells that can enhance an-
giogenesis and metastasis and suppress the immune response against tumors. Egeblad is interested
in how different types of myeloid cells are recruited to tumors and how their behavior in the tumor
microenvironment, for example, their physical interactions with cancer cells and other immune
cells, influence cancer progression. Stromal cells and the extracellular matrix can also influence drug
responses, for example, by impairing drug delivery to the cancer cells. The lab is addressing how
therapy affects cancer and stromal cells in different tumor microenvironments, in part by using im-
aging to follow the response to chemotherapy in mice in real time.
Yuri Lazebnik and colleagues study cell fusion in the context of the hypothesis that viruses and
other common human pathogens might cause cancer under certain conditions. They have estab-
lished that massive chromosomal instability can be engendered by a transient event causing genomic
destabilization without permanently affecting mechanisms such as mitosis or proliferation. The
agent, in this instance, is an otherwise harmless virus that causes chromosomal disruption by fusing
cells whose cell cycle is deregulated by oncogenes. The resulting cells have unique sets of chromo-
somes and some can produce aggressive epithelial cancers in mice. Having developed a method of
producing hybrid cells more efficiently—a means of isolating viral fusogenic proteins—Lazebnik
and colleagues are attempting to induce fusion under controlled conditions in order to explore the
consequences for cell viability and survival.
Changes in tissue architecture are often the first signs of cancer, but very little is known about
the genes, proteins, and pathways that regulate cellular shape and polarity. Senthil Muthuswamy
has developed a new paradigm for thinking about this aspect of cancer biology. Using sophisticated
model systems such as three-dimensional cell culture platforms and transgenic mice, his team found
that a protein called Scribble normally regulates proper differentiation of breast epithelial cells and
coerces them into the correct organization and shape and enforces resistance to cancer. They also
found that deregulation of the Scribble pathway results in the development of undifferentiated tu-
mors in mice. Muthuswamy’s team finds that Scribble is frequently mislocalized from cell mem-
branes or not expressed in human breast cancer lesions, which suggests that understanding the
pathways regulated by Scribble can help to identify therapies aimed at preventing precancerous le-
sions from becoming invasive. 
Darryl Pappin’s lab develops chemical and computational methods for analysis of proteins and
peptides. These are fundamental tools for proteomics and are vital in many fields of biological in-
vestigation. Proteins and peptides are typically analyzed via mass spectrometry, a method that in-
volves fragmenting samples by colliding them with gas atoms in a vacuum. Masses of the resulting
fragments are measured, and computer algorithms match results with known or predicted molecules
whose amino acid sequences are either known or inferred. Pappin has developed search engines for
mass spectrometry data that enable investigators to sift hundreds of thousands of experimental spec-
tra at a time for database matches. He also seeks to reduce sample complexity via an approach he
calls chemical sorting. This includes the use of chelation to enrich phosphopeptides from the total
83
CANCER: SIGNAL TRANSDUCTION
peptide pool and the use of specific affinity-tagged small-molecule inhibitors to segregate classes of
kinases or phosphatases for more specific mass spectroscopic analysis.
Jacek Skowronski and colleagues study mechanisms involved in the induction of AIDS by human
and simian immunodeficiency viruses (HIV and SIV), focusing on the function of accessory proteins
called Nef, Vpr, and Vpx. These virulence factors modify the cellular milieu to disrupt adaptive re-
sponses and/or innate antiviral responses and provide an environment conducive for viral replication.
Skowronski and colleagues have discovered new details about how a simian strain of the AIDS virus
replicates in macrophages, a type of immune-system cell. Their studies have revealed that Vpx enables
efficient reverse transcription in the simian virus and thus overcomes an innate block that otherwise
prevents viral replication. This suggests a strategy by which a future drug might interfere with the
reproductive machinery of the virus to prevent or limit its ability to spread.
Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely
sensitive to the reversal of certain mutations. Raffaella Sordella and colleagues study why cells in
certain cancers are responsive to the inhibition of one particular gene or gene product. Why, for in-
stance, do non-small-cell lung cancer cells that have a particular mutation in the EGF (epidermal
growth factor) receptor respond dramatically to its inhibition by the drug Tarceva? This occurs in
15%–20% of patients, the great majority of whom, within 1–3 years, develop resistance. Various
mutations have been implicated in about half of resistant patients. Sordella and colleagues are fo-
cusing on as yet unidentified mechanisms of resistance, at work in other cases. They have preliminary
in vitro data indicating a genetic signature predicting a positive response to other treatment modal-
ities. With colleagues at the National Institutes of Health, they are testing this hypothesis in tumor
samples taken from relapsed patients.
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases,
or PTPs, which remove phosphate groups from other proteins. By changing the phosphorylation
state of proteins, PTPs can profoundly affect the health of entire organisms. Tonks’ group seeks to
characterize fully the PTP family, understand how their activity modifies signaling pathways, and
how those pathways are abrogated in serious illnesses, from cancer to Parkinson’s disease. The overall
goal is to identify new targets and strategies for therapeutic intervention in human disease. They
have, for instance, sought to define the role of JNK stimulatory phosphatase 1 in regulating a sig-
naling pathway critical in Parkinson’s and have investigated new roles for PTPs in regulating sig-
naling events in breast cancer, identifying three PTPs as potential novel tumor suppressors. This
year, Tonks and colleagues published results of experiments suggesting one way in which cascades
of intracellular signals are regulated at what they call a decision point, where cells commit to repair
broken DNA strands or commit suicide following DNA damage. A protein, EYA, was found by
the lab to regulate the formation of specialized microenvironments on DNA called γ-H2A.X foci,
which allow the cell to summon repair enzymes to the site of broken DNA strands.
Several years ago, Lloyd Trotman discovered that the loss of a single copy of a master tumor sup-
pressing gene called PTEN is sufficient to permit tumors to develop in animal models of prostate
cancer. His team later found that complete loss of PTEN paradoxically triggers senescence, an ar-
rested state that delays or blocks cancer development in affected cells. These findings explained why
many patients only display partial loss of this tumor suppressor and establish a novel mechanism of
cancer initiation. His lab has recently been expanding these findings in collaboration with clinicians
at Memorial Sloan-Kettering Cancer Center, with the aim of identifying patients who have devel-
oped tumors with metastasis-favoring mutations. The interdisciplinary team aims to generate mouse
models that accurately reflect the core genetic changes of human metastatic prostate cancer to de-
velop novel therapies using small molecules or RNA interference technology developed at CSHL.
In addition, Trotman’s lab is studying regulation of PTEN stability and nuclear transport, as many
patients have tumors that aberrantly target PTEN for cytoplasmic degradation.
Linda Van Aelst’s lab studies how aberrations in intracellular signaling involving enzymes called
small GTPases can result in disease. They are particularly interested in Ras and Rho GTPases, which
help control cellular growth, differentiation, and morphogenesis. Alterations affecting Ras and Rho
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function are involved in cancer and various neurodevelopmental disorders. This year, Van Aelst‘s
team extended their study of mutations in a Rho-linked gene called oligophrenin-1 (OPHN1), part
of an effort to connect the genetic abnormalities associated with mental retardation to biological
processes that establish and modify the function of neuronal circuits. They discovered that sponta-
neous activity drives the protein OPHN1 into dendritic spines, where they stabilize synaptic AMPA
receptors. They showed how defective OPHN1 signaling results in loss of spines, synaptic strength,
and plasticity. They also studied what happens on the presynaptic side of the synapse, discovering
that OPHN1 helps neurons transmit messages by controlling the retrieval of synaptic vesicles. This
suggests that the symptoms of X-linked mental retardation could stem not only from defects in
dendritic spine structure and function, but also from inefficient synaptic vesicle retrieval.
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Cells and the extracellular matrix (ECM) form tissues,
and collections of the tissues join together in structural
and functional units to form organs. Solid tumors are
not random mixtures of cells and ECM, but rather, they
resemble organs, although structurally and functionally
abnormal. Organs are composed of the cells that per-
form the main organ function (e.g., secrete hormones
or enzymes) and the stroma, the supportive framework
of an organ. The stroma can be divided into several
classes: the ECM, which is composed of proteoglycans,
hyaluronic acid, and fibrous proteins (e.g., collagen),
and stromal cells. The stromal cells include mesenchy-
mal supporting cells (e.g., fibroblasts and adipocytes),
cells of the vascular system, and cells of the immune sys-
tem. Interactions between epithelium and stroma are es-
sential for normal organ development as well as for
tumors. As tumors develop and progress, they undergo
dramatic morphological changes, which involve both
the cancer cells and the stroma. Stromal components
proposed to have a more pronounced tumor-promoting
function in advanced stages than in earlier stages include
the immune cell infiltrate and type I collagen.
We have developed an imaging method that permits
real-time spinning disk microscopy of tumor–stroma
interactions in mouse models of human breast cancer.
This allows us to follow, for example, vascular leakage,
immune cell infiltration, and cancer cell proliferation
and death in real-time. We use this technology to un-
derstand how breast and pancreatic cancer is affected
by the stroma. 
Effects of the Tumor Microenvironment
on Response to Cancer Therapy
Despite the large number of patients treated with cy-
totoxic chemotherapy, we are literally blind to the ef-
fects of the treatment on cancer cells in intact tumors.
Knowledge of the mechanism of actions of chemother-
apy mostly comes from cell culture experiments or
xenograft animal models. Such models do not reflect
the complex interactions between cancer cells and their
microenvironment found in spontaneous tumors. Mu-
INTERACTIONS BETWEEN TUMOR AND HOST IN CANCER
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tations in cancer cells can result in anticancer drug re-
sistance. However, the abnormal organization of the
tumor tissue affects the ability of anticancer drugs to
reach the cancer cells. In normal tissues, cells are within
a few cell diameters of a blood capillary, enabling effi-
cient drug delivery. When cancer cells proliferate faster
than the cells that form capillaries, the resulting increase
in distance from blood vessels impairs drug delivery.
The tumor vasculature is often poorly organized with
leaky vasculature and sparse or absent lymphatics. This
leads to increased interstitial fluid pressure, thereby in-
hibiting drug distribution. The rate of diffusion
through the tumor tissue is also affected by the proper-
ties of drugs (e.g., molecular weight, shape, charge, and
solubility), by uptake in cancer or stromal cells, and by
binding to the ECM (Fig. 1). For example, type I col-
lagen influences the distribution of antibodies and
chemotherapeutic drugs. 
We are using our imaging technology to study how
the microenvironment influences the response to cyto-
toxic therapy, focusing on drug distribution. Together
with Dr. Lisa Coussens’ Laboratory at the University of
California, San Francisco, we have shown that vessel
stability in tissues involves matrix metalloproteinase ac-
tivity and transforming growth factor-β1 (TGF-β1).
Following acute tissue damage, plasma proteins rapidly
extravasate out of the vasculature in wild-type mice.
Short-term treatment of mice in vivo with a broad-
spectrum metalloproteinase inhibitor or an activin-like
kinase 5 (ALK5) inhibitor further enhanced vessel leak-
age. Neoplastic tissues are in a constant state of tissue
damage and exhibit hyperleaky vasculature. Using im-
aging, we have found that inhibition of ALK5 or
knock-out of matrix metalloproteinase-9 (MMP-9) in
mammary carcinomas further enhance vascular leakage
(Fig. 2). We are currently testing if this increased leak-
age can be used to improve the delivery of therapeutics
into tumors. 
The microenvironment can regulate anticancer drug
responses, but we are also finding that drug treatment
can change the microenvironment of tumors. We are
focusing on the effects of cytotoxic therapy on the in-
nate immune cells of the myeloid lineage. Breast carci-
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mice contains increased levels of the chemokine CCL2,
which is involved in recruitment of monocytes and
neutrophils. We are currently investigating whether the
changed myeloid cell infiltrates influence the overall
tumor response to chemotherapy. 
Collagen Architecture in Cancer Progression
The interstitial matrix is a major category of ECM and
consists of macromolecules such as fibrillar collagens,
fibronectin, and proteoglycans. Type I collagen is the
major fibrillar collagen in tissues, and it forms a scaffold
that provides stability to tissues. Type I collagen also
has signaling functions mediated by integrins and dis-
coidin domain receptors. The synthesis and proteolytic
remodeling of the fibrillar type I collagen increases in
many tumors. Type I collagen-degrading enzymes, in-
cluding matrix metalloproteinases (MMPs), are impli-
cated in cancer progression. MMP-dependent collagen
remodeling promotes cancer progression by creating
spaces for cells to migrate and by producing fragments
of collagen with new biological activities. 
By genetic targeting of both type I collagen and the
MMP that cleaves it, we have found that cleavage of col-
nomas are infiltrated with different types of myeloid
cells, including monocytes, neutrophils, and different
types of macrophages with either tumor-promoting or
-inhibiting functions. The myeloid cells can promote
tumor progression by stimulating cancer cell prolifera-
tion, tumor angiogenesis, and metastasis or by suppres-
sing the immune response. A common side effect of
chemotherapeutic treatment is the inhibition or killing
of myeloid cells in the bone marrow. By spinning disk
confocal microscopy, we have observed that myeloid
cells are recruited to tumors treated with cytotoxic
chemotherapy. These myeloid cells express neutrophil
and monocyte markers, and tumor lysate from treated
Figure 1. Tumor tissue organization influences drug response.
The overall architecture of the tumor has a direct effect on the
ability of a cancer drug to penetrate the tissue and reach the can-
cer cells. Abnormal leakage from blood vessels, together with in-
sufficient lymphatic drainage, especially from the middle of
tumors, contributes to increased interstitial pressure in the tumor
tissue that inhibits penetration of drugs into the deeper areas of
the tumors. Cancer drug penetration is also limited by their bind-
ing to ECM proteins, such as collagen, or their uptake by stromal
cells, such as macrophages. Cancer cells furthest away from the
blood vessel not only are exposed to the lowest drug concentra-
tions, but also receive the lowest amounts of nutrients and oxy-
gen from the circulation and therefore have the lowest
proliferative index. Because many cancer-cell drugs preferentially
target actively proliferating cells, this effect contributes to the in-
ability of drugs to target cells in hypoxic areas. Cancer cells fur-
ther from the blood vessel are also exposed to a low-pH
microenvironment where many cytotoxic drugs become inactive.
Thus, the organization of the tumor tissue results in limited drug
availability and efficacy in the hypoxic areas of tumors, areas
speculated to contain some of the most aggressive cancer cells.
The changing microenvironment in different parts of the tumors
therefore results in an apparent difference in drug sensitivity.
Figure 2. Regulation of drug distribution in tumors by TGF-β re-
ceptor signaling. (A) Inhibition of TGF-β receptor signaling
(ALK5-I) increases the infiltration of dextran into mammary car-
cinomas compared to control treated mice (dimethylsulfoxide).
Live mice were imaged for 60 min after intravenous (i.v.) injec-
tion of fluorescent dextrans and quantum dots (Qdots). Bar, 100
µm. (B) Quantification of the increased dextran infiltration into
late-stage carcinomas after inhibition of TGF-β receptor signaling
(ALK5-I, n = 5 mice per treatment).
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lagen by stromally produced MMPs controls ductal ep-
ithelial invasion in normal mammary gland development
in mice. Epithelial ductal invasion is reduced in the ab-
sence of MMP14 (MT1-MMP) or MMP2 or when col-
lagen is rendered resistant to MMP cleavage by mutation.
To address the role of collagen remodeling for epithelial
invasion in cancer, we have cross-bred mouse mammary
tumor virus–polyomavirus middle T antigen (MMTV-
PyVmT) mice, which develop aggressive mammary car-
cinoma, with mice with MMP-resistant collagen.
Primary tumor size was not affected, but metastasis to
the lungs was significantly reduced. 
Tumors are often discovered as nodules that are
harder than the surrounding tissue. This reflects the
changes in ECM stiffening and architecture. An abnor-
mal collagen architectural structure correlates with
tumor progression. Whereas collagen fibers are curly and
oriented in parallel to normal or hyperplastic epithe-
lium, there is a progressive change in the fibers so that
they are straighter and mostly perpendicular to the
tumor border in the late stages. This changed architec-
ture may promote cell invasion by enabling cells to mi-
grate along the collagen fibers or by enhancing integrin
signaling. Enzymes of the lysyl oxidase family, involved
in collagen fiber cross-linking, promote cancer progres-
sion and metastasis. In collaboration with Dr. Weaver’s
lab at the University of California, San Francisco, we
have found that inhibiting collagen cross-linking in
mouse models of mammary carcinoma changes tumor
initiation and progression: Tumor onset is delayed and
the progression stage of the tumors is lower. Tumor fi-
brosis and cancer cell phosphoinositol-3 kinase (PI3K)
activity were also reduced. We are now investigating the
effects of collagen cross-linking in pancreatic carcinoma. 
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During the last year, we continued to test a hypothesis
that viruses can contribute to carcinogenesis and/or
tumor progression by fusing cells, thereby combining
properties of diverse cells and further increasing their
diversity through inducing chromosomal instability.
To test the possibility that fusion of tumor cells to
hematopoietic cells can facilitate metastasis of cancer
cells, we began a collaboration with Dr. James Bliska
(Stony Brook University), who provided us with mouse
macrophage progenitors and taught us how to culture
them. We developed an approach to derive clonogenic
CELL-TO-CELL FUSION AS A LINK BETWEEN VIRUSES AND CANCER
Y. Lazebnik A. Gottesman
hybrids of these cells with human prostate cancer and
will test these hybrids for their metastatic potential. 
To understand how cell fusion causes massive chro-
mosomal instability, a phenomenon that we reported
previously, we established a collaboration with Dr.
Keith Killian (National Institutes of Health) to analyze
early genomic and epigenomic changes occurring in hy-
brids.
Overall, by comparing the properties of cell hybrids
with those of cancer cells, we hope to better understand
carcinogenesis and tumor progression. 
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The molecular mechanisms that regulate the develop-
ment and progression of premalignant lesions are
poorly understood. A better understanding will aid in
identification of new predictive biomarkers and drug
targets for premalignant disease. Today, pathologists use
a number of criteria to diagnose and predict prognosis
of premalignant breast lesions and salient among them
are changes in cell number and changes in cell and tis-
sue architecture. Although we are beginning to under-
stand a lot about the mechanisms that regulate cell
proliferation, very little, if anything, is known about
the mechanisms that regulate disruption of cell and tis-
sue differentiation. We believe that gaining a better fun-
damental insight into the mechanisms that regulate
changes in cell differentiation during the development
and progression of premalignant lesions will identify
the molecular targets that pathologists can use tomor-
row to make a better prognosis of premalignant lesions.
In this process, we may also identify novel strategies to
treat premalignant disease. 
Epithelial cells within a normal breast are organized
into ducts and lobules. Each lobule consists of many
individual units referred to as an acinus. Within an ac-
inus is a layer of luminal and myoepithelial cells sur-
rounding an empty lumen. The epithelial cells
surrounding this lumen have an asymmetric distribu-
tion of membrane proteins where the membrane that
is in contact with lumen, referred to as the apical sur-
face, is rich in glycoproteins and microvilli, and the
membrane that is in contact with the neighboring cell
or the surrounding tissue is rich in cell–cell and cell–
matrix junctions and is referred to as basolateral surface.
This characteristic organization is lost early in prema-
lignant disease and the tissue continues to lose its struc-
ture and organization during progression to
malignancy. Surprisingly, we know little about what
role these changes have during the cancer process and,
more importantly, if the changes observed in premalig-
nant lesions are harbingers of what is yet to come.
The current understanding of the molecular mecha-
nisms by which epithelial cells establish and maintain
EPITHELIAL CELL BIOLOGY AND CANCER
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this asymmetry, also referred to as polarity, suggests that
there are several proteins and protein complexes which
function as a highly interactive network during estab-
lishment and maintenance of epithelial cell polarity.
One such complex, the Par6/aPKC/Cdc42, regulates
polarization processes during epithelial morphogenesis,
astrocyte migration, and axon specification. We have
identified a direct interaction between ErbB2 and the
Par complex that is necessary for ErbB2-induced trans-
formation of organized mammary epithelial cells. This
is a major discovery because it identifies, for the first
time, that oncogenes can directly interact with polarity
protein complexes. We are currently dissecting the sig-
naling pathway by which ErbB2 disrupts the normal
function of the Par complex and how it affects the ac-
tivity of the polarity kinase aPKC (atypical protein ki-
nase C), as well as the downstream effects on other
components of the Par6/aPKC pathway. The evidence
we have accumulated over this year points to a role for
the aPKC target, Lgl, as a critical mediator of ErbB2-
induced disruption of cell and tissue architecture. We
are currently investigating the role this pathway has dur-
ing ErbB2-induced transformation of cells as well as the
role it has during progression of premalignant breast le-
sions in human breast. 
In addition to interacting with Par6/aPKC, activa-
tion of ErbB2 also induces disruption of Par3 from the
polarity complex. During the last year, we asked if Par3
has a role during ErbB2-induced transformation of
human mammary epithelial cells. We find that Par3
maintains the integrity of cell–cell junctions and inhi-
bition of cell invasion, suggesting that Par3 may have
an important role during progression of ErbB2-positive
breast cancers. We are currently investigating how Par3
regulates ErbB2-induced disruption of 3D acini and its
implications for ErbB2-positive human breast cancers.
We are interested in investigating whether changes
in polarity proteins function as drivers of tumorigenesis.
To directly test this possibility in mouse models of
human breast cancer, we have generated and character-
ized a mouse model that expresses an altered version of
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receptor-proximal events that regulate transformation of
epithelial cells. Using inducible activation of ErbB2 au-
tophosphorylation site mutants and an MCF-10A three-
dimensional culture system, we investigated pathways
used by ErbB2 to transform epithelia. We reported that
ErbB2 induces cell proliferation and loss of three-dimen-
sional organization by redundant mechanisms, whereas
it disrupts apical basal polarity and inhibits apoptosis
using Tyr-1201 and Tyr-1226/7, respectively. Signals
downstream from Tyr-1226/7 were also sufficient to
confer paclitaxel resistance. The Tyr-1226/7 binds Shc,
and knockdown of Shc blocked the ability of ErbB2 to
inhibit apoptosis and mediate paclitaxel resistance. Tyr-
1226/7 is known to activate the Ras/Erk pathway; how-
ever, paclitaxel resistance did not correlate with
activation of Erk or Akt, suggesting the presence of a
novel mechanism. Thus, we demonstrated that targeting
pathways used by ErbB2 to inhibit cell death is a better
option than targeting cell proliferation pathways. Fur-
thermore, we identified a novel function for Shc as a reg-
ulator of apoptosis and drug resistance in human
mammary epithelial cells transformed by ErbB2. Thus,
research in our laboratory is developing a better under-
standing of how cell polarity pathways are regulating cell
transformation and how ErbB2 transforms human
breast epithelial cells. Together, these studies are likely
to identify new ways for treating breast cancer.
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a polarity protein, Scribble. These mice develop tumors,
albeit after a long time and with low frequency. These
observations are striking because it demonstrates that
alterations in polarity proteins can function as initiators
of tumorigenesis. These observations also suggest that
alterations in polarity proteins are likely to make the
cells and tissue receptive for random somatic mutations
that drive the tumorigenesis process. We are currently
investigating the mechanisms by which these tumors
arise, and in doing so, we hope to identify molecular
alterations that can function as predictive biomarkers
for preneoplastic lesions.
In addition to regulating apical–basal polarity in ep-
ithelial cells, polarity proteins are also critical regulators
of normal differentiation of progenitor cells in Dro-
sophila. We have discovered that deregulation of Scribble
in pluripotent mammary cells promotes symmetric cell
division and blocks differentiation of progenitor cells
along a luminal epithelial lineage. We find that loss of
Scribble activates Notch signaling. Inhibition of Notch
signaling rescues the loss of the differentiation pheno-
type, demonstrating that Scribble regulates differentia-
tion by controlling Notch signaling. These observations
identify a novel relationship between cell polarity path-
ways and normal differentiation of mammary progenitor
cells. Because changes in pathways that regulate normal
development are implicated in initiation of cancer, we
believe that understanding the mechanisms by which
Scribble regulates epithelial differentiation will have im-
portant implications for development of premalignant
disease.
In addition to investigating cell polarity pathways
and biology of premaligant disease, we also are interested
in developing a deeper understanding of pathways
downstream from ErbB2 signaling that are required for
transformation of human mammary epithelial cells. Be-
cause patients with ErbB2-positive cancers fare poorly
in the clinic, we believe that this will identify novel
strategies for therapeutic intervention of ErbB2-positive
cancers. In this context, we had previously reported the
identification of Brk, a Src family tyrosine kinase, as a
novel member of the ErbB2 signaling pathway and a
potential drug target for ErbB2-positive breast cancers.
During the past year, we have completed a study that
was aimed at developing a deep understanding of the
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The year 2009 was one for restructuring and rebuilding.
The proteomics laboratory had been effectively moth-
balled from the fall of 2007, with CSHL researchers
looking to outside resources to fulfill protein and peptide
analysis. I was recruited in late 2008 to a faculty position,
with scientific oversight for the proteomics Shared Re-
source. It was decided early on that the laboratory should
remain in the same location, in the Beckman lower level,
but it was soon realized that this would require complete
refurbishment of the existing laboratory space. Planning
was completed by the end of the year, and searches were
started to recruit additional laboratory members. In
March, Dr. Cristian Ruse joined the lab from Scripps (La
Jolla) as manager of the Shared Resource facility. Some
laboratory space was quickly refurbished by the begin-
ning of April while building work continued on the main
laboratory across the hall. Two of the smaller mass spec-
trometers (an existing LTQ ion trap and a new Agilent
6520 QTOF) were installed and commissioned, and
some small-scale projects were undertaken. In came
equipment for packing homemade capillary LCs, a brace
of Proxeon Capillary HPLC pumps, and database search-
ing software was installed on the CSHL bluehelix cluster
(with much help from Todd Heywood and other mem-
bers of IT). July saw the arrival of Cexiong Fu (from Uni-
versity of Medicine and Dentistry, New Jersey), just in
time to provide essential support for the 2009 Proteomics
Course, breaking new ground in the recently completed
laboratories on the Hillside campus. In September, the
main laboratory space was completed and the existing
two instruments were moved and joined in October by
a Vantage triple-quadrupole mass spectrometer, intended
to be used primarily for multiple reaction monitoring
(MRM) work. Instrument installations were completed
in early December with the arrival of the Thermo Orbi-
trap XL mass spectrometer, with the first two-dimen-
sional MudPIT samples being run just in time for
Christmas. Samantha Peacock joined the lab immedi-
ately after the New Year.
A considerable amount of time during the fall was
taken up in fitting out and testing the new instruments.
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An expanding repertoire of techniques was and contin-
ues to be added to instruments and taught to individual
lab members. These techniques now include quantita-
tive two-dimensional whole-proteome analysis using
iTRAQ or SILAC on the ion traps, phosphopeptide
site identification in proteins and protein complexes,
and tailored data analysis. Efforts are currently being
directed to optimizing iTRAQ quantitation using the
Orbitrap and high-energy collision dissociation (HCD)
and phosphopeptide enrichment protocols using tita-
nium dioxide columns. By late December, a number of
facility projects were under way. 
Phosphorylation of Subunits
of the Origin Recognition Complex
For this investigation, we established two independent
procedures for the analysis of site-specific phosphoryla-
tion from the origin recognition complex (ORC) protein
complexes. First, we implemented a variant of multidi-
mensional protein-identification technology (MudPIT)
for enhanced detection of phosphopeptides. Our method
harnesses the chromatographic properties of different
packing materials for MudPIT columns. The approach
begins to segregate phosphopeptides and normal pep-
tides in different fractions of the MudPIT process, where
phosphopeptides elute at low salt and are concentrated
in a few early chromatographic fractions. Phosphopep-
tide mapping was performed with multiple proteases,
both specific and nonspecific, to produce redundant
overlapping sets of peptides, before analysis by liquid
chromatography mass spectrometry (LCMS). In a com-
plementary approach, we also enriched phosphopeptides
with titanium dioxide affininity chromatography. In
total, we identified 24 phosphorylation sites, of which
16 were site-localized based on MS/MS fragmentation
and eight were unlocalized. For this purpose, we used the
InSpecT software toolkit that allows for scoring of phos-
phate localization following statistical identification of
nontryptic phosphopeptides.
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data acquired for this large project necessitated paral-
lelized database searches. The MASCOT search program
is currently running on 64 processors allowing for fast
processing of large batches of MudPIT runs. To optimize
our MudPIT system, we also developed a new routine
for data-dependent acquisition on the linear ion trap
(LTQ). In this case, the LTQ was set to acquire peptide
masses with higher resolution by scanning in an en-
hanced scan mode. Both selection of peptide precursors
for further CID fragmentation and database searches
with MASCOT benefited significantly from the higher
resolution and charge state assignment.
MudPIT Analyses of SF2
Complexes
We completed a large-scale project that investigated in-
teraction partners of the SF2/ASF oncoprotein and other
splicing factors. To this end, we implemented an efficient
MudPIT strategy based on autosampler delivery of salt
pulses. By combining salt pulses with organic solvent gra-
dients, we were able to run back-to-back MudPIT analy-
ses with virtually no carryover. In this format, we were
able to complete more than 30 12-step MudPIT analyses
in a brief period of time. Computational investigation of
C. Ruse
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Our interest lies in understanding the molecular mech-
anisms that underlie the pathogenesis of AIDS and, in
particular, in understanding the functional consequences
of interactions between viral proteins and the regulatory
machineries in the infected cells. The main focus of our
research is to understand the functions of accessory vir-
ulence factors of human and simian immunodeficiency
viruses (HIV and SIV). We also initiated a new direction
aimed at understanding the biochemical underpinnings
of selected innate mechanisms that block HIV infection,
such as that mediated by cellular tripartite motif-con-
taining protein 5 (TRIM5). Accordingly, we have di-
rected a major effort toward the identification of
mechanisms and downstream effectors that mediate the
effects of Vpr and Vpx in the infected cells. These exper-
iments have led to the description of several novel cellu-
lar proteins that tightly associate with these factors in
hematopoietic cells. Among them are the E3 ubiquitin
ligase complexes that regulate cell cycle progression and
the repair of damaged DNA. Remarkably, we found that
both the Vpr and Vpx proteins target a novel substrate
adaptor for Cullin-4 and function through their associ-
ated Cullin 4 E3 ubiquitin ligase complexes. Our current
effort is concentrated on the identification of cellular
proteins that are recruited to these E3 complexes by Vpr
and Vpx, as they are likely cellular factors that modulate
HIV replication. Here, we describe in more detail our
studies of lentival Vpr and Vpx.
Functions of Vpr and Vpx Lentiviral
Accessory Factors
Vpr and Vpx are multifunctional virion-associated acces-
sory proteins of simian and or human immunodeficiency
viruses (HIV-1, HIV-2, and SIV). One function of HIV-
1 Vpr is to mediate translocation of viral reverse tran-
scription complexes into the nucleus in nondividing cells,
such as terminally differentiated macrophages. The other
is to perturb the cell cycle progression of the infected cell.
Both functions are thought to be important for facilitat-
ing the HIV-1 life cycle in the infected host. Unlike HIV-
1, which possesses only the vpr gene, HIV-2 and SIVmac
viruses specify both the vpr and a closely related vpx gene.
CELL SIGNALING IN HIV PATHOGENESIS
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The Vpr proteins encoded by SIV and HIV-2 block cell
cycle progression in the G2/M phase similar to HIV-1
Vpr, but they do not have the ability to promote nuclear
transport of the preintegration complexes in nondividing
cells. Interestingly, Vpx proteins are strictly required for
the abilities of viruses of HIV-2/SIVsm lineages to trans-
duce monocyte-derived cells. This probably reflects the
ability of Vpx to overcome an as yet uncharacterized
block to an early event in the virus life cycle in these cells,
but the underlying mechanisms has remained elusive. Be-
cause Vpx and Vpr function as adaptor proteins, we
thought to identify cellular proteins that they bind, to
obtain novel insights into their functions. 
Vpx and Vpr Usurp a Specific Cullin-4-based
E3 Ubiquitin Ligase Using a DCAF1 Substrate
Receptor
We used a combination of biochemical and proteomic
approaches to identify cellular proteins associated with
human and simian Vpx/Vpr proteins. With these tools,
we previously showed that Vpr and Vpx accessory factors
target and function through Cullin-4-based E3 ubiquitin
ligase using a DCAF1 substrate receptor. Our findings
support a model in which Vpr, as well as Vpx, usurps
Cullin-4 E3 ubiquitin ligase using the VprBP/ DCAF1
to inactivate a cellular factor that inhibits lentivirus repli-
cation in infected cells. Indeed, viral accessory proteins
are known to use E3 ubiquitin ligases to direct ubiquiti-
nation and proteasomal degradation of cellular proteins
that mediate innate immunity to viral infection. Our on-
going experiments are aimed at identifying cellular pro-
teins whose ubiquitination is altered by Vpr and Vpx.
We expect that our findings will advance the understand-
ing of these important virulence factors.
TRIM5 Is Bound to the 19S Regulatory 
Particle of the 26S Proteasome
TRIM5 is a cellular protein that can block infection of
HIV-1 as well as other retroviruses. TRIM5 proteins re-
strict the retrovirus life cycle at least at two stages: by tar-
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ity of a mutant TRIM5 molecule (K74R) that retains
only six lysines in its RING domain and is not polyu-
biquitylated to bind 26S proteasome. TRIM5 K74R sta-
bly and specifically associated with 26S proteasome, as
it precipitated the complete 26S proteasome complex
under conditions that stabilize the 26S complex. Strik-
ingly, and in contrast to wild-type TRIM5, K74R pre-
cipitated only the 19S regulatory subcomplex under
conditions that favor 19S dissociation from 20S, thus
indicating that it docks specifically to the 19S regulatory
subcomplex. The spectrum of 19S subunits found to be
associated with K74R suggests that it docks to 19S prob-
ably via its base, similar to other proteins that modulate
proteasome function, and, importantly, confirms that
K74R binding to 19S is not mediated by TRIM5 polyu-
biquitylation, because the 19S subunits that serve as
polyubiquitin receptors were not found. Our findings
indicate that TRIM5, besides being degraded by the pro-
teasome, also stably associates with the 19S regulatory
subcomplex by a polyubiquitylation-independent mech-
anism. We hypothesize that via its binding to the 19S
subcomplex TRIM5 recruits the 26S proteasome to the
restricted viral capsid and that this physical interaction
with the 19S subcomplex is crucial for TRIM5’s full
ability to restrict retrovirus infection.
geting early postentry events that lead to reverse tran-
scription of the viral genome, which requires functional
26S proteasome, and by interfering with transport of the
viral preintegration complex to the nucleus. To address
the underlying mechanisms, we performed comprehen-
sive proteomic analyses of TRIM5-associated cellular
proteins from cell lines stably expressing rhesus monkey
TRIM5. These experiments were performed in close col-
laboration with Michael Washburn, Laurence Florens,
and Selene Swanson at the Stowers Institute for Medical
Research (Kansas City). Strikingly, we identified 26 out
of 31 subunits of 26S proteasome in highly purified
TRIM5 preparations. This demonstrated that TRIM5
tightly associates with 26S complex, but it was surprising
in that the 26S complex normally dissociates into its 19S
regulatory and 20S catalytic subcomplexes under the pu-
rification conditions used. This probably reflects TRIM5
degradation because such a behavior is expected of
stalled 26S proteasome–substrate complexes. We next
addressed the roles of TRIM5 polyubiquitylation. A sys-
tematic scan of the TRIM5 molecule with lysine-to-
arginine substitutions revealed that at most only four
lysines located in the SPRY domain are required for
TRIM5 to restrict infection, and these lysines are not
the sites of polyubiquitylation. We also analyzed the abil-
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The goal of our lab is to identify better cancer therapies.
Despite the large variety of genetic abnormalities that
they typically harbor, cancer cells are incredibly sensitive
to the reversal of certain mutations. A few years ago,
Bernard Weinstein described this phenomenon as
“oncogene addiction.” Examples are provided by c-
Myc, Ki-Ras, Ha-Ras, Bcr-Abl, Her-2, and Wnt1. Un-
derstanding why cancer cells are dependent on specific
oncogenes could lead to the development of more ef-
fective therapies. Recently, we identified new epidermal
growth factor receptor (EGFR) somatic mutations in
non-small-cell lung cancer (NSCLC) patients that re-
spond dramatically to treatment with gefitinib (Iressa)
or erlotinib (Tarceva), two selective inhibitors of EGFR.
In particular, we demonstrated that the presence of
these mutations render the cells “addicted” to signaling
activated by the mutant EGFR alleles. This finding
spurred new excitement on the possibility of treating
cancer patients in a “personalized” manner. Based on
our studies in several cancer centers, lung cancer pa-
tients are now screened for the presence of EGFR mu-
tations, and based on the genetic status of the tumors,
patients are treated either with standard chemotherapy
or with EGFR inhibitors.
TGF-β1 and TGF-β2 Are Necessary 
and Sufficient for Erlotinib Resistance and 
EMT and, through an Increased Activation 
of the IL-6 Axis, to Unleash Tumor Cells 
from their EGFR Dependency
Unfortunately, in a majority of cases, the dramatic re-
sponses observed upon treatment with EGFR inhibitors
are transient, and within a short period of time, patients
who initially responded to treatment suffer a relapse.
Studies have now shown that the acquisition of an addi-
tional mutation in exon 20 of EGFR, resulting in a thre-
onine–methionine substitution at position 790 (e.g.,
T790M mutation) and/or amplification of c-MET, ac-
count for ~50% of cases of erlotinib-acquired resistance.
MOLECULAR TARGETED THERAPY OF LUNG CANCER EGFR 
MUTATIONS AND RESPONSE OF EGFR INHIBITORS
R. Sordella M. Camiolo M. Pineda
S. Fenoglio A. Saborowski
T. Lindsted Z. Yao
To uncover new molecular mechanisms of gefitinib
and erlotinib resistance in NSCLC, we have developed a
cell-based system. We grew lung-tumor-derived cells that
express EGFR oncogenic mutations in the presence of a
high concentration of Tarceva, and we selected cells that
become unleashed from their EGFR dependency. Inter-
estingly, ~13% of these cells displayed morphological fea-
tures of mesenchymal cells. They not only lost their
cobblestone-like morphology and acquired a more elon-
gated shape, but they also displayed enhanced motility
and invasion capabilities. The epithelial-mesenchymal
transition (EMT) is a complex program that involves ac-
tivation of many different signal transduction pathways.
Among them, we were able to show that an increased au-
tocrine secretion of transformation growth factor-β
(TGF-β1) and TGF-β2 was sufficient to induce the ex-
pression of master regulators of EMT such as SNAI and
ZEB2 and of interleukin 6 (IL-6). Interestingly, we
found that an augmented secretion of IL-6 was sufficient
to decrease the cells’ sensitivity to erlotinib treatment.
Our studies thus present first evidence that TGF-β1
and TGF-β2, in addition to having pivotal roles in the
EMT, are also important determinants of primary er-
lotinib resistance in NSCLC through the establishment
of an EGFR-independent autocrine secretion of IL-6.
Whereas our data indicate that a cell-autonomous
mechanism was responsible for the increased expression
of TGF-β1 and TGF-β2, these same cues may also be
produced by the tumor microenvironment, thus inducing
erlotinib resistance in a paracrine fashion. Interestingly,
IL-6 is a pleiotropic cytokine that exerts important bio-
logical functions in a wide variety of systems and
processes, including inflammation, acute-phase reaction,
nervous and endocrine systems, bone metabolism, and
hematopoiesis. Thus, we hypothesized that the secretion
of IL-6 by the tumor microenvironment during the
course of inflammation could impair cell sensitivity to er-
lotinib. If correct, this hypothesis could provide a new
clue to explain the high degree of heterogeneity in the re-
sponse to erlotinib treatment of NSCLC tumors harbor-
ing mutant EGFR. To test this hypothesis, we used a
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properties. These cells displayed an increased expression
of the surface marker CD44 and a decreased expression
of CD24. Significantly, these same cells have mesenchy-
mal-like features, increased migratory and invasive abil-
ities, and augmented metastatic potential compared to
the bulk cell population. Because gene expression profile
analysis revealed that CD44 expression is higher and
CD24 expression is lower in the erlotinib-resistant cells
that we generated when compared to the parental cells,
we reasoned that in our experimental model system, er-
lotinib-resistant mesenchymal-like cells could exist as a
side population and as such could have been present in
the parental-sensitive H1650 cell line before erlotinib
treatment. 
By using CD44 and CD24 as surface markers, we
were able to identify in erlotinib-sensitive parental cells,
before erlotinib treatment, a subpopulation of cells with
features similar to those of erlotinib-resistant derived
cells. Specifically, we found that in the erlotinib-naïve
cells, a CD44high/CD24low-enriched cell fraction was
characterized by a mesenchymal appearance, by in-
creased expression of TGF-β1, TGF-β2, and IL-6. Im-
portantly, these cells were also more resistant to erlotinib
treatment compared to the CD44low/CD24high fraction.
To exclude the possibility that the occurrence of er-
lotinib-resistant mesenchymal-like cells was due to ar-
tifical in vitro growth conditions and/or to events that
occurred during establishment of the cell lines, we ex-
tended our analysis to cells obtained from patients with
NSCLC. We were able to identify CD44high/CD24low
cells in preparations from early-stage erlotinib-naïve
human NSCLC tumors and bone marrow of patients
with NSCLC. The CD44high/CD24low cells, like the in-
vitro-derived erlotinib-resistant cells, had decreased ex-
pression of E-cadherin and higher levels of expression
of IL-6, Vimentin, TGF-β1, and TGF-β2. 
The presence of cells with features similar to those
of erlotinib-resistant cells (i.e., heightened expression
of TGF-β1, TGF-β2, and IL-6 present in early-stage
erlotinib-naïve NSCLC cells from patients) in early-
stage erlotinib-naïve tumors suggests that cells which
have the potential to be resistant to erlotinib and to dis-
play an increased metastatic capability are already pres-
ent in tumors before erlotinib treatment and therefore
could contribute to minimal residual disease. As a con-
sequence, our results indicate that therapies based solely
on the inhibition of the EGFR will not be sufficient for
the effective treatment of NSCLC patients.
mouse model system previously described by Vasunia et
al. (Carcinogenesis 15: 1723–1727 [1994]) in which cu-
taneous inflammation and secretion of IL-6 are induced
by topical treatment of the mouse epidermis with a low
dose of 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
Specifically, we injected subcutaneously immuno-
compromised mice with NSCLC cells expressing mu-
tant EGFR. When the tumors reached a volume of
~100 mm3, we topically treated the epidermis with TPA
for 5 days. Mice were then treated with erlotinib for 9
days at a dosage equivalent to that used in patients. 
Immunostaining of tumor sections using an anti-IL-
6 antibody confirmed that TPA augmented IL-6 expres-
sion in the tumors. By comparing tumor burden after
different treatments, we found that TPA treatment dra-
matically reduced the response to erlotinib treatment. To
determine whether increased IL-6 produced by the
tumor microenvironment upon TPA treatment was re-
sponsible for the diminished erlotinib response, we de-
creased IL-6 availability by injecting the mice with an
antibody that neutralizes mouse IL-6 antibody. Remark-
ably, cotreatment with a mouse IL-6 neutralizing anti-
body decreased the effect of TPA and increased the
tumor sensitivity to erlotinib. These results thus suggest
that, in addition to the tumor genome/epigenome (e.g.,
different genomic or epigenetic aberrations in addition
to mutant EGFR such as the T790M mutation or c-Met
amplification), differences in IL-6 levels due either to
tumor cell-autonomous mechanisms or to the activation
of the tumor microenvironment (i.e., inflammation con-
sequent to chemotherapy, infection, or tumor location)
may account for differences observed in the response of
NSCLC tumors to erlotinib treatment. Several studies
have reported increased levels of IL-6 in ~30% of
NSCLC. Taken together, these results suggest the intrigu-
ing possibility that adjuvant treatments designed to either
control inflammation and/or decrease the bioavailability
of IL-6 may provide an effective means to improve re-
sponses to EGFR TKI treatment in patients with
NSCLCs harboring EGFR oncogenic mutations. 
Erlotinib-resistant Mesenchymal-like 
Cells are Present in Cell Lines and in
Tumors before Erlotinib Treatment
Several groups recently described the existence of a sub-
population of cells in certain breast-cancer-derived cell
lines and in breast cancers that displayed stem-cell-like
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The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes, including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed in
a target substrate reflects the coordinated activity of the
kinases that phosphorylate it and the protein phos-
phatases that catalyze the dephosphorylation reaction.
We study the protein tyrosine phosphatases (PTPs),
which, like the kinases, represent a major family of sig-
naling enzymes. Overall, the objective of the lab is to
develop tools for analysis of PTP regulation and func-
tion and integrate them with state-of-the-art cell and
animal models, to define critical tyrosine-phosphoryla-
tion-dependent signaling events in human disease. It is
anticipated that these studies will lead to identification
of novel therapeutic targets and biomarkers at two lev-
els. By elucidating the signaling function of PTPs in
disease models, we will reveal examples in which the
PTPs themselves, or regulators of PTP function, are tar-
gets. Furthermore, we will use the PTPs as probes to
define critical signaling pathways in human disease
from which novel targets will be identified.
During the last year, Gaofeng Fang joined the lab as
a postdoctoral fellow, having completed his Ph.D. in
the lab of Celine Gelinas at the University of Medicine
and Dentistry of New Jersey. In addition, Gyula Bencze
joined as a visiting scientist from Mate Hidvegi’s lab in
Budapest, Hungary. 
Currently, there are four broad areas of research in
the lab covering functional analysis of members of the
PTP family, regulation of PTP function, in particular
by reversible oxidation, development of novel ap-
proaches to therapeutic intervention in PTP function,
and characterization of a knockout mouse model to de-
fine the function of JSP1, a member of the PTP family
that is a novel regulator of mitogen-activated protein
kinase (MAPK) signaling.
Protein Tyrosine Phosphatases and the Control of Signal Transduction
N.K. Tonks     G. Bencze         A. Haque         M. Ramesh
                       B. Boivin           N. Krishnan     U. Schwertassek
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Functional Analysis of the “PTPome”
There are ~100 PTP genes in the human genome, and
various studies from many labs have pointed to the
functional importance of these enzymes in the control
of cell signaling. It is now apparent that they have the
capacity to act both positively and negatively in the reg-
ulation of signal transduction. Furthermore, the PTPs
have the potential to display exquisite substrate, and
functional, specificity in vivo. Nevertheless, the major-
ity of the members of the PTP family have yet to be
characterized. Hence, the PTPs remain a largely un-
tapped resource that can be exploited to reveal new in-
sights into the regulation of signal transduction. There
are several projects in the lab that utilize a library of
short hairpin RNAs (shRNAs) that we have generated
to target each of the PTPs (five shRNAs for each PTP),
which allows us to interrogate systematically the func-
tion of these signaling enzymes by RNA interference
(RNAi) in various disease models.
The Function of PTPs in Breast Cancer
We have continued our collaborative studies with Senthil
Muthuswamy at CSHL in cell models of breast cancer.
We have shown that suppression of three PTPs, PTPRG,
PTPRR, and PTPN23, enhanced motility of MCF10A
mammary epithelial cells. PTPRR-directed shRNAs en-
hanced cell motility in a HER2-dependent manner,
whereas shRNAs to both PTPRG and PTPN23 en-
hanced motility in either the presence or the absence of
HER2 signaling. Interestingly, further investigation
showed that only PTPN23 shRNA induced invasion
when cells were grown on a Matrigel/Collagen mixture.
However, although PTPN23 shRNA itself was sufficient
to enhance invasiveness, activation of HER2 signaling
accelerated the effects, indicating cooperation between
suppression of PTPN23 and activation of HER2. We
are currently identifying the critical PTP substrates that
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microscopy and biolistic gene delivery of green fluores-
cent protein (GFP)-tagged constructs into organotypic
slices of the hippocampus. The organotypic slice culture
system maintains the tissue architecture of the hippocam-
pus and produces a mosiac that permits analysis of the
transfected neuron in a more natural context. This is one
of the few systems where images with subcellular resolu-
tion can be taken, in real time, from living tissues. In an
initial characterization of the enzymatic activity of
tumor-derived mutations, we demonstrated that G129E
selectively ablates the lipid phosphatase activity of
PTEN, leaving protein phosphatase activity intact. Sub-
sequently, a novel Y138L mutant has been shown to pre-
serve the lipid, but not the protein phosphatase activity
of PTEN. We have observed that expression of wild-type
PTEN in organotypic brain slices led to a decrease in
spine density. Strikingly, the G129E tumor-derived, pro-
tein-phosphatase-active PTEN mutant produced the
same reduction in spine density as the wild-type protein,
whereas catalytically dead (C124S) and protein-phos-
phatase-deficient, but lipid-phosphatase-active (Y138L),
mutants were without effect (Fig. 1). PTEN was shown
initially to favor acidic substrates in vitro. Interestingly,
the carboxy-terminal segment of PTEN contains an
acidic stretch of residues that contains multiple sites of
phosphorylation by casein kinase 2. We have demon-
strated that the PTEN C-tail is a substrate of PTEN pro-
tein phosphatase activity in vitro and in 293 cells.
underlie these effects. Although the genes for PTPRG
and PTPN23 are located at chromosome 3p21, a hot
spot for deletions in various cancers, this is the first in-
dication of potential roles in breast cancer.
The Function of “Missing in Metastasis”: 
A Putative Regulator of RPTPδ
Missing in Metastasis (MIM) is an actin-binding protein
that induces actin-rich membrane protrusions, reduces
stress fibers, and inhibits cell motility by regulation of
cortactin and actin polymerization. Furthermore, ex-
pression of MIM is significantly reduced in multiple
metastatic cancer cells. Taken together, these observa-
tions suggest a function for MIM in suppression of
metastasis. MIM has also been shown to bind to a re-
ceptor PTP, PTPδ. This interaction may provide a link
between tyrosine-phosphorylation-dependent signaling
and control of the actin cytoskeleton in metastasis. In
collaboration with Rob Lucito and Senthil Muthu-
swamy here at CSHL, we have been investigating the
contribution of MIM to metastasis by studying its func-
tion in MCF10A mammary epithelial cell models of
breast cancer. We have shown that suppression of MIM
by RNAi led to enhanced migration of MCF10A cells.
In addition, in MCF10A cells that ectopically express
HER2, suppression of MIM cooperated with activation
of HER2 to accelerate invasion. Moreover, we observed
that the absence of MIM led to a suppression of tyrosine
phosphorylation of selected proteins, and this was ab-
rogated by cosuppression of RPTPδ. Currently, we are
using mass spectrometry approaches to identify the crit-
ical tyrosine-phosphorylated proteins through which
MIM and RPTPδ exert these effects. 
Functional Analysis of the Protein 
Phosphatase Activity of PTEN
The tumor suppressor phosphatase PTEN displays in-
trinsic activity toward both protein and phosphatidyli-
nositol phospholipid substrates in vitro. Whereas the
lipid phosphatase activity of PTEN is important for its
tumor suppressor function, the significance of its protein
phosphatase activity is unknown and represents a gap in
our understanding of the function of this important reg-
ulator of cell signaling. We have developed an in vivo
assay of PTEN function, which has revealed an effect of
its protein phosphatase activity on the density of neu-
ronal spines in cultured hippocampal organotypic brain
slices. The approach utilized two-photon laser-scanning
Figure 1. Effects of PTEN expression on spine density in hip-
pocampal neurons. (Top) Representative two-photon images of
apical dendrites from cells biolistically transfected with GFP-
tagged PTEN constructs in organotypic slice cultures of rat hip-
pocampus. (Bottom) Quantitation of the effects of each plasmid
on spine density. In each case, data were derived from eight dif-
ferent transfected cells in different brain slices and by quantita-
tion of >250 spines. 
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Furthermore, the dephosphorylation of the PTEN C-
tail is required for the reduction in spine density. It has
been shown that expression of the C2 domain of PTEN
in glioma cell lines, in the absence of the catalytic do-
main, suppressed migration as efficiently as the wild-type
enzyme (Raftopoulou, Science 303: 1179 [2004]). It was
also shown that dephosphorylation of Thr-383, from a
cluster of four phosphorylation sites at the carboxyl ter-
minus of PTEN, was required for inhibition of cell mi-
gration by the C2 domain in the context of the
full-length protein. Therefore, we tested expression of the
isolated C2 domain in our system, but observed no effect
on spine density, thereby distinguishing our analysis from
the study in glioma cells. In contrast, we have observed
that the PDZ-binding motif at the extreme carboxyl ter-
minus of PTEN was required for the reduction in spine
density. Our data suggest that the protein phosphatase
activity of PTEN and the phosphorylation of Ser and
Thr residues in its carboxy-terminal segment are of reg-
ulatory significance to the control of spine density, per-
haps through controlling interactions between PTEN
and PDZ domain-containing proteins. In an interesting
symmetry with PI3K, which possesses lipid kinase activ-
ity toward exogenous substrates and the ability to au-
tophosphorylate, our data suggest that PTEN may
autodephosphorylate; thus, the critical protein substrate
for PTEN may be PTEN itself. 
Regulation of PTP Function
by Reversible Oxidation
The signature motif of the PTP family, [I/V]
HCxxGxxR[S/T], contains an invariant Cys residue,
which, due to the unique environment of the active site,
is characterized by an extremely low pKα. This promotes
the function of this Cys residue as a nucleophile in catal-
ysis, but renders it highly susceptible to oxidation, with
concomitant abrogation of nucleophilic function and in-
hibition of PTP activity. Work from several labs, includ-
ing this one, has now established that multiple PTPs are
transiently oxidized and inactivated in response to a wide
array of cellular stimuli, which represents a novel tier of
control of tyrosine-phosphorylation-dependent signal-
ing. We have developed approaches to detect reversible
oxidation of PTPs in vivo that involve labeling with bi-
otinylated small molecules the active-site Cys residue in
those PTPs that undergo stimulus-induced reversible ox-
idiation. The advantage of this approach over those al-
ready in use is that we can now detect oxidation of all
the major subtypes from within the PTP family, in par-
ticular receptor PTPs. We are currently examining the
role of reversible oxidation in regulating PTP function
in various cell and animal models. 
Development of Novel Approaches 
to Therapeutic Intervention in PTP Function
Despite the fact that “big pharma” are experts in drug
development, they tend to operate only in areas of chem-
istry in which the individual company is comfortable,
coupled with tried and true strategies of generating ac-
tive-site-directed small-molecule inhibitors. They tend
not to commit internal resources to new strategies for
therapeutic development, but instead look to the outside
for breakthroughs. Venture capitalists now lack the pa-
tience for discovery and want a clear path to the clinic
that will provide a rapid return on investment, which
limits opportunities for novel approaches to drug devel-
opment in the biotechnology sector. Therein lies the op-
portunity for academia, with its freedom to think
without boundaries and to challenge existing paradigms.
In the current economic climate, it is perhaps only in ac-
ademia that such risks can be taken that are required to
develop new strategies that exploit areas and targets cur-
rently viewed by industry as “undruggable” and thereby
benefit patients through discovery of new therapies.
Hopefully, CSHL will make the appropriate investment
to seize this historic opportunity and be a catalyst to drive
new and creative approaches to drug discovery. 
Currently, our work in this area is primarily focused
on PTP1B, the prototypic member of the PTP family.
The phenotype of the knockout mouse, together with
structural and biochemical data from various groups, has
established PTP1B as a key regulator of insulin and lep-
tin signaling. Consequently, it became a highly prized
target in the pharmaceutical industry for therapeutic in-
tervention in diabetes and obesity. In addition, the es-
tablishment of PTP1B as a critical positive regulator of
signaling downstream from the HER2 oncoprotein ty-
rosine kinase has identified it as a candidate therapeutic
target in breast cancer. As a result, there have been major
programs in industry focused on developing small-mol-
ecule inhibitors of PTP1B to address these major unmet
medical needs. Nevertheless, these efforts have been frus-
trated by technical challenges arising from the chemical
properties of the PTP-active site. Many companies, as
well as academic groups, have produced active site-di-
rected inhibitors of PTPs that are potent, specific, and
reversible, but their high affinity depends upon their
charge, which limits their bioavailability and their po-
tential for drug development. Consequently, new ap-
proaches to inhibition of PTP1B, other than active-
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site-directed small-molecule inhibitors, are required to
reinvigorate drug development efforts.
Harnessing Reversible Oxidation of 
PTP1B as a Novel Approach to 
Therapeutic Intervention in Diabetes, 
Obesity, and Cancer
Previously, we had demonstrated that oxidation of the cat-
alytic Cys residue in PTP1B induced profound changes
in the architecture of the enzyme that triggered residues
from the active site to adopt solvent exposed positions in
a process that was readily reversible. Previously, we had
also shown that insulin induces the transient oxidation
and inactivation of PTP1B (and TCPTP) and that this
suppression of PTP function by oxidation is important
for an optimal signaling response in insulin-responsive
cells. Considering this, and the structural consequences of
reversible oxidation, we set out to test the hypothesis that
stabilization of this inactive conformation (PTP1B-OX),
which would be formed following insulin-induced pro-
duction of ROS (reactive oxygen species), would augment
the hormone response by removing an inhibitory con-
straint on signaling. 
To achieve this, we have used phage display technol-
ogy to generate conformation-specific antibodies that
recognize oxidation-specific epitopes in the oxidized
conformation of PTP1B (PTP1B-OX) that would not
be found in the active, reduced enzyme. We generated
single-chain fragment-variable (scFv) constructs, which
are composed of the variable light (VL) and variable
heavy (VH) regions of the antibody molecule artificially
joined with a neutral peptide linker. We have identified
scFvs that bound specifically to the oxidized form of
PTP1B in vitro and showed significant inhibition of the
reactivation of PTP1B-OX by reducing agent, but did
not exert any direct inhibitory effect on the phosphatase
activity of the reduced enzyme in assays. In validating
this approach further, we observed that expression of the
scFvs to PTP1B in cells as “intrabodies” enhanced and
extended the time course of insulin-induced phospho-
rylation of the β-subunit of the insulin receptor and
IRS-1, but had little or no impact on the basal level of
tyrosyl phosphorylation. Furthermore, expression of the
scFv intrabody also enhanced and extended the time
course of insulin-induced downstream signaling, meas-
ured by phosphorylation of PKB (protein kinase B).
These data illustrate that stabilization of the inactive ox-
idized conformation of PTP1B potentiated insulin sig-
naling in a similar manner to inhibiting the catalytically
active form of the phosphatase. 
These redox-dependent changes in conformation sug-
gest a novel way to think about inhibiting PTPs in a ther-
apeutic context. Reversible oxidation of PTP1B generates
a form of the enzyme in which the problematic chemical
properties of the enzyme are circumvented and new bind-
ing surfaces for small-molecule inhibitors are presented.
Therefore, if it is possible to stabilize the oxidized, inactive
form of PTP1B with an appropriate therapeutic molecule
that mimics the effects of these antibodies, then this could
provide a new strategy for PTP-directed drug develop-
ment that may circumvent the difficulties that are faced
when targeting the PTP-active site. Currently, we are at-
tempting to initiate high-throughput screening efforts to
identify such molecules. Our data illustrate that stabiliza-
tion of the inactive PTP1B-OX conformation would po-
tentiate insulin signaling in a similar manner to inhibiting
the catalytically active form of the enzyme. In addition,
if one assumes that in responding to insulin the cell tar-
gets for oxidation the pool of PTP1B that is important
for regulation of the signaling response, then this strategy
will also target that pool specifically, possibly also reduc-
ing complications of side effects that may accompany in-
hibition of the native enzyme as a whole. Other PTPs in
addition to PTP1B have also been shown to form a cyclic
sulphenamide upon oxidation, suggesting that this ap-
proach may offer a general strategy for inhibiting this en-
zyme family. 
Development of Allosteric Inhibitors
of PTP1B
Another complementary strategy for development of
therapeutics that would avoid targeting the catalytic
center of PTP1B would be to look for allosteric in-
hibitors. We have now identified a novel allosteric site
on PTP1B. Originally, we purified PTP1B from
human placenta in a 37 kDa truncated form that is sta-
ble and readily expressed and purified as a recombinant
protein and, therefore, has been the focus of attention
to date for biochemical and mechanistic analysis, as well
as for drug screening. Nevertheless, PTP1B exists in
vivo as a 435-residue protein of ~50 kDa, in which the
carboxy-terminal segment, which is deleted from the
37 kDa protein, serves a regulatory function. In the case
of TCPTP, the closest relative of PTP1B, we have
demonstrated previously that this carboxy-terminal seg-
ment is inhibitory to activity. In our hands, the equiv-
alent segment of PTP1B was also inhibitory, but the
effects were not as pronounced as in TCPTP. 
We have characterized the mechanism of action of a
natural product that was shown to induce weight loss,
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and increase insulin sensitivity, in diet-induced and ge-
netically obese animal models and was thought to be a
noncompetitive inhibitor of PTP1B. We have demon-
strated that this molecule was a reversible, selective, and
noncompetitive inhibitor of PTP1B. Furthermore, forms
of PTP1B that contained the inhibitory carboxy-termi-
nal segment were about tenfold more potently inhibited
than the 37-kDa form, which comprises residues 1–321.
Sequential deletions from the carboxyl terminus indi-
cated that this high-affinity inhibition was lost when the
protein was truncated beyond the segment that exerts an
autoinhibitory effect. Consistent with our kinetic analy-
sis, isothermal titration calorimetry (ITC) indicated that
there was only one low-affinity site on PTP1B(1–321),
but two binding sites on PTP1B(1–394). Scatchard
analysis indicated positive cooperativity between the two
sites. Binding of inhibitor to the “full-length” enzyme
blocked binding of the substrate analog orthovanadate,
suggesting that engagement of this carboxy-terminal site
influences the active site. Interestingly, analysis by gel fil-
tration and analytical ultracentrifugation revealed that
binding of the inhibitor induced a conformational
change in PTP1B(1–394) to a more “compact” struc-
ture, which was not seen in PTP1B(1–321). In fact, we
observed that PTP1B(1–394) displayed resistance to
trypsinization in the presence of the inhibitor. Using site-
directed mutagenesis, we have identified two binding
sites for the inhibitor in PTP1B(1–394) and have now
shown that point mutation in two residues, one from
each site, was sufficient to abrogate inhibition. The im-
portance of this study is that it suggests a novel mecha-
nism of inhibition that involves the regulatory
carboxy-terminal segment of the protein. Furthermore,
it supports the presence of an additional binding site(s)
for inhibitory small molecules within this noncatalytic
portion of PTP1B that would have been missed in the
high-throughput screens that have been conducted to
date in industry using the 37 kDa form of the enzyme
that comprises only the catalytic domain. Currently, we
are attempting to initiate high-throughput screens to
identify further allosteric inhibitors.
Functional Analysis of JSP1 
Previously, we identified JNK stimulatory phosphatase
1 (JSP1) as a dual specificity phosphatase (DSP) that
has the capacity to activate the JNK MAPK specifically,
exerting its effects upstream of the MAP2K enzyme
MKK4 in the JNK signaling cascade. This illustrates a
new potential tier of control of the JNK signaling path-
way and a novel aspect of the role of protein phos-
phatases in the control of MAPK signaling, raising the
possibility that JSP1 may offer a new perspective on the
study of various disorders associated with aberrant JNK
signaling. We are continuing our characterization of
mice that contain a targeted deletion of the jsp1 gene,
particularly with respect to the role of JSP1 in regulat-
ing JNK signaling in the neurodegenerative processes
that lead to Parkinson’s disease and in the role of JSP1
in innate immunity. 
In addition to a single DSP catalytic domain, JSP1
contains a potential myristoylation site at its amino ter-
minus (MGNGMXK). Among the members of the
PTP family, this is unique to JSP1 and its closest relative
DUSP15/JSP2. Consequently, we investigated whether
JSP1 was myristoylated and examined the functional
consequences of myristoylation. In collaboration with
Tom Neubert (Skirball Institute, New York University),
we used mass spectrometry to show that wild-type JSP1,
but not a JSP1 mutant in which glycine 2 was mutated
to alanine (JSP1-G2A), was myristoylated in cells. Ab-
rogation of myristoylation did not impair the intrinsic
phosphatase activity of JSP1, but it changed the subcel-
lular localization of the enzyme. Using JSP1 tagged at
the carboxyl terminus with GFP, we observed that the
wild-type enzyme colocalized with Golgi markers and is
excluded from the nucleus, whereas the nonmyristoy-
lated form of JSP1 is uniformly distributed throughout
the cell. Compared to wild type, the ability of nonmyris-
toylated JSP1 to induce JNK activation and phospho-
rylation of the transcription factor c-JUN was
attenuated. Upon expression of wild-type JSP1, a sub-
population of cells, with highest levels of the phos-
phatase, was induced to float off the dish and undergo
apoptosis. In contrast, cells expressing similar levels of
JSP1-G2A remained attached, further highlighting that
the myristoylation mutant was functionally compro-
mised. Thus, these studies indicate an important role for
myristoylation-dependent localization of JSP1 in the
regulation of its signaling function.
Characterization of Novel
Cancer Therapeutics
Albert Szent-Gyorgyi, Nobel laureate for the discovery
of vitamin C, focused his later years in research on trying
to find a cure for cancer and became interested in the
properties of flavones in wheat germ. In pursuing this
theme, Dr. Mate Hidvegi and his colleagues from Bu-
dapest, together with scientists at American Biosciences
Inc, have identified a fermented wheat-germ extract
termed Avemar®. It has been commercialized in Europe
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and the United States as a nutraceutical that displays an-
ticancer and antimetastatic properties. As part of a col-
laboration involving Dr. Hidvegi and his colleagues, as
well as Darryl Pappin and Jim Watson here at CSHL,
we have begun studies aimed at identifying and charac-
terizing the active constituents of Avemar®.
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PTEN is a tumor suppressor that is among the most fre-
quently lost or mutated genes in human cancer. It is
unique in directly opposing the enzymatic activity of
phosphoinositol-3 kinase (PI3K) and the downstream
proto-oncogene Akt kinase, which promotes cell survival
and proliferation. This signaling pathway is deregulated
in a majority of, for example, breast, prostate, and brain
tumors. By modeling Pten loss in mice, we have discov-
ered how cells in the prostate can sense the complete loss
of Pten and respond to this insult by withdrawing into
cellular senescence, which is now recognized as a cell-in-
trinsic human antitumoral defense mechanism. This
finding defines a clear role for the p53 gene. It is essential
for preventing lethal prostate cancer by mounting the
senescence response after Pten loss, but it does not initiate
tumor growth when lost on its own. Moreover, discovery
of the senescence response suggests that tumors should
favor retention of some PTEN. Indeed, many human
cancers present either with partial loss of the PTEN gene
or with partial functional impairment. Collectively, these
findings have defined PTEN as a haploinsufficient tumor
suppressor in several tissues and thus emphasize the need
for understanding its regulation.
The emergence of patient genome data is now al-
lowing us to probe for genome-wide changes that are
consistent with the progression features identified in
the mouse. Conversely, we are also probing the mouse
tumor genome for spontaneous changes that drive tu-
morigenesis downstream from their engineered genetic
changes. This two-pronged approach is allowing us to
move from identification and validation of new cancer
genes to connecting the dots by uncovering the princi-
ples that underlie PTEN-mutant cancer progression.
Nuclear versus Cytoplasmic Akt
Activity in Cancer
M. Chen, D. Nowak, C. Pratt, M. Zeeman, D. Grace [in collab-
oration with A. Newton, University of San Diego, California]
Through our previous studies, we have learned that not
only quantitative, but also qualitative regulation of Akt
EMERGING PRINCIPLES OF TUMOR SUPPRESSION
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kinase controls Pten mutant tumorigenesis and its pro-
gression via a senescence defeat or senescence bypass
pathway. The qualitative change in active Akt kinase lo-
calization from the plasma membrane to the nucleus is
a direct consequence of loss of promelocytic leukemia
(PML) nuclear bodies (NBs). We could show that in
mice, Pml achieves pAkt inactivation through its ability
to recruit both Akt and its phosphatase PP2a into these
bodies, resulting in specifically nuclear Akt inactivation.
These findings demonstrated the importance of coor-
dinated Akt inactivation and revealed that this process
is efficiently achieved through the phosphatase PP2a.
Furthermore, it highlighted how deregulating cellular
partitioning of Akt activity via control of phosphatases
could bypass the senescence response. 
Recently, a second direct phosphatase of Akt, named
PHLPP, has been identified. PHLPP joins PTEN and
PP2a phosphatases with the potential of regulating tu-
morigenesis. In contrast to the qualitative changes men-
tioned above, PHLPP controls the amplitude of Akt
activation, similar to PTEN. By studying mice, which
are mutant for Phlpp or Phlpp and Pten, we have been
able to define Phlpp as a tumor suppressor in the
prostate. It antagonizes Akt activation at the plasma
membrane, and this function is crucial in preventing
prostate cancer after partial loss of Pten. Intriguingly,
combined loss of Pten and Phlpp triggers the above-
mentioned p53 response, and we could show that these
tumors need to abolish p53 to form. Thus, we find that
the cooperating phosphatases direct Akt activity and lo-
calization with entirely differential outcomes with re-
spect to p53 activation. We are currently confirming
these findings in human prostate cancer samples.
Nuclear PTEN and Cancer
M. Chen, A. Naguib, M. Zeeman, C. Pratt [in collaboration
with B. Carver, W. Gerald, and C. Sawyers, Memorial 
Sloan-Kettering Cancer Center, New York]
Despite its plasma membrane function, PTEN has
been consistently observed in cell nuclei, but the mech-
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Akt, illustrating that a threshold must be crossed for
initiation of cancer. 
It is important to note that such spontaneous down-
regulation of Pten is never observed in prostates of wild-
type animals, sometimes observed in Pten+/– prostates
(30% of mice), and is always occurring in Ptenhy/– ani-
mals (mice with one-fourth of normal Pten levels).
These observations strongly suggest that lower Pten lev-
els increase the probability of its spontaneous reduction
below the Akt-activating and tumor-promoting thresh-
old. Thus, they demonstrate the importance of stable
Pten levels in a tissue even after Pten has received a genetic
hit. Because this finding should form the basis of a ther-
apeutic approach, we set out to test the therapeutic ef-
fect of Pten up-regulation in prostate. An important
open question behind this approach is that restoration
of PTEN might not just antagonize tumor growth, but
also revert tumor growth, analogous to the concept of
oncogene addiction, even after cells have suffered spon-
taneous cooperating lesions. 
In collaboration with the lab of Dr. Lowe, we have
established several mouse models that allow for RNAi-
mediated reversible knockdown of Pten in prostate.
These models now enable us to systematically test if and
how established tumors respond to restoration of Pten.
Thus, they serve as a genetic model for PI3K-inhibitor
therapy. We will also test how Pten restoration treat-
ment depends on context through genetic alterations,
including loss of Phlpp, Pml, and other cooperating
tumor suppressors that we have identified. Through
this approach, we have knocked down Pten levels in
mouse prostate until tumors have formed with features
that are highly similar to those of the traditional knock-
out models. We are now following up the effects of Pten
restoration using magnetic resonance imaging (MRI)
methods. Of the 250,000 American men diagnosed
with prostate cancer each year, roughly half will present
with partial PTEN loss in their lesions, and thus we ex-
pect our results to be of great importance in establishing
the genetic framework for successful treatment of
prostate cancer through PTEN stabilization or PI3K
pathway inhibition.
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anism and relevance of this localization have remained
unclear. We have recently resolved this paradox by
demonstrating that contrary to polyubiquitination, nu-
clear PTEN import depends on its monoubiquitination
and that mutation of the main PTEN ubiquitination
site abolishes import in vitro and in patients, giving rise
to inheritable Cowden’s disease because of low cyto-
plasmic PTEN stability. But most notably, this mutant
retains catalytic activity, demonstrating that PTEN nu-
clear import is essential for tumor suppression. These
findings exemplify an elemental insight into cancer bi-
ology by demonstrating how the collaboration of a ge-
netic lesion (the inherited mutation) with a posttrans-
lational cellular response (enhanced degradation) coop-
erates in tumorigenesis. Through this analysis, we have
furthermore unraveled a link between two critical
means of PTEN regulation, namely, stability and nu-
cleocytoplasmic shuttling. We are currently investigat-
ing the mediators of both processes in vitro by using
RNA interference (RNAi) approaches and in vivo
through gene targeting in mouse.
Regulation of PTEN Activity in Prostate
Cancer Initiation and Treatment
H. Cho, A. Naguib, J. Murn, M. Zeeman [in collaboration
with C. Miething and P. Premsrirut, S. Lowe Lab, 
Cold Spring Harbor Laboratory]
On the basis of our previously published work, the ac-
tual Pten protein levels inside prostatic epithelia decide
over benign or malignant tumor formation (Trotman
et al., PLos Biol 3: 385 [2003]), whereas complete Pten
loss was shown to prevent tumorigenesis through the
p53-dependent senescence response until p53 mutation
paves the way for full-blown cancer. Accordingly,
prostates of mice harboring partial Pten loss sponta-
neously degrade Pten to allow formation of prostate
cancer. Yet, importantly, these lesions do not go on to
completely lose Pten at the gene or protein level, a com-
pelling illustration of their ability to maximize prolif-
eration while avoiding the senescence response caused
by complete Pten loss. Our analysis of human prostate
cancer specimens also confirms frequent retention of
clearly reduced PTEN levels. Therefore, by using mouse
models with partial Pten loss, we found that sponta-
neous and subtle further reduction of Pten levels trig-
gers activation of the downstream oncogenic kinase
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Ras and Rho family members have key roles in cellular
activities controlling cell growth control, differentia-
tion, and morphogenesis. Alterations that affect normal
Ras and Rho function have been found to result in the
development of several disease processes, including can-
cer and neurodevelopmental disorders. Our ultimate
goal is to understand how aberrations in Ras and Rho
signaling components contribute to the development
of these disease/disorder processes. Toward this end, my
lab has continued to define the functions of selected
GTPases, their regulators, and effectors in models of
neurodevelopmental disorders and cancer. Below are
highlighted the main projects that have been carried
out during the past year. 
The Rho-Linked Mental Retardation Protein
Oligophrenin-1 Has a Critical Role at Both 
the Pre- and Postsynaptic Side of the 
Hippocampal CA3-CA1 Synapse 
Mutations in genes encoding regulators and effectors
of Rho GTPases have been found to underlie various
forms of mental retardation (MR). Oligophrenin-1
(OPHN1), which encodes a Rho-GTPase-activating
protein, was the first identified Rho-linked MR gene.
It was initially identified by the analysis of a balanced
translocation t(X;12) observed in a female patient with
mild MR. Subsequent studies have revealed the pres-
ence of OPHN1 mutations in families with MR asso-
ciated with cerebellar hypoplasia and lateral ventricle
enlargement. All OPHN1 mutations identified to date
have been shown, or predicted, to result in OPHN1
loss of function; however, the pathophysiological role
of OPHN1 has remained poorly understood. We pre-
viously demonstrated that the OPHN1 protein is
highly expressed in the brain, where it is found in neu-
rons of all major regions, including hippocampus and
cortex, and is present pre- and postsynaptically. Signif-
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icantly, we have now obtained data demonstrating a
critical role for OPHN1 at both the pre- and postsy-
naptic sides of the hippocampal CA3-CA1 synapse. 
Postsynaptic OPHN1 controls synapse maturation and
plasticity by stabilizing AMPA receptors. By temporally
and spatially manipulating OPHN1 gene expression, we
have obtained evidence that postsynaptic OPHN1
through its Rho-GAP activity has a key role in the ac-
tivity-dependent maturation and plasticity of excitatory
synapses by controlling their structural and functional
stability. Specifically, we found that synaptic activity
through N-methyl-D-aspartate receptor (NMDAR) ac-
tivation drives OPHN1 into dendritic spines, where it
forms a complex with α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) and selec-
tively enhances AMPAR-mediated synaptic transmission
and spine size by stabilizing synaptic AMPARs. Conse-
quently, decreased or defective OPHN1 signaling pre-
vents glutamatergic synapse maturation and causes loss
of synaptic structure, function, and plasticity. These re-
sults indicate that normal activity-driven glutamatergic
synapse development is impaired by perturbation of
postsynaptic OPHN1 function. Thus, these findings
link genetic deficits in OPHN1 to glutamatergic dys-
function and imply that defects in early circuitry devel-
opment are an important contributory factor to this
form of MR.
Presynaptic OPHN1 controls synaptic vesicle endo-
cytosis via endophilin A1. Neurons transmit informa-
tion at chemical synapses by releasing neurotransmitters
that are stored in synaptic vesicles (SVs) at the presy-
naptic side. After release, these vesicles need to be effi-
ciently retrieved in order to maintain synaptic trans-
mission. In concurrence, malfunctions in SV recycling
have been associated with cognitive disorders. Interest-
ingly, we have found that presynaptic OPHN1 is im-
portant for efficient SV retrieval. We demonstrated that
reduced/defective OPHN1 signaling impairs SV endo-
cytosis at hippocampal synapses. We further showed
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terestingly, we also observed that a significant propor-
tion of Dock7 shRNA-expressing cells remained in the
VZ/SVZ several days after electroporation, suggesting
that DOCK7 knockdown could as well affect the pro-
liferation and/or differentiation potential of cortical
progenitor cells. Indeed, we obtained evidence demon-
strating that DOCK7 knockdown in the VZ progeni-
tors increases the number of proliferating S-phase cells
and maintains the cells as cycling progenitors, thereby
attenuating differentiation of daughter cells into neu-
rons. These findings point to a critical role for DOCK7
in the genesis of cortical neurons. We are currently ex-
tending these studies to define the precise mechanistic
underpinnings. 
Role of Rap1 Signaling in Morphogenetic
Processes
The Rap1 protein, a member of the Ras family, was ini-
tially identified as an antagonist of oncogenic Ras pro-
teins; however, more recent studies indicate that the
function of Rap1 is largely Ras-independent. Rap1 has
been assigned critical functions in the morphogenesis
of epithelial tissues, and recent studies suggest that dys-
regulated Rap1 signaling may be intrinsic to malignant
processes. However, how Rap1 controls epithelial mor-
phogenesis in vivo has remained largely elusive. We
have identified a signaling module that contains PDZ-
GEF, a Rap1-specific exchange factor, Rap1 itself, and
the adaptor protein AF-6. By investigating develop-
mental events in Drosophila as a genetically tractable
model system, we demonstrated that PDZ-GEF, Rap1,
and Canoe, the Drosophila AF-6 ortholog, function in
a linear pathway that governs epithelial migration and
gastrulation events in the embryo, as well as cell shape
in expanding imaginal discs, the precursors to diverse
adult structures. We found that the activity of this path-
way in part impinges on Myosin II as a motor protein
that modulates cell shape in epithelial morphogenetic
processes.
More recently, we have uncovered an additional role
for AF-6/Canoe as a Rap1 effector in mitotically active
epithelia, such as imaginal discs. Our experiments show
that AF-6/Canoe is key to a mechanism that reconsti-
tutes E-cadherin-based adherens junctions at the apical
membrane between sister cells late in cytokinesis. A fail-
ure in this process causes cells to aberrantly disperse and
missort in their respective tissue domains. By conduct-
ing further genetic analysis, we found that AF-6/Canoe
in this context acts on its interacting protein Echinoid,
that OPHN1 forms a complex with endophilin A1, a
protein implicated in membrane curvature generation
during SV endocytosis. Importantly, OPHN1 mutants
defective in endophilin A1 binding, or with impaired
Rho-GAP activity, failed to substitute for wild-type
OPHN1, indicating that OPHN1’s interactions with
endophilin A1 and Rho GTPases are important for its
function in SV endocytosis. These findings also suggest
that defects in efficient SV retrieval may contribute to
the pathogenesis of OPHN1-linked cognitive impair-
ment.
The Rac Activator DOCK7 Has an Important
Role in Early Steps of Neuronal 
Development
DOCK7 is a member of the evolutionarily conserved
DOCK180-related protein superfamily, which we iden-
tified as a novel activator of Rac GTPases. We found
that DOCK7 is highly expressed in major regions of
the brain during early stages of development and, im-
portantly, that the protein is asymmetrically distributed
in unpolarized hippocampal neurons and becomes se-
lectively expressed in the axon. We then obtained evi-
dence that DOCK7 has a critical role in the early steps
of axon formation in cultured hippocampal neurons.
Knockdown of DOCK7 expression prevents axon for-
mation, whereas overexpression induces the formation
of multiple axons. We further demonstrated that
DOCK7 and Rac activation leads to phosphorylation
and inactivation of the microtubule destabilizing pro-
tein stathmin/Op18 in the nascent axon and that this
event is important for axon development. Thus, our
findings unveiled a novel pathway linking the Rac ac-
tivator DOCK7 to a microtubule regulatory protein
and highlight the contribution of microtubule dynam-
ics to axon development. 
More recently, we began to assess DOCK7’s role in
the development of cortical neurons in vivo. To this
end, we implemented the in utero electroporation
method that enables highly efficient introduction of
vectors coexpressing proteins or short hairpin RNAs
(shRNAs) of interest with a fluorescent protein marker,
e.g., enhanced green fluorescent protein (EGFP) or 
tdTomato, into ventricular zone (VZ) cells in embry-
onic cerebral cortices. We found that either reducing
or increasing DOCK7 expression levels in progenitor
cells in the embryonic cerebral cortex impairs normal
migration of cortical cells, indicating that appropriate
levels of DOCK7 are critical for normal migration. In-
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a Drosophila homolog of the Nectin family of IgG ad-
hesion proteins. Echinoid expands the apical adherens
junctional belt to its normal circumferential size down-
stream from AF-6/Canoe. Surprisingly, our functional
dissection also suggests that an independent function
of Echinoid acts in parallel to AF-6/Canoe in the gen-
eral maintenance of adherens junctions. Our observa-
tions thus provide insights into a novel molecular
framework that perpetuates adherens junctional conti-
nuity in mitotically active epithelia. 
Role of Dok Proteins in Mitogenic and 
Oncogenic Signaling
Dok-1 (also called p62dok) was initially identified as a
tyrosine phosporylated 62-kD protein associated with
Ras-GAP in Ph+ chronic myeloid leukemia (CML)
blasts and in v-Abl-transformed B cells. This protein
was termed Dok (downstream of kinases), because it
was also found to be a common substrate of many re-
ceptor and cytoplasmic tyrosine kinases. Subsequently,
six additional Dok family members have been identi-
fied. Among them, Dok-1 and Dok-2 share the ability
to bind to a negative regulator of Ras, Ras-GAP. We
previously described that Dok-1 attenuates growth-fac-
tor-induced cell proliferation and that Dok-1 inactiva-
tion in mice causes a significant shortening of the
latency of the fatal myeloproliferative disease induced
by p210bcr-abl. Strikingly, in collaboration with Dr. Pan-
dolfi’s group, we also found that mice lacking both
Dok-1 and Dok-2 spontaneously develop a CML-like
myeloproliferative disease, likely resulting from in-
creased cellular proliferation and reduced apoptosis.
Thus, Dok proteins function as negative regulators of
mitogenic and oncogenic signaling. 
Whereas our data showed that Dok-1 opposes
p210Bcr-Abl-driven leukemogenesis, the p210Bcr-Abl-
induced disease does eventually progress with time. That
this progression takes place implies that Dok-1 function
eventually becomes incapacitated. Interestingly, we ob-
served that p210Bcr-Abl, v-Abl, and oncogenic forms of
Src induce down-regulation of Dok-1 expression in a
number of cells lines and that the reduction in the levels
of Dok-1 protein requires tyrosine kinase activity of
these oncogenes. Our preliminary data indicate that
oncogene tyrosine-kinase-induced Dok-1 down-regula-
tion involves proteasome-mediated proteolysis. We are
currently corroborating these data and investigating the
precise underlying molecular mechanism(s). Inactiva-
tion of tumor suppressors is an event that is observed in
numerous tumors. Because the inactivation of the Dok-
1 gene accelerates the progression of CML in mouse
models, whereas overexpression of Dok-1 dramatically
inhibits the proliferation of p210Bcr-Abl expressing cells as
well as Src-induced transformation, our current findings
suggest that oncogene-induced down-regulation of
Dok-1 might be an event that contributes to the pro-
gression of tumorigenesis. 
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CSHL neuroscientists seek to understand the means by which the developing brain gives rise to
complex neural networks underlying memory, behavior, and cognition. In addition to its investiga-
tions into the functioning of the healthy brain, the Laboratory is engaged in the discovery of genes
implicated in mental illnesses and the determination of how mutations in these genes influence
brain function in animals. This, in turn, is envisioned as the basis for a profound understanding of
brain abnormalities associated with diseases such as Alzheimer’s, Parkinson’s, autism, schizophrenia,
and depression, new knowledge that will form the basis for the next generation of treatments.
Because biological mechanisms of memory are highly conserved through evolution, many features
of human memory are observed in simpler organisms such as fruit flies. Joshua Dubnau and col-
leagues identify genes that are important for memory and conserved across phyla, many of which
are likely to be relevant to human memory. They recently discovered genes involved in controlling
when and where specific proteins are synthesized within a neuron. These genes likely regulate neu-
ronal communication during learning. The lab also seeks to discover how the neural circuitry of
the fly brain works. They have recently shown that short- and long-term memories form in different
sets of neurons: One circuit provides a memory that decays quickly and the other provides a memory
that forms slowly but persists. Both types of traces, the team discovered, depend on the activity of
a gene called rutabaga. Dubnau’s team also explores how groups of genes interact to form memories,
an approach designed to shed light on complex gene networks whose dysfunction likely underlie
human cognitive disorders.
Grigori Enikolopov and colleagues study stem cells in the adult brain. They have generated several
models to account for how stem cells give rise to progenitors, and ultimately, to neurons, and they
are using these models to determine the targets of antidepressant therapies, identify signaling path-
ways that control generation of new neurons, and search for neuronal and neuroendocrine circuits
involved in mood regulation. Recent experiments have suggested to the team a new model of how
stem cells are regulated in the adult brain, with a focus on stem cells’ decision on whether to di-
vide—and embark on a path of differentiation—or remain quiescent. This model explains why the
number of new neurons decreases with advancing age. Enikolopov’s group is also part of a team
that identified and validated the first biomarker that permits neuronal progenitor cells to be tracked,
noninvasively, in the brains of living humans and animals. The lab is now using these discoveries to
reveal how neurogenesis is related to the course of diseases such as depression, bipolar disorder,
Alzheimer’s, and Parkinson’s.
Hiro Furukawa’s lab is studying neurotransmission at the molecular level. They focus on two
types of calcium ion channels: NMDA receptors and calcium homeostasis modulators (CALHM).
Both are involved in regulation of neuronal activities and in the pathogenesis of Alzheimer’s disease.
NMDA receptors are very large molecules whose three-dimensional atomic structure Furukawa’s
group has undertaken to solve by dividing them into several domains. They seek to understand the
pharmacological specificity of neurotransmitter ligands and allosteric modulators in different sub-
types of NMDA receptors in order to provide a blueprint for future drug design. This year, they
published the crystal structure of the extracellular region of the NR2B subunit of the receptor, which
includes an amino-terminal domain whose uniqueness makes it a potentially interesting drug target.
The team is also working to reveal the molecular architecture of CALHM in order to determine
the mechanism by which this calcium-specific ion channel opens. Such structural information prom-
ises to be useful in the design of novel drugs for treatment of Alzheimer’s, which has been linked to
a mutation of the gene coding for CALHM.
To better understand neuronal circuits, Josh Huang and colleagues have developed novel means
of visualizing the structure and connectivity of different cell types at high resolution in living animals
and of manipulating the function of specific cell types with remarkable precision. Huang is partic-
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ularly interested in circuits that use GABA, the brain’s primary inhibitory neurotransmitter. The
lab’s work has direct implications in neurological and psychiatric illness such as autism and schizo-
phrenia, which involve altered development and function of GABAergic circuits. This past year,
they discovered that neurons connect to very specific partners at very specific spots in the developing
cerebellum, thanks to an underlying framework of molecular “guides” called glial cells that nudge
nerve fibers to grow in the right direction and make the right contacts. The lab also made good
progress in studying perturbations in the developing GABAergic system in a mouse model of Rhett’s
syndrome, one of the autism spectrum disorders.
Adam Kepecs studies the neurobiological principles by which the brain makes decisions. He and
his colleagues view decisions as elementary units of behavior, from which more complex behaviors
are assembled. Yet even simple decisions involve the integration of sensory and memory information
with emotional and motivational attributes, requiring the concerted action of millions of neurons
across brain regions. Therefore, they take an integrative approach, combining experiments involving
well-controlled rodent behavior with electrophysiology, optical-genetic manipulations, and quanti-
tative analysis. They are currently pursuing two broad directions. First, they seek to elucidate the
principles of decision-making, and in particular how the brain computes and uses confidence esti-
mates about decisions. Second, they want to understand how specific cell types and neural pathways
participate in the neural circuit dynamics underlying decision processes. Toward these goals, they
conduct electrophysiological recordings of large populations of neurons in behaving mice and rats.
In addition, they are adapting optical and genetic tools for use in behaving animals in order to ma-
nipulate specific neural cell types and pathways with the long-term goal of causally linking the ac-
tivity of specific neural types and pathways to behavioral decisions. 
Alexei Koulakov and colleagues are trying to figure out the mathematical rules by which the
brain assembles itself, with particular focus on the formation of sensory circuits such as those in-
volved in visual perception and olfaction. The visual system of the mouse was chosen for study in
part because its components, in neuroanatomical terms, are well understood. What is not known is
how projections are generated that lead from the eye through the thalamus and into the visual cortex,
how an individual’s experience influences the configuration of the network, and what parameters
for the process are set by genetic factors. Even less is known about the assembly of the neural net
within the mouse olfactory system, which, in the end, enables the individual to distinguish one
smell from another with astonishing specificity and to remember such distinctions over time. These
are among the challenges that engage Koulakov and his team.
Dysfunction of excitatory, glutamatergic synapses in the brain is believed to have an important
role in the pathogenesis of major psychiatric disorders, including schizophrenia and depression. But
what are the causes? Where in the brain does this dysfunction occur? How does it result in the be-
havioral symptoms of illness? To address these issues, Bo Li and colleagues are studying normal
synaptic plasticity and disease-related synaptic changes in brain circuits involved in schizophrenia
and depression. Their long-term goal is to develop methods allowing the manipulation of activity
in specific brain circuits in order to change disease-related behaviors. They use a variety of method-
ologies, including patch-clamp recording and calcium imaging of labeled neurons, two-photon im-
aging of spine morphology and tagged receptors, in vivo virus injection, RNA-interference-based
gene silencing, activation of specific axon terminals using light-gated cation channels, activation or
silencing of specific brain regions using transgenes, and assessment of the behavioral consequences
of certain manipulations. A new project focusing initially on the gene ErbB4 seeks to determine the
genetic causes of NMDA receptor hypofunction, a pathology believed to contribute to the etiology
of schizophrenia. 
Partha Mitra seeks to develop an integrative picture of brain function, incorporating theory, in-
formatics, and experimental work. His theoretical interests are primarily in formalizing the treatment
of biological function using ideas and methods from engineering. In informatics work, his lab is
developing computational tools for integrative analysis of neurobiological data, spanning electro-
physiological, neuroanatomical, and genomic data from multiple species pertaining to the brain.
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Mitra has organized the Brain Architecture Project, a multi-institutional effort to curate information
from the literature about human neuroanatomical connectivity that will also advocate for large-
scale studies of connectivity in model organisms. This year, Mitra received funding from the National
Institutes of Health for a multiyear project that will culminate in a first-draft mesoscopic-scale
circuit map of the entire mouse brain. This is contemplated as a first step to mapping vertebrate
brain architecture across species. Separately, he and colleagues published results of neurobiology re-
search demonstrating the de novo evolution of song culture in zebra finches, starting from an isolate
population.
Pavel Osten’s lab works on identification and analysis of brain regions, neural circuits and con-
nectivity pathways that are disrupted in genetic mouse models of autism and schizophrenia. Osten
hypothesizes that (1) systematic comparison of many genetic mouse models will allow determination
of overlaps in pathology—neural circuit endophenotypes—responsible for the manifestation of neu-
ropsychiatric disorders and (2) neuron-circuit-based classification of autism and schizophrenia will
provide key circuit targets for detailed mechanistic studies and therapeutic development. Osten and
colleagues are developing the first systematic approach to the study of neural circuits in mouse mod-
els of psychiatric diseases, based on a pipeline of anatomical and functional methods for analysis of
mouse brain circuits. An important part of this pipeline is high-throughput two-photon microscopy
for whole-mouse brain imaging. Other methods include virus-vector-based anatomical tracing,
transgenic and knock-in “indicator” mouse lines for monitoring expression of activity-regulated
genes, and both in vitro and in vivo two-photon imaging and electrophysiology. 
Jonathan Sebat’s laboratory studies the role of genetic variation, and particularly gene copy-num-
ber variation, in schizophrenia, autism, and other neuropsychiatric illnesses. This past year, Sebat
and collaborators discovered a rare mutation associated with dramatically increased schizophrenia
risk. The mutation is a gene copy-number variation in a chromosomal region, 16p11.2, already
linked to autism. Previously, they had demonstrated a significantly increased rate of rare structural
mutations in the genomes of people with schizophrenia as compared with healthy controls. They
found, moreover, that the mutations were powerful and that the genes disrupted by the mutations
nearly half the time were involved in pathways known to be important in brain development. One
implication is that the universe of genetic risk factors for schizophrenia includes many different rare
mutations, each one present in comparatively few individuals, or even a single one. In prior work,
Sebat, in collaboration with Michael Wigler, discovered that spontaneous mutations—genetic errors
in children that do not occur in either parent—are far more common in autism than previously
thought.
Stephen Shea’s lab studies the neural circuitry underlying social communication and decisions.
He uses natural social communication behavior in mice as a model to understand circuits and
processes that are evolutionarily conserved and therefore shared broadly across species, likely con-
tributing to disorders such as autism. This past year, Shea and colleagues examined how emotion
and arousal enable mice, via their olfactory systems, to store memories of other individuals and of
related social signals. The team succeeded in exploiting the tight neurobiological linkage between
emotion and arousal, on the one hand, and memory, on the other hand, to effectively create mem-
ories in anesthetized mice. They were then able to study properties of the created memories in great
detail, linking mechanisms of neuromodulation with those of neural plasticity and behavior. The
lab’s immediate objective is to make targeted recordings from different neurons in the circuit and
image the activity of large groups of neurons as memories are being formed, to see how they interact
to produce the neuronal firing-rate changes that presumably store memories. Ultimately, the Shea
lab aims to include recordings from awake, behaving mice and other techniques to understand this
process all the way from the level of a live social encounter to the movement of neurotransmitter
receptors at the synapse. 
What is a memory? When we learn an association, information from two different sensory
streams must somehow be bound together in the brain. For example, we may learn the smell of an
unripe banana predicts its starchy taste. What changes in neural activity underlie this learning—
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what synapses change strength, what ion channel properties change? How do these changes alter
cellular and network-level responses so our perception of the odor is linked to the aversive reaction
to the starchy taste? These are the questions that drive research in Glenn Turner’s laboratory. His
team addresses these questions by monitoring neural activity using a combination of electrophysi-
ological methods to examine individual neurons with very high resolution and functional imaging
to track activity of hundreds of neurons simultaneously. To test how the network functions, they
use molecular genetic techniques to manipulate activity of specific neurons in learning and memory
centers of the fly brain. They also examine the effects of learning-related genes on neuronal response
properties. In this way, they directly test their predictions about neural coding, both at the level of
spike trains and at the level of animals’ perception.
Anthony Zador and colleagues study how brain biology gives rise to higher-level properties such
as complex behavior. They have focused on how the cortex processes sound, how that processing is
modulated by attention, and how it is altered in pathology. In the lab’s “core assay,” the response of
single neurons to sound stimuli is examined under distinct behavioral conditions. In animal models
of autism, the team is trying to link an inability to screen out background sounds with changes in
neural circuits. Separately, by showing that a very small minority of available auditory neurons in
a rat cortex reacted strongly when exposed to a specific sound, the lab challenged the standard model
of sound representation. Zador’s team has generated evidence supportive of an alternative theory of
information processing in the brain, showing that animals in the midst of decision-making have
the ability to distinguish incoming signal “spikes” separated by as little as three milliseconds. This
lends credence to a “timing” model of information processing as opposed to one based on the rate
of signal firing.
Yi Zhong’s lab studies the neural basis of learning and memory. They work with fruit fly models
to study genes involved in human cognitive disorders, including neurofibromatosis, Noonan’s syn-
drome, and Alzheimer’s disease. Mutations of the neurofibromatosis 1 (NF1) gene cause learning
defects and neurofibromas—nerve-sheath tumors that split apart nerve fibers. The lab’s analyses of
Drosophila NF1 mutants have revealed how expression of the mutant gene affects a pathway crucial
for learning. They have also discovered that the NF1 gene and a gene called corkscrew, both impli-
cated in Noonan’s, share a biochemical pathway. Recently, they succeeded in linking specific genetic
defects in Noonan’s with long-term memory deficiencies that are among the symptoms of the illness.
In fly models, they discovered the molecular underpinnings of an observed “spacing effect”—the
fact that learning tends to be preserved longer in memory when learning sessions are spaced out be-
tween rest intervals. They demonstrated that a protein, SHP-2 phosphatase, controls the spacing
effect by determining how long resting intervals between learning sessions need to last so that long-
lasting memories can form. Zhong’s team has succeeded in reversing memory deficits in mutant
flies, work that suggests longer resting intervals for Noonan’s patients might reverse their memory
deficits.
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Understanding complex behaviors such as memory will
require a multidisciplinary approach that will include dis-
covery and manipulation of the relevant genetic/cell sig-
naling pathways and the relevant neural circuits. Work in
genetic model systems such as Drosophila can contribute
to our understanding in several ways. First, by enabling
discovery of genes and genetic pathways underlying be-
havior, such model systems provide entry points for dis-
section of cellular mechanisms that are often conserved.
Second, systematic manipulation of gene function in rel-
evant anatomical loci of the brain allows a conceptual in-
tegration of findings from cellular and behavioral
neuroscience. Our gene discovery efforts already have
identified a role in memory for highly conserved path-
way(s) involved with subcellular control of translational
regulation. Many of these molecules have counterparts in
vertebrates that also appear to have important roles in
brain function and, in some cases, may be linked to
human cognitive dysfunction. Our genetic investigations
also provide insight to investigate the neural circuitry rel-
evant to memory because gene expression patterns often
suggest hypotheses that can be tested spatially to restricted
genetic manipulations. Our recent findings demonstrate
that short-term and long-term memory are supported by
anatomically distinct memory traces. This too appears to
reflect a fundamental (but poorly understood) feature of
memory formation. Finally, at the behavioral level, we are
uncovering properties of learned fear that may be relevant
to fear disorders in humans.
Synaptic Targets of Pumilio
J. Dubnau, W. Li, L. Prazak
Using a series of genome-wide screens, we identified a
role in memory for a number of mRNA-binding pro-
teins (Dubnau et al., Curr Biol 13, 286 [2003]), includ-
ing several with known roles in mRNA localization and
translational control. In humans, cellular mechanisms of
local translation are of relevance to the etiology of Frag-
ile-X mental retardation syndrome. Our genetic studies
in Drosophila already support a role in memory for sev-
GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Blum H. Qin
M. Cressy L. Prazak
W. Li 
eral components of this cellular machinery, including
staufen and oskar, which are known components of a cel-
lular mRNA localization machinery in oocytes, and
pumilio, which is a translational repressor protein whose
vertebrate orthologs are highly conserved but largely un-
studied. Although pumilio function has been most care-
fully studied in the context of embryonic patterning,
several recent findings demonstrate that pumilio also has
an important role in the nervous system, including long-
term memory formation (see, e.g., Dubnau et al., Curr
Biol 13, 286 [2003]]; Berger et al., Alcohol Clin Exp Res
32, 895 [2008]; Chen et al., PLoS Comput Biol 4, e40
[2008]). In neurons, pumilio appears to have a role in
homeostatic control of excitability via down-regulation
of para, a voltage-gated sodium channel, and it may more
generally modulate local protein synthesis in neurons via
translational repression of eIF-4E. Aside from these, the
biologically relevant targets of pumilio in the nervous sys-
tem were largely unknown in any species. 
We hypothesized that pumilio might have a role in reg-
ulating the local translation underlying synapse-specific
modifications during memory formation. To identify rel-
evant translational targets, we used an informatics ap-
proach (in collaboration with M. Zhang’s lab at CSHL)
to predict pumilio targets among mRNAs whose products
have synaptic localization (Chen et al., PLoS Comput Biol
4, 340 [2008]). We then used both in vitro binding and
two in vivo assays to functionally confirm the fidelity of
this informatics screening method. We found that
pumilio strongly and specifically binds to RNA sequences
in the 3′UTR (untranslated region) of four of the pre-
dicted target genes, demonstrating the validity of our
method. We then demonstrated that one of these pre-
dicted target sequences, in the 3′UTR of discs large (dlg1),
the Drosophila PSD95 ortholog, can functionally substi-
tute for a canonical Nanos response element (NRE) in
vivo in a heterologous functional assay in the embryo.
We also demonstrated that endogenous levels of dlg1
(Chen et al., PLoS Comput Biol 4, 340 [2008]) and an-
other neuronal target, 14-3-3, can be regulated by pumilio
in a neuronal context, the adult mushroom bodies (MB),
which is an anatomical site of memory storage (Fig. 1 and
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new gene expression. An underlying assumption of this
cellular view of memory consolidation is that these dif-
ferent mechanisms occur within a single neuron. At the
neuroanatomical level, however, different temporal
stages of memory can engage distinct neural circuits, a
notion that has not been conceptually integrated with
the cellular view. We have investigated this issue in the
context of aversive Pavlovian olfactory memory in
Drosophila. Previous studies have demonstrated a cen-
tral role for cAMP signaling in the mushroom body
(MB). The Ca2+-responsive adenylyl cyclase rutabaga is
believed to be a coincidence detector in γ neurons, one
of the three principal classes of MB Kenyon cells. We
have conducted the first systematic investigation of the
requirements for cAMP signaling in each of the three
major MB neuron subtypes for each of the temporal
phases of memory (Blum et al. 2009). We spatially re-
stricted expression of the rutabaga+ cDNA to each of
the major subtypes of MB neurons and examined
memory during a time course after training. Using this
approach, we are able to separately restore short-term
and long-term memory traces to a rutabaga mutant
with expression of rutabaga in different subsets of MB
neurons (see, e.g., Fig. 2). Our findings suggest a model
in which the learning experience initiates two parallel
associations: a short-lived trace in MB γ-neurons, and
a long-lived trace in α/β neurons (Blum et al. 2009;
Blum and Dubnau 2010). Our current efforts focus on
elucidation of the signaling differences relevant to learn-
ing that lie downstream from the DA1 dopamine re-
ceptor within these two neuronal cell types.
Enhancer/Suppressor Screening by Selective
Breeding: Modeling Rubenstein–Taybi 
Syndrome in Drosophila
M. Cressy, J. Dubnau [in collaboration with P. Mitra 
and D. Valente, Cold Spring Harbor Laboratory]
Most quantitative phenotypes have a complex genetic
etiology. Even in cases with an apparently “simple”
Mendelian inheritance, epistatic interactions within the
genetic background can have profound impacts on phe-
notype. In addition to its obvious importance to our
understanding of genotype-to-phenotype relationships,
the “sensitivity to genetic background” can impact both
severity and clinical outcome of genetic disorders. Ru-
binstein–Taybi syndrome (RTS), for instance, is a rare
congenital disorder characterized in part by mental re-
tardation. In greater than 50% of patients, RTS is
caused by mutations in one copy of the cAMP response
element–binding (CREB) protein (CBP) located in
data not shown). Our current efforts focus on several ad-
ditional neuronal targets of pumilio, construction of in
vivo sensors to image local neuronal translation, and
higher-throughput in vivo approaches to fully character-
ize the combinatorial action of pumilio and other regula-
tors to control neuronal translation.
Neural Circuitry of Memory
A. Blum, M. Cressy, H. Qin, J. Dubnau 
A common feature of memory and its underlying
synaptic plasticity is that each can be dissected into
short-lived forms involving modification or trafficking
of existing proteins and long-term forms that require
Figure 1. Dlg is repressed by overexpression of Pum in MB
Kenyon cells. An MB-expressing Gal4 line (OK107) was used to
drive expression of both UAS-mCD8::GFP (Green) and UAS-Pum
transgenes. Shown are optical sections of the MB lobes. In wild-
type (top), Dlg expression is detected both in MB lobes and AL
and in the MB peduncle (not shown). In contrast, Dlg expression
is dramatically reduced in the MB lobes (bottom) and peduncle
(not shown) of Pum overexpressing MBs. AL glomeruli, also
stained by Dlg antibody, serve as an internal control.
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Figure 2. rutabaga expression in γ neurons supports short-term memory but not long-term memory. In contrast,
rutabaga expression in α/β neurons supports long-term but not short term memory. Memory retention was tested 2
min (a) and 3 h (b) after a single training session as well as 24 h after either massed (c) or spaced (d) training. Only
spaced training gives CREB-dependent long-term memory. In each case, performance was compared among the fol-
lowing groups: rut2080 mutant males with a UAS-rut+ transgene but no Gal4 driver (rut2080/Y; UAS-rut), rut2080
heterozygous females with a UAS-rut+ transgene but no Gal4 driver (rut2080/+;UAS-rut), rut2080 mutant males with
a UAS-rut+ transgene and either the 201Y or C739 driver alone, or the 201Y and C739 Gal4 drivers combined, and
rut2080 heterozygous females with a UAS-rut+ transgene and these Gal4 lines. In contrast with the rut2080/Y;UAS-
rut mutant males, rut2080 mutant males with both a UAS-rut+ transgene and either the 201Y or 201Y combined with
C739 Gal4 drivers exhibit nearly normal levels of performance measured 2 min after training, whereas C739 expres-
sion caused no improvement (P < 0.05, N = 6 for all groups) (a) and only expression combined with both the 201Y
and C739 drivers significantly improved performance 3 h after a single training session (P < 0.05, N = 8 for all groups)
(b). Only expression combined with both the 201Y and C739 drivers significantly improved performance 24 h after
massed training (P < 0.05, N = 18 for all groups) (c). For 24 h after spaced training, expression with the C739 driver
alone resulted in significant improvement of performance; however, this effect was augmented by combining both
C739 and 201Y expression (P < 0.05, N = 23 for all groups). In all cases, no significant improvements were observed
in control females that were rut2080/+;UAS-rut and contained a Gal4 line with the exception of flies carrying both
the 201Y and C739 drivers combined after spaced training.
16p13.3. Mouse models of this disorder demonstrate
that the cognitive defects of the CBP mutants can be
rescued by pharmacological stimulation of cAMP sig-
naling. Even with this relatively simple inheritance pat-
tern, however, there is considerable clinical variability
both among RTS patients and between CBP mutant
mice in different genetic backgrounds.
Despite its widespread relevance, the mechanisms by
which multigene interactions modulate phenotype are
ill understood. Historically, experimental dissection of
gene interaction has depended on two strategies: for-
ward mutagenesis and selective breeding. Each of these
approaches has its own limitations. Forward mutagen-
esis has traditionally been the workhorse for the genetic
dissection of cellular mechanisms and entails a two-
tiered strategy. First is the identification of individual
genes that influence a particular phenotype, followed
by analysis of pair-wise gene interactions via modifier
screens. Although this strategy has been tremendously
successful at revealing the fundamental molecular
mechanisms, it has not fully modeled the complexity
of gene networks underlying phenotype. On the other
hand, multigenerational selective breeding has been
successfully used to study the genetic architecture un-
derlying complex phenotypes across a wide variety of
organisms. This strategy more closely models the multi-
gene interactions that influence phenotype and that
may be relevant to the natural evolution of phenotypic
change. Unlike forward mutagenesis, however, when
used on its own, this strategy does not elucidate the un-
derlying molecular mechanisms. We have developed a
novel approach that combines the strengths of these
two methods. Our approach relies on artificial selection
over the course of multiple generations to “evolve”
combinations of known and molecularly tagged gene
variants that interact to modify the memory defect of
the rutabaga adenylyl cyclase. This is an attempt to
model the effects of genetic background on phenotypic
severity in RTS and also is designed to use experimental
evolution to mimic classical suppressor screens. We first
established large populations of animals that are ho-
mozygous for a null mutation in the rutabaga gene.
These populations were engineered to contain con-
trolled heterogeneity at 23 loci that first were identified
via a forward mutagenesis (Dubnau et al., Curr Biol 13,
286 [2003]). Each animal in the starting population
was homozygous for a different combination of three
or four of these 23 mutations. Thus, the possible allele
space is combinatorially quite large. The second stage
of this project is multigenerational selective breeding to
evolve combinations of alleles that are capable of sup-
pressing the rutabaga learning defect. 
We used selective breeding for improved memory
(rutabaga suppression) on three replicate populations for
41 generations (Fig. 3). Control populations were al-
lowed to drift in parallel. A robust response to selection
is seen beginning at about generation 13. We then used
a high-throughput genotyping to determine allele fre-
quencies and coinheritance patterns for all 23 loci for
288 animals per population across the replicate popula-
tions (Fig. 3). Multivariate analyses of these high-dimen-
sional data examined which of the 23 loci were
responsible for the phenotypic effect. Samples with more
than 30% failed reactions were discarded, and values for
the remaining missing data were assigned by drawing
from the empirical genotype distributions of the valid
calls. This procedure (imputation) was repeated 100
times to ensure an accurate depiction of the allele fre-
quencies. The allele frequencies showed little variance
over the 100 imputations (data not shown). A singular
value decomposition (SVD) was then performed on
each imputed matrix. The SVD is typically used for di-
mensional reduction and is also the algorithm used in
principal component analysis (PCA). The SVD, how-
ever, is a matrix factorization technique that need not
be interpreted in statistical terms (as in PCA). An SVD
provides orthonormal bases for both the column space
and the row space of the original data matrix. In our
case, we obtain a “sample space” effectively describing
the genotypes of typical flies and an “allele space,” ef-
fectively describing the relevant allelic contributions. 
Having obtained these descriptive spaces, linear dis-
criminant analysis (LDA) was used to discriminate be-
tween selected and unselected groups across generations
in the reduced sample space. LDA defines the direction
of separation between selected and unselected popula-
tions (Fig. 3, middle panel), and when projected into
“allele space,” this vector gave a list of weights describ-
ing the contribution of each allele to the phenotypic ef-
fect (Fig. 3, bottom panel). Positive weights suggest
alleles beneficial to the memory task, and negative
weights suggest alleles detrimental to the memory task.
Neither the SVD nor LDA showed significant differ-
ences over the 100 imputations to fill in missing data
(due to lack of genotype calls), lending support to the
robustness of the method.
These data identify eight alleles that are predicted to
underlie the selection response. We used standard
Mendelian genetics to generate flies that were homozy-
gous for the rutabaga1 allele and heterozygous for one of
the transposon mutations identified in the SVD (Fig. 3).
This experiment has been completed for each of the eight
elevated alleles and for the one allele that is most dramat-
ically elevated in the UNSELECTED direction (E1847).
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In each case, we compared memory performance to that
of the rutabaga mutant to test for suppression (improve-
ment in learning). We also tested the effects in animals
that were heterozygous for the recessive rutabaga1 mu-
tant. We find that the learning performance of null
rutabaga animals is significantly improved if these ani-
mals also are heterozygous for any of the top three alleles
(D0077, E3272, or E3945) identified from the SVD
(Fig. 3). In contrast, memory is not significantly im-
proved or decreased with the other five of the top eight
alleles (Fig. 3 and data not shown) or with E1847 (Fig.
3), which was the allele significantly opposing the sepa-
ration. These data serve as an independent confirmation
that several of the identified alleles are causally related to
the memory performance improvement in the selected
lines and that the SVD analyses are predictive of the be-
havioral outcomes. It is gratifying that the three highest-
impact alleles in the multivariate analysis are each
individually capable of partially suppressing the rutabaga
learning defect. Current efforts on this project focus on
testing the following four hypotheses:
•   Hypothesis 1: Multiple genetic solutions underlie
the response to selection.
•   Hypothesis 2: Multigene interactions contribute
to the selection response.
•   Hypothesis 3: Genetically different “solutions” to
selection share mechanistic similarities.
•   Hypothesis 4: The separation between
selected/unselected groups found in the analysis is
due to selection in the memory task and not to a
founder effect, neutral drift, or natural selection.
Extinction Learning: A Model 
for Posttraumatic Stress Disorder
H. Qin, J. Dubnau
Repeated representation of the conditioned stimulus
(CS) without the reinforcement of the unconditioned
stimulus (US) results in the diminishment of condi-
tioned responding. This process is called extinction (of
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Figure 3. Experimental evolution of rutabaga suppression. (Top
panel, MOR) Performance for one or the three selected lines (Mor)
over the course of 41 generations; mean data for three selected
lines are shown for comparison. Similar responses are seen in each
of the three unselected populations (not shown). Importantly, no
response to selection was observed in a control population with
no variation at the 23 loci (not shown). (Bottom two panels) Mul-
tivariate analyses of the genotype data. The first three components
in the SVD account for ~40% of the variance. The SVD transfers
each genotype into a three-dimensional meta-genotype space in
which the directions are no longer allele dosages, but instead,
some representation of genotypes more related to genotype inter-
actions. When each animal is plotted in the meta-genotype space
(middle panel), there is a definite separation between the groups
(similar results at generation 11; not shown). LDA was used to give
the direction of separation (w). Because the SVD also gives a cor-
responding meta-allele space, we can project the allele profile vec-
tors onto w, giving the amplitude of contribution of each allele to
w. Allele contributions (bottom panel) are sorted so that largest ef-
fects are to the left. Alleles above the zero line are predicted to
cause the separation between selected and unselected groups.
Pavlovian conditioning). Extinction was first studied
by Pavlov in 1927 and has been reported in both ap-
petitive and aversive paradigms. Extinction is not sim-
ply erasing the original CS-US association but appears
to be a new learning process that antagonizes the orig-
inal memory. This type of learning is important biolog-
ically, but it also has received attention because of its
potential relevance to posttraumatic stress disorder
(PTSD), in which an individual continues to fear a par-
ticular set of stimuli or a context. This debilitating fear
can be highly resistant to extinction.
We are taking advantage of the abundant molecular
and genetic tools of Drosophila melanogaster to investi-
gate mechanisms of extinction following Pavlovian
“fear” learning. We have established a robust assay of
extinction (Fig. 4) and have tested a series of the classic
learning mutants for effects on extinction. The surpris-
ing result from this analysis is that we observe a robust
extinction learning in mutations that disrupt either
cAMP signaling or N-methyl-D-aspartate (NMDA) re-
ceptor function. We also observe extinction in muta-
tions that disrupt either short-term memory or long-
lived memory. In contrast, genetic disruption of the
development of a single neural cell type appears to
block extinction (Qin and Dubnau 2009). These results
establish an entry point to dissect the neural circuits
that serve the fear conditioning versus extinction.
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Figure 4. Extinction of “fear” conditioning in Drosophila. Extinc-
tion paradigm (top panel) involves three stages. First, animals are
trained in a Pavlovian olfactory avoidance assay using 10 sessions
of spaced training. This leads to a robust and stable long-term
“fear” memory. Second, 24 h after training, animals are subjected
to varying numbers of extinction learning sessions. These consist
of repeated exposure to the odors in the absence of the electric
shock reinforcement. Finally, the animals are tested for avoidance
of the conditioned odor. Using 5, 15, or 30 sessions of extinction,
we observe a robust extinction of the fear avoidance. Control
groups receive exposure to air only. Our genetic investigations
of extinction show that this form of learned safety is resistant to
disruption of key signaling pathways with established roles in
synaptic plasticity. These include cAMP signaling (not shown)
and NMDAR1 (bottom panel). NMDAR1 mutant animals (EP331)
display significantly reduced fear memory to begin with, but this
residual memory can be extinguished robustly (compared with
wild-type 2202U animals).
We study stem cells, their contribution to tissue plas-
ticity, and the signals that control their fate. Our main
focus is on stem cells of the brain and the neuroen-
docrine tissues. We use animal models to study the fate
of stem cells and to learn how physiological stimuli,
aging, disease, and therapies affect stem cells and the
tissue where these cells reside. Our particular interest is
in mechanisms that control stem cells’ quiescence and
entry into division cycle. We also study the signals that
mediate interactions between stem cells and their mi-
croenvironment, with particular attention to the versa-
tile signaling molecule, nitric oxide (NO). We are also
working to translate the knowledge we generate with
animal models to human studies.
Neural Stem Cells and Brain Disorders
New neurons are continuously generated in restricted
areas of the brain; one is the hippocampus, a region cru-
cial for cognitive function. New neurons are born from
neural stem cells as a result of a complex cascade of
events including symmetric and asymmetric divisions,
exit from the cell cycle, programmed elimination, and
continuous changes of morphology. This cascade culmi-
nates with the young neuron establishing connections
with other cells and becoming integrated into the pre-
existing neuronal circuitry. Production of new neurons
from stem cells is a highly dynamic process and can be
modified by a wide range of intrinsic and extrinsic fac-
tors that can enhance or suppress neurogenesis and may
affect any step of the differentiation cascade. We aim to
define each step of the cascade and to determine the tar-
gets of important proneurogenic or antineurogenic stim-
uli. Our main approach is to generate transgenic
reporter animal lines, to combine them with other ge-
netically modified lines, to use these complex compound
lines to dissect the neurogenesis cascade into distinct
stages, and then to identify the steps that are specifically
affected by a particular stimulus. We used this approach,
aided by computational modeling (in collaboration with
Dr. Alex Koulakov, CSHL), to produce a new scheme
of the stem cell life cycle. We are using this scheme to
address the basic mechanisms that control the quies-
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cence, self-renewal, differentiation, and death of stem
cells in the adult and aging brain. Furthermore, this
scheme will now serve as a general platform upon which
we and other researchers will be able to project the ac-
tion of any agent that alters neurogenesis. 
We have already used this scheme to identify the tar-
gets of various antidepressant drugs and treatments, ex-
ercise, radiation, chemotherapeutic agents, trauma,
Parkinson’s disease, and aging. In particular, we found
that diverse antidepressant therapies such as fluoxetine,
exercise, and deep brain stimulation of distant brain re-
gions converge on the same downstream step of the cas-
cade, without affecting the stem cells; in contrast,
electroconvulsive shock, another antidepressant ther-
apy, activates division of stem cells. 
We have also found that trauma and disease can ac-
tivate stem cells of the hippocampus, even when distant
regions of the brain are damaged. In particular, we
found that moderate traumatic brain injury (with cor-
tical impact) promotes division of stem cells in the adult
hippocampus. Furthermore, in the model of Parkinson’s
disease, we found that ablation of dopaminergic neurons
of the substantia nigra (which project to the hippocam-
pus) can also activate hippocampal stem cells. Together,
these results suggest that even distant events such as a
trauma of the cortex or ablation of neurons in the mid-
brain can activate neural stem cells of the hippocampus;
such activation may reflect the induction of innate repair
and plasticity mechanisms by the injured brain.
Our results also suggest an explanation of the age-re-
lated decline in hippocampal neurogenesis. Age is the
major factor that affects neurogenesis, and, given the po-
tential significance of new neurons for cognitive func-
tion, it has been hypothesized that reduced neurogenesis
may contribute to age-related cognitive impairment.
Our results indicate that a decrease in the number of
new neurons in the hippocampus is a consequence of a
decrease in the number of neural stem cells. Moreover,
the decrease in stem cells is a division-coupled process
and is a direct consequence of their functioning to pro-
duce new neurons. We now propose a “disposable stem
cell” model to explain the disappearance of hippocampal
neural stem cells, the appearance of new astrocytes, the
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suppresses cell division, thus helping to control the bal-
ance between proliferation and differentiation. It thus
arises as a regulator of stem cell activity in a range of tis-
sues. For instance, it acts as a negative regulator of cell di-
vision in the developing and adult nervous system, such
that by manipulating NO levels, we can change the num-
ber of neural stem and progenitor cells. Furthermore, we
found that the neuronal NO synthase isoform (nNOS),
usually associated with brain function, regulates hemato-
poiesis in vitro and in vivo: nNOS is expressed in stromal
cells and produces NO, which acts as a paracrine regulator
of hematopoietic stem cells.
We continue to discover the diversity of biological
functions of NO. Our current work focuses on the role
of NO as a regulator of morphogenesis during early de-
velopment. We found that during early development,
NO coordinates two major morphogenetic processes: cell
division and cell movement. Inhibition of NO synthase
during early development of Xenopus increases prolifera-
tion in the neuroectoderm and inhibits convergent ex-
tension in the axial mesoderm and neuroectoderm,
indicating that during development, NO suppresses di-
vision and facilitates movement of cells. We further
found that NO controls these processes through two
overlapping but separate signaling pathways. Concurrent
control by NO helps ensure that the crucial processes of
cell proliferation and morphogenetic movements are co-
ordinated during early development. 
We have now discovered yet another role of NO and
nNOS during early development: its function as a regu-
lator of planar polarity of cilia. We demonstrated planar
polarity of the distribution of cilia in the Xenopus larvae
and found that NO and XNOS1 (an ortholog of nNOS)
are important mediators of this polarity. We also found
a new mode of establishing planar polarity by function-
dependent stabilization of cilia growth. Moreover, we
demonstrated that the role of NO in mediating planar
polarity of cilia extends to mammalian tissues, highlight-
ing its role in human health and disease.
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remodeling of the neurogenic niche, and the age-related
decline in the production of new neurons.
The changes that neural stem cells undergo during
aging or disease suggest that being able to detect varia-
tions in the level of neurogenesis in the live brain may be
important for diagnostic purposes. In collaboration with
Dr. Helene Benveniste (Stony Brook University and
Brookhaven National Laboratory), we are working to
characterize changes in magnetic resonance spectra of the
live animal and human brain that would be indicative of
the changes in neurogenesis. Moreover, this approach is
now being investigated in a number of preclinical and
clinical trials, and it may become useful for following
neurological and psychiatric disorders and cancer.
Stem Cells in Nonneural Tissues
Adult tissues undergo continuous cell turnover in re-
sponse to stress, damage, or physiological demand. New
differentiated cells are generated from dedicated or fac-
ultative stem cells or from self-renewing differentiated
cells. Adult stem cells are often morphologically unspe-
cialized, can survive for a long time or undergo long-
term self-renewal, and are located in specialized niches
that restrict their division and support their undifferen-
tiated status. Toward the goal of identifying, isolating,
and tracking adult stem cells, we generated a series of
compound reporter transgenic mouse lines where stem
and progenitor cells and their progeny in a number of
tissues are marked by fluorescent proteins. Interestingly,
the same reporter lines that highlight stem cells of the
developing and adult nervous system also help to high-
light stem and progenitor cells in a range of other organs
and tissues, including nonneuronal tissues. The list now
includes stem cells of such dissimilar structures as brain
and spinal cord, hair follicles, liver, pancreas, skeletal
muscle, testis, ciliary margin of the eye, anterior pitu-
itary, and mesenchymal stem cells. This observation
points to a close (and yet unexplained) relation between
expression of nestin and stem-like properties of cell pop-
ulations in these tissues. It also provides a means of iso-
lating adult stem and progenitor cells, tracing their
lineage, and studying the mechanisms controlling their
quiescence, division, self-renewal, and differentiation.
NO, Stem Cells, and Development
Much of our interest is related to a versatile signaling mol-
ecule, nitric oxide (NO), a crucial regulator of vasodila-
tion, immunity, and neurotransmission. We found that
in several developmental and differentiation contexts, NO
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The research in my group is aimed at understanding the
molecular basis for the function of cell surface proteins
that trigger cellular signal transductions involved in neu-
rotransmission in the mammalian brain. Our goal is to
help design compounds with therapeutic potentials in
neurological diseases and disorders including schizo-
phrenia, depression, stroke, and Alzheimer’s disease. To-
ward this end, we are conducting structural and
functional studies on neurotransmitter receptor ion
channels and intramembrane enzymes, which facilitate
and modulate the strength of neurotransmission. To
achieve our goals, we use X-ray crystallography to de-
termine the three-dimensional structures of target pro-
teins and test structure-based mechanistic hypotheses by
site-directed mutagenesis in combination with biochem-
ical and biophysical techniques including electrophysi-
ology. Our group is currently focused on understanding
the structure and function of three classes of cell surface
proteins, N-methyl-D-aspartate receptor (NMDAR),
calcium homeostasis modulator (CALHM), and γ-sec-
retase, dysfunctions of which are highly implicated in
the pathogenesis of Alzheimer’s disease.
Structure and Function of NMDARs 
NMDARs belong to the family of iGluRs, which me-
diate the majority of excitatory synaptic transmission
in the mammalian brain. Dysfunctional NMDARs are
implicated in neurological disorders and diseases in-
cluding seizure, stroke, schizophrenia, Parkinson’s dis-
ease, and Alzheimer’s disease. NMDARs are multimeric
ligand-gated ion channels composed of the NR1 and
NR2 subunits, which bind glycine and L-glutamate, re-
spectively. Unlike non-NMDARs that can form func-
tional ion channels as homotetramers, the NMDARs
can only function as the NR1-NR2 heteromultimers,
and opening of the ion channels requires binding of
both glycine and glutamate to NR1 and NR2, respec-
tively. The four distinct NR2 subunits control ion chan-
nel properties and show different spatial and temporal
expression patterns; thus, there has been enthusiasm to
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create subtype-specific compounds that can target spe-
cific neuronal circuits. 
The NMDAR subunits are modular proteins com-
posed of the amino-terminal domain (ATD), ligand-
binding domain (S1S2), transmembrane domain (TM),
and carboxy-terminal domain (CTD) (Fig. 1). The do-
main of focus in this study is the ATD at the extracellu-
lar region, which mediates allosteric regulation of the
NMDAR ion channel activities. From the pharmaceu-
tical perspective, most of the compounds that target the
NMDAR S1S2 ligand-binding cores (Fig. 1) cause se-
vere side effects due to nonspecific binding to different
NMDAR subtypes. This stems from high sequence
Figure 1. Domain organization of NMDAR subunit. The amino-ter-
minal domain (ATD) at the extracellular region is followed by S1,
transmembrane region (TM) 1 and 2, P-loop, the S2 segment, TM
3, and carboxy-terminal domain (CTD). The S1 and S2 peptides
form a ligand-binding core that binds agonists and antagonists. ATD
in NMDARs bind allosteric modulators (zinc and phenylethanol-
amines). TM forms the ion channel in the context of the heteromul-
timeric assembly of NR1 and NR2 subunits, which is blocked by
magnesium at resting membrane potential. CTD interacts with in-
tracellular proteins such as PSD95 and CAMKII to mediate cellular
signal transduction important for synaptic plasticity.
on the intact NR1/NR2B NMDARs as assessed by two-
electrode voltage-clamp (TEVC) experiments. We have
also spotted a region in the clamshell cleft that is clus-
tered with hydrophobic residues. To understand the po-
tential functional roles of the hydrophobic residues, we
have conducted systematic structure-based mutagenesis
on those residues in combination with TEVC (Fig. 3).
We have found that mutations of hydrophobic residues
have a significant effect on potency and efficacy of
phenylethanolamine-mediated allosteric inhibition but
have little or no effect on zinc-mediated allosteric inhi-
bition. These results have suggested that zinc and
phenylethanolamine have distinct binding sites at the
clamshell cleft even though they both mediate allosteric
inhibition. To verify this functional hypothesis, we are
currently attempting to solve the NR2B ATD structure
in complex with phenylethanolamine compounds in-
cluding ifenprodil. We are continuing with our effort to
understand the mechanism by which bindings of zinc
and/or phenylethanolamines to NMDARs inhibit ion
channel activities by further conducting X-ray crystal-
lographic studies on the NR1/NR2B ATD complex.
Structure and Function of Calcium
Homeostasis Modulator
Calcium homeostasis in neuronal synapses is main-
tained by the cell surface and endoplasmic reticulum
identity and therefore, high structural similarity within
the S1S2 ligand-binding domains of the NR2 subunits
(namely, NR2A–NR2D). In contrast, sequence identity
is moderate (30%–40%) in ATD, thus making this do-
main an attractive drug target. Indeed, a group of com-
pounds called phenylethanolamine and zinc specifically
bind NR2B ATD and allosterically inhibit the activity
of the NR2B containing NMDARs. To date, the mo-
lecular mechanism for the ATD-mediated regulation is
not well understood, and structural information for the
NMDAR ATD has not been available. Our group has
recently solved the structure of NR2B ATD and an-
swered questions involving the molecular mechanism of
ATD-mediated allosteric inhibition.
We have completed X-ray crystallographic studies on
NR2B ATD in two states: zinc-bound states and the apo
state. This X-ray crystallographic study has revealed that
the NR2B ATD has a clamshell-like overall architecture
composed of two lobes, which we call the R1 and R2
domains (Fig. 2). Using the anomalous dispersion
method in X-ray crystallography, we have been able to
unambiguously identify a binding site for a zinc ion
deep in the clamshell cleft. The clamshell structure is
found in the closed conformation where the zinc ion at
the cleft appears to induce the global domain closure.
Indeed, mutation of residues involved in zinc coordina-
tion as well as the R1-R2 interdomain interaction ham-
pered the extent of zinc-mediated allosteric inhibition
Figure 2. Crystal structure of NR2B ATD in complex with zinc. (A) Overall architecture of NR2B ATD composed of two lobes, R1 (top)
and R2 (bottom) domains. Zinc sphere in mesh area is coordinated by hydrophilic residues at the cleft sticks at top. A patch of hy-
drophobic residues is observed on the opposite side of the clamshell cleft sticks at bottom. (B,C). Enlargement of the zinc-binding site
(B) and hydrophobic site responsible for binding of phenyethanolamine compounds (C). 
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(ER) membrane proteins including NMDARs, voltage-
gated calcium channels, IP3 receptors, and the recently
identified CALHMs. Spatiotemporal regulation of Ca2+
concentration is pivotal for brain physiology, including
learning and memory formation. Disruption of calcium
homeostasis has long been suggested to cause neurode-
generative diseases including Alzheimer’s disease (AD).
Currently, there is little or no knowledge on the func-
tional properties of CALHM. A moderate degree of se-
quence similarity to NMDARs at the transmembrane
region suggests that the CALHM ion channels are cal-
cium-permeating ion channels. However, whether or
not CALHM ion channels are regulated by external lig-
ands is not known. Thus, by using biochemical, elec-
trophysiological, and structural biological approaches,
we are aiming to dissect the function of CALHM at a
molecular level. We have, so far, been able to express
and purify CALHM proteins with a size homogeneity
suitable for crystallographic studies. We plan to conduct
X-ray crystallographic studies to obtain atomic struc-
tures and electrophysiological experiments to charac-
terize the ion channel property of CALHM.
Structure and Function of γ-Secretase
γ-Secretase is a multimeric protein complex of four trans-
membrane proteins including presenilin, nicastrin, APH-
1, and PEN-2. Together, the complex mediates the
paradigm of a molecular event called regulated intramem-
brane proteolysis, which is a type of proteolysis that oc-
curs within the membrane. Intramembrane proteases are
involved in numerous cellular processes including cho-
lesterol homeostasis, development, immuno-surveillance,
and Alzheimer’s disease pathogenesis. γ-Secretase cleaves
various single-transmembrane substrates including amy-
loid precursor protein and Notch ligand. A mechanistic
understanding of the activities in γ-secretase and in-
tramembrane proteases in general is restricted due to lim-
ited numbers of available crystal structures. Structural
information about γ-secretase is currently limited to low-
resolution images obtained by single-particle analysis
using cryoelectron microscopy. Our group is interested
in revealing atomic structures of γ-secretase to gain in-
sights into intramembrane proteolysis, substrate speci-
ficity, inhibition, and functional modulation. Currently,
we are working toward understanding the mechanism of
substrate recognition mediated by one of the γ-secretase
components, nicastrin.
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Figure 3. Validation of zinc- and ifenprodil-binding sites. (A) Dose
response of zinc-mediated inhibition on the wild-type and mutant
NR1/NR2B NMDAR ion channels as assessed by TEVC held at 
–20 mV membrane potential. (B) Residues affecting zinc inhibi-
tion do not have any effect on phenylethanolamine sensitivity.
Values in the bar graphs are IC50 of zinc and ifenprodil inhibi-
tions. (C) Mutagenesis of I133 located in the middle of the hy-
drophobic site showing a large shift in IC50 value upon mutation.
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The neocortex is the crowning achievement of evolu-
tion and subserves our uniquely human abilities. Al-
though mental functions emerge from interactions
between multiple distinct neocortical areas, cortical net-
works consist of stereotyped modular circuits, subtly
specialized across regions and mammalian species. A
key obstacle to understanding how cortical circuits per-
form complex computations is the stunning diversity
of neuron types and a lack of knowledge about the basic
biology of their construction. Although a minority,
GABAergic interneurons are crucial in establishing the
functional balance, flexibility, and computational archi-
tecture of cortical circuits. Understanding the origin,
organization, and function of GABAergic interneurons
is key to discovering the general principles that govern
how information is processed by neural circuits. 
Toward a Genetic Dissection 
of the GABAergic System
For decades, the heterogeneity of cell types has been a
major challenge to studying cortical GABAergic in-
terneurons using conventional anatomical and physio-
logical techniques. The genetic approach is ideal for
dissecting the complexity of the GABA system by tapping
into the intrinsic gene regulatory mechanisms that gen-
erate and maintain the diverse cell types. Using mouse
genetic engineering (gene targeting and Cre/loxP recom-
bination-regulated gene expression), we have generated
~20 knockin “driver lines” expressing Cre or inducible
CreER to establish “genetic access” to all major classes
GABAergic neurons. Characterization of GABA Cre
drivers indicates that our genetic strategy captured most
of the anatomically and physiological defined cell classes.
In addition, an intersectional strategy combining Cre and
Flp lines further increased specificity, suggesting that
highly distinct cell types can be captured by overlapping
two driver systems. These genetic tools allow reliable and
systematic visualization and functional manipulation of
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defined GABAergic cell types, and they also enable cell-
type-based genomic analysis of their molecular profiles.
A number of driver lines allow us to visualize the “life his-
tory” of subsets of GABA neurons (e.g., dendrite-target-
ing somatostatin interneuron), from their birth in
ganglionic eminence to their action in mature cortical
circuits. We are examining whether and how cell lineage
and developmental history influence the assembly of
GABA neurons into cortical circuits. These driver mice
will significantly accelerate progress in studying all aspects
of the GABAergic system. 
Activity-dependent Maturation
and Plasticity of Inhibitory Synapses 
and Circuits
GABA-mediated synaptic inhibition is crucial in neural
circuit operations. The development of inhibitory
synapses and innervation patterns in the neocortex is a
prolonged process, extending well into the postnatal pe-
riod, and is regulated by neural activity and experience.
Such activity-dependent inhibitory synapse development
is a major component of the functional maturation of
inhibitory circuits, which organize neural ensemble and
network dynamics, but the underlying mechanisms are
poorly understood. We previously provided evidence for
the hypothesis that GABA signaling acts beyond synaptic
transmission and regulates inhibitory synapse develop-
ment; in other words, similar to glutamate signaling at
developing excitatory synapses, GABA may coordinate
presynaptic and postsynaptic maturation at inhibitory
synapses. 
In the past year, we have made significant progress
in understanding how presynaptic GABAB receptors
and neurexin (NRX)–neuroligin synaptic adhesion
molecules contribute to GABA-mediated regulation of
inhibitory synapse development. We found that devel-
oping basket cell axons and presynaptic boutons are
highly dynamic. Interfering with GABAB receptor func-
125
126 Research
systematically examined the developmental changes of
the V1 Pv cell network around the critical period (from
postnatal 17 to 44), including (1) the intrinsic proper-
ties of Pv cells and especially (2) Pv-cell-mediated
GABAerigc synapses on both pyramidal cells (Pv-Py)
and Pv cells (Pv-Pv). We found that the changes in both
intrinsic and firing features of Pv cells support the de-
velopmental enhancement of the typical fast-spiking
characteristics during this period. As for the Pv-cell-
mediated inhibition, both Pv-Pv and Pv-Py synapses
exhibit very similar short-term plasticity with slight de-
velopmental changes. Interestingly, Pv-Pv synapses al-
ways show much faster kinetics than Pv-Py synapses at
different development stages. But both types of
synapses mature with increasingly faster kinetics with
the same developmental trajectory before postnatal 23,
and then become stable. This maturation time course
correlates with the developmental increase of α1-
GABAA receptors. Such kinetics change is also specific
at Pv-cell-mediated synapses. Our results and experi-
mental strategy set the stage for genetic manipulation
of specific properties of Pv interneurons to establish a
causal relationship between the maturation of the Pv
cell network and critical period plasticity in the primary
visual cortex. 
Cell-type-based Epigenomic Analysis of
GABAergic Neurons
A systematic understanding of gene expression profiles
and the epigenomes of different classes of interneurons
during development and in response to stimulus will
yield fundamental insight into the genetic logic under-
lying the construction and function of GABAergic cir-
cuits. A major challenge in epigenomic analysis of
mammalian brains is that cellular heterogeneity-distinct
epigenomes are simply inaccessible to sequencing tech-
nology. Using genetic engineering in mice, we are
building a comprehensive tagging system that allows
purification of chromatin DNA, ncRNA (noncoding
RNA), and mRNA from genetically defined cell popu-
lations from tissues. Genetic tagging of nucleic acids is
achieved by cell-type-specific expression of epitope-
tagged DNA- or RNA-binding proteins. DNA or RNA
species from a defined cell type are isolated directly
from tissue homogenates by affinity purification using
antibodies against epitope tags or by fluorescence-as-
sisted cell sorting (FACS) of cells from dissociated tis-
sues. We are analyzing major GABAergic neuron types
from several cortical areas and across key stages of cor-
tical development. 
tion by either antagonists or single-cell knockouts
destabilizes nascent GABAergic terminals. These results
suggest that local activation of presynaptic GABAB re-
ceptors stabilizes nascent synaptic contacts and con-
tributes to activity-dependent regulation of inhibitory
synapse development. We further examined the role of
NRXs by live imaging of NRX–synaptopHlorin (SEP)
fusion proteins in basket interneurons and showed that
(1) the two major isoforms NRX1 have striking differ-
ences in subaxonal localization, whereas the long
NRX1α is diffuse along axons with enrichment at
presynaptic bouton and the short NRX1β is exclusive
to developing presynaptic terminals; (2) the strict presy-
naptic localization of NRX1β is likely achieved by
binding to postsynaptic neuroligins; (3) both NRX1α-
SEP and NRX1β-SEP are highly dynamic along basket
axons, as revealed by FRAP (fluorescence recovery after
photo bleaching); and (4) neural activity and presynap-
tic GABAB receptor activation promote the stabilization
of NRX1β-SEP at developing presynaptic terminals.
Together, these results show how GABA signaling en-
gages the synaptic adhesion system in activity develop-
ment of inhibitory synapses. Because a prominent role
of the fast-spiking basket interneuron network is in or-
ganizing the dynamics of neural ensembles, deficient
basket cell innervation may have implications in a va-
riety of neurodevelopmental disorders.
Functional Maturation of GABAergic 
Interneurons in Neocortex
Neuronal circuits often display remarkable plasticity to
sensory input especially during early postnatal life. A
representative example is that the closure of one eye
during a critical period can permanently shift the re-
sponse property of neurons in the primary visual cortex
(V1) to favor inputs from the open eye–ocular domi-
nance (OD) shift. Although much progress has been
made in studying the anatomical, physiological, and
molecular components of OD plasticity, a comprehen-
sive understanding of how these components are inte-
grated in the context of relevant cortical circuitry
remains a challenge. Accumulating evidence suggests
that proper function of GABAergic inhibitory neurons
in V1 is critical in establishing the physiological circuit
architecture that allows OD plasticity to proceed. In-
deed, a subset of inhibitory neurons—parvalbumin
(Pv)-positive basket cells—is suggested to be involved
in OD plasticity, but data so far are correlative. 
Combining cell-type-specific Cre knockin mice,
Cre-activated viral vectors, and electrophysiology, we
GABAergic Interneurons and 
Neurodevelopmental Disorders
We are studying alterations of GABAergic inhibitory
circuits in mouse models of the Rett syndrome (RTT),
the best-characterized form of autism spectrum disor-
der. RTT is caused by mutations in the X-linked gene
MeCP2. Our general hypothesis is that MeCP2 muta-
tions perturb the postnatal maturation of the connec-
tivity, function, and plasticity in subsets of inhibitory
interneurons in distributed brain areas, leading to al-
tered development, maladaptive plasticity of neural cir-
cuits, and characteristic behavioral deficits. We have
characterized the maturation of major GABAergic
markers in the neocortex of MeCP2-null mice before
(P14, P21) and after (P30, P60) the onset of their be-
havior phenotype. Compared to wild type, MeCP2-null
mice showed increased expression of Gad67 and Pv in
the cortex at all time points tested. Interestingly, at P14,
Pv neurons in the MeCP2-null cortex also have more
elaborate neuronal processes compared to wild-type sec-
tions. These data suggest that MeCP2 deficiency may
accelerate the maturation of Pv neurons in the cortex
presymptomatically and might contribute to altered de-
velopment of neural circuits. At P30 and P60, MeCP2-
null mice showed major deficits of SOM (somatostatin)
neurons as indicated by a significant decrease in SOM-
labeled neurite arbors in the cortex. These data reveal
that MeCP2 deficiency leads to profound and differen-
tial alterations in different subsets of GABAergic neu-
rons. These studies will significantly improve our
understanding of how altered MeCP2 expression dis-
turbs the development of GABAergic circuits and reveal
new insights into the pathogenesis of RTT. 
For the past two decades, the predominant model of
MeCP2 function is DNA binding and transcriptional
regulation. In the past year, we have discovered a novel
biochemical function of MeCP2 in regulating mRNA
translation. We found that MeCP2 was associated with
hundreds of neuronal transcripts in the mouse brain
and directly bound subsets of these mRNAs in vitro. In
the brains of MeCP2-deficient mice, the levels of
MeCP2-associated mRNAs were not notably altered,
whereas the levels of proteins encoded by these mRNAs
were significantly altered. Furthermore, we found that
MeCP2 was associated with the translation machinery
protein EF1A1 and a negative regulator of translation
p54/DDX6. MeCP2 was detected in polyribosome
fractions. Together, these studies reveal an unexpected
role of MeCP2 in mRNA translation and suggest that
altered regulation of translation may contribute to the
pathogenesis of RTT.
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Research in our laboratory focuses on the neurobiological
mechanisms and computational principles of decision
making. We view complex behaviors as sequences of ele-
mentary decisions, which can be conveniently studied in
isolation to expose their underlying neural processes. Yet
even simple decisions involve the integration of sensory
and memory information with emotional and motiva-
tional attributes requiring the concerted action of millions
of neurons across brain regions. Therefore, we take an in-
tegrative approach, combining tightly controlled rodent
behavior with electrophysiological recordings to monitor
neural activity, molecular tools to perturb genetically iden-
tified neural circuit elements, and quantitative analysis to
guide and sharpen the neurobiological questions.
At present, we are pursuing two broad directions. First,
we seek to understand the principles of decision making
and, in particular, how confidence estimates are computed
and used by the brain. Recently, we discovered neural cor-
relates of decision confidence in the orbitofrontal cortex
of rats, and we are currently investigating both the neural
mechanisms and the algorithms by which this signal sup-
ports adaptive behavior. Second, we want to understand
how specific cell types participate in the neural circuit dy-
namics of local processing and how different brain regions
with specialized functions coordinate their activity. Toward
these goals, we are adapting molecular and optical tools
for use in behaving mice in order to identify and manip-
ulate defined neuronal subtypes and pathways.
Ultimately, we would like to gain mechanistic insights
into decision processes in the hope that these will be of
utility not only for a basic scientific understanding, but
also for better treatments of brain dysfunctions of decision
making, such as pathological gambling, drug abuse, and
anxiety disorders.
Behavioral Tasks to Study Confidence 
Judgments
G. Costa, A. Lak [in collaboration with Z.F. Mainen,
Instituto Gulbenkian de Ciêcia (IGC)]
If you are asked to evaluate your confidence in something
you know—how sure are you that it is true—you can read-
ily answer. What is the neural basis for such judgments? Is
NEURAL CIRCUIT DYNAMICS UNDERLYING DECISION MAKING
A. Kepecs D. Kvitsiani S. Ranade
A. Lak J. Sanders 
knowledge about beliefs an example of the human brain’s
capacity for self-awareness? Or is there a simpler explana-
tion that might suggest a more basic yet fundamental role
for uncertainty in neural computation? To study these
questions, we are developing new behavioral tasks.
Our goal was to establish a variant of our well-studied
olfactory categorization task, in which an estimate of de-
cision uncertainty or confidence about the original deci-
sion is turned into a behavioral action. We first sought to
develop a task for measuring confidence behaviorally on
a trial-by-trial basis in order to examine the neural mech-
anisms of confidence judgments. To manipulate confi-
dence, we used an olfactory mixture categorization task
to systematically vary decision uncertainty by changing
the ratio of the two components in the odor mixture. To
measure confidence, we delayed reward delivery after cor-
rect choices and measured the time an animal was willing
to wait at the reward ports. In incorrect trials (which were
only signaled by the lack of reward delivery), we noticed
that rats stayed longer following difficult (uncertain) de-
cisions than after easier (certain) decisions. To extend
these observations to correct choices, we introduced a
small fraction of “catch” trials for which reward was omit-
ted. In these omitted reward trials, rats waited longer on
average than in incorrect trials. To make these waiting
time estimates robust, we optimized the parameters of this
task to maximize the differences in waiting time for dif-
ferent levels of uncertainty. In this new task, the duration
rats are willing to wait at the reward port reflects decision
uncertainty. Therefore, this task allows us to examine how
the timing of the decision to leave the reward port (“abort
decision”) depends on the uncertainty about the original
decision. This will enable us to study how access to an in-
ternal measure of decision confidence is used in an adap-
tive behavior and examine the nature of the neural
processes underlying decision confidence.
Orbitofrontal Cortex Inactivation Impairs
Confidence Judgments
A. Lak, G. Costa [in collaboration with Z.F. Mainen, IGC]
We previously discovered neurons in the orbitofrontal
cortex (OFC) that signal decision confidence. We are pur-
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veals little about the boundary. Therefore, statistical
principles suggest that the decision boundary should be
adjusted more following difficult trials with high un-
certainty than for trials with no uncertainty. Consistent
with this, we found that rats biased their decisions to-
ward the most recently rewarded direction as if their
decision boundary was shifted. Moreover, the magni-
tude of this bias was proportional to the uncertainty of
the previous decision, as predicted. This bias, however,
was only observed for difficult decisions, suggesting that
the category boundary and not the side-bias was being
updated. Therefore, our results show that rats are “ac-
tive learners,” combining reward feedback and decision
uncertainty estimates to update their decision strategy.
These findings establish a new learning phenome-
non, in which animals appear to use their uncertainty
to adjust their learning. Future studies will examine the
neural basis of this active learning process.
Multiple-choice Decision Tasks
in Head-fixed Mice
J. Sanders
Systems neuroscience is increasingly relying on trans-
genic mice to gain molecular control of neural circuits,
but the development of well-controlled behavioral tasks
that mice can perform has lagged behind. Primate elec-
trophysiologists work almost exclusively with head-fixed
animals due to the superior behavioral control available.
Head-fixed mouse behaviors would also facilitate the use
of large-scale electrophysiological recordings, optical im-
aging, and stimulation methods that are difficult to im-
plement in freely moving animals. Previous studies of
head-fixed mouse behaviors have been restricted to vir-
tual navigation and to single a lick-port to register “lick”
or “lick-withheld” responses. These behavioral setups do
not allow well-controlled cognitive tasks and therefore
we have embarked on the development of response in-
terfaces that would allow mice to make multiple-choice
decisions. Therefore, we designed an ultra-light track-
ball interface, which mice can use to register multiple
behavioral responses with their paws. Initial studies
using this setup showed that mice can perform at more
than 95% accuracy on a two-choice discrimination task
requiring them to roll the ball toward the source of a
sound for reward. We are currently optimizing our train-
ing protocol, as well as developing force-sensitive resistor
technology, to reliably register the delicate paw presses
of mice in order to create an alternative, potentially eas-
ier-to-use multiple-choice interface. 
suing these initial observations by trying to establish that
confidence-related neural activity in the OFC is causally
related to confidence judgments. 
We hypothesized that inactivating OFC leaves the
odor-guided decision intact while impairing the use of
confidence-guided abort decisions. Therefore, we bilat-
erally implanted double cannulae to temporary block-
ade neural activity in the lateral and ventrolateral
portions of OFC. We measured rats’ confidence using
the waiting time version of our olfactory categorization
task discussed above. On testing days, rats received an
intra-OFC infusion of muscimol (a GABAergic agonist
that silences neural activity) or a saline control solution.
Our preliminary results show that waiting time patterns
of OFC-inactivated animals are disrupted without af-
fecting olfactory discrimination performance. 
These preliminary results are consistent with studies
of human patients with orbitofrontal lesions who are un-
able to judge their degree of uncertainty, indicating that
the functions of OFC we are investigating in rats are con-
served across species. By establishing that OFC is a causal
contributor to a confidence-guided decision, we hope to
lay a strong foundation for a broader examination of the
neural mechanisms underlying confidence estimation. 
How Uncertainty Boosts Learning 
A. Kepecs [in collaboration with N. Uchida, Harvard 
University, and Z.F. Mainen, IGC]
Statistical learning theory proposes that “active learners”
use their uncertainty estimates to optimally set their
learning rate so as to learn more when uncertain and less
when certain. In the machine-learning literature, it is
well established that active learning based on informa-
tive data points speeds up learning. However, little is
known about whether these principles apply to animal
learning. We tested the hypothesis that rats are active
learners and use uncertainty estimates to learn optimally.
To study this issue, we used our odor-mixture cate-
gorization task in rats and examined the trial-by-trial
updating of behavioral strategy. As animals learn to per-
form a categorization task, they use reinforcement feed-
back to establish the decision boundary, yet this
boundary may be continually updated during ongoing
performance after overt learning asymptotes.
Indeed, we found that animals were dynamically ad-
justing their decision strategy even after extensive train-
ing. For difficult decisions (those near the category
boundary), the outcome is very informative about lo-
cation of the decision boundary, whereas the outcome
of pure odor trials (far from the decision boundary) re-
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Contextual Novelty Processing 
in the Mouse Hippocampus
J. Sanders
When experiencing a known pattern of events, we can
effortlessly sense when something new and unexpected
replaces the familiar. During our earlier experiments on
sequence processing, we gathered preliminary evidence
that hippocampal cells have a characteristic response to
such novel events. 
We trained head-fixed mice to listen while an un-
changing sequence of eight unique sounds was played,
and to respond with a lick upon its completion for re-
ward. We then recorded populations of cells in the CA1
field of the mouse hippocampus and presented ran-
domly interleaved trials containing the familiar se-
quence, a sequence of totally novel sounds, and a version
of the familiar sequence with two sounds borrowed from
the totally novel sequence. In this final type of sequence,
CA1 cells fired more spikes in response to a novel sound
when presented as an unexpected part of the familiar se-
quence than when the same sound was presented as part
of the totally novel sequence. In addition, spiking re-
sponses to familiar sounds following an unexpected
novel sound were suppressed with respect to the same
sounds as part of the familiar sequence. 
Most recordings from rodent hippocampus con-
ducted in freely moving animals indicated that neurons
behave as “place cells” representing unique spatial lo-
cations in the environment. By showing that the same
neurons can also signal abstract novelty information,
we hope to broaden the classic interpretation of rodent
hippocampal processing.
Neural Circuit Dynamics of Genetically
Identified Neurons in Behaving Mice
D. Kvitsiani, S. Ranade [in collaboration with Z.J. Huang,
Cold Spring Harbor Laboratory]
Neural circuits exhibit exquisitely precise connections
between specific, often molecularly defined, neural cell
types. Genetically targeted fluorescent markers provide
a powerful handle to explore the specificity in the ar-
chitecture of neural circuits, mostly using in vitro
preparations. Although systems neuroscience has been
very successful in relating activity of neurons to percep-
tion and behavior, identity of the recorded neurons re-
mains mostly unknown. Our goal is to develop a
method for the control and identification of extracel-
lularly recorded neurons in freely behaving animals.
Using channel rhodopsin-2 (ChR2), genetically de-
fined neuron classes can be made light-activatable so that
one can optically control the generation of spikes with
millisecond precision. To take advantage of these molec-
ular tools, we are developing methods to simultaneously
optically activate and electrophysiologically record genet-
ically defined neuron types in behaving mice. To activate
molecularly defined classes of neurons, we used a knockin
mouse line targeting Cre expression to parvalbumin (PV)-
type interneurons and generated a new Cre line for calre-
tinin-expressing neurons. To express ChR2, we created a
cytomegalovirus (CMV) loxpSTOPloxp-ChR2 adeno-
associated virus (AAV) vector, which provides high-level
and very specific (>95%) expression of ChR2 in PV+ in-
terneurons. We designed a new “microdrive” that can
house up to 10 independently movable electrodes and/or
fiber-optics. This new drive is lightweight (<4 g) and thus
can be chronically implanted on the head of a mouse. We
also designed custom-built fiber-optic connectors that can
be mounted on the drive and pass light from external
sources (LED or laser). Currently, these tools enable us to
optically stimulate neurons and electrophysiology record
them at the same time in freely moving mice. 
We aim to use these tools to understand how the di-
versity of inhibitory neuron types in medial prefrontal
cortex (mPFC) underlies distinct neural circuit dynam-
ics. Specifically, mPFC activity is organized into oscilla-
tions spanning multiple timescales. These neural
population oscillations are known to change depending
on a behavioral state of an animal—from active explo-
ration to different sleep states. We hypothesize that PV
interneurons regulate the θ (4–10 Hz) rhythm (because
they can directly inhibit excitatory principal cells),
whereas CR interneurons regulate the γ (40–100 Hz)
rhythm (because they tend to inhibit other interneu-
rons). Therefore, CR and PV interneurons might have
complementary roles in controlling neural population
rhythms. Currently, we are testing the functional roles of
these interneuron classes by characterizing their activity
using optical tagging and stimulating them to observe
the consequences on global neural activity and behavior.
Paying Attention to Light: Optogenetic 
Dissection of Cholinergic System 
during Behavior
S. Ranade, M. Grabois, J. Sanders
The cholinergic basal forebrain (CBF) is a vitally impor-
tant yet poorly understood neuromodulatory system that
is thought to have significant roles in cognitive functions.
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Projections of CBF innervate the entire cortical mantle
and release acetylcholine, which modulates cortical pro-
cessing and enhances synaptic plasticity. Past research,
using primarily pharmacology and lesion studies, has
identified the neurotransmitter acetylcholine as a key
modulator of learning, memory, and attention—key fea-
tures of cognition. However, the anatomical and neuro-
chemical heterogeneity of the cholinergic system,
combined with lack of sophisticated techniques, has pre-
vented a systems-level understanding of the role of acetyl-
choline in cognitive processes. The goal of this project is
to understand the function of the CBF, the neural system
underlying the release of acetylcholine, using a powerful
combination of molecular genetic, electrophysiological,
optogenetic, and psychophysical techniques.
We use a knockin mouse line expressing the Cre re-
combinase under the control of a cholinergic neuron-spe-
cific promoter, choline acetyl transferase, to specifically
target cholinergic neurons among the heterogeneous neu-
ronal types of the CBF. Expression of the optical activator
ChR2, delivered locally to the CBF via viral vectors, en-
ables us to directly and specifically manipulate choliner-
gic neurons with high spatiotemporal precision. In
addition, we have also successfully developed a sustained
attention task in mice. In this task, mice are trained to
respond to a target sound and ignore a distractor sound.
Mice learn this task in a couple of weeks and show stable
performance.
Using these techniques, we are now in position to
manipulate the activity of cholinergic neurons during
the execution of various cognitive tasks and tease out
the role of acetylcholine during behavior. These tools
enable an unprecedented degree of mechanistic inves-
tigation of the behavioral functions of the CBF system
and provide an entry point for future studies of
cholinergic degenerative diseases, such as Alzheimer’s
disease.
Cholinergic Modulation of Auditory 
Cortical Responses
S. Ranade, T. Hromadka [in collaboration with A. Zador,
Cold Spring Harbor Laboratory]
Acetylcholine has profound physiological effects on the
activity of its target neurons. For instance, nucleus
basalis stimulation leads to desynchronization of the
cortical EEG, whereas local pharmacological applica-
tion of acetylcholine to pyramidal neurons leads to in-
creases in the firing rate, as well as changes in the
receptive field properties of cortical neurons. However,
most of these effects have been observed with extracel-
lular stimulation and pharmacological manipulations,
both of which are susceptible to noncholinergic effects.
The goal of this project is to understand the effects of
acetylcholine release on spontaneous, as well as stimu-
lus-evoked, activity on cortical neurons.
We therefore targeted the light activator ChR2 to
cholinergic neurons (see previous section) projecting to
auditory cortex to evoke light-triggered release of acetyl-
choline. Using this technique, we performed extracel-
lular and cell-attached recordings in anesthetized mice
and observed the effect of acetylcholine on auditory
cortical responses. We found that a high percentage of
neurons increased their firing rate in response to light
activation. In some cases, we also observed a broadening
and a reorganization of the auditory tuning curves of
cortical neurons. These experiments provide a proof of
principle that light activation of cholinergic terminals
can lead to changes in neuronal responses and provide
the foundation for biophysical studies probing the un-
derlying modulatory mechanisms. 
Rapid Light-induced Transcription 
in Mammalian Cells
A. Kepecs [In collaboration with F. Albeanu, Cold Spring
Harbor Laboratory]
Genetically encoded optical modulators have revolu-
tionized neuroscience. A serious impediment to their
use in probing neural circuitry during behavior is that
at present we cannot target them to functionally de-
fined neural populations—only to neurons defined by
genetic markers or anatomical projections. One way to
achieve functional targeting is to first use imaging tech-
niques to characterize a functional population of neu-
rons and then use light-activated transcription to
induce genetically encoded activity indicators and op-
tical modulators specifically in this functionally defined
neuron class. 
Toward this goal, we are developing a genetically
encoded light-induced transcription system that can
be used in the brain in vivo. We are presently testing a
two-component system that upon light activation
would rapidly and persistently release a tTa driver to
induce the transcription of any construct under the
tTA-responsive promoter tetO. In principle, this sys-
tem is generic, and therefore, depending on its effi-
ciency and leak, we foresee applications beyond
neuroscience for precise spatiotemporal targeting of
gene expression.
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A. Kepecs
Our laboratory develops theoretical models for neural pro-
cessing. We work in parallel on three important topics.
First, we have proposed a model for combining genetic
information and experience (nature and nurture) during
the development of neural connectivity. Our model de-
scribes how genes can help build neural networks and how
neural activity adds a layer of plasticity to the network
topology that reflects learning and experience. This model
has been tested on simple circuits that are formed in the
visual system and can be rewired using genetic, surgical,
and pharmacological manipulations. Second, we have
been developing the neural network theory for olfactory
processing. Our theory attempts to describe the olfactory
space, which has been an illusive concept taunting the
imagination of chemists, neuroscientists, and experimental
psychologists alike. In our theory, we attempted to link
several levels of olfactory perception: chemical, genetic,
neural, and perceptual. Our main result so far has been
the mapping between chemical and perceptual spaces that
was established on the basis of a database of human olfac-
tory responses. We can say now that we have a robust de-
scription of the human perceptual olfactory space. This
description is analogous to the understanding of, for ex-
ample, the main directions in the human color space, i.e.,
red, green, and blue. These main perceptual directions can
be understood in terms of the properties of the underlying
chemical compounds, at least, on the level of correlation.
We also proposed a network theory for information pro-
cessing in the olfactory bulb. We suggest that the granule
cells, the inhibitory neurons of the olfactory bulb, form
representations of smells using the network implementa-
tion of sparse overcomplete representations. Granule cells
are remarkable because, unlike most of the neurons in the
adult mammalian nervous system, they are continuously
replaced by the new neurons produced from the neural
stem cells. Third, we have been working on the mathe-
matical description of adult neural stem cell differentiation
and proliferation in the hippocampus. These models can
describe the evolution in time of various markers that ex-
perimental researchers use to study the division/differen-
tiation cascade. By comparing the computational/
theoretical models to experimental data, one can under-
stand changes occurring in neurogenesis due to aging and
antidepressant therapies. 
THEORETICAL AND COMPUTATIONAL NEUROSCIENCE 
A. Koulakov D. Tsigankov
Competition Is a Driving Force
in Topographic Mapping
A. Koulakov [in collaboration with C. Pfeiffenberger,
J.W. Triplett, J. Yamada, B.K. Stafford, and D. Feldheim, 
Univrsity of California, Santa Cruz]
Connectivity in the brain is established on the basis of
chemical labels and structured activity. For the two-di-
mensional, topographically organized projection from
the retina to the superior colliculus (SC), the Eph fam-
ily of receptor tyrosine kinases and their ephrin ligands
exert the role of chemical labels. Despite specific effects
of receptor activation on retinal axons, axons respond
to relative, rather than absolute, levels of chemical la-
bels, which endows the mapping mechanism with sub-
stantial robustness. However, it is not known how
axons compare global levels of chemical labels. Here,
we present experimental and computational evidence
that interaxon competition has a nonredundant role as
a mapping mechanism for the retinocollicular projec-
tion. We investigated topographic maps in the SC of
Math5 mutant mice in which the overall number of
retinal axons is severely reduced. We showed that topo-
graphic maps are substantially distorted under condi-
tions of reduced competition (Fig. 1). RGC axons
project almost entirely to the anterior-medial portion
of the SC where repulsion from ephrin-A ligands is
minimized and where their attraction to ephrin-Bs is
maximized. We conclude that chemical labels alone do
not instruct the formation of the map. We provide a
mathematical model for topographic mapping that in-
corporates molecular labels, neural activity, and axon
competition. 
Optimal Axonal and Dendritic 
Branching Strategies during Development 
of Neural Circuitry
D. Tsigankov, A. Koulakov
In developing brain, axons and dendrites are capable of
connecting to each other with high precision. Recent
advances in imaging allowed us to monitor the axon,
dendrite, and synapse dynamics in vivo. It is observed
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The Structure of Human 
Olfactory Space
A. Koulakov [in collaboration with A. Enikolopov 
and D. Rinberg, HHMI Janelia Farm]
We analyze the psychophysical responses of human ob-
servers to an ensemble of monomolecular odorants.
Each odorant is characterized by a set of 146 percep-
tual descriptors obtained from a database of odor char-
acter profiles. Each odorant is therefore represented by
a point in highly multidimensional sensory space. In
this work, we study the arrangement of odorants in
this perceptual space. We argue that odorants densely
sample a two-dimensional curved surface embedded in
the multidimensional sensory space (Fig. 2). This sur-
face can account for more than half of the variance of
the psychophysical data. We also show that only 12%
of experimental variance cannot be explained by
curved surfaces of substantially small dimensionality
(<10). We suggest that these curved manifolds repre-
sent the relevant spaces sampled by the human olfac-
tory system, thereby providing surrogates for olfactory
sensory space. For the case of two-dimensional approx-
imation, we relate the two parameters on the curved
surface to the physicochemical parameters of odorant
molecules. We show that one of the dimensions is re-
lated to eigenvalues of molecules’ connectivity matrix,
whereas the other is correlated with measures of mol-
ecules’ polarity. We discuss the behavioral significance
of these findings. 
that the majority of axon and dendrite branches formed
are retracted later during the development. In this
study, we computationally analyzed different axonal
and dendritic branching strategies that minimize the
number of transient branches required to establish the
connectivity with particular precision. We apply these
branching rules to the development of retinotectal
topographic connectivity and find that axons and den-
drites have different optimal branching strategies. The
axonal optimal strategy is to form new branches in the
vicinity of existing synapses, whereas the optimal rule
for dendrites is to form new branches preferentially in
the vicinity of synapses with correlated pre- and post-
synaptic electric activity. We show that experimentally
observed different reactions to the NMDA (N-methyl-
D-aspartate) receptor block in the dynamics of axonal
and dendritic branching implies that these two branch-
ing strategies are implemented in the developing brain.
We suggest that the difference in branching strategies
of axons and dendrites could be detected by measuring
the spatial correlations between synapses and branch
points on the developing arbors. We thus predict that
these correlations should be reduced for dendrites but
not for axons under the conditions of NMDA receptor
block.
Figure 1. As the number of retinal cells is progressively decreased
in the model, the projection from retina to the superior colliculus
(SC) of the midbrain deforms until only a part of the target is filled
with axons (top right). The case of ~5% of retinal cells present
corresponds to the phenotype observed in Math5–/– knockout
mice, in which retinal progenitors produce only 5% of the nor-
mal number of neurons. The structure of retinocollicular connec-
tivity observed in these animals is consistent with the results of
the model shown here (top right). This argues strongly in favor of
the mechanism involving competition between axons for space
and trophic factors in the target. Chemical labels alone (Eph re-
ceptors and ephrins) cannot enforce the correct connectivity.
Figure 2. The structure of human olfactory space. The odors
(crosses) cluster around a two-dimensional curved surface in the
perceptual space. The two-dimensional surface exists in a 146
dimensional space of various perceptual descriptors. The param-
eters defining the positions on the surface (X and Y) are related
to the molecule’s chemical composition and hydrophobicity.
Sparse Incomplete Representations: 
A Novel Role for Olfactory Granule Cells
A. Koulakov [in collaboration with D. Rinberg, 
HHMI Janelia Farm]
Mitral cells of the olfactory bulb form sparse represen-
tations of odorants and transmit this information to the
cortex. The olfactory code carried by the mitral cells is
sparser than the inputs they receive. In this study, we
analyzed the mechanisms and functional significance
of sparse olfactory codes. We consider a model of the
olfactory bulb containing populations of excitatory mi-
tral and inhibitory granule cells. We argue that sparse
codes may emerge as a result of self organization in the
network leading to the precise balance between mitral
cells’ excitatory inputs and inhibition provided by the
granule cells. We propose a novel role for the olfactory
granule cells. We show that these cells can build repre-
sentations of odorant stimuli that are not fully accurate.
Due to the incompleteness in granule cell representa-
tion, the exact excitation-inhibition balance is only es-
tablished by some mitral cells leading to sparse
responses. Our model suggests a functional significance
of the dendrodendritic synapses that mediate interac-
tions between mitral and granule cells. The model ac-
counts for the sparse olfactory code in the steady state
and predicts that transient dynamics may be less sparse.
Disposable Tissue Hypothesis: A New Model
for Hippocampal Neurogenesis
A. Koulakov [in collaboration with G. Enikolopov 
and J. Encinas, Cold Spring Harbor Laboratory] 
New neurons are continuously generated throughout
the life of an animal in at least two areas of the mam-
malian brain: olfactory bulb and hippocampal dentate
gyrus. Hippocampal neurogenesis dynamically responds
to a multitude of extrinsic stimuli and may be important
for behavior, pathophysiology, brain repair, and the re-
sponse to drugs that modulate mood. New neurons are
produced from a limited population of stem cells whose
number declines with age. What factors determine the
rate of decline in the hippocampal stem cell population?
How can the rate of production of new neurons be var-
ied? In this study, we have shown that soon after a stem
cell is used for production of new neurons, it becomes
an astrocyte, i.e., leaves the pool of neuroprogenitors.
Therefore, one can think of the stem cells as disposable:
Once they are used, they cannot be reused again. The
decline in the number of stem cells therefore occurs in
a use-dependent manner. Does this mean that the more
neurons produced, the faster the stem cells are lost? Not
necessarily. The sequence of transformations that a cell
must undergo before if becomes a new neuron is very
complex. One of the steps involves an intermediate form
of neuroprogenitors that are called amplifying cells.
These cells divide rapidly, about once per day, to make
more neurons. It turns out that antidepressant drugs,
such as Prozac, affect the divisions of the intermediate
amplifying cells without much impact on primary (dis-
posable) stem cells. Together with the experimental
group of Grisha Enikolopov at CSHL, we have devel-
oped a computational model for the division/differen-
tiation cascade that leads to the production of new
neurons. Comparing the computational model to ex-
perimental results leads to detailed information about
the changes occurring in the neurogenesis cascade due
to antidepressant drugs, aging, and other therapies. Our
approach will provide unique insights to the computa-
tional properties of the neural stem cells and their im-
portance for mental health. 
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Research in my laboratory is directed toward under-
standing the synaptic mechanisms of psychiatric disor-
ders. Synaptic plasticity is believed to serve as the
cellular mechanism for learning and memory, and im-
pairments in this process have been linked to psychi-
atric disorders, including schizophrenia and depression.
We use rodent models of psychiatric disorders, as well
as a number of complementary methodologies, includ-
ing behavioral assays, electrophysiology, two-photon
imaging, in vivo circuit tracing, electrical deep-brain
stimulation, molecular genetics, and optogenetic tech-
niques to address questions in three major areas: (1) the
synaptic mechanisms of depression, (2) the synaptic
mechanisms underlying normal adaptive behaviors,
such as resilience to depression or behavioral flexibility,
and (3) the synaptic mechanisms of schizophrenia. 
The Synaptic Circuitry of the Lateral
Habenula and Behavioral Depression
The neural basis of mood disorders is poorly understood.
As a consequence, efforts to develop novel and more ef-
fective therapies for depression have largely been unsuc-
cessful. Recent studies indicate that neurons in the lateral
habenula (LHb) signal “disappointment” and may have
an important role in depression; however, the mecha-
nisms by which the LHb contributes to depression are
unknown. We will be testing the hypothesis that aberrant
activity in the synaptic circuitry of the LHb underlies be-
havioral depression and that normalization of LHb neu-
ronal activity is integral to the efficacy of antidepression
treatments. The overall goal of this project is to gain a
better understanding of the cellular changes responsible
for the pathogenesis of depression. Using animal models
of depression, we will assess aberrant neuronal activity in
the LHb and determine its underlying synaptic mecha-
nisms. Furthermore, by selectively manipulating the ac-
tivity of LHb neurons and determining the behavioral
outcomes, we will be able to test the causal relationship
between aberrant LHb neuronal activity and behavioral
depression. Importantly, this research program will result
FUNCTION AND PLASTICITY OF CENTRAL SYNAPSES IN ANIMAL
MODELS OF PSYCHIATRIC DISORDERS
B. Li S. Ahrens
S. Liu
Z. Perova
in the development of methods that allow the modula-
tion of depression-like behavior in animals.
Depression and Resilience: The Role of the
Medial Prefrontal Cortex 
We will be testing the hypothesis that normal synaptic
plasticity in neurons of the medial prefrontal cortex
(mPFC) has an important role in behavioral flexibility
and resilience to depression, whereas its impairments lead
to behavioral depression. The mPFC has been implicated
in executive function and behavioral flexibility. Recent
studies suggest that mPFC is critical in the determination
of whether an organism has control over a stressor. Rats
with inactivated mPFC are prone to behavioral depres-
sion induced by stressors (Amat et al., Nat Neurosci 8,
365–371 [2005]). Aberrant activity of the mPFC also ac-
companies clinical depression, and deep-brain stimula-
tion in mPFC leads to remission of treatment-resistant
depression (Mayberg et al., Neuron 45, 651–660 [2005]).
However, the cellular processes in mPFC accompanying
behavioral depression are not clear. The cellular mecha-
nisms in mPFC that underlie controllability, therefore af-
fording resilience to behavioral depression, are also
unknown. In this research project, we will determine the
causal relationship between plastic changes in the gluta-
matergic synapses onto mPFC neurons and an animal’s
susceptibility or resilience to behavioral depression. 
The mPFC and LHb are synaptically connected and
belong to a synaptic circuitry strongly implicated in de-
pression. The first and second projects are integral com-
ponents of a synergistic effort aimed for a more
complete understanding of the synaptic and circuitry
mechanisms underlying depression. 
Genetic Deficiency, NMDAR 
Hypofunction, and Schizophrenia 
In this project, we are studying the genetic causes of N-
methyl-D-aspartate  receptor (NMDAR) hypofunction,
136
Neuroscience     137
two-photon imaging, and cutting-edge molecular ge-
netic technology, we will be able to directly test the
causal links among genetic deficiency, neurodevelop-
ment deficits, and NMDAR hypofunction, major ef-
fectors believed to contribute to the pathophysiology
of schizophrenia.
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a pathological process believed to contribute to the eti-
ology of schizophrenia. We will first focus on ErbB4, a
gene with polymorphisms and mutations associated
with schizophrenia. The central hypothesis to be tested
is that ErbB4 controls glutamatergic synapse develop-
ment and plasticity in GABAergic inhibitory interneu-
rons. ErbB4 deficiency early in life will lead to
NMDAR hypofunction and impede the recruitment of
GABAergic interneurons into cortical or subcortical
microcircuits. Furthermore, we hypothesize that this
will result in specific circuit dysfunction and aberrant
behavior later in life that are similar to those brought
about by psychotomimetic NMDAR blockade or by
direct NMDAR deficiency. By using a number of com-
plementary techniques including electrophysiology,
Bo Li
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Our basic research philosophy is to combine theoreti-
cal, computational, and experimental approaches for
the study of complex biological systems, with a partic-
ular focus on neurobiological questions. Efforts in our
group fall into three main areas: informatics, theory,
and experimental work. 
Our neuroinformatics research involves the applica-
tion of analytical tools to large volumes of neurobiolog-
ical data, as well as the development of informatics
infrastructures for data and knowledge integration. Our
study in the area of theoretical engineering applies the-
ories developed in human-engineered systems to study
the theoretical principles underlying biological systems.
The final area of our research is experimental and has
previously consisted of collaborative studies in multiple
species including Drosophila, zebra finch, macaque mon-
key, and human infants. We have now started a major
in-house experimental project to generate the first brain-
wide mesoscale connectivity map in the mouse.
Continuing in our laboratory in 2009 were Peter
Andrews (scientific informatics manager), Jayant
Kulkarni (postdoctoral fellow), Vadim Pinskiy (gradu-
ate student), Dan Valente (postdoctoral fellow), Haibin
Wang (postdoctoral fellow), and Caizhi Wu (postdoc-
toral fellow). Hilary Cox (Research Associate), Pascal
Grange (postdoctoral fellow), and Jamie Jones (Labo-
ratory Technician) joined us this past year, and Jason
Bohland left our lab to become an assistant professor
at Boston University. 
We also have close collaborative ties with multiple re-
search groups at CSHL and other institutions, which
currently include Dr. Nicholas D. Schiff at the Weill
Medical College of Cornell University, where Dr. Mitra
is an adjunct associate professor; a consortium of zebra
finch researchers; Josh Dubnau at CSHL with whom we
perform an integrative analysis of memory formation in
Drosophila; the Brain Architecture Project, with collabo-
rators at multiple institutions, notably, Harvey Karten
(University of California, San Diego) and Michael
Hawrylycz at the Allen Institute of Brain Research; and
a collaboration with Gregory Hannon at CSHL on im-
proving next-generation sequencing technologies. 
INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra P. Andrews J. Jones D. Valente
H. Cox J. Kulkarni H. Wang
P. Grange V. Pinskiy C. Wu
The Brain Architecture Project
H. Cox, V. Pinskiy, C. Wu, P. Grange, H. Wang, J. Jones
In a famous article in the early 1990s, Francis Crick and
Ted Jones bemoaned “the backwardness of human neu-
roanatomy.” After almost a century of modern neuro-
science and the Decade of the Brain, we still know
shockingly little about how our own brains are con-
nected. We have set out to address this problem in the
Brain Architecture Project, starting with the mouse and
ultimately working toward the human brain.
The problem we address is fundamental. Brain func-
tion is dictated by its circuitry, but currently, we know
comparatively little about how the mammalian brain is
connected: Only 10% of all mesoscale connections in
the most-studied mammal (rat) have been cataloged
and only perhaps one-third have been probed at all. 
In a position paper published in PLoS Computational
Biology in 2009, we proposed a large-scale project to de-
termine the brain-wide interregional connectivity matrix
of the mouse brain at a mesoscopic resolution (see Fig.
1). To execute these plans, we have successfully obtained
two National Institutes of Health (NIH) grants this year
(a Transformative-R01 an RC1 Challenge Grant). 
A high-throughput pipeline has been developed to
process tissue from tracer-injected mice through to
image analysis. For each injected location, after 3–21
days of tracer transport, the whole brain is sectioned
and imaged using an automated microscope system.
The software components of the pipeline take these
stacks of digitized microscopy images and perform seg-
mentation and three-dimensional reconstruction to re-
constitute the three-dimensional brain. This brain
volume is then registered with the Allen Reference Atlas
(ARA) in a series of steps. These registrations allow us
to determine for each tracer injection where the injected
area projects to and from. By combining the data from
across the full cohort of 200–400 injection sites, a com-
plete wiring diagram can be generated.
Although the total amount of data generated by the
project is expected to be large (terabytes to petabytes), we
expect that the principal challenges will be in terms of
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das of at least eight of the 20 NIH institutes. Generating
the first unbiased, brain-wide connectivity map in the
mouse brain will have broad neuroscientific implica-
tions. The study of neural development, associative and
integrative brain function, and brain evolution will ben-
efit tremendously from finally having the data necessary
to meaningfully constrain theories. We also propose to
demonstrate the disease-model utility of this approach
in order to hasten its widespread adoption. We have
chosen autism and schizophrenia because they are
among the most heritable, prevalent, and devastating
neuropsychiatric disorders afflicting humanity.
software to enable suitable compression schemes to per-
mit effective transmission through the Internet (which
remains a low-bandwidth medium), as well as suitable vi-
sualization and search tools. The Allen Institute has ex-
tensive experience in this domain, and Dr. Mitra has
established a collaborative relationship with Dr. Mike
Hawrylycz at the Allen Institute. He will work with the
advice of Dr. Hawrylycz to ensure that the informatics
infrastructure works across time in the manner specified.
The availability of public data sets and open source
duplicatable pipeline technologies will potentially im-
pact the entire neuroscience community and the agen-
Figure 1. Stages of the proposed pipeline for the “connectivity scanner.” The images indicate the major experi-
Figure 2. Automated registration of reconstructed section data to ARA. (A) Stacked outer contours of reconstructed
sections. (B) Affine registration with outer contours of ARA using Hausdorff distance measure. (C) Two-dimensional
deformable B-spline registration of ARA to a two-dimensional section, showing cortical parcellation (left). Tracer
labeled cells (arrows) are localized within the primary motor cortex. (D) Nissl labeling registered to ARA with
overlay of expression of the LOC4332228 expression pattern, highly expressed in Layer 4, demonstrating integra-
tion with the Allen Brain Atlas. 
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We are additionally developing a novel technique for
assaying long-range connectivity in the human brain
and are pursuing the aims of mining and integrating in-
formation about brain connectivity from the research
literature using computational linguistics techniques.
Through this project, Cold Spring Harbor Labora-
tory has become a leading center for filling the critical
knowledge gap urged by Dr. Crick, and championed
by Jim Watson.
For more information, see the Brain Architecture
Project website: http://brainarchitecture.org.
Gene Expression in the Mouse
P. Grange 
We continue our collaboration with the Allen Institute
of Brain Science with a project to leverage the genome-
scale high-resolution expression maps created within
the Allen Brain Atlas (ABA) to study coexpression pat-
terns of genes implicated in addiction and related phe-
notypes. Pascal Grange has just joined Dr. Mitra’s lab
as a postdoctoral fellow and will be working closely
with the Allen Institute. Pascal was previously working
on string theory at the Institute for Advanced Study at
Princeton and will be analyzing the Allen Institute data
set of genes expressed in the mouse brain, using ad-
vanced statistical methods.
Toward an Integrative Model 
of Memory in Drosophila
D. Valente
In 2009, Dr. Mitra’s professorship supported a project
aimed toward an integrative model of memory forma-
tion in Drosophila (postdoctoral fellow: Dan Valente).
During the past year, we have continued our behavioral
studies of flies in a flight simulator, an assay that will
allow us to dynamically probe the learning process at
all levels of biological organization in a single animal.
Dr. Valente has made significant improvements to the
training protocol and has performed a series of experi-
ments aimed at understanding the range of system pa-
rameters required to observe learning in this setup. A
precise description of these parameters has been essen-
tial in generating hypotheses regarding fly nervous sys-
tem mechanisms. Dr. Valente has also begun work on
a predictive model for flight behavior. This model will
allow us to better match the virtual flight experience to
a real flight experience and maximize the ability of flies
to form associative memories. The success of this proj-
ect will establish a single-fly visual learning assay for use
by all the fly labs at CSHL and will provide the
Drosophila learning community with a more detailed
description of the dynamics of the learning process.
We also continued our collaboration with Josh Dub-
nau’s lab on an experimental evolution study of epista-
tic gene interactions in Drosophila. Our role has been
the analysis of genotypic results at two generations of
the selective breeding. We have developed a method
that uses multivariate analysis and machine learning
techniques to predict alleles responsible for the pheno-
typic difference between selected and unselected
groups. These predictions were then experimentally ver-
ified in the Dubnau lab. This work is being prepared
for publication. 
Advanced Algorithms for Genetic 
Sequence Analysis
D. Valente [in collaboration with the Hannon lab, Cold
Spring Harbor Laboratory]
This project sought to improve the base-calling proce-
dure for Illumina genome analyzers to obtain more ac-
curate and longer sequence reads. Such an improvement
would boost overall output per run, increase genomic
coverage, and improve the ability to detect sequence
variants. Longer reads also increase mapping precision
and may even enable de novo genome assembly.
We are currently working on a method to improve
base calling in the next-generation sequencing platform
from Illumina. This started as a collaborative project
with Greg Hannon’s lab at CSHL. We have extended
our previously published random-walk model which de-
scribes phasing and fading errors to include cross-talk
errors during the sequencing process. Dr. Valente is cur-
rently writing a base caller using this extended model,
which is expected to be a vast improvement over current
base-calling techniques. The algorithm is near comple-
tion and the work is being prepared for publication.
Integrative Study of Zebra Finch 
Vocal Development
H. Wang
Our principal goals for this study are to provide the infor-
matics infrastructure for data management and mining,
to develop signal processing algorithms, and to analyze
experimental data from collaborating laboratories.
We proposed a theoretical framework to understand
how the song culture evolves, through interactions
among phenotype, genotype, and environment. Our
models illustrate that the song culture results from an
extended developmental process, a “multigenerational”
phenotype partly genetically encoded in an isolated
founding population and partly in environmental vari-
ables, but taking multiple generations to emerge.
The publication this year of a manuscript in Nature,
“De novo emergence of song culture in the zebra
finch,” is the culmination of several years of collabora-
tive work with Ofer Tchernichovski’s lab at City Col-
lege of New York. This research dealt with the complex
interrelationship among nature, nurture, and culture in
the tractable animal model provided by the song system
in the zebra finch. Songbirds exhibit social learning of
song vocalizations, and song culture provides a labora-
tory-like microcosm with salient similarities to human
culture. Birdsong research has traditionally focused on
the learning of a song by the juvenile from adults, but
this research deprecates the origin of the adult cultured
song. 
It has long been realized that a dimensionally accu-
rate and detailed atlas of the zebra finch brain is an es-
sential tool. Recent progress in neuroanatomical
research has made such a digital atlas possible, driven
by the availability of automated scanning microscopes
and the ability to store and analyze tera/petabyte-scale
data sets. Through a collaboration with Harvey Karten
at the University of California, San Diego, we have ob-
tained high-resolution images of Nissl and myelin-
stained zebra finch brain sections, which are available
at www.zebrafinch.org/atlas as part of our informatics
infrastructure for zebra finch birdsong study.
Meetings/Training/Education
P. Mitra
The first meeting for the Mouse Brain Architecture
Project (MBAP) was held December 1, 2009 at Cold
Spring Harbor Laboratory. The meeting was attended
by 45 individuals, including project staff, collaborators,
scientists conducting related research, representatives
from relevant vendors, and representatives from the
NIMH (National Institute of Mental Health). MBAP
staff members introduced the project, described ad-
vancements made in terms of tissue sectioning proto-
cols, and sought expert opinions from meeting
attendees on the experimental choices that will be made
within the pilot phase of the project. Meeting attendees
also gave short presentations describing related neu-
roanatomy projects in mouse and other species and
about issues related to microscopy and informatics. Fi-
nally, there was a discussion about the development of
an upcoming CSHL summer course in modern neu-
roanatomy, and an art exhibit featuring sculptor Fré
Ilgen’s rendition of the nervous system.
Jason Bohland completed his postdoctoral fellow-
ship in my laboratory and has earned a faculty position
at Boston University to continue our work as collabo-
rators.
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What causes autism and schizophrenia? It is well estab-
lished that both psychiatric disorders are highly heritable
and human geneticists are uncovering the underlying sus-
ceptibility genes. The growing wealth of genetic knowl-
edge, however, does not guarantee rapid progress in
understanding what causes autism and schizophrenia at
the level of neural circuits. In fact, even though it is gen-
erally believed that these disorders are caused by subtle
disruptions in brain circuits, our understanding of which
particular circuits are affected is rudimentary at best. 
Our research focuses on the study of neural circuits
in genetic mouse models of autism and schizophrenia.
We have established a novel high-throughput mi-
croscopy method, which enables us to rapidly map
mouse brain circuits at cellular resolution. We are now
applying this method to systematically compare brain
circuits in different genetic mouse models, with the aim
to begin mapping the causal relationship: Genome→
neural endophenotype→disease manifestation. The exper-
imental questions we ask are:
1.  What neural circuit deficits are linked to specific ge-
netic mutations? This research is done by comparing
neural circuits between mutant mice and wild-type
littermates, with the aim of identifying gene-specific
neural endophenotypes. 
NEURAL ENDOPHENOTYPES IN MOUSE MODELS
OF AUTISM AND SCHIZOPHRENIA
P. Osten Y. Bao N. Takada
L. Kadiri J. Taranda
2.  How can many genetic variants result in a similar
disease manifestation? This research is done by com-
paring different genetic mouse models, with the aim
of identifying shared “core” neural circuit endophe-
notypes. 
Our work uses whole-mount microscopy, transgenic
reporter mice, anatomical tracing, and electrophysiol-
ogy. Below we describe our progress in these areas.
Whole-mount Microscopy
Two-photon microscopy for automated whole-mount
imaging is a key part of our experimental approach (Fig.
1). The microscope, built in a collaboration with Tis-
sueVision Inc. (Cambridge), works as follows: (1) A
fixed mouse brain is placed on a motorized stage, which
moves it in x-y direction so that the top view is imaged
as a mosaic. (2) The stage moves the brain toward a
built-in vibratome, which cuts off the imaged section.
(3) The cycles of mosaic imaging and sectioning are re-
peated. Once all data are collected, image-processing
and brain-morphing software are used to assemble the
brain sections and align them to a virtual brain atlas for
data analysis (Fig. 2). 
Figure 1. Schema and the actual instrument. The x-y-z stage moves the brain under the objective, so that the top
view is imaged as a mosaic. The stage also delivers the brain to the vibratome for sectioning.
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of neural circuits in the mouse offspring after pharma-
cological activation of specific brain circuits by neuro-
transmitter agonists and antagonists (Fig. 4). We have
initiated work on three mouse models of autism: the
16p11.2 deletion and duplication mice generated by our
collaborator Alea Mills at CSHL and neuroligin R451C
mice generated by Tom Südhof’s group (Stanford). We
first focus on analysis of the balance between excitation
and inhibition (E/I) in the brain, testing a hypothesis
that autism susceptibility genes cause E/I disbalance dur-
ing development. We reason that such E/I disbalance
may not only increase the risk of seizures as observed in
autistic children, but also cause more subtle circuit dis-
ruptions contributing to autistic behavior. 
Anatomical Tracing and Electrophysiology
The work described above aims to identify brain areas
and circuits disrupted in different genetic mouse mod-
els of autism and schizophrenia. Once such regions are
found, our next step is to use anatomical tracing and
electrophysiological recording to examine in detail the
anatomical and cellular changes underlying the circuit
deficits. Anatomical tracings are done using traditional
tracers, such as cholera toxin B for retrograde tracing,
and virus vector-based mapping of anterograde axon
pathways. Electrophysiological recordings are done in
vitro in acute brain sections and in vivo by whole-cell
recording in anesthetized mice.
Summary
As our work progresses, we believe that we will be able
to begin to “connect the dots” between whole-brain
screening of neural circuits and anatomical and electro-
physiological analyses of the relevant pathways and
Transgenic Reporter Mice
To map brain circuits by whole-mount microscopy, we
use transgenic reporter mice expressing GFP from pro-
moters of immediate-early genes (IEGs), such as c-fos
and Arc. Because IEG expression is regulated in the
brain by neural activity, these reporter mice enable us to
monitor IEG expression and by extension neural circuit
activity by simple visualization of fluorescent labeling of
GFP-positive cells (Fig. 3). Our approach to use this
method to screen brain circuits in mouse models of
autism and schizophrenia involves breeding selected ge-
netic mouse models with the reporter mice and analysis
Figure 2. Mouse brain imaged by whole-
mount microscopy. Transgenic green flu-
orescent protein (GFP)-expressing mouse
brain was imaged rostrocaudally in 130
sections. The single sections were then re-
aligned in a three-dimensional volume, as
shown on the right. The total imaging time
was 5 h 49 min.
Figure 3. IEG-based visualization of activated neural circuits in the
c-fos–GFP reporter mouse. Clear GFP labeling is seen in activated
neurons in the striatum (A) and lateral septum (B) after injection
of an antipsychotic drug haloperidol (A–B), but not in saline-
treated control mice (C–D). Bars: (A) 200 µm, (inset) 50 µm.
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brain areas. We expect that this work will provide a
deeper understanding of neural endophenotypes un-
derlying autism and schizophrenia in humans. Impor-
tantly, we hope that our work will also lead to
translational opportunities: If our approach allows us
to discover signatures of neuropsychiatric disorders in
the mouse brain, then it can also be used to search for
treatments by screening for drugs that eliminate the ab-
normality and restore normal activity.
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Figure 4. Experimental pipeline. Autism mouse models are bred with IEG-indicator mice and neurotransmitter ag-
onists, and antagonists are used to activate specific brain circuits in the mouse offspring. Behavior (overall activity,
seizure induction) is monitored to evaluate the relationship: drug dose→behavioral effect→brain circuit activa-
tion.
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Figure 1. Detection of 16p11.2 microduplications by MeZOD.
The major focus of our laboratory is to identify genetic
causes of mental illness using a successful approach that
we pioneered: high-resolution analysis of rare copy-
number variants (CNVs) in the human genome. We
have developed an experimental design that allows us
to identify rare mutations that confer high risk for dis-
ease. Our approach is to screen the genomes of patients
with schizophrenia and bipolar disorder to identify
deletions and duplications of the DNA that disrupt
genes. These mutations are subsequently tested for as-
sociation with disease in families and in large samples
of patients and healthy individuals. This approach is
based in part on the findings of our previous genetic
studies of autism spectrum disorders (ASDs), which es-
tablished an important role for rare spontaneously oc-
curring CNVs in the etiology of ASDs. With support
from the Stanley Foundation, we have now successfully
applied this approach to studies of schizophrenia and
bipolar disorder, and our work has already had a signif-
icant impact on the field. Our findings, coupled with
studies by other groups, have shown that rare CNVs
have an important role in the genetics of psychiatric
disorders. Furthermore, we have shown that a substan-
tial number of the risk variants detected in the DNA
of patients are not inherited from a mother or father
but instead occur by spontaneous mutation. Most in-
dividual CNVs that have been definitively identified to
date increase risk of mental illness by ≥10-fold, strongly
suggesting that these mutations have a causal role. 
Analysis of Copy-number Variation
in Schizophrenia
V. Vacic, S. McCarthy
Studies by our group and others have demonstrated
that individually rare structural variants contribute to
risk of schizophrenia (SZ) and other neurocognitive
disorders.  Multiple studies have now shown that the
mutational burden of rare structural variants is signif-
icantly greater in patients with SZ than in healthy con-
RARE STRUCTURAL VARIATION IN THE GENOME
AND ITS ROLE IN HUMAN DISEASE 
J. Sebat M. Kusenda V. Vacic
D. Malhotra K. Ye
S. McCarthy S. Yoon
trols. In addition, specific loci have been identified
where structural mutations are significantly associated
with SZ. For example, large deletions at 1q21.1,
15q13.3,  and 22q11.2 have been shown to confer sub-
stantial risk of SZ. A recent study by our group has
found that microduplications of 16p11.2 are signifi-
cantly associated with SZ (Fig. 1, Table 1; see McCarthy
et al. 2009). The SZ-associated regions described here
confer significant risk. For instance, the observed odds
ratios for the microduplication of 16p11.2 range from
8.3 to 25.8.
These findings suggest that rare structural variants
have a role in the etiology of SZ. Furthermore, evidence
suggests that little of the overall contribution of rare
CNVs to SZ can be explained by the handful of loci
described above (Sebat et al. 2009). We hypothesize
that genetic risk of SZ consists in part of rare variants,
and these risk alleles involve many different genes.
Analysis of structural variation in larger samples is re-
quired to definitively identify novel CNV risk factors. 
In an effort to identify novel CNV risk factors in
SZ, we have recently carried out a two-stage study of
copy number variation, using a primary sample of 742
cases and 856 controls scanned in the Nimblegen HD2
platform, and using as a replication data set CNV calls
made from the GAIN and MGS studies of SZ and the
International Schizophrenia Consortium (ISC). The
replication sample consisted of 7488 cases and 6689
controls, bringing the combined sample size to 8230
cases and 7545 controls.
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Investigating the Role of Rare CNVs
in Bipolar Disorder
D. Malhotra
Our research in bipolar disorder (BD) aims to make a
significant contribution to the field in two ways: by im-
proving the scientific understanding of BD through ge-
netic studies and by creating a novel genomic resource
for geneticists. To these ends, we have initiated a genetic
study, the genetics of early-onset mania (GEM).  The
goals of our genetic study of bipolar disorder are (1) to
perform genome-wide analysis of copy-number varia-
tion in bipolar families, (2) to assess the overall contri-
bution of de novo and inherited mutations in sporadic
and familial BD, and (3) to identify novel candidate
genes for further study.
Central to this study is the recruitment of new bipo-
lar families who will form the GEM family collection.
GEM is unique from other family collections in that a
significant fraction of patients are “sporadic” cases and
a significant fraction of patients have an early age at
onset. (AAO < 18). This new collection will be made
available to the scientific community where we antici-
pate it will become a valuable resource for researchers
who are interested in investigating genetic and epige-
netic causes of bipolar disorder.
We have completed a preliminary analysis of data from
our genetic study of BD (described in this report), and
these data showed that rare structural variants, including
de novo mutations and inherited CNVs, contribute to
BD. We have performed an analysis of de novo CNVs in
families and observed a higher rate of de novo mutation
In the first stage, we screened the primary sample for
CNVs that are present in multiple cases and not present
in a sample of matched controls. After eliminating
CNVs that were less than 100 kb in size and CNVs that
did not impact genes, we identified a total of 66 unique
target loci. To measure statistical association in the
replication sample, we tested the difference in locus-
based mutational burden between cases and controls
using a Fisher’s exact conditional test. In this study, all
of the previously identified loci described above showed
a statistically significant association (data not shown).
In addition, duplications at a single 7q36.3 region was
significantly associated with SZ after correction for the
66 loci tested (α = 0.0008). 
The 7q36.3 region represents a novel locus that
confers significant risk of SZ. This finding serves to
highlight novel genes within the region. One of par-
ticular interest is the vasointestinal peptide receptor 2
(VIPR2). VIPR2 is a class II G-protein-coupled recep-
tor that is activated by both vasoactive intestinal pep-
tide (VIP) and pituitary-adenylyl-cyclase-activating
polypeptide (PACAP). VIP and PACAP have been
shown to have wide pharamacological effects and bio-
logical functions. Notably, PACAP is involved in pain-
related behavior, psychomotor functioning, and
memory performance. PACAP-deficient mice display
increased locomotor, exploratory and explosive jump-
ing activity, and a deficit in prepulse inhibition of the
acoustic startle response, all of which are attenuated by
risperidone. In addition, within the superchiasmatic
nucleus, VIPR2 is required for maintenance of normal
circadian rhythms.
Table 2. Significant Association of 7q36.3 Microduplications with Schizophrenia
Primary sample Replication sample
Locus CNV type cases controls cases controls OR [96% CI] replication P value
7q36.6 duplication 2 0 12 0 INF [3.3, INF] 0.0002
2p16.3/NRXN1 deletion 2 0 14 2 6.4 [p1.7, INF] 0.0022
3q29 duplication 2 0 8 0 INF [2.0, Infinity] 0.0049
Table 1. Duplications and Deletions at 16p11.2 among Persons with Schizophrenia and Controls
Subjects Deletions Duplications
Series Diagnosis (n) n % n % OR (95% CI) P value
Primary schizophrenia 1906 1 0.05 12 0.63 24.8 (3.3, 199) 1.2 x 10–5
controls 3971 3 0.08 1 0.03
Replications schizophrenia 2645 0 0.00 9 0.34 8.4 (1.3, 50.5) 0.022
controls 2420 1 0.04 1 0.04
Combined schizophrenia 4551 1 0.02 21 0.46 14.5 (3.3, 62.0) 4.3 x 10–5
controls 6381 4 0.06 2 0.03
in BD compared to healthy controls. Furthermore, we
observed a higher rate of de novo mutation in sporadic
cases as compared to patients with a family history of
mental illness. These results provide strong preliminary
evidence that de novo CNVs contribute in part to the ge-
netics of BD. A majority of these mutations involve genes,
thus highlighting strong candidate regions for further
study. In addition, we have performed an analysis of rare
inherited CNVs in families. These results provide prelim-
inary evidence for the increased mutational burden of rare
inherited CNVs in BD.
Analysis of Structural Variation
in the 1000 Genomes Project
S. Yoon, K. Ye
The primary goal of this project is to define genome-
wide patterns of structural variation by high-resolution
analysis of CNV using two advanced technologies: mi-
croarray comparative genomic hybridization (CGH)
and next-generation sequencing (NGS). We have a
complete collection of all primary data for the project,
including a total of more than 500 HapMap samples.
We have begun the process of validating CNVs and
genotype calls and have designed a custom Agilent array
containing dense coverage of ~800 common CNVs and
an additional set of rare inherited and de novo CNVs.
Microarray CGH analysis will be performed on
HapMap samples using this custom array to validate
our CNV calls and to better define the breakpoints of
variants identified in this study.
Through our participation in the 1000 genomes
project, we have performed an analysis of structural
variation in whole-genome sequence data on multiple
individuals. For these studies, we developed a novel
method for detection of CNVs based on coverage
depth: event-wise testing (EWT). This call set is cur-
rently being integrated with CNV call sets from multi-
ple groups using complementary approaches. These
results will constitute the first official data release of the
1000 genomes pilot project, which will tentatively be
published in late fall.
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The overarching research goal in our laboratory is to un-
derstand how processing in specific brain circuits works
to support natural communication behaviors. We aim
to reveal neural mechanisms that allow organisms to de-
tect and recognize familiar individuals, to gather infor-
mation about their identity and social status, and to
select appropriate behaviors. Mice are capable of acquir-
ing detailed profiles of one another from the smells and
sounds experienced during their social encounters. These
dossiers may include information on a mouse’s sex, ge-
netic identity, reproductive state, levels of distress or sex-
ual interest, or even recently consumed foods, details that
are indispensable for survival and mating success. Ini-
tially, we are working to understand the neuronal activ-
ities and mechanisms in primary sensory brain areas that
support these forms of communication. In the future,
we anticipate moving deeper into the brain to ascertain
where the sensory data from those regions are collected
and integrated into hormonal and electrical signals that
promote appropriate behavioral choices.
The scientific benefit of this approach is twofold.
First, we want to identify fundamental principles for
how the brain controls complex behavior. To this end,
it is our belief that the nervous system’s function is best
interpreted in the context of the behaviors it was evo-
lutionarily designed to perform. Thus, it is advanta-
geous to use natural behaviors such as intraspecific
communication. Second, impairment of social percep-
tion and cognition is a core feature of autism spectrum
disorder (ASD); for example, patients may have diffi-
culty perceiving and interpreting communication ges-
tures such as speech, facial expressions, and “body
language.” This broad feature is recapitulated in many
mouse models of ASD that carry genetic variants iden-
tified in human ASD populations. Therefore, if we can
ascertain the neural circuit substrates of social behavior
in normal mice, we can make and test predictions for
how the circuitry is affected in the mouse models. The
results are likely to tell us more about the synaptic mod-
ifications that occur in human autism.
The three broad areas of research in our lab concern
(1) olfactory communication and memories for familiar
individuals, (2) examination of vocal (auditory) com-
NEURAL CIRCUITRY FOR SOCIAL COMMUNICATION
S. Shea H. Demmer
munication between mother mice and their pups, and
(3)  recording from neurons in awake behaving animals
to reveal the neural encoding of social cues during a live
encounter with another mouse.
Noradrenaline and Memories for 
Familiar Individuals
How do we remember individuals that we have previ-
ously encountered? Substantial evidence indicates that
many animals remember each other based on olfactory
cues. Memories are especially strong for individuals en-
countered during key life events such as mating with a
new partner or the birth of a litter of young. These im-
portant events typically evoke massive release of the neu-
rochemical noradrenaline (NA), initiating a heightened
state of emotion and arousal. This surge appears to cause
long-lasting modifications to the responses to odorants
in the olfactory bulb, which is the first processing station
for scent in the mammalian brain. Indeed, it was hy-
pothesized that the coincidence of an odor stimulus with
a surge of NA is minimally sufficient to store a memory.
We exploited the intimate relationship between NA, ol-
factory bulb activity, and behavior to create and study
olfactory memories in the anesthetized mouse. We dis-
covered that indeed, when NA release is evoked by stim-
ulating locus coeruleus, the source of most NA, while
the sleeping mouse sniffed an odorant, neural responses
to that odor underwent specific long-term alterations.
Remarkably, once awake, the mouse’s subsequent be-
havior toward the odorant was also changed. In other
words, the mouse seemed to remember the odor and
treat it as though it were familiar.
The ability to induce ethologically relevant memories
under anesthesia opens up exciting possibilities for ob-
serving the synaptic mechanisms underpinning such
memories using advanced techniques that are currently
impossible in behaving animals. For example, we are be-
ginning to use several imaging approaches in genetically
modified mice during memory formation. These exper-
iments will allow us to separately visualize olfactory bulb
input and output as well as wide-scale neuronal popu-
lations to ascertain how and where NA-dependent plas-
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them and they will therefore call out to their mother
with a very high-frequency peep. New mothers develop
sensitivity to these cries and respond by moving toward
their source (phonotaxis) to retrieve the pup. Mothers
will also approach a speaker emitting playback of syn-
thetic calls, providing a simple assay for their perception
of manipulated calls. Such experiments suggest that
there are sharp limits to the types of sounds that will
elicit phonotaxis, possibly implying a neural selectivity
mechanism that creates a perceptual boundary between
pup distress cries and other sounds and vocalizations.
We are using optogenetic techniques to probe inputs to
ultrasound-sensitive neurons and hopefully reveal
synaptic mechanisms for selective responses to distress
calls in the auditory cortex of mothers.
Neural Activity during Social 
Encounters
We are building a setup for recording individual neu-
rons during social encounters and other behavioral as-
says involving the perception of social and nonsocial
information. There are two broad related goals to this
approach. The first goal is to examine the encoding of
social information such as body odors and vocalizations
in primary sensory structures of awake animals. We hy-
pothesize that activity in response to these signals may
be labile to associative learning, attention, and arousal
which we may be able to manipulate in the context of
social encounters. The second goal is to record from
neurons in deep-brain neuromodulatory centers during
these encounters as well. Neurons that release noradren-
aline and dopamine are likely responsive to social sig-
nals and may modulate encoding of sensory data and
associative plasticity. Understanding the context-depen-
dent activity patterns of these neurotransmitters is
therefore critical to developing models for how they af-
fect behavior.
ticity is coordinated and interacts among neuronal pop-
ulations. We are also beginning to use high-resolution
electrophysiological techniques targeted to specific cell
types in order to build a circuit picture of how different
olfactory bulb cell types adapt their firing to result in
long-term changes to circuit output. Finally, in collabo-
ration with CSHL colleagues Bo Li and Florin Albeanu,
we intend to visualize and record the detailed molecular
changes associated with olfactory memories. Most forms
of long-term plasticity at excitatory synapses involve the
redistribution of receptors for the neurotransmitter glu-
tamate into and out of the synapse. This process can be
observed by imaging the movement of receptors tagged
with a fluorescent protein. We will use virus-mediated
gene delivery to express modified receptors in specific
neural populations and then induce olfactory memories
in vivo in anesthetized mice to observe the movement
of these receptors at the synapse to strengthen neuronal
connections that store the memory. This series of exper-
iments, if successful, will provide an unprecedented win-
dow onto the molecular underpinnings of a natural
form of memory as it is forming.
Vocal Communication between 
Mothers and Pups
Far outside the range of our hearing, in the ultrasound
band, mice are constantly holding conversations with
one another in a language that is poorly understood at
best. Many types of vocalizations are emitted by males
and females, juveniles and adults, in a variety of behav-
ioral contexts. We would like to better understand the
perceptual significance of these calls to the mice and
how they are used to guide behavioral choices.
One form of vocalization that is actually reasonably
well understood is the pup distress call. Before acquir-
ing vision and full mobility, young mice will occasion-
ally become separated from the nest. This is stressful for
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The brain has a tremendous capacity to form many
highly accurate memories; it is precisely this facility
that is lost in diseases such as Alzheimer’s and other
dementias. Our overall goal is to understand how
brain areas involved in learning and memory represent
different stimuli with distinct patterns of neural activ-
ity and how these activity patterns are modified by
learning. 
We use the olfactory system of Drosophila as a
model for investigating these questions. Our research
focuses mostly on a brain area involved in learning and
memory known as the mushroom body (MB), which
is analogous to the olfactory cortex in the mammalian
brain. To understand how olfactory information is rep-
resented in the MB, we monitor neural activity using
both electrophysiological and functional imaging tech-
niques. We have found that MB neurons are extremely
odor-selective in their responses. This high selectivity
is a general feature of brain areas involved in learning
and memory, including the hippocampus and cerebel-
lum. Using the simplicity and genetic manipulability
of Drosophila, our goal is to establish how this speci-
ficity arises and how it is maintained in the face of
learning-related changes. The extremely powerful ge-
netic tools in Drosophila enable us to manipulate neu-
ral activity in precisely defined ways that help us to
understand how this circuit functions. For example, by
controlling activity of the neurons immediately presy-
naptic to the MB, we can determine how MB neurons
integrate different inputs and establish how many in-
puts must be active and with what temporal properties
to drive a MB neuron to respond. Using this type of
approach, we are currently evaluating how MB re-
sponse properties arise, and how they are modified by
the action of important neuromodulatory systems. Ad-
ditionally, extensive genetic studies of olfactory learn-
ing and memory have identified many of the genes
involved in learning and memory. One of our goals is
to understand how these molecules affect network-level
activity. 
NEURAL CODING AND MEMORY FORMATION IN THE DROSOPHILA
OLFACTORY SYSTEM
G. Turner R. Campbell T. Hige
E. Gruntman K. Honegger
Population Coding in the Olfactory 
System
R. Campbell, K. Honegger
Our goal is to establish how different stimuli are repre-
sented in distinct patterns of neural activity—how dif-
ferent do two combinatorial patterns of olfactory
receptor neuron (ORN) activity have to be in order to
be recognized as distinct? We are assessing whether they
are distinct by evaluating population-level responses in
MB neurons and by measuring olfactory discrimination
using behavioral assays. These experiments will tell us
what is the smallest unit of activity that makes two ol-
factory stimuli distinct. 
We chose two different types of olfactory stimuli to
evaluate how distinctly they are represented: (1) Of a
panel of 110 monomolecular odor compounds, we
chose the pair of odors that evoked the most similar re-
sponse pattern in the ORNs and (2) we used a blend
of two odors and varied the relative levels of the two,
smoothly morphing the blend from [100%A 0%B] to
[0%A 100%B]. To investigate population-level neu-
ronal responses to these stimuli, we track the activity of
>100 neurons simultaneously using functional imaging
with a genetically encoded calcium indicator. We selec-
tively express this indicator in MB neurons using stan-
dard genetic approaches and use two-photon imaging
to monitor the activity of ~150 MB neurons simulta-
neously. Using multivariate analysis techniques, we have
established how effectively an ideal observer could dis-
criminate different odors based on the activity patterns
in the MB. This gives us a description of how discrim-
inable odors are in terms of neural activity—a “neuro-
metric” curve. We find that the ideal observer can
distinguish both the extremely similar pair of
monomolecular odors and the odor blend at [70:30]
versus [30:70]. 
Although an ideal observer can distinguish these
stimuli, can the fly really achieve this? We have tested
this behaviorally using the standard Pavlovian paradigm
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of stimulating different numbers of presynaptic neurons
and using different stimulation strengths to get an esti-
mate of how many presynaptic neurons must be active
and at what spike rate in order to evoke a spiking re-
sponse in a MB neuron. 
Our second approach is to directly examine the in-
puts to MB neurons, using functional imaging to char-
acterize those inputs where they synapse onto the
dendrites of the MB neurons. Activity of these synapses
leads to calcium influx, which we detect using synthetic
fluorescent calcium indicators. We load these indicators
into an individual neuron via a patch-clamp recording
electrode. By measuring calcium influx at synaptic sites
using two-photon imaging, we can derive an odor tun-
ing curve for individual dendritic inputs while simul-
taneously monitoring the whole cell’s odor response via
the recording electrode at the cell body. This approach
allows us to directly determine whether different den-
dritic sites have different odor tuning properties. It also
enables us to establish whether multiple dendritic sites
must be activated to drive the MB neuron to spike. Ul-
timately, we hope to generate a model that explains how
different dendritic inputs are integrated to give rise to
the whole cell’s odor-tuning properties. 
Neuromodulatory Influences on Olfactory
Information Processing
T. Hige, K. Honegger
Neuromodulatory systems such as dopamine have an im-
portant role in learning and memory. In Drosophila, it is
known that dopamine release is both necessary and suf-
ficient for performance in the standard Pavlovian olfac-
tory conditioning assay. The two leading hypotheses for
the function of dopaminergic inputs are (1) they convey
information about the shock punishment and (2) they
control arousal levels and influence the intensity of the
animal’s sensory responses. At the circuit level, these two
hypotheses make two different predictions. The first hy-
pothesis predicts that dopamine influences synaptic plas-
ticity, either increasing the competence for plasticity to
occur or prolonging short-term plasticity that accompa-
nies neuronal activity. The second hypothesis suggests
that dopamine may control the propagation of sensory
information through the olfactory circuit. We are testing
these two hypotheses by electrophysiologically character-
izing neurons downstream from the MB. We have found
that dopamine can block sensory responses in these
of learned olfactory discrimination in a T maze. We find
that flies are in fact capable of distinguishing the
monomolecular pair of odors. They are also capable of
distinguishing the [70:30] versus [30:70] blends, al-
though their performance is lower, indicating that it is
a more difficult discrimination. By evaluating finer gra-
dations in the blend odor, we plan to identify the point
in the psychometric function where two blend odors are
just barely distinguishable. By evaluating the MB odor
responses at this point, we will be able to determine the
pattern of activity that makes two odors just detectably
different from each other. This will establish the smallest
unit of activity that distinguishes two olfactory stimuli,
a fundamental quantity for understanding how olfactory
stimuli are represented in neural activity. 
Combinatorial Coding of Olfactory 
Information
E. Gruntman, K. Honegger, G. Turner
The brain has a limited number of sensory inputs, which
must be used combinatorially to endow the brain with
its immense representational capacity. This is particularly
true in olfactory system: It has been estimated that hu-
mans can recognize 10,000 different odors even though
we only have ~300 different ORNs. Odors elicit re-
sponses in multiple neuron types at the first two layers of
the olfactory system, consistent with the combinatorial
coding hypothesis. However, for a combinatorial code to
be meaningful, there must be downstream neurons that
respond selectively to particular combinatorial patterns
of input activity. Anatomical evidence suggests that the
neurons at the third layer, i.e., the MB, are the neurons
that integrate combinatorial information. MB neurons
exhibit extremely odor-specific responses. We hypothesize
that this selectivity arises because MB neurons receive and
require multiple different inputs to be active in order for
a MB neuron to exhibit a spiking response.
We are testing this hypothesis in two ways. First, we
are using the light-activated ion channel channel-
rhodopsin to stimulate specific second-order neurons
(projection neurons or PNs) while recording synaptic
responses in MB cells. By determining the frequency of
a synaptic connection between the stimulated PNs and
the MB population, we have derived an estimate of the
connectivity across these layers. These experiments in-
dicate that MB neurons likely receive inputs from about
five PNs on average. We are currently testing the effects
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downstream neurons. This suggests that dopamine con-
trols signal propagation through the MB, and dopamine
release can close the gate of information flow, consistent
with the second hypothesis above. We are directly testing
this possibility by examining signal propagation within
the MB using imaging techniques. This model suggests
that the salience of a sensory stimulus can be controlled
by regulating signal propagation within the brain, po-
tentially providing a mechanistic cellular underpinning
that contributes to the fundamental cognitive process of
attention. 
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Glenn Turner
My laboratory is interested in how neural circuits un-
derlie normal processing and attention in the auditory
cortex, and how this processing is disrupted in cogni-
tive disorders such as autism. To address these ques-
tions, we use a combination of computational,
electrophysiological, and imaging techniques at the
molecular, synaptic, cellular, circuit, and behavioral
levels.
Disruption of Auditory Cortical Circuits 
by Autism Candidate Genes
T. Hromadka, Q. Xiong
Autism is a highly heritable disorder thought to arise
through disruption of neural circuits. Many candidate
genes have been implicated, but how these genes lead
to the autistic phenotype remains unclear. We hypoth-
esize that the circuit defect underlying autism involves
an imbalance between excitatory and inhibitory neural
activity. To test this hypothesis, we are using in vitro
and in vivo methods to assess circuit dysfunction in the
auditory cortex. Previous work from my laboratory has
shown that excitation and inhibition are exquisitely bal-
anced in the auditory cortex, and so this assay should
be a very sensitive measure of disruption in animal
models in which autism candidate genes have been dis-
rupted. We are currently using several mouse models of
autism, including MeCP2, PTEN, and neuroligin, to
test this hypothesis. 
At the in vitro level, we are using adeno-associated
virus (AAV) to express channelrhodopsin-2 (ChR2, a
light-activated cation channel) in the axons of neurons
which project to the auditory cortex. We then use
whole-cell patch-clamp recording in acute auditory cor-
tex brain slices to compare the light-evoked response
properties between wild-type neurons/mice and autistic
neurons/mice.
NEURAL CIRCUITRY OF UNDERLYING NORMAL AND ABNORMAL
PROCESSING IN THE CORTEX 
A. Zador K. Borges G. Otazu Q. Xiong
T. Hromadka H. Oviedo Y. Yang
S. Jaramillo H. Oyibo P. Znamenskiy
S. Koh A. Reid
Cholinergic Modulation 
of Auditory Responses
T. Hromadka [in collaboration with S. Ranade and
A. Kepecs, Cold Spring Harbor Laboratory]
The cholinergic neuromodulatory system originating
from nucleus basalis has been implicated in many in-
teresting brain functions, such as attention and cortical
plasticity. Traditional methods of studying cholinergic
modulation of neuronal activity usually either have
rather poor spatial resolution, as direct stimulation of
nucleus basalis leads to a diffuse modulation of cortical
activity in the entire brain, or provide imprecise tem-
poral control in case of direct acetylcholine application
into a specific cortical area.
We are using optogenetic techniques with extra/in-
tracellular recordings to study cholinergic modulation of
sensory processing in the auditory cortex of mice. Spa-
tiotemporal precision of acetylcholine release is provided
by selectively expressing ChR2 in nucleus basalis neurons
projecting to auditory cortex. We record sound-evoked
responses of single neurons while selectively modulating
neuronal activity “on-demand” by shining brief pulses
of blue light onto the cortical surface, which selectively
releases acetylcholine from axons of cholinergic neurons
projecting from the nucleus basalis.
Effect of Engaging in an Auditory Task
on Responses in Auditory Cortex 
G. Otazu, Y. Yang
Although systems involved in attentional selection have
been studied extensively, much less is known about
nonselective systems. To study these preparatory mech-
anisms, we have compared activity in the auditory cor-
tex elicited by sounds while rats performed an auditory
task (“engaged”) with those elicited by identical stimuli
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for a number of reasons. For example, expression can
be highly dependent on where the transgene is located
in the genome. 
We have developed a novel approach for transgene
expression. Our transgenic constructs comprise a gene
of interest followed by a promoter, with flanking lox
sites. In this configuration, the transgene will not be ex-
pressed, as it precedes the promoter. However, one can
then introduce Cre recombinase, either with viral ex-
pression of Cre or by crossing these mice with a separate
Cre line. In the presence of Cre, the transgene-pro-
moter segment will be excised from the chromosome
and form a circular, plasmid-like construct. Because the
promoter will now be upstream of the transgene, the
transgene will be expressed.
Because the transgene is “silent” until it is excised
from the chromosome, this strategy avoids problems as-
sociated with location-dependent effects on expression.
In addition, the fact that expression is Cre-dependent
makes this approach flexible for a variety of applica-
tions. Temporal and spatial control of transgene expres-
sion can be achieved with virally mediated Cre
expression. Alternatively, the ability to cross the same
transgenic mouse line with any Cre-expressing line will
allow for cell-type-specific expression of the transgene. 
During the past year, we have designed and made
two transgenic constructs, injected them into mouse
embryonic stem cells, and identified founder mice.
These mice are now being bred, and once we have
colonies of sufficient size, we will use a Cre virus to test
whether expression can be achieved after excision of the
transgene from the genome. 
Temporal Expectation Modulates Neuronal
Responses in the Auditory Cortex
S. Jaramillo 
When a stimulus occurs at a predictable instant in time,
anticipation of the stimulus improves the speed and ac-
curacy with which it is detected. We have developed a
two-alternative choice task paradigm in freely moving
rats to study the neural mechanisms underlying this
phenomenon in the auditory system. Behavioral meas-
urements confirm that valid expectations improved
both reaction times and detection thresholds. We are
also using tetrodes to record responses from single neu-
rons in the auditory cortex of rats performing the task.
Responsive neurons often showed an increased evoked
response to tones immediately preceding the expected
moment of appearance of the target when compared
while subjects were awake but not performing a task
(“passive”). Surprisingly, we found that engagement
suppressed responses, an effect opposite in sign to that
elicited by selective attention. In the auditory thalamus,
engagement enhanced spontaneous firing rates but did
not affect evoked responses. These results demonstrate
that in the auditory cortex, neural activity cannot be
viewed simply as a limited resource allocated in greater
measure as the state of the animal passes from somno-
lent to passively listening to engaged and attentive, but
that instead the engaged condition possesses a charac-
teristic and distinct neural signature in which sound-
evoked responses are paradoxically suppressed (Otazu
et al. 2009).
Role of Interneurons in Auditory
Cortex Function
K. Borges, A. Reid
Fast synaptic inputs to neurons in the auditory cortex
are either inhibitory or excitatory. Cortical interneurons
are tremendously diverse. One interneuron subclass, de-
fined molecularly by the expression of parvalbumin
(“PV+”), seems to be ideally positioned to mediate the
fast component of the characteristic barrage of inhibition
elicited by a sound. We are testing the hypothesis that
PV+ inhibitory interneurons mediate fast sound-evoked
inhibitory synaptic currents in the auditory cortex. 
Our proposal seeks to establish a causal link between
a physiological property—the fast sound-evoked inhi-
bition that contributes to receptive field dynamics—
and a component of the underlying cortical circuitry.
We approach the problem at three different levels, from
brain slices through in vivo physiology to behavior. Al-
though we are currently focusing on the role of one par-
ticular interneuron subclass (PV+), our approach,
which combines electrophysiological and molecular
tools, can readily be generalized to other subclasses and
can be extended to probe the circuitry underlying other
sensory and behaviorally elicited neuronal responses.
Development of a Novel Strategy
for Expressing Transgenes in Mice
K. Borges
The expression of transgenes in mice is a standard tech-
nique used in many areas of biological research. How-
ever, establishing new transgenic lines can be difficult
against responses to the same tones occurring long be-
fore the expected target. In addition, grouping behav-
ioral trials according to the subject’s reaction time
reveals correlations between the strength of the neu-
ronal responses and performance.
PINP: Identifying Neurons with
ChR2 during In Vivo Recording
T. Hromadka, S. Koh
Neural circuits consist of a heterogeneous mixture of
neurons with different neuroanatomical projections and
patterns of molecular expression. Recordings of neural
activity in behaving animals reveal tremendous func-
tional heterogeneity as well: Nearby neurons often re-
spond very differently to the same stimulus or action.
However, little is known about how this structural cir-
cuit-level heterogeneity contributes to function, in part
because of the technical difficulty of identifying neu-
rons during in vivo recordings in behaving animals. 
To overcome this difficulty, we have developed a
technique we call “PINP” (photostimulation-assisted
identification of neuronal populations), which allows
us to “tag” subpopulations of neurons for identification
during in vivo electrophysiological recordings (Lima et
al. 2009). The tag is a light-gated ion channel—the
algal protein ChR2—whose expression can be geneti-
cally restricted to a subpopulation of neurons. In the
subpopulation of neurons expressing ChR2, a brief
flash of blue light triggers a single action potential with
millisecond precision.
We are using this approach to test the hypothesis that
neuroanatomical connectivity represents one important
structural correlate of the functional diversity in the ro-
dent cortex. To do this, we restrict ChR2 expression to
subsets of neurons in the rat auditory cortex (ACx). ACx
pyramidal neurons project to multiple brain regions, in-
cluding the amygdala, the posterior parietal cortex, or
the contralateral ACx, and presumably carry different
information about auditory stimuli to these centers. To
target ACx neurons specifically based on their projection
pattern, we inserted the ChR2-coding region into a her-
pes simplex virus (HSV). The HSV travels in a retro-
grade fashion through the axons of infected neurons.
ChR2-tagged neurons, i.e., neurons projecting to the
infected area, can be identified by their low latency and
reliable spiking response to a brief light flash. Thus, for
example, we have used this approach to identify the sub-
population of layer-5 ACx neurons that project to the
contralateral cortex. 
Retrograde Tagging of Neurons
for Electrophysiological Identification
and Manipulation of Activity
P. Znamenskiy 
Neural circuits consist of a heterogeneous mixture of
neurons with different neuroanatomical projections and
patterns of molecular expression. Recordings of neural
activity in behaving animals reveal tremendous func-
tional heterogeneity as well: Nearby neurons often re-
spond very differently to the same stimulus or action.
One attractive hypothesis is that this functional diver-
sity reflects in part the anatomically and molecularly
defined neuronal subtypes. Activity of neurons with dif-
ferent patterns of projections also undoubtedly has dis-
tinct roles in behavior. To test these hypotheses would
require a tool to selectively tag and manipulate popu-
lations of neurons based on their projection targets. Ex-
pression of ChR2, a light-gated cation pump, can serve
as such a tag. ChR2-expressing neurons can be identi-
fied in electrophysiological recordings through their re-
sponses to light. Light can be used to manipulate their
activity with millisecond precision. 
Viruses capable of retrograde transport may provide
a method for restricting ChR2 expression to an
anatomically defined subset of neurons. We have pre-
viously used recombinant HSV to tag callosal projec-
tion neurons in auditory cortex (Lima et al. 2009).
However, this method is apparently limited because it
appears to tag mainly intracortical projections. We are
therefore developing an alternative to HSV: pseudora-
bies virus (PrV) amplicons. 
PrV amplicons also have the added benefit of ex-
traordinary packaging capacity (up to 150 kb). This
opens up the possibility of using large regulatory ele-
ments to tag neuronal subtypes defined by expression
of molecular markers, akin to BAC (bacterial artificial
chromosome) transgenics. However, unlike BAC trans-
genics, such a method would be applicable in any
species. We are exploring the possibility of using PrV
amplicons to target specific subtypes of interneurons
(such as parvalbumin- and somatostatin-expressing
neurons) and neurons producing specific neuromodu-
lators (acetylcholine and dopamine).
Causal Role of Auditory Cortex in Behavior
P. Znamenskiy 
An understanding of the causal role of populations of
neurons in behavior requires manipulations such as in-
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activation or stimulation. To better understand how
neurons in the auditory cortex contribute to decisions
driven by sounds, we have devised a two-alternative
forced-choice auditory discrimination task optimized
for conducting microstimulation experiments. In this
task, rats are presented with strings of short overlapping
pure tones of different frequencies and are required to
discriminate whether high-frequency (20–40 kHz) or
low-frequency (5–10 kHz) tones were more frequent
in the stimulus. Although the basic discrimination
(high vs. low) is very easy, the task can be made arbi-
trarily difficult by decreasing the difference in the fre-
quency of high and low tones. To respond correctly on
such difficult trials, rats must integrate sensory evidence
over extended stimulus epochs. This task is ideally
suited to study the role of the auditory cortex through
microstimulation. Because high and low tones are an
entire octave apart, their representation within the pri-
mary auditory cortex is separated by ~1 mm. Therefore,
by stimulating different regions of the auditory cortex
it should be possible to “inject” sensory evidence into
the circuit, thus biasing the rat’s responses. The next
step will be to study the contribution of different neu-
ronal subpopulations identified by their molecular
markers or anatomical connections to decision making
using ChR2-assisted photostimulation.
Mapping of Auditory Cortex
Circuitry Using Laser-scanning
Photo Stimulation
H. Oviedo [in collaboration with I. Bureau, Cold Spring 
Harbor Laboratory, and K. Svoboda, HHMI, Janelia Farm 
Research Campus, Ashburn, Virginia]
It is widely assumed that the organization of the sensory
cortex can be described by a “canonical” circuit. Ac-
cording to this view, sensory input from the thalamus
arrives at cortical layer 4, propagates to layer 2/3, and
then descends to layer 5 before exiting a brain region.
However, until recently, it has been technically difficult
to test this hypothesis directly. We are applying a new
approach, laser-scanning photostimulation (LSPS), to
map the circuitry within the rodent auditory cortex.
Using this approach, we can directly compare the cir-
cuitry within the auditory cortex to that of other sen-
sory cortices, such as the better-studied barrel cortex. 
Surprisingly, we found that local inputs to cortical
layers 2 and 3 differ depending on whether or not the
auditory cortex is cut to preserve information across fre-
quencies. Along the anteroposterior frequency axis,
input to layer 3 (but not layer 2) arises predominantly
out of column, whereas along the dorsoventral isofre-
quency axis, connections are mostly columnar. Further-
more, this circuit anisotropy is associated with
functional differences in sound-evoked responses:
Layer-3 neurons receiving out-of-column input are not
responsive to simple pure tone stimuli. These results
suggest that the microcircuitry of auditory cortex is spe-
cialized to the unique one-dimensional representation
of sound in the auditory cortex.
Different Sensory Cortical Areas Have
Different Sensitivity to Cortical
Timing Information
Y. Yang
It is well established that animals can exploit the fine
temporal structure of some stimuli; for example, inter-
aural time differences of <1 msec are used for spatial lo-
calization of sound. It is also clear that cortical neurons
can lock with millisecond precision to the fine temporal
structure of some stimuli. However, it has been difficult
to establish whether the fine temporal structure of cor-
tical responses can be used in a behavioral context to
guide decisions. To address this question directly, we
have therefore adopted a direct approach to probe the
precision with which cortical timing information can
be used to guide behavior in the rat. To bypass subcor-
tical auditory pathways, we stimulate the cortex di-
rectly, using transient biphasic current trains delivered
via chronically implanted intracortical microelectrodes.
Using this approach, we have previously reported that
the auditory cortex can make use of information on a
time scale as short as 3 msec. We have now extended
this approach to compare auditory cortex with other
brain areas. 
To determine whether the auditory cortex is unique
in its ability to utilize such fine timing differences to
drive behavior, or if the cortex operates according to
general principles shared across different regions, we
compared the ability of different sensory areas to resolve
subtle differences in neural timing. In the visual cortex,
we found that although animals could be trained to re-
solve differences as short as 15 msec in neuronal activ-
ity, they could not resolve differences as short as 5 msec.
This lower limit of 5–15 msec was significantly higher
than the limit of 3 msec we observed in the auditory
cortex and is consistent with the view that the visual
cortex is “slower” than the auditory cortex. Surprisingly,
we found that the barrel cortex was even “faster” than
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the auditory cortex, with a lower limit below 1 msec.
Our results suggest that different cortical areas are dif-
ferentially able to derive behaviorally relevant informa-
tion from the fine timing of neural activity.
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Molecular Basis of Long-term 
Memory Induction 
R. Pagani
Memory that is induced by repeated training improves
when presentations are spaced over time compared to
equal numbers of training exposures without spacing.
This augmentation in memory formation is called the
spacing effect and is a common phenomenon in the an-
imal kingdom. The spacing effect has been widely stud-
ied in both basic and applied research because of its
relevance for psychology, education, therapy, and ad-
vertising. 
In the course of studying Drosophila models of Noo-
nan syndrome (NS), we discovered that disease-associ-
ated mutations hampered memory formation and
altered the spacing effect. NS is an autosomal dominant
genetic disorder characterized by facial dysmorphia and
other developmental abnormalities, including learning
difficulties and mental retardation. Mutations causing
NS have been identified in five genes, PTPN11, SOS1,
RAF1, BRAF, and KRAS, all of which encode proteins
that are components of the Ras/mitogen-activated pro-
tein kinase (MAPK) signaling pathway. Gain-of-
function (GOF) germline PTPN11 mutations cause
~50% of NS cases. The PTPN11 gene and its ortholog
in fruit flies, corkscrew (csw), encode the evolutionarily
conserved protein tyrosine phosphatase SHP2, which is
recruited to many receptor tyrosine kinases upon activa-
tion and is generally a positive regulator of Ras/MAPK
signaling.
Recently, we identified csw as a genetic factor con-
trolling the spacing effect in Drosophila (Pagani et al.
2009). We found that csw gain-of-function mutations
impair long-term memory (LTM) formation by pro-
longing the length of the resting intervals between
repetitive training required for induction of LTM.
This prolonged resting interval correlated with altered
training-induced MAPK activity within each resting
interval.
NEURAL BASIS OF LEARNING AND MEMORY
IN DROSOPHILA
Y. Zhong J. Beshel L. Wang 
R. Pagani C. Xu
PI3K Signaling Is Involved in Aβ-induced
Memory Loss in Drosophila
L. Wang
Genetic studies of early-onset familial Alzheimer’s dis-
ease (AD) provide a causative link between AD and β-
amyloid (Aβ) peptides. A body of evidence suggests that
Aβ peptides are capable of modifying a number of bio-
chemical pathways, such as phosphoinositide-3 kinase
(PI3K), c-Junk, caspase, and cyclin-dependent kinase-5
(CDK-5). An alteration in these pathways may lead to
a wide range of cellular dysfunctions, such as disturbed
metal ion homeostasis, Ca2+ dysregulation, and impaired
neurotransmission. However, how Aβ42 alters these sig-
naling pathways and how these alterations lead to patho-
logical phenotypes have not been well studied.
We used a transgenic Drosophila AD model to iden-
tify the biochemical pathways through which Aβ42 in-
duces age-dependent memory loss, the early hallmark
of AD. With electrophysiology and immunohisto-
chemisty studies, we found a hyperactivated PI3K
pathway in Aβ42-expressing flies. Our following
Pavlovian olfactory conditioning tests indicated an
amelioration of immediate memory loss after inhibi-
tion of PI3K activity. Furthermore, this reduced PI3K
activity correlated with reduced Aβ42 accumulation in
fly brains, including both oligomer and fibril aggre-
gates. Because no recovery of neurodegeneration was
found in Aβ42-expressing flies with inhibited PI3K,
we speculate that the Aβ42-induced memory deficit
and neurodegeneration are mediated through different
signaling pathways. 
State-dependent Odor Processing in the
Drosophila Mushroom Body
J. Beshel
An animal’s internal milieu may have a significant role
in facilitating odor perception in addition to developing
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The fruit fly is a well-established model for studying ol-
faction and olfactory-associated learning and therefore
can help us to address such questions. Our previous
findings suggest that the MB, the second neuronal relay
in the olfactory pathway that is also known as a learning
and memory center in the fruit fly, responds to near-
field mechanical stimuli, i.e., air flow. 
We are able to express the genetically engineered
high-sensitivity calcium indicator G-CaMP in most
neurons in the MB by using enhancer-trap lines. With
two-photon microscopy, we can monitor the activities
of MB neurons in vivo. The “snapshots” indicate that
in the calyx, the input site of the MB, the turning pro-
file to different flow rates of pure air flow is different
from that of air flow carrying odorant; the activity pat-
tern in response to both odor and air flow in the calyx
seems not to equal the linear sum of the activity pat-
terns for each. All of this suggests that olfactory and
mechanical sensory stimuli interact with each other in
the MB, at least at the input level. 
Future work will include analysis of the activity pro-
file of MB neuron cell bodies and MB lobes. This may
lead to an understanding of how these two senses in-
teract at the output level of the MB, and consequently
if, and, or how this affects flies’ behavior.
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and expressing odor memory. The relative simplicity of
the Drosophila nervous system makes it an attractive
candidate in which to investigate how alterations in the
internal state affect sensory processing and ultimately
behavior. Recent studies have demonstrated that the
satiety state has a profound impact on the expression
of memory in flies, and genetic dissection has pointed
to a subset of neurons innervating the higher-order ol-
factory center—the mushroom bodies (MBs)—as im-
portant for mediating these changes. Yet, there remains
no direct evidence how such neuromodulation modifies
MB processing to lead to appropriate behavioral expres-
sion.
Using two-photon laser-scanning microscopy in
combination with the P-Gal4 enhancer trap system to
target the expression of the Ca2+ probe G-CaMP in spe-
cific subsets of MB neurons, we monitored in vivo
odor-evoked activity profiles of flies under differing lev-
els of satiety. As predicted by previous work, hungry
and fed flies displayed varying responses to monomol-
ecular odorants at the level of the MB vertical lobes.
This effect, however, was not limited to MB output.
Responses in the calyx, the dendritic region of MB in-
trinsic neurons, also varied as a function of satiety, sug-
gesting that modulation set in motion by hunger does
not simply function to open a “gate” for MB output.
Rather, hunger may also serve to shape odor represen-
tations at the level of MB input.
Such multiple controls over olfactory system cir-
cuitry may allow the animal to navigate its environ-
ment, surrounded by vast amounts of odor infor-
mation, while retaining sensitivity of olfactory function
to what is relevant without the expenditure of energy
resources on what is not. Future experiments will seek
to address whether the changes in MB activity are re-
lated only to the expression of acquired memories in
flies or whether the satiety state can modify even more
basic behaviors such as olfactory acuity or innate odor
preferences.
Mechanosensory Integration in Drosophila
C. Xu
One of the fundamental questions in neuroscience is
how sensory inputs are represented in the central brain.
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Uncovering the molecular processes governing how plants grow and develop is of fundamental bi-
ological interest and importance, with vital implications not only for agriculture, but also for human
health. Plant Genetics has long had a major role in the advance of all areas of research at CSHL,
epitomized by the work of Nobel laureate Barbara McClintock, who discovered transposable genetic
elements in work on maize in the 1940s. Plant geneticists at the Laboratory have been among the
leaders of efforts to sequence the first plant genomes, and they continue to be at the center of se-
quencing and genome-annotation projects involving a host of cereal crops that feed the planet’s
growing population. CSHL plant geneticists also have been pioneers in the study of RNA interfer-
ence, in stem cell research, and, most recently, in efforts to spur the development of next-generation
biofuels and related alternative energy sources. 
David Jackson and colleagues study genes and signals that regulate plant growth and architecture.
This past year, they identified a gene called GAT1 that controls communication between plant cells
via small channels called plasmodesmata. These channels, which direct the flow of nutrients and
signals through growing tissues, are regulated during development. GAT1, they discovered, encodes
an enzyme found mainly in meristems, the stem-cell-rich tip of the plant where new growth takes
place. The enzyme improves the flow of traffic through plasmodesmata by acting as an antioxidant.
The lab continues to work on RAMOSA3, a gene, first identified by Jackson several years ago, which
gives rise to an enzyme that, among other factors, controls branching in inflorescences. Jackson has
also undertaken to develop 100 maize lines that express fluorescent proteins across the full spectrum
of cellular compartments. These are being made available to the broader scientific community, en-
abling observations of processes never before seen in living plants. A team that included Jackson,
for instance, has drawn upon this resource to identify a gene called sparse inflorescence1 that proves
vital in the formation of corn ears.
Zachary Lippman’s research focuses on understanding how tomato plants are elegantly pro-
grammed through their DNA code to generate a specified number of flowers in a repetitive zigzag
arrangement on a branching structure called an inflorescence. Proceeding from a base of knowledge
they have built regarding the special repetitive growth habit represented by tomato, called sympodial
growth, Lippman’s lab is addressing basic and applied questions on how plants are able to shift from
making leaves to making flowers, and the number of flowers different types of species are ultimately
able to make. The lab is particularly interested in learning how these vegetative-to-reproductive
“phase transitions” were involved in the evolution of diverse inflorescence branching patterns in
tomato’s larger Solananaceae family, which ranges from simple (plants with a single branch carrying
a single flower) to complex (plants with dozens of branches harboring dozens of flowers). Their aim
is to decipher both the developmental and molecular bases of the natural variation for inflorescence
branching seen in that important family with an eye to increasing crop yields.
Epigenetic mechanisms of gene regulation—chemical and conformational changes to DNA and
the chromatin that bundles it—have important impact on genome organization and inheritance
and on cell fate. These mechanisms are conserved in eukaryotes and provide an additional layer of
information superimposed on the genetic code. Robert Martienssen, a pioneer in the study of epi-
genetics, investigates mechanisms involved in gene regulation and stem cell fate in yeast and model
plants including Arabidopsis and maize. He and his colleagues have shed light on a phenomenon
called position-effect variegation, caused by inactivation of a gene positioned near densely packed
chromosomal material called heterochromatin. They have found that heterochromatin is pro-
grammed by small RNA molecules arising from repeating genetic sequences. This past year, Mar-
tienssen and colleagues described a remarkable process by which “companion cells” to sperm in
plant pollen grains provide them with instructions that protect sperm DNA from damage. Com-
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panion cells lose epigenetic marks in genomic regions containing transposons, resulting in their ac-
tivation. Short interfering RNAs (siRNAs) bearing the epigenetic information are then transported
from the companion to the sperm, effectively inoculating the germline against transposon damage.
Martienssen’s group also continues to work on problems related to the creation of plant-based bio-
fuels. 
The growing tips of plants, called meristems, contain a population of stem cells that serve as a
persistent source of daughter cells from which new organs arise. They also produce signals important
for the determination and patterning of lateral organs. Marja Timmermans and colleagues are using
a genomic approach to study genes active in the meristem. They have also used mutational analyses
to unravel the mechanism that suppresses stem cell fate during organ development. They have shown
that this process requires a highly conserved epigenetic mechanism. In particular, they have found
that the chromatin remodeling factor HIRA, through interaction with specific DNA-binding pro-
teins, mediates the recruitment of polycomb repressive complexes to stem cell factors, an action
that stably represses their expression in differentiating organs. The lab has also identified regulatory
mechanisms that allow for the precise spatial accumulation of developmentally important small
RNAs in plants. This work has revealed that polarity in leaves is established via opposing gradients
of mobile small RNAs. Description of the mobile small RNA, tasiR-ARF, in pattern formation sug-
gests possible roles of other small RNAs as morphogen-like signals during development in plants
and animals.
Plant Genetics     161
162
Research in our lab is aimed at identifying novel genes,
signals, and pathways that regulate multicellular growth
and development. All organisms develop by carefully con-
trolling the flow of information (“signals”) that passes be-
tween cells and tissues. We are particularly interested in
discovering these signals and finding out how they are
transmitted and how they function. As an example, we
have identified genes that control how plant cells commu-
nicate with each other through small channels, called plas-
modesmata. These channels were described in plants more
than 100 years ago, but their central importance and how
they are regulated is just beginning to emerge. Plasmodes-
mata are critical for plant growth because they allow the
flow of nutrients and signals through growing tissues. In
the past year, we discovered an important mechanism by
which transport through these channels is controlled via
regulation of protein folding, by a chaperonin gene that
regulates the specific transport of a transcription factor,
KNOTTED1. KNOTTED1 is a homeodomain protein
that is expressed in the plant stem cells and is necessary to
keep these cells in a pluripotent state. 
We also continue to identify maize genes with novel
roles in shoot development and plant architecture. We
have recently identified genes that control branching, stem
cell proliferation, and leaf growth. One of these, compact
plant2, encodes a subunit of a heterotrimeric G protein
that has previously not been linked with stem cell prolif-
eration in plants. Finally, we continue to develop a collec-
tion of “fluorescent-protein”-tagged maize lines that are
an essential resource for all maize researchers. This is the
first collection of its kind and promises to enhance maize
genetics research through characterization of developmen-
tal gene pathways and identification of maize promoters
that can be used in crop improvement.
A Role for Chaperonins during KNOTTED1
Cell-to-Cell Trafficking
X.M. Xu, J. Wang, P. Borrill, L. Panda
Cell-to-cell communication has critical roles in specifying
cell fate and coordinating development in all multicellular
DEVELOPMENTAL BIOLOGY: STEM CELLS, SIGNALING, 
AND CONTROL OF PLANT ARCHITECTURE
D. Jackson Y. Benitez K. Chen A. Eveland U. Hernandez Y.K. Lee J. Wang
P. Bommert S. Choi S. Goldshmidt R. Johnston L. Panda C. Whipple
P. Borrill S. DeBlasio D. Heigl G. Nguyen M. Pautler T. Zadrozny
organisms. A new paradigm for such communication in
plants is the selective trafficking of informational macro-
molecules such as transcription factors through plasmod-
esmata (PDs), channels that traverse the cell wall and
connect plant cells to their neighbors. In addition to cell-
fate specification, PDs also function in viral movement,
transport of metabolites, and cell-to-cell spread of RNA
interference (RNAi), which points to their fundamental
importance in coordinating plant defense, metabolism,
and development. Despite the discovery of PD more than
100 years ago, and our increasing recognition of their
functional significance, the underlying components and
mechanisms of PD trafficking remain poorly understood.
Hence, we are taking an unbiased genetic strategy to dis-
sect these molecular components and mechanisms, using
a transgenic reporter system. 
The maize KNOTTED1 (KN1) homeodomain pro-
tein was the first plant protein found to selectively traffic
through PD, and its trafficking appears to be important
for its function in shoot stem cell maintenance. A gain-
of-function trafficking assay in Arabidopsis was developed
to demonstrate that the carboxy-terminal region of KN1
(KN1C), which contains the homeodomain, is necessary
and sufficient for KN1 trafficking in vivo. The trafficking
assay relies on complementation of leaf hair (trichome)
development in hairless glabrous1 (gl1) mutants. GL1, a
MYB transcription factor, is required in the epidermis for
trichome initiation and acts cell autonomously. However,
expression of a fusion between GL1 and KN1C in cells
underlying the epidermis can rescue trichomes in a gl1
mutant background, because the fusion protein can traf-
fic through PDs into the epidermal cells. Thus, this sys-
tem provides a simple and tractable model to understand
how proteins traffic cell to cell. Factors critical for KN1
trafficking can be uncovered through isolating mutants
defective in trichome rescue.
As a proof of concept for our genetic strategy, combin-
ing mapping, and illumina-based sequencing, a mutant
with attenuated KN1 trafficking was identified as encod-
ing a chaperonin. Using artifical microRNA (miRNA)
knockdowns, we found that additional chaperonin sub-
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most current sequence analysis programs are unable to
identify proteins that might be targeted to more than one
cellular compartment or might have more than one func-
tion. Although there are several approaches to experimen-
tally validate gene function, none are more commonly
used than fluorescent protein (FP) technology.
Successfully optimized for use within living plant cells,
FPs genetically linked to a protein or regulatory element
of interest make the normally invisible protein of interest
visible, and easy to track. Because of their relatively small
size, FP fusions rarely interfere with native protein tar-
geting, function, and trafficking. Thus, FP technology is
a powerful tool that can be used to noninvasively mark
protein expression and localization to study various sub-
cellular processes, live and in vivo. 
Maize cells consist of interconnected but discrete
compartments that help to maintain cellular function
and order. Because identifying proteins that localize to
these domains is critical to fully understanding maize
physiology and development, we have set out to generate
100 stable, natively expressed, FP fusion lines to provide
a useful, molecular resource for the maize community
and to ultimately uncover guiding information for crop
improvement. From the lines developed thus far, we now
have unprecedented views of maize cellular architecture
and can study real-time dynamics of cell structure, func-
tion, and protein localization, including known proteins
from several hormone signaling pathways, such as the
jasmonic acid metabolic enzyme, LIPOXYGENASE10,
which shows a distinct, developmental localization pat-
tern in maize inflorescences. The tagged lines provide
complete marker coverage of almost all subcellular com-
partments, including motile organelles such as peroxi-
somes and nuclear markers such as histone H1, which
displays a punctate localization pattern. Where possible,
these FP fusion lines have been shown to complement
their respective mutant alleles, indicating functional ac-
tivity. Data on the characterization of these lines, includ-
ing confocal micrographs, are freely accessible on our
public website, http://maize.jcvi.org/cellgenomics/index.
shtml. The website also includes a community submis-
sion form to request one’s favorite gene to be tagged.
Constructs and seeds from verified transgenic plants are
also available for use by the scientific community. The
ultimate goal for the creation of these FP-tagged trans-
genic plant collections is to provide a molecular resource
for the maize community to use for functional studies,
such as FRAP (fluorescence recovery after photobleach-
ing), FRET (fluorescence resonance energy transfer),
mass spectrometry, and ChIP (chromatin immunopre-
cipitation). 
units also function during KN1 trafficking, suggesting
that the whole chaperonin complex is required for traf-
ficking. Furthermore, genetic interaction data provide ev-
idence that the endogenous function of KN1-related
genes in stem cell maintenance in Arabidopsis requires
chaperonin activity, clearly supporting the functional rel-
evance of chaperonin-mediated trafficking through PD. 
The central question is how a chaperonin protein
might be involved mechanistically in KN1 trafficking.
Chaperonins have been characterized in fungal and
mammalian systems as a key component of the cellular
chaperone machinery, facilitating efficient protein fold-
ing in the cytosol. Proteins are thought to undergo par-
tial unfolding during PD translocation, which makes
the discovery of this chaperonin particularly exciting.
Meanwhile, it is also possible that chaperonins may
function during posttranslocation protein folding
and/or in maintaining proteins in an unfolded state that
is competent for PD transport. The latter scenario
would be analogous to posttranslational endoplasmic
reticulum (ER) translocation. Our preliminary analysis
through cell-type-specific complementation experi-
ments strongly suggests that chaperonins are involved
during posttranslocational refolding. In summary, a
functional characterization of chaperonins, the first fac-
tor known to be critical for KN1 PD trafficking, has
furthered our understanding of developmental regula-
tion and mechanisms of selective cell-to-cell trafficking. 
Generation of Fluorescent-protein-tagged
Maize Lines for High-throughput Analysis 
of Protein Localization and Function
S. DeBlasio, T. Zadrozny, A. Goldschmidt, C. Whipple,
U. Hernandez, J. Wang [in collaboration with A. Chan 
and Y. Xiao, The J. Craig Venter Institute, and A. Sylvester,
University of Wyoming]
With the recent release of the maize B73 genome se-
quence, we have entered into a new scientific era where
computational genome annotations must now be vali-
dated or deduced by experimentation in order to truly
understand the precise function(s) of all maize proteins
as well as identify the regulatory elements controlling
their expression. Even though annotation algorithms are
based on published experimental data such as homology
with genes/proteins that have previously been character-
ized, the functional information assigned to maize gene
sequences can only be considered a prediction. In fact,
there are still many cases where a putative function/local-
ization could not be assigned to a sequence due to lack
of homology with orthologous sequences. In addition,
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We are currently working to optimize the LhG4 two-
component trans-activation expression system, which has
been successfully used in Arabidopsis, for use in maize.
This system uses the transcription factor LhG4, expressed
by a cell or tissue-specific promoter, to drive the expres-
sion of any reporter in trans, via pOp transcription-fac-
tor-binding sites. The reporter can be any gene expressed
in a tissue-specific manner, such as a fluorescent protein
or an FP fusion protein, a gene of interest for tissue-spe-
cific expression, a silencing construct for tissue-specific
knockdowns, or even a gene encoding a toxin for ablation
experiments. Our goal is to generate ~50 promoter con-
structs and produce an array of cell- and tissue-specific
driver lines that we will use to analyze the changes which
occur within meristems during differentiation and devel-
opment. From our previous work creating the natively
expressed FP fusion lines to highlight subcellular com-
partments, we have already identified several tissue-spe-
cific promoters, including a-ZEIN (endosperm) and
ZmMADS16 (floral organ primordia) (Fig. 1). 
Digital Expression Signatures during 
Maize Development
A.L. Eveland, N. Satoh-Nagasawa, M. Regulski, 
A. Goldshmidt [in collaboration with D. Ware, Cold Spring
Harbor Laboratory; M. Beatty and H. Sakai, DuPont Crop
Genetics; R. Schmidt, University of California, San Diego;
and E. Vollbrecht, Iowa State University]
Genome-wide expression signatures that mark perturba-
tions in developmental programs contribute to identifi-
cation and functional analysis of central regulators and
associated pathways. In this work, we are using next-gen-
eration sequencing to profile genome-wide transcriptional
changes in maize reproductive tissues at specific stages of
development. We also use mutations in key developmen-
tal genes to test the effect of gene-specific perturbations
in normal reproductive growth at the transcriptional level.
Genetic studies have previously anchored these genes into
core developmental pathways. Here, computational
methods are used to integrate and analyze expression data
sets, which will provide a basis for inferring the gene net-
works associated with these pathways. 
A primary objective of this work is to resolve tran-
scriptional mechanisms that modulate branch pattern-
ing in maize inflorescences. Branching architecture is
an important agricultural trait with clear relevance to
grain yield and harvesting ability. In maize, male and
female flowers develop in separate inflorescences called
tassels and ears, respectively. In both structures, branch-
ing patterns are determined by developmental fate of a
series of axillary meristems (highly organized stem cell
populations), which are initiated during early develop-
ment. Loss-of-function mutations for genes in the
RAMOSA (RA) pathway have demonstrated a common
effect on determinacy of axillary meristems and thus re-
sult in highly branched phenotypes in the ear and tassel.
To investigate additional regulatory and biochemical
processes that contribute to meristem determinacy, we
are using Illumina deep-sequencing strategies to com-
pare genome-wide transcript profiles from ra1, ra2, and
ra3 mutant ears during different developmental stages.
Expression profiles from normal ears and tassels are
being analyzed in parallel, and these include samples
enriched for meristematic cells taken from sections
along the developing inflorescences. The Illumina-
based sequencing methods currently being used include
tag-based digital gene expression (DGE) and RNA-Seq. 
An initial data set, which compared transcript pro-
files of immature (2 mm) ramosa3 mutant ears to wild-
type using DGE, was used to generate a framework for
analysis of tag-based expression data in maize. The RA3
gene encodes a trehalose-phosphate phosphatase (TPP),
and determining its function could reveal a link be-
tween developmental and metabolic processes during
maize inflorescence development. From these data, we
identified ~23K high-confidence genes expressed in im-
mature ears and used comparative genomics to leverage
Figure 1. Tissue-specific fluorescent maize reporter lines. The images are confocal micrographs showing expression
of fluorescent protein-tagged proteins in endosperm (A), meristem stem cells (B), glume leaf primordia (gp) (C), and
floral promordia (D). Promoters discovered from this work will be used to create a trans-activation expression resource. 
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information from Arabidopsis and rice in functional
analyses of differentially expressed maize genes. These
included key enzymes in relevant biochemical pathways
and regulatory components such as transcription factors
and miRNAs. Candidate genes from these results have
been identified and will be used in downstream genetic
and molecular analyses to further characterize their role
with respect to RA3 and control of branching. 
Currently, we are constructing and sequencing DGE
and RNA-Seq libraries from normal and mutant maize
ears. A pipeline for mapping and analysis of RNA-seq
data with the newly assembled maize reference genome
is being optimized in collaboration with Doreen Ware’s
lab. The sequence-based expression data sets will then
be integrated to generate a transcriptional framework,
which can be continually referenced and improved as
new data sets become available. Including genome-wide
analyses of single loss-of-function mutants in this
framework enables us to classify transcriptional changes
that result from specific perturbations of the system.
Incorporation of additional data from ChIP-Seq and
yeast–2-hybrid experiments (currently under way) will
provide genome localization and protein–protein inter-
action information for the RA genes as well as other
candidates, and thus a more comprehensive view of
molecular mechanisms underlying branching architec-
ture in maize inflorescences.
Regulation of Meristem Size in Maize and Its
Impact on the Evolution of Inflorescence
Morphology
P. Bommert, Y.K. Lee, M. Pautler, D. Heigl, S. Choi [in 
collaboration with M. Komatsu and H. Sakai, DuPont
Crop Genetics]
One of the most remarkable morphological changes ob-
served during the domestication of inflorescences in
maize is the change from a two-rowed ear in teosinte, the
ancestral form of maize, toward the multirowed ears of
modern elite maize hybrid lines, which have up to 24
rows of seeds. We found that this change in seed row
number is tightly linked to the size of the inflorescence
meristem (IM), which is constituted by a group of stem
cells located at the tip of developing ears. It is also known
that this change in morphology is dependent on the ac-
tivity of multiple genes. Our goal is to identify and ana-
lyze these genes controlling the size of the inflorescence
meristem and thereby controlling the important agro-
nomical trait of seed row number. Maize is a good system
to identify these genes, because the ear appears to be very
sensitive to changes in gene activity, most likely as a result
of domestication, and ear and tassel meristem pheno-
types are easy to identify even in case of weak mutations.
One of these mutations is compact plant2 (ct2). ct2 mu-
tants are significantly shorter than their wild-type siblings,
but more interestingly, ct2 mutants are characterized by
enlarged IMs and vegetative meristems, resulting in se-
verely fasciated ears and in an increased tassel spikelet den-
sity. We used a map-based cloning approach to isolate ct2.
Using ~900 F2 mutants, we narrowed down the chromo-
somal location to an interval of ~250 kb on chromosome
1, which is highly syntenic to rice and sorghum. By se-
quencing several candidate genes in the different ct2 alle-
les, we found that ct2 encodes the α subunit of a heterotri-
meric G protein. Heterotrimeric G proteins form signal
transduction complexes composed of three dissimilar sub-
units: Gα, Gβ, and Gγ. In Arabidopsis, maize, and rice,
Gα is encoded by a single-copy gene and is involved in
multiple aspects of growth and development, including
cell proliferation and cell elongation. However, a link to
stem cell proliferation has not been previously established.
Initial analysis of transgenic plants expressing CT2 fused
to yellow fluorescent protein (YFP) indicates that CT2
protein is strongly expressed within meristems. This will
allow not only tissue and subcellular expression analysis,
but also proteomic applications using YFP as a purifica-
tion tag. Previous studies have linked rice Gαwith giberel-
lic acid hormone signaling, and we found that the GA
synthesis rate-limiting enzyme GA20 oxidase is signifi-
cantly down-regulated in ct2 mutants, suggesting a novel
link between GA action and meristem size regulation. 
Another gene that we are in process of cloning using
a map-based cloning approach is fasciated ear3 (fea3).
fea3 mutants are affected during female and male inflo-
rescence development, as they develop fasciated ears with
an extra number of kernel rows and tassels with an in-
creased spikelet density. Using a total of 950 recombi-
nants, we narrowed down the fea3 region to ~800 kb on
chromosome 3, which is covered by five bacterial artifi-
cial chromosomes (BACs) representing 15 genes. In ad-
dition to the fea3-Reference allele, which is of unknown
origin, we successfully isolated additional fea3 alleles by
a targeted ethylmethanesulfonate (EMS) screen as well
as by bulked segregant mapping of other fasciated mu-
tants. The 15 candidate genes are currently being se-
quenced in these fea3 alleles to identify the FEA3 gene. 
We are also mapping a newly identified mutant, fea
1905, that has a thickened tassel and massively fasciated
ears due to enlarged IMs. We have mapped the muta-
tion to a small interval on chromosome 6, containing
~80 annotated genes, and continue to narrow down its
position and sequence candidate genes. We have crossed
fea 1905 to ra1 and ra3, as well as other fasciated ear
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mutants to identify further genetic interactions. Future
work includes phenotypic characterization, as well as ex-
pression analysis, to elucidate function and mode of ac-
tion for these novel genes. We are also mapping a
collection of ~40 additional fasciated mutants by bulked
segregant analysis using the Sequenom platform. We ex-
pect some of them to be allelic to each other or to some
of the already cloned or mapped fasciated mutants.
However, we also expect some to represent new genes
involved in IM size regulation. 
We also continue to study the fasciated ear2 (fea2)
gene, which was cloned in our lab several years ago. fea2
encodes an extracellular receptor involved in stem cell
homeostasis. fea2 mutants are characterized by “fasci-
ated” or enlarged ears, which have more than 40 rows
of seed. We found that fea2 maps to a major quantita-
tive trait locus (QTL) controlling seed row number and
are currently analyzing fea2 expression levels within the
IM in the parental lines of the QTL population; we ex-
pect to find a correlation between fea2 expression level
and IM size. Besides this molecular approach, we also
searched for hypomorphic alleles to further substantiate
our hypothesis that allelic variation of fea2 contributes
to variation in seed row number. Using the maize TILL-
ING resource, we isolated four new EMS-induced fea2
alleles, of which one of them has a single amino acid
change within the extracellular receptor domain. Inter-
estingly, homozygous mutants of this line show a sig-
nificant increase in row number (from ~16 to ~18)
without disturbing the overall ear morphology, indicat-
ing the potential of the fea2 gene to alter IM size and
seed row number within a range similar to that found
in natural populations. 
Investigation of Molecular Mechanisms
Controlling Meristem Determinacy and
Inflorescence Branching in Maize
S. DeBlasio, M. Pautler
We are interested in studying the development of the
maize inflorescence because its architecture is critical to
reproductive success. This has a wide range of implica-
tions in hybrid seed production and ultimately crop
yield. The shape of the maize inflorescence is controlled
by the fate and activity of axillary meristems, which sub-
tend the suppressed leaves of the tassel and ear. The clas-
sical ramosa (ra1, 2, 3) mutants have highly branched
inflorescences, due to increased activity of spikelet pair
meristems. RA1 and RA2 encode transcription factors,
but RA3 is predicted to be a trehalose sugar metabolic
enzyme. Although RA3 is a functional trehalose-6-
phosphate phosphatase (TPP) in vitro and in vivo in
yeast, trehalose levels are unchanged in the ra3 mutant.
This, together with several other lines of evidence, sug-
gests that RA3 could have an additional unsuspected
function in maize. First, RA3 has a discrete expression
pattern subtending axillary meristems, suggesting a de-
velopmental, rather than general metabolic, role. Sec-
ond, RA3 acts genetically upstream of RA1 and regulates
its expression. Finally, RA3 immunolocalization shows
that the protein is both nuclear and cytoplasmically lo-
calized and forms a speckled pattern. A yeast–2-hybrid
screen was conducted in order to gain a better under-
standing of how RA3 functions. Approximately 3.1 mil-
lion clones were screened from an inflorescence cDNA
library. The results of this screen suggest that RA3 in-
teracts with several transcription factors, including those
belonging to the zinc finger–homeodomain (ZF-HD)
class. We therefore believe that RA3, like some meta-
bolic enzymes in yeast (e.g., hexokinase), may have an
additional role in transcriptional regulation.
To test this hypothesis, we are currently verifying RA3
interacting proteins in planta using coimmunoprecipita-
tion experiments in a transient tobacco leaf expression
system using epitope tagged proteins. Further character-
ization of the putative interactors, including expression
analysis via in situ hybridization, is currently in progress.
We have also obtained transgenic plants harboring a flu-
orescently tagged ZF-HD protein identified from the
Y2H screen. The targeted approach described above will
be complemented by immunoprecipitation coupled with
mass spectroscopy conducted using extracts from trans-
genic maize plants. We now have green fluorescent pro-
tein (GFP) and FLAG-tagged RA3 transgenic plants
available, and we are screening for strongly expressing
stable lines. We will also use these lines to directly assay
whether RA3 occupies the promoter of RA1 in vivo,
using ChIP, and search for other possible binding sites in
the genome using ChIP-Seq. 
In summary, these diverse approaches will elucidate
the mechanisms of inflorescence stem cell determinacy
and branching, providing candidate genes for crop im-
provement.
Characterization of Mechanisms Regulating
Spikelet-pair Meristem Determinacy
S. Goldshmidt, M. Pautler
We are using the maize mutants, ramosa1 (ra1), ramosa2
(ra2), and ramosa3 (ra3), which show an indeterminate
phenotype, to characterize molecular networks regulated
by these genes. Several approaches are being applied for
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this purpose. First, we use Illumina transcriptome analy-
sis to identify genes regulated by RAMOSA gene activity.
We first performed detailed analysis of ear phenotypes in
ramosa mutants. We found that elongated branches in
ears of ramosa mutants could be detected in ear primor-
dia larger then 1.5 mm, when the first spikelet meristems
are detected in wild-type ears. On the basis of this analy-
sis, we collected two sets of ears (1–1.5 mm and 1.5–2
mm) for every mutant and wild-type genotype (Fig. 2).
RNA is currently being used for construction of Illumina
RNA-Seq libraries for whole transcriptome analysis be-
fore and at the very early stage after manifestation of the
phenotype. This way, we will be able to compare relative
changes in transcriptome profiles of the mutant and
wild-type plants, before mutant phenotypes are obvious,
as well as dynamic changes in the transcriptome profiles
during transition of the spikelet-pair meristem into the
spikelet meristem stage. 
We are also taking a genetic approach to identify
genes participating in the RAMOSA network. We per-
formed an EMS-based ramosa3 enhancer/suppressor
screen and analysis of double-mutant combinations of
the ramosa genes with maize meristem maintenance
genes, such as knotted1 (kn1), fasciated ear2 (fea2), and
thick tassel dwarf1 (td1), and with genes involved in
auxin hormone transport and synthesis, such as barren
inflorescence2 (bif2) and sparse inflorescence1 (spi1). Cur-
rently, we have identified and verified three unknown
suppressors and two enhancers of the ramosa3 pheno-
type, and molecular mapping of the genes is under way.
We also detected suppression of the ramosa3 phenotype
by a kn1-e1 loss-of-function mutant; this result sup-
ports the previous proposition that RAMOSA3 has a
non-cell-autonomous activity on the maintenance of
the spikelet-pair meristem. As an independent genetic
approach, we are also mapping a naturally occurring
genetic suppressor of ra3, discovered when we crossed
the mutant to the A619 inbred line. Finally, we are ex-
ploiting natural variation in maize by crossing ra3 to
diverse inbred lines that represent the founders of the
maize nested association mapping (NAM) population.
Initial screening of F2 families has revealed a strong en-
hancer of ra3, which we will map.
As an additional strategy, in collaboration with Dr.
Florin Albeanu at CSHL, we have developed novel two-
photon microscopy-based approaches for the imaging
of fluorescent-protein-labeled molecular markers. This
approach enables us to perform detailed and unbiased
analysis of auxin activity markers that report different
morphogenetic events during development. Combining
these approaches will enable us to better characterize the
mechanisms of RAMOSA activity, and the activity of
genes that participate in the RAMOSA network. 
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Figure 2. Developmental stages of maize ear primordia used for
RNA-seq expression profiling.
168
One of the most remarkable manifestations of plant evo-
lution is the diversity of floral branching systems called
inflorescences. The number and pattern of branches
within inflorescences are determined by specialized
groups of pluripotent stem cells at growing tips called
shoot apical meristems (SAMs). In contrast to the near
complete consumption of stem cell populations for
organ formation during animal development, the stem
cells residing in the SAMs of plants integrate environ-
mental signals with genetic pathways to continuously
generate new organs and drive reproductive “phase tran-
sitions” throughout life. Beyond genetic frameworks, lit-
tle is known about the molecular networks controlling
reproductive phase transitions, especially with respect to
distinct growth habits from diverse species. Research in
our lab aims to discover the genes, pathways, and net-
works that control phase transitions in a widely de-
ployed, but poorly understood, growth habit called
“sympodial” that is characteristic of most perennial
species, including trees. We are taking advantage of de-
velopmental, genetic, and molecular tools in the tomato
(Solanum lycopersicum) to understand how meristems
reiterate to generate a multibranched, multiflowered in-
florescence. Importantly, tomato is a member of the
nightshade (Solanaceae) family that includes other well-
known crop plants, such at potato, pepper, eggplant,
petunia, and tobacco. Therefore, we anticipate that our
discoveries will address questions that are relevant to
evolution as well as agriculture.
A related focus in the laboratory is exploring why
intercrossing different inbred plants often creates hy-
brids that produce more flowers, fruits, and seeds than
their parents. This increased vigor in hybrids, known
as heterosis, is a widespread phenomenon in nature and
is a major contributor to food production worldwide.
In addition to studying heterosis quantitative trait loci
(QTL) derived from wild tomato species that regulate
the rate of inflorescence production, we have recently
discovered that mutations in flowering genes can cause
heterosis. We are now exploring the role of pleiotropic
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dosage effects of these genes on plant development as a
potential explanation for this type of heterosis.
Two Major Genes Controlling
Inflorescence Meristem Determinacy
and Branching in Tomato
Z. Lippman
Tomato generates a few-flowered inflorescence organ-
ized in a zigzag pattern, but there are three classical mu-
tants called compound inflorescence (s), anantha (an), and
falsiflora (fa) that bear highly branched inflorescences
(Fig. 1). Interestingly, the s mutant, which is the only
known inflorescence branching mutant in the eudicot
lineage that makes normal fertile flowers, resembles
many wild Solanaceae species such as Solanum crispum
that have highly branched inflorescences. One major
project in our lab is exploring whether similarities be-
tween mutant and wild phenotypes suggest that branch-
ing complexity in nature is based on the regulation of
genes such as AN or S or the pathways in which they re-
side. Thus, we are focusing our efforts on understanding
the functions of AN and S, which we have found to en-
code an F-box protein ortholog of a gene called UN-
USUAL FLORAL ORGANS (UFO) that controls the
identity of floral organs (petals, sepals, and so on), and
a homeodomain transcription factor related to a gene
called WUSCHEL HOMEOBOX 9 (WOX9) that is in-
volved in patterning the embryo within the plant seed.
Interestingly, these genes have little or no effect on
branching in inflorescences that grow continuously (so-
called “indeterminate” monopodial shoots), as is found
in Arabidopsis. However, we have found that transient
sequential expression of S followed by AN promotes
branch termination and flower formation in sympodial
plants. The phenotypes caused by mutations in the AN
and S genes indicate that any delay (or reversion) in the
formation of a flower from an inflorescence meristem
allows for an extended developmental period for branch-
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nuum), and our research suggests that greater complexity
arises from the production of reiterating modular units
of stem cells called sympodial inflorescence meristems
(SIMs). For example, in tomato, an additional lateral
SIM forms before formation of each flower, and this
process reiterates to form 6–15 flowers, depending on
the variety. In pepper, in contrast, the transition from
SIM to flower is very rapid and prevents the formation
of additional SIMs. Still, pepper maintains the ability
to produce a compound inflorescence from only a single
flower, because we have found that mutations in the
pepper ortholog of AN generate a highly branched struc-
ture. Taken together, our findings suggest the existence
of a previously uncharacterized developmental mecha-
nism whereby inflorescence elaboration can be con-
trolled through temporal regulation of floral fate.
A Comparative Molecular Study
of Inflorescence Development
K. Liberatore, S.-J. Park
Despite growing knowledge on the mechanisms of flow-
ering in some model species (e.g., Arabidopsis), it is un-
clear to what extent vegetative to inflorescence and
inflorescence to flower transitions are similar or different
in plants such as Arabidopsis and tomato. In contrast to
the single reproductive phase transition that takes place
in Arabidopsis, the sympodial habit of the tomato devel-
ops three distinct shoot systems, each of which under-
goes an independent transition with both morphological
and molecular signatures. One project under way in the
lab is to study in greater detail the molecular mecha-
nisms that distinguish sympodial from monopodial
growth by determining if key branching genes in the
tomato are functionally conserved in Arabidopsis. We are
using a series of transgenic knockdown tools to deter-
mine if the ortholog of S in Arabidopsis, WOX9, has a
role in inflorescence development and complexity in
monopodial species. Curiously, mutations in Arabidopsis
WOX9 have been characterized and have so far been
limited to developmental defects restricted to the early
stages of embryonic patterning. This early embryonic
defect and resulting seedling lethality have prevented a
more detailed analysis of later stages of development. By
selectively targeting the elimination of WOX9 using a
library of tissue-specific promoters, for example,
through RNA interference (RNAi), we hope to deter-
mine if and when WOX9 functions to regulate inflores-
cence meristem elaboration.
ing to occur. In support of the relevance of the S gene
in nature, we have found that more than 40 domesti-
cated varieties of tomato with branched inflorescences
carry mutations in S. Given that these plants produce
more flowers and fruits, some of these mutant alleles
were probably selected by breeders when the tomato was
first brought into cultivation more than 200 years ago. 
Arguably, some of the most extensive variation in in-
florescence complexity is found in the Solanaceae family.
For example, the simplest Solanaceae inflorescence is a
solitary flower represented by pepper (Capsicum an-
Figure 1. Early branching patterns of normal and mutant tomato
inflorescences. Scanning electron micrographs and schematics
of inflorescence development. Schematics reflect sequential in-
florescence sympodial units (ISUs) each composed of a sympo-
dial inflorescence meristem (SIM) branch (line with arrow) that
terminates with a flower (FM, oval). Circles in micrographs reflect
corresponding structures in schematics. (Top panels) Two stages
of sympodial inflorescence development and mature zigzag in-
florescence in a normal tomato. (Middle panels) s inflorescences
develop extra SIMs due to mutations in the ortholog of WOX9.
Additional SIMs (circles) eventually form flowers. (Black asterisks)
Asymmetrical development of meristem branches (black arrows
in schematics). (Lower panels) Strong alleles of an, defective in
the tomato ortholog of UFO, produce extra SIMs instead of flow-
ers. (L) Leaf; (SYM) sympodial shoot meristem. Bars, 100 µm. 
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A Comparative Morphological Study
of Inflorescence Development
K. Liberatore
How inflorescence meristems develop and branch is
only beginning to be studied in diverse species, and there
is scarce data for sympodial species. The s and an mu-
tants are ideal genotypes to serve as genetic and mor-
phological foundations to study the mechanisms that
control sympodial inflorescence branching. In particular,
s is responsible for the majority of inflorescence com-
plexity among domesticated tomatoes, and all strong
branching lines found thus far are due to a single allele
of s (Lippman et al., PLoS Biol 6: e288 [2008]). To es-
tablish a morphological foundation of how sympodial
inflorescence complexity arises during the earliest stages
of SIM development, we are carrying out a comprehen-
sive comparative study among Solanaceous plants with
different levels of inflorescence complexity. We are using
scanning electron microscopy (SEM), in situ hybridiza-
tion, and transgenic gene knockdown to decipher the
“rules” of branching for sympodial species. We are aim-
ing to achieve, for the first time, a detailed temporal
compilation of precisely staged meristems representing
all points of the vegetative to reproductive transition on
the primary shoot and subsequent SIM reiteration. 
By comparing s and an tomato mutants with wild
tomato species and other Solanaceae species, we are al-
ready establishing a developmental baseline on which to
draw conclusions about how SIMs are initiated and re-
iterated before terminating in flowers. We have screened
more than 150 Solanaceae and quantified inflorescence
branching, and from these data, we have selected a sub-
set of species that represent a range of architecture types,
including Nicotiana benthamiana, C. annuum (pepper)
and Petunia nyctaginiflora (petunia) (single flower inflo-
rescences), Solanum cleistogamum (two flowers per in-
florescense), Solanum conglobatum and Solanum
americanum (tomato-like inflorescence), and Styrax pe-
ruvianum and Nicotiana tobaccum (branched, many
flowers per inflorescence). As our model predicts, our
preliminary results suggest that the initial SIM of
branched species take slightly longer to reach the floral
transition, thereby allowing more SIMs to develop.
To deepen our understanding of molecular hall-
marks of this transition, we are using comparative in
situ hybridization with orthologs of inflorescence meris-
tem and floral meristem identity genes such as
S/WOX9, FALSIFLORA/LEAFY (FA/LFY) and ANAN-
THA/UNUSUAL FLORAL ORGANS (AN/UFO).
Using these molecular markers, we believe that key
steps in the initiation to flowering can be precisely
marked, such as boundaries between the shoot apical
meristem, the sympodial inflorescence meristem, and
floral meristem, perhaps even before a morphological
change is seen. In addition, we are using genes such as
FILAMENTOUS FLOWER and ANTEGUMENTA to
mark sites of organ initiation, which may subtend each
reiterating SIM. These studies will augment the SEM
analysis by answering the following questions: Which
genes mark the initiation and therefore reiteration of
the SIM? Does the existence of a subtending bract
(morphologically visible or not) explain the formation
of more complex inflorescence types, which are then
lacking in single flower species?
The Molecular Dynamics Underlying
Altered Developmental Fates of
Apical Plant Meristems
S.-J. Park
Mechanisms controlling SAM growth and floral induc-
tion have been identified in Arabidopsis, as have floral
induction genes; however, the dynamic molecular
changes that occur during phase transitions have proven
to be difficult to study due to physical restrictions. Fur-
thermore, the dynamics of the transition in Arabidopsis
are not necessarily extendable to other species. We are
taking advantage of the three types of meristems of
tomato to elucidate the dynamic changes in gene ex-
pression that take place during reproductive transitions
in plants. Tomato meristems are easily dissected under
a stereomicroscope and can be collected in sufficient
amounts for RNA extraction. We are growing wild-type
plants and precisely harvesting meristems with only two
visible leaf primordia every 3 days until floral termina-
tion. After the transition, we are collecting SYM, SIM,
and FM tissue. This experimental design has provided
us with material for expression analyses on eight stages
of sympodial growth, with a focus on the temporal dy-
namics of the vegetative to inflorescence phase transi-
tion of the primary shoot. Our preliminary results using
marker genes such as AN, S, AP1, and other floral and
vegetative markers suggest that reproductive transitions
are not sudden, but rather highly quantitative and dy-
namic. Furthermore, each meristem seems to have its
own molecular signature. 
We are now leveraging our microharvesting technique
to profile gene expression genome-wide using new se-
quencing technologies such as Illumina/Solexa (mRNA-
Seq) that enable quantitative transcriptome analyses.
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Using these data, phase transition markers will be deter-
mined based on subsets of genes that show informative
expression during SAM termination. Coexpressed genes
will be used to identify pathway candidates and promoter
motifs, especially as they relate to known developmental
and hormone regulatory genes. These profiles will be
compared to SYM and SIM transcriptomes to determine
the extent to which these phase transitions are similar or
different from the primary shoot and each other. This
analysis may shed light on a mechanism that explains
how SYMs and SIMs are released from dormancy—a
process that may be regulated by auxin and other un-
known factors. These data will also provide a list of can-
didate genes for functional studies using reverse genetic
tools. Finally, known and newly identified informative
genes will be used to create a library of stage-specific pro-
moters to drive fluorescent markers, along with hormone
reporters, to visualize expression, first statically and then
dynamically in real time. Although the focus of this pro-
posal is on the tomato, the knowledge gained will extend
to related Solanaceae and will augment and complement
work in nonsympodial plants, such as Arabidopsis and
grasses.
Novel Inflorescence Branching
Mutants
C. MacAlister
To increase our understanding of the pathways and net-
works regulating inflorescence patterning, we are inves-
tigating mutants with novel inflorescence architecture
defects. In particular, we are characterizing and cloning
the gene responsible for a new tomato mutant called
fasciated flower (faf ), which produces a highly branched
inflorescence with greatly enlarged flowers and fruits
that have increased organ number. This phenotype sug-
gests that some genes have dual roles in regulating de-
terminacy, affecting both the inflorescence and floral
meristems. In contrast, s and an seem to be specific to
the inflorescence meristem. Indeed, our analysis of faf:s
double mutants indicates that the two mutant pheno-
types are additive, indicating that these genes operate
in separate genetic pathways. Consistent with this, our
early SEM data suggest that faf mutants begin to man-
ifest an enlarged meristem even in the vegetative phase
of development and that this meristem continues to en-
large as the floral phase transition ensues. This results
in the formation of multiple ectopic sympodial shoots
(SYMs) on the sides of the enlarged primary meristem,
which is poised to become an extremely large flower
that resembles a sunflower head. Branching also occurs
as the SYMs transition to flowering, but to a lesser de-
gree than the primary flowering event. This distinction
between the primary and secondary shoot meristems is
in line with our preliminary molecular studies which
show that these meristems have distinct identities re-
flected in different molecular signatures. We have al-
ready fine-mapped the faf mutation, and we have now
embarked on gene cloning by sequencing the mRNA
from four alleles of faf in a common genetic back-
ground. If successful, this would be the first example of
gene cloning using next-generation sequencing tech-
nology in a plant genome as complex as the tomato.
We are also studying a classical mutation called ter-
minating flower (tmf ), which uniquely affects only the
primary inflorescence meristem by creating a single ter-
minal flower, whereas all other inflorescences derived
from axillary or sympodial shoots develop normally. In-
terestingly, this mutation was originally reported as
being derived from a single tomato plant grafted with
a shoot from an eggplant. A somatic mutation ensued
resulting in a mutant sector of the plant. Our prelimi-
nary work suggests tmf has a complex genetic basis, in-
volving at least two unlinked mutations. We are now
taking advantage of our recent efforts to sequence a
polymorphic wild species of tomato, Solanum pimpi-
nellifolium, to generate large mapping populations to
identify the responsible genes.
Identification and Characterization
of Single-gene Mutations Causing
Heterosis in Tomato
Z. Lippman [in collaboration with D. Zamir, Hebrew
University, Israel]
Despite countless studies in multiple systems, the ge-
netic and molecular underpinnings for how hybrid
progeny outperform their parental inbreds (heterosis)
have not been resolved. On the basis of classical studies
in noncrop plants and recent findings in yeast, we have
begun testing a new hypothesis that single-gene muta-
tions can cause phenotypic overdominance in the het-
erozygous state through a reduction in gene dosage. By
taking advantage of a large “mutant library” in an iso-
genic cultivated tomato background (Solanum lycoper-
sicum, cv. M82), we have identified multiple genes that
show heterosis through overdominance. However, the
extent and manner by which single-gene mutations
cause heterosis is unknown. We have used a robust phe-
nomics platform to resolve the genetic and developmen-
tal basis of heterosis in two mutants for which we have
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already identified the underlying genes. Surprisingly, we
have discovered that SINGLE FLOWER TRUSS (SFT),
which is the genetic originator of the flowering hormone
florigen that drives the reproductive transition in all
plants, increases yield up to 60% when loss-of-function
alleles are heterozygous. Yield overdominance from sft
heterozygosity is robust, occurring in distinct genetic
backgrounds and environments, and we show that sev-
eral traits integrate pleiotropically to drive heterosis in a
multiplicative manner. Our results suggest that a simple
reduction in the dosage of a single gene can cause dra-
matic transgressive variation. These findings provide the
first example of a single overdominant gene for yield and
suggest that screening for mutations with heterozygous
effects on growth can improve productivity in other
agricultural organisms.
On the basis of these findings, we are now extending
our studies to screen for other mutants that show het-
erosis in the heterozygous state. Furthermore, because
of the greatly reduced genomic complexity of single-
gene heterosis, we are performing targeted and global
quantitative gene expression analyses to link heterotic
effects with transcriptional changes in developmental
pathways and/or larger transcriptional networks. 
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Soonju Park, Zach Lippman
Plants and fission yeast exhibit a wealth of epigenetic
phenomena, including transposon regulation, hetero-
chromatic silencing, and gene imprinting, important
both for plant breeding and for human health. They pro-
vide excellent model organisms to address the question
of how epigenetic information is propagated to daughter
cells. We are investigating the inheritance of heterochro-
matic silencing using the fission yeast Schizosaccharomyces
pombe and the model plant Arabidopsis thaliana using a
variety of genetic and genomic approaches. We discov-
ered that fission yeast RNA interference (RNAi), which
is required for transcriptional silencing of centromeric
heterochromatin, occurs during S phase, allowing for
copying of heterochromatic histone modifications fol-
lowing DNA replication and cell division. We also
showed that in plants, cells in culture and male germline
cells undergo massive epigenomic changes correlated
with the appearance of a novel class of 21-nucleotide
small interfering RNA (siRNA) from transcriptionally
reactivated transposable elements (TEs). On the basis of
our discovery of mobile endogenous small RNA signals
in plants, we propose a model for the role of pro-
grammed TE reactivation in germline companion cells
as part of a developmental mechanism for first revealing
and then silencing TEs via small RNA. This year, we wel-
comed postdocs Kate Creasey, Andrea Schorn, Fred van
Ex, Chunlao Tang, and URP Lisa Lim. We said farewell
to Watson School students Eyal Gruntman and Sarah-
jane Locke, and postdoc Rebecca Schwab. Anna Kloc
graduated from the genetics program at SUNY Stony
Brook for a postdoc at Yale, and Keith Slotkin accepted
a position at Ohio State University. 
Epigenetic Reprogramming and Small RNA
Silencing of Transposable Elements in Pollen
R.K. Slotkin, F. van Ex, M.W. Vaughn, M Tanurd^zic´ [in 
collaboration with J.D. Becker and J.A. Feijó, Gulbenkian
Institute, Lisbon]
The mutagenic activity of TEs is suppressed by epigenetic
silencing and siRNAs, especially in gametes that could
EPIGENETIC INHERITANCE AND REPROGRAMMING
IN PLANTS AND FISSION YEAST
R. Martienssen J. Calarco J.-J. Han J. Le Pen A. Schorn R.K. Slotkin M.W. Vaughn
A.-Y. Chang K. Hansen L. Lim R. Schwab M. Tanurd^zic´ J. Xue
K. Creasey D. Irvine U. Ramu R. Shen V. Thapar M. Zaratiegui
P. Finigan A. Kloc M. Regulski J. Simorowski F. van Ex
transmit transposed elements to the next generation. In
pollen from the model plant Arabidopsis, we have found
that TEs are unexpectedly reactivated and transpose, but
only in the pollen vegetative nucleus, which accompanies
the sperm cells but does not provide DNA to the fertil-
ized zygote. TE expression coincides with down-regula-
tion of the heterochromatin remodeler DECREASE IN
DNA METHYLATION 1 and of many TE siRNAs.
However, 21-nucleotide siRNAs from Athila retrotrans-
posons are generated and accumulate in sperm, suggest-
ing that siRNA from TEs activated in the vegetative
nucleus can target silencing in gametes (Fig. 1). We pro-
pose a conserved role for reprogramming in germline
companion cells, such as nurse cells in insects and vege-
tative nuclei in plants, to reveal intact TEs in the genome
and regulate their activity in gametes.
Control of Female Gamete Formation
by a Small RNA Pathway
R.K. Slotkin, A. Schorn, K. Creasey [in collaboration 
with J.P. Vielle-Calzada, Langebio-Cinvestav Mexico]
In the ovules of most sexual flowering plants, female ga-
metogenesis is initiated from a single surviving gametic
cell, the functional megaspore, formed after meiosis of
the somatically derived megaspore mother cell (MMC).
Because some mutants and certain sexual species exhibit
more than one MMC, and many others are able to form
gametes without meiosis (by apomixis), it has been sug-
gested that somatic cells in the ovule are competent to
respond to a local signal likely to have an important func-
tion in determination. We have found the Arabidopsis
protein ARGONAUTE 9 (AGO9) controls female ga-
mete formation by restricting the specification of game-
tophyte precursors in a dosage-dependent, non-cell-
autonomous manner. Mutations in AGO9 lead to the
differentiation of multiple gametic cells that are able to
initiate gametogenesis. The AGO9 protein is not ex-
pressed in the gamete lineage; instead, it is expressed in
cytoplasmic foci of somatic companion cells. Mutations
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Heterochromatin, Small RNA, and 
Postfertilization Dysgenesis in 
Allopolyploid and Interploid 
Hybrids of Arabidopsis spp.
M. Tanurd^zic´, P. Finigan, J. Le Pen,  M. Vaugh [in 
collaboration with R.W. Doerge, Purdue University, 
and L. Comai, University of California, Davis]
In many plants, including Arabidopsis, hybrids between
species and subspecies encounter postfertilization bar-
riers in which hybrid seeds fail to develop or else give
rise to infertile progeny. In Arabidopsis, some of these
barriers are sensitive to ploidy and to the epigenetic sta-
tus of donor and recipient genomes. Recently, a role has
been proposed for heterochromatin in reprogramming
events that occur in reproductive cells, as well as in the
embryo and endosperm after fertilization. The 21-nu-
cleotide siRNAs from activated transposable elements
accumulate in pollen and are translocated from com-
panion vegetative cells into the sperm (see Fig. 1); how-
ever, in the maturing seed 24-nucleotide siRNAs are
primarily maternal in origin. Thus, maternal and pa-
ternal genomes likely contribute differing small RNAs
to the zygote and to the endosperm. As heterochro-
matic sequences also differ radically between, and
within, species, small RNA sequences will diverge in
hybrids. If transposable elements in the seed are not tar-
geted by small RNA from the pollen, or vice versa, this
could lead to hybrid seed failure. Heterochromatin also
has a role in apomix is and nucleolar dominance and
may use a similar mechanism.
Endogenous Trans-acting siRNAs
Mediate Non-cell-autonomous Effects
on Gene Regulation in Arabidopsis
R. Schwab [in collaboration with O. Voinnet 
and M. Crespi, CNRS France]
Different classes of small RNAs refine the expression of
numerous genes in higher eukaryotes by directing pro-
tein partners to complementary nucleic acids, where they
mediate gene silencing. Plants encode a unique class of
small RNAs, called trans-acting small interfering RNAs
(tasiRNAs), which posttranscriptionally regulate protein-
coding transcripts, as do microRNAs (miRNAs), and
both small RNA classes control development through
their targets. tasiRNA biogenesis requires multiple com-
ponents of the siRNA pathway and also miRNAs. But
although 21-mer siRNAs originating from transgenes
can mediate silencing across several cell layers, miRNA
in SUPPRESSOR OF GENE SILENCING 3 and RNA-
DEPENDENT RNA POLY MERASE 6 exhibit a defect
identical to that of ago9 mutants, indicating that the
movement of small RNA silencing out of somatic com-
panion cells is necessary for controlling the specification
of gametic cells. AGO9 preferentially interacts with 24-
nucleotide small RNAs derived from TEs, and its activity
is necessary to silence TEs in female gametes and their
accessory cells. Our results show that AGO9-dependent
small RNA silencing is crucial to specify cell fate in the
Arabidopsis ovule and that epigenetic reprogramming in
companion cells is necessary for small RNA-dependent
silencing in plant gametes.
Figure 1. Epigenetic reprogramming and small RNA silencing of
TEs in pollen. (Top) Expression of five different TEs, monitored
with the Ath1 Affymetrix microarray, is restricted to pollen and
immature seeds, as well as cultured cells (not shown). (Bottom)
A model for small RNA signals in the pollen grain (stained with
DAPI). TEs are expressed in the vegetative nucleus (right), which
loses heterochromatin due to loss of the DECREASE IN DNA
METHYLATION 1 (DDM1) protein. TE transcripts are rapidly con-
verted into small RNA, which are translocated into sperm cells
where they silence any TE active in the germline. 
action seems to be spatially restricted to the producing
or closely surrounding cells. We have previously de-
scribed the isolation of a gene-trap reporter line for
TAS3a, the major locus producing AUXIN RESPONSE
FACTOR (ARF)-regulating tasiRNAs in the Arabidopsis
shoot. Its activity is limited to the adaxial (upper) side of
leaf primordia, thus spatially isolated from ARF activities,
which are located in the abaxial (lower) side. We have
shown by in situ hybridization and reporter fusions that
the silencing activities of ARF-regulating tasiRNAs are
indeed manifested non-cell-autonomously to spatially
control ARF activities. Endogenous tasiRNAs are thus
mediators of a mobile developmental signal and might
provide effective gene silencing at a distance beyond the
reach of most miRNAs.
The Maize Genome: Complexity, 
Diversity, and Dynamics
J.-J. Han, C. Tang, M. Regulski, M.W. Vaughn [in 
collaboration with D. Ware and W.R. McCombie, 
Cold Spring Harbor Laboratory, and the maize 
genome-sequencing consortium]
An improved draft nucleotide sequence of the 2.3-Gb
genome of maize revealed more than 32,000 predicted
genes. Nearly 85% of the genome is composed of hun-
dreds of families of transposable elements, dispersed
nonuniformly across the genome. By comparison with
our previous genome sequencing by methylation filtra-
tion, we correlated methylation-poor regions with Mu
transposon insertions, high gene density, and recombina-
tion. Careful annotation of a contiguous 22-Mb region
of maize chromosome 4 revealed 84% of the sequence is
composed of TEs nested within each other, of which most
families are low-copy. 544 gene models were identified,
as well as five miRNA genes. They include several candi-
dates for the classical dominant Tunicate1, a pre-
Columbian trait (podcorn) that maps to the interval and
undergoes rearrangements and copy-number changes. 
Mapping Epigenetic Mutations in Fission
Yeast Using Whole-genome 
Next-generation Sequencing
D. Irvine, M. Zaratiegui, K. Hansen, A.-Y. Chang, 
M.W. Vaughn, L. Lim, A. Kloc [in collaboration with 
W.R. McCombie, Cold Spring Harbor Laboratory]
Fission yeast is an important model for epigenetic stud-
ies due to the ease with which genetic mutants can be
isolated. However, it can be difficult to complement
epigenetic phenotypes with genomic libraries in order
to identify the genes responsible. This is because epige-
netic phenotypes are typically unstable, and they can
prohibit complementation if silencing cannot be reesta -
blished. We have resequenced the fission yeast genome
following mutagenesis to readily identify a novel mu-
tant involved in heterochromatic silencing. Candidate
genes were identified as functional single-base changes
linked to the mutation, which were then reconstituted
in a wild-type strain to recapitulate the mutant pheno-
type. By this procedure, we identified a weak allele of
ubc4, which encodes an essential E2 ubiquitin ligase, as
responsible for the swi*603 mutant phenotype. In com-
bination with a large collection of mutants and suppres-
sor plasmids, next-generation genomic resequencing
promises to dramatically enhance the power of yeast ge-
netics, permitting the isolation of subtle alleles of es-
sential genes, alleles with quantitative effects, and
enhancers and suppressors of heterochromatic silenc-
ing. This provides a complementary strategy to analysis
of the fission yeast deletion library, based on evolution-
ary prediction of genes involved in RNAi. We have also
sequenced small RNA and other populations of small
molecules from S. pombe and related species to investi-
gate the evolution of small RNA silencing and hete-
rochromatin in this model eukaryotic cell.
Enhancer-trap and Gene-trap Tagging of
Transposons in Arabidopsis
J. Simorowski, U. Ramu, R. Shen
We have continued to grow our collection of gene-trap
and enhancer-trap insertions in Arabidopsis and have
now sequenced close to 40,000 insertion sites. Of re-
cent interest, we have found insertions that monitor ex-
pression of TE in pollen and in RNAi-deficient ovules.
We have also found enhancer-trap insertions that accu-
rately report the expression of noncoding precursors of
trans-acting siRNA, as well as genes required for cell–
cell movement of RNA signals. These and many other
individual lines have been distributed to other groups
at CSHL, as well as to the community as a whole.
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Miguel Zaratiegui Biurrun
Plants have the distinctive ability to form new organs
throughout their lifetime, which can span hundreds or
even thousands of years. The growing tip of a plant con-
tains a population of stem cells that are located within
a specialized niche, termed the shoot apical meristem
(SAM). These stem cells divide to maintain the SAM
and to generate daughter cells from which lateral or-
gans, such as leaves and flowers, arise. The research in
our lab aims to dissect the genetic networks that operate
within the SAM to regulate stem cell homeostasis and
to generate and pattern leaves.
Adaxial–Abaxial Patterning  
by Opposing Small RNAs 
D. Chitwood [in collaboration with former postdoc 
F. Nogueira, University of Sao Paulo, Sao Paulo, Brazil]
Outgrowth and patterning of lateral organs in plants de-
pend on the specification of adaxial–abaxial (upper/
lower) polarity. We have shown that this asymmetry is
generated by a novel patterning mechanism in which
small RNAs establish opposing fates of the axis. In maize,
microRNA (miRNA) miR390 accumulates on the adax-
ial (upper) side of developing leaves where it triggers the
biogenesis of 21-nucleotide TAS3-derived trans-acting
short interfering RNAs (tasiRNAs) (Fig. 1A). These con-
fine the accumulation of abaxial determinants, including
AUXIN RESPONSE FACTOR3 (ARF3) and miR166,
to the lower side of leaves. miR166, in turn, demarcates
the abaxial side by repressing expression of class III
homeodomain leucine zipper (HD-ZIPIII) transcription
factors that specify adaxial fate. 
Our findings indicate that establishment of organ po-
larity requires the precise spatiotemporal accumulation
and relative efficacy of TAS3-derived tasiRNAs and
miR166. To investigate the regulatory mechanisms that
allow for the precise spatiotemporal accumulation of
these polarizing small RNAs, we used laser-microdissec-
tion coupled to reverse transcriptase–polymerase chain
reaction (RT-PCR) to determine the expression profiles
of their precursor transcripts within the maize shoot apex.
PLANT DEVELOPMENTAL GENETICS
M. Timmermans K. Bergami C. Fernandez-Marco K. Petsch
D. Chitwood C. Hu E. Plavskin
C. Clendaniel A. Husbands D. Skopelitis
M. Dotto M. Lodha
Our data reveal that the pattern of mature miR166 ac-
cumulation results, in part, from intricate transcriptional
regulation of its nine precursor loci and that only a subset
of mir166 family members contributes to the establish-
ment of leaf polarity. We also showed that the polar ex-
pression of miR390 is established and maintained
independent of the tasiRNA pathway. The comparison
of small RNA localization data with the expression pro-
files of precursor transcripts suggests that miR166 and
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Figure 1. Pattern formation in leaves via small RNA mobility. (A)
The tasiR-ARF pathway. (B) In situ hybridization using an LNA
(locked nucleic acid) probe reveals a gradient of tasiR-ARF ac-
cumulation that is strongest on the adaxial (upper) side of the
leaf and dissipates away toward the abaxial (lower) side. (C)
Summary of the localization patterns of tasiR-ARF pathway com-
ponents. Although miR390 accumulates uniformly throughout
leaves, tasiR-ARF biogenesis is restricted to the few most-adaxial
cell layers of leaves by the localized expression of AGO7 and
TAS3A. tasiR-ARFs accumulate outside this defined domain of
biogenesis and form a gradient across leaves (B), indicative of
the mobility of this small RNA (C, dotted arrow). tasiR-ARFs act
through a dose-dependent mechanism, such that this small RNA
gradient creates a precisely defined domain of ARF3 expression
and sharpens the adaxial–abaxial boundary. 
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These data identify the first mobile positional signal
in adaxial–abaxial patterning of the leaf. Moreover, our
study reveals two novel RNA interference (RNAi)-based
patterning mechanisms. First, subspecialized interac-
tions between RNAi effector proteins and small RNAs,
such as that between miR390 and AGO7, can act to
spatially limit small RNA activity during development.
Second, the movement of small RNAs, such as tasiR-
ARFs, outside of their domain of biogenesis, precisely
patterns targets and might serve to convey positional in-
formation, demonstrating that small RNAs can serve as
mobile, inductive signals during development. 
Dissecting Small RNA Mobility in Plants
D. Skopelitis, C. Hu
An intriguing question is whether miRNAs, like en-
dogenous siRNAs, can traffic between cells. Given the
scope of miRNA-regulated gene networks in develop-
ment, the cell-to-cell movement of miRNAs would
have important implications with respect to their po-
tential to act as inductive signals and generators of pat-
tern. Using in situ hybridization and pMIR390:GUS
reporter constructs, we have shown that expression of
both MIR390 precursors is limited to developing leaf
primordia and the region below the shoot apical meris-
tem, whereas mature miR390 accumulation extends
into the meristem proper. At least one other miRNA,
miR391, shows a similar discrepancy between the lo-
calization pattern of the mature miRNA and its precur-
sor in the meristem region. Unlike miR390, miR391
possesses a 5′ U and is loaded into AGO1, suggesting
that the possible movement of miR390 would not be
an outcome of its unique recruitment into an AGO7
complex, but it may be a general property of miRNAs
expressed beneath the SAM.
To further investigate the possible movement of 
miRNAs in a variety of developmental contexts, we have
generated artificial miRNAs against PHYTOENE DE-
SATURASE (miR-PDS), whose silencing activity results
in an easy observable photobleaching phenotype. When
expressed from the epidermis, in a mutant background
defective in production of secondary siRNAs, miR-PDS
results in the silencing of PDS in subepidermal cell lay-
ers, consistent with small RNA mobility. Similarly, ex-
pression of a modified TAS3 precursor in which the
tasiR-ARFs are replaced by small RNA sequences tar-
geting PDS (TAS3-PDS) from the epidermis results in
a photobleaching phenotype. We are taking advantage
of these genetic resources to analyze parameters of small
RNA mobility, such as tissue specificity and direction
miR390 accumulation is also regulated at the level of bio-
genesis and/or stability. Furthermore, mir390 precursors
accumulate exclusively within the epidermal layer of the
incipient leaf, whereas mature miR390 accumulates in
the subepidermal layers as well. Regulation of miR390
biogenesis, stability, or even discrete trafficking of
miR390 from the epidermis to underlying cell layers pro-
vides possible mechanisms that define the extent of
miR390 accumulation within the incipient leaf, which
patterns this small field of cells into adaxial and abaxial
domains via the production of tas3-derived tasiRNAs. 
Pattern Formation via Small RNA Mobility
D. Chitwood [in collaboration with former postdoc
F. Nogueira, and  T. Montgomery, M. Howell, and 
J. Carrington, Oregon State University, Corvallis]
A recurring theme in pattern formation is the interpre-
tation of relative distance from a point source through
the activity of mobile, positional signals. siRNAs that are
produced upon transgene-induced gene silencing or dur-
ing viral infection are known to move systemically
throughout plants, but intercellular movement of devel-
opmentally relevant endogenous small RNAs had not
been observed. By comparing the pattern of tasiR-ARF
accumulation with the localization of tasiR-ARF biogen-
esis components (Fig. 1), we sought to determine
whether this unique class of endogenous siRNAs is mo-
bile and can traffic between cells from their source of bio-
genesis. Using an ARF3-based sensor of tasiR-ARF
activity, we showed that tasiR-ARFs act throughout the
leaf but more strongly on the upper (adaxial) side than
on the lower (abaxial) side. tasiR-ARFs thereby delimit
expression of the abaxial determinant ARF3 discretely to
the lower side of the leaf. In situ hybridization analysis
revealed that miR390, whose activity initiates tasiR-ARF
biogenesis, accumulates ubiquitously in leaves. In con-
trast, the tasiR-ARF biogenesis factor ARGONAUTE7
(AGO7) and the tasiR-ARF precursor TAS3A both lo-
calize exclusively to the two adaxial-most cell layers. Con-
sequently, tasiR-ARF biogenesis is restricted to the
adaxial side of developing leaves where miR390 colocal-
izes with AGO7 and TAS3A. However, tasiR-ARF activ-
ity is detected outside this region of biogenesis, indicating
that tasiR-ARFs traffic from the adaxial to the abaxial
side. Indeed, in situ hybridization analysis revealed that
tasiR-ARFs accumulate in a gradient across leaves that is
strongest adaxially and dissipates toward the abaxial side
of the leaf. This small RNA gradient is interpreted into
adaxial and abaxial domains of high and low tasiR-ARF
activity that creates a discrete pattern of ARF3 expression
on the abaxial side of the leaf.
and range of movement, and whether this is dose de-
pendent. We are also using stable uniform bleaching
lines in forward genetic screens to identify factors in-
volved in the cell-to-cell trafficking of miRNAs and
tasiRNAs.
The Ancestral Role of the tasiRNA Pathway
E. Plavskin [in collaboration with R. Quatrano, 
Washington University, St. Louis, Missouri]
Genes involved in tasiRNA biogenesis, as well as
miR390 and the TAS3 loci themselves, are conserved
in the moss Physcomitrella patens. Even more interest-
ing, tasiRNAs produced from Physcomitrella TAS3 loci
target transcripts of AUXIN RESPONSE FACTOR
genes. Early divergent land plants such as Physcomitrella
lack true leaves, and their “leaf-like” lateral outgrowths
are composed of a single cell layer. The ancestral role of
the TAS3 tasiRNA pathway will thus be distinct from
its known role in adaxial–abaxial patterning of leaves
in flowering plants. To dissect the developmental
processes in moss regulated by tasiR-ARFs, we are char-
acterizing knockouts of genes involved in tasiRNA bio-
genesis in Physcomitrella, as well as the targets of the
moss tasiR-ARFs. We have shown that sgs3 loss-of-
function mutants display a branching defect in the fil-
amentous stage of growth. These mutants also appear
to undergo a precocious transition from filamentous
growth to budding—reminiscent of the early transition
from juvenile to adult growth seen in Arabidopsis
tasiRNA biogenesis mutants. A knockout of PpARF2,
one of the targets of the miR390-dependent tasiRNAs,
was found to be lethal, which might reflect a defect in
branch formation. Using a transcriptional reporter, we
have found that the MIR390b precursor is expressed
strongly in the protonema. Reporter constructs to mon-
itor expression of the other two MIR390 precursors, ad-
ditional tasiRNA biogenesis components, and the ARF
targets are being generated, as well as mutants that ex-
press tasiRNA-insensitive versions of the ARF targets.
Analysis of these Physcomitrella mutants and reporter
lines will shed light on the ancestral role of this highly
conserved small RNA pathway in plant development.
The START Domain Regulates HD-ZIPIII
Activity and Organ Polarity
A. Husbands
The HD-ZIPIII transcription factors PHABULOSA
(PHB), PHAVOLUTA (PHV), and REVOLUTA (REV)
are required and sufficient for the specification of adaxial
cell fate. Their role as adaxial determinants was uncovered
through dominant mutations that prevent the cleavage of
PHB, PHV, and REV transcripts by miR166. Such mu-
tant transcripts accumulate on both sides of developing
leaf primordia resulting in their adaxialization. HD-
ZIPIII proteins contain a predicted START lipid/ sterol-
binding domain, suggesting that HD-ZIPIII activity may
further be regulated by an unknown ligand. To assess
whether the START domain is important for PHB func-
tion, we generated transgenic Arabidopsis lines that express
START domain variants of a PHB-YFP fusion protein.
As recessive loss-of-function phb mutants display no dis-
tinguishing phenotypes, these PHB-YFP reporters also
carry silent mutations in the miR166 target site. As ex-
pected, nearly all T1 transformants expressing the
miR166-insensitive PHB-YFP fusion develop severely
adaxialized leaves. Expression of a PHB-YFP variant, in
which two highly conserved arginine residues in the
START domain are mutated to leucine, yielded plants
with less severe leaf phenotypes. Transgenic lines expres-
sing a PHB-YFP variant with a deletion of the START
domain resemble wild-type plants. 
Confocal imaging revealed that the START-deleted
PHB-YFP fusion protein, like normal PHB, localizes to
the nucleus. This indicates that the START-deleted PHB-
YFP protein is not inherently unstable and that the
START domain is critical for PHB function. Moreover,
these data argue against a role for the START domain in
regulating the subcellular localization of PHB. We are
currently investigating other potential mechanisms
through which the START domain may regulate PHB
activity, such as DNA-binding affinity, activation of tran-
scription, or interaction with required protein partners.
Preliminary data using a modified yeast–one-hybrid ap-
proach suggest that the START domain may be dispen-
sable for transcription activation in yeast. These yeast
strains will also be used to screen a 380,000 small-mole-
cule library for putative agonists/antagonists of PHB and
other HD-ZIPIII proteins in collaboration with partners
at the Memorial Sloan-Kettering Cancer Center.
Characterization of Novel tasiRNA
Loci in Maize
M. Dotto [in collaboration with M. Aukerman, M. Beatty,
and R. Williams, DuPont-Pioneer, Wilmington, Delaware]
tasiRNAs are processed from noncoding TAS precursor
transcripts. Following cleavage by a miRNA-loaded
ARGONAUTE complex, one of the cleavage products
is converted into double-stranded RNA (dsRNA)
through the activities of RDR6 and LBL1/SGS3 and
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subsequently processed by DCL4 into phased 21-nu-
cleotide siRNAs. Arabidopsis contains four characterized
TAS gene families. AGO1 is required for the biogenesis
of tasiRNAs from the TAS1, TAS2, and TAS4 loci,
whereas miR390-loaded AGO7 triggers the biogenesis
of TAS3 tasiRNAs. We previously identified four TAS3
loci in the maize genome; however, the TAS1, TAS2,
and TAS4 loci are not conserved between Arabidopsis
and maize. To identify potential novel TAS loci in
maize, we are using a deep-sequencing approach to
compare the small RNA content between wild-type and
lbl1 mutant apices. In addition, we are characterizing
small RNAs that associate with specific AGO proteins.
The maize genome encodes 20 AGO proteins, includ-
ing one AGO7 and four AGO1 homologs. We are gen-
erating transgenic maize plants expressing FLAG-
tagged versions of ZmAGO7 and ZmAGO1b to isolate
associated small RNAs via immunoprecipitation. We
expect to identify novel tasiRNAs, miRNAs, and pos-
sibly the transcripts that are the targets of these small
RNAs. For additional information regarding the small
RNA pathways in maize, we are also characterizing
small RNAs that associate with ZmAGO10. This AGO
protein has been implicated in the miRNA and
tasiRNA-mediated regulation of meristem maintenance
and leaf development in Arabidopsis.
Regulation of Maize Leaf Determination
and Patterning by Laxmidrib1
M. Dotto [in collaboration with B. Lin, J. Jaqueth, and K. Fen-
gler, DuPont-Pioneer, Wilmington, Delaware]
Laxmidrib1-O (Lxm1-O) is a dominant ethylmethane-
sulfonate (EMS)-induced mutation in maize that causes
pleiotropic developmental phenotypes that vary depend-
ing on inbred background. The most-penetrant defect is
the presence of a flexible midrib. In addition, in Lxm1-
O mutants, the blade/sheath boundary is displaced dis-
tally into the leaf blade, a phenotype reminiscent of that
caused by ectopic KNOX expression. In the W22 inbred,
Lxm1-O also causes the partial adaxialization of leaves.
These observations indicate a role for Lxm1 in leaf de-
termination and patterning. To further characterize the
role of Lxm in these processes, we analyzed its interaction
with rs2, Rld1-O, and lbl1. Like Lxm1-O, mutation of
the myb domain protein RS2 leads to ectopic KNOX ex-
pression in developing primordia, resulting in the forma-
tion of leaves with a characteristic rough sheath
phenotype. Surprisingly, in Lxm1-O rs2 double mutants,
this sheath phenotype is nearly completely suppressed,
whereas the Lxm1 blade phenotype is slightly enhanced.
In maize, abaxial–adaxial patterning requires the activity
of Rld1 and lbl1, which encode an HD-ZIPIII transcrip-
tion factor and a homolog of the tasiRNA biogenesis
component SGS3, respectively. Rld1-O single mutants
develop adaxialized leaves due to ectopic expression of
Rld1 caused by insensitivity to miR166 regulation.
Lxm1-O and Rld1-O enhance each other, resulting in the
formation of severely adaxialized leaves. In contrast,
Lxm1-O suppresses the partial abaxialized leaf pheno-
types of weak lbl1 mutants. Efforts to clone Lxm1 by a
map-based approach are ongoing. Lxm1 maps to a region
spanning 200 kb on chromosome 3. 
Small RNA-regulated Gene Networks
in SAM Function and Adaxial–Abaxial 
Patterning
K. Petsch [in collaboration with M. Scanlon, Cornell 
University, Ithaca, New York; D. Janick-Buckner, Truman
State University, Kirksville, Missouri; G. Muehlbauer, 
University of Minnesota, Minneapolis; J. Yu, Kansas 
State University, Manhattan; P. Schnable, Iowa State 
University, Ames]
Mutations that block tasiRNA biogenesis in maize lead
to the formation of abaxialized leaves. To gain insight
into gene networks regulated by tasiRNAs and/or in-
volved in adaxial–abaxial patterning, we used laser cap-
ture microdissection (LCM) coupled with microarray
analyses to compare the global gene expression profiles
in the SAM and the first leaf of wild-type and lbl1 mu-
tants. We identified 352 genes whose expression is sig-
nificantly altered in lbl1. Interestingly, 47 of these genes
also show differential expression between the incipient
leaf and the SAM proper. In situ hybridization analysis
identified two potential new polarity factors among the
subset of genes enriched in the incipient leaf. seven-
absentia-like is expressed adaxially and shows reduced
expression in lbl1 mutants, whereas expression of a
squamosa promoter binding protein-like is enriched in
the abaxial domain of normal leaf primordia and accu-
mulates ectopically in lbl1 mutants. 
We are currently screening various reverse genetic re-
sources available in maize for mutations in selected
genes differentially expressed in lbl1. Mutant alleles
have been identified for a SCARECROW-like protein
related to AtSCL9/14, rdr6, a putative B3 DNA-bind-
ing domain containing protein and arf3a. These mu-
tants are currently under analysis for defects in
adaxial–abaxial patterning and SAM function. To fur-
ther supplement our analysis of genes involved in the
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regulation of adaxial–abaxial patterning, we are also an-
alyzing several dicer-like4 (dcl4) mutants. Both lbl1 and
dcl4 function in the same tasiRNA pathway and are sin-
gle-copy genes. However, severe alleles of lbl1 result in
embryo lethality, whereas null mutations in dcl4 show
phenotypic resemblance to the weak lbl1-ref allele. The
possibility that another DICER family member can
partially compensate for the loss of dcl4 activity is cur-
rently being tested. This project will provide novel in-
sights into the gene networks controlled by tasiRNAs
and their contribution to organ polarity.
Establishment of Determinacy during
Organ Development
M. Lohda, C. Clendaniel
Stem cell activity in the SAM is maintained in part by
the class I KNOX homeobox genes. To give rise to differ-
entiating structures, such as leaves, KNOX gene expres-
sion needs to be maintained in a stable “off” state
throughout lateral organ development. We have previ-
ously shown that this process is mediated by the tran-
scription factors AS1 and AS2, which recruit the
chromatin-remodeling factor HIRA to the KNOX loci.
We have now identified a role for a polycomb repressive
complex 2 (PRC2) in the stable silencing of KNOX genes
during leaf development. PRC2 complexes have histone
H3K27 trimethylation (H3K27me3) activity, and we
have identified this repressive mark on nucleosomes at
the BP and KNAT2 loci in leaves of Arabidopsis. Besides,
mutations in the PRC2 component CLF lead to a reduc-
tion in the levels of this H3K27me3 mark at the KNOX
loci and the ectopic expression of KNOX genes in devel-
oping leaves. Moreover, we have shown that in as1 hira
mutants, the levels of H3K27me3 are significantly re-
duced, consistent with a role for the AS1-AS2-HIRA
complex in the recruitment of PRC2. To assess this pos-
sibility, we have developed tagged lines for the PRC2
components MSI1 and CLF, and raised monoclonal and
polyclonal antibodies against HIRA. These resources are
being used to monitor recruitment of PRC2 and HIRA
to the KNOX loci in wild-type and as1, as1 hira, and clf
mutant seedlings. To determine whether the AS1-AS2-
HIRA complex can interact directly with PRC2 compo-
nents, we have used biomolecular fluorescence com-
plementation (BiFC). This revealed a physical interaction
between HIRA and MSI1. These data suggest that cellu-
lar differentiation is achieved via an epigenetic mecha-
nism in which HIRA serves as an intermediary factor that
recruits PRC2 to pluripotency determinants. HIRA and
PRC2 have also been implicated into the regulation of
stem cell homeostasis in mammals, such that our findings
in plants may provide an excellent framework for future
studies on HIRA- and PcG-mediated gene silencing in
mammalian embryonic stem cells and induced pluripo-
tent stem cells. 
Characterization of chups, an Embryonic
Patterning Mutant in Arabidopsis
C. Fernandez-Marco, K. Bergami
Embryogenesis in Arabidopsis proceeds through a series
of stereotypic divisions. An asymmetric division of the
zygote gives rise to the apical embryonic lineage and
the basal extra-embryonic suspensor. After several more
rounds of cell division, the upper tier of the embryo
proper generates the shoot apical meristem, whereas the
upper cell of the suspensor undergoes two successive
asymmetric divisions to give rise to the root apical
meristem. We have identified a mutant that delays em-
bryonic development. At the time of fruit dehiscence,
mutant embryogenesis has progressed to just the late
globular or heart stage. We have called this mutant
chupa chups (chups), which means lollipop in Spanish.
Despite the delay in embryogenesis, patterning of the
shoot apical meristem is unaffected in chups mutants.
In contrast, cell division of the hypophysis, the special-
ized cell of the suspensor that ultimately gives rise to
the quiescent center of the root stem cell niche, is per-
turbed in chups. Characterization of molecular markers
suggests that auxin transport is altered in chups. As a re-
sult, an auxin maxima is no longer established at the
boundary between the proembryo and suspensor, lead-
ing to a failure to specify the hypophysal cell. chups mu-
tant embryos can be rescued by transferring fertilized
ovules onto culture medium. Consistent with the
above-mentioned patterning defects, rescued mutant
seedlings develop a normal shoot but lack a root. We
are currently using map-based and next-generation se-
quencing approaches to clone the chups mutation. The
outcome of these experiments will allow us to position
CHUPA CHUPS in the genetic network that patterns
the root stem cell niche during embryogenesis.
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Christina Fernandez Marco
CSHL is at the leading edge of efforts to manage and interpret the massive amounts of information
generated by biological experiments, across fields. Recently, the Laboratory took a further step into
this realm by creating a Center for Quantitative Biology. The new center reflects the importance of
math and statistics in the forging of new approaches to problems and new ways of understanding
the results of contemporary experimentation.
The insights of W. Richard McCombie and colleagues have led to the introduction and opti-
mization of novel methods of high-throughput genome sequencing. His team has made it possible
to catalog variation among individual organisms in a way that would have been unthinkable a decade
ago. They have brought online a new generation of Solexa sequencers and optimized their function
to a level at which 10 billion DNA bases can be sequenced in a typical day, and on some days, as
many as 20 billion. McCombie’s team took part in the effort, completed this year, to sequence the
genome of maize, one of the world’s most important crops. They have also had an important role
in projects to sequence the flowering plant Arabidopsis thaliana, the fission yeast Schizosaccharomyces
pombe, and Homo sapiens. New work is under way to sequence genes of special interest, including
DISC1, a strong candidate gene for schizophrenia, and genomic regions likely implicated in bipolar
illness. With Sloan-Kettering Cancer Center, they are using a method called hybrid resequencing,
developed with Greg Hannon, to look at mutations in samples collected from patients with prostate
cancer.
Lincoln Stein’s lab is developing databases, data analysis tools, and user interfaces to organize,
manage, and visualize the vast body of information being generated by biologists. They have recently
established the modENCODE Data Coordination Center, which is responsible for collecting, in-
tegrating, and publishing the information collected by the ENCODE (ENCyclopedia of DNA El-
ements) consortium in a form that can be extended and combined with information from other
human and model organism genome databases. The lab has also had an important role in the
HapMap project, a database of human single-base-pair variations that provides information on the
genetic variability of 11 human populations. Stein’s group also manages and curates the WormBase
and Reactome databases and is involved in the iPlant Collaborative, an effort to better enable plant
biology researchers to collaborate in cyberspace.
Using multidisciplinary approaches that combine computational analysis, modeling, and pre-
diction with experimental verification, Doreen Ware’s lab seeks a deeper understanding of the evo-
lution of genome sequences in plants. By looking comparatively across the genomes of plants in the
same lineage, they seek answers to such questions as: how are genes conserved and lost over time
and what are the fates of duplicated genes? Ware’s team also studies gene regulation in plants, looking
at cis-regulatory elements and characterizing microRNA genes and their targets, with the objective
of understanding how these parts of the plant genome work together to determine spatial and tem-
poral expression of genes. The lab had an important role in the 4-year project to produce a reference
genome of maize, providing annotations for the genome and helping to generate a draft haplotype
map, a gauge of maize’s genetic diversity. They have devoted special attention to examining diversity
in maize and grape, with the ultimate aim of accelerating development of strategies to introduce
new germplasm, needed to meet the demands of an increasing population and a changing environ-
ment. They have also brought fully sequenced genomes into an integrated data framework, to en-
hance the power of their comparative studies; it now includes the genomes of Arabidopsis, maize,
rice, sorghum, grape, and poplar. 
Michael Zhang’s laboratory develops mathematical and computational methods that can be com-
bined with advanced experimental technologies to transform data into biological knowledge about
transcription and gene expression, work that has manifold implications for the study of cancer and
many other diseases. Their tools, used by investigators throughout CSHL and beyond, are designed
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to identify functional genetic elements within molecular sequences as well as pathways that control
and regulate gene expression. Zhang’s group has developed a series of computational tools that make
use of statistical pattern-recognition techniques to identify exons, promoters, and posttranslational
modification signals in large genomic DNA sequences. They also study alternative splicing of exons
and collaborate with other labs to characterize splicing enhancers and silencers. 
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Expanding Our Ability to Examine 
Genome Variation
Much of our activities in 2009 were focused on building
an infrastructure that would allow large-scale studies with
next-generation sequencing. To do this, we made improve-
ments in both the wet lab and computational segments of
the process. For the wet lab processes, we expanded the
number of Illumina sequencers and staff. This required an
extensive effort in training and focus on quality control.
Ms. Laura Cardone was made manager of the sequencing
group and led the training efforts. For the informatics
arena, we streamlined the analysis pipeline and trained ad-
ditional staff in its operation. The software provided by Il-
lumina for analysis of data from the instruments underwent
several revisions during 2009. These improvements, cou-
pled with better chemistry, gave a dramatic increase in in-
strument throughput and quality. Figure 1 shows the
monthly output in sequences for all projects at CSHL.
In addition, in late 2009 we began exploring ways to
make these capabilities further available to the CSHL
community. The main roadblock to this is the amount
of computational analyses required. We are testing sev-
eral options and have as a goal for 2010 the implemen-
tation of a Lab-wide infrastructure to support the
bioinformatic analysis of next-generation sequence data.
DEVELOPMENT OF NEXT-GENERATION SEQUENCING TECHNOLOGY
W.R. McCombie J. Busuttil M. Gierszewska S. Mavruk J. Parla
L. Cardone I. Grabill P. Mocombe D. Rebolini
T. Caulfield M. Kramer S. Muller L. Spiegel
M. Chen S. Lata M. Ossipov J.C. Yao
E. Ghiban D. Lewis
Family-based Analysis of Bipolar Disorder
by Whole-genome Resequencing
This work was done in collaboration with D. Blackwood and
D. Porteous (University of Edinburgh).
We are studying a large Scottish pedigree where many
family members have bipolar disorder  or recurrent
major depressive disorder. A genetic study of this family
by our collaborators at the University of Edinburgh
suggested that a 20-Mb critical region on chromosome
4 has significant linkage to bipolar disorder (Le Hellard
et al., Biol Psychiatry 61: 797–805 [2007]). 
We decided to use next-generation sequencing (Illu-
mina Genome Analyzer II [GAII]) to resequence the en-
tire genome of individuals from this family, focusing
analysis on the 20-Mb critical region on chromosome 4.
We hope to discover rare variants associated with bipolar
disorder susceptibility. We completed the sequencing of
two individual samples from this family using paired-end
101-cycle and 125-cycle runs and achieved ~21x–25x
coverage on each individual. Reads from all flow cells for
each individual sample were then aligned to UCSC
hg18. We processed the mapping and single-nucleotide
polymorphism (SNP) calling by using the Burrows–
Wheeler alignment (BWA) and sequence alignment map
(SAM) tools (Li et al., Bioinformatics 25: 2078–2079
[2009]) pipeline. Potential polymerase chain reaction
(PCR) duplicates were removed, and error-prone variant
calls were then filtered out by using a minimum consen-
sus quality score of 20 and a minimum read depth of
20x. As expected, ~3–4 million SNPs were found in each
individual. However, there were fewer SNPs in common
between these two individuals and also not present in the
public SNP database. In fact, a relatively small number
of variants were common in both affected individuals,
not present in the SNP database and in coding exons of
the critical regions.
We are currently extending this study to another af-
fected individual and two unaffected family members to
further genetically refine possible bipolar-associated vari-
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Figure 1. Comparison of total bases generated versus total high-
quality bases for monthly Illumina runs from December 2008
through December 2009.  We use the quality measure of Q30 to
indicate a very-high-quality sequence for the purpose of pushing
the limits on quality.  Much-lower-quality bases are still quite use-
ful, but focusing on the more stringent Q30 metric provides con-
stant pressure to improve production quality.
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DISC1 target region. The coverage of this region at 30x
or greater sequencing depth was used to qualify our
data for subsequent SNP analysis, for which we re-
quired an 80% cutoff per sample (Table 1). For SNP
identification, we used the Maq software written by
Heng Li (Genome Res 18: 1851–1858 [2008]). 
On the basis of the results of our first pass attempt
to PCR-amplify and resequence DISC1, we identified
463 samples that did not meet our 80% coverage at
≥30x cutoff for SNP analysis. Subsequently, we initiated
a second round of resequencing for these samples, which
involved a few instances of repeated PCR amplification
of DISC1, but mostly just resequencing of the original
DISC1 amplicons generated from these samples.
For samples that did obtain adequate coverage dur-
ing our first round of DISC1 resequencing, we pro-
ceeded to validate identified SNPs using capillary
sequencing (ABI 3730), starting in December of 2009.
Our initial validations revealed a high rate of false pos-
itives that were likely introduced during sample prepa-
ration. Interestingly, virtually all of these patients have
been genotyped, so we have many thousands of SNPs
to examine for false negatives, and this rate is quite low.
So it appears that we are introducing a small number
of variants into the process and then effectively detect-
ing them. We are continuing with various validation
studies to identify the major source of false positives
and are working on revising our validation plan based
on our ongoing results.
Targeted Resequencing of DTNBP1 Using
Long-range PCR and Illumina Sequencing 
This work was done in collaboration with A. Malhotra 
and T. Lencz (Zucker Hillside Hospital).
Variants in the DTNBP1 (dystrobrevin-binding pro-
tein-1) gene are associated with bipolar disorder and
may also be associated with modulating effects in
schizophrenia. Our collaborators at the Zucker Hill-
side Hospital provided 70 schizophrenia patient sam-
ples and controls to be sequenced. PCR primers were
designed to tile overlapping amplicons ranging from
~2 to 10 kb across the ~140-kb DTNBP1 gene region
ants. The sequence data will be validated by a variety of
techniques, including comparison of whole-genome se-
quencing by high-density genotyping (Illumina-IVb),
and selected variants will be validated using Sanger se-
quencing. The resulting studies will enhance our under-
standing of molecular mechanisms of the cause and
development of bipolar disorder and further lead to novel
diagnosis and treatment of this psychiatric disorder.
Targeted Resequencing of the Human
DISC1 Gene Using Long-range PCR 
and Illumina Sequencing
This work was done in collaboration with D. Blackwood, 
D. Porteous, and I. Deary (University of Edinburgh) and 
P. Visscher and A. McRae (University of Queensland).
Disrupted in schizophrenia-1 (DISC1) is a strong can-
didate gene for association with schizophrenia and
other major psychiatric disorders. With our collabora-
tors in Edinburgh and Queensland, we are determining
variation in the DISCI region in ~1000 affected pa-
tients and 1000 controls. To resequence the DISC1
gene, we designed primers to generate 4–11-kb ampli-
cons to tile across an ~523-kb region of chromosome 1
containing DISC1. The scope of this project encom-
passes 2210 samples, which can be divided into groups
of individuals diagnosed with schizophrenia, bipolar
disorder, unipolar disorder, or control individuals not
diagnosed with psychiatric illness. We were able to ul-
timately scale our throughput up to 100 samples am-
plified per week in order to complete our DISC1
amplifications in about 1 year. During 2009, we suc-
cessfully amplified 1508 of the remaining 1533 samples
to be amplified from our 2210 sample set (Table 1).
This was accompanied by the sequencing of the newly
amplified samples using paired-end 36-cycle Illumina
sequencing runs. To enable higher throughput during
sample sequencing, we developed custom sequencing
adaptors to append molecular bar codes onto each sam-
ple library prior to sequencing. Our custom bar codes
consist of a unique string of five bases that are present
at the beginning of each sequence read. The use of our
bar codes for this project allowed us to multiplex up to
six individuals per lane of Illumina sequencing, thus
greatly reducing cost and increasing the speed of the
project.
To analyze the DISC1 data generated by our Illu-
mina sequencers, we used a Perl script to split the se-
quence reads according to bar-code sequence and used
ELAND software (included in the Illumina analysis
pipeline) to align the reads from each sample to our
Table 1. Overview of Samples Resequenced in our DISC1 Study
during 2009
Total samples in study                                                 2210
Samples amplified and sequenced                              1508
Range of coverage at ≥30x                                       0–99%
Average coverage at ≥30x                                            79%
with 1–2 kb flanking upstream and downstream. The
samples were whole-genome-amplified and then
PCR-amplified. Of the 70 samples, 68 were success-
fully PCR-amplified and sequenced on the Illumina
instruments. The samples were multiplexed with our
custom bar-code adaptors so that three to six samples
could be sequenced per lane. The samples were se-
quenced with paired-end 36-bp runs, and the bar
codes in each lane were deconvoluted with a Perl
script. Individual samples were then aligned to the
DTNBP1 reference sequence (downloaded from
UCSC hg18) and coverage was assessed. Samples with
<90% of the region covered at 30-fold depth or better
were sequenced again to improve coverage. We ob-
tained >90% coverage at the required depth on 59 of
the 68 samples. The samples were then analyzed for
variants. Alignment and SNP calling was performed
with Maq (Li, Genome Res 18: 1851–1858 [2008]).
Duplicate read pairs (which are likely PCR artifacts)
were removed, and the SNP calls were then filtered
for a minimum consensus quality score of 20 and
minimum coverage depth of 20-fold. The SNP call
data for all patients were then sent to our collaborators
at Hillside, who chose 773 variants for further valida-
tion. Variants were chosen for validation based on the
following criteria:
1. Annotated and unannotated variants that differ sig-
nificantly between risk haplotype carriers and non-
carriers.
2. Exonic variants and variants within 100 bp upstream
and downstream from the exons.
3. Variants in the 3′ and 5′ untranslated regions.
4. Variants that are potentially triallelic.
5. Nonannotated variants with an MAF >0.05. 
Validation efforts for the selected variants are now
in progress using Sanger sequencing on ABI 3730 cap-
illary sequencing instruments.
Sequencing from Mixed Prostate Cancer
Cell Populations with the Illumina Platform
This work was done in collaboration with C. Sawyer, 
H. Scher, and D. Danilla (Memorial Sloan-Kettering 
Cancer Center).
Next-generation sequencing has opened new opportuni-
ties in cancer genomics. One important consideration in
the study of cancer is the fact that many tumors are very
heterogeneous and contain multiple cell types. We are
interested in evaluating our ability to determine the min-
imum percentage of neoplastic cancer cell types that
must be present in order to be detected in a background
of normal DNA and sequencing errors.
To test the limits of detection on the Illumina GAII
sequencing platform, our collaborators from Memorial
Sloan-Kettering Cancer Center provided sorted cell mix-
tures of LnCap and VCap human prostate cancer cell
lines. The samples ranged from pure LnCap and pure
VCap samples (0, 5, 10, 20, 50, and 100 cells each) to
mixtures of the two cell types (cell ratios of 0/50, 10/40,
25/25, and 50/50). PCR primers were chosen to tile
across the p53 gene, and each of the cell populations was
PCR-amplified and then sequenced on the Illumina
GAII. The samples were bar coded and pooled so that
two samples were sequenced per lane. The bar codes were
then sorted with a Perl script, and the sequence reads for
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Table 2. Examples of Allele Frequency Detected in the Mixed Cell
Populations
p53 Ref Geno-
position Sample Base type A C G T NRAF
16917 LNCaP 50 C C/T 3 1368 3 1863
VCaP 50 C C 3 3899 3 3
LNCaP/VCaP C C 6 2329 1 1
0/50 C5
LNCaP/VCaP C C/T 1 1784 2 505
10/40 E4
LNCaP/VCaP C C/T 1 2733 1 1221
25/25 D3
LNCaP/VCaP C C/T 1 1413 2 1710
50/50 C6
LNCaP/VCaP C C/T 1 1918 0 1131
40/10 E2
LNCaP/VCaP C C/T 0 1480 4 1569
50/0 D1
LNCaP/VCaP C C/T 4 12898 9 386 NRAF
50/0 E1 only
3%
25889 LNCaP 50 G A/G 483 0 320 0
VCaP 50 G G 2 0 479 0
LNCaP/VCaP G G 2 0 593 1
0/50 D5
LNCaP/VCaP G A/G 66 0 226 1
10/40 D4
LNCaP/VCaP G A/G 333 2 316 1
25/25 D3
LNCaP/VCaP G A/G 72 0 641 0 NRAF 
40/10 C2 only
10%
LNCaP/VCaP
50/0 D1 G A/G 537 1 273 0
LNCaP/VCaP G A/G 95 0 1091 0 NRAF
50/0 E1 only
8%
LNCaP/VCaP G A/G 335 0 350 0
50/50 C6
each sample were aligned to the p53 reference (UCSC
hg18) using the Illumina ELAND alignment software.
SNPs were then called using the SnpFinder program
(Zhenyu Xuan, CSHL). The SnpFinder program uses a
heuristic method that counts alleles present in the un-
derlying reads mapped to each position to determine re-
gions where the alleles differ from the reference. 
Three SNP positions where a variant was clearly pres-
ent in the pure LnCap but not the pure VCap cells were
analyzed to determine the allele frequency of the nonref-
erence allele in the mixed cell populations (see Table 2,
on previous page). 
Although the nonreference allele was detected in the
mixed cell populations, it was not always present at what
we would typically consider significant levels (minimum
20% minor allele frequency for a heterozygote). We will
use this information and expand this study to develop
models for SNP detection in heterogeneous samples.
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E. Ghiban
I have moved the bulk of my laboratory to the Ontario
Institute for Cancer Research in Toronto, Ontario, but
I still maintain a small group at CSHL working on the
iPlant Collaborative project.
The iPlant Collaborative is a virtual organization of
faculty, students, postdoctoral fellows, staff, high-perfor-
mance computing experts, and professional software de-
velopers drawn from CSHL, the University of Arizona,
and the Texas Advanced Computer Center. iPLant is de-
signed to solicit and meet biological grand challenge
questions from the plant science community and, in close
consultation with this community, create a cyberinfra-
structure that makes it possible to meet these challenges.
In 2009, two self-forming grand challenge teams were
chosen by a community representative Board of Directors
to work with iPlant personnel to develop “Discovery En-
vironment (DE),” a cyberinfrastructure and user interface
to help with the biological grand challenges.
In 2009, our group took on leadership of the en-
gagement team or the iPlant Tree of Life (iPToL) Grand
Challenge Project. The fundamental aim of this project
is to assemble a comprehensive phylogenetic tree of half
a million known species of green plants for better
knowledge of evolutionary relationships, which will
yield new insights across the plant sciences. The engage-
ment team is composed of team leader plus 10 analysts
and developers and interfaces directly with the working
group leaders and plant science community members
to develop prototype software and analyze design re-
quirements for the iPlant core software development
GENOME-SCALE DATABASES OF PATHWAYS, GENETIC VARIATIONS,
AND EVOLUTION
L. Stein S. Avraham B. Faga A. Kanapin G. Wu
S. Cain G. Gopinathrao W. Spooner Z. Zha
N. de la Cruz T. Harris P. Van Buren W. Zhao
team. The scientific leader of this team and three of the
analysts are based at CSHL.
Collaborative implementation of the grand chal-
lenge is organized into working groups with focused de-
velopment goals. The four main working groups are Big
Trees, Data Assembly, Tree Reconciliation, and Trait
Evolution. Two cross-cutting working groups to de-
velop shared data and compute infrastructure are Data
Integration and Tree Visualization. 
Development efforts made in collaboration with
these working groups in 2009 will combine to result in
an early 2010 release of the iPToL discovery environ-
ment, which is a web-based application that will be a
portal for the green plant tree of life, for visualization,
browsing, and analysis. 
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Our lab conducts collaborative research in the field of
plant genomics, with both basic and applied objectives.
In the next 50 years, grain yields will need to double to
match population growth—in a changing climate, with
fewer inputs of water and fertilizer, and on increasingly
marginal lands. Plant biology is poised to make signif-
icant contributions to meet these needs, as well as the
growing demand for renewable energy resources. Ap-
plication of multidisciplinary research with a basis in
genomics will contribute to our understanding of com-
plex traits and help drive a second “green revolution.”
Ongoing activities in the last year supported bioinfor-
matics approaches to manage, analyze, and visualize re-
lationships between sequence and phenotype data. The
resulting resources of sequences, gene annotations, vari-
ation data, expression profiles, standards, and software
will support future experiments in the laboratory as well
as the field.
Maize Genome Sequencing
Project
Our group has led data coordination, analysis, and vi-
sualization efforts as part of the Maize Genome Se-
quencing Consortium, a 4-year, multi-institutional
project funded by the National Science Foundation
(NSF). The project seeks to sequence the Zea mays
B73 genome. Over the course of the project, our
group has developed and refined a comprehensive an-
notation pipeline, based on standard bioinformatics
tools provided by the Ensembl project. The pipeline
is now a central resource for all plant genome assem-
blies important for various distinct projects in our lab,
such as Gramene and OMAP (the Oryza Map Align-
ment Project). We also develop, run, and support
MaizeSequence.org, the official public portal of the
maize project. The site provides a maize genome
browser, research tools, and full access to the maize
data and tightly integrates with other online resources,
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such as Gramene. 2009 marks an exciting fourth and
final year of the project. On the basis of the complete
sequencing effort of the maize genome, an initial at-
tempt at a genome assembly, to which our group has
contributed significant effort, has been released. We
have collaborated with various researchers to analyze
and annotate the maize genome (Fig. 1) and provide,
among others, a reliable set of 32,540 ordered genes.
All of the data that we collected from our collaborators
are now accessible through our web portal
www.maizesequence.org and as part of a Science pub-
lication in November.
Figure 1. Overview of the maize B73 genome, showing 10 chro-
mosomes. Concentric plots, from outer to inner rings: physical
map, repeat density, gene density, synteny with sorghum, and syn-
teny with rice. Genes and repeats form density gradients that are
negatively correlated along centromere-telomere axes. Duplicate
regions formed from polyploidy are indicated with ribbons.
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ease resistance, and agricultural sustainability. During the
past year, our group has been at the forefront of a wave of
studies leveraging advances in DNA-sequencing technolo-
gies to assess genetic variation. We have developed a robust
bioinformatics platform for identifying DNA variation
from billions of short DNA sequences and utilized it to
create high-resolution variation maps of two important
agricultural crops: maize and grapevine.
Constructing a haplotype map of maize. Our col-
laborators at Cornell University, the University of Mis-
souri, and the North Carolina State University recently
constructed the maize nested association mapping
(NAM) population, consisting of 27 diverse varieties.
This NAM population represents much of the genetic
and phenotypic diversity in maize and is a significant
resource for phenotypic trait analysis in this crop. Be-
cause an overrepresentation of highly repetitive DNA
elements exists in the maize genome, we used a strategy
that selectively sampled the gene space of the genome,
and utilized Illumina sequencing technology to produce
more than 32 billion DNA base pairs across the 27 va-
rieties. From these reads, we identified more than 3.3
million single-nucleotide polymorphisms (SNPs) in the
genome. The genotypes and distribution of these SNPs
are also valuable in estimating population genetics pa-
rameters in the maize (Fig. 2).
Consequences of Ancient
Tetraploidy in Maize
Whole-genome doubling (polyploidization) is a predom-
inant mode of speciation in flowering plants. In both
monocots and eudicots, recurrent rounds of polyploidy
are thought to have provided raw material for the evolu-
tion of new traits and possibly contributed to the extraor-
dinary adaptive radiation of these groups. We are studying
how ancient tetraploidy in the maize lineage shaped the
structure and function of its genome. Although highly re-
arranged, orthologous regions covering ~90% of the B73
assembly were mapped to rice and sorghum, grasses that
diverged from maize prior to duplication. Using this in-
formation, we reconstructed remnants of maize’s two an-
cestral subgenomes (designated A and B), which were
likely brought together by interspecies hybridization some
5–12 million years ago. Although loss of redundant du-
plicate genes is a common outcome of whole-genome du-
plication, an unanticipated finding was a strong
imbalance of gene loss between subgenomes. We estimate
that the A parent lost ~23% of its genes, compared to
~56% of genes lost in the B parent. Thus, the current
gene complement of maize is dominated by the contri-
butions of one parent over the other. Greater than 8000
genes were retained as duplicates in both subgenomes,
suggesting that they have essential, rather than redundant,
function. Analysis of Gene Ontology terms showed a sta-
tistically significant enrichment for genes with regulatory
function, in particular transcription factors. In a separate
study, we found that maize has 35 additional microRNA
(miRNA) genes compared to sorghum, almost all directly
attributable to duplication and retention from polyploidy.
Together, these results suggest that polyploidization con-
tributes to the evolution of regulatory network complex-
ity. Future challenges include experiments to understand
how duplicate genes may have diverged in function. Clas-
sical forward genetics, large-scale expression studies, and
analysis of the maize epigenome may reveal additional
patterns of bias between the two subgenomes of maize.
Surveying the Genetic Diversity
in Crops Using High-throughput 
Sequencing Platforms
Having a comprehensive catalog of genetic variation in a
species paves the way toward genome-wide genotype-to-
phenotype association studies. In agricultural plant
species, this will help with the identification of genetic loci
underlying important agronomic traits such as yield, dis-
Figure 2. Diversity and recombination across the 10 maize chro-
mosomes. Concentric plots, from inner to outer rings: SNP dis-
tribution, resequencing coverage, population recombination rate,
gene density, repeat density, karotypes, FST, nucleotide diversity,
Tajima’s D, recombination rate versus heterozygosity. 
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From these SNPs, we were able to infer that the ge-
netic diversity among these maize varieties averages one
difference every 44 bp, and we believe that this is a
lower boundary of the estimated diversity. We also
found that an average of 7% of DNA sequences from
any other maize variety cannot be mapped to the refer-
ence genome, indicating that there is a certain amount
of unique genome space in each variety, marked by
larger structural DNA variation or peppered with many
SNPs.
We also compared the empirically determined pop-
ulation recombination rate of the NAM population
with the estimated historical recombination rate and
found them to be highly correlated. This suggests that
there still is retention of factors that influence recom-
bination, which has not evolved much over time. We
also found a significant inverse correlation between re-
combination and residual heterozygosity in these inbred
maize lines, with residual heterozygosity more prevalent
in the pericentromeric regions. This suggests that the
phenomenon of hybrid vigor, where the progeny of two
genetically different parents has superior traits to either
parent, may be a result of genes within these pericen-
tromeric regions. In other words, formation of recom-
binant haplotypes with favorable allelic combinations
are restricted by the lack of recombination, supporting
the theory that pseudo-overdominance accounts for hy-
brid vigor in F1 hybrids. We could also identify large
genomic segments with a high recombination rate but
low nucleotide diversity; these regions are candidate re-
gions for domestication loci in the maize genome, and
37 of these have lower diversity than the known domes-
tication gene tb1.
Given that maize is cultivated across various cli-
mates, we wanted to see if we could differentiate trop-
ical and temperate varieties of maize based on their
genetic differences. Using a principal component analy-
sis, we could identify dimensions that would suffi-
ciently separate out the tropical, temperate, and sweet
corn varieties. 
We believe that this haplotype map will be a valuable
resource for genetic mapping studies in this NAM pop-
ulation, and we are expecting exciting results from this
in the near future. 
Genetic diversity of the grapevine. Large, genome-
wide genetic mapping studies for important agronomic
trait loci in the grapevine have been hamstrung by the
absence of a high-resolution variation and linkage-dis-
equilibrium map of the genome. In this study, we lever-
aged the advances in DNA sequencing technologies to
assess the natural DNA variation that exists in this im-
portant fruit crop. 
A sample of 10 grape cultivars and seven closely re-
lated wild-grape species were sequenced. Using a series
of heuristic filters that separate genuine polymorphisms
from variant repetitive elements and sequencing errors,
we are able to derive a set of more than 470,000 mark-
ers that segregate in the grapevine. Of these, more than
71,000 scored with high confidence. Besides being a re-
source for enabling genome-wide association studies,
these markers allowed us to survey the linkage-disequi-
librium (LD) structure of the grapevine. We found that
LD decays rapidly across the genome, and conse-
quently, a high density of markers will be needed to per-
form an effective association study.
A genotyping microarray was also designed by care-
fully selecting 9000 markers that were informative in
separating the cultivars and wild species. Using this
Vitis9KSNP chip to genotype a set of grapevine samples
and doing a principal component analysis, we showed
that these markers are sufficient in distinguishing be-
tween grapevine cultivars, hybrids, and wild species (Fig.
3). We are currently using this array to genotype more
than 1200 cultivated grape and 250 wild-grape species
that are part of the USDA germplasm repository.
The results from this work suggest that genotyping
microarrays are useful for assessing population structure,
verifying germplasm collections, and for breeders to cor-
roborate their stock. However, genome-wide genetic
mapping studies in high-diversity plant species such as
the grapevine are better served using high-throughput
Figure 3. Discriminating grape varieties based on genotypes assayed
using the 10K chip array. A principal component analysis shows that
the genotypes from the 10K chip array is sufficient to group grape
varieties into phylogenetic classifications. This chip is now being
used to genotype the USDA grape germplasm collection.
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sequencing platforms for genotyping. These sequencing
technologies provide the necessary resolution for suffi-
ciently powered association studies that are otherwise
not cost effective using genotyping arrays. 
Characterizing Regulatory
Networks in Plants
The advances in various experimental and bioinformatics
techniques in the last decade have provided notable im-
petus to our knowledge of gene regulatory mechanisms.
To develop a systems-level understanding of regulatory
networks, we are focused on the interplay of transcrip-
tional and posttranscriptional regulatory mechanisms
that operate under abiotic stress conditions and during
reproductive development. The regulatory machinery as-
sociated with development and plant responses to the en-
vironment uses two key control mechanisms: one at the
transcriptional level and the other at the posttranscrip-
tional level. The molecular basis for transcriptional reg-
ulation is the binding of transcription factors (TFs) to
transcription-factor-binding sites and the impact of these
interactions to activate or repress gene expression. At the
posttranscriptional level, miRNAs regulate gene expres-
sion through cleavage of mRNAs or repression of protein
production. miRNAs are small noncoding RNAs that
regulate many genes involved in developmental control,
developmental transitions, plant growth, development,
and stress response.
miRNA gene discovery and target characterization.
We conducted a genome-wide survey of maize miRNA
genes on the first complete assembly of the maize B73
reference genome version 1(B73 RefGen_v1). We de-
veloped stringent and robust computational pipelines to
predict miRNAs and their targets. On the basis of com-
putational approaches using homology and secondary
structure modeling, we identified 150 high-confidence
genes within 26 miRNA families. Of these 26 miRNA
families, the expressions of 25 were verified in five maize
tissue types (root, seedling, tassel, ear, and pollen) by
deep sequencing of small RNA libraries. Polymerase
chain reaction–rapid amplification of cDNA ends
(PCR-RACE) of 68 miRNA transcript precursors, rep-
resenting 18 families conserved across several plant
species, showed that splice variation and the use of al-
ternative transcriptional start and stop sites are common
within this class of genes.
Our computational target prediction pipeline iden-
tified 247 unique putative targets of these miRNA fam-
ilies. We also predicted putative targets of five miRNA
families (miR482, miR528, miR529, miR827, and
miR1432) not previously identified in maize. More than
50% of miRNA families were predicted to target TFs,
suggesting a predominant role of these miRNA genes in
the regulation of transcriptional networks. Characteri-
zation of the functions of the target genes of all 26
miRNA families, on the basis of gene ontology, sup-
ported their roles in a wide spectrum of regulatory func-
tions and biological processes including gene expression,
metabolism, catalysis, transport, and response to stimuli. 
Yeast one-hybrid is a gene-centric approach for map-
ping regulatory relationships. We are using the yeast
one-hybrid (Y1H) system to identify transcription factors
that bind to specific gene promoters. In the last year, we
screened 171 Arabidopsis TFs expressed in root stele
against 28 miRNA promoterss. We observed 20 interac-
tions out of 4104 possible interactions between 15 tran-
scription factors and eight miRNA promoters. This
information will help advance our knowledge of regula-
tory networks associated with development and crop
stress tolerance and provide direction for crop improve-
ment. This work is a collaboration with Drs. Philip Ben-
fey (Duke, Marian Walhout of University of Massa-
chusetts) and Siobhan Brady (University of California,
Davis).
Using ultra-high-throughput sequencing to char-
acterize expression profiles of mRNA and small
RNAs. Genome-wide expression signatures that mark
specific perturbations in developmental programs con-
tribute to functional resolution of central regulators. In
this work, we are using ultra-high-throughput sequenc-
ing approaches to profile genome-wide transcriptional
changes in maize (Zea mays L.) reproductive tissues at
specific stages of development. We also use mutations
in key developmental genes to test the effect of gene-
specific perturbations in normal reproductive growth
at the transcriptional level. Genetic studies have previ-
ously anchored these genes into core developmental
pathways. Here, computational methods are used to in-
tegrate and analyze expression data sets, which will pro-
vide a basis for inferring the gene networks associated
with these pathways. This work is a joint project with
David Jackson at CSHL.
With the recent release of an assembled maize
genome sequence, we use this resource to build robust
and well-documented pipelines for mapping and analy-
sis of high-throughput, sequence-based transcript data
in maize. Next-generation sequencing approaches cur-
rently being used include tag-based digital gene expres-
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sion (DGE) and RNA-Seq. Our evaluation of these
methods in association with the maize genome com-
pares throughput, specificity, and coverage of expressed
genes, including resolution of quantitative expression
profiles for low-copy transcripts. Various statistical
methods are also being evaluated for analysis of differ-
entially expressed genes. On the basis of these analyses,
standardized methods are being developed for incorpo-
rating new data sets as they become available. 
Early stages of maize ear and tassel development,
which are the female and male reproductive organs, re-
spectively, are investigated in this work. By profiling nor-
mal development in these tissues using a whole-
transcriptome RNA-Seq approach, we can improve cur-
rent maize gene models and use the transcript profiles
to anchor expression data from mutant ears and tassels
at the same stage of development. Groups of genes
showing differential expression or coexpression in re-
sponse to specific perturbations are identified. Compar-
ative genomics and bioinformatics tools are used to
leverage existing information from Arabidopsis and rice
to orthologous maize genes for which functional anno-
tations are not known. On the basis of such comparative
approaches, genes in common biochemical pathways are
identified using well-curated pathway tools in related
species. These data provide curation of metabolic path-
ways in maize. We also use sequence similarities to iden-
tify transcriptional regulators in maize. Integration of
data sets from mutant-based perturbations will help de-
termine which of these transcription factors are central
components in the transcriptional network and thus
candidates for downstream functional and genetic ex-
periments. These analyses will provide evidence for reg-
ulators of maize ear and tassel architecture, an important
agricultural trait with clear relevance to grain yield and
harvestability. 
Gramene Comparative Genomics: A Model
for Understanding Function through Evolu-
tion and Genome Organization
The ability to connect information within and across
species through comparative mapping, integration of ge-
nomic sequence, genetic and physical maps, and pheno-
types adds significant value to existing genome-
sequencing and genome-mapping studies. Gramene is a
collaborative project that leverages sequence and func-
tional information from multiple plant genomes to pro-
mote translational genomics in agriculture. The Gramene
website (http://www.gramene.org) serves as a portal to
multiple genome browsers and manually curated data-
bases of genes, proteins, biochemical pathways, quanti-
tative trait loci (QTL), ontologies, germplasm, and ge-
netic diversity data. 
In the last year, our group has completed several mile-
stones on the Gramene project, including the release of
the 29th and 30th builds since 2000. Of the many im-
provements made, we increased the number of se-
quenced genomes in our Ensembl genome browser to
13 agronomically and scientifically important species.
These databases were created in partnership with the
European Bioinformatics Institute (EBI) and are now
also available through the Ensembl Plant portal. The
collaboration with EBI has focused on the integration
of content, quality control, and the development of new
features. A major addition in the last year has been the
new large-scale SNP-chip-based genotype data sets for
rice and Arabidopsis, plus the addition of a basic coordi-
nate-based search tool that allows users to retrieve allele
calls. Finally, Gramene added an entirely new module
focusing on germplasm resources targeted at the breed-
ing community.
The iPlant Collaborative
The iPlant Collaborative (http://iplantcollaborative.
org) is an NSF-funded cyberinfrastructure collaborative
for the plant sciences. Its mission is to foster the devel-
opment of a diverse, multidisciplinary community of
scientists, teachers, and students and a cyberinfrastruc-
ture that facilitates significant advances in the under-
standing of plant science through the application of
computational thinking and approaches to Grand
Challenge problems in plant biology.
Currently there are two community-defined Grand
Challenge projects: (1)Tree of life (iPToL) and (2) geno-
type to phenotype (iPG2P). The iPToL project seeks to
resolve the evolutionary relationships among the half-
million known species of green plants and to convey
these in the form of comprehensive phylogenetic trees.
Owing to its sheer scale, complexity, and profound na-
ture, this undertaking represents a true “moonshot” for
the life sciences. The required cyberinfrastructure will
scale up current phylogenetic methods by 100-fold or
more, enable the dissemination of data associated with
such large trees, and implement scalable “post-tree”
analysis tools to foster integration of the plant tree of
life with the rest of the botanical sciences. The iPG2P
project aims to elucidate the relationships between
plant genotypes and the resultant phenotypes in com-
plex environments, one of the foremost challenges in
biology. 
Bioinformatics and Genomics      195
This year’s effort was directed at tool and method
development to analyze and integrate next-generation
sequence data and permit broader access of these re-
sources to the general research community. Broader im-
pacts of the iPlant Collaborative will be achieved not
only by solving Grand Challenge questions, but also by
its focus on community building and educational out-
reach. The DNA Subway project is a collaboration be-
tween the iPlant Collaborative and the Dolan DNA
Learning Center to provide high-level genome analysis
tools to biology teachers and students. Several members
of the Ware lab actively participate in working groups
of the iPToL and iPG2P Grand Challenge projects.
Through requirements analysis, project management
and coordination, prototyping, and direct engagement,
they facilitate communication between the community
collaborators and the cyberinfrastucture developers.
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In the last year, New York University student Jeff
Rosenfeld finished his Ph.D. and took a staff scientist
position at Long Island Jewish Hospital. Xiaowo Wang
took an assistant professor position at Tsinghua Uni-
versity in China, Dr. Michaela Oswald-Pisarski moved
to the Wigler lab, and Dr. Chenghai Xue moved to the
Gingeras lab here at CSHL. Avila Mail was our URP
student from Cornell University and Xuxin Chen was
our rotation student from Stony Brook University. Dr.
Zhenyu Xuan has started a new tenure-track faculty po-
sition at University of Texas, Dallas. I have accepted an
endowed Cecil H. and Ida Green Distinguished Chair
Professor and a directorship of a new Center for Sys-
tems Biology at the University of Texas, Dallas. Two
postdoctoral fellows, Drs. Zhihua Zhang and Wemyu
Chung, have also moved to the new lab at the Univer-
sity of Texas, Dallas.
High-resolution Human Core Promoter
Prediction with CoreBoost_HM 
Correctly locating the gene transcription start site and
the core promoter is important for understanding the
transcriptional regulation mechanism. We have inte-
grated specific genome-wide histone modification and
DNA sequence features together to predict RNA poly-
merase II core promoters in the human genome. Our
new predictor CoreBoost_HM, which is an extension of
our previous sequence-based algorithm CoreBoost, out-
performs all existing promoter prediction algorithms by
providing significantly higher sensitivity and specificity
at high resolution. We demonstrated that even though
the histone modification data used in this study are from
a specific cell type (CD4+ T cell), our method can be used
to identify both active and repressed promoters. We have
applied it to search the upstream regions of microRNA
(miRNA) genes and show that CoreBoost_HM can ac-
curately identify the known promoters of the intergenic
miRNAs. We also identified a few intronic miRNAs that
may have their own promoters. This result suggests that
our new method can help to identify and characterize
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the core promoters of both coding and noncoding genes
(Wang et al. 2009).
Determination of Enriched Histone 
Modifications in Nongenic Portions 
of the Human Genome 
Chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-Seq) has recently been
used to identify the modification patterns for the methy-
lation and acetylation of many different histone tails in
genes and enhancers. In collaboration with the Zhao lab
at the National Institutes of Health, we have extended
our previous analysis of histone modifications (Wang et
al., Nat Genet 40: 897 [2008]) to gene deserts, pericen-
tromeres, and subtelomeres. Using data from human
CD4+ T cells, we have found that each of these nongenic
regions has a particular profile of histone modifications
that distinguish it from the other noncoding regions. Dif-
ferent methylation states of H4K20, H3K9, and H3K27
were found to be enriched in each region relative to the
other regions. These findings indicate that nongenic re-
gions of the genome are variable with respect to histone
modification patterns, rather than being monolithic. We
furthermore used consensus sequences for unassembled
centromeres and telomeres to identify the significant his-
tone modifications in these regions. Finally, we compared
the modification patterns in nongenic regions to those at
silent genes and genes with higher levels of expression.
For all tested methylations with the exception of
H3K27me3, the enrichment level of each modification
state for silent genes is between that of nongenic regions
and expressed genes. For H3K27me3, the highest levels
are found in silent genes. In addition to the histone mod-
ification pattern difference between euchromatin and
heterochromatin regions, as is illustrated by the enrich-
ment of H3K9me2/3 in nongenic regions, while
H3K9me1 is enriched at active genes, the chromatin
modifications within nongenic (heterochromatin-like)
regions (e.g., subtelomeres, pericentromeres, and gene
deserts) are also quite different. (Rosenfeld et al. 2009).
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selected CpG islands (CGI), representing more than
25,000 CpG sites. A single lane of Illumina sequencing
permitted methylation states to be definitively called
for more than 90% of target sites. The accuracy of the
hybrid selection approach was verified using conven-
tional bisulfite capillary sequencing of cloned poly-
merase chain reaction (PCR) products amplified from
a subset of the selected regions. This confirmed that
even partially methylated states could be successfully
called. A comparison of human primary and cancer
cells revealed multiple differentially methylated regions.
More than 25% of islands showed complex methyla-
tion patterns either with partial methylation states
defining the entire CGI or with contrasting methyla-
tion states appearing in specific regional blocks within
the island. We observed that transitions in methylation
state often correlate with genomic landmarks, including
transcriptional start sites and intron–exon junctions.
Methylation, along with specific histone marks, was en-
riched in exonic regions, suggesting that chromatin
states can foreshadow the content of mature mRNAs.
(Hodges et al. 2009). 
To prepare the computational algorithm for this
work, we have extended our previous Solexa reads-map-
ping algorithm RMAP to allow mapping of bisulfite se-
quencing reads. We have also added the capability of
analyzing pair-end reads as well as single reads (Smith
et al. 2009). This new algorithm has been very popular
and downloaded by many labs around the world.
The Transcriptome of Human CD34+
Hematopoietic Stem-progenitor Cells
Studying gene expression at different hematopoietic
stages provides insight for understanding the genetic
basis of hematopoiesis. In collaboration with the Wang
lab at Northwestern University and the Rowley lab at
Chicago University, we analyzed gene expression in
human CD34+ hematopoietic cells that represent the
stem-progenitor population (CD34+ cells). We col-
lected more than 459,000 transcript signatures from
CD34+ cells, including the de-novo-generated 3′ ex-
pressed sequence tags (3′ ESTs) and the existing se-
quences of full-length cDNAs, ESTs, and serial analysis
of gene expression (SAGE) tags, and performed an ex-
tensive annotation on this large set of CD34+ transcript
sequences. We determined the genes expressed in
CD34+ cells, verified the known genes, and identified
the new genes of different functional categories in-
volved in hematopoiesis; dissected alternative gene ex-
pression including alternative transcription initiation,
An Integrative Genomics Approach 
Identifies Hypoxia-inducible Factor 1 
Target Genes that Form the Core 
Response to Hypoxia
The transcription factor hypoxia-inducible factor 1
(HIF-1) has a central role in the transcriptional re-
sponse to oxygen flux. To gain insight into the molec-
ular pathways regulated by HIF-1, it is essential to
identify the downstream target genes. In collaboration
with the Xavier lab at Massachusetts General Hospi-
tal/Harvard Medical School, we developed a strategy to
identify HIF-1-target genes based on an integrative ge-
nomic approach combining computational strategies
and experimental validation. To identify HIF-1 target
genes, microarrays data sets were used to rank genes
based on their differential response to hypoxia. The
proximal promoters of these genes were then analyzed
for the presence of conserved HIF-1-binding sites.
Genes were scored and ranked based on their response
to hypoxia and their HIF-binding site score. Using this
strategy, we recovered 41% of the previously confirmed
HIF-1 target genes that responded to hypoxia in the
microarrays; we also produced a catalog of predicted
HIF-1 targets. In addition, we carried out experimental
validation for ANKRD37 as a novel HIF-1 target gene.
Together, these analyses demonstrate the potential to
recover novel HIF-1 target genes and the discovery of
mammalian regulatory elements operative in the con-
text of microarray data sets (Benita et al. 2009).
High-definition Profiling of Mammalian 
DNA Methylation by Array Capture and 
Single-molecule Bisulfite Sequencing
DNA methylation stabilizes developmentally pro-
grammed gene expression states. Aberrant methylation
is associated with disease progression and is a common
feature of cancer genomes. Presently, few methods en-
able quantitative, large-scale, single-base resolution
mapping of DNA methylation states in desired regions
of a complex mammalian genome. In collaboration
with the Hicks, Hannon, Wigler, and McCombie labs
at CSHL, we developed an approach that combines
array-based hybrid selection and massively parallel
bisulfite sequencing to profile DNA methylation in ge-
nomic regions spanning hundreds of thousands of
bases. This single-molecule strategy enables methyla-
tion-variable positions to be quantitatively examined
with high sampling precision. Using bisulfite capture,
we assessed methylation patterns across 324 randomly
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splicing, and adenylation; identified the antisense and
noncoding transcripts; determined the CD34+ cell-spe-
cific gene expression signature; and developed the
CD34+ cell transcription map in the human genome.
Our study provides a current view on gene expression
in human CD34+ cells and reveals that early
hematopoiesis is an orchestrated process with the in-
volvement of more than half of the human genes dis-
tributed in various functions. The data generated from
our study provide a comprehensive and uniform re-
source for studying hematopoiesis and stem cell biology
(Kim et al. 2009).
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Kazimierz Wrzeszczynski (left) and Michael Zhang
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent re-
search by outstanding young scientists who, during their graduate studies, displayed exceptional
promise of becoming leading scientists of the future. The purpose of this program is to provide an
opportunity for these young scientists to work independently at the Laboratory for a period of 3
years on projects of their own choosing. Fellows are provided with a salary, research support, and
technical assistance so that they can accomplish their goals free of distraction. The interactions
among research groups at the Laboratory and the program of courses and meetings on diverse topics
in biology contribute to a research environment that is ideal for innovative science by these Fellows. 
The success of the program is apparent from the list of distinguished alumni, most notably, Carol
Greider, last year’s recipient of the Nobel Price in Physiology or Medicine for her work on telomerase
and telomere function. She joined the Fellows program in 1998 and, after completing her fellowship,
was a member of the CSHL faculty for 9 years. She is currently the Daniel Nathans Professor and
Director of Molecular Biology and Genetics at Johns Hopkins University School of Medicine.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1986), Scott Lowe (1995), and
Marja Timmermans (1998) are now members of the faculty at the Laboratory, and Marja is the Di-
rector of the Fellows program.  Eric Richards (1989) is currently the Vice President of Research and
a scientist at the Boyce Thompson Institute for Plant Research at Cornell University, and David Bar-
ford (1991) is a Fellow of the Royal Society and a Professor of Molecular Biology at the Institute of
Cancer Research in London. Ueli Grossniklaus (1994) also was a member of our faculty before leaving
to become a Professor at the Institute of Plant Biology, University of Zürich, Switzerland. Térence
Strick (2000) left at the end of his fellowship to become a Group Leader at the Institute Jacques
Monod, Centre National de la Recherche Scientifique and Universités de Paris VI and VII. Both Lee
Henry (2000) and Ira Hall (2004) moved to Virginia upon completion of their fellowships. Lee joined
a project headed by Thomas Südhof at HHMI’s Janelia Farm in Ashburn, and Ira is Assistant Professor
in the Department of Biochemistry and Molecular Genetics at the University of Virginia in Char-
lottesville. Patrick Paddison, who had joined the Fellows Program in 2004, recently left to become an
Assistant Member at the Fred Hutchinson Cancer Research Center in Seattle, Washington.
Currently, the lab hosts two Fellows: Florin Albeanu did his graduate studies at Harvard Univer-
sity in the laboratories of Venki Murthy and Markus Meister, where he investigated the logic of
odor maps in the olfactory bulb of rodents. As a Fellow, Florin is taking advantage of optical imaging,
electrophysiology, and optogenetic tools to understand what computations occur at the neural circuit
level in the olfactory bulb of behaving mice. Chris Vakoc joined us from Gerd Blobel’s laboratory
at the University of Pennsylvania, where he studied chromatin looping mechanisms in long-range
enhancer function. As a Fellow, Chris is studying the role of histone lysine methylation in normal
and malignant hematopoiesis.
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Understanding Neuronal Circuits in the
Mammalian Olfactory Bulb
A. Dhawale, M. Davis, F. Albeanu
In many regions of the brain, neurons form an ordered
representation of the outside world. For example, the “ho-
munculus” of the somatosensory cortex is a point-to-point
topographic map of the body surface onto the brain sur-
face. The spatially organized convergence of sensory inputs
often leads to similar response properties in target neurons
that are in the close vicinity. Whether their individual in-
formation content is redundant or independent depends
on the circuit architecture (the interplay between common
input, lateral signals, and feedback from other brain areas)
and the computational goals of the network. 
We use optogenetic tools (such as two-photon im-
aging of genetically encoded neuronal activity reporters
or light-gated neuronal activity switches) coupled with
electrophysiological measurements (extracellular and
intracellular recordings) to study how sensory systems
encode information from the environment. We want
to understand how these inputs get processed at differ-
ent junctions or synapses of the underlying neuronal
circuits and how these representations change with the
state of the system and its circuits (awake vs. anes-
thetized, naïve vs. conditioned). The broad scope of this
effort is observing how perceptions arise.
The olfactory system, particularly the olfactory bulb
(OB), in rodents provides us with an ideal substrate to
answer these questions, given its well-defined circuitry
and multilayered organization. Rodents, being nocturnal
animals, depend heavily on olfaction for survival—find-
ing food, mates or avoiding predators. Airborne chemicals
or odors are translated into neuronal signals by specific
receptors in the nose and sent first to the bulb and then
to higher centers in the brain (olfactory cortex). The bulb
thus being the relay center provides the opportunity to
study both the nature of the inputs it receives and the na-
ture of output it sends to the brain and the computations
that allow for this input–output transformation.
In the bulb, sensory neurons expressing the same
type of olfactory receptor converge in tight focus, form-
ing ~2000 clusters of synapses called glomeruli. The
layout of glomeruli on the bulb is highly reproducible
across individuals with a precision of one part in 1000.
However, nearby glomeruli are as diverse in their re-
sponses to odors as distant ones, lacking an apparent
chemotopic arrangement (Soucy et al. 2009). From
each glomerulus, a few dozen mitral cells (principal out-
put neurons of the OB) carry the output further to the
olfactory cortex and several other brain areas. The mi-
tral cells typically have only one primary dendrite that
projects to a single glomerulus, but they can sample in-
puts on their primary and secondary dendrites from
functionally diverse glomeruli via several types of in-
terneurons (Fig. 1). Thus, a few dozen mitral cells share
input from the same parent glomerulus (sister cells),
but they may have different inhibitory surrounds. 
Are Outputs from the Same 
Glomerulus Redundant?
We generated transgenic mice expressing channel-
rhodopsin-2 in all olfactory sensory neurons under the
control of the olfactory marker protein (OMP) pro-
moter. By selectively stimulating individual glomeruli
via DLP patterned illumination, and recording extracel-
lularly from the mitral cell layer using tetrodes, we iden-
tified mitral cells that receive common input (Fig. 2).
We found that sister mitral cells had highly correlated
responses to odors as measured by average spike rates,
but their spike timing with respect to respiration was
differentially altered. In contrast, nonsister mitral cells
correlated poorly on both these measures. We therefore
propose that sister cells carry two different channels of
information to the cortex: (1) average activity represent-
ing shared glomerular input and (2) phase-specific in-
formation that refines odor representations and is
substantially independent for sister mitral cells.
What Roles Does the Inhibitory Network
Have in Shaping the Bulb Outputs?
Activity in the bulb is a rich mix of excitation and inhi-
bition, via both direct inputs and feedforward and feed-
back connections by a wide variety of cell types.
Juxta-glomerular cells are local interneurons that sur-
round the glomeruli and send neurites within and across
glomeruli. In the external plexiform layer, another class
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Figure 1. Main olfactory bulb wiring schematics. (Courtesy of F. Markopoulos.)
of interneurons, the granule cells, mediates cross-talk be-
tween mitral cells via reciprocal synapses with lateral mi-
tral cell dendrites (Fig. 1). Both interneuron types are
generic denominations for heterogeneous neuronal pop-
ulations with respect to wiring, gene expression, and
physiological properties. Despite decades of study in the
slice preparation, little is known about how these in-
terneurons operate in the intact circuit in vivo.
First, we aimed to understand if bulb interneurons
modulate the spiking time of mitral cells. We have
started by expressing light-gated molecular switches of
neuronal activity (such as channelrhodopsin-2 and
halorhodopsin) in genetically defined subsets of bulb
interneurons. We are using a Cre/Lox strategy and tak-
ing advantage of several interneuron-specific Cre lines
generated by Josh Huang’ group at CSHL.
Optical Dissection of Olfactory 
Microcircuits: What Computations 
are Performed on the Inputs by 
the Bulb Circuitry?
We set out to sample the activity of large and diverse neu-
ronal populations from the two layers of the bulb in re-
sponse to numerous odorants. Recent developments in
multiphoton microscopy and new generations of genet-
ically encoded neuronal activity reporters allow monitor-
ing both glomeruli (inputs) and mitral cells (outputs)
responses simultaneously. Toward this end, we built two
custom multiphoton microscopes and two large-scale
odor delivery machines (165 odorants). Preliminary ex-
periments indicate that the activity patterns at the level
of mitral cell bodies are not simply scaled down versions
of glomerular representations (Fig. 3). Therefore, we have
started to systematically investigate the contributions of
lateral signals and feedback from other areas to bulb
input-output transform via optogenetic strategies. 
The Bulb Vision Project
We are using light activation of glomeruli in awake,
head-restrained OMP-chr2 mice to ask how different
spatiotemporal input patterns get processed at the level
of the mitral cells and influence behavior. Using light
activation of the glomeruli bypasses the inherent un-
certainty of olfactory stimuli delivery, as odor plumes
diffuse slowly and in complex patterns. Our goal is to
generate olfactory percepts by strictly controlled pat-
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Figure 2. DLP patterned illumination in ORC mice maps the parent glomeruli of mitral cells in vivo. (A, Left) A
DLP projector coupled to a system of three lenses delivered light patterns to activate individual glomeruli on the
dorsal surface of the bulb. A CCD (charge-coupled device) camera was used to visualize the bulb surface and
record the position of the light stimulus. (Top panel, right) Dorsal surface of the bulb with a tetrode positioned in
the mitral cell layer. One square light spot is being projected onto the surface of the bulb. (Inset) Cartoon schematic
of glomeruli on the bulb, a subglomerular-size light spot and dual tetrodes positioned in the mitral cell layer. (a)
DLP projector, with color wheel removed from optical path, (b) focusing lens, (c) blue excitation filter, (d) dichroic
mirror, (e) emission filter, (f) CCD camera, (g) dual-tetrode, (h) olfactory bulb. (B, Top) Raw voltage traces corre-
sponding to the four channels of a tetrode showing light-induced changes in firing patterns of the units recorded.
(Center) Raster plot shows changes in spiking activity of a single isolated unit across 25 light-stimulation trials,
each 200 msec long; dots mark spike occurrence times. (Bottom) Peristimulus time histogram (PSTH) with 25-
msec time bins, summing spikes over the trials shown in the center panel.
terned light stimulation and dissect the neurocorrelates
of these patterns that dictate olfactory behavior at the
level of olfactory bulb circuitry.
Other Collaborative Projects 
with CSHL Groups 
We are also collaborating with fellow scientists on the
following projects: Kepecs: optical monitoring of cholin-
ergic modulation of cortical circuits; Koulakov and
Hannon: bringing the gap between the functional re-
sponses of glomeruli to odors and odor receptor se-
quences; Li and Shea: monitoring synaptic plasticity of
bulb circuits and AMPA receptor trafficking in real time,
during learning; Zador: optical monitoring of neuronal
activity in genetically and anatomically defined cortical
circuits in animal models of cognition; and Jackson:
using optical tools to study molecular mechanisms con-
trolling branching of maize inflorescence. 
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Epigenetic Inheritance and Cancer
C.R. Vakoc
Chromatin is the fundamental packaging material of eu-
karyotic genomes, composed of DNA in its native com-
plex with protein. The basic organizational unit of
chromatin is the nucleosome, composed of an octamer
of core histones wrapped by 147 bp of DNA. Chromatin
is charged with the critically important task of both pro-
tecting the genetic code and animating its many func-
tions. Replication, recombination, and transcription of
DNA in the cell all occur in a chromatin context, and
hence, elaborate control mechanisms have evolved to
govern chromatin structure in these diverse scenarios.
The central interest of our laboratory is to understand
the enzymatic mechanisms that control chromatin and
how such pathways establish heritable chromatin states
and participate in the pathophysiology of cancer. 
A major focus of our work is a class of molecules re-
ferred to as human Trithorax proteins, or also known
as the mixed-lineage leukemia (MLL) family. MLL pro-
teins are large modular chromatin regulators that utilize
catalytic (methyltransferase activity of histone H3 lysine
4) and noncatalytic mechanisms (chromatin-binding
and scaffold functions) to maintain the “ON” state of
gene expression. One fascinating feature of MLL or-
thologs in other species is their unique capacity to
maintain heritable states of gene activity, as exemplified
by the MLL orthologs in Drosophila maintaining heri-
table programs of Hox gene expression, a phenomenon
known as cellular memory. Although most of the classic
epigenetic inheritance phenomena have been classically
linked with the “OFF” state of expression, the epige-
netic maintenance of the “ON” state by MLL stands
alone as one of the only known mechanisms in nature
that stably preserves active chromatin in a manner her-
itable through somatic cell divisions. A key interest in
our laboratory is define the molecular mechanism of
epigenetic inheritance by MLL proteins. 
In addition to having essential functions in main-
taining active chromatin during normal ontogeny and
differentiation, the MLL1 protein is also a proto-onco-
gene in acute leukemia that can be mutated via chro-
mosomal translocation to generate oncogenic fusion
proteins. MLL1 fusion proteins induce a hyperactive
chromatin state as compared to wild-type MLL1,
which leads to up-regulation of MLL1’s normal target
genes to block hematopoietic cell differentiation and
induce leukemia. Thus, MLL1 leukemias represent a
clear situation where chromatin dysfunction directly
causes a human cancer. In collaboration with Johannes
Zuber in Scott Lowe’s laboratory at CSHL, we have
begun using a mouse model of MLL1 leukemia to ex-
plore the causal relationship between chromatin regu-
lation and the pathogenesis of cancer.
202 Research
Figure 3. Odor responses of glomerular and
mitral cell body layers via multiphoton imag-
ing of GCAMP2 signals. (Left) Glomeruli,
(center) mitral cell bodies, (right) best func-
tional matches between glomerular and mi-
tral cell body odor responses to a panel of
125 stimuli. (G) Glomerulus, (M) mitral cells
from Kv3.1 GCAMP2 mice. (Fletcher et al., J
Neurophysiol 102: 817–830 [2009].)
Epigenetic Inheritance Mechanisms
Used by MLL1
Evidence across many metazoan species implicates the
MLL1 protein in preserving a mitotically heritable “ON”
chromatin state. However, the molecular mechanisms
underlying this function have not been determined.
MLL1 possesses a catalytic SET domain that labels his-
tone molecules in the nucleosome with H3K4 methyla-
tion. Although plenty of evidence suggests that histone
methylation can participate in maintaining heritable
chromatin states in various contexts, the SET domain of
MLL is actually not required to perform most of its es-
sential functions in vivo, i.e., an MLL-null mouse is em-
bryonic lethal, whereas MLL∆SET mice are born at
normal mendelian ratios with a minimal phenotype (Ter-
ranova et al., Proc Natl Acad Sci 103: 6629–6634
[2006]). This observation suggests that MLL must use
an additional noncatalytic means of maintaining herita-
ble active chromatin. With this question in mind, we set
out to investigate whether MLL has evolved specialized
mechanisms to protect active chromatin from disruption
during cell division which might underlie an inheritance
function. We chose to investigate MLL’s status during
M phase of the cell cycle, because during mitosis, gene
activity is temporarily extinguished and must self-renew
within daughter cell chromatin upon re-entry into G1.
Indeed, the condensed state of mitotic chromosomes ba-
sically prevents access of most chromatin-associated pro-
teins during M phase. To our surprise, however, we
found that MLL remains attached to condensed mitotic
chromosomes as revealed by immunofluorescence in sev-
eral cell types. We then used genome-wide location
analysis to identify the mitotic target genes of MLL,
which revealed that MLL has essentially latched on to
the genes that were the most highly expressed in the
genome, prior to the cells having entered mitosis and si-
lenced gene transcription. This observation suggested to
us that MLL might be “bookmarking” gene activity dur-
ing mitosis, wherein MLL itself might be serving as an
epigenetic mark to tell daughter cells which genes to ex-
press upon completion of mitosis. Consistent with this
hypothesis, we found that when MLL was depleted,
daughter cells displayed delayed kinetics of gene reacti-
vation. We went on to show that MLL tethers additional
chromatin regulators (Menin, RbBP5, and Ash2L) to its
occupied sites within mitotic chromatin to “mark” sites
of premitotic gene activity.
Collectively, our observations support the “MLL
epigenetic mark” as a widespread mechanism to faith-
fully and efficiently restore gene activity following mi-
tosis in human cells. We speculate that the ultimate
service this mechanism provides to cellular tissues is to
supply momentum to the status quo and allow dividing
cells to resist changes in gene expression. This would be
supported by MLL knockout phenotypes in vivo,
where hematopoietic cells exhibit compromised self-re-
newal and instead aberrantly differentiate and adopt
more-differentiated cell fates. In follow-up to this work,
we seek to identify the precise molecular mechanism by
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Figure 4. The MLL1 protein as an epigenetic mark that facilitates inheritance of gene expression states through mitosis.
The transition from G2 into M phase is associated with eviction of RNA polymerase II (pol II) and most DNA-binding
proteins from their interphase chromosomal locations. The exodus of transcription machinery is coupled with the ac-
quisition of MLL1 occupancy to “mark” locations that possessed premitotic gene activity. MLL1 occupancy endures
through chromosome inheritance to each daughter cell. Upon completion of mitosis, MLL facilitates the return of
transcriptional machinery back to its premitotic locations, likely through direct physical interactions with the largest
subunit of RNA pol II. Upon restoration of high-level transcription, MLL is redistributed away from its mitotic locations
to novel interphase locations where it serves as a coactivator for a number of DNA-binding transcription factors.
which MLL uniquely attaches itself to mitotic chro-
matin. In addition, a continued interest of ours is in
evaluating how progression through mitosis brings
about the capacity for changes in gene expression states,
and how mechanisms like that described above provide
resistance to reprogramming cellular state. 
MLL Leukemia: A Model to Study
the Causality between Chromatin 
Malfunction and Cancer 
In addition to the unique molecular features of wild-type
MLL, mutant forms of MLL found in leukemia also ex-
ploit chromatin-regulatory mechanisms to block myeloid
cell differentiation and maintain a leukemic phenotype.
A major long-term goal of the lab is to use a mouse
model of leukemia as a model system to study epigenetic
inheritance and to explore the therapeutic potential of
manipulating chromatin regulators to reverse the
leukemia phenotype. In the past year, we have initiated
an exciting collaboration with Johannes Zuber in Scott
Lowe’s laboratory to investigate how chromatin regula-
tors participate in the pathogenesis of MLL leukemia.
Using a combination of in vivo delivery of conditional
RNA interference (RNAi) together with biochemical as-
says of chromatin in leukemic cells, we seek to gain a ro-
bust structure–function relationship between mutant
forms of MLL that maintain the disease and the epige-
netic “lesions” they inflict upon the chromatin fiber. 
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Molecular Networks 
I. Iossifov
My research is focused on building and refining models
of molecular networks, as well as on applying these
models to study the genetics of various human diseases.
I devise methods to reliably extract knowledge about
molecular interactions from the biomedical literature,
use data integration methods to combine the literature-
based information with results from high-throughput
experiments, and build statistical methods to interpret
genomic data and to generate hypothesis based on
whole-genome molecular networks. 
Drosophila Segmentation Network
In collaboration with Dr. Kevin White’s lab at the Uni-
versity of Chicago, we built an integrated model of the
segmentation network around two key transcription
factors (Ftz and Eve) involved in the process of embry-
onic segmentation in Drosophila melanogaster. In addi-
tion to the literature-mined molecular network, the
model included lists of differentially expressed genes in
Ftz and Eve null mutants compared to wild type, genes
identified through chromatin immunoprecipitation
(ChiP)-chip assays for the binding sites of Ftz and Eve,
and a large yeast two-hybrid assay. The fly ortholog of
the human uniquitin E3 ligase, SPOP, was identified
to be central to the integrated model and further analy-
sis revealed its role in modulating tumor necrosis factor
(TNF)-mediated JNK (c-Jun N-terminal kinase) sig-
naling and thus its potential role in human cancer. A
tissue microarray screen of 18 cancer types showed that
SPOP was highly expressed in clear-cell renal cell carci-
noma (RCC) and that SPOP’s expression could be used
to distinguish histological subtypes of RCC.
Cerebellum Development through Human
and Mouse Networks
We used text mining to extract and purify two large mo-
lecular networks, one for humans and one for mice, and
used the networks to study the etiology of five cerebellum
phenotypes. We demonstrated quantitatively that genes
involved in development-related malformations differ in
their system-level properties from degeneration-related
genes. We showed that there is a high degree of overlap
among the genes implicated in developmental malfor-
mations, that these genes have a strong tendency to be
highly connected within the molecular network, and that
they also tend to be clustered together, forming a com-
pact molecular network neighborhood. In contrast, the
genes involved in malformations due to degeneration do
not have a high degree of connectivity, are not strongly
clustered in the network, and do not overlap significantly
with the development-related genes. In addition, taking
into account the above-mentioned system-level proper-
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ties and the gene-specific network interactions, we made
highly confident predictions about novel genes that are
likely also involved in the etiology of the analyzed phe-
notypes. Included in our list of predicted genes was the
Ascl1 gene, which is involved in neuronal commitment
and differentiation and whose role in cerebellum devel-
opment was independently demonstrated. 
Figure Mining for Biomedical Research
Together with Dr. Raul Rodriguez-Esteban (Pfizer Re-
search Technology Center), we built a search engine to
retrieve the figures that are publicly available through
PubMed Central. The main feature of our search engine
is its ability to search for figures by type in addition to
a keyword-based search. For example, one can find all
of the pathway diagrams that include p53. We classified
all figures into a few high-level classes (gel, pathways,
structure, and time) based on the words in the figures’
caption, on text within the figure itself (extracted
through the use of OCR), and on global image prop-
erties such as color histogram and shape structure. We
then indexed the figures based on the assigned type, the
words in the figures’ caption, in the figure itself, and in
the article containing the figure. 
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Yet another year has flown by here at the Watson School of Biological Sciences (WSBS). It is hard
to believe we are now beginning our second decade and our 11th year! 
In April 2009, we welcomed a new member to Team Watson, WSBS Co-
ordinator, Dr. Judith Wieber. Judy has a Ph.D. in biochemistry/physical
chemistry and has most recently worked as a program coordinator and in-
structor in the Department of Computational Biology, School of Medicine,
University of Pittsburg. She came to us with a strong background in teach-
ing, course development, publishing, marketing communications, and ad-
ministration. 
Faculty Changes
In 2009, three new faculty members joined the Laboratory: Mikala Ege-
blad, Alexander Krasnitz, and Stephen Shea. Assistant Professor Mikala
Egeblad came to the Watson School from the University of California, San
Francisco, where she was a postdoctoral fellow. She studies how the dy-
namics of the interactions between the tumor microenvironment and cancer cells change during
anticancer treatment. Her laboratory uses transgenic mouse models of cancer and a live-imaging
method, which she developed, that allows them to watch and quantify the innate immune response
to tumors in live mice.
Alexander Krasnitz, an Assistant Professor, first came to CSHL in 2005 as a Senior Computer
Scientist in Michael Wigler’s laboratory. He is a computational physicist by training with expertise
in distilling information from massive quantities of noisy data and interpreting complex experimen-
tal outcomes through models. His current research looks at high-level analysis of microarray-derived
data in cancer biology. 
Assistant Professor Stephen Shea came to the Watson School from Duke University Medical
Center, where he was a postdoctoral fellow. The focus of his research is neural circuits and their
control of behavior. The long-term goal in his laboratory is to anatomically and physiologically trace
complete neural circuits that mediate social decision arcs using communication behavior in mice.
We are very pleased to have each of these exciting newcomers work with our students. They have
already become members of student Thesis Committees and Qualifying Exam Committees, and
they have participated as guest lecturers in our fall courses. We look forward to their participation
in additional WSBS activities in the future.
Four faculty members departed the Laboratory in 2009: Jonathan Sebat, Jacek Skowronski, Lincoln
Stein, and William Tansey. All four served the School and its students in various roles including in-
structor, guest lecturer, rotation advisor, mentor, examiner, and Thesis Committee members. Addi-
tionally, William Tansey served as the School’s Director of Graduate Studies from July 2004 to May
2007 and the Chair of the Curriculum Development and Integration Committee from 2003 to 2007.
We are extremely grateful for his contributions to the development of the School’s unique and inno-
vative curriculum. We will miss our fellow colleagues, but we wish them well in their new endeavors.
The Sixth WSBS Graduation
Graduation is the highlight of the year and April 26, 2009 saw the Watson School’s sixth graduation
ceremony. The graduating class of 2009 comprised Allison Blum and Shu-Ling Chiu from the en-
Team Watson: (Left to right) Leemor Joshua-Tor,
Alyson Kass-Eisler, Dawn Pologruto, Kim Geer,
and Judy Wieber
2009 WSBS DOCTORAL RECIPIENTS
                                    Thesis                      Academic           
Student                       advisor                    mentor                Current position
Allison Blum                 Josh Dubnau              Hollis Cline           Postdoctoral fellow with Dr. Ruth Lehmann at the 
                                                                                                     Skirball Institute of Biomolecular Medicine, New York 
                                                                                                     University School of Medicine
Daniel H. Chitwood     Marja Timmermans   Alea A. Mills          Postdoctoral fellow with Drs. Neelima Sinha and Julin 
                                                                                                     Maloof at the University of California, Davis
Shu-Ling Chiu              Hollis Cline               Alea A. Mills          Postdoctoral fellow in Dr. Richard Huganir’s laboratory at
                                                                                                     Johns Hopkins University School of Medicine
Keisha John                   Linda Van Aelst          Josh Dubnau         Postdoctoral fellow with Dr. Mary Beth Hatten at The 
                                                                                                     Rockefeller University
Jermy Wilusz                 David L. Spector        John R. Inglis        Postdoctoral fellow with Dr. Phillip Sharp at the Massa-
                                                                                                     chusetts Institute of Technology 
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tering class of 2002, Daniel Chitwood and Keisha John from the entering class of 2004, and Jeremy
Wilusz from the entering class of 2005, who were awarded the Ph.D. degree. Sarahjane Locke from
the entering class of 2005 was awarded a Master’s degree. Sarahjane left the program early and is
currently working at the University of Vermont as a Research Project Assistant. 
This year, the graduation celebrated the educational programs at the Laboratory. Honorary de-
grees were bestowed on the WSBS founding dean Dr. Winship Herr in recognition of the 10th an-
niversary of the School, on Dr. Alfred Goldberg in recognition of the 50th anniversary of the
Undergraduate Research Program, on Mr. David Micklos in celebration of the 20th year of the
Dolan DNA Learning Center, and on Dr. Jeffrey Miller in recognition of his scholarly contributions
through the CSHL press. Winship delivered the commencement address recounting all of the ex-
citement in the founding of the School. 
As with each graduation, we extended a special welcome to the family members and friends of
our students who attend the ceremony. Among these special guests were family members who trav-
eled from Taiwan to take part in this special event.
(Left to right) WSBS Dean Leemor Joshua-Tor with 2009 graduates Allison Blum, Keisha John, Shu-Ling Chiu, Jeremy Wilusz,
Daniel Chitwood, and CSHL President Bruce Stillman
2009 THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2004
Daniel Chitwood, March 4, 2009
Patterning in leaves via a cascade of small RNAs. 
Thesis Examining Committee
Chair:                              David Jackson
Research mentor:            Marja Timmermans
Academic mentor:           Alea A. Mills
Committee member:       David L. Spector
Committee member:       James Carrington, Oregon State 
                                       University
External examiner:          Timothy Nelson, Yale University 
Keisha John, March 6, 2009
Characterization of the role of  dock7 in neuronal 
development.
Thesis Examining Committee
Chair:                              Alea A. Mills
Research mentor:            Linda Van Aelst
Academic mentor:           Josh Dubnau
Committee member:       Hollis Cline
Committee member:       Peter Scheiffele, Columbia 
                                      University
External examiner:          Mary Beth Hatten, The Rockefeller 
                                       University
ENTERING CLASS OF 2005
Jeremy Wilusz, March 23, 2009
3′-end processing of long nucleus-retained noncoding RNAs
yields tRNA-like small RNAs.
Thesis Examining Committee
Chair:                              Senthil K. Muthuswamy
Research mentor:            David L. Spector
Academic mentor:           John R. Inglis
Committee member:       Adrian R. Krainer
Committee member:       Gordon G. Carmichael, University 
                                       of Connecticut
External examiner:          James L. Manley, Columbia 
                                       University
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Teaching Award
At this year’s graduation ceremony, Dr. Gregory Hannon was presented with the fourth
annual Winship Herr Faculty Teaching Award, named in honor of the School’s founding
dean. Greg has been an active member of the School’s teaching faculty since its inception.
He has been the lead instructor of our fall Scientific Reasoning and Logic (SRL) course
for the past 4 years and leads the highly innovative Study Section module of the SRL
course. He was chosen by the students for this award, based on his enthusiasm, excel-
lence, and creativity in teaching. The following is some of what the students had to say
about Greg:
The design of the Study Section module itself demonstrates, in part, Greg’s teaching cre-
ativity. Many graduate programs provide opportunities for students to critically assess science
that has already been done, but few require students to look into the future of science and
to critically assess the reasoning and logic of proposed experiments in this way.
Greg went beyond what was required to ensure that we all achieved our best in the courses. It is ob-
vious that he teaches because he is passionate and cares about our learning. Even with his very busy
schedule he would find the time to ensure that we all got the best learning experience.
Admissions 2009
The School received 209 applications for the 2009/2010 academic year and is deeply indebted
to its Admissions Committee, which reviewed, interviewed, and selected candidates for our doc-
toral program. The Admissions Committee for the 2009 Entering Class comprised Gregory Han-
non (Chair), Josh Dubnau, Leemor Joshua-Tor, Adam Kepecs, Adrian R. Krainer, Zachary
Lippman, Robert Lucito, Nicholas Tonks, Lloyd Trotman, and Linda Van Aelst—a truly remark-
able team!
Gregory Hannon
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DOCTORAL THESIS RESEARCH
Academic Research 
Student mentor mentor Thesis research 
ENTERING CLASS OF 2004
Galen A. Collins Marja Timmermans William Tansey Role of ubiquitin ligases and activator 
Beckman Graduate Student destruction in transcription.
Oliver L. Fregoso Nicholas Tonks Adrian R. Krainer Proteomic analysis to elucidate the splicing and  
Seraph Foundation Fellow nonsplicing roles of SR proteins.
William Randolph Hearst Scholar
Shraddha S. Pai Anthony Zador Carlos D. Brody Determining the neuroanatomical loci and 
Charles A. Dana Fellow electrical correlates of duration discrimination 
in the rat.
David R. Simpson Scott Lowe Willliam Tansey Revealing insights into cancer biology with 
Beckman Graduate Student tumor-derived mutations in c-Myc.
ENTERING CLASS OF 2005
Patrick M. Finigan Senthil K. Muthuswamy Robert Martienssen Epigenetic mechanisms involved in centromere
Beckman Graduate Student function.
Amy Y. Leung David L. Spector William Tansey Role of H2B–ubiquitylation in chromatin 
Beckman Graduate Student localization.
Hiroshi Makino Hollis Cline Roberto Malinow Optical determination of the spatial distribution
Elisabeth Sloan Livingston Fellow of experience-dependent bidirectional synaptic 
plasticity.
Katherine McJunkin Terri Grodzicker Scott Lowe Using negative-selection RNAi screens to
Robert and Teresa Lindsay Fellow identify novel treatment strategies for 
hepatocellular carcinoma.
Frederick D. Rollins Jan A. Witkowski Gregory Hannon An RNAi screen for modifiers of cellular 
Cashin Fellow response to the targeted therapeutic Erlotinib.
Oliver Tam David Jackson Gregory Hannon The role of RNAi machinery in oocyte matura-
Bristol-Myers Squibb Fellow tion and embryonic development of the mouse.
ENTERING CLASS OF 2006
Yaniv Erlich John R. Inglis Gregory Hannon microRNA target identification by systematic 
Goldberg-Lindsay Fellow sensor expression.
Eyal Gruntman Josh Dubnau Glenn Turner Olfactory perception in Drosophila.
Elisabeth Sloan Livingston Fellow
Colin Malone David J. Stewart Gregory Hannon Dissecting small RNA pathways in
Beckman Graduate Student Drosophila.
NSF Graduate Research Fellow
Amy Rappaport William Tansey/ Scott Lowe Identification and characterization of tumor
Barbara McClintock Fellow Marja Timmermans suppressor genes in acute myeloid leukemia.
Claudio Scuoppo Scott Lowe Gregory Hannon Identification of novel oncosuppressors through
Engelhorn Scholar an in vivo RNAi screen in the eµ-myc model.
ENTERING CLASS OF 2007
Megan Bodnar Nicholas Tonks David L. Spector The nuclear choreography of chromatin 
Starr Centennial Scholar dynamics, gene expression, and gene repression 
in embryonic stem cells.
Ralph Burgess Bruce Stillman Gregory Hannon Recombination hotspots: Characterizing fine-
Starr Centennial Scholar scale variation in the frequency of meiotic  
recombination across the mammalian genome.
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DOCTORAL THESIS RESEARCH (continued)
Academic Research 
Student mentor mentor Thesis research 
Joseph Calarco David Jackson Leemor Joshua-Tor/ Mechanistic insights into chromatin regu-
David H. Koch Fellow Robert Martienssen lating proteins in Schizosaccharomyces 
pombe and Arabidopsis thaliana.
Saya Ebbesen David J. Stewart Scott Lowe In vivo identification and characterization 
Starr Centennial Scholar of novel tumor suppressors relevant to 
human breast cancer.
Paloma Guzzardo Adrian R. Krainer Gregory Hannon A potential role for small RNAs in hete-
Leslie C. Quick, Jr. Fellow rochromatin formation in Drosophila 
William Randolph Hearst Scholar melanogaster somatic cells.
Kyle Honegger John R. Inglis Glenn Turner Neuronal and circuit mechanisms creating 
Crick-Clay Fellow sparse odor representations in the mush-
room body of Drosophila.
Marek Kudla David Jackson Gregory Hannon 3′UTR role in posttranscriptional regula-
George A. and Marjorie H. Anderson Fellow tionof gene expression.
Michael Pautler Robert Lucito David Jackson The RAMOSA pathway and inflorescence 
William R. Miller Fellow branching in maize.
Maria Pineda Adrian R. Krainer Raffaella Sordella Mechanism of “addiction” to receptor 
Beckman Graduate Student tyrosine kinases in non-small-cell lung 
William Randolph Hearst Scholar carcinoma.
Yevgeniy Plavskin Jan A. Witkowski Marja Timmermans The evolution of the miR390-dependent  
Alfred Hershey Fellow tasiRNA pathway and its function in the 
development of basal land plants.
Joshua Sanders Bruce Stillman Adam Kepecs Trans-regional coordination of activity in 
Edward and Martha Gerry Fellow the mouse brain.
Zhenxun Wang Terri Grodzicker Adrian R. Krainer Alternative splicing of pyruvate kinase M 
A*STAR Fellow in tumorigenesis.
Petr Znamenskiy Terri Grodzicker Anthony Zador Pathways for attention and action in the 
David and Fanny Luke Fellow auditory system.
ENTERING CLASS OF 2008
Philippe Batut Alexander Gann Thomas Gingeras Contributions of transposable elements to 
Florence Gould Fellow the evolution of gene regulation in the 
Proposal defense: February 2010 Drosophila phylogeny.
Mitchell Bekritsky W. Richard McCombie Michael Wigler Evaluating the puzzle of tumor evolution 
Beckman Graduate Student using single-cell sequencing.
Proposal defense: January 2010
Dario Bressan Z. Josh Huang Gregory Hannon A genomic approach toward the elucida-
Lindsay Fellow tion of connectivity patterns at cellular res-
Proposal defense: January 2010 olution in complex neural networks.
Carrie Clendaniel David Jackson Marja Timmermans Role of hira in the regulation of develop
Beckman Graduate Student mentally important target loci.
Proposal defense: March 2010
Melanie Eckersley-Maslin Gregory Hannon David L. Spector Making the choice: Mechanistic insights 
Genentech Foundation Fellow into random autosomal monoallelic expres-
Proposal defense: February 2010 sion in mammalian cells.
Jiahao Huang Terri Grodzicker Raffaella Sordella Network control of epithelial–mesenchy-
Beckman Graduate Student mal transition (EMT) progression, mainte-
Proposal defense: February 2010 nance, and reversion.
Sang Geol Koh Glenn Turner Anthony Zador Attention-dependent information routing 
George A. and Marjorie H. Anderson Fellow in the mouse auditory cortex.
Proposal defense: February 2010
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The Watson School 2009 class enjoying dinner at the home of Dr. and Mrs. Watson. (Left to right) Kristen Delevich, Silvia Fenoglio,
Ian Peikon, Stephane Castel, James Watson, Kaja Wasik, Cinthya Zepeda Mendoza, Wee Siong Goh
DOCTORAL THESIS RESEARCH (continued)
Academic Research 
Student mentor mentor Thesis research 
Katie Liberatore Adrian R. Krainer Zachary Lippman The “rules” of floral branching systems: A 
Starr Centennial Scholar comparative morphological and molecular 
Proposal defense: February 2010 study of inflorescence development.
Ozlem Mert John R. Inglis Scott Lowe Characterization of the role of E2F7 in 
George A. and Marjorie H. Anderson Fellow oncogene-induced senescence and tumori-
Proposal defense: January 2010 genesis.
Elizabeth Nakasone Alea A. Mills Mikala Egeblad Understanding the effects of cytotoxic 
Leslie C. Quick, Jr. Fellow chemotherapeutics on the innate immune 
William Randolph Hearst Fellow response.
Proposal defense: March 2010
Zinaida Perova Linda Van Aelst Bo Li Role of medial prefrontal cortex in behav-
Charles A. Dana Fellow ioral depression.
Proposal defense: January 2010
Felix Schlesinger Gregory Hannon Thomas Gingeras Classification of transcription start sites 
Crick-Clay Fellow outside known core promoters.
Proposal defense: January 2010
Nilgun Tasdemir Josh Dubnau Scott Lowe Investigating the molecular overlaps be-
Lindsay Fellow tween epigenetic reprogramming and trans-
Proposal defense: January 2010 formation.
Elvin Wagenblast Jan A. Witkowski Gregory Hannon Role of stem/progenitor cells in mammary 
Starr Centennial Scholar gland and breast tumors.
Proposal defense: January 2010
Susann Weissmueller Raffaella Sordella Scott Lowe In vivo identification and characterization
Annette Kade Fellow of tumor suppressor genes in hepatocellular 
Proposal defense: January 2010 carcinoma.
Entering Class of 2009
On August 24, 2009, the Watson School opened its doors for the
11th time to welcome yet another new class. This year, seven stu-
dents joined the School: Stephane Castel, Kristen Delevich, Silvia
Fenoglio, Wee Siong Goh, Ian Peikon, Kaja Wasik, and Cinthya
Zepeda Mendoza. Reflecting CSHL’s eclectic mix of nationalities,
the entering class of 2009 is also international, hailing from the
United States, Canada, Italy, Mexico, Poland, and Singapore.
Academic Mentoring
The Watson School takes great pride in the level of mentoring
that it offers its students. One of the very special aspects in this
regard is our two-tiered mentoring approach whereby each stu-
dent receives an academic mentor as well as a research mentor.
Entering students select by mutual agreement a member of the
research or nonresearch faculty to serve as an academic mentor—
a watchful guardian to look over and encourage the student
through the sometimes-trying process of their doctoral education. This program continues to receive
much support from the faculty who volunteer to be academic mentors, and it has rightfully become
a vital ingredient to our success. This year’s new academic mentors for the entering class of 2009 are
The Fall Term Curriculum
Our faculty continues to do an outstanding job of developing and delivering the curriculum. For a sec-
ond year in a row, they have risen to the challenge of teaching a large class of students, and we are ex-
tremely grateful for their considerable time and effort in maintaining the high-quality course work that
we strive to provide. The Curriculum Development and Integration Committee (CDIC)—Adrian R.
Krainer (Chair), David Jackson, Leemor Joshua-Tor, Nicholas Tonks, and Glenn Turner—continues
to carefully monitor and develop the curriculum. Glenn replaced Z. Josh Huang, who had served since
2005, on the committee this year. We thank Josh for his input and advice while serving on the com-
mittee. In addition to the outstanding course instructors and guest lecturers from within the Laboratory,
our courses also continue to attract an impressive array of guest lecturers from other institutions.
ENTERING CLASS OF 2009
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The 2009 entering class: (Back, left to right) Kristen Delevich, Ian
Peikon, Stephane Castel, Wee Siong Goh; (front, left to right) Silvia
Fenoglio, Kaja Wasik, Cinthya Zepeda Mendoza
Stephane Castel, University of Guelph
Academic mentor: Lloyd Trotman
Kristen Delevich, University of Pittsburgh 
Academic mentor: Bo Li
Silvia Fenoglio, University of Turin 
Academic mentor: Linda Van Aelst
Wee Siong Goh, University of Pennsylvania 
Academic mentor: Hiro Furukawa
Ian Peikon, Duke University 
Academic mentor: Mickey Atwal 
Kaja Wasik, Warsaw University 
Academic mentor: Jan A. Witkowski
Cinthya Zepeda Mendoza, National 
Autonomous University of Mexico 
Academic mentor: Thomas Gingeras
STUDENT MENTOR
Stephane Castel Lloyd Trotman
Kristen Delevich Bo Li
Silvia Fenoglio Linda Van Aelst
Wee Siong Goh Hiro Furukawa
STUDENT MENTOR
Cinthya Zepeda Mendoza Thomas R. Gingeras
Ian Peikon Gurinder (Mickey) Atwal
Kaja Wasik Jan A. Witkowski
Recruiting Efforts
Recruitment for the graduate program’s 2009 class and our Undergraduate Research Program (URP)
of 2009 was once again managed by Ms. Dawn Pologruto, the School’s Director for Admissions
and Student Affairs. As in years past, Dawn traveled the length and breadth of the country repre-
senting CSHL and WSBS. The table on the following page details recruitment fairs and conferences
in which we have participated, together with the names of faculty, students, and administrators who
represented WSBS on these occasions. To further raise awareness of our programs, we also mailed
more than 15,000 letters to colleges and universities in the United States and abroad.
Interinstitutional Academic Interactions
It is important to bear in mind that many of the graduate students who pursue their thesis research
at CSHL are not in the WSBS graduate program. Indeed, a large percentage of students are from
Stony Brook University (SBU), via a program established between CSHL and SBU more than 30
years ago. In addition, we often have visiting students from institutions around the world who come
to study in our laboratories. WSBS provides an on-site “home” for these students, helps to ensure
that they feel part of the CSHL community, and assists them with the complexities of performing
doctoral research away from their parent institutions. The students listed in the box below joined us
this year. 
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student                                         CSHL research mentor                  Affiliation and program
Timour Baslan                                    James Hicks                                          Stony Brook, Molecular and Cellular Biology
Matthew Camiolo                              Raffaella Sordella                                  Stony Brook, Genetics
Sudipto Chakrabortty                        Thomas Gingeras                                  Stony Brook, Genetics
Dong-Woo Hwang                            Alea A. Mills                                         Stony Brook, Genetics
Willey Liao                                         Michael Q. Zhang                                Stony Brook, Applied Math and Statistics
Baoyi Liu                                            Scott Powers                                         Stony Brook, Genetics
Yifan Mo                                            Michael Q. Zhang                                Stony Brook, Applied Math and Statistics
Vadim Pinskiy                                    Partha Mitra                                         Stony Brook, Biomedical Engineering
Jie Wu                                                Michael Q. Zhang                                Stony Brook, Applied Math and Statistics
Xin Zhou                                           Scott Powers                                         Stony Brook, Molecular and Cellular Biology
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A Major Change to Graduate Student Seminar
Continuing the tradition begun in the summer of 2008, three Graduate Student Symposia were
held in 2009 at the Laboratory’s Genome Research Center in Woodbury: one each in January,
April, and October. Each Symposium consisted of a full day of activities including 20-minute and
10-minute talks by senior students and poster presentations by more junior students. Lunch and
a wine and cheese reception rounded out the program and provided opportunities for more infor-
mal interactions. As with the inaugural event held in August 2008, the students and faculty in at-
tendance found the Symposia to be very worthwhile events. The Graduate Student Symposium is
open to the entire Laboratory community, but it is run largely by the students themselves. We are
grateful to the two student chairs of the Symposium—Xiaoyun Wu (SBU) and Colin Malone
(WSBS)—for their dedication and hard work in helping to refine the format and extend the success
of the Graduate Student Symposium and to Judy Wieber for overseeing the administrative ele-
ments.
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2009 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event                                                            Location                                        Date                   WSBS representatives/titles
Rice University: The Institute of Biosciences     Rice University                                   January 14             Dawn Pologruto, Director of Admissions 
and Bioengineering Information Fair                                                                                                       and Student Affairs
Wellesley College: Women in Science Fair         Wellesley College                                February 25           information sent for distribution
State University of New York, Farmingdale:       Cold Spring Harbor Laboratory         May 1                    Katie Liberatore, Graduate Student;
Information Session and Visit                                                                                                                   Hassana Oyibo, Graduate Student;
                                                                                                                                                                    Dawn Pologruto
                                                                                                                                                                    Fred Rollins, Graduate Student
New York City College of Technology:               Cold Spring Harbor Laboratory         July 16                   Eugene Plavskin, Graduate Student;
NSF STEP Program Visit                                                                                                                         Dawn Pologruto
23rd Symposium of  The Protein Society:         Boston, Massachusetts                        July 26                   Michael Pautler, Graduate Student
Graduate School Fair
University of Medicine and Dentistry, New       Cold Spring Harbor Laboratory         July 30                   Michael Pautler; Dawn Pologruto
Jersey: Summer Internship Program Visit                                                                                                 
University of Puerto Rico, Cayey: Minority       University of Puerto Rico, Cayey       September 16        Paloma Guzzardo, Graduate Student
Access for Research Careers (MARC) 
Program Information Session
Massachusetts Institute of Technology:              Massachusetts Institute of                  September 17        Eugene Plavskin; Petr Znamenskiy, 
Career Fair                                                       Technology                                                                    Graduate Student
University of Puerto Rico, Rio Piedras:              University of Puerto Rico,                 September 17        Paloma Guzzardo
Minority Access for Research Careers             Rio Piedras
(MARC) Program Information Session
Massachusetts Institute of Technology:               Massachusetts Institute of                  September 18        Eugene Plavskin; Petr Znamenskiy
Information Session                                         Technology                                                                    
Universidad Interamericano de Puerto Rico:     Universidad Interamericano               September 18        Paloma Guzzaardo
Information Session                                         de Puerto Rico
Cornell University: Information Session             Cornell University                              September 22        Amy Rappaport, Graduate Student;
                                                                                                                                                                  Fred Rollins, Graduate Student
Cornell University: Graduate and                      Cornell University                              September 23        Amy Rappaport; Fred Rollins
Professional School Day                                                                                                                           
University of Maryland, Baltimore County:      University of Maryland,                     September 28        Keisha John, Watson School of Biological 
Meyerhoff Scholarship Program Visit              Baltimore County                                                          Sciences Alumna
The Johns Hopkins University: Information      The Johns Hopkins University           September 29        Saya Ebessen, Graduate Student
Session
Notre Dame University: Information Session     Notre Dame University                      October 1              Carrie Clendaniel, Graduate Student
Northwestern University: Information Session   Northwestern University                    October 2              Carrie Clendaniel
Washington University, St. Louis:                      Washington University, St. Louis       October 5              Colin Malone, Graduate Student
Information Session 
Georgetown University: Information Session     Georgetown University                      October 6              Dawn Pologruto
Hunter College: Minority Access for                 Hunter College                                  October 7              Amy Rappaport
Research Careers (MARC) Program 
Information Session
University of California, Berkeley: Graduate      University of California, Berkeley       October 7–8          Colin Malone
School Fair
University of New Mexico: Information            University of New Mexico                  October 8              Katie Liberatore
Session
University of Guelph, Canada: Information       University of Guelph, Canada            October 8              Joseph Calarco, Graduate Student; 
Session                                                                                                                                                      Michael Pautler
Barry University: Minority Access for                Barry University                                 October 9              Maria Pineda, Graduate Student
Research Careers (MARC) Program 
Information Session
University of Toronto: Information Session        University of Toronto                         October 9              Joseph Calarco; Michael Pautler
California Institute of Technology: Career          California Institute of Technology      October 14            Colin Malone
Fair
Princeton University: Information Session         Princeton University                           October 15            Katie McJunkin, Graduate Student
Society for Advancement of Chicanos and         Dallas, Texas                                       October 15–17      Melanie Eckersley-Maslin, Graduate 
Native Americans in Science (SACNAS)                                                                                                  Student; Katie Liberatore
Princeton University: Graduate and                   Princeton University                           October 16            Katie McJunkin
Professional School Fair
Yale University: Information Session                  Yale University                                    October 22            Kyle Honegger, Graduate Student
Harvard University: Information Session           Harvard University                             October 23            Kyle Honegger
University of California, Los Angeles:                 University of California,                    October 28            Elizabeth Nakasone, Graduate Student
Graduate School Fair                                       Los Angeles
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students
and postdoctoral fellows departed from the Laboratory during 2009:
Postdoctoral Fellows
Victoria Aranda Calleja Anne Daulny Bing Hu Gonzalo Hugo Otazu 
Yoselin Benitez Alfonso Ebru Demir Robyn Johnston Aldana
Anka Bric Katalin Fejes-Toth William Keyes Ananda Sarkar
Santanu Chakraborty Gidon Felsen Sandra Kuhlman Richard Slotkin
Samit Chatterjee Fuqiang Geng Claus-Dieter Kuhn Vihra Sotirova
Min Hsuan Chen Vladimir Grubor John Kurland Clinton Whipple
Shuaili Chen Nobuhiko Hiramatsu Nancy Liu Sullivan Zuo Zhang
Wen Yu Chung Katarzyna Hrecka Jernej Murn
Graduate Students
Allison Blum Keisha John Xiaofei Liu Jeffrey Rosenfeld
Abhishek Chakraborty Danny Khalil Alexandra Lucs Hongjae Sunwoo
Hsueh-Cheng Chiang Anna Kloc Hazeem Okunola Jeremy Wilusz
Daniel Chitwood Jane Lee-Osborne Avi Rosenberg Wen Xue
Xingyue He
Executive Committee 
A large measure of the Watson School’s success can be traced to the sage advice, guidance, and gover-
nance of the School’s Executive Committee. I wish to thank faculty members Terri Grodzicker, W.
Richard McCombie, Alea A. Mills, David L. Spector, Nicholas Tonks, and Linda Van Aelst, who con-
tinued to serve on the Executive Committee through 2009. Dick McCombie and Nick Tonks completed
their second terms in December 2009. We are grateful for the insights and advice that Dick and Nick
brought to the Committee as members for 6 years. As happens each year, there was also turnover among
the student representatives. SBU representative Xiaoyun Wu completed her term in September and was
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2009 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE (continued)
Event Location Date WSBS representatives/titles
University of Southern California: University of Southern October 29 Elizabeth Nakasone
Information Session California
Annual Biomedical Conference for Phoenix, Arizona November 4–7 Paloma Guzzardo; Keisha John; 
Minority Students (ABRCMS) Dawn Pologruto; Hassana Oyibo, 
Graduate Student
Queensborough Community College: Queensborough Community November 4 information sent for distribution
Experiential Learning Conference College
Stanford University: Graduate School Fair Stanford University November 5 Megan Bodnar, Graduate Student
California Forum for Diversity for Graduate University of California,  November 7 Megan Bodnar
Education: Graduate School Fair Santa Cruz
University of Pennsylvania: University of Pennsylvania November 12– Virtual Fair
Bioengineering/Biotechnology Virtual December 15
Career Fair
Sigma Xi Annual Conference and Research Houston, Texas November 12–15 Dawn Pologruto
Symposium
SUNY, Farmingdale: Information Cold Spring Harbor Laboratory November 20 Hassana Oyibo; Dawn Pologruto;
Session and Visit Eugene Plavskin
Vassar College: Genetics and Bioinformatics Cold Spring Harbor Laboratory December 3 Yaniv Erlich, Graduate Student; 
Course Visit and Information Session Dawn Pologruto; Fred Rollins;
Doreen Ware, Assistant Professor
California State University, Sacramento: California State University, December 5 information sent for distribution
Science Educational Equity Program Sacramento
Dean’s Report      221
replaced by Matthew Lazarus. WSBS representative Eugene Plavskin also completed his term in De-
cember. We are thankful to Xiaoyun and Eugene for their honest and thoughtful advice. 
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher and
educator to give the Gavin Borden Lecture, which is dedicated to the graduate students at the laboratory.
Dr. Ralph J. Greenspan—the Dorothy and Lewis B. Cullman Fellow in Experimental Neurobiology
at The Neurosciences Institute in San Diego—was this year’s Gavin Borden Fellow. His lecture Genes
and Behavior: Is There a Unifying Principle, or Is It Just a Lot of Stuff? was thoroughly enjoyed and evoked
many questions from the audience. In addition, Ralph shared his experiences as a scientist during dinner
as well as at a roundtable lunch and discussion with the graduate students the following day.
The Watson School Continues to Benefit from Generous Benefactors
We are very pleased to announce the granting of a new fellowship from the Genentech Foundation
to the WSBS. This fellowship will be used to support the educational and research costs for one stu-
dent for a period of 3 years. We also hope that by creating this relationship with Genentech, the
entire WSBS community will benefit from the connection to a leader in the biotechnology industry.
In 2008, we established the Gonzalo Río Arronte Fellowship, to be held by a qualified Mexican grad-
uate student at the WSBS. This year, I am pleased to report the appointment of Ms. Cinthya Zepeda
Mendoza as the first recipient. Cinthya received her Bachelor’s degree from the Undergraduate Program
in genomic sciences at the National Autonomous University of Mexico and joined the WSBS entering
class of 2009 in August. As part of her fellowship, Cinthya will be expected to have a role in the devel-
opment of genomic sciences in Mexico on completion of her graduate and postdoctoral training. 
We are extremely grateful to our generous donors, whose one-time gifts or continued support
made our 2009 programs possible, including Abrams Charitable Trust, an anonymous donor, The
Banbury Fund, The Arnold and Mabel Beckman Foundation, Bristol-Myers Squibb Corporation,
Mr. and Mrs. Richard M. Cashin, Mr. and Mrs. Landon Clay, Lester Crown, The Dana Foundation,
The William Stamps Farish Fund, Mr. and Mrs. Alan Goldberg, Florence Gould Foundation,
William Randolph Hearst Foundation, Dr. Mark Hoffman, Annette Kade Charitable Trust, Mr.
David H. Koch, Mr. and Mrs. Robert D. Lindsay and Family, Mr. and Mrs. David Luke III,
Medicus Polish American Society, Mr. and Mrs. William R. Miller, The Millipore Foundation, The
Quick Family, The Rathmann Family Foundation, and The Roy J. Zuckerberg Family Foundation.
We are also very fortunate to hold a National Research Service Award Predoctoral Training Grant
from the National Institutes of Health, National Institute of General Medical Sciences. 
Student Achievements
The WSBS students continue to impress us all with their accomplishments. They publish their research
findings in prestigious international journals and obtain fellowships to pursue their research interests.
Our students have published more than 140 papers to date, a remarkable accomplishment for a school
in its 11th year. In addition, our current students and alumni have been successful in receiving prestigious
awards and fellowships. In 2009, Jeremy Wilusz was awarded the RNA Society/Scaringe Award. Three
current students—Joseph Calarco, Michael Pautler, and Stephane Castel—were all awarded Graduate
Scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC). WSBS
alum Patrick Paddison was named a Pew Scholar in the Biomedical Sciences. WSBS graduate Elizabeth
Murchsion received a L’Oreal UNESCO UK and Ireland Fellowship For Women In Science, and WSBS
graduate Christopher Harvey received a Helen Hay Whitney Postdoctoral Fellowship.
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2009 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Asari H, Zador AM. 2009. Long-lasting context dependence constrains neural encoding models in rodent auditory cortex. J
Neurophysiol 102: 2638–2656.
Benitez-Alfonso Y, Cilia M, Roman AS, Thomas C, Maule A, Hearn S, Jackson D. 2009. Control of Arabidopsis meristem de-
velopment by thioredoxin-dependent regulation of intercellular transport. Proc Natl Acad Sci 106: 3615–3620.
Blum AL, Li W, Cressy M, Dubnau J. 2009. Short- and long-term memory in Drosophila require cAMP signaling in distinct
meuron types. Curr Biol 19: 1341–1350.
Bolduc FV, Tully T. 2009. Fruit flies and intellectual disability. Fly 3: 91–104.
Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, Krasnitz A, Xuan Z, Zuber J, Wigler M, Hicks J, McCombie RW,
Hemann MT, Hannon GJ, Powers S, Lowe SW. 2009. Functional identification of tumor-suppressor genes through an in
vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16: 324–335.
Chitwood DH,  Nogueira FTS, Howell MD, Montgomery TA, Carrington  JC, Timmermans MCP. 2009. Pattern formation
via small RNA mobility. Genes Dev 23: 549–554.
Collins G, Lipford R, Deshaies RJ, Tansey WP. 2009. Gal4 turnover and transcription activation. Nature 461: E7–E7.
Czech B, Zhou R, Erlich Y, Brennecke J, Binari R, Villalta C, Gordon A, Perrimon N, Hannon GJ. 2009. Hierarchical rules
for Argonaute loading in Drosophila. Mol Cell 36: 445–456.
Couvillion MT, Lee SR, Hogstad B, Malone CD, Tonkin LA, Sachidanandam R, Hannon GJ, Collins K. 2009. Sequence,
biogenesis, and function of diverse small RNA classes bound to the Piwi family proteins of Tetrahymena thermophila. Genes
Dev 23: 2016–2032.
Erlich Y, Chang K, Gordon A, Ronen R, Navon O, Rooks M, Hannon GJ. 2009. DNA Sudoku—Harnessing high-throughput
sequencing for multiplexed specimen analysis. Genome Res 9: 1243–1253.
Husbands AY, Chitwood DH, Plavskin Y, Timmermans MCP. 2009. Signals and prepatterns: New insights into organ polarity
in plants. Genes Dev 23: 1986–1997.
Lima SQ, Hromádka T, Znamenskiy P, Zador AM. 2009. PINP: A new method of tagging neuronal populations for identi-
fication during in vivo electrophysiological recording. PLoS One 4: e6099.
Makino H, Malinow R. 2009. AMPA receptor incorporation into synapses during LTP: The role of lateral movement and ex-
ocytosis. Neuron 64: 381–390.
Malone CD, Hannon GJ. 2009. Small RNAs as guardians of the genome. Cell 136: 656–668.
Malone CD, Brennecke J, Dus M, Stark A, McCombie WR, Sachidanandam R, Hannon GJ. 2009. Specialized piRNA path-
ways act in germline and somatic tissues of the Drosophila ovary. Cell 137: 522–535.
Nogueira FT, Chitwood DH, Madi S, Ohtsu K, Schnable PS, Scanlon MJ, Timmermans MC. 2009. Regulation of small
RNA accumulation in the maize shoot apex. PLoS Genet 1: e1000320. 
Rechavi O, Erlich Y, Amram H, Flomenblit L, Karginov FV, Goldstein I, Hannon GJ, Kloog Y. 2009. Cell contact-dependent
acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev 23: 1971–1979.
Sunwoo H, Dinger ME, Wilusz JE, Amaral PP, Mattick JS, Spector DL. 2009. MEN ∈/β nuclear retained non-coding RNAs
are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res. 19: 347–359. 
Wilusz JE, Sunwoo H, Spector DL. 2009. Long noncoding RNAs: Functional surprises from the RNA world. Genes Dev 23:
1494–1504.
Zuber J, Radtke I, Pardee TS, Zhao Z, Rappaport AR, Luo W, McCurrach ME, Yang M-M, Dolan ME, Kogan SC, Downing
JR, Lowe SW. 2009. Mouse models of human AML accurately predict chemotherapy response. Genes Dev 23: 877–889. 
WSBS Family Events
Finally, I am pleased to announce that this was a great year for both the WSBS students and ad-
ministration as we celebrated some wonderful personal occasions. On May 13, student Eyal Grunt-
man, his wife Neomi, and son Jonathan welcomed baby Eli. On May 16, we celebrated the marriage
of Dawn Meehan to Thomas Pologruto. In addition, Kyle Honegger (entering class of 2007) became
engaged. Our congratulations and best wishes to all of them.
Leemor Joshua-Tor
Professor and Dean
Dean’s Report      223
Eli Gruntman, Eyal and Neomi’s new baby boy! Marriage of Dawn Meehan and Thomas Pologruto
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Alyson Kass-Eisler and Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship, The David Pall Visiting Lectureship, 
The Fairchild Martindale Visiting Lectureship, The Lucy and Mark Ptashne Visiting 
Lectureship, The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference Center
to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty.
These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents students read assigned papers. These intensive courses are modeled on the Cold Spring Harbor
Laboratory Lecture Courses held each summer at the Banbury Conference Center. In Spring 2009,
there were two such courses: Evolution and Microbial Pathogenesis.
Evolution
Attended by the entering classes of 2007 and 2008
INSTRUCTOR Nipam Patel, University of California, Berkeley
VISITING LECTURERS Rob DeSalle, American Museum of Natural History
David Linberg, University of California, Berkeley
Mike Palopoli, Bowdoin College
TEACHING FELLOWS Crystal Chaw, University of California, Berkeley
Brian Kraatz, University of California, Berkeley
Anna-Sapfo Malaspinas, University of California, Berkeley
Brian Moore, University of California, Berkeley
The field of evolutionary biology touches upon all other areas of the biological sciences, because
every form of life and every biological process represent an ongoing evolutionary “experiment.” Our
aim in this course was to both discuss our understanding of the mechanisms of evolution and explore
how evolutionary data can be used to further our understanding of various biological problems.
The course began with a discussion of the diversity of organisms that currently exist and our
methods for understanding the evolutionary relationships between these organisms. We then went
on to study how paleontological data are collected and used to understand the history of life on
earth. We then examined how DNA sequence data can be used to understand the evolutionary his-
tory of organisms, genes, and genomes. Within this molecular and genetic framework, our focus
shifted to the mechanisms of evolutionary change and how variation within populations leads to
the evolution of new species. Finally, we discussed how morphological changes are brought about
through evolutionary changes in development and gene regulation. The hope was that this course
would provide the student with a general overview of evolutionary biology and how to use evolu-
tionary data to gain further insight into all manner of biological problems. The course ran from
Saturday, March 28, to Sunday, April 4 and included a class favorite field trip and curator tour at
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the American Museum of Museum of Natural History in New York City. As in previous years, the
course was highly rated by all of the students.
Microbial Pathogenesis
Attended by the entering classes of 2005 and 2006
INSTRUCTORS Stanley Maloy, Center for Microbial Sciences, San Diego
Ronald K. Taylor, Dartmouth Medical School
VISITING LECTURERS Heran Darwin, New York University
Darren Higgins, Harvard Medical School
Linda Kenney, University of Illinois, Chicago
Throughout recorded history, microbial pathogens have been a major cause of human disease and
mortality. However, with the advent of effective antibiotics, it seemed like the war on microbes had
been won. Hence, for several decades, health-related research shifted to topics like cancer, heart disease,
and genetic diseases. Although research in microbial pathogenesis slowed, the microbes demonstrated
the efficacy of evolution. Microbial resistance to antibiotics developed faster than new antibiotics
could be made available, and the resistance spread throughout the microbial world. The global ex-
pansion of food distribution networks has increased the incidence of common microbial pathogens.
Simultaneously, emerging microbial pathogens filled new ecological niches, such as indwelling medical
devices that provide a surface for biofilms and the growing population of patients who are immuno-
compromised due to primary infections such as HIV or due to therapies for chronic diseases. Fur-
thermore, recent discoveries have demonstrated that some diseases (e.g., ulcers) previously believed
Evolution course participants: (Front row, left to right) Philippe Batut, Dario Bressan, Crystal Chaw, Carrie Clendaniel, Maria Pineda,
Mitchell Bekritsky, Beth Nakasone, Zina Perova, Jiahao Huang, Joe Calarco. (Middle row, left to right) Marek Kudla, Saya Ebbesen, Brian
Moore, Anna-Sapfo Malaspinas, Katie Liberatore, Ozlem Mert, Melanie Eckersley Maslin. (Back row, left to right) Ralph Burgess, Kyle
Honegger, Josh Sanders, Felix Schlesinger, Megan Bodnar, Mike Pautler, Nilgun Tasdemir, Paloma Guzzardo, Hassana Oyibo, Zhenxun
Wang, Petr Znamentskiy, Sang-Geol Koh, Eugene Plavskin, Elvin Wagenblast, Susann Weismeuller, Hernan Garcia, Michael Palopoli.
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to be caused by a genetic predisposition or environmental conditions are actually caused by microbes.
This microbial offensive has summoned a renewed counterattack on microbial pathogens that has
intensified during the last several years. Meanwhile, a variety of new tools have become available that
make it possible to dissect the molecular basis of pathogenesis both from the microbial and host per-
spectives. Recently, the complete DNA sequence of bacterial pathogens has provided valuable insights
into how microbial pathogens evolve and the extent of gene transfer between pathogens. These ad-
vances have revealed new ways to control infection, including the identification of novel targets for
antimicrobials and novel approaches for vaccine development. Nevertheless, many more questions
remain unanswered and many pathogens are still poorly understood.
Understanding bacterial pathogenesis demands a detailed knowledge of the host response as well
as the pathogen itself. Both of these perspectives provide potential strategies for solving important
clinical problems. To elucidate these distinct aspects of microbial pathogenesis requires an interdis-
ciplinary approach, integrating the fields of microbiology, eukaryotic cell biology, immunology, and
genomics. 
This course focused on mechanisms of microbial pathogenesis and the host response, and the
scientific approaches that are used to investigate these mechanisms. How do microbes adhere to
host cells? How do environmental cues direct the response of microbial pathogens? How do micro-
bial pathogens modulate host cells to expedite virulence? How do host cells respond to microbial
pathogens? How does the host immune system react to microbial pathogens? What does genomics
tell us about how microbial pathogens evolve? How do emerging pathogens take advantage of new
ecological niches? Although there are numerous microbial pathogens, the answers to these questions
indicate that many pathogens use similar approaches to solve common problems. The course inte-
grated lectures by the instructors, directed readings of research papers, and seminars by the instruc-
tors plus three invited speakers who specialize in various aspects of bacterial pathogenesis. The course
ran from Saturday, April 19, through Sunday, April 25. The students rated this course as one of
their favorites. 
Microbial Pathogenesis course participants: (Front row, left to right) Karen Liu, Claudio Scuoppo, Yaniv Erlich, Amy
Leung, Katie McJunkin. (Middle row, left to right) Heran Darwin, Amy Rappaport, Oliver Tam, Hiroshi Makino. (Back
row, left to right) Stanley Maloy, Fred Rollins, Jeremy Wilusz, Colin Malone, Patrick Finigan, Ronald Taylor.
Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Amanda McBrien (Lead) Jermel Watkins
Jennifer Cutillo Elna Gottlieb
Jason Williams Erin McKechnie
ADMINISTRATOR Carolyn Reid
As science plays an increasing role in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory’s Dolan DNA Learning Cen-
ter, where students teach laboratory courses to high school and middle school students. From these
teaching experiences, they learn how to communicate with nonbiologists and to inspire and educate
creative young minds. The teaching module entailed pairs of students teaching one morning or af-
ternoon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors
taught the Watson School students the didactic process; it was not until the 5th week that the grad-
uate students taught on their own. At the end of the 12 weeks, the students were very excited about
their teaching experience. 
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research
that leads to a unique contribution to human knowledge. After the fall course term, students par-
ticipate in laboratory rotations. These rotations provide students and faculty the opportunity to get
to know each other and to explore possibilities for doctoral thesis research. At the end of each rota-
tion, students make short presentations of their studies to the other students and their rotation ad-
visors. These talks give students an opportunity to share their laboratory experiences and to learn
how to give a scientific presentation. With this latter goal in mind, in addition to the research men-
tors, the instructors of the Scientific Exposition and Ethics core course and members of the School’s
Executive Committee attend the talks and give individual feedback to students on their presentations.
This year, 22 WSBS faculty members and one research professor served as rotation mentors to our
largest class to date, some mentoring more than one student.
ROTATION MENTORS Mickey Atwal Adrian R. Krainer Bruce Stillman
Josh Dubnau Bo Li Marja Timmermans
Mikala Egeblad Zach Lippman Glenn Turner
Thomas Gingeras Scott Lowe Linda Van Aelst
Gregory Hannon Robert Martienssen Doreen Ware
James Hicks Alea A. Mills Michael Wigler
Josh Huang Raffaella Sordella Anthony Zador
Adam Kepecs David L. Spector
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FALL CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific 
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation, The William Stamps Farish Lectureship
INSTRUCTORS Gregory Hannon (Lead) Leemor Joshua-Tor
Alexander Gann Scott Lowe
David Jackson Glenn Turner
GUEST LECTURERS Josh Dubnau Robert Martienssen
Mikala Egeblad Thomas Schalch (postdoctoral fellow)
Grigori Enikolopov Raffaella Sordella
Hiro Furukawa Bruce Stillman
Adam Kepecs Lloyd Trotman
Bo Li
VISITING LECTURERS Elizabeth Lacy, Memorial Sloan-Kettering Cancer Center
William Merrick, Case Western Reserve University
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core
course, which forms the heart of the curriculum, students (1) acquired a broad base of knowledge
about the biological sciences, (2) learned the scientific method, and (3) learned how to think criti-
cally. This course consisted of six biweekly modules, each of which had a different theme. Each
week, students read an assigned set of research articles and at the end of the module, provided written
answers to a problem set that guided them through several of the articles. Twice weekly, students at-
tended lectures related to the week’s topic that included concepts and fundamental information as
well as experimental methods. During each week, the students met among themselves to discuss
the assigned papers not covered by the problem set. Each week, students spent an evening discussing
the assigned articles with faculty. The module topics for this course were as follows:
Module 1 Macromolecular Structure and Function Module 4 Signaling in Development
Module 2 Gene Expression Module 5 Neuroscience
Module 3 Cell Proliferation and Cancer Module 6 NIH Study Section
The Darrell Core Course on Scientific Exposition and Ethics 
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation, The John P. and Rita M. Cleary 
Visiting Lectureship, The Seraph Foundation Visiting Lectureship, 
The Susan T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS David J. Stewart (Lead)
Alea A. Mills 
Arne Stenlund
TEACHING ASSISTANT Emily Hodges
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GUEST LECTURERS Walter Goldschmidts
Jan A. Witkowski
VISITING LECTURERS Misha Angrist, Duke University
Olga Akselrod, The Innocence Project
Robert Charrow, Greenberg Traurig, LLP
Avner Hershlag. North Shore University Hospital 
Boyana Konforti, Editor, Nature Structural & Molecular Biology
Michael Zigmond, University of Pittsburgh
The 2009 Scientific Exposition and Ethics (SEE) core course content remained essentially the same
as in 2008. David Stewart, an instructor last year, took over as lead instructor. Alea Mills, last year’s
lead instructor, and Arne Stenlund, also returning from last year, were the other instructors. The
faculty instructors were again joined by a postdoctoral fellow, Emily Hodges, as a teaching assistant,
a format our students have taken to very well.
This core course offered instruction in the fundamental elements of scientific exposition—writing
skills and public speaking—and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of ex-
ample-based lectures and discussion groups. Writing skills included the fundamentals of modern sci-
entific English and the organization and preparation of papers, research abstracts, and grant
applications. Oral presentation skills were taught by instructors with different modes of presentation.
Together with instructors, students critiqued formal seminar presentations at the Laboratory. Instruc-
tion and discussions about ethics included the ethical implications of biological discovery on society
as well as the nature and boundaries of ethical behavior of scientists and their rights and responsibil-
ities. A primary objective of the course was that students consider exposition and ethics an integral
part of scientific research.
Research Topics
ORGANIZERS Kimberley Geer 
Alyson Kass-Eisler
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar,
at which faculty members and CSHL fellows presented their current research topics and methods
of investigation each Wednesday evening over dinner. The students learned how to approach im-
portant problems in biology. These seminars, together with the annual fall Laboratory In-House
Symposium, provided students with a basis for selecting laboratories in which to do rotations. The
weekly speakers were
Florin Albeanu Leemor Joshua-Tor Alea A. Mills Marja Timmermans
Gurinder (Mickey) Atwal Adam Kepecs Partha Mitra Lloyd Trotman
Josh Dubnau Alexei Koulakov Pavel Osten Glenn Turner
Mikala Egeblad Adrian R. Krainer Darryl Pappin Christopher Vakoc
Grigori Enikolopov Alexander Krasnitz Scott Powers Linda Van Aelst
Hiro Furukawa Bo Li Stephen Shea Doreen Ware
Thomas Gingeras Zachary Lippman Raffaella Sordella Michael Wigler
Gregory Hannon Scott Lowe David L. Spector Anthony Zador
Z. Josh Huang Robert Martienssen Arne Stenlund Yi Zhong
David Jackson W. Richard McCombie Bruce Stillman
Specialized Disciplines Courses
The content of the three Specialized Disciplines in Biology (SD) courses—Genetics, Systems Neu-
roscience, and Cellular Structure and Function—has largely remained the same from last year, with
just some changes to the guest and visiting lecturers.
Genetics and Genomics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship, The Pfizer Lectureship, The George 
B. Rathmann Lectureship, The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Josh Dubnau (Lead)
Thomas Gingeras
GUEST LECTURERS Mickey Atwal
Zachary Lippman
VISITING LECTURER Abraham Palmer, University of Chicago
This course placed modern human genetics and genomics into the context of classical organismal
genetics. History, perspective, and technique were described around four levels of analysis: naturally
occurring variation, genome evolution, genetic screens, and gene epistasis. How do gene mutations
help to define biological processes? How are more complex traits genetically dissected into simpler
(underlying) components? What concepts and techniques are used to organize genes into pathways
and networks? How are genes mapped, cloned, and engineered to identify functional domains of
proteins? What gene variation exists in natural populations? What are the functional consequences
of gene variation? How is it detected? How are genomes organized and coordinately regulated? How
can genomic information be catalogued, organized and mined? These questions and concepts were
fleshed out using examples from the literature.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship, The Klingenstein Lectureship, The William 
R. Miller Lectureship
INSTRUCTORS Anthony Zador (Lead)
Adam Kepecs
GUEST INSTRUCTORS Florin Albeanu
Alexei Koulakov
VISITING LECTURER Mayank Mehta, Brown University
This course provided an overview of key aspects neuroscience. The emphasis was on spanning levels:
How can we go from molecules through cells and circuits to behavior? There were three main com-
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ponents to the class: lectures, problem sets, and a final project. The last week of class was spent on
the final project in which the students found and presented a neuroscience paper that spanned levels,
for example, from the molecular to the synaptic or the circuit level to the behavioral. 
Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship, The Sigi Ziering Lectureship, The Martha F. Gerry 
Visiting Lectureship
INSTRUCTORS Linda Van Aelst (Lead)
Raffaella Sordella
GUEST INSTRUCTORS Mikala Egeblad
Darryl Pappin
David L. Spector
Bruce Stillman
VISITING LECTURERS Gregg Gundersen, Columbia University
Alexey Khodjakov, Wadsworth Laboratory
Timothy McGraw, Weill Cornell Medical College
Elizabeth Miller, Columbia University
Sandy Simon, The Rockefeller University
Marc Symons, The Feinstein Institute for Medical Research
With the complete genome sequence available for many organisms, there is now an increasing em-
phasis on understanding the function of the gene products. This understanding requires an increas-
ing appreciation of the structure and function of the cell as well as dynamic associations within the
cell. This course provided a basic overview of the structural and functional organization of cells with
particular emphasis on cellular compartmentalization and communication. Topics of focus included
the cytoskeleton, cell adhesion and signaling, membrane transport, gene expression, and nuclear
organization. In addition, the course provided insight into the basic toolbox of the cell biologist of
the 21st century.
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POSTDOCTORAL PROGRAM
PROGRAM DIRECTOR Nicholas Tonks
PROGRAM ADMINISTRATOR Alyson Kass-Eisler
Cold Spring Harbor Laboratory is proud of its rich tradition in postdoctoral education and has a
deep commitment to the postdoctoral experience. CSHL has long been recognized as a place for
nurturing young scientists, with postdoctoral researchers being an integral part of the discovery
process. The Laboratory currently employs ~140 postdoctoral fellows working in the labs of 43
principal investigators. Current fields of research expertise include genetics; molecular, cellular and
structural biology; neuroscience; cancer; plant biology; genomics; and quantitative biology. The
postdoctoral community at CSHL is diverse and international, arriving at the Laboratory with many
different backgrounds and with needs that change during the course of the postdoctoral years. The
Postdoctoral Program Office works closely with the fellows and the Laboratory administration to
coordinate and organize educational and career development activities. Dr. Alyson Kass-Eisler, the
Postdoctoral Program Officer, and Dr. Nicholas Tonks, the Scientific Director of the Postdoctoral
Program, provide the day-to-day support for the postdoctoral program, which is overseen by the
Dean of the Watson School, Dr. Leemor Joshua-Tor.
In 2009, we held a number of courses and workshops aimed at postdoctoral fellows. On January
28, we were fortunate to host Dr. Colin Goddard, Chief Executive Officer at OSI Pharmaceuticals,
who talked to the students about “Marrying Bio Science & Business: The Changing Face of
Biotech.” In this lively discussion, Dr. Goddard talked about the difficulties and joys of a career in
biotechnology and fielded questions about the industry from the student participants.
On April 13, the Watson School presented a screening of the documentary film “Naturally Ob-
sessed: The Making of a Scientist.” The film is a true story about the struggle to become a scientist
and the satisfaction of discovery. This 1-hour film was produced and directed by Carole Rifkind
and her husband, Dr. Richard Rifkind, who were present during the screening and gave a “Q&A”
session after the film. 
The first annual National Postdoc Appreciation Day was held on September 24. To celebrate,
CSHL hosted a lecture from Dr. Kathleen Flint, Project Manager at the National Postdoctoral As-
sociation, on “Getting the Most Out of Your Postdoc Experience.” Following the lecture, we took
advantage of the beautiful weather and enjoyed pizza in the new Hillside Campus courtyard. 
On October 2, we brought back the very popular course on grant writing. The first part, led by
Walter Goldschmidts and his CSHL Office of Sponsored Research (OSP) staff, focused on intro-
ductory grant writing and the grant application process. A new session on identifying postdoctoral
fellowships was added this year and included presentations by Dr. Jill Hemish from OSP, Dr. Alyson
Kass-Eisler, and postdoctoral fellow Dr. Vishal Thapar. CSHL faculty members W. Richard Mc-
Combie and Linda Van Aelst gave an overview of the grant review process with their presentation,
“True Confessions of Peer Review.” The last part of the program was an effective writing session led
by Dr. Philip Vassallo, author of The Art of On-The-Job Writing, who also did one-on-one writing
consultations with fellows.
Leadership Training was held October 13 and 14 for postdocs who are beginning to plan for
their next career step. Sessions on “Motivating and Coaching Your Lab Team,” “Creating a Profes-
sional Lab,” and “Dealing with Interpersonal Conflict” were presented by Dr. Lee Ginsburg from
Miller Ginsburg Management Consulting. These sessions were extremely useful for those postdocs
who are about to start their own laboratories.
Each year, Laboratory President Dr. Bruce Stillman holds a “Town Hall” meeting specifically for
postdoctoral fellows. This year’s Town Hall meeting took place on December 8. Dr. Stillman took
the opportunity to highlight the generous benefits our postdocs receive. The fellows took the oppor-
tunity to talk about what they think could be improved at the Lab. One area that would make life
easier for the postdoctoral fellows would be to increase shuttle service at the Laboratory. The Meetings
and Courses office will be working with the fellows to implement some of the suggestions.
CSHL has been a member of a special ambassador recruitment program from Merck Research
Laboratories (MRL) since 2005. This program provides the postdoctoral fellows and students at
CSHL an inside connection to a scientist working at MRL. As a result of this program, a postdoctoral
fellow from Dr. Bruce Stillman’s laboratory, Dr. Maarten Hoek, was hired as a Research Scientist in
2007. As a result of this program, Dr. Zuo Zhang, a postdoctoral fellow from Dr. Adrian Krainer’s
laboratory, joined MRL as a Research Scientist in 2009. The relationship between MRL and CSHL
has been extremely beneficial, and we will be looking toward building additional relationships in
the future. Drs. Li and Hoek will be visiting again in January 2010.
Four years ago, the School initiated a prize for the best posters by a postdoctoral fellow and the
best poster by a graduate student at the Laboratory’s annual In-House Symposium. Each “prize” is
given in the form of an educational grant of $500. In addition to providing a forum for the post-
doctoral fellows to show off their research, and potentially win a prize, it gives the entire scientific
community a chance to come together and share ideas beyond the walls of their individual labora-
tories. It has been a great success for both the presenters and the Laboratory community as a whole.
This year, 16 posters were presented for the postdoctoral prize, which was won by Dr. Anirban Paul,
a postdoc in Z. Josh Huang’s laboratory. 
During the past couple of years, we have increasingly widened the role of postdoctoral fellows in
the curricular activities of the School. Our fellows have been involved in preparing our students for
the challenging Fall Term curriculum, by working as one-on-one tutors during the summer.
Throughout the Fall Term, postdoctoral fellows are used as tutors for all aspects of the curriculum,
providing one-on-one tutoring and group tutoring and participating in discussion sessions. In 2007,
the Scientific Exposition and Ethics course took further advantage of the expertise of our postdoc-
toral community by hiring two fellows as teaching assistants. These two fellows were an integral
part of the course by providing their expertise in discussions, editing of the students writing work,
and critiquing oral presentations. This format was highly successful and was used again in Fall 2009.
Since 2003, all postdoctoral fellows and graduate students at the Laboratory have been enrolled
in a special initiative of the New York Academy of Science (NYAS), called the Science Alliance. The
Science Alliance for graduate students and postdoctoral fellows is a consortium of universities, teach-
ing hospitals, and independent research facilities in the New York City metropolitan area that have
formed a partnership with NYAS. The aim of the Alliance is to provide career and professional de-
velopment monitoring for postdoctoral fellows and graduate students in science and engineering,
through a series of live events and a dedicated web portal. In addition, the Science Alliance gives
graduate students and postdoctoral fellows the opportunity to network with their peers across in-
stitutions and with key leaders in academia and industry. On July 29, we were fortunate to host Dr.
Robert Tillman, Director of the Science Alliance, for a talk on “Need a doctor? Career first-aid for
Ph.D.s.” Dr. Tillman also did a one-on-one resume clinic for postdoctoral fellows.
Every other year, the NYAS, in partnership with area institutions including CSHL, hosts “What
can you be with a Ph.D?”, a 2-day science and technology career symposium. The symposium took
place at New York University on November 13–14. The event featured talks by leaders in the phar-
maceutical and biotechnology industries, science entrepreneurs, media, government, and academia.
It also included exhibitor booths and a networking reception.
We are extremely proud that our postdoctoral fellows have also been successful in obtaining pres-
tigious individual fellowships and awards. Alexei Aravin, a postdoctoral fellow in Gregory Hannon’s
lab, was named a finalist for the New York Academy of Science’s Blavatnik Award, and Erkan
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Karakas, from Hiro Furukawa’s lab, received CSHL’s Harvey L. Karp award. Current postdocs also
hold fellowships from national, international, federal, state and private foundations including the
American Cancer Society; Brodeur Breast Cancer Foundation; Chapman Fellowship; DAAD, Ger-
nan Academic Exchange Service; DFG German Science Foundation; Ellison Medical Foundation;
Heart and Stroke Foundation; Human Frontier Science Program; Lauri Strauss Leukemia Founda-
tion; NARSAD; National Institutes of Health; New York State Department of Health, HRSB, Breast
Cancer Research and Education Program; The Patterson Trust; Sass Foundation Fellowship; Sir
Keith Murdock fellowship; The Andrew Seligson Memorial Clinical Fellowship for Cancer Research;
The Leukemia and Lymphoma Society; The Lymphoma Research Foundation; United States De-
partment of Agriculture; and United States Department of Defense. Three CSHL postdoctoral fel-
lows have also been fortunate to secure career development funding through the very competitive
National Institutes of Health’s Pathways to Independence Award. To increase the Laboratory’s fel-
lowship funding and to bring new programs to CSHL, the School will be submitting a new post-
doctoral training grant in cancer to the National Institutes of Health in May. We hope to receive
funding for this exciting program in 2010. 
Finally, a most important measure of our postdoctoral program’s success is the ability of post-
doctoral fellows to secure permanent positions at the end of their training. In 2009, the Laboratory’s
departing postdoctoral fellows went on to positions at Brigham Young University, Bristol Myers
Squibb, California Institute of Technology, Centre for Genomic Regulation (Barcelona, Spain),
Duke University, Memorial Sloan-Kettering Cancer Center, Merck Research Laboratories, National
Institute of Plant Genome Research (India), Ohio State University, St. Jude Children’s Research
Hospital, University of Colorado, and Wake Forest School of Medicine to name just a few.
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UNDERGRADUATE RESEARCH PROGRAM
PROGRAM DIRECTOR David Jackson
PROGRAM ADMINISTRATOR Dawn Pologruto
Each summer, 20–25 undergraduates from around the world and across the country participate in
the CSHL summer Undergraduate Research Program (URP). More than 740 students have partic-
ipated in the URP since the program was founded in 1959. 
The fundamental objective of the program is to give students an opportunity to conduct first-
rate research. Participants learn about scientific reasoning, laboratory methods, theoretical principles,
and scientific communication. The specific objectives of the program are to (1) give college under-
graduates a taste of conducting original research at the cutting edge of science, (2) encourage aware-
ness of the physical and intellectual tools necessary for modern biological research, (3) foster an
awareness of the major questions currently under investigation in the biomedical and life sciences,
and (4) promote interactions with laboratory scientists through an immersion in the research envi-
ronment.
During the 10-week program, URPs work with CSHL senior staff members on independent re-
search projects, specifically in the areas of cancer biology, neuroscience, plant biology, cellular and
molecular biology, genetics, macromolecular structure, and bioinformatics. 
URPs work, live, eat, and play among CSHL scientists. They have a very busy academic and
social calendar for the summer. They attend lectures in the Goldberg Faculty Lecture Series from
CSHL faculty members and outside faculty members including, in 2009, talks by Dr. Stanley Maloy,
San Diego State University, and Dr. Alfred Goldberg, Harvard University. URPs also attend a Bioin-
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The 2009 Design Your Own Tee Shirt
formatics Workshop Series, where they learn how to identify patterns in DNA and protein sequences
and how to interpret them. Lectures by CSHL faculty are specifically designed for URPs. URPs
were also invited to join Dr. and Mrs. Watson for a pizza party and Dr. and Mrs. Stillman for dinner.
BBQ and pool parties, volleyball games, sailing lessons, designing the URP tee shirt, competing in
the annual CSHL Petri Dish Race and Scavenger Hunt, and the ever-famous URP vs. PI volleyball
match rounded out the engaging program. This year was the second year the URPs beat the faculty
team in volleyball—quite an accomplishment!
At the beginning of the summer, URP students write an abstract and present a talk on their pro-
posed research. Concluding the program in August, URP participants prepare a final report and
present their results in a 15-minute talk at the URP Symposium. The following students, selected
from 528 applicants, took part in the 2009 program:
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Christopher Bennett, McGill University
Advisor: Dr. Adrian R. Krainer
Sponsor: Robert H.P Olney Fund Fellowship
Presence of intronic splicing silencers downstream from 5′ splice
sites.
Philippa Borrill, University of Cambridge
Advisor: Dr. David Jackson
Sponsor: C. Bliss Memorial Fund Fellowship
Cell-to-cell trafficking of transcription factor
KNOTTED1/SHOOTMERISTEMLESS: Why and how?
Marcela Carmona, University of Pennsylvania
Advisor: Dr. Marja Timmermans
Sponsor: National Science Foundation and Department of
Defense
The contribution of polarity determinants to organ development.
Philip Coffman, University of New Mexico
Advisor: Dr. Partha P. Mitra
Sponsor: Steamboat Foundation Fellowship
Completing the circuit: A practical technique to trace long-range
projections in the brain.
Danielle Feldman, Hunter College
Advisor: Dr. Josh Dubnau
Sponsor: Hunter College Fund Fellowship and National Science
Foundation and Department of Defense
Expression and localization of lightoid (Beck-1) in the Drosophila
melanogaster central nervous system.
Emma Fink, Amherst College
Advisor: Dr. David L. Spector
Sponsor: James D. Watson Fund Fellowship
Tracking the subcellular localization of Malat1, a long ncRNA, in
live cells.
Daniel Goltz, Whitman College
Advisor: Dr. W. Richard McCombie
Sponsor: National Science Foundation and Department of
Defense
Targeted resequencing of the synaptome genes using microarray
exon capture.
Debbie Goodman, Columbia University
Advisor: Dr. Gregory Hannon
Sponsor: William Townsend Porter Foundation Fellowship
microRNAs regulating gene expression in muscular
differentiation.
Mark Grabois, Columbia University
Advisor: Dr. Adam Kepecs
Sponsor: Former URP Fund Fellowship
Roles of cholinergic basal forebrain projections in attention.
Lisa Lam, University of California, Berkeley
Advisor: Dr. Robert Martienssen
Sponsor: Former URP Fund Fellowship
Reestablishment of silencing events in Schizosaccharomyces pombe.
Aviva Mail, Cornell University
Advisor: Dr. Michael Q. Zhang
Sponsor: National Science Foundation and Department of
Defense
Detection of genomic structural variation from high-throughput
sequence data.
Michael Mitchell, University of Arizona
Advisor: Dr. Bruce Stillman
Sponsor: 30th Anniversary URP Fund Fellowship
Elucidating the role of DDX5 in cell proliferation and its
regulation of essential genes.
Alan Rodriguez Penney, University of Puerto Rico, 
Rio Piedras
Advisor: Dr. Bo Li
Sponsor: National Science Foundation and Department of
Defense
Effect of ketamine on striatum and nucleus accumbens neuronal
activity.
Julia Rogers, Yale University
Advisor: Dr. Leemor Joshua-Tor
Sponsor: National Science Foundation and Department of
Defense
Transducer and repressor complex in the yeast GAL induction
system.
Natalie Straight, Carnegie Mellon University
Advisor: Dr. Z. Josh Huang
Sponsor: Dorcas Cummings Fund Fellowship
Characterizing cell adhesion molecules in GABAergic synapses:
Neurexin and neuroligin.
Tim Wang, University of California, Berkeley
Advisor: Dr. Scott Powers
Sponsor: Former URP Fund Fellowship
An investigation of the liver cancer epigenome.
Katie Washington, Notre Dame University
Advisor: Dr. Raffaella Sordella
Sponsor: University of Notre Dame URP Fund Fellowship
Molecular mechanism of EGFR addiction in H4006 non-small-
cell lung carcinoma.
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PARTNERS FOR THE FUTURE
PROGRAM DIRECTOR Yuri Lazebnik
PROGRAM ADMINISTRATOR Theresa Saia
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an oppor-
tunity for talented Long Island high school students to have hands-on experience in biomedical re-
search at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island
high school students in their junior year. Each high school science chairperson may nominate up to
three students. The top candidates are interviewed by CSHL scientists and up to 10 top students
are chosen to participate in the program. Students selected to the program are paired with a scientist
mentor and spend a minimum of 10 hours per week, September through March of their senior
year, conducting original research. At the conclusion, the students present their projects to an en-
thusiastic audience of the students’ scientific mentors and colleagues, CSHL administrators, parents,
and teachers. Although the students learn a great deal about modern biology and state-of-the-art
research techniques, the main advantage of the program is that they are exposed to day-to-day life
2009/2010 Partners for the Future participants: (Left to right) Benjamin Hartman, Lipsa Panda, Sabrina Layna, 
in a laboratory. Interacting with scientists and support staff, the students learn to define and pursue
a research goal while solving problems that may occur along the way.
The 2009–2010 Partners for the Future were chosen from among 16 semifinalist nominations
and they are listed below:
Partner High School CSHL Mentor Laboratory
Nikita Anand Cold Spring Harbor High School Gregory Hannon Gregory Hannon
Benjamin Hartman North Shore High School Mikala Egeblad Mikala Egeblad
Sabrina Layne Oyster Bay High School Kate Creasey Robert Martienssen
Norah Liang Patchogue–Medford High School Alea A. Mills Alea A. Mills
Steven McGarty Cold Spring Harbor High School Partha Mitra Partha Mitra
Lipsa Panda Syosset High School Morgan Xu David Jackson
Joshua Weiss Smithtown High School East Mickey Atwal Mickey Atwal
238 Watson School of Biological Sciences
MEETINGS AND COURSES
ACADEMIC AFFAIRS
The Meetings and Courses program at the Laboratory serves to communicate new discoveries, con-
cepts, and methodologies to an international community of scientists. The program consists of ad-
vanced laboratory and lecture courses, as well as large meetings and biotechnology conferences that
are held almost year round. More than 8000 scientists ranging from graduate students and post-
doctoral fellows to senior faculty come from around the world to attend these events at Cold Spring
Harbor. A growing international program complements the main program of meetings and courses.
In 2009, the 27 laboratory and lecture courses that were held
at the Laboratory attracted more than 1180 participants (including
teaching faculty, students, and technicians). These courses covered
a diverse array of topics in molecular biology, neurobiology, struc-
tural studies, and bioinformatics. The primary aim of the courses
remains to teach students the latest advances that can be immedi-
ately applied to their own research. Courses are always being eval-
uated and updated to include the latest concepts and approaches.
Increasingly, many courses feature a strong computational com-
ponent as biology grows ever more interdisciplinary, incorporating
methodologies from computer science, physics, and mathematics. 
Instructors, course assistants, and course lecturers come from
universities, medical schools, research institutes, and companies around the world to teach at Cold
Spring Harbor. Their excellence and dedication make the course program work so well. We would
especially like to thank Drs. Karen Adelman, Thomas Brutnell, Beverley Clark, Christopher Fall,
Mark Farrant, Vivian Irish, Elizabeth Toby Kellogg, Partha Mitra, Jennifer Normanly, Thomas
Oelgeschlager, Randall Smith, and Malcolm Whiteway, some of whom retired this year after many
years of service. 
Grants from a variety of sources support the courses. The core support provided through the re-
cently renewed grant from the Howard Hughes Medical Institute remains critical to our course pro-
gram. The courses are further supported by multiple awards from the National Institutes of Health
(NIH) and the National Science Foundation (NSF), and additional support for individual courses
is provided by various foundations and other sources. The courses also depend on equipment and
reagents that are loaned or donated by a large number of companies. These are invaluable for making
it possible to keep up with the latest technologies.
The Laboratory held 25 academic meetings this year, which brought together almost 7000 sci-
entists from around the world to discuss their latest research. The 74th Cold Spring Harbor Sympo-
sium on Quantitative Biology on “Evolution: The Molecular Landscape” was dedicated to Charles
Darwin on the occasion of the bicentennial of his birth and the 150th anniversary of the publication
of On the Origin of Species. Opening night speakers included Janet Browne, Ed Wilson, David Kings-
ley, and Marc Hauser, and Douglas Wallace presented the Reginald Harris lecture on “Energetics in
Eukarotic and Human Origins.” Kevin Padian enlightened a mixed audience of scientists and lay
friends and neighbors with his Dorcas Cummings lecture on “Darwin, Dover & Intelligent Design,”
and Brian Charlesworth ended the meeting with a masterful and thought-provoking summary. Spe-
cial sessions were held on “Cultural Evolution,” including presentations on principles of natural se-
lection applied to linguistics, ideas, and economics by Daniel Dennett, Matt Ridley, and Niall
Ferguson, and on “Evolution and the Public,” in which Kevin Padian, Ken Miller, Barbara Forrest,
and Eugenie Scott discussed so-called “intelligent design” and the threat such irrational and anti-
scientific attitudes pose to education in the United States.
L. Stein and R. Martienssen at the Personal Genomes Meeting
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A prime feature of the meetings is that there are very few invited
speakers. Meetings organizers select talks from abstracts that are submit-
ted. This format ensures that the latest findings will be presented and
that young scientists will have the chance to describe their work. The
annual meetings on The Biology of Genomes, Retroviruses, and Mech-
anisms of Eukaroytic Transcription, and Neurobiology of Drosophila
were all oversubscribed, and many others attracted strong or record at-
tendances. New meetings on Molecular and Cellular Biology of Plas-
minogen Activation and Single-cell Techniques were held this year. Many
of these meetings have become essential for those in the field and are
held on a biannual basis. Partial support for individual meetings is pro-
vided by grants from the NIH, NSF, foundations, and companies. Core
support for the meetings program is provided by the Laboratory’s Cor-
porate Sponsor Program.
The joint Cold Spring Harbor/Wellcome Trust conference series held at the genome campus
south of Cambridge, England, included four meetings, on Mouse Genetics and Genomes: Devel-
opment and Diseases; Pharmacogenomics; Integrated Approaches to Brain Complexity; and Engi-
neering Principles. These conferences follow the Cold Spring Harbor model in that the majority of
talks are selected from the abstracts. They attracted 367 participants in total.
Finally, 2009 saw the continued development of the Cold Spring Harbor Asia program, as a
wholly owned affiliate. An inaugural Banbury-style meeting on Large-scale Planting of Transgenic
Crops in Asia: Policy Issues, Scientific Advances, Regulatory Considerations, and Economic Benefits
was held at an adjacent facility in Suzhou, China, in November and attracted a highly international
group of more than 70 scientists, policy specialists, and economists from academia, industry, and
government. CSH Asia’s Corporate Advisory Board also met to advise the Laboratory and its affiliate
on its new educational initiative in China and Asia.
The success of the very large number of meetings and courses is also due to the skilled work of
many CSHL staff and faculty who contribute their expertise, efforts, and good humor to the pro-
gram. We thank IT coordinator Taimur Arif, who left CSHL for pastures new, for his dedication
and service toward the program.
Terri Grodzicker
Dean
Academic Affairs
David Stewart
Executive Director
Meetings and Courses Program
C. Ponting and E. Birney at the Genome Informatics
meeting
E. Koonan at the 74th CSHL Symposium on Quantitative Biology M. Timmermans and M. Bevin at the Plant 
Genomics meeting
74TH COLD SPRING HARBOR LABORATORY 
SYMPOSIUM ON QUANTITATIVE BIOLOGY
Evolution: The Molecular Landscape
May 27–June 1 400 Participants
ARRANGED BY David Stewart, Bruce Stillman, and Jan Witkowski
Cold Spring Harbor Laboratory
The 74th Cold Spring Harbor Laboratory Symposium on Quantitative Biology on
Evolution: The Molecular Landscape was dedicated to Charles Darwin on the occasion
of the bicentennial of his birth and the 150th anniversary of the publication of On
the Origin of Species. The Laboratory celebrated the 100th anniversary in 1959 with
its 24th Symposium on Genetics and Twentieth Century Darwinism. What was en-
tirely absent from that Symposium, and what dominated the Symposium 50 years
later, are the contributions molecular biology has made to our understanding of evo-
lution. Even as the details of Darwin’s ideas have been modified over the years, ev-
idence from molecular studies has strengthened his fundamental thesis. 
The 2009 Symposium set out to examine the current state of many of the ideas
that Darwin developed in his four great books: On the Origin of Species by Means of
Natural Selection, The Variation of Animals and Plants Under Domestication, The De-
scent of Man and Selection in Relation to Sex, and The Expression of Emotions in Man
and Animals. Leading investigators were invited to present their latest research in a diversity of fields
ranging from the origins of life (unicellular and multicellular) to speciation and domestication to the
evolutionary basis of human attributes. An overarching theme of the meeting was the extent to which
much of evolutionary biology can now be viewed in a molecular, and often genomic, framework and
the extraordinary degree to which many of Darwin’s insights remain profoundly relevant today.
The Symposium included two rather unusual sessions. Evolutionary concepts have had an impact
far beyond the boundaries of science, and there is hardly a field of human endeavor
that has not been influenced by evolutionary thinking. To acknowledge this con-
tribution of Darwin, there was a session on “Cultural Evolution” that included
presentations on principles of natural selection applied to linguistics, ideas, and
economics by, respectively, Daniel Dennett, Matt Ridley, and Niall Ferguson. In
the second unusual session, “Evolution and the Public,” Kevin Padian, Ken Miller,
Barbara Forrest, and Eugenie Scott discussed so-called “intelligent design” and the
threat such irrational and antiscientific attitudes pose to education in the United
States.
In arranging this Symposium, the organizers were dependent on the guidance
of a broad cadre of advisors including Drs. Nicholas Barton, Hans Ellegren, Claire
Fraser-Liggett, David Haussler, Gerry Joyce, Susan McCouch, Svante Pääbo, Sally
Otto, Richard Wrangham, and James D. Watson. Opening night speakers included
Janet Browne, Ed Wilson, David Kingsley, and Marc Hauser, and Douglas Wallace
presented the Reginald Harris lecture on “Energetics in Eukarotic and Human Origins.” Kevin Pa-
dian enlightened a mixed audience of scientists and lay friends and neighbors with his Dorcas Cum-
mings Lecture on “Darwin, Dover, and Intelligent Design” and Brian Charlesworth ended the
meeting with a masterful and throught-provoking summary. 
B. Stillman
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This Symposium was attended by 400 scientists from over 25 countries, and the program in-
cluded 69 invited presentations, six Symposium fellows short talks selected from the abstracts, and
more than 175 poster presentations. 
Funds to support this meeting were obtained from the National Institutes of Health. Financial
support from the corporate benefactors, sponsors, affiliates, and contributors of our meetings program
is essential for these Symposia to remain a success and we are most grateful for their continued support. 
PROGRAM
Dorcas Cumming Lecture: Darwin, Dover, and Intelligent
Design
K. Padian, University of California, Berkeley
Evolution and Development
Chairperson: N. King, University of California, Berkeley
Symposium Fellows
Chairperson: J. Thornton, University of Oregon, Eugene
Evolution and the Public
Chairperson: K. Padian, University of California, Berkeley
Domestication
Chairperson: D. Ware, Cold Spring Harbor Laboratory
Human Evolution
Chairperson: D. Page, Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts
Social Interactions
Chairperson: D. Page, Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts
Mutation
Chairperson: L. Shapiro, Stanford University School of Medicine,
California
Summary
Chairperson: B. Charlesworth, University of Edinburgh
Introduction
B. Stillman, Cold Spring Harbor Laboratory
RNA and Proteins
Chairperson: S. Lindquist, Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts
Cellular Evolution
Chairperson: N. Patel, University of California, Berkeley
Selection and Adaptation
Chairperson: M. Bulyk, Brigham & Women’s Hospital, Harvard
Medical School, Boston, Massachusetts
Cultural Evolution
Chairperson: L. Caporale, New York
Reginald B. Harris Lecture: Epigenetics in Eukaryotic and
Human Origins
D.C. Wallace, University of California, Irvine
Diversity
Chairperson: H. Hoekstra, Harvard University, Cambridge,
Massachusetts
Genome Evolution
Chairperson: C. Fraser-Liggett, University of Maryland School of
Medicine, Baltimore
Evolution of Systems
Chairperson: R. Greenspan, The Neurosciences Institute, San
Diego, California
J. Witkowski, E.O. Wilson V. Ramakrishnan, J. Szostak, A. Gann
MEETINGS
Plant Genomes: Genes, Networks, and Applications
March 4–7 111 Participants
ARRANGED BY Steve Briggs, University of California, San Diego
Mary Lou Guerinot, Dartmouth College
Detlef Weigel, Max-Planck Institute for Developmental Biology
The theme of the meeting highlighted the move from understanding
the function of individual genes to the analysis of larger functional net-
works, and it highlighted ways in which this knowledge has increas-
ingly practical applications. The latter is not limited to breeding, but
it is also useful for ecological research. The expertise of the three coor-
ganizers spanned the major areas of the meeting, from translational
genomics (Mary Lou Guerinot and Steven Briggs) to natural genetic
diversity (Detlef Weigel).
Following the tradition of the meeting, the two keynote presenta-
tions, by Andrew Clark (Cornell) on comparative genomics in Dro-
sophila and Aviv Regev (Broad institute/MIT) on regulatory network
analysis in yeasts and mammals, provided exciting insights into current
work outside of plants. 
A special highlight of the meeting was the first session, celebrating
the recently finished maize genome sequence. Virginia Walbot (Stanford) and Pat Schnable (Iowa
State) demonstrated how maize geneticists are already benefitting from this achievement. Maize is
also notable for being the first crop in which breeders and farmers made extensive use of the heterosis
phenomenon, in which hybrid progeny outperforms its inbred parents. Loren Rieseberg (University
of British Columbia), Dani Zamir (Hebrew University), Detlef Weigel, and Rob Martienssen pre-
sented very different approaches to studying and exploiting genetic and epigenetic effects in hybrids.
We are currently witnessing a revolution in DNA sequencing ability, as sequencing capacity at the
same cost has been increasing severalfold annually over the past 3 years. Joe Ecker (Salk Institute), Bran-
don Gaut (University of California, Irvine), and Regine Kahmann (Max-Planck Institute for Terrestrial
Microbiology) discussed excellent examples of the impact that these new technologies have on plant
sciences.
Until recently, the major limitation in connecting genotype with
phenotype was the acquisition of genotype information, be it by typing
individual DNA markers or by sequencing complete genomes. With
sequencing prices dropping rapidly, and no end in sight, this is com-
pletely changing, and the major bottleneck now is high-throughput
phenotyping. Innovative approaches to this problem were showcased
in the talks by Philip Benfey (Duke), Natasha Raikhel (University of
California, Riverside), and Mary Lou Guerinot. Of course, the geno-
typing and phenotyping information needs to be captured and inter-
preted in an integrated fashion. Doreen Ware (CSHL), Jim Carrington
(Oregon State), Lothar Willmitzer (Max-Planck Institute for Molecular
Plant Physiology), and Tom Mitchell-Olds (Duke) demonstrated dif-
ferent approaches to solving this problem. The ultimate challenge then
244
D. Weigel, M.L. Guerinot
P. Benfy, A Millar
PROGRAM
Keynote Address: The Drosophila 12 Genomes Project
A. Clark, Cornell University
Celebrating the Maize Genome
Chairperson: V. Walbot, Stanford University, California
Hybrids and Heterosis
Chairperson: L. Rieseberg, University of British Columbia,
Vancouver, Canada
Genomes: Plants And Microbes
Chairperson: J. Ecker, Salk Institute for Biological Studies, La
Jolla, California
Innovative Phenotyping
Chairperson: P. Benfey, Duke University, Durham, North
Carolina
Integrating Omics
Chairperson: D. Ware, Cold Spring Harbor Laboratory
Models/Iplant/Arabidopsis 2010
Chairperson: J. Traas, Ecole Normale Supérieure de Lyon, France
Discussion of Arabidopsis 2010 and Plant Genome Research
Program
Led by G. Coruzzi, A. Millar, and J. Ecker
Keynote Address: Transcriptional Network Evolution
A. Regev, Broad Institute
Evolution Inside and Outside the Lab
Chairperson: J. Bergelson, University of Chicago, Illinois
is to combine these data and to construct genetic, cellular, and physical networks as discussed by
Jan Traas (ENS Lyon), Elliot Meyerowitz (Caltech), Andrew Millar (Edinburgh University), and
Gloria Coruzzi (New York University). The last area is the focus of the NSF-funded iPlant initiative,
which was discussed following the network/models session in the context of presenting the results
of a workshop that had been held at the Banbury Center under the auspices of NSF and several in-
ternational funding agencies.
As mentioned above, not only are the advances in plant biology impacting plant breeding, but
they are also important for understanding evolutionary and ecological processes in general, as was
discussed by Joy Bergelson (University of Chicago) and Masa Yano (NIAS Tsukuba). Finally, in ad-
dition to the invited presenters mentioned by name, each session featured shorter talks drawn from
submitted abstracts. Those not selected had a chance to present their work in a poster session.
Although the meeting was smaller than in previous years, attendees were all very happy about
the high caliber of talks and many mentioned that the speaker lists had made this program partic-
ularly attractive. Apart from the current funding climate allowing fewer scientists to attend confer-
ences, this conference was held between the Plant and Animal Genome Meeting in San Diego in
January and the Annual Maize Meeting the following week, and these were likely factors that reduced
the number of potential attendees.
This meeting was supported by the National Science Foundation and a gift from Dow Agro-
sciences.
D. Ware, A. Eveland
K. Slotkin, M. Katari
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Keynote Address: Toward a Global Gene Regulatory Net-
work for Sea Urchin Development
E. Davidson, California Institute of Technology
Protein–Protein Interactions
Chairperson: A.-C. Gavin, European Molecular Biology
Laboratory, Heidelberg, Germany
Signaling
Chairperson: S. Gaudet, Dana-Farber Cancer Institute, Harvard
Medical School, Boston, Massachusetts
Keynote Address
J. Ferrell, Stanford University School of Medicine
Posttranscriptional Networks
Chairperson: F. Piano, New York University, New York
Systems Biology: Networks
March 18–22 177 Participants 
ARRANGED BY Anne-Claude Gavin, EMBL, Germany
Trey Ideker, University of California, San Diego
Marc Vidal, Dana-Farber Institute/Harvard Medical School
Marian Walhout, University of Massachusetts Medical School
Central to Systems Biology is the notion that all living systems are made up of networks of interac-
tions. These networks span multiple scales of space and time, from networks of interacting atoms
that influence protein structure, to networks of genes and proteins, to networks giving rise to disease.
Biological networks also come in a variety of flavors, including networks related to transcription,
posttranscription, translation, physical interaction, genetic interaction, metabolic flow, and functional
relationships. This year’s program focused on progress related to several of these major types: (1) ge-
netic, (2) transcriptional, (3) metabolic, (4) signaling, (5) protein–protein, and (6) posttranscriptional.
The program opened on Wednesday with the first of two Keynote Addresses from Eric Davidson on
global gene regulatory networks in sea urchin development. The goal of Davidson’s research is a
global network in which all inputs derive from nodes within the network, obtained from a model of
the genomic regulatory code directing embryonic specification. The opening day continued with an
evening session on genetic networks, with discussions ranging from linkage analysis to interactions
and pathways. The program continued on Thursday with a day filled with two sessions devoted to
transcriptional networks. Late afternoon on Thursday welcomed all attendees to enjoy a wine and
cheese party. Accepted posters were divided into two groups and presented over two poster sessions
on Thursday and Saturday. Friday included three important sessions on network medicine, metabolic
networks, and protein–protein interactions. The program continued on Saturday with a session on
signaling. Saturday evening provided the attendees with a second well-received Keynote Address from
James Ferrell, concluding the evening with a banquet of cocktails and dinner. The full program con-
cluded on Sunday with a session devoted to posttranscriptional networks.
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health.
PROGRAM
Genetic Networks
Chairperson: A.G. Fraser, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Transcriptional Networks I
Chairperson: M. Walhout, University of Massachusetts Medical
School, Worcester
Transcriptional Networks II
Chairperson: M. Bulyk, Brigham & Women’s Hospital, Harvard
Medical School, Boston, Massachusetts
Network Medicine
Chairperson: T. Ideker, University of California, San Diego
Metabolic Networks
Chairperson: J. Collins, Boston University, Massachusetts
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Computational Cell Biology
March 24–27 123 Participants
ARRANGED BY Galit Lahav, Harvard Medical School
Leslie Loew, University of Connecticut Health Center
Alex Mogilner, University of California, Davis
John Tyson, Virginia Polytechnic Institute & State University
The inventory of molecules participating in pathways and generating
forces that regulate many aspects of cell physiology is now known in great
detail. However, these pathways and mechanochemical networks are so
complex as to defy reliable understanding by an intuitive, qualitative rea-
soning. During the past decade, it has become clear that computer simu-
lations based on realistic biophysical models of regulatory networks can
be useful in making sense of enormous volumes of quantitative data and
in guiding new experimental studies. Success in this endeavor requires
close collaboration among life scientists, mathematical modelers, and com-
puter scientists. In March 2001, Les Loew and his colleagues at the Uni-
versity of Connecticut Health Center hosted the first multidisciplinary
workshop on Computational Cell Biology at the Cranwell Center in
Lenox, Massachusetts. The meeting was attended by an enthusiastic group
of quantitative biochemists and cell biologists, modeling experts, and soft-
ware developers. The first meeting featured oral presentations and poster sessions that highlighted the
interplay between experiments and models, and a unique afternoon session of software demonstrations.
By popular demand, the UConn group hosted two more workshops, in 2003 and 2005. At the third
meeting, a leadership group was commissioned to find a more permanent home for the meeting, with
Cold Spring Harbor Laboratory identified as the first place to try. When approached with this idea,
David Stewart immediately gave his full support and scheduled the first Computational Cell Biology
Meeting at Cold Spring Harbor in March 2007. The 2007 meeting was organized by John Tyson,
Les Loew, and Tom Pollard, assisted by a distinguished panel of session chairs. 
In 2009, the fifth (second at CSHL) meeting returned, and the format of the first CSHL meeting
was maintained, including the popular software demos, along with an emphasis on the most mature
areas of the field (neuronal cell biology, cell signaling, cytoskeletal dynamics, development, cell
growth, division and death). Compared to the previous meeting, a session on bacterial physiology
was not organized in order to decrease an overlap with more systems-biology-oriented meetings. In
addition, the organizers decided that there is no need to invite session organizers—four meeting or-
ganizers can effectively play this role themselves. 
The oral presentations at the meeting consisted of longer invited talks by established leaders in
the field and of shorter talks chosen from abstracts submitted by registered participants; similar to
the previous meeting, this combination was very successful. This way, many young graduate students
and postdocs were given a chance to showcase their work before an interdisciplinary audience, and
they were excellent in illustrating the power of a combined experimental-theoretical attack on out-
standing problems in cell biology. The quality of the poster session was also very high; this session
was lively and judging from remarks of many participants very enjoyable. One problem with sched-
uling that is becoming clear from the last two meetings is that the schedule is very tight due to the
fact that the meeting structure was inherited from the Lenox workshops, and the duration shortened.
Perhaps one fewer session, or fewer talks per session, or just one Keynote Address has to be planned
for the future.
L. Loew, J. Tyson
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The meeting was opened by a Keynote Address by Uri
Alon, who gave a chalk talk on robustness in cell regulatory
networks. The second Keynote Address was given by Ravi
Iyengar, who told about recent work of his lab on deciphering
cell signal transduction. Cell signaling (two sessions) contin-
ued to be the leading theme of the meeting with exciting talks
by J. Gunawardena (Harvard) about multiple steady state in
dynamics of posttranslational modification codes, Tim Elston
(University of North Carolina) on modeling signaling events
that lead to chemotrophic growth, A. van Oudenaarden
(Massachusetts Institute of Technology) on stochastic effects
in cell “decision making,” Long Cai (California Institute of
Technology) on stochastic frequency modulation in calcium localization bursts, and a number of
short talks. The neuronal biology session was met with significant enthusiasm opened by fascinating
reports on information processing by Samuel Wang (Princeton), multiscale modeling of the brain
by U. Bhala (NCBS, Bangalore), and the neocortex as a distributed network of linear integrators by
R. Yuste (Columbia), again followed by excellent short talks. The cytoskeletal dynamics session vi-
brated with excitement created by O. Weiner’s (Unversty of California, San Francisco) report on
pioneering experiments promising to start a next generation of quantitative experimentation in cell
biology and on waves in chemotactic and motile cells. This was followed by equally excellent talk
by R. Loughlin (University of California, Berkeley), still a graduate student, on a combination of
modeling and experiment promising to unravel the mechanism of mitotic spindle maintenance.
The cell growth, division, and death session was opened by eminent P. Sorger (Harvard), who told
about using systems biology methods to understand cell-to-cell variability in response to death lig-
ands. A. Anderson/V. Quaranta (Florida University/Vanderbilt) followed with the talk on developing
and verifying a model of tumor invasion. J. Toetcher/ A. Loewer (Massachusetts Institute of Tech-
nology/Harvard) introduced the audience to the mammalian DNA-damage response mechanisms.
The development session was sparkling with brilliance of two invited talks by Vic Foe (Washington
University) on using agent-based modeling and experiments to prove that multiple redundant mech-
anisms are responsible for mitotic apparatus regulating cytokinesis, and by Steve Altschuler (Uni-
versity of Texas) on heterogeneity in cancer cells and on the role of discreteness in yeast polarization.
Finally, a very special session on new methods and software was started by J. Stiles (Pittsburgh) who
reported advances in three-dimensional in silico multiscale simulations of cell molecular processes.
His talk was followed by a number of short reports and many demonstrations.
A special feature of this meeting was an informal talk by Uri Alon on how to nurture young sci-
entists.
The uniformly high quality of the science reported at this meeting and the cooperative spirit of
the experimentalists, theoreticians, and computer scientists in attendance upheld the opinion of the
Cold Spring Harbor Meetings staff to welcome Computational Cell Biology into their regular meet-
ing schedule. The meeting will continue on its biennial schedule (March/April 2011). Quantitative
measurements and realistic mathematical modeling are here to stay in cell biology, and this CSHL
meeting promises to be a flagship venue for reporting the best developing work in the field.
The meeting was well supported by a grant from the National Institutes of Health, through the
National Technology Center on Networks and Pathways at the University of Connecticut Health
Center. This grant will be most likely gone and unavailable to support one more similar meeting;
more money will have to be applied for (perhaps to NSF who indicated an enthusiasm for this meet-
ing series).
U. Alon
248 Meetings
PROGRAM
Keynote Address
U. Alon, Weizmann Institute
Cell Signaling I
Chairperson: J. Tyson, Virginia Polytechnic Institute and State
University, Blacksburg
Neuronal Cell Biology
Chairperson: L. Loew, University of Connecticut Health Center,
Farmington
Poster Session
Keynote Address: Cell State Change Decisions Triggered 
by Receptors 
Chairperson: R. Iyengar, Mount Sinai School of Medicine
Cytoskeletal Dynamics
Chairperson: A. Mogilner, University of California, Davis
Cell Growth, Division, and Death
Chairperson: G. Lahav, Harvard Medical School, Boston,
Massachusetts
New Tools and Software Development
Chairperson: I.I. Moraru, University of Connecticut Health
Center, Farmington
Development
Chairperson: A. Mogilner, University of California, Davis
Cell Signaling II
Chairperson: J. Tyson, Virginia Polytechnic Institute and State
University, Blacksburg
S. Altschuler, G. Lahav
Carticaturist at the cocktail party
A. Mogilner, T. Elston
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Molecular and Cellular Biology of Plasminogen Activation
March 31–April 4 113 Participants
ARRANGED BY Katherine Hajjar, Weill Cornell Medical College
Stella Tsirka, University Medical Center at Stony Brook
Elaine Wolff, University of Illinois at Urbana, Champaign
This 12th Workshop is unique in that the scientific program is entirely abstract-
driven. Thus, all of the presentations are selected from submitted abstracts. This al-
lows emphasis upon new discoveries that are largely unpublished, and fosters
productive interactions among young investigators, postdoctoral fellows, graduate
students, and established investigators. Key subject areas of the meeting included
structure, function, and regulation of the plasminogen activator system, matrix met-
alloproteinases and novel proteases; plasminogen activators in inflammation and
host defense, tumor biology, neurobiology, tissue remodeling, and novel therapeu-
tics; and vascular biology and angiogenesis.
The meeting was subscribed to by 108 attendees and included participants from
15 countries including Australia, Austria, Belgium, Canada, Denmark, France, Ger-
many, Italy, Japan, Mexico, Norway, Spain, Sweden, United Kingdom, and the
United States. The attendees included 48 students and postdocs (44%), meeting
one of the objectives of encouraging participation by young investigators in the
workshop. Not only did young investigators participate in the workshop, but about 75% of the pre-
sentations were given by young investigators. Almost half of the participants were women, with five
of them serving as session chairs.
S.K. Hajjar, S. Tsirka
University, New York; S. Gonias, University of California
School of Medicine, San Diego, La Jolla
Plasminogen Activators and Tumor Biology
Chairpersons: R. Szabo, NIDCR, National Institutes of Health,
Bethesda, Maryland; F. Blasi, IFOM-FIRC Institute of
Molecular Oncology, Milano, Italy
Plasminogen Activators and Neurobiology
Chairpersons: G. Hoyer-Hansen, Finsen Laboratory-
Rigshospitalet, Copenhagen, Denmark; D. Lawrence,
University of Michigan, Ann Arbor
The Plasminogen Activator System and Tissue Remodeling
Chairpersons: A. Deora, Weill Medical College of Cornell
University, New York; S. Strickland, The Rockefeller University,
New York
The Plasminogen Activator System and Novel Therapeutics
Chairpersons: R. Medcalf, Monash University, Victoria,
Australia; P. Declerck, University of Leuven, Belgium
PROGRAM
Keynote Address: Modeling, Mimicking, and Modulating
Tumor Metastasis: Involvement of a Few Old (Protease)
Friends
J. Quigley, Scripps Research Institute
Structure, Function, and Regulation of the Plasminogen 
Activator System
Chairpersons: N. Behrendt, Finsen Laboratory, Copenagen,
Denmark; K. Akassoglou, Gladstone Institutes, University of
California, San Francisco
Plasminogen Activators, Matrix Metalloproteinases, and
Novel Proteases
Chairpersons: S. Netzel-Arnett, University Of Maryland,
Baltimore; H. Crawford, SUNY, Stony Brook University
Plasminogen Activators in Inflammation and Host Defense
Chairpersons: P. Ragno, University of Salerno, Italy; T. Bugge,
National Institutes of Health, Bethesda, Maryland
Vascular Biology and Angiogenesis
Chairpersons: D. Falcone, Weill Medical College of Cornell
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Synapses: From Molecules to Circuits and Behavior
April 14–18 200 Participants
ARRANGED BY Hollis Cline, Cold Spring Harbor Laboratory
Richard L. Huganir, Johns Hopkins University School of Medicine/HHMI
Thomas Sudhof, University of Texas Southwestern Medical Center
The brain consists of a vast network of excitable cells (neurons) that con-
duct electrical impulses and communicate with each other via specialized
junctions (synapses). Information is processed and stored in the nervous
system through patterns of electrical activity and via changes in the
strength and structure of synapses. All aspects of nervous system function,
including perception, cognition, and action, depend on proper informa-
tion processing by synapses. As master regulators of neuronal excitability
and synaptic communication, ion channels and receptors lie at the heart
of neurobiology. In recent years, the molecular and cell biological analysis
of neuronal ion channels and receptors has revolutionized our understand-
ing of the basic mechanisms that control electrical signaling and synaptic
function in the nervous systems. The convergence of advances in biochem-
istry, molecular genetics, microscopic imaging, and electrophysiology has
made synaptic biology one of the most exciting and rapidly growing in
neuroscience. Increasingly, scientists are moving to in vivo systems to in-
vestigate the synaptic basis of behavior in living animals via the genetic engineering of channels, re-
ceptors, and other synaptic proteins in mice and other model organisms.
The entire field is poised for further breakthroughs that will not only illuminate basic workings
of the brain, but also shed light on neurological and psychiatric diseases that stem from abnormal
neuronal excitability and synaptic dysfunction. Indeed, genetic association
studies already point to genes for synaptic structure and function as being
involved in neuropsychiatric illnesses, in particular autism. Future ad-
vances will be facilitated by cross-fertilization of ideas and technologies
between scientists studying channels, receptors, and synapses at all levels,
in diverse organisms and using different methodological approaches. 
This fourth meeting was very successful, bringing together participants
from the United States, Europe, and Asia in an atmosphere of social and
scientific exchange. As listed below, a wide range of topics were discussed.
Compared to earlier meetings, the 2009 meeting emphasized the physiol-
ogy and pathophysiology of synapses and the behavioral and systems im-
plications of their functions. More than 50 attendees were selected to give
oral presentations of their work, and the majority of the rest presented
posters. Outstanding plenary lectures were given by Clay Ried and Cori
Bargmann.
The overall response to the meeting was extremely positive, continuing to cement the reputation
of this Cold Spring Harbor conference in the field. Attendees enjoyed the breadth of subjects covered
and the chance to interact with investigators in related but distinct fields. The unusual opportunity
for junior investigators (including postdocs and students) to present their own work was welcomed. 
The meeting was supported with funds from the National Institute on Drug Abuse and the Na-
tional Institute of Mental Health, branches of the National Institutes of Health.
T. Grodzicker, H. Cline
M. Zhen, T. Sudhof
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R. Huganir, C. Bargmann
Poster session in Bush Auditorium
Neuronal and Circuit Plasticity
Chairpersons: L. Luo, Stanford University, California; F. Engert,
Harvard University, Cambridge, Massachusetts
Keynote Address: A Hub-and-Spoke Circuit for Pheromone
Attraction and Social Behavior in C. elegans
C. Bargmann, The Rockefeller University
Behavioral Plasticity
Chairpersons: D. Anderson, California Institute of Technology,
Pasadena; J. Tsien, Medical College of Georgia, Augusta
PROGRAM
Keynote Address: Toward Complete Functional and 
Structural Imaging of Cortical Circuits
R.C. Reid, Harvard Medical School
Diseases of Synapses and Circuits
Chairpersons: U. Heberlein, University of California, San
Francisco; C. Walsh, Beth Israel Deaconess Medical Center,
Boston, Massachusetts
Ion Channels, Receptors, and Transporters
Chairpersons: A. Patapoutian, Scripps Research Institute, Del
Mar, California; E. Gouaux, Oregon Health and Science
University, Portland
Synaptic Formation and Function
Chairpersons: Y. Jin, University of California, San Diego;
H. McMahon, MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom
Synaptic Plasticity
Chairpersons: P. Castillo, Albert Einstein College of Medicine,
Bronx, New York; L. Chen, University of California, Berkeley
Imaging Synaptic Structure and Function
Chairpersons: R. Yasuda, Duke University Medical Center,
Durham, North Carolina; G. Miesenboeck, Oxford University,
United Kingdom
Imaging Neuronal Circuits
Chairpersons: A.-S. Chiang, National Tsing Hua University,
Hsinchu, Taiwan; J. Fetcho, Cornell University, Ithaca, New
York
252 Meetings
The Ubiquitin Family
April 21–25 225 Participants
ARRANGED BY Judith Frydman, Stanford University
J. Wade Harper, Harvard Medical School
Matthias Peter, Institute of Biochemistry, Switzerland
Brenda Schulman, St. Jude Children’s Research Hospital
This fourth meeting, following the successful inauguration
of this series in 2003, focused on ubiquitin and a group of
structurally related “ubiquitin-like” proteins, and their roles
in regulation of various cellular processes. Major questions in
the field include how specificity in ubiquitin and ubiquitin-
like protein conjugation reactions is maintained, and the mo-
lecular mechanisms that are used to control the specificity of
ubiquitin chain linkages. These questions are being elegantly
addressed using structural biology, sophisticated kinetic stud-
ies, systematic library screening, and proteomics technologies
by an increasing number of investigators in the field. In ad-
dition, important advances continue to be made in under-
standing how ubiquitin and its family members contribute
to the operation of diverse cellular pathways, and how these
functions are perturbed in diseases ranging from viral infec-
tions to cancers. Exciting progress is also being made in the development of small-molecule inhibitors
of a range of enzymes involved in ubiquitin and ubiquitin-like protein pathways.
The meeting this year attracted more than 220 scientists who engaged in lively discussions con-
cerning the roles of ubiquitin in protein turnover, the structure and mechanism of a large multi-
subunit protease called the proteasome that catalyzes the degradation of ubiquitinated proteins, and
the involvement of ubiquitin quality-control mechanisms used by cells to eliminate otherwise toxic
misfolded proteins. There is also a growing understanding of nonproteolytic roles of ubiquitin and
ubiquitin-like proteins. A wide array of experimental systems, including yeast, plants, and mammals,
were used to probe the function of ubiquitin and ubiquitin-like proteins in diverse physiological
processes ranging from control of mitosis, hormone signaling in plants, metabolic control of sulfur
B. Schulman, J. Frydman, J.W. Harper
R. Sever, D. NathA. Goldberg, D. Bar-Sagi
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Poster session in Grace lobby
Spring shower!
M. Hochstrasser, N. Fang
T. Sommer, Max-Delbruck Center for Molecular Medicine,
Berlin, Germany
UBLs in Signaling I: Receptors, Plasma Membrane/Endoso-
mal Trafficking
Chairpersons: D. Rotin, Hospital for Sick Children, Toronto,
Canada; A. Weissman, NCI-Frederick, Maryland
UBLs in Signaling II: Intracellular Communication and Reg-
ulation of Organismal Biology
Chairpersons: D. Bar-Sagi, New York University Medical Center,
New York; F. Melchior, University of Göttingen, Germany
incorporation into tRNA, to how the proteasome is assembled. Other highlights of the meeting
this year concerned progress on the dynamics of enzymes that function in ubiquitin conjugation,
revealing how in-depth kinetic analyses of these systems can reveal underlying mechanisms control-
ling the rate and specificity of substrate ubiquitination. In summary, this meeting has continued to
be a unifying forum that helps us understand the regulatory mechanisms by which ubiquitin and
ubiquitin-like proteins function and their ever-growing roles in cellular physiology and disease.
The meeting was funded by the National Cancer Institute and the National Institute of Child
Health & Human Development, branches of the National Institutes of Health.
PROGRAM
Conjugation, Removal, and Recognition of Ubiquitin and
Ubiquitin-like Proteins I
Chairpersons: N. Zheng, University of Washington, Seattle; K.D.
Wilkinson, Emory University School of Medicine, Atlanta,
Georgia
Conjugation, Removal, and Recognition of Ubiquitin and
Ubiquitin-like Proteins II
Chairpersons: R. Klevit, University of Washington, Seattle; M.
Hochstrasser, Yale University, New Haven, Connecticut
Substrate Targeting and Degradation
Chairpersons: A. Goldberg, Harvard Medical School, Boston, Massa-
chusetts; M. Tyers, Mount Sinai Hospital, Toronto, Canada
Nuclear Functions of UBLs
Chairpersons: K. Vousden, Beatson Institute for Cancer Research,
Glasgow, United Kingdom; J.-M. Peters, Research Institute of
Molecular Pathology, Vienna, Austria
Regulation of Intracellular Pathways
Chairpersons: D. Finley, Harvard Medical School, Boston, Massa-
chusetts; R. Deshaies, California Institute of Technology, Pasadena
Quality Control
Chairpersons: R. Hampton, University of California, San Diego;
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Telomeres and Telomerases
April 28–May 2 314 Participants
ARRANGED BY Joachim Lingner, Swiss Institute for Experimental Cancer Research
Virginia Zakian, Princeton University
Dorothy Shippen, Texas A&M University
The conference consisted of eight sessions of talks and two poster sessions.
As in 1999, 2001, 2003, and 2005, the format was to invite two chairs per
session, who were a mix of established scientists in the field and younger
scientists who had already made their mark by publishing as independent
investigators. Many session chairs gave a scientific (12 min) presentation.
The rest of the presentations (also 12 min) were chosen from submitted ab-
stracts, allowing as many presentations as possible. These presentations were
primarily by graduate students and postdoctoral fellows. Attendance ex-
ceeded 300 participants, a high fraction of whom presented the 150 posters
and 80 talks.
The talks and posters covered all aspects of telomere and telomerase bi-
ology, including telomerase structure, enzymology, and regulation, telomere
length regulation, protection and processing of chromosome ends, the con-
sequences of telomere dysfunction, telomere dynamics in cancer, and telom-
erase-independent telomere maintenance.
The scientific content was very high throughout the conference in both the talks and the posters.
A large body of unpublished data was presented and extensively discussed in an open fashion. Formal
and informal discussions were lively and informative. The conference was judged to be highly suc-
cessful based on verbal and email communications to the organizers. There is strong enthusiasm for
another meeting on the same topic in 2011.
The meeting was funded by the National Institute on Aging, a branch of the National Institutes
of Health.
L. Vega, V. Zakian
Consequences of Telomere Dysfunction
Chairpersons: S. Marcand, CEA, Fontenay-aux-Roses, France; E.
Blackburn, University of California, San Francisco
Proteins and RNA Bound to Telomeric and Subtelomeric
Chromatin
Chairpersons: J. Karlseder, The Salk Institute, La Jolla, Califor-
nia; Z. Songyang, Baylor College of Medicine, Houston, Texas
Telomeres in Senescence, Proliferation, and Cancer
Chairpersons: M. Blasco, Spanish National Cancer Centre,
Madrid; W. Wright, University of Texas Southwestern Medical
Center, Dallas
Telomeres and Recombination
Chairpersons: R. Wellinger, Université de Sherbrooke, Canada;
K. Riha, Austrian Academy of Sciences, Vienna
PROGRAM
Telomerase Structure and Biochemistry
Chairpersons: T. Cech, University of Colorado, Boulder; Y. Tzfati,
Hebrew University of Jerusalem, Israel
End Resection and Protection
Chairpersons: C. Price, University of Cincinnati, Ohio; A.
Bertuch, Baylor College of Medicine, Houston, Texas
Telomeres and DNA Damage Sensing
Chairpersons: S. Gasser, Friedrich Miescher Institute, Basel,
Switzerland; C. Greider, Johns Hopkins University, Baltimore,
Maryland
Telomere Length Regulation
Chairpersons: L. Harrington, Ontario Cancer Institute, Toronto,
Canada; K. Friedman, Vanderbilt University, Nashville,
Tennessee
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Plenary Session
Chairperson: C. Elsik, Georgetown University, Washington, D.C.
Evolution and Comparative Genomics
Chairperson: R. Tellam, CSIRO, St. Lucia, Australia
From Genome to Biology
Chairperson: M. Rijnkels, Baylor College of Medicine, Houston,
Texas
Discussion Panel: Next Generation of Tools and Resources
Panel Leader: S. Kappes, USDA-ARS, Beltsville, Maryland
Panel Members:  S. Bauck, Merial
The Bovine Genome
May 9–11 54 Participants
ARRANGED BY Christine Elsik, Georgetown University
Harris Lewin, University of Illinois at Urbana Champaign
Jerry Taylor, University of Missouri
Kim Worley, Baylor College of Medicine
This special meeting was hosted by the Bovine Genome Sequencing and Analysis Consortium and
the Bovine HapMap Consortium to present the state of the art in bovine genome sequencing, as-
sembly, analysis, and applications to the animal agriculture constituency; to discuss future research
priorities based on the consortia’s accomplishments; and to promote bovine as a model for mam-
malian biology and evolution. The meeting was attended by scientists from 13 countries and in-
cluded university faculty, postdoctoral fellows, and graduate students; government research scientists;
and cattle industry representatives. 
Invited presentations were made by 15 scientists representing the Sequencing and HapMap Con-
sortia and 22 poster abstracts were presented. A number of the poster presentations were made by
graduate students and postdoctoral fellows attending the meeting. The meeting was warmly received
by all participants, with the hope that further opportunity will arise to support the attendance of
many younger scientists at future meetings.
The organizers are grateful for the sponsorship of Affymetrix, Illumina, Roche/454, Merial, Pfizer,
the USDA ARS, and CSREES. Without this assistance, the meeting would not have been possible. 
PROGRAM
M. Allan, Pfizer Animal Genetics
T. Harkins, Roche 454
R. Barkovich, Affymetrix
D. Bailey, Illumina
D. Hamernick, University of Nebraska, Lincoln
Genomic Variation and Population Genetics
Chairperson: W. Barendse, CSIRO, St. Lucia, Australia
Genomic Technologies and Applications
Chairperson: C. Van Tassell, USDA-ARS, Beltsville, Maryland
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The Biology of Genomes
May 5–9 537 Participants
ARRANGED BY Michael Ashburner, University of Cambridge
Andrew Clark, Cornell University
Kerstin Lindblad-Toh, Broad Institute
George Weinstock, Washington University
This annual meeting marked the 22nd annual gathering of
genome scientists in this setting. The past decade has seen re-
markable progress in the mapping, sequencing, and annota-
tion of the genomes of many “model organisms” and
publication of finished and draft sequences of human
genomes, in addition to model organisms and hundreds of
bacteria. Most remarkable has been the enormous progress in
DNA sequencing technology over the last few years, leading
to advances in many areas with notable breakthroughs in
human applications, particularly in cancer genomics. Just
over 500 people from around the world attended the meeting,
with more than 300 abstracts presented describing a broad
array of topics relating to the analysis of genomes from a
number of different organisms. 
The session topics are listed below. There were numerous
reports on progress in using new sequencing technologies, with high expectations for additional ad-
vances as these become more widely available. The keynote talks were delivered by Claire Fraser-
Liggett and Barbara Meyer.
The ELSI (Ethical, Legal, and Social Implications) panel was chaired by Laura Rodriguez and
the discussion topic was Data Sharing, Identifiably, and Informed Consent in Community Resource
Genomics Projects.
Major sponsorship for this meeting meeting was provided by Roche. Additional funding was
provided by Illumina, Inc., and the National Human Genome Research Institute, a branch of the
National Institutes of Health.
G. Weinstock, H. Sussman, A. Clark
T. Gingeras R. Wilson T. Hubbard
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D. Schwartz
Between sessions
E. Pennisi
Population Genomic Variation
Chairpersons: F. DiPalma, Broad Institute, Cambridge,
Massachusetts; G. McVean, University of Oxford, United
Kingdom
Guest Speakers
C. Fraser-Liggett, University of Maryland School of Medicine,
Baltimore
B. Meyer, HHMI/University of California, Berkeley
Computational Genomics
Chairpersons: A. Regev, Broad Institute, Cambridge,
Massachusetts; O. White, University of Maryland, 
Baltimore
PROGRAM
Functional and Cancer Genomics
Chairpersons: L. Chin, Harvard Medical School, Boston,
Massachusetts; V. Velculescu, Johns Hopkins University,
Baltimore, Maryland
Genetics of Complex Traits
Chairpersons: T. Mackay, North Carolina State University,
Raleigh; J. Cohen, University of Texas Southwestern Medical
Center, Dallas
High-throughput Genomics and Genetics
Chairpersons: B. Wold, California Institute of Technology,
Pasadena; J. Ecker, Salk Institute for Biological Studies, La
Jolla, California
Genetics and Genomics of Nonhuman Species
Chairpersons: S. Dellaporta, Yale University, New Haven,
Connecticut; J. Werren, University of Rochester, New York
ELSI Panel Discussion: Data Sharing, Identifiability, and 
Informed Consent in Community Resource Genomics
Projects
Chairpersons: L.L. Rodriguez, National Human Genome
Research Institute, NIH
S. Wallace, University of Montreal
K. Kato, Kyoto University
B. Koenig, Mayo Clinic
A. Cambon-Thomsen, University of Toulouse
Evolutionary Genomics
Chairpersons: C. Ponting, University of Oxford, United
Kingdom; A. Siepel, Cornell University, Ithaca, New York
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Phosphorylation, Signaling, and Disease
May 12–16 167 Participants
ARRANGED BY Sara Courtneidge, The Burnham Institute
Ben Neel, Ontario Cancer Institute
Nicholas Tonks, Cold Spring Harbor Laboratory
This eighth meeting brought together scientists from the United
States, Europe, the Far East, and South Pacific. Specifically focused
on tyrosine phosphorylation in prior years, the meeting was expanded
this year to include the most current work on the structure, regula-
tion, and function of all protein kinases and protein phosphatases in
biology. The meeting began with an opening keynote address by Ben-
jamin Cravatt.
The format of the meeting was designed around areas of biological
interest, rather than according to particular enzymes or enzyme fam-
ilies. A major thrust within the pharmaceutical industry is to exploit
signal transduction pathways as sources of targets for novel therapeu-
tic strategies. Therefore, the program for this meeting addressed the
role of protein phosphorylation in the regulation of signal transduc-
tion under normal and pathophysiological conditions. 
There were 54 speakers selected to present their data in sessions
that dealt with receptor-proximal signaling; physiology and disease;
cancer; metabolic and stress signaling; signaling pathways in survival
and proliferation, and model systems. A variety of systems were de-
scribed with great progress reported in genetic and biochemical ap-
proaches to the characterization of physiological functions for protein
phosphorylation. 
This meeting was funded in part by the National Cancer Institute,
a branch of the National Institutes of Health. and with contributions
from the Corporate Sponsors.
B. Neel, E. Miraldi
E. Miraldi, F. Chaudhary
Nonreceptor Kinases
Chairperson: R. Marais, Institute of Cancer Research, London,
United Kingdom
Development, Disease, and Darwin
Chairperson: A. Rao, Harvard Medical School, Boston,
Massachusetts
Downstream Signaling
Chairperson: L. Feig, Tufts University School of Medicine,
Boston, Massachusetts
Tumor Suppressors
Chairperson: M. Park, McGill University Cancer Center,
Montreal, Canada
PROGRAM
Keynote Address
B. Cravatt, The Scripps Research Institute
Receptor Signaling
Chairperson: S. Muthuswamy, Ontario Cancer Institute,
Toronto, Canada
Cancer
Chairperson: T. Van Dyke, NCI-Frederick, Maryland
Metabolism
Chairperson: T. Tiganis, Monash University, Melbourne,
Australia
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Retroviruses
May 18–23 491 Participants
ARRANGED BY Alan Engelman, Dana-Farber Cancer Institute
Wei-Shau Hu, National Cancer Institute
This conference focused on recent progress in retrovirology, including
studies of human pathogens such as human immunodeficiency virus 1
(HIV-1) and human T-lymphotropic virus I (HTLV-1), animal retro-
viruses such as Rous sarcoma virus (RSV) and feline immunodeficiency
virus (FIV), and endogenous elements such as endogenous retroviruses
and yeast transposable elements. A majority of the submitted abstracts
focused on studies of virus replication mechanisms and host cell–virus
interactions. Additionally, studies on antiviral compounds, drug-resis-
tance mechanisms, potential new human pathogens, and results from
clinical trials were presented. 
Following the recent format of the meeting, two keynote speakers
were invited to each present a 1-hour talk and all of the other presenta-
tions were selected by the organizers from submitted abstracts. The in-
vited keynote speakers were Dr. Ronald Desrosiers and Dr. Volker Vogt. Dr. Desrosiers is a Professor
at Harvard University and the Director of New England Primate Research Center. He is a highly
respected pioneer in simian immunodeficiency virus (SIV) animal models for HIV-1 studies and
vaccine research. He presented a historic progression of SIV studies in vaccine development and
pathogenesis, discussing the discovery of Nef, an accessory protein, and its essential role in main-
taining viral pathogenicity in macaques and in humans. Additionally, Dr. Desrosiers presented a re-
cent study on a promising novel approach for vaccine development, which stimulated significant
discussion that extended beyond the confines of Grace Auditorium. Dr. Volker Vogt, a professor
from Cornell University, has made tremendous contributions to our current understanding of retro-
virus assembly. Dr. Vogt first gave a historic perspective of the retrovirus field and the Cold Spring
Harbor retroviruses (RNA Tumor Virus) meetings. He then centered his talk on his journey in sci-
entific research and the lessons he learned. In the last 5 minutes, he stepped out of his scientific
A. Engelman, W.-S. Hu
M. Thali, E. Freed T. Hope, K. Beemon, C.M. Stoltzfux
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work and talked about who we are as scientists and his view of living without bias
in other aspects of our lives to make our world a better place. Dr. Vogt’s talk was
poignant and earnest. Many scientists said that Dr. Vogt’s talk was the most inspiring
and moving keynote talk in the history of the Retroviruses meeting. 
The submitted abstracts were organized into 10 oral presentation sessions and
three poster presentation sessions. The 10 oral sessions are listed below. One of the
most high-profile topics of the meeting was the function of the host protein Teth-
erin/Bst-2 and the mechanisms different viruses use to counter this host restriction
factor. Tetherin was discovered in 2008 by the laboratories of Drs. Paul Bieniasz and
John Guatelli as a host factor that inhibits HIV-1 infection by blocking the release of
virus from infected cells. These seminal studies moreover identified the HIV-1 acces-
sory protein Vpu as the viral countermeasure of tetherin action. More than a dozen
talks from various laboratories were given in the 2009 Retroviruses meeting on the
recent progress in our understanding of this topic. Tetherin inhibits the replication of multiple retro-
viruses as well as other enveloped viruses like those belonging to Filoviridae (Ebola and Marburg
virus). Various viruses have interestingly evolved different mechanisms to counter tetherin’s action.
Although HIV-1 uses Vpu to suppress tetherin function, various SIVs, including SIVmac, SIVagm,
SIVgsn, and SIVrcm, use Nef to achieve the same goal. As expected from studies of other restriction
factors, the interplay between different animal tetherins and viruses is species-specific. The species-
specific feature may provide an explanation to the intriguing observation that SIVmac and HIV-2,
two very closely related viruses that recently diverged from a common ancestor SIVsm, use different
gene products to suppress tetherin function: SIVmac uses Nef, whereas HIV-2 uses its envelope gly-
coprotein. Multiple presentations also discussed the mechanisms by which Vpu inhibits tetherin
functions and the key amino acid motifs that mediate the Vpu–tetherin interaction. A functional
“artificial tetherin” was also described; this hybrid molecule was generated by splicing different func-
tional domains from various host molecules to reveal a highly potent synthetic that, expectedly, was
completely resistant to HIV-1 Vpu. 
Several interesting talks were given in the “RNA mechanisms” session this year. The interactions
between viral RNA and Gag protein during HIV-1 particle assembly were captured using total in-
ternal reflection microscopy (TIRF) analyses by Dr. Paul Bieniasz’ laboratory. This study revealed
that viral RNA signals were first observed on cell surface, followed by Gag protein signals, suggesting
that RNA binding is the nucleation event of Gag assembly. This work was presented by Dr. Nolween
Jouvenet, who received the Andy Kaplan Award in 2009. Using confocal microscopy, the locations
of viral RNA and Gag were studied in HIV-1- and FIV-based systems by Dr. Eric Poeschla’s labo-
ratory. Although RNA and Gag can be seen to colocalize near the plasma membrane
in both HIV-1 and FIV, only HIV-1 Gag and RNA were colocalized near the peri -
nuclear region. It is known that RNA secondary structures in the untranslated re-
gions of the HIV-1 genome have essential roles in HIV-1 replication; the importance
of RNA secondary structures in the coding region was explored by Dr. Ronald
Swanstrom’s laboratory. Mutants containing synonymous mutations in the HIV-1
genome predicted to alter secondary structures had decreased viral replication fitness
compared with that of the wild-type genome, suggesting that these previously un-
defined secondary structures have important roles during viral replication. 
There were several surprising and intriguing studies that emerged during the
meeting. A presentation by Dr. Massimo Pizzato indicated that the function of HIV-
1 Nef can be replaced by an unrelated viral protein from murine leukemia virus
(MLV), glycogag, perhaps as a consequence of convergent evolution. Another interesting study from
Dr. Vinay Pathak’s laboratory compared the connection subdomain of the reverse transcriptase be-
tween subtype B and CRF-01 AE HIV-1 and found that the AE connection domain can confer
high-level AZT resistance in the presence of TAM (thymidine analog) mutations. This study reveals
R. Desrosiers
Poster melee
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that the high divergence of the HIV-1 genome increases the complexity of
the mechanisms of drug resistance; such studies are especially important be-
cause antiviral roll-out programs are beginning to be implemented in resource-
poor countries that are mostly affected with nonsubtype B HIV-1 variants.
Dr. Marc Johnson’s laboratory reported that the expression of HIV-1 Vpu fa-
cilitated the incorporation and pseudotyping of gibbon ape leukemia virus
(GALV) Env protein into HIV-1 particles; this is the first example of an ac-
cessory protein that may affect pseudotyping, potentially expanding the reper-
toire of pseudotyped viruses for use in basic cell biology as well as therapeutic
gene therapy. Assembly near cell–cell contact sites has previously been reported
in HIV-1. Dr. Walter Mothes’ laboratory reported that MLV assembly is also
facilitated near cell–cell contact sites; furthermore, the cytoplasmic tail of MLV Env promoted as-
sembly near these sites. In a late-breaker insertion talk, Dr. Mark Yeager’s laboratory presented results
that purified TRIM5-α protein assembles into sheets in vitro that contained threefold symmetry.
Interestingly, this sheet forms a complementary lattice with an in-vitro-assembled capsid lattice,
providing insights into how TRIM5-α may interact with capsid to restrict HIV-1 replication. 
Following its initial description last year that the karyopherin β-protein transportin-3 is an im-
portant HIV-1 cofactor, about half of the Uncoating/Nuclear Import session was dedicated to talks
on the mechanism of transpotin-3 in lentiviral reverse transcriptase/preintegration complex nuclear
translocation. The Integration session was composed of papers using a wide variety of techniques,
including fluorescence imaging of nuclear preintegration complexes (Hope/Cereseto) as well as small-
angle scattering studies of novel RSV (Anne Skalka) and HIV-1 (Bushman/van Duyne) structures.
Dr. Peter Cherepanov’s analysis of a new maedi-visna virus–LEDGFp75 cocrystal structure shed sig-
nificant new light on the integration mechanism. Dr. Zeger Debyser’s group presented two papers
on the role of the critical LEDGFp75 integration cofactor, one that utilized DamID to determine a
genome-wide map of LEDGFp75-binding sites and a second that, interestingly, redirected HIV-1
integration to novel sites via artificial proteins composed of the factor’s integrase-binding domain
fused to known chromatin-binding domains. This latter study demonstrates the ability to direct in-
tegration to predetermined sites, which might be useful down the road for targeted gene therapy. 
P. Bieniasz, M. Malim
Cocktails on Blackford lawn
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The Retroviruses meeting is the premiere conference for retrovirologists who work on basic mo-
lecular and cellular biological aspects of infection. Several aspects of the meeting make it unique
and essential for most retrovirologists to attend. It is the most scientifically intense meeting in the
field, covering most of the topics of current retroviral research. Because the program is abstract-
driven and emphasizes unpublished studies, only the most recent progress is discussed. Most of the
presentations are given by postdoctoral fellows and graduate students; therefore, the meeting provides
an excellent venue for trainees to present their work and to get feedback on their research. The
format of the meeting also provides an opportunity for interactions between scientists during the
question and answer part of oral presentations and during poster sessions. All of these features and
the reputation of this meeting make it the premiere conference for basic research on retroviruses.  
The meeting was funded in part by the National Institute of Allergy and Infectious Diseases, a
branch of the National Institutes of Health.
PROGRAM
RNA Mechanisms
Chairpersons: L. Mansky, University of Minnesota, Minneapolis;
R. Swanstrom, University of North Carolina, Chapel Hill
Pathogenesis
Chairpersons: R. Gummuluru, Boston University School of
Medicine, Massachusetts; I. Singh, University of Utah, Salt
Lake City
Keynote Address: Lessons from Four Decades of Research on
Retrovirus Assembly
V. Vogt, Cornell University
Assembly
Chairpersons: F. Bouamr, National Institutes of Health, Bethesda,
Maryland; H. Gottlinger, University of Massachusetts Medical
School, Worcester
Tetherin/BST-2/CD317
Chairpersons: P. Cannon, University of Southern California, Los
Angeles; D. Evans, Harvard Medical School, Boston,
Massachusetts
Drug Resistance/Antivirals/Evolution
Chairpersons: V. Pathak, NCI-Frederick, Maryland; E. Freed,
NCI-Frederick, Maryland
Entry/Envelope
Chairpersons: Y. Wu, George Mason University, Manassas,
Virginia; R. Davey, University of Texas Medical Branch,
Galveston
Uncoating/Nuclear Import
Chairpersons: A. Fassati, University College London, United
Kingdom; N. Landau, New York University School of Medicine,
New York
Apobec/RT
Chairpersons: J. DeStefano, University of Maryland, College
Park; H. Matsuo, University of Minnesota, Minneapolis
Keynote Address: Use of SIV to Guide AIDS Vaccine 
Development Efforts
R. Desrosiers, Harvard Medical School
Integration
Chairpersons: Z. Debyser, University of Leuven, Belgium; H.
Levin, NICHD, National Institutes of Health, Bethesda,
Maryland
Trim/Accessory Proteins
Chairpersons: J. Luban, University of Geneva, Switzerland; O.
Fackler, Universitätsklinikum Heidelberg, Germany
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Chairperson: S. Frasier, California Institute of Technology, Pasadena
Probing Single Cells at the Nanometer Scale
Chairperson: J. Lippincott-Schwartz, National Institutes of
Health, Bethesda, Maryland
Single-cell Modeling and Computation
Chairperson: A. Klein, Harvard University Medical School,
Boston, Massachusetts
General Discussion 
Keynote Address: Connectomics in the Developing Nervous
System
J. Sanes, Harvard University, Cambridge, Massachusetts
Single-cell Genomics and Transcriptomics
Chairperson: P. Blainey, Stanford University, California
Single-cell Proteomics and Metabolomics
Chairperson: J. Sweedler, University of Illinois, Urbana
Probing Single Live Cells
Workshop on Single-cell Techniques
July 16–19 55 Participants
ARRANGED BY James Eberwine, University of Pennsylvania Medical School 
Xiaoliang Sunney Xie, Harvard University
The goal of this first workshop was to bring together scientists who work with
single cells using different experimental paradigms and to discuss the progress
that is being made. Nearly 60 scientists convened with 17 talks given. A
panoply of cell types was discussed including bacteria, algae, plants, C. elegans,
and mammalian cells. The range of techniques used to investigate single-cell
biology that were discussed included single-cell dissection and transcriptomics,
proteomics, lipidomics, and metabolomics, all at single-cell resolution. An im-
portant component of the meeting was a discussion of various imaging modal-
ities including single-molecule resolution optics, PALM, STORM, and X-ray
tomography. The importance of, and necessity for, microfabrication and nan-
otechnology was highlighted in several talks. With the large amount of data
generated for any particular cell and the large number of cells that comprise a
multicellular organism, the discipline of computational biology as an organizing and analysis com-
ponent of single-cell biology was featured in nearly every presentation. The continued analysis of sin-
gle-cell biology will undoubtedly lead to a better understanding of disease state, better production of
biofuels, and insight into evolutionary mechanics that is unachievable using pooled cells. 
This Workshop was sponsored in part by Carl Zeiss MicroImaging and the PENN Genome
Frontiers Institute.
PROGRAM
X.S. Xie, J. Eberwine
Group photo
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A. Ikui, A. Kitazono
Yeast Cell Biology
August 11–15 255 Participants
ARRANGED BY Daniel Lew, Duke University
Peter Pryciak, University of Massachusetts Medical School
Lois Weisman, University of Michigan
This conference was the 13th biannual international meeting devoted to diverse aspects of cell bi-
ology in yeasts. These model eukaryotes have served as a workhorse for investigation into widely
conserved and fundamental features of eukaryotic cell biology. In addition to their well-known ge-
netic and molecular tractability, this meeting highlighted how recent advances exploiting the im-
pressive yeast knowledge base continue to expand the frontiers of cell biology. For example, an
ingenious new strategy reported by Elmar Schiebel exploits the inherent folding rates of fluorescent
proteins to monitor protein age in living cells. Another clever strategy reported by Dan Gottschling,
dubbed the “mother enrichment program,” allows a detailed look at how yeast cells themselves
change with age, revealing an unexpectedly early onset of defects in a variety of cellular processes
that are miraculously reversed by “rejuvenation” of daughter cells. 
Several exciting presentations reported new findings resolving old mysteries, including how per-
oxisomes are generated (Tabak and Rachubinsky labs) and how secretory vesicles are ferried to their
destinations (Weisman and Bretscher labs). Other talks reported surprising new twists in processes
that were believed to be well understood. For example, presentations from M. Peter’s lab revealed
that a signaling scaffold protein can be switched, by a single phosphorylation event, to become a
ubiquitin ligase and that pH has a hitherto unsuspected role in signaling glucose deprivation. A
presentation from F. Cross reported unexpected “endocycles” of cell cycle regulators upon arrest of
the cell cycle, and work from A. Gladfelter suggested that the same cell cycle controllers that coor-
dinate nuclear and cytoplasmic events in yeast have novel roles promoting a lack of coordination
between nuclei sharing the same cytoplasm in a multinucleate fungus. 
Although traditionally focused on the Baker’s yeast Saccharomyces cerevisiae, this year’s meeting
showcased the rapidly growing influence of the fission yeast Schizosaccharomyces pombe, particularly
in the study of the cytoskeleton and cytokinesis. After more than 100 years of investigation, this ex-
quisitely regulated process is finally yielding its secrets to an intense combination of experimental
approaches ranging from biophysics to cell biology to genetics. Intriguingly, the force-producing
mechanisms and the regulatory triggers for cytokinesis appear to differ between the two yeasts, and
the advances reported at the meeting produced a set of new puzzles to solve for the next meeting.
G. Sprague, R. Miller
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S. Barva, S. Lee M. Cyert, K. Whitworth, T. Aronin
Washington, Baltimore, Maryland; E. Schiebel, University of
Heidelberg, Germany
Organelles
Chairpersons: B. Glick, University of Chicago, Illinois; J.
Nunnari, University of California, Davis
Cytoskeleton
Chairpersons: D. Drubin, University of California, Berkeley;
D. Pellman, Dana-Farber Cancer Institute, Harvard Medical
School, Boston, Massachusetts
Nuclear Organization
Chairpersons: J. Aitchison, Institute for Systems Biology, Seattle,
Washington; D. Gottschling, Fred Hutchison Cancer Research
Center, Seattle, Washington
The successes of the past two decades of research into diverse aspects of cell biology produced a
knowledge base so large and detailed that it sometimes appeared as if different fields would become
so specialized as to inhibit communication between investigators focusing on different areas. How-
ever, empowered by new systems biology approaches developed and road-tested in this most tractable
of all eukaryotes, as well as the informed knowledge sharing promoted by the Saccharomyces genome
database, there is now a trend in the opposite direction, toward a more holistic understanding of
the organism. By bringing together investigators from all walks of cell biology who share common
organism-specific approaches, this meeting has consistently helped to maintain open lines of com-
munication and fostered our ability to integrate understanding and exchange insights from disparate
areas. This was an intensely enjoyable meeting in which we learned a huge amount and delighted
in the continuing new insights revealed by our beloved fungi, as well as the startling ingenuity and
consistent innovation of our colleagues.
This meeting was funded in part by the National Science Foundation.
PROGRAM
Polarity and Cytokinesis
Chairpersons: A. Bretscher, Cornell University, Ithaca, New York;
M. Peter, Institute of Biochemistry, Zürich, Switzerland
Cell Cycle and Proteolysis
Chairpersons: F. Cross, The Rockefeller University, New York;
D. Morgan, University of California, San Francisco
Signaling Networks
Chairpersons: R. Brent, The Molecular Sciences Institute,
Berkeley, California; M. Cyert, Stanford University, California
Membrane Trafficking
Chairpersons: S. Ferro-Novick, HHMI/University of California,
San Diego; R. Hampton, University of California, San Diego
Chromosomes and Mitosis
Chairpersons: D. Koshland, HHMI/Carnegie Institution of
266 Meetings
Eukaroytic mRNA Processing
August 18–22 338 Participants
ARRANGED BY Douglas Black, HHMI/University of California, Los Angeles
Lynne Maquat, University of Rochester Medical Center
Joan Steitz, Yale University School of Medicine
This seventh meeting presented and discussed recent developments
in mRNA metabolism. As in the past, the regulation of alternative
pre-mRNA splicing was a focus, as was the mechanism of spliceo-
some assembly and catalysis. Additional areas included mRNA 3′-
end formation, mRNA decay, mRNA trafficking, and the coupling
of RNA processing to transcription and export. Additional sessions
covered genome-wide approaches to understanding RNA-mediated
gene regulation and, for the first time, the control of microRNA
(miRNA) biogenesis and mechanisms of RNA interference (RNAi). 
In the splicing mechanisms session, several talks described new
structural data on RNA recognition within the spliceosome or the
overall conformation of the catalytic complex. Other results pro-
vided important new results on the role of metal ions in catalysis
and the function of DEAH-box helicases in driving conformational
changes during the catalytic cycle. The recognition of the branch
point by the U2 small nuclear ribonucleoprotein (snRNP) and of exon sequences adjacent to the 5′
splice site was also described. Finally, a talk presented new examples of trans-splicing in Drosophila
as identified by new deep-sequencing methods.
Several presentations on 3′-end formation focused on links between polyadenylation and tran-
scription and quality control. Progress was described in characterizing the processing of the 3′ ends
of histone mRNAs. Other talks examined the biogenesis and function of miRNAs. The regulation
D. Black, L. Maquat, J. Steitz
Coffee break under canvas
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RNA Decay and Translation
Chairperson: H. Le Hir, CNRS, Gif-sur-Yvette, France
Coupled Processes
Chairperson: K. Neugebauer, Max-Planck Institute for Cell
Biology and Genetics, Dresden, Germany
Splicing Regulation II
Chairperson: X.-D. Fu, University of California, San Diego
Genome-wide Approaches
Chairperson: B. Blencowe, University of Toronto, Canada
of miRNAs by poly(ADP-ribose) and by cell-specific cofactors was described. Effects on miRNA
processing in the nucleus by the spliceosome and heterogeneous nuclear RNP (hnRNP) proteins
were presented, as were the roles of partner proteins in determining the specificity of dicer processing
in the cytoplasm.
Talks in the RNA movement and RNA/protein interactions session examined a variety of im-
portant RNA-binding factors. Presentations described the different modes of recognition used to
bind RNA. The coupling of export factor assembly to the disassembly of the 3′-processing complex
and the coupling of poly(A)-binding and 3′-untranslated region (3′UTR)-binding factors to RNA
export were discussed, as were mechanisms for the nuclear retention of RNA. The targeting and lo-
calization of mRNAs in the Drosophila embryo and to the endoplasmic reticulum (ER) and mito-
chondria and the role of splicing in these processes were also examined. 
In splicing regulation, there has been significant progress in deciphering the detailed regulatory
mechanisms, as well as the biological roles of particular factors and splice variants. Biochemical and
yeast genetic approaches have identified specific points in the spliceosome assembly pathway affected
by particular factors. Multiple talks presented new data on the autoregulation of splicing factors
and the regulation of splicing during cellular differentiation. Another active area was the examination
of roles for splicing regulation in human disease and the development of splicing targeted thera-
peutics.
In the RNA decay session, the nonsense-mediated decay pathway was a particular focus including
work on its global regulation, its coupling to translation and to splicing via the exon junction com-
plex, and the remodeling or recycling of NMD factors during decay. New studies of nuclear and
viral pathways of mRNA decay were also presented covering both the known nuclear exosome path-
way and a new pathway.
The major theme in the session on genome-wide approaches was regulatory networks. Newly
refined array methods, new high-density sequencing methods, and the wider dissemination of meth-
ods for measuring genome-wide RNA binding by proteins were all evident. Combining these meth-
ods with RNAi approaches is allowing networks of processing events controlled by particular proteins
or during particular developmental or physiological events to be assessed. Computational approaches
to predicting regulation were also presented.
This meeting was funded in part by the National Cancer Institute and the National Institute of
Child Health and Human Development branches of the National Institutes of Health, and by the
National Science Foundation. The Laboratory would in addition like to thank the RNA Society
for its support of this meeting. 
PROGRAM
Splicing Mechanisms
Chairperson: B. Schwer, Weill Cornell Medical College, New
York
3′ Ends and microRNAs
Chairperson: S. Buratowski, Harvard Medical School, Boston,
Massachusetts
RNA Movement and RNA/Protein Interactions
Chairperson: A. Corbett, Emory University School of Medicine,
Atlanta, Georgia
Splicing Regulation I
Chairperson: J. Valcárcel, Centre for Genomic Regulation,
Barcelona, Spain
268 Meetings
Mechanisms of Eukaryotic Transcription
August 25–29 407 Participants
ARRANGED BY Stephen Buratowski, Harvard Medical School
Barbara Graves, University of Utah
Steven Hahn, Fred Hutchinson Cancer Research Center
Regulation of gene transcription has a central role in the growth and development of eukaryotic or-
ganisms. Transcriptional responses occur as a consequence of cell signaling, environmental stresses,
and developmental cues. The field of transcription encompasses a broad range of study from struc-
tural biology to developmental biology. This 10th meeting appropriately covered many aspects of
eukaryotic transcription and brought together a diverse group of scientists who took part in eight
plenary sessions and three poster sessions. The meeting began with a new session entitled Chromatin
Dynamics that covered mechanisms of chromatin structure rearrangement that are essential for reg-
ulated gene expression. The next session, Coactivator Complexes and Activator Mechanisms, cen-
tered on the mechanisms of coactivator complexes that bridge transcription activators and the general
transcription factors. The next two sessions discussed mechanisms of transcription, which revealed
a new understanding of the transcription initiation process and the emerging importance of mech-
anisms used to regulate gene expression after transcription initiation. Histone Modifications and
Transcription described new mechanisms whereby histone modifications lead to changes in tran-
scription and chromatin organization. Regulation of Transcription Factor Activity and Specificity
highlighted diverse mechanisms used to regulate transcription factor activity ranging from covalent
modification to elaborate gene-regulatory networks controlling the expression of key transcription
factors. The focus of the last two sessions turned to biological aspects of transcriptional regulatory
mechanisms. Developmental Regulation described transcriptional regulatory mechanisms that con-
trol development, and Signaling Mechanisms described novel signaling pathways that regulate tran-
scription and oncogenesis. The meeting was very well received by the participants and will occur
again in 2011. 
The meeting was funded in part by grants from the National Institutes of Health and the National
Science Foundation.
Histone Modifications and Transcription
Chairperson: J. Conaway, Stowers Institute for Medical Research,
Kansas City, Missouri
Regulation of Transcription Factor Activity and Specificity
Chairperson: K. Struhl, Harvard Medical School, Boston,
Massachusetts
Developmental Regulation
Chairperson: K. Jones, Salk Institute for Biological Studies, La
Jolla, California
Signaling Mechanisms
Chairperson: K. Zaret, University of Pennsylvania School of
Medicine, Philadelphia
PROGRAM
Chromatin Dynamics
Chairperson: J. Workman, Stowers Institute for Medical Research,
Kansas City, Missouri
Coactivator Complexes and Activator Mechanisms
Chairperson: C. Wolberger, HHMI/Johns Hopkins University
School of Medicine, Baltimore, Maryland
Initiation, Elongation, and Termination I
Chairperson: I. Grummt, German Cancer Research Center,
Heidelberg
Initiation, Elongation, and Termination II
Chairperson: D. Brow, University of Wisconsin, Madison
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Eukaryotic DNA Replication
September 1–5 338 Participants
ARRANGED BY Stephen P. Bell, HHMI/Massachusetts Institute of Technology
Joachim Li, University of California, San Francisco
This 11th biannual meeting was the second meeting that ex-
panded the scope of the meeting by including presentations on
DNA repair and checkpoint processes that monitor the in-
tegrity of the DNA replication process. The meeting demon-
strated the remarkable progress that has been made in the past
2 years. Accordingly, this meeting is crucial in bringing together
an international array of researchers investigating all aspects of
eukaryotic DNA replication and genome maintenance. The
most recent advances in the field were presented together with
new approaches for analyzing DNA replication, making this
meeting the most important in the field. A total of 338 inves-
tigators participated in the 10 scientific sessions, with a total of
275 platform and poster presentations. The eight platform and
two poster sessions were marked by spirited and enthusiastic exchanges of new results. In the scien-
tific sessions, many audience members participated in the question and answer sessions, and the
poster sessions were both of very high quality and well attended.
Sessions held at the meeting are listed below. In particular, the meeting illustrated the incorpo-
ration of structural approaches to understand the events of initiation, the reconstitution of many of
the key steps in the replication initiation and DNA-repair events, and the incorporation of genome-
wide methodology to understand the complexities of metazoan DNA replication and repair. In ad-
dition, the presentations illustrated our increasing understanding of the control of DNA replication
during development as well as the close coordination between the DNA repair and checkpoint
processes and DNA replication initiation and elongation. 
Essential funding for the meeting was provided by the National Cancer Institute, a branch of
the National Institutes of Health, and the National Science Foundation.
J. Li, S. Bell
Postreplicative Repair and Lesion Bypass
Chairperson: T. Kunkel, National Institutes of Health/NIEHS,
Research Triangle Park, North Carolina
Origin Selection and Pre-RC Assembly
Chairpersons: A. Dutta, University of Virginia, Charlottesville; J.
Hamlin, University of Virginia, Charlottesville
Chromatin and Development
Chairperson: M. Mechali, Institute of Human Genetics, CNRS,
Montpellier, France
Response to Replication Stress
Chairpersons: P. Burgers, Washington University School of
Medicine, St. Louis, Missouri; A.-K. Bielinsky, University of
Minnesota, Minneapolis
PROGRAM
Origin Activation and Replisome Assembly
Chairperson: H. Araki, National Institute of Genetics, Mishima,
Japan
Chromatin and Origin Timing
Chairperson: J. Walter, Harvard Medical School, Boston,
Massachusetts
Cell Cycle Controls and Genomic Instability
Chairperson: T. Orr-Weaver, Whitehead Institute, Massachusetts
Institute of Technology, Cambridge
Replisome Structure and Function
Chairperson: S. Gasser, Friedrich Miescher Institute, Basel,
Switzerland
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Microbial Pathogenesis and Host Response
September 8–12 247 Participants 
ARRANGED BY Andrew Camilli, Tufts University School of Medicine
Brendan Cormack, John Hopkins University School of Medicine
Theresa Koehler, University of Texas–Houston Medical School
Despite advances in modern health care, infectious diseases continue
to be major causes of human morbidity and mortality. The evolu-
tion of microbial pathogens with humans has resulted in complex
interactions that impact the struggle between the infectious invader
and the susceptible host. Increased understanding of these interac-
tions with the goal of developing new therapeutics and preventive
strategies requires collaborative and interdisciplinary scientific ap-
proaches. This meeting brought together a diverse group of inter-
national scientists who approach the study of bacterial and fungal
pathogens from a broad range of perspectives. Investigators from
the disciplines of molecular microbiology, eukaryotic cell biology,
immunology, and genomics, and representing academia, industry,
and the public health sector, shared recent findings concerning mi-
crobial and host aspects of infectious diseases.
The meeting focused on bacterial and fungal pathogens and the
host response and defense to these invading microbes. Oral sessions were topic-based and included
studies of multiple and diverse organisms. Areas covered included structural analysis of virulence
factors, host immune response and immune evasion strategies, microbial communities, and reser-
voirs, microbial metabolism and physiology and microbial genomics. Speakers for each session were
a mixture of established leaders in the field and young investigators; 40% of the speakers, including
postdoctoral fellows and graduate students, were chosen from submitted abstracts. Dr. Olaf
Schneewind, Professor and Chair of the Department of Microbiology at the University of Chicago,
presented the keynote address. Dr. Schneewind is an internationally recognized leader in microbial
pathogenesis. His presentation addressed processing of microbial cell-surface proteins and attach-
ment to peptidoglycan by the sortase enzyme, as well as immune recognition of these proteins and
their application to vaccine development for gram-positive organisms.
B. Cormack, T. Koehler, A. Camilli
Poster session in the Grace lobby
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Structural Insights into Virulence
Chairperson: P. Ghosh, University of California, San Diego
Metabolism and Virulence
Chairperson: J. Slauch, University of Illinois, Urbana,
Champaign
Immune Evasion
Chairperson: J. Cox, University of California, San Francisco
Reservoirs and Transmission
Chairperson: C. Kumamoto, Tufts University, Boston,
Masaschusetts
The Immune Host
Chairperson: M. Starnbach, Harvard Medical School, Boston,
Massachusetts
Communities
Chairperson: P. Watnick, Children’s Hospital, Harvard Medical
School, Boston, Massachusetts
Keynote Address: Cell-surface Proteins at the Microbial–
Host Interface
O. Schneewind, University of Chicago, Illinois
Genomes
Chairperson: C. Fraser-Liggett, University of Maryland School of
Medicine, Baltimore
The informal atmosphere combined with the broad perspectives
of the meeting participants resulted in a free flow of novel and re-
freshing ideas on pathogenesis, with the atmosphere of a small meet-
ing. Active questioning and discussion followed all oral presentations,
was evident throughout the posters sessions, and continued during a
wine and cheese reception and other social gatherings. We strongly
encouraged submission of abstracts by junior researchers in the field
and many young investigators were in attendance. Some of these in-
teractions have already produced fruitful scientific collaborations.
This meeting was partially supported by funds from the National
Institute of Allergy and Infectious Diseases.
PROGRAM
R. Miller-May, J. O’Loughlin
A. Pezzicoli
S. Chen, A. Sikora
272 Meetings
PROGRAM
Keynote Address: Setting the Tone for Personal Genomes
G. Church, Harvard University, Cambridge, Massachusetts
Introductory Remarks
J.D. Watson, Cold Spring Harbor Laboratory
G. Church, Harvard University: Overview of technologies and
status/application of personal genome sequencing.
T. Hudson, Ontario Institute for Cancer Research: Genetic
analysis of 20 loci implicated in colorectal cancer.
Whole-genome Studies and Cancer
Chairpersons: E. Mardis, Washington University School of
Medicine, St. Louis, Missouri; L. Chin, Harvard Medical
School, Boston, Massachusetts
Personal Genomes
September 14–17 200 Participants
ARRANGED BY George Church, Harvard University
Paul Flicek, European Bioinformatics Institute
Richard Gibbs, Baylor College of Medicine
Elaine Mardis, Washington University School of Medicine
This special meeting was arranged both to celebrate and to criti-
cally examine a significant milestone in human genetics—the first
“personal genomes.” Ultra-high-throughput sequencing strategies
are used in a very limited number of laboratories and few scien-
tists, and even fewer clinical geneticists, are familiar with the im-
plications of the “$1000 genome.” This meeting provided an
opportunity to explore a number of important themes including
(1) technical status of sequencing whole genomes: successes, prob-
lems, new developments, new approaches on the way; (2) making
sense of the content of whole genomes: what are we learning about
human genetics from genome scale studies?; (3) applications of
whole-genome studies: How are genome-scale studies providing
new insights on clinical genetics?; and (4) preparing for the
“whole-genome” world: What happens when everyone has their
genome sequenced? The meeting featured a combination of talks
and posters and included a panel discussion on the ethical, legal,
and social implications (ELSI) of these rapidly changing technolo-
gies. The critical success and timeliness of the meeting can be
judged from the considerable enthusiasm of the audience and the
appearance of two major editorials citing details of the conference
in subsequent issues of Nature magazine. The collective decision
was taken to hold the meeting for a third time at Cold Spring Har-
bor in the fall of 2010.
    This meeting was funded in part by Roche-454 Sequencing and
Illumina, Inc.
J.D. Watson
E. Lai, C.T. Caskey
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Genomes in Inherited Disease
Chairpersons: R. Gibbs, Baylor College of Medicine, Houston,
Texas; R. Lifton, Yale University School of Medicine, New
Haven, Connecticut
Keynote Address: Inflection Point for Genome Science
C.T. Caskey, University of Texas Health Science Center
TPANEL: New Ethical Challenges and Personal Genomes
M. Angrist, Duke University, Durham, North Carolina:
Historical overview of personal genomes.
J. Lupski, Baylor College of Medicine, Houston, Texas: My
personal genome experience.
V. Hughes, New York, New York: Potential impact of personal
genomics in a disease focus group.
A. McGuire (co-chair), Baylor College of Medicine, Houston,
Texas: Ethical issues related to clinical integration and
research use of personal genomes.
P. Reilly (co-chair), Third Rock Ventures, Massachusetts: Ethical
issues moving forward.
Scanning the Exome and Personal Transcriptomes
Chairpersons: J. Shendure, University of Washington, Seattle; C.
Nusbaum, Broad Institute of MIT and Harvard, Cambridge,
Massachusetts
Data Analysis and Visualization Tools
Chairpersons: P. Flicek, European Bioinformatics Institute,
Hinxton, United Kingdom; S. Brenner, University of
California, Berkeley
Future Technologies for Personal Genomics
Chairpersons: R. Wilson, Washington University, St. Louis,
Missouri; S. Quake, Stanford University, California
P. Reilly, M. Pollock
T. Hudson, A. Metspalu
V. Hughes J. Lupski, L. RichardsA. McGuire
274 Meetings
Stem Cell Biology
September 22–26 242 Participants
ARRANGED BY Konrad Hochedlinger, Massachusetts General Hospital 
Brigid Hogan, Duke University Medical Center
Allan Spradling, HHMI/Carnegie Institution
This inaugural meeting was designed to bring together re-
searchers taking a broad range of approaches to analyzing
stem cells from a diverse collection of tissues and experi-
mental organisms, both in vivo and in vitro. Regardless
of their experimental strategy, speakers agreed that the
field’s paramount goal is to understand stem cell behavior
in vivo during tissue development, homeostasis, and re-
pair, including cellular reprogramming. The key subject
areas of the meeting are listed below. A prominent goal of
the meeting was to juxtapose insights from invertebrate
model systems boasting favorable biology and powerful
experimental tools with those from mammalian and
human systems with a long history of study and great clin-
ical relevance. A significant fraction of the material pre-
sented was unpublished and some fascinating discoveries
were described for the first time. The meeting highlight
was an exceptional keynote presentation containing a large
amount of new data of central relevance to stem cell biol-
ogy. The ensuing discussion had to be cut off after 20
minutes to make way for the concert. Overall, meeting
participants were extremely positive, a typical comment
being: “This is the most biologically focused stem cell
meeting I have ever attended.” 
The meeting included participants from at least 20 dif-
ferent countries representing Australia, North America,
South America, Asia, South Asia, and Europe. Although
many attendees are renowned in their fields, a large num-
ber of participants were young scientists. In addition to
the high-quality program, the meeting attracted these
young participants because nearly half the speakers, in-
cluding many junior researchers, were selected from the
submitted abstracts. A highly interactive atmosphere was
successfully created by limiting all talks to 20 minutes,
leaving one-third of the alloted time for discussion, which
often expanded greatly on the formal presentations. 
A. Spradling, B. Hogan, K. Hochedlinger
J. Rossant, S. Morrison
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PROGRAM
Anatomy and Function of the Stem Cell Niche I
Chairperson: K. Hochedlinger, Massachusetts General Hospital,
Boston
Anatomy and Function of the Stem Cell Niche II
Chairperson: D.L. Jones, Salk Institute for Biological Studies, La
Jolla, California
Epithelial Stem Cells I
Chairperson: B. Hogan, Duke University Medical Center,
Durham, North Carolina
Epithelial Stem Cells II
Chairperson: J. Rossant, The Hospital for Sick Children, Toronto,
Canada
Cell Lineage Determination, Differentiation, and Plasticity
Chairperson: L. Zon, Children’s Hospital, Boston, Massachusetts
Tissue Regeneration, Repair, and Reprogramming
Chairperson: M. Busslinger, Research Institute of Molecular
Pathology,Vienna, Austria
Tissue Regeneration, Maintenance, and Repair
Chairperson: Y. Yamashita, University of Michigan, Ann Arbor
Stem Cell Self-renewal and Differentiation
Chairperson: H. Clevers, Hubrecht Institute, Utrecht, The
Netherlands
Keynote Address: Lgr5 Intestinal Stem Cells in Self-renewal
and Cancer
H. Clevers, Hubrecht Institute
Pluripotency
Chairperson: A. Spradling, HHMI/Carnegie Institution,
Baltimore, Maryland
C. Blanpain, V. Greco S. Ellis, J. Kung
276 Meetings
Neurobiology of Drosophila
September 29–October 3 441 Participants
ARRANGED BY Vivian Budnik, University of Massachusetts
Paul Taghert, Washington University Medical School
As in previous years, the goal of this meeting was to foster commu-
nication of ideas, techniques, and new discoveries within the field of
Drosophila neurobiology. The meeting was structured with platform
and poster presentations by a variety of researchers including graduate
students, postdoctoral fellows, and junior and senior faculty. The top-
ics for the platform sessions were chosen to reflect the areas of
Drosophila neurobiology in which cutting-edge advances are being
made: neuronal cell development, neural circuits and function, simple
and complex behaviors, sensory systems, synaptic transmission, and
the evolution of neural systems. A small number of abstracts submit-
ted in each of these areas were selected by the respective session chairs
for platform presentations, and the rest were presented as posters.
The research reported used a wide range of techniques, including ge-
netic, molecular, cellular, biochemical, physiological, and behavioral
approaches to basic questions of nervous system development and
function. Among the highlights of the meeting were the creative ways in which researchers are using
Drosophila to understand the molecular and cellular underpinnings of many different physiological
and pathological processes. A focal point in the meeting was the
Keynote Address by Gerry Rubin who described the substantial ef-
forts to advance Drosophila neurobiology at Janelia Farm. In addition,
the meeting included reports of important advances in the develop-
ment of the nervous system, the perception of external stimuli, in
particular olfactory cues, by the fly, and the design of new technology.
The Elkins plenary lecture was presented by Young Kwon from Craig
Montell’s laboratory. He spoke about the physiology and genetics of
temperature-sensitive channels. The environment of the meeting al-
lowed many opportunities for informal discussions among all partic-
ipants. The high quality of the presentations, the development of
novel techniques, and the exciting new directions of Drosophila re-
search demonstrate the vitality of this area. Discussions at the meeting
led to the sharing of ideas that were valuable to everyone in the field.
The meeting was funded in part by the National Institute of Neu-
rological Disorders and Stroke and the Eunice Kennedy Shriver Na-
tional Institute for Child Health and Human Development, branches
of the National Institutes of Health.
P. Taghert, V. Budnik
A. Stewart, M. Rolls
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PROGRAM
Development and Metamorphosis of the Brain
Chairperson: J. Kumar, Indiana University, Bloomington
Behavior (Reproductive, Locomotor, Appetitive, Social, 
Aggressive)
Chairperson: J. Levine, University of Toronto, Canada
Elkins Memorial Lecture: TRP Channels Required for 
Sensing Temperature and Insect Repellents
Y. Kwon, Johns Hopkins School of Medicine
Neural Circuits: Assembly and Function
Chairperson: I. Meinertzhagen, Dalhousie University, Halifax,
Canada
Sensory Systems: Coding and Topographic Mapping
Chairperson: S. Tsunoda, Colorado State University, Fort Collins
A. Wise, T. VenkatesH. Lawal, S. Aust, P. Halder, A. Ziegler
J. Levine, G. Rubin
Genome Studies and Neural Evolution
Chairperson: S. Reppert, University of Massachusetts Medical
School, Worcester
Keynote Address: A Brief Overview of Ongoing Work on the
Fly Brain at Janelia Farm
G. Rubin, HHMI/Janelia Farm Research Campus
Synapse Development and Plasticity
Chairperson: J. Sierralta, Universidad de Chile, Santiago
Higher Brain Functions (Learning, Memory, Sleep, 
Attention, Choice)
Chairperson: K. Han, Pennsylvania State University, University
Park
J. Goto, K. Kitamoto
278 Meetings
Cell Death
October 6–10 267 Participants
ARRANGED BY J. Marie Hardwick, Johns Hopkins University
Shigekazu Nagata, Graduate School of Medicine, Kyoto University
Junying Yuan, Harvard Medical School
The meeting opened with two Keynote presentations delivered by Jun-
ying Yuan and Doug Wallace, an expert on the molecular basis of mi-
tochondrial disease. Junying Yuan provided an overview and articulated
the frontiers of the field before describing her recent work on a new
programmed necrotic cell death pathway, its key molecular players, and
small molecule inhibitors, which has opened new therapeutic oppor-
tunities previously thought to be impossible based on the assumption
that necrosis is a nonprogrammed and uncontrollable cell death. In ad-
dition to two poster sessions, there were eight oral sessions covering the
topics of developmental cell death (organismal and immunological),
apoptotic and nonapoptotic cell death pathways (autophagy, necrosis,
inflammatory), new therapeutic targets (including new evidence for
death receptors and caspases in Alzheimer’s disease, presented in the
oral and poster sessions), regulation of metabolism and mitochondrial
dynamics by cell death factors, noncanonical functions of cell death regulators in the nervous system,
systems biology approaches to understanding cell death, and a range of therapeutic strategies to in-
duce cell death in cancer cells, backed by both basic science and clinical evidence. 
Speakers from around the globe included high-profile investigators who were both invited speak-
ers/chairs and abstract presenters. These included Craig Thompson, Beth Levine, Vishva Dixit,
Marc Tessier-Lavign (CSO, Genentech), Richard Youle, Doug Green, Yigong Shi, Scott Lowe, Her-
mann Steller, Jerry Adams, Eileen White, and many others who spoke on a range of topics and
model systems as they relate to mechanisms of cell death. Despite the many exciting new discoveries
presented here, it was also clear that many of the major questions in this field remain unanswered,
including those concerning the central molecular players in apoptosis. 
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health.
J. Yuan, J.M. Hardwick
M. Bots, J. Zuber, L. Dow H. Steller, H. Engleberg-Kulka
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PROGRAM
Keynote Addresses
Chairperson: J.M. Hardwick, Johns Hopkins University,
Baltimore, Maryland
J. Yuan, Harvard Medical School, Boston, Massachusetts:
Mechanisms of programmed cell death: From apoptosis to
necroptosis.
D.C. Wallace, University of California, Irvine: Mitochondria,
bioenergenetics, and epigenoemics in health and disease.
Developmental Cell Death: Organismal and Immunological
Chairperson: S. Nagata, Kyoto University Graduate School of
Medicine, Japan
Autophagy, Necrosis, and Inflammation
Chairpersons: E. White, Rutgers University, New Brunswick,
New Jersey; B. Levine, University of Texas Southwestern
Medical Center, Dallas
Posttranslational Regulation of Cell Death and Therapeutic
Targets
Chairpersons: V. Dixit, Genentech Inc., South San Francisco,
California; S. Kornbluth, Duke University School of Medicine,
Durham, North Carolina
Metabolism at the Interface of Death and Survival
Chairpersons: C. Thompson, University of Pennsylvania,
Philadelphia; J. Lieberman, Harvard Medical School, Boston,
Massachusetts
Structure, Biochemistry, and Genetics of Cell Death
Chairpersons: Y. Shi, Tsinghua University, Beijing, China; D.
Andrews, McMaster University, Hamilton, Canada
Cell Death Signaling Pathways
Chairpersons: D. Green, St. Jude Children’s Research Hospital,
Memphis, Tennessee; P. Sorger, Havard Medical School, Boston,
Massachusetts
Mitochondria: Mediators of Death and Survival
Chairpersons: R. Youle, National Institutes of Health/NINDS,
Bethesda, Maryland; N. Daniel, Dana-Farber Cancer Institute,
Boston, Massachusetts
Noncanonical Functions of Cell Death Factors: Neurons to
Plants
Chairpersons: M. Tessier-Lavigne, Genentech Inc., South San
Francisco, California; E. Jonas, Yale University, New Haven,
Connecticut
Cancer Cell Death Mechanisms: Bench to Bedside
Chairpersons: S. Lowe, Cold Spring Harbor Laboratory; Z. Fuks,
Memorial Sloan-Kettering Cancer Center, New York
E. Jonas, T. Rostovtseva
L. Grantham
280 Meetings
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Assembly and Informatics for New Sequencing Technologies
Chairpersons: I. Birol, BC Cancer Agency, Vancouver, Canada;
M. Brudno, University of Toronto, Canada
Epigenomics and Gene Regulation
Chairpersons: E. Segal, Weizmann Institute of Science, Rehovot,
Israel; X.S. Liu, Dana-Farber Cancer Institute, Boston,
Massachusetts
Data Management, Text Mining, Curation, and Visualization
Chairpersons: G. Micklem, University of Cambridge, United
Kingdom; D. Church, National Center for Biotechnology
Information, Bethesda, Maryland
Comparative and Evolutionary Genomics
Chairpersons: A. Regev, Broad Institute of MIT and Harvard,
Cambridge, Massachusetts; C. Ponting, Oxford University,
United Kingdom
Keynote Address: Understanding Genome-scale Data Sets
with Reactome
L. Stein, Ontario Institute for Cancer Research
Population and Statistical Genomics
Chairperson: R. Nielsen, University of California, Berkeley
Transcriptomics and Medical Genomics
Chairperson: J. Parkhill, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Genome Informatics
October 27–30 329 Participants
ARRANGED BY Michele Clamp, Broad Institute of MIT and Harvard
James Kent, University of California, Santa Cruz
The ninth Cold Spring Harbor Laboratory/Wellcome Trust conference
continues to highlight the latest developments in genome research and,
once again, was a vital and exciting meeting. This conference series
began at the Wellcome Trust Conference Center in Hinxton, United
Kingdom in 2001 and now alternates between the United Kingdom
and the United States. The series follows a format similar to traditional
Cold Spring Harbor meetings, in that the majority of oral presentations
are drawn from openly submitted abstracts.
The explosion of biological data requires a concomitant increase in
the scale and sophistication of information technology. This ranges
from the storage of data and associated data models, to the design of
effective algorithms to uncover nonobvious aspects of these data sets,
to ontologies to concisely describe biological information, and finally
to software systems to support curation, visualization, and exploration.
The conference brought together some of the leading scientists in this growing field, and researchers
from other large-scale information handling disciplines were also invited to attend. The key topics
of the meeting are listed below. For the first time, we had a session on microbial pathogens, a field
with which most bioinformaticians are unfamiliar, and it generated much excitement and discussion.
The keynote speaker was Professor Lincoln Stein, who addressed understanding genome-scale data
sets with reactome. In all, more than 325 participants attended, with more than 30% of delegates
coming from outside North America, a highly unusual statistic for a U.S. meeting, and the meeting
hosted a record 215 scientific presentations in talks and posters.
This meeting was funded in part by the National Human Genome Research Institute, a branch
of the National Institutes of Health.
M. Clamp, J. Kent
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Harnessing Immunity to Prevent and Treat Disease
November 11–14 133 Participants
ARRANGED BY Kathrin Jansen, Wyeth Pharmaceuticals 
Robert Seder, Vaccine Research Center, NIH/NIAID
Susan Swain, Trudeau Institute
This fifth winter conference, previously called Molecular and Immuno-
logical Approaches to Vaccine Design, focused on new findings about
the basic regulation of innate and adaptive immunity in the context of
infectious and autoimmune disease and cancer and how the immune
system might be harnessed to tackle each of these. Indeed, the first
keynote speaker, Jim Allison, showed promising results on clinical trials
using strategies to block CTLA-4, which unleashed T cells’ improved
response to certain cancers and restricted their growth. He also high-
lighted the role of several additional co-stimulatory pathways that could
influence T-cell immunity.
The first session on innate immunity covered our increasing appre-
ciation of the many roles of innate cells, including natural killer (NK)
cells and dendritic cells (DC) of many subsets. It emerged that many
of the regulatory mechanisms determining innate cell functions, such
as cytokines interleukin-10 (IL-10), IL-12, type I interferon (IFN), and IL-21, are those known to
regulate both B and T lymphocytes. Several speakers throughout this session highlighted the im-
portance that efficient activation of antigen-presenting cells, such as specific DC subsets, had for
influencing an effective response in which T cells, secreting multiple effector cytokines such as IFN-
β, TNF-α (tumor necrosis factor-α), and IL-2, are generated. Furthermore, new data were presented
showing that memory T cells can induce innate inflammation, independent of pathogen recognition
pathways.
These topics were further explored in the second session on vaccines and adjuvants for nonin-
fectious diseases. Data were presented showing that DNA vaccination may be a promising approach
for treatment of autoimmune disease such as diabetes or multiple sclerosis through undefined mech-
anisms. In addition, it may be possible to harness adaptive immune responses to block development
of Alzheimer’s. Although treatments for all these disease are still some time away, this is an increas-
ingly exciting possibility. 
There were two sessions on T-cell immunity which revealed that the breadth of CD4 and CD8
T-cell responses are much greater than previously considered. The ability of the regulatory T cell to
modulate immune responses becomes more and more apparent, especially in mucosal sites where
they have a critical role. Roles for Th17 in repair have become clearer. The pathways of differenti-
ation of CD4 (which often apply to CD8 as well) are also revealed to be at multiple levels. For in-
stance, it seems that the T cells that enter B-cell follicles (TFH) only turn into cells helping germinal
center formation by turning on a program involving down-regulation of one factor, BLIMP, and
up-regulation of an opposing factor, BCL-6. This decision seems to be location dependent. In ad-
dition, T:B cognate interaction seems to be necessary for the final differentiation to mature TFH,
which supports germinal center formation and the production of high-affinity isotype-switched
antibodies that have key roles in protective immunity. Another program involving BLIMP and op-
posed by T-BET (a member of the T-box family) seems to control exhaustion of T cells. Pathways
to memory T-cell formation are also being investigated and the mTOR pathway seems to have a
key role.
R. Seder, J. Banchereau
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PROGRAM
Keynote Addresses: Perspectives on Immunotherapy 
for Cancer
R. Steinman, The Rockefeller University
J. Allison, Memorial Sloan-Kettering Cancer Center
Innate Immunity and Adjuvants
Chairperson: B. Pulendran, Emory University, Atlanta, Georgia
Keynote Address: Challenges to Vaccination
P. Offit, Children’s Hospital of Philadelphia
Vaccines and Adjuvants for Noninfectious Diseases
Chairperson: D. Selkoe, Harvard Medical School, Boston,
Massachusetts
Immunity to Infectious Disease I
Chairperson: J. Kolls, Louisiana State University Health Sciences
Center, New Orleans
Vaccines for Challenging Diseases and New Threats
Chairperson: K. Subbarao, National Institutes of Health/NIAID,
Bethesda, Maryland
Keynote Address: Development of a Conjugated Polysaccha-
ride Vaccine that Affords Expanded Worldwide Coverage
Against Pneumococcal Disease
E. Emini, Wyeth Pharmaceuticals
As we better understand the kinds of immune responses and the regulatory pathways determining
both effector and memory generation of different types, we should be able to translate this knowledge
into more effective vaccine strategies tailored to particular pathogens and targets such as tumors.
By bringing together the vaccine designers and those discovering basic mechanisms, we hope to in-
form and energize both groups so that translation can occur as rapidly as possible. The enthusiastic
participation of attendees in discussions, in and outside the formal conference sessions, suggests
that this goal was achieved.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, a
branch of the National Institutes of Health, and Wyeth Research Institute.
M. Eichelberger, A. Hassantougighi
K. Jansen, D. Selkoe L. Richert
Keynote Address: CD8 T-cell Immunity to Virus
R. Ahmed, Emory University School of Medicine
Immunity to Infectious Disease II
Chairperson: R. Seder, National Institutes of Health/NIAID,
Bethesda, Maryland
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Keynote Address: AAV Immunity: Antibodies and 
Inflammation
J. Wilson, University of Pennsylvania
Monitoring Gene Delivery and Expression
Chairpersons: S. Carlson, Mayo Clinic, Rochester, Minnesota;
R. Blasberg, Memorial Sloan-Kettering Cancer Center, New
York
In Vivo Barriers to Gene Delivery
November 18–21 76 Participants 
ARRANGED BY Nori Kasahara, UCLA Geffen School of Medicine
Stephen Russell, Mayo Clinic College of Medicine
James M. Wilson, University of Pennsylvania
It is now 20 years since the first FDA-approved human gene transfer
study, but this extremely promising field of endeavor is still nowhere
close to realizing its full therapeutic potential. There have been a few
notable successes, such as the use of autologous hematopoietic stem
cells transduced with the interleukin-2 (IL-2) γ-chain or adenosine
deaminase for the treatment of severe combined immunodeficiency.
However, the dream of genetically based therapies for the treatment of
a multitude of other more common human ailments has not yet been
achieved. Although clinical “home runs” have been few and far be-
tween, the scientific understanding and the technological underpinning
of gene therapy have been moving forward in leaps and bounds, and
there is currently a great deal of optimism that we are entering an era
in which we will see increasing numbers of clinically approved gene
therapy products. This conference provided a forum for the presentation
of the most recent advances in technologies and approaches used for monitoring vector trafficking,
evading neutralizing antibodies, avoiding vector mislocalization, increasing extravasation, enhancing
persistence, improving the manufacturing yield, or otherwise addressing the barriers that interfere
with the accuracy and efficiency of gene delivery and the durability of expression. 
This unique forum was designed to stimulate future research studies in this important area and
to promote interactions among researchers in diverse basic scientific areas relevant to this field. The
conference was held the week before Thanksgiving and attracted 76 participants, including many
eminent field leaders and a strong showing of more junior scientists (more than 50% of attendees
were postdoctoral scientists or Ph.D. students). Overall, the meeting was considered a great success
by those who attended. This was a highly interactive group of scientists that engaged in stimulating
discussions after each of the oral presentations and very lively interactions at the poster sessions and,
of course, in the bar after each of the evening sessions. Throughout the meeting, it was clear that
the field of gene therapy has reached a very exciting stage in its development, and we expect to see
significant progress addressing the in vivo barriers to gene delivery in the years ahead. 
PROGRAM
Mislocalization, Sequestration, and Targeting
Chairpersons: A. Baker, University of Glasgow, United Kingdom;
A. Srivastava, University of Florida, Gainesville
Persistence
Chairpersons: J. Bartlett, Research Institute at Nationwide
Children’s Hospital, Columbus, Ohio; M. Sadelain, Memorial
Sloan-Kettering Cancer Center, New York
G. Kueberuwa, S. Russell
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Extravasation and Tissue Penetration
Chairpersons: N. Kasahara, University of California Geffen
School of Medicine, Los Angeles; L. Seymour, University of
Oxford, United Kingdom
Bench to Bedside
Chairpersons: M. Serabian, Food and Drug Administration,
Rockville, Maryland; K. High, Children’s Hospital of
Philadelphia, Pennsylvania
D. McCarty D. Dingli, H. Li
Keynote Address
L. Naldini, San Raffaele Telethon Institute for Gene Therapy
Vector Neutralization
Chairpersons: M. Agbandje-McKenna, University of Florida,
Gainesville; M. Perreau, Centre Hospitalier Universitaire
Vaudois, Lausanne, Switzerland
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Rat Genomics and Models
December 2–5 142 Participants
ARRANGED BY Edwin Cuppen, Hubrecht Institute
Norbert Hübner, Max-Delbrück Center for Molecular Medicine
Anne Kwitek, University of Iowa
James Shull, University of Wisconsin
This sixth winter biotechnology conference has been held
biannually since 1999 at the Cold Spring Harbor Labo-
ratory. This conference series is the first in the United
States to focus exclusively on the unique physiological rel-
evance of the rat as a model organism for biomedical re-
search into the molecular origins of human diseases. A
complementary meeting outside of the United States is
held in the alternating years, with the most recent meet-
ings being held in Hinxton, United Kingdom (2008),
Melbourne, Australia (2006), and Kyoto, Japan (2004).
The primary goals of this meeting were (1) to promote
interactions between biomedical researchers who utilize
rat models in the study of physiology, pathophysiology,
toxicology, immunology, neuroscience, and oncology and
(2) to provide an interface between the research community and the various public and commercial
entities that support biomedical research in which rat models are utilized.
The meeting was organized into oral presentations by invited speakers, speakers selected following
evaluation of submitted abstracts, poster sessions, and workshops. Keynote lectures were presented
by Dr. Michael Gould, Svante Pääbo, and Matthias Mann. The remaining oral presentations were
organized into six sessions based on diseases or technologies. The key topics and their chairs are pre-
sented below. 
Dr. Hübner led a workshop devoted to genome databases and data mining tools. In this work-
shop, Dr. Elizabeth Worthey presented an overview of the rat genome viewer developed by the Rat
Genome Database, and Dr. Kim Pruitt from the National Center for Biotechnology Information
presented a summary of new data mining tools developed within that organization. Finally, 57 ab-
stracts were presented in an interactive poster session.
J. Shull, N. Hübner, A. Kwitek, E. Cuppen
Dolan DNA Learning Center poster presenters
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A. Voskresenskiy M. Busch-Dienstfertig, M. Schwemmle
It is clear that this conference serves an important role in meeting the needs of those in the bio-
medical research community who use rat models in genetics and genomics-based research. The or-
ganizers and attendees expressed high enthusiasm for continuing the present biannual meeting
format at the Cold Spring Harbor Laboratory and other sites in the future.
This meeting was funded in part by the National Heart, Lung, and Blood Institute, a branch of
the National Institutes of Health.
PROGRAM
Keynote Address
S. Pääbo, Max-Planck Institute for Evolutionary Anthropology
and Biology
Manipulating the Genome
Chairpersons: Q.-L. Ying, University of Southern California, Los
Angeles; E. Cuppen, Hubrecht Institute, Utrecht, The
Netherlands
Systems Biology/Resources
Chairpersons: P. Flicek, European Bioinformatics Institute,
Hinxton, United Kingdom; A. Kwitek, University of Iowa,
Iowa City
Keynote Address
M. Mann, Max-Planck Institute for Biochemistry
Cardiovascular
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; R. Kreutz, Charité-Universitätsmedizin Berlin,
Germany
Tumor Biology
Chairpersons: J. Shull, University of Wisconsin, Madison; C.
Walker, University of Texas M.D. Anderson Cancer Center,
Smithville
Keynote Address: Susceptibility to Breast Cancer: A Complex
Trait
M. Gould, University of Wisconsin, Madison
Metabolism/Inflammation
Chairpersons: Å. Lernmark, Lund University, Sweden; T.
Aitman, Imperial College, London, United Kingdom
Workshop: Databases
Chairperson: N. Hübner, Max-Delbrück Center for Molecular
Medicine, Berlin, Germany
Tools Demo: RGD Pathway Tools
Neurosciences/Behavior/Disease
Chairpersons: B.E. Levin, VA Medical Center, East Orange, New
Jersey; T. Serikawa, Kyoto University, Japan
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities
do not adequately teach them. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into research in a particular
area. To ensure up-to-date coverage of current research work, we bring together course faculty from
many laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 15–28
INSTRUCTORS K. Adelman, National Institutes of Health/NIEHS, Research Triangle Park, North Carolina
R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
M. Marr, Brandeis University, Waltham, Massachusetts
ASSISTANTS J. Cao, University of California, Los Angeles
M. Chambers, University of California, Los Angeles
R. Chumanov, University of Wisconsin, Madison
C.-F. Huang, M.D. Anderson Cancer Center, University of Texas, Houston
Y.-C., Lee, M.D. Anderson Cancer Center, University of Texas, Houston
S. Nechaev, NIEHS/Research Triangle Park, North Carolina
K. Pennington, Brandeis University, Waltham, Massachusetts
N. Thompson, University of Wisconsin, Madison
W. Turki-Judeh, University of California, Los Angeles
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Adams, S., Ph.D., Mayo Clinic Jacksonville, Florida
Arizgolshani, O., B.S., University of California, Los Angeles
Bartlow, P., B.S., University of Pittsburgh, Pittsburgh,
Pennsylvania
Bellail, A., Ph.D., Emory University, Atlanta, Georgia
Broghammer, A., Dipl., University of Aarhus, Denmark
Catera, R., M.S., The Feinstein Institute for Medical Research,
Manhasset, New York
Chen, E., Ph.D., National Institutes of Health, Bethesda,
Maryland
Cherk, C., B.A., University of California, Berkeley
Hao, C., Ph.D., Emory University, Atlanta, Georgia
Knies, J., Ph.D., Brown University, Providence, Rhode Island
Lange, S., Ph.D., University of Texas M.D. Anderson Cancer
Center, Science Park, Smithville
Lomenick, B., B.S., University of California, Los Angeles
Minaker, S., B.Sc., University of British Columbia, Vancouver,
Canada
Shapiro, M., A.B., University of Texas Health Science Center,
San Antonio
Stanciu, L., Ph.D., Purdue University, West Lafayette, Indiana
Toomey, E., B.S., University of Utah, Salt Lake City
This course was for scientists unfamiliar with techniques of protein isolation and characterization.
It was a rigorous program that included laboratory work all day and a lecture with a discussion ses-
sion every evening. Each student became familiar with each of the major techniques in protein pu-
rification by actually performing four separate isolations including (1) a regulatory protein from
muscle tissue, (2) a sequence-specific DNA-binding protein, (3) a recombinant protein overexpressed
in Escherichia coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, elec-
trophoretic, and chromatographic techniques included precipitation by salts, pH, and ionic poly-
mers; ion-exchange, gel-filtration, hydrophobic-interaction, and reverse-phase chromatography;
lectin affinity, ligand affinity, oligonucleotide affinity, and immunoaffinity chromatography; poly-
acrylamide gel electrophoresis and electroblotting; and high-performance liquid chromatography.
Procedures were presented for solubilizing proteins from inclusion bodies and refolding them into
active monomeric forms. Methods of protein characterization were utilized to include immunolog-
ical and biochemical assays, peptide mapping, amino acid analysis, protein sequencing, and mass
spectrometry. Emphasis was placed on strategies of protein purification and characterization. Guest
lecturers discussed protein structure, modification of proteins, methodologies for protein purification
and characterization, and applications of protein biochemistry to cell and molecular biology.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
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SEMINARS
Adelman, K., NIEHS/Research Triangle Park, North Carolina:
Stress-responsive genes are poised for activation.
Burgess, R., University of Wisconsin, Madison: Welcome and
introduction to course. Introduction to protein purification.
RNA polymerase–σ factor interactions and use of LRET-
based assays for drug discovery and biochemistry.
Chumanov, R., University of Wisconsin, Madison: Halo-Tag
and CARM1 purification.
Courey, A., University of California, Los Angeles: System-wide
analyses of Groucho and SUMO in Drosophila development.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Why do prostate cancer cells go to the bone?
Marr, M., Brandeis University, Waltham, Massachusetts:
Controlling gene expression in response to extracellular
signals.
Nechaev, S., NIEHS/Research Triangle Park, North Carolina:
Promoting proximal RNA Polymerase II Stalling Genome-
wide.
Thompson, N., University of Wisconsin, Madison:
Immunoaffinity chromatography.
Cell and Developmental Biology of Xenopus
April 17–28
INSTRUCTORS R. Keller, University of Virginia, Charlottesville
K. Kroll, Washington University School of Medicine, St. Louis, Missouri
ASSISTANTS C. Flournoy, University of Virginia, Charlottesville
S. Louie, University of Virginia, Charlottesville
P. Skoglund, University of Virginia, Charlottesville
Xenopus is the leading vertebrate model for the study of gene function in development. The combi-
nation of lineage analysis, gene-knockout strategies, experimental manipulation of the embryo, and
genomic/bioinformatic techniques made it ideal for studies on the molecular control of embryo
patterning, morphogenesis, and organogenesis. This course combined intensive laboratory training
with daily lectures from recognized experts in the field. Students learned both emerging technologies
and classical techniques to study gene function in Xenopus development. An important element was
the informal interaction between students and course faculty.
This course was supported with funds provided by the National Institute of Child Health and
Human Development, the National Science Foundation, and the Howard Hughes Medical Institute.
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SEMINARS
Amaya, E., University of Manchester, United Kingdom: Post-
gastrula organogenesis.
Grainger, R., University of Virginia, Charlottesville: Genomic
approaches for enhancer identification in Xenopus.
Harland, R., University of California, Berkeley: Biology of the
organizer.
Hill, C., Cancer Research UK/London Research Institute,
London, United Kingdom: TGF-β superfamily signaling in
early Xenopus development.
Houston, D., University of Iowa, Iowa City: Roles of localized
maternal mRNAs in Xenopus axis formation.
Keller, R., University of Virginia, Charlottesville:
Morphogenesis.
Khokha, M., Yale University, New Haven, Connecticut:
Introduction to Xenopus tropicalis.
Kroll, K., Washington University School of Medicine, St.
Louis, Missouri, and Keller, R., University of Virginia,
Charlottesville: Introduction to Xenopus.
Zimmerman, L., National Institute for Medical Research,
London, United Kingdom: Genetics approaches in Xenopus
tropicalis.
Zorn, A., Children’s Hospital Medical Center, Cincinnati,
Ohio: Mesendoderm and gut development.
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PARTICIPANTS
Belgacem, Y., Ph.D., University of California, Davis
Danilchik, M., Oregon Health & Science University, Portland
Dolde, C., Dipl., German Cancer Research Center,
Heidelberg, Germany
Gentsch, G., M.A., University of Cambridge, United Kingdom
Hager, H., B.S., Vanderbilt University, Nashville, Tennessee
Immani, S., Ph.D., University of California, Davis
Lau, N., Ph.D., Massachusetts General Hospital, Boston
Møbjorg, N., Ph.D., University of Copenhagen, Denmark
Morales Diaz, H., B.S., Dana Farber Cancer Institute, Boston,
Massachusetts
Nicetto, D., B.S., Ludwig-Maximilian Universitat, Munchen,
Germany
Park, P., Ph.D., Case Western Reserve University, Cleveland,
Ohio 
San Miguel-Ruiz, J., B.S., University of Minnesota,
Minneapolis
Singh, A., Ph.D., National Cancer Institute at Frederick,
Frederick, Maryland
Sproul, A., Ph.D., Mount Sinai Medical School, New York
Thelie, A., Ph.D., Institut de Biologie et de Medecine
Moleculaire, Charleroi, Germany
Watson, F., Ph.D., Washington & Lee University, Lexington,
Virginia
Molecular Neurology and Neuropathology
June 3–9
INSTRUCTORS M. Cookson, National Institute on Aging/NIH, Bethesda, Maryland
B. Davidson, University of Iowa, Des Moines
H. Orr, University of Minnesota, Minneapolis
This intensive 1-week discussion course offered successful applicants a unique opportunity to learn
the latest concepts and methodologies associated with the study of human neurological disorders
such as Alzheimer’s, Parkinson’s, and epilepsy. Participants discussed in detail the strengths and
weaknesses of the accumulated experimental evidence underlying our current understanding of these
diseases. Fundamental questions, such as how and why particular neurons die in certain disorders,
were discussed in the context of identifying the best experimental approaches to finding answers,
whether through the use of transgenic and/or lesion-induced mouse models, functional brain and/or
cellular imaging, gain/loss-of-function molecular and viral approaches, cellular transplantation, or
a combination of these approaches. The course examined why many of these disorders share appar-
ently common features—protein aggregation, specific vulnerability of certain classes of neuron, long
incubation period—and discussed to what extent these features reflect common pathological mech-
anisms. Extended seminars and discussion by a wide range of leading investigators further illumi-
nated developments in this rapidly moving field. Participation in the course provided an essential
conceptual and methodological framework for anyone intending to pursue rigorous research.
This course was supported with funds provided by the Howard Hughes Medical Institute.
292
SEMINARS
Cookson, M., National Institute on Aging/NIH, Bethesda,
Maryland: Parkinson’s disease.
Davidson, B., University of Iowa, Des Moines: Polyglutamine
and RNA.
Duff, K., Columbia University, New York: Models of
Alzheimer’s disease.
Han, M.H., Stanford University, Stanford, California:
Multiple sclerosis.
Heikenwaelder, M., Institute for Neuropathology, Zurich,
Switzerland: The molecular biology of prion diseases.
Iadecola, C., Cornell University, Ithaca, New York: 
Stroke.
McNamara, J., Duke University, Durham, North Carolina:
Neurotrophins and epileptogenesis.
Morris, H., Cardiff University, Cardiff, United Kingdom:
Neurological aspects.
Nelson, D., Baylor University, Houston, Texas: Fragile
X/FTAS.
Orr, H., University of Minnesota, Minneapolis: Triplet repeat
disorders.
Rademakers, R., Mayo Clinic College of Medicine,
Jacksonville, Florida: Frontotemporal and other dementias.
Wong, P., Johns Hopkins University, Baltimore, Maryland:
ALS.
Wynshaw-Boris, A., University of California, San Diego:
Disorders of neuronal migration.
Vonsattel, J.P., Columbia University, New York:
Neuropathology.
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PARTICIPANTS
Anaya, F., B.S., University College, London Institute of
Neurology, United Kingdom
Bjorkblom, B., Ph.D., Stavanger University Hospital,
Stavanger, Norway
Coombs, K., B.S., Arizona State University, Tempe
Gideons, E., B.S., National Institutes of Health, Bethesda,
Maryland
Gray, S., Ph.D., University of North Carolina, Chapel Hill
Griffiths, L., B.S., University of Edinburgh, Edinburgh,
United Kingdom
Hagan, C., Ph.D., University of Washington, Seattle
Hart, M., B.S., University of Pennsylvania, Philadelphia
Hemsley, K., Ph.D., Women’s and Children’s Hospital, South
Adelaide, Australia
Krako, N., B.S., Scuola Normale Superiore, Pisa, Italy
McKee, M.A., M.D., Henry Ford Hospital, Ann Arbor,
Michigan
Morales-Villagran, A., Ph.D., University of Guadalajara,
Jalisco, Mexico
Pancrazi, L., Ph.D., Scuola Normale Superiore, Pisa, Italy
Panos, J., B.S., Western Michigan University, Kalamazoo
Plun-Favreau, H., Ph.D., University College, London Institute
of Neurology, United Kingdom
Runko, A., Ph.D., National Institutes of Health, Bethesda,
Maryland
Scali, M., B.S., Scuola Normale Superiore, Pisa, Italy
Thut, C., Ph.D., Merck Research Labs, West Point,
Pennsylvania
White, M., Ph.D., University of Edinburgh, Edinburgh,
United Kingdom
Advanced Bacterial Genetics
June 3–23
INSTRUCTORS J. Kirby, University of Iowa, Iowa City
S. Lovett, Brandeis University, Waltham, Massachusetts
A. Segall, San Diego State University, San Diego, California
ASSISTANTS A. Cendrowski, Brandeis University, Waltham, Massachusetts
M. Coleman, Massachusetts Institute of Technology, Cambridge
I. Naili, San Diego State University, San Diego, California
J. Willett, University of Iowa, Iowa City
This course presented logic and methods used in the genetic dissection of complex biological
processes in diverse bacteria. Laboratory methods included classical mutagenesis using transposons,
mutator strains, and chemical and physical mutagens; detection and quantitation of gene expression
changes using various reporter genes and real-time polymerase chain reaction (PCR); the mapping
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SEMINARS
Bernhardt, T., Harvard Medical School, Cambridge,
Massachusetts: Genetic analysis of cell wall biogenesis and
phage mediated bacteriolysis.
Dworkin, J., Columbia University, New York: Identification of
a novel signaling pathway that responds to muropeptides.
Gital, Z., Princeton University, Princeton, New Jersey: Novel
cytoskeletons and cytoskeletal regulators in Caulobacter
crescentus.
Goulian, M., University of Pennsylvania, Philadelphia:
Deciphering bacterial cell signaling circuits.
Gross, C., University of California, San Francisco: Envelope
stress and synthetic biology.
Hughes, K., University of Utah, Salt Lake City: Flagellar
synthesis.
Maloy, S., San Diego State University, San Diego, Calfornia:
From chromosome rearrangements to vaccines.
Pogliano, K., University of California, San Diego, La Jolla: 
The mechanism of sporulation in Bacillus subtilis.
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of mutations using genetic and physical techniques; modern approaches to the generation and analy-
sis of targeted gene disruptions and fusions using PCR and cloning methods; epitope insertion mu-
tagenesis; site-directed mutagenesis; and fluorescence microscopy. Key components of the course
were sophisticated genetic methods in the analysis of model bacteria (including Escherichia coli, Sal-
monella, Bacillus subtilis, and Myxococcus xanthus) and the use of a wealth of new genomic sequence
information to motivate these methods. 
Invited lecturers presented various genetic approaches to study bacterial mechanisms of metab-
olism, development, and pathogenesis. 
The course admits 16 students, both foreign and U.S. residents, from diverse backgrounds and
career levels for intensive (but fun) instruction in microbial genetics. 
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Alexander, R., Ph.D., Yale University, New Haven,
Connecticut
Atwal, M., Ph.D., Cold Spring Harbor Laboratory
Blackburn, M., B.S., Massachusetts Institute of Technology,
Cambridge
Cha, J., Ph.D., New York University Medical Center, New
York
Cimini, D., Ph.D., Second University of Naples, Naples, Italy
Gallego, A., B.S., Instituto de Biotecnologia, Cuernavaca,
Mexico
Guida, B., B.S., Arizona State University, Tempe
Hargreaves, K., B.Sc., University of Leicester, United
Kingdom
Hatahet, F., B.Sc., University of Oulu, Finland
Hove-Andersen, J., M.S., Technical University Denmark,
Frederiksberg, Denmark
Hunt, D., Ph.D., University of Hawaii, Honolulu
Kannan, S., Ph.D., University of Arkansas for Medical
Science, Little Rock
Neuvonen, J., M.S., University of Turku, Finland
Sermaswan, R., Ph.D., Khon Kaen University, Thailand
Singh, A., M.S., Emory University, Atlanta, Georgia
Teng, S.-W., B.S., Princeton University, Princeton, New Jersey
Ion Channel Physiology
June 3–23
INSTRUCTORS B. Clark, University College London, United Kingdom
M. Farrant, University College London, United Kingdom
N. Golding, The University of Texas, Austin
A. Lee, University of Iowa, Iowa City
M. Nolan, University of Edinburgh, United Kingdom
ASSISTANTS J. Davie, Max-Planck Institute for Medical Research, Heidelberg, Germany
P. Dodson, University of Edinburgh, Edinburgh, United Kingdom
A. Fink, Columbia University, New York
D. Garden, University of Edinburgh, Edinburgh, United Kingdom
J. Gruendermann, University College London, United Kingdom
K. Hansen, Emory University School of Medicine, Atlanta, Georgia
L. Kreiner, Emory University, Atlanta, Georgia
L. Scott, University of Texas, Austin
K. Vervaeke, University College London, United Kingdom
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SEMINARS
Armstrong, C., University of Pennsylvania, Philadelphia: Ion
channels: Design and purpose.
Dudman, J., Janelia Farm Research Campus, Ashburn,
Virginia: HCN channels.
Golding, N., University of Texas, Austin: Dendrites.
Hausser, M., University College London, United Kingdom:
Synaptic integration.
Hille, B., University of Washington, Seattle: Voltage-gated
channels.
Jones, M., University of Wisconsin, Madison: The simplest
possible theory of allostery in the GABAA receptor.
Larsson, P., University of Miami, Miami, Florida: Structure
and function of voltage-gated proton channels.
Lee, A., University of Iowa, Iowa City: Voltage-gated Ca2+
channel signaling complexes.
Mantegazza, M., Instituto Neurologico Besta/Inserm Avenir,
Milan, Italy: Voltage-gated Na+ channels and epilepsy.
Scanziani, M., University of California, San Diego, La Jolla:
Microcircuits.
Schaefer, A., Max-Planck Institut für Medizinische Forschung,
Heidelberg, Germany: From glutamate receptors to behavior.
Sjöström, J., University College London, United Kingdom: A
dendritic switch for synaptic plasticity.
Soltesz, I., University of California, Irvine: Modulatory
mechanisms, cannabinoids.
Traynelis, S., Emory University, Atlanta, Georgia: Control of
NMDA receptor function.
von Gersdorff, H., Oregon Health & Science University,
Portland: Quantal size and multiquantal release at a sensory
synapse.
The primary goal of this course was to investigate, through lectures and laboratory work, the prop-
erties of ion channels that allow neurons to carry out their unique physiological functions in a variety
of neural systems. Areas of particular interest included channels that (1) are activated by neurotrans-
mitter at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites,
(3) respond to neuromodulators with changes in functional properties, and (4) are developmentally
required and regulated. The research interests of guest lecturers reflect these areas of emphasis. The
laboratory component of the course introduced students to electrophysiological approaches for the
study of ion channels in their native environments. Hands-on exercises included patch-clamp record-
ing of ion channel activity in acutely isolated or cultured cells or neurons in brain slice preparations.
Different recording configurations were used (e.g., whole-cell, cell-free, and nucleated patches) to
examine macroscopic or single-channel activity. Similarly, various methods of ligand and drug ap-
plication were demonstrated. The advantages and disadvantages of each method, preparation, and
recording technique were considered in relation to the specific scientific questions being asked. Ad-
missions priority is given to students and postdocs with a demonstrated interest, specific plans, and
a supportive environment to apply these techniques to a defined problem. 
This course was supported by the Howard Hughes Medical Institute.
PARTICIPANTS
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Anthony, T., Ph.D., California Institute of Technology,
Pasadena
Bohlen, C., B.S., University of California, San Francisco
Collins, K., Ph.D., Yale University, New Haven, Connecticut
Gold, M., Ph.D., University of Washington, Seattle
Graves, A., B.A., Northwestern University, Evanston, Illinois
Kawate, T., M.A., Oregon Health & Science University,
Portland
McCarthy, E., Ph.D., Yale School of Medicine, New Haven,
Connecticut 
Petzold, B., M.S., Stanford University, Stanford, California
Rowe, A., Ph.D., University of Texas, Austin
Taves, S., B.S., University of North Carolina, Chapel Hill
Vandenberg, A., B.S., University of California, San Francisco
Vecchia, D., M.S., University of Padova, Italy
Molecular Embryology of the Mouse
June 3–23
INSTRUCTORS K. Hadjantonakis, Sloan-Kettering Institute, New York
J. Rivera, University of Massachusetts Medical School, Worcester
L. Pevny, University of North Carolina, Chapel Hill
ASSISTANTS G. Kwon, Sloan-Kettering Institute, New York
A. Piliszek, Sloan-Kettering Institute, New York
L. Williams, University of North Carolina Medical School, Chapel Hill
R. Williams, University of North Carolina, Chapel Hill
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse development. Lectures provided the conceptual basis for contemporary
research in mouse embryogenesis and organogenesis, whereas laboratory practicals provided extensive
hands-on introduction to mouse embryo analysis. Experimental techniques included in vitro culture
and manipulation of preimplantation and postimplantation embryos, embryo transfer, culture and
genetic manipulation of embryonic stem cells, production of chimeras by embryo aggregation and by
embryonic stem (ES) cell injection, and transgenesis by pronuclear microinjection. In addition, the
practicals featured increased emphasis on phenotypic analysis of mutants, including techniques of his-
tology, in situ hybridization, immunohistochemistry, skeletal preparation, organ culture, and tissue
recombination. The course also introduced the generation of iPS cells (induced pluripotent cells) and
time-lapse microscopy of early gastrulation embryos and organ cultures (eye, kidney, and gut).
This course was supported with funds provided by the National Cancer Institute.
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SEMINARS
Anderson, K., Sloan-Kettering Institute, New York: Hedgehog
signaling, cilia, and development.
Anton, E., University of North Carolina School of Medicine,
Chapel Hill: Cortical development and radial glial/neural
stem cells.
Behringer, R., University of Texas M.D. Anderson Cancer
Center, Houston: Generation and analysis of transgenic
mice.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Germ cells, genital ridges, and sex differentiation.
Collignon, J., Institut Jacques Monod, Paris, France: TGF-β
signaling in early embryo development.
Conlon, F., University of North Carolina, Chapel Hill: Heart
development.
Costantini, F., Columbia University, College of Physicians &
Surgeons, New York: Kidney organogenesis.
Dickinson, M., Baylor College of Medicine, Houston, Texas:
Imaging cardiovascular function in mouse development and
tissue engineering.
Eglis, M., Columbia University, New York: Nuclear
reprogramming.
Hadjantonakis, K., Sloan-Kettering Institute, New York:
Imaging cell behavior in early mouse embryos.
Hogan, B., Duke University Medical Center, Durham, North
Carolina: Lung organogenesis.
Huppert, S., Vanderbilt University, Nashville, Tennessee: 
Liver organogenesis and regulation of three-dimensional
intrahepatic bile duct formation/maintenance.
Johnson, R., M.D. Anderson Cancer Center, Houston, Texas:
Limb development.
Joyner, A., Memorial Sloan-Kettering Cancer Center, New
York: Patterning and cell fate mapping of the nervous
system.
Justice, M., Baylor College of Medicine, Houston, Texas:
Mouse ENU mutagenesis: From genomics to genetic
modifiers of disease.
Kenney, A., Memorial Sloan-Kettering Cancer Center, New
York: Hedgehog signaling in cerebellar development and
meduloblastomas.
Lovell-Badge, R., MRC National Institute for Medical
Research, London, United Kingdom: Sry, sex determination,
and sox genes.
Magnuson, T., University of North Carolina, Chapel Hill:
Epigenetics.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: Molecular genetics of pluripotent cells in the
mouse.
Pevny, L., University of North Carolina, Chapel Hill:
Retinogenesis.
Rivera, J., University of Massachusetts Medical School,
Worcester: Lineage analysis and early postimplantation.
Rossant, J., The Hospital for Sick Children, Toronto, Canada:
Chimeras, ES cell lineages.
Shen, M., Columbia University Medical Center, New York:
Prostate development.
Solter, D., Institute of Medical Biology, Singapore:
Preimplantation development.
Soriano, P., Mount Sinai School of Medicine, New York: Gene
traps and PDGF/EPH/ephrin signaling.
Stewart, C., National Cancer Institute, Frederick, Maryland:
ES cells, mouse strains.
Takahashi, J., HHMI/Northwestern University, Evanston,
Illinois: Circadian rhythms.
Tam, P., Children’s Medical Research Institute, Sydney,
Australia: Gastrulation.
Threadgill D., University of North Carolina, Chapel Hill:
Welcome, introductions, and overview. One hundred years
of the mouse in research.
Trainor, P., Stowers Institute for Medical Research, Kansas
City, Missouri: Craniofacial development disease and
evolution.
PARTICIPANTS
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Bledau, A., M.S., Center for Regenerative Therapies, Dresden,
Germany
Burda, J., B.S., Mayo Clinic, Rochester, Minnesota
Cerda-Esteban, N., Dipl., Max-Delbruck Center for
Molecular Medicine, Berlin, Germany
Demidov, O., Ph.D., Institute of Molecular & Cell Biology,
Singapore
Deuve, L.-J., Ph.D., Institut Pasteur, Paris, France
Domigan, C., B.S., University of California, Los Angeles
Dorr, K., B.S., University of North Carolina, Chapel Hill
Heronymus, T., B.A., Northeastern Ohio University College 
of Medicine, Rootstown
Hong, S.-J., Ph.D., Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts
Oddsson, A., M.S., Karolinska Institutet, Stockholm, Sweden
Rak-Raszewska, A., M.Sc., University of Liverpool, United
Kingdom
Sanchez Manuel, M., B.S., University of Salamanca, Spain
Schmerr, M., Ph.D., Cleveland Clinic, Cleveland, Ohio
Szypowska, A., M.Sc., Universitair Medisch Centrum Utrecht,
The Netherlands
Integrative Statistical Analysis of Genome-scale Data
June 8–23
INSTRUCTORS H. Bussemaker, Columbia University, New York
V. Carey, Harvard University, Boston, Massachusetts
C. Leslie, Memorial Sloan-Kettering Cancer Center, New York
M. Reimers, Virginia Commonwealth University, Richmond
ASSISTANTS M. Fazalollahi, Columbia University, New York
M. Figueroa, Cornell University, Ithaca, New York
E. Lee, Columbia University, New York
P. Palta, University of Tartu, Estonia
T. Riley, Rutgers University, Piscataway, New Jersey
M. Waisberg, National Institutes of Health/NIAID, Bethesda, Maryland
The availability of a variety of genome-scale data sets, and the need to integrate such data sets, is a
central feature of modern biological research. Experimental and computational biologists seeking
to make sense of such data sets need to have a firm grasp of the relevant statistical and analytical
methodology. This course was designed to build competence in quantitative methods for the analysis
of high-throughput molecular biology data. Topics included are listed on the following page.
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•   Introduction to R and Bioconductor
•   Review of multivariate statistics (multiple testing, regression, machine learning)
•   Survey of key high-throughput technologies (both microarray and sequencing based)
•   Low-level microarray data analysis (quality control, normalization) 
•   Analysis based on predefined gene sets (e.g., Gene Ontology)
•   Classification and prognosis of cancer samples by machine learning 
•   cis-regulatory sequence analysis (motif finding, weight matrices)
•   Modeling of transcriptional networks through integration of mRNA expression, ChIP, and se-
quence data
•   Integration of genotype (SNP) data and expression data
•   Integration of epigenetic (DNA methylation) data and expression data
Detailed lectures and presentations by guest speakers in the morning and evening were combined
with hands-on computer tutorials in the afternoon, in which the methods covered in the lectures
were applied to actual high-throughput data for yeast and human. Students were assumed to have
a basic familiarity with the R programming language at the start of the course.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Benito, E., B.S., Institute for Neurosciences in Alicante, Spain,
San Juan de Alicante, Spain
Biddie, S., B.Sc., National Institutes of Health, Bethesda,
Maryland
Buchanan, G., Ph.D., University of Adelaide, Australia
Chao, M., B.A., Stanford University School of Medicine, Palo
Alto, California
Chen, D., Ph.D., University of Vienna, Austria
Cui, Y., B.S., University of Kansas Medical Center, Kansas
City
Della Gatta, G., Ph.D., Columbia University, New York
Duan, Q., Ph.D., Brigham & Women’s Hospital, Boston,
Massachusetts
Eveland, A., Ph.D., Cold Spring Harbor Laboratory
Fazzio, T., Ph.D., University of California, San Francisco
Greiner, D., M.D., Baylor College of Medicine, Houston,
Texas
Gupta, A., M.S., University of Maryland/NIH, Bethesda
Imam, F., Ph.D., Harvard University, Cambridge,
Massachusetts
Jima, D., M.S., Duke University Medical Center, Durham,
North Carolina
Khankhanian, P., B.A., University of California, San Francisco
Lenstra, T., M.Sc., University Medical Center, Utrecht, The
Netherlands
Leshkowitz, D., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Lidschreiber, M., M.Sc., Munich University, Germany
Liu, X., M.S., University of Maryland Institute for Genome
Science, Baltimore
Mukherjee, S., M.S., Gerstner Sloan-Kettering Graduate
School, New York
Roessler, S., Ph.D., National Cancer Institute/NIH, Bethesda,
Maryland
Tagne, J.-B., Ph.D., Boston University School of Medicine,
Boston, Massachusetts
Tang, W., Ph.D., National Cancer Institute, Bethesda,
Maryland
Wu, X., M.D., Ohio State University, Columbus
Yang, M., B.S., National Institutes of Health/NHGRI,
Rockville, Maryland
Zamudio, J., B.S., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Bekiranov, S., University of Virginia, Charlottesville: Intro to
oligo arrays and second-generation sequencing technology.
Physics of hybridization.
Bulyk, M., Brigham & Womens Hospital and Harvard
Medical School, Boston, Massachusetts: Protein binding
microarrays I. Protein binding microarrays II.
Bussemaker, H., Columbia University, New York: Gene-set-
based analysis. Representations of protein–DNA-binding
specificity. Methods for de novo motif discovery. Linear
models of transcriptional regulation I. Linear models of
transcriptional regulation II. Overview of methods for
predicting expression from sequence.
Carey, V., Harvard University, Boston, Massachusetts:
Bioconductor/R for analysis of genome-scale data.
Culhane, A., Dana Farber Cancer Institute, Harvard,
Cambridge, Massachusetts: Ordination.
Darnell, R., HHMI/The Rockefeller University, New York:
Mapping protein–RNA interactions using HT sequencing II.
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Futcher, B., Stony Brook University, Stony Brook, New York:
Lessons from early microarray studies.
Irizarry, R., Johns Hopkins Bloomberg School of Public
Health, Baltimore, Maryland: Affymetrix preprocessing:
RMA, GCRMA, fRMA. Contemporary microarray
applications: Genotyping, copy-number estimation
(emphasis on batch effects), and whole-genome DNA.
Methylation measurements. Sequencing base calling and
quality assessment.
Kliebenstein, D., University of California, Davis: Quantitative
genetics I. Quantitative genetics II.
Leslie, C., Memorial Sloan-Kettering Cancer Center, New
York: Regulation by microRNAs. Intro to machine learning.
Cancer classification.
Liu, S., Dana Farber Cancer Institute, Harvard University,
Boston, Massachusetts: Analyzing ChIP-chip data. Analyzing
ChIP-Seq data/epigenetics.
Lucito, R., Cold Spring Harbor Laboratory: Epigenetics and
cancer.
Reimers, M., Virginia Commonwealth University, Richmond:
Array CGH and ChIP-chip methods.
Zhang, M., Cold Spring Harbor Laboratory: Epigenetics.
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Workshop on Autism Spectrum Disorders
June 19–26
INSTRUCTORS D. Geschwind, University of California, Los Angeles
P. Levitt, Vanderbilt University, Nashville, Tennessee
S. Spence, National Institute of Mental Health, Bethesda, Maryland
ASSISTANT B. Bill, University of California, Los Angeles
Autism spectrum disorders (ASDs) are developmental disorders with complex phenotypes defined by
a triad of symptoms that include disrupted social abilities, verbal and nonverbal communication skills,
and restricted interests with repetitive behaviors. Co-occurring neurological and medical conditions
are not unusual in these disorders. The underlying etiology remains a mystery, but ASDs are the most
highly heritable of neuropsychiatric disorders. This Workshop examined dimensions of ASD on var-
ious levels, including sessions on characteristics of the clinical syndrome; the neuropathology, imaging,
and cognitive neuroscience studies that implicate circuits and systems involved in ASD; the current
state of findings from human genetics; concepts regarding the developmental neurobiological basis of
ASD; the use of experimental models; and current etiological theories and hypotheses of ASD.
In addition to hearing about the most recent research in these areas, we explored and debated
controversial topics and challenges to basic assumptions in the field. An exceptional faculty with
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Ben Shalom, D., Ph.D., Ben-Gurion University, Be-er-Sheva,
Israel
Ciaramitaro, V., Ph.D., University of California, San Diego/
The Salk Institute for Biological Studies, La Jolla, California
D’Cruz, A.-M., B.S., University of Illinois, Chicago
Esposito, G., Ph.D., University of Trento, Rovereto TN, Italy
Florentini, C., B.S., University of Geneva, Geneva,
Switzerland
Harony, H., Ph.D., University of Haifa, Haifa, Israel
Jacob, S., M.D., University of Illinois, Chicago
Johnston, P., B.S., Institute of Psychiatry, King’s College
London, United Kingdom
Kilpinen, H., B.S., Institute for Molecular Medicine, Helsinki,
Finland
Lopatina, O., Ph.D., Kanazawa University Graduate School of
Medicine, Kanazawa, Ishikawa, Japan
Lowe, J.K., Ph.D., University of California, Los Angeles
Millman, F., B.S., Curtin University of Technology, Perth,
diverse interests brought the most up-to-date results and theories to the students, making this Work-
shop a valuable resource for young researchers starting out in this fast-moving and expansive field.
Not only did it help them build the foundation for their future research, it introduced them to
many potential collaborators from different disciplines working to understand ASD. 
This course was supported with funds provided by Autism Speaks, the Nancy Lurie Marks Family
Foundation, and the Simons Foundation.
PARTICIPANTS
Australia
Oberman, L., Ph.D., Beth Israel Deaconess Medical Center,
Boston, Massachusetts
Percaccio, C.R., Ph.D., University of Washington, Seattle
Philip, R., Ph.D., University of Edinburgh, Lothian, United
Kingdom
Rudie, J., B.S., University of California/David Geffen School
of Medicine, Los Angeles
Santos, R., B.S., University of California, Irvine
Stanfield, A., Ph.D., University of Edinburgh, Edinburgh,
Midlothian, United Kingdom 
Strathearn, L., M.D., Baylor College of Medicine, Houston,
Texas
Wilson, E., B.S., Macquarie University, Sydney, Australia
Zaki, J., B.S., Columbia University, New York
Zinkstock, J., M.D., Institute of Psychiatry, King’s College
London, United Kingdom
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SEMINARS
Biederer, T., Yale University, New Haven, Connecticut:
Synaptic differentiation and autism spectrum disorders.
Fombonne, E., McGill University, Montreal, Canada:
Epidemiology of ASD.
Geschwind, D., University of California, Los Angeles/Matt
State/Yale University: Introduction to human genetics.
Genetic findings in ASD: Common variants, rare mutations.
Geschwind, D., University of California, Los Angeles/Matt
State/Yale University and Bill, B., University of California,
Los Angeles: Genomic tools exercises: Bioformalities,
database access, data gathering, and uses.
Hensch, T., Riken Institute, Japan: Critical periods/plasticity
mechanisms.
Kasari, C., University of California, Los Angeles: Treatments
overview.
Levitt, P., Vanderbilt University, Nashville, Tennessee:
Neuroanatomical systems implicated in ASD and
neuropathology. Introduction to developmental
neurobiology. Neurodevelopmental process in ASD.
Martinez, F., University of Arizona, Tucson: Environmental
contributions: Asthma as a model.
Minshew, N., University of Pittsburgh, Pennsylvania: Adults
with autism.
Murphy, D., Institute of Psychiatry, Kings College: Neuro-
imaging findings in ASD.
Nelson, C., Harvard University, Boston, Massachusetts:
Introduction to imaging and ERP. Neurocognition and face
processing mechanisms.
Pardo-Villamizar, C., Johns Hopkins University School of
Medicine, Baltimore, Maryland: Neuroimmunology.
Paylor R., Baylor College of Medicine, Houston, Texas:
Mammalian animal models.
Rapin, I., Albert Einstein School of Medicine, Bronx, New
York: History of ASD.
Rogers, J., Baylor College of Medicine, Houston, Texas:
Evolutionary perspectives.
Sebat, J., Cold Spring Harbor Laboratory: Chromosomal
abnormalities/syndromes.
Spence, S., National Institute for Mental Health, Bethesda,
Maryland: Clinical assessments (clinical videos, student
exercises: ADI-R, ADOS, SRS). Medical models/comorbi-
dities. Endophenotypes-language delay, epilepsy/regression,
OFC.
Szyf, M., McGill University, Montreal, Canada: Epigenetics.
Zwaigenbaum, L., University of Alberta, Edmonton, Canada:
Clinical presentation, core features. ASD measures, broader
phenotypes, phenotypic variability, outcomes.
Special guest: Portia Iversen, author of “Strange Son.”
Computational Cell Biology
June 26–July 16
INSTRUCTORS T. Elston, University of North Carolina, Chapel Hill
C. Fall, University of Illinois, Chicago
L. Loew, University of Connecticut Health Center, Farmington
G. Smith, College of William & Mary, Williamsburg, Virginia
J. Tyson, Virginia Polytechnic Institute, Blacksburg
Computational cell biology is the field of study that applies the mathematics of dynamical systems
together with computer simulation techniques to the study of cellular processes. The field encompasses
several topics that have been studied long enough to be well established in their own right, such as
calcium signaling, molecular motors and cell motility, the cell cycle, and gene expression during de-
velopment. In addition to providing a recognizable larger community for topics such as these, this
course provided a base for the development of newer areas of inquiry, for example, the dynamics of
intracellular second-messenger signaling, of programmed cell death, of mitotic chromosome move-
ments, and of synthetic gene networks. Unlike computational genomics or bioinformatics, compu-
tational cell biology focuses on simulation of the molecular machinery (genes-proteins-metabolites)
that underlie the physiological behavior (input-output characteristics) of living cells.
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Barik, D., Ph.D., Virginia Polytechnic Institute and State
University, Blacksburg 
Borinskaya, S., B.S., University of Connecticut Health Center,
Farmington
Braga, J., Ph.D., Instituto de Medicina, Lisboa, Portugal
Brown, S.-A., M.A./B.A., University of Connecticut Health
Center, Farmington 
D’Ausillo, C., B.S., Dartmouth College, Hanover, New
Hampshire
Fai, T., B.S., New York University, New York
Fant, A., B.S., University of North Carolina, Chapel Hill
Fertig, E., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Frick, P., B.S., Vanderbilt University, Nashville, Tennessee
Gomez-Cabrero, D., Ph.D., Clinical Gene Networks AB,
Stockholm, Sweden
Gottstein, W., M.S., Institute for Theoretical Biology, Berlin,
Germany
Huang, W., B.S., The Huck Institutes of Life Sciences,
This 3-week course incorporated a series of lectures on the mathematics of dynamical systems,
computational simulation techniques, cell biology, and molecular biology. Practicing theoreticians
and experimentalists rotated for 1–3-day visits during the course to give lectures and interact with
the students. Midway through the course, students selected an area for independent study, and the
focus of the last week of the course was largely on these projects, supplemented by continued visiting
lecturers.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
University Park, Pennsylvania
Hunziker, A., M.S., Niels Bohr Institute, Copenhagen,
Denmark
Kang, Q., B.E., Indiana University, Bloomington
LaMar, M., Ph.D., The College of William & Mary,
Williamsburg, Virginia 
McDougal, R., B.S., The Ohio State University, Columbus
Mifsud, W., M.D., University of Cambridge, United Kingdom
Ogasawara, H., Ph.D., ATR, Kyoto, Japan
Pang, T.Y., B.S., SUNY, Stony Brook, New York
Petznick, G., M.Sc., University of Applied Sciences Wildau,
Germany 
Purcell, O., M.Sc., University of Bristol, United Kingdom
Razinkov, I., B.S., University of California, San Diego
Siegal-Gaskins, D., Ph.D., Ohio State University, Columbus
Soneral, P., Ph.D., Bethel University, St. Paul, Minnesota
Williams, C., Ph.D., North Carolina State University, Raleigh
Wuttke, A., B.S., Uppsala University, Sweden
Xu, B., B.S., Princeton University, Princeton, New Jersey
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SEMINARS
Bhalla, U., National Center for Biological Sciences, Bangalore,
India: Research results: Neuronal signaling–Electricity meets
chemistry. Research results: Switches and memory.
Blackwell, A., George Mason University Krasnow Institute,
Fairfax, Virginia: Background and concepts: Signaling
pathways in synaptic plasticity and learning. Research results:
The role of the basal ganglia in learning.
Civelekoglu-Scholey, G., University of California, Davis:
Background and concepts: Modeling mitosis–How dynamic
microtubules and mitotic motors cooperate to segregate the
genome. Research results: Modeling mitosis–How dynamic
microtubules and mitotic motors cooperate to segregate the
genome.
Cytrynbaum, E., University of British Columbia, Vancouver,
Canada: Didactic series–Stochastic models of polymers.
Didactic series–Stochastic models of molecular motors.
Background and concepts–Deterministic and stochastic
models of polymer dynamics in bacterial cell division.
Research results–Deterministic and stochastic models of
polymer dynamics in bacterial cell division.
Dupont, G., Universite Libre de Bruxelles, Brussels, Belgium:
Background and concepts: Minimal model for Ca2+.
Research results: Modeling calcium signaling. 
Elston, T., University of North Carolina, Chapel Hill:
Background and concepts: Modeling simple gene networks.
Research results: Modeling signal transduction in yeast.
Ermentrout, G.B., University of Pittsburgh, Pennsylvania:
Didactic series–I, Planar systems of differential equations.
Didactic series–II, Simple biophysical models for excitability.
Introduction to dynamical systems using XPP.
Fall, C., University of Illinois, Chicago: Didactic series: Scope
of cellular dynamics. 
Hasty, J., University of California, San Diego, La Jolla:
Background and concepts: Engineered gene networks–
Variability and oscillations. Research results: Engineered
gene networks–Variability and oscillations.
Haugh, J., North Carolina State University, Raleigh:
Background and concepts: Quantitative cell
biology–Integrating experiments and modeling. Research
results: Analysis of intracellular signaling driven by cell
population and live cell microscopy data. 
Hucka, M., California Institute of Technology, Pasadena:
SBML, BioModels database, and related resources. 
Iyengar, R., Mt. Sinai School of Medicine, New York:
Network analysis: Getting the big picture. Integrating
network analyses and differential equation-based models.
Keener, J., University of Utah, Salt Lake City: Cardiac cells
and excitability. Cardiac arrhythmias: Excitability in spatially
extended systems. 
Lahav, G., Harvard Medical School, Boston, Massachusetts:
Background and concepts: The DNA-damage signaling
network. Research results: Studying p53’s dynamics in single
cells.
Lechleiter, J., University of Texas Health Sciences Center, San
Antonio: Background and concepts: Biology of calcium
signaling. Research results: Biology of calcium signaling.
Loew, L., University of Connecticut Health Center,
Farmington: Background and concepts: Dendritic nucleation
model. Research results: Dendritic nucleation model.
Mendes, P., University of Manchester School of Computer
Science, Manchester, United Kingdom: Parameter estimation
using COPAS1.
Moraru, I., University of Connecticut Health Center,
Farmington: Overview of virtual cell and the concept of cell
physiology.
Peskin, C., New York University, New York: Computation of
blood flow in the heart by the immersed boundary method.
Generalizations of the immersed boundary method for
cardiac electrophysiology, the dynamics of bent twisted
filaments in fluid, and fluid–structure interaction with
Brownian motion.
Phair, R., Integrative Bioinformatics, Los Altos, California: A
revisionist model of protein and lipid traffic in the Golgi
apparatus. A scientific consultant’s idealistic but passionate
view of CCB.
Pomerening, J., Indiana University, Bloomington: Didactic
series–Molecular and physiological principles of cell cycle
regulation. Research results: Cell cycle control systems–
Bistability and oscillations in the Xenopus early embryo.
Didactic series–Positive feedback as a recurring theme in
signaling systems. Didactic series–Fusing computational and
experimental approaches to uncover systems-level signaling
behaviors.
Schaff, J., University of Connecticut Health Center,
Farmington: Spatial modeling using virtual cell.
Sherman, A., National Institutes of Health/NIDDK, Bethesda,
Maryland: ER vs. plasma membrane drive calcium
oscillations. Metabolically regulated and driven calcium
oscillations.
Slepchenko, B., University of Connecticut Health Center,
Farmington: Compartmental modeling.
Smith, G., The College of William & Mary, Williamsburg,
Virginia: Didactic series–Cellular biophysics and ODEs.
Didactic series–Random walks and diffusion. Didactic
series–Reaction-diffusion and advection. Didactic series–
Markov chain models of ion channels. Didactic series–
Deterministic and stochastic reaction networks. Background
and concepts–Markov chain models and calcium release sites.
Research results–Moment closure for local control of
calcium-induced calcium release in cardiac myocytes.
Terman, D., Ohio State University, Columbus: Didactic
series–Nonlinear dynamics review and new concepts.
Didactic series–Waves in biology. Didactic series–Fast and
slow time scales.
Tyson, J. and Barik, D., Virginia Polytechnic Institute and
State University, Blacksburg: Didactic series–How do cells
compute? Didactic series–Network motifs and functional
modules in macromolecular regulatory systems. Didactic
series–Design principles of biochemical oscillators. Didactic
series–Past, present, and future computational biology.
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Advanced Techniques in Plant Science
June 26–July 16
INSTRUCTORS T. Brutnell, Boyce Thompson Institute, Ithaca, New York
V. Irish, Yale University, New Haven, Connecticut
E. Kellogg, University of Missouri, St. Louis
J. Normanly, University of Massachusetts, Amherst
ASSISTANTS J. Lee, University of Massachusetts, Amherst
M. Pieck, Boston University, Boston, Massachusetts
L. Wang, Cornell University, Ithaca, New York
This course provided an intensive overview of topics in plant physiology, biochemistry, and devel-
opment, focusing on molecular genetic and analytical approaches to understand plant biology. It
emphasized recent results from Arabidopsis, maize, and a variety of other plants and provided an in-
troduction to current methods used in plant molecular biology. It was designed for scientists with
some experience in molecular techniques or plant biology who wish to work with plants using the
latest technologies in genomics, molecular biology, and biochemistry. The course consisted of a vig-
orous lecture series, a hands-on laboratory, and informal discussions. Discussions of important topics
in plant research were presented by the instructors and invited speakers. These seminars included
plant morphology and anatomy; plant development (such as development of flowers, leaves, male
and female gametophytes, and roots); perception of light and photomorphogenesis; cell-wall biosyn-
thesis, function, and perception of hormones; and application of research results to address current
agronomic problems. Lectures describing bioinformatics tools available to the plant community
and the resources provided by plant genome projects were also included. Speakers provided overviews
of their fields, followed by in-depth discussions of their own work. The laboratory sessions provided
an introduction to important techniques currently used in plant research. These included studies of
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Borges, F., Lic., Instituto Gulbenkian de Ciencia, Oeiras,
Portugal
Brondani, C., Ph.D., Brazilian Organization for Agriculture
Research, Madison, Wisconsin
Christiansen, M., M.S., Aarhus University, Slagelse, Denmark
Fiil, B., M.S., University of Copenhagen, Denmark
Goodspeed, D., B.S., Rice University, Houston, Texas
Horner, W., B.S., Syngenta Biotechnology, Inc., Research
Triangle Park, North Carolina
Liu, J., B.S., Rice University, Houston, Texas
Liu, X., B.S., University of Minnesota, St. Paul
Powikrowska, M., Ms.C., University of Copenhagen,
Denmark
Toyokura, K., M.S., National Institute for Basic Biology,
Okazaki, Japan
Van Houtte, H., M.S., VIB K.U. Leuven, Heverlee, Belgium
Wendell, M., M.S., Norwegian University of Life Sciences,
Aas, Norway
Winter, N., B.S., University of Vienna, Austria
Zhang, P., B.S., University of Southern California, Los Angeles
plant development, mutant analysis, histochemical staining, transient gene expression, gene silenc-
ing, applications of fluorescent protein fusions, protein interaction and detection, proteomics ap-
proaches, several different approaches for quantifying metabolites, transient transformation, and
techniques commonly used in genetic and physical mapping. The course also included several short
workshops on important themes in plant research.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
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SEMINARS
Brutnell, T., Boyce Thompson Institute, Ithaca, New York:
Plastids.
Celenza, J., Boston University, Boston, Massachusetts:
Secondary metabolites: Glucosinolates.
Dinesh-Kumar, S., Yale University, New Haven, Connecticut:
Plant pathogen interactions.
Folta, K., University of Florida, Gainesville: Strawberry
genomics.
Grotewold, E., University of Ohio, Columbus: Regulatory
networks.
Harmer, S., University of California, Davis: Circadian
rhythms. 
Harmer, S., University of California, Davis and Kellogg, E.,
University of Missouri, St. Louis: iPlant.
Irish, V., Yale University, New Haven, Connecticut:
Reproductive development.
Jackson, D., Cold Spring Harbor Laboratory: Shoot meristem
development.
Jander, G., Boyce Thompson Institute, Ithaca, New York:
Quantitative genetics.
Kellogg, E., University of Missouri, St. Louis: Phylogenetics.
Kim, H.-J., Dartmouth College, Hanover, New Hampshire:
Transient transformation and analysis using plant
protoplasts.
Kuhlemeier, C., University of Bern, Switzerland: Phyllotaxis.
Maloof, J., University of California, Davis: Light regulation.
Morohashi, K., Ohio State University, Columbus: ChIP and
ChIP-chip approaches to establish plant regulatory motifs.
Normanly, J., University of Massachusetts, Amherst:
Metabolomics.
Nuhse, T., University of Manchester, United Kingdom:
Proteomics.
Paszkowski, U., Universite de Lausanne, Switzerland: Root
development and physiology.
Rose, J., Cornell University, Ithaca, New York: Cell walls.
Schaller, G.E., Dartmouth College, Hanover, New 
Hampshire: Hormone signaling.
Slotnik, K. and Tanurdzic, M., Cold Spring Harbor
Laboratory: Epigenetics.
Sussex, I., Yale University, New Haven, Connecticut:
Introduction to plant structure.
Timmermans, M., Cold Spring Harbor Laboratory:
microRNA regulation.
Vogel, J., Western Regional Research Center, USDA-ARS,
Albany, California: Feedstock development for biofuels.
Wang, X., University of Missouri, St. Louis: Lipid signaling.
Neurobiology of Drosophila
June 26–July 16
INSTRUCTORS R. Allada, Northwestern University, Evanston, Illinois
H. Broihier, Case Western Reserve University, Cleveland, Ohio
D.E. Featherstone, University of Illinois, Chicago
ASSISTANTS K. Chen, University of Illinois, Chicago
B. Chung, Northwestern University, Evanston, Illinois
V. Kilman, Northwestern University, Evanston, Illinois
I. Nechipurenko, Case Western Reserve University, Cleveland, Ohio
C. Miller, Case Western Reserve University, Cleveland, Ohio
This laboratory/lecture course was intended for researchers at all levels from beginning graduate
students through established primary investigators who want to use Drosophila as an experimental
system for nervous system investigation. The 3-week course was divided into the study of develop-
ment, physiology/function, and behavior. Daily seminars introduced students to a variety of research
topics and developed those topics by including recent experimental contributions and outstanding
questions in the field. Guest lecturers brought original preparations for viewing and discussion and
directed laboratory exercises and experiments in their area of interest. The course provided students
with hands-on experience using a variety of experimental preparations that are used in the investi-
gation of current neurobiological questions. The lectures and laboratories focused on both the de-
velopment of the nervous system and its role in controlling larval and adult behaviors. In addition
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Cho, R., Ph.D., Massachusetts Institute of Technology,
Cambridge
Dean, T., M.S., University of Pennsylvania/School of
Medicine, Philadelphia
Gomez-Marin, A., Ph.D., Centre for Genomic Regulation,
Barcelona, Spain
Johnson, O., B.S., Louisiana State University Health Sciences
Center, New Orleans
Kozhevnikova, E., M.S., Erasmus Medical Center, Rotterdam,
Germany
Linford, N., Ph.D., Baylor College of Medicine, Houston,
Texas
McLear, J., Ph.D., Utica College, Utica, New York
Samuel, A., Ph.D., Harvard University, Cambridge,
Massachusetts
Shirangi, T., Ph.D., HHMI/University of Wisconsin,
Madison
Xiong, X., B.S., University of Michigan, Ann Arbor
Yi, C., A.B., Harvard Medical School, Boston, Massachusetts
Yuva, A.Y., B.S., University of Muenster, Germany
to an exposure to the molecular genetic approaches available in Drosophila, students learned a variety
of techniques including embryo in situ hybridization, labeling of identified neurons, electrophysi-
ology (intracellular recording and voltage clamping), optical imaging of neuronal and cellular ac-
tivity, and the analysis of larval and adult behavior. Collectively, the course provided a comprehensive
and practical introduction to modern experimental methods for studying the Drosophila nervous
system. 
This course was supported with funds provided by the National Institute of Mental Health, the
National Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
Neurobiology of Drosophila 311
SEMINARS
Allada, R., Northwestern University, Evanston, Illinois:
Circadian rhythms and sleep.
Benton, R., University of Lausanne, Switzerland: Olfaction.
Broihier, H., Case Western University, Cleveland, Ohio: Fly
genetics 101. Motorneurons.
Ejima, A,, Brandeis University, Waltham, Massachusetts:
Courtship and learning.
Freeman, M., University of Massachusetts, Worcester: Glia.
Bioinformatics/web tools.
Goodwin, S., Glasgow University, Glasgow, United Kingdom:
Courtship and learning. 
Grueber, W., Columbia University, New York: Dendrites.
Jefferis, G., Cambridge University, Cambridge, United
Kingdom: Olfactory development. Mosaic techniques.
Kernan, M., SUNY, Stony Brook, New York:
Mechanotransduction and hearing.
Kravitz, E. and Certel, S., Harvard Medical School, Boston,
Massachusetts: Aggression.
Lee, C.-Y., University of Michigan, Ann Arbor: Neural stem
cells.
Levitan, E., University of Pittsburgh, Pittsburgh, 
Pennsylvania: Imaging.
Lueven, P., VIB and K.U. Leuven, Belgium: Neurotransmitter
release, vesicle cycling, and acute protein inactivation.
Montell, C., Johns Hopkins University, Baltimore, Maryland:
Vision, taste, sensory transduction.
O’Connor-Giles, K., University of Wisconsin, Madison: NMJ
structure and development.
O’Dowd, D., University of California, Irvine: Channels and
membrane properties.
Rothenfluh, A., University of Texas Southwestern, Dallas: Flies
and drugs.
Sigrist, S., European Neuroscience Institute Gottingen,
Germany: Protein tagging, live tracking, and nanoimaging.
Turner, G., Cold Spring Harbor Laboratory: Research talk and
patch demo.
van Swinderen, B., University of Queensland, Australia and
Clandinin, T., Stanford University, Palo Alto, California:
Attention/visual behavior.
Waddell, S., University of Massachusetts, Worcester and
Dubnau, J., Cold Spring Harbor Laboratory: Learning and
memory.
Advanced Techniques in Molecular Neuroscience
June 30–July 16
INSTRUCTORS C. Lai, Indiana University, Bloomington
R. Lansford, California Institute of Technology, Pasadena
B. Stevens, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts
ASSISTANTS T. Bell, University of Pennsylvania, Philadelphia
C. Canaria, California Institute of Technology, Pasadena
C. Challis, Indiana University, Bloomington
S. Gattu, Indiana University, Bloomington
V. Gradinaru, Stanford University, Stanford, California
D. Huss, California Institute of Technology, Pasadena
D. Schafer, Children’s Hospital, Boston, Massachusetts
This newly revised laboratory and lecture course is designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in mo-
lecular neuroscience. The course curriculum was divided into three sections: an extensive and up-
to-date set of laboratory exercises, daily lectures covering the theoretical and practical aspects of the
various methods used in the laboratory, and a series of evening research seminars. The informal and
interactive evening lectures were given by leading molecular neuroscientists and served to illustrate
the ways in which the various experimental approaches have been used to advance specific areas of
neurobiology. In this year’s course, the laboratory portion included topics such as an introduction
to the design and use of animal virus vectors in neurobiology; the use of small interfering RNAs
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Abel, J., Ph.D., University of Virginia Medical School,
Charlottesville
Biedenkapp, J., M.A., Massachusetts Institute of Technology,
Cambridge
Boije, H., Ph.D., Uppsala University, Sweden
Chetty, S., B.A., University of Berkeley, California
Foo, L., B.Sc., Stanford University, Stanford, California
Gulacsi, A., Ph.D., The Rockefeller University, New York
Hinman, M., B.A., Case Western Reserve University,
Cleveland, Ohio
Joseph-de Saram, P., M.Phys., Princeton University, 
Princeton, New Jersey
Leak, R., Ph.D., University of Pittsburgh, Pennsylvania
Leao, R., Ph.D., Karolinska Institute, Stockholm, Sweden
Liang, W., Ph.D., Translational Genomics Research Institute,
Phoenix, Arizona
Mainardi, M., B.S., Scuola Normale Superiore, Pisa, Italy
Phillips, M., B.S., University of Houston, Houston, Texas
Stress, M., M.S., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Weishhana, K., Ph.D., Emory University School of Medicine,
Atlanta, Georgia
Young, C., M.Sc., University of Calgary, Canada
(siRNA) for regulating the expression of specific genes in neurons; practical exercises in gene-delivery
systems including mammalian cell transfection protocols and single-cell electroporation techniques
for targeted gene transfer in vivo; an introduction to overall strategies, use, and design of bacterial
artificial chromosome (BAC) transgenic vectors; multiplex and whole-genome expression analyses
using the most recent DNA microarray technologies (including labeled probe preparation, data
analyses, mining, and interpretation); quantitative real-time reverse transcriptase–polymerase chain
reaction (RT-PCR) analyses from small numbers of cells (RNA purification, PCR optimization, in-
terpretation of results); single-cell PCR and cDNA library construction; methods and application
of RNA amplification (aRNA). Each laboratory module was followed by comprehensive data analy-
ses and interpretation, protocol troubleshooting, and suggestions for ways to improve or modify
the existing technique. Finally, course participants were introduced to bioinformatics and a wide
range of Internet resources available to molecular neuroscientists.
This course was supported with funds provided by the National Institute of Mental Health, the
National Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
SEMINARS
Barres, B., Stanford University School of Medicine, Stanford,
California: Neuron–glial interactions in the CNS.
Darnell, R., The Rockefeller University, New York: Decoding
RNA maps in the brain.
Eberwine, J., University of Pennsylvania Medical School,
Philadelphia: Metastability of the genome–Impact on
neuronal phenotype and dendritic biology.
Fishell, G., New York University Medical School, New York:
Making up your mind: The developmental and genetic
origins of cortical interneurons.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Connectomics.
Lipscombe, D., Brown University, Providence, Rhode Island:
Neuronal calcium channels: Spliced for optimal function.
Lledo, P.-M., Institut Pasteur, Paris, France: Development of
neural stem cells in adult circuits.
McCombie, W., Cold Spring Harbor Laboratory: Introduc-
tion to genomic analysis. 
Reiter, J., University of California, San Francisco: The cell
biology of signaling: Primary cilia interpret Hedgehog cues
in development and disease.
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Structure, Function, and Development of the Visual System
July 1–14
INSTRUCTORS B. Chapman, University of California, Davis
W.M. Usrey, University of California, Davis
ASSISTANT C. Speer, Ph.D., University of California, Davis
This lecture/discussion course explored the functional organization and development of the visual
system as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It
was designed for graduate students and more advanced researchers who wish to gain a basic under-
standing of the biological basis for vision and to share in the excitement of the latest developments
in this field. Topics included phototransduction and neural processing in the retina; functional ar-
chitecture of striate cortex; cellular basis of cortical receptive field properties; the anatomy, physiol-
ogy, and perceptual significance of parallel pathways; functional parcellation of extrastriate cortex;
the role of patterned neuronal activity in the development of central visual pathways; and molecular
mechanisms of development and plasticity in the visual system.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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SEMINARS
Berson, D., Brown University, Providence, Rhode Island:
Retina 1.
Brose, K., Cell Press, Cambridge, Massachusetts: Behind the
scenes of the review process at neuron.
Chapman, B., University of California, Davis: How the visual
system got its stripes.
Chichlilnisky, E.J., The Salk Institute, La Jolla, California:
Ensemble coding of visual information in primate retina.
Dacey, D., University of Washington, Seattle: Parallel visual
pathways and retinal microcircuits.
Feller, M., University of California, Berkeley: The 
mechanisms and function of retinal waves.
Ferster, D., Northwestern University, Evanston, Illinois: 
Striate cortex 2.
Fitzpatrick, D., Duke University, Durham, North Carolina:
The functional architecture of cortical circuits.
Guido, W., Virginia Commonwealth University, Richmond:
Development of the retinogeniculate pathway: Structure,
function, and underlying mechanisms.
Hirsch, J., University of Southern California, Los Angeles:
Comparing thalamus with cortex: Conserved and unique
features of neural circuits that build visual receptive fields.
Horton, J., University of California, San Francisco: Striate
cortex 1.
Kanwisher, N., Massachusetts Institute of Technology,
Cambridge: fMRI investigations of the functional
organization of the ventral visual pathway.
Krauzlis, R., The Salk Institute, San Diego, California:
Coordination of voluntary eye movements.
Moore, T., Stanford University, Stanford, California: Neural
control of visual spatial attention.
Movshon, A., New York University, New York: Visual 
response properties of MT neurons.
Neitz, J., University of Washington, Seattle: Photopigments
and photoreceptors, their evolution, and their role in vision.
Oberdorfer, M., National Institutes of Health, Bethesda,
Maryland: NEI/NIH support for vision research.
Ruthazer, E., McGill University, Montreal, Canada: Visual
system development in fish and frogs.
Shadlen, M., University of Washington, Seattle: A vision of
decision-making.
Sherman, M., University of Chicago, Chicago, Illinois: The
role of thalamus in the flow of information to cortex.
Stone, L., NASA Ames Research Center, Moffett Field,
California: Visual processing for perception and oculomotor
action.
Usrey, M., University of California, Davis: Visual processing 
in the retinogeniculocortical pathway.
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PARTICIPANTS
Ashourvan, A., Ph.D., School of Optometry, Bloomington,
Indiana
Baker, L., B.S., Colorado State University, Fort Collins
Cerri, C., B.S., Scuola Normale Superiore of Pisa, Italy
Day-Brown, J., B.S., University of Louisville, Louisville,
Kentucky
Failor, S., B.S., Center for Neuroscience, University of
California, Davis
Hansen, B., B.S., University of Texas Health Science Center,
Houston
Lee, S.-H., Ph.D., University of California, Berkeley
Manno, I., B.S., Scuola Normale Superiore of Pisa, Italy
Mayo, J.P., B.S., University of Pittsburgh, Pittsburgh,
Pennsylvania
Okazaki, Y., B.S., Graduate School of Frontier Biosciences,
Osaka, Japan
Otero-Millan, J., B.S., Barrow Neurological Institute, Phoenix,
Arizona
Pietrasanta, M., B.S., Scuola Normale Superiore of Pisa, Italy
Ringuette, R., B.S., University of Ottawa, Ottawa, Canada
Triplett, J., Ph.D., University of California, Santa Cruz
Tsirlin, I., B.S., York University, Center for Vision Research,
Toronto, Canada
Wagner-Schuman, M., B.S., Medical College of Wisconsin,
Milwaukee
Whiting, R., B.S., University of Missouri, Columbia
Wright, T., Grad., Hospital for Sick Children, Gothenburg
University, Toronto, Canada
Zeiner, K., B.S., University of St. Andrews, St. Andrews,
United Kingdom
Biology of Memory
July 15–29
INSTRUCTORS C. Alberini, Mount Sinai School of Medicine, New York
K. Martin, University of California, Los Angeles
J. Raymond, Stanford University, Stanford, California
ASSISTANTS H. Carlisle, California Institute of Technology, Pasadena
R. Fromke, University of California, San Francisco
This lecture course provided an introduction to cellular, molecular, and systems approaches to learn-
ing and memory. It was suited for graduate students and postdoctoral fellows in molecular biology,
neurobiology, and psychology as well as research workers who are interested in an introduction to
this field. The course covered topics ranging from behavioral considerations of learning and memory
to gene regulation in the nervous system. The lectures provided an intensive coverage of modern
behavioral studies of learning and memory, the cell and molecular biology of neuronal plasticity,
cellular and molecular mechanisms of simple forms of learning and memory, and systems approaches
to learning in vertebrates and humans. Lectures were complemented by exercises in which students
worked in small groups with lecturers to discuss topical issues in learning and memory, to evaluate
recent studies, and to identify and formulate new research questions and approaches. The course
was thus designed not only to introduce students to the field of learning and memory, but also to
provide an intellectual framework upon which future studies can be built. 
This course was supported with funds provided by the Howard Hughes Medical Institute.
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SEMINARS
Alberini, C., Mount Sinai School of Medicine, New York:
Memory consolidation and reconsolidation.
Byrne, J., University of Texas/Houston Medical School,
Houston: Aplysia as a model system for studying memory.
Doupe, A. and Brainard, M., University of California, San
Francisco: Birdsong and vocal learning.
Eichenbaum, H., Boston University, Boston, Massachusetts:
Hippocampal-mediated memories.
Goldman, M., University of California, Davis: Computational
approaches to learning and memory.
Holland, P., Johns Hopkins University, Baltimore, Maryland:
Learning theory.
Martin, K., University of California, Los Angeles: Cell biology
of learning-related plasticity.
Raymond, J., Stanford University, Stanford, California:
Cerebellar-mediated memories.
Siegelbaum, S., Columbia University, New York: Synaptic
plasticity and information processing in the hippocampus.
Silva, A., University of California, Los Angeles: Molecular
cognition; animal models of cognitive disorders.
Squire, L., University of California, San Diego: Historical
overview of memory research. Studies of memory in humans.
Waddell, S., University of Massachusetts Medical School,
Worchester: Drosophila as a model system for studying
learning and memory.
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PARTICIPANTS
Achat-Mendes, C., Ph.D., Harvard Medical School,
Southborough, Massachusetts
Arum, O., Ph.D., Southern Illinois University School of
Medicine, Springfield
Bambah-Mukku, D., B.S., Mount Sinai School of Medicine,
New York
Chen, J., B.S., Stanford University, Stanford, California
Combs-Bachmann, R., B.S., University of Massachusetts,
Amherst
De Vito, L., B.S., Boston University, Boston, Massachusetts
Dorrn, A., B.S., University of California, San Francisco
Glerup, S., Ph.D., University of Aarhus, Arhus C, Denmark
Hangya, B., B.S., Institute of Experimental Medicine,
Hungary, Academy of Science, Budapest, Hungary
Ho, V., B.S., University of California, Los Angeles
Komorowski, R., B.S., Boston University, Boston,
Massachusetts
Li, X., B.S., Columbia University, New York
Manakou, S., B.S., Wellcome Trust Sanger Institute,
Cambridge, United Kingdom
McKenzie, S., B.S., Boston University, Boston, Massachusetts
Modi, M., B.S., National Centre for Biological Sciences,
Bangalore, India
Netek, A., B.S., University of Texas Medical School, Houston
Pacheco, D., Ph.D., Cayetano Heredia University, Lima, Peru
Phillips, G., B.S., University of California, Irvine
Ramamoorthi, K., B.S., Massachusetts Institute of Technology,
Cambridge
Rao, D., B.S., University of North Carolina, Chapel Hill
Xie, X.S., Ph.D., Harvard University, Cambridge,
Massachusetts
Proteomics 
July 17–August 1
INSTRUCTORS T. Andacht, Centers for Disease Control and Prevention, Atlanta, Georgia
J. Bruce, University of Washington, Seattle
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
D. Pappin, Cold Spring Harbor Laboratory
ASSISTANTS A. Farley, Vanderbilt University School of Medicine, Nashville, Tennessee
C. Fu, Cold Spring Harbor Laboratory
P. Kirby, University of Georgia, Athens
C. Ruse, Cold Spring Harbor Laboratory
P. Samir, Vanderbilt University School of Medicine, Nashville, Tennessee
C. Weisbrod, University of Washington, Seattle
This intensive laboratory and lecture course focused on cutting-edge proteomics approaches and
technologies. In the protein profiling portion of the course, students gained hands-on experience
in several quantitative proteome analysis methods, including two-dimensional gel electrophoresis
and isotopic labeling strategies. Students were trained to use DIGE, or differential in-gel elec-
trophoresis, for gel-based protein quantification. Differentially expressed proteins were determined
using advanced gel analysis software and identified using MALDI mass spectrometry. Students were
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Bargaje, R., M.S., IGIB, New Delhi, India
Boyer, A., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
Chung, J., B.S., UNIFESP, São Paulo, Brazil
Dzijak, R., M.Sc., Institute of Molecular Genetics, Prague,
Czech Republic 
Evans, T., Ph.D., The University of Iowa, Iowa City
Hao, C., Ph.D., Emory University, Atlanta, Georgia
Islekel, H., Ph.D., Dokuz Eylü University, Izmir, Turkey
Kadam, K., Ph.D., National Institute for Research in
Reproductive, Health, Mumbai, India
Klein, I., Dipl., University of Giessen, Germany
Li, W., University of Kentucky, Lexington
Narendra, D., B.A., National Institutes of Health, Bethesda,
Maryland
Pattison, S., Ph.D., Queen’s University of Belfast, North
Ireland
Pratap, S., B.S., Meharry Medical School, Nashville,
Tennessee
Savaryn, J., B.S., Medical College of Wisconsin, Milwaukee
Vaitheesvaran, B., Ph.D., SUNY, Stony Brook, New York
Wang, F., Ph.D., Children’s Hospital of Philadelphia,
Philadelphia, Pennsylvania
taught differential and quantitative mass spectrometry approaches to profile and identify changes
in proteomes. Students were trained in high-sensitivity microcapillary liquid chromatography cou-
pled with nanospray-ESI and tandem mass spectrometry. Both single-dimension and multidimen-
sional microcapillary liquid chromatography separations coupled to mass spectrometry were taught.
Students gained hands-on experience purifying and identifying protein complexes and posttransla-
tional modifications using the latest technologies. A strong emphasis was placed on data analysis
throughout the course. The overall aim of the course was to provide students with the fundamental
knowledge and hands-on experience necessary to be able to perform and analyze proteomics exper-
iments and to learn to identify new opportunities in applying proteomics approaches to their own
research.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
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SEMINARS
Abbatiello, S., Broad Institute of MIT and Harvard,
Cambridge, Massachusetts: MRM and biomarkers.
Arnaudo, A. and Li, T. Princeton University, Princeton, New
Jersey: Magnetic isolation of protein complexes. 
Chait, B., The Rockefeller University, New York: Proteomic
analysis of protein complexes.
Chaurand, P., Vanderbilt University School of Medicine,
Nashville, Tennessee: Tissue imaging using mass
spectrometry.
Clauser, K., Broad Institute of MIT and Harvard, Cambridge,
Massachusetts: De novo interpretation of tandem mass
spectra.
Dufresne, C., Thermo Fisher Scientific, West Palm Beach,
Florida: Electron transfer dissocation.
Eng, J., University of Washington, Seattle: Tandem mass
spectrometry data analysis.
Friedman, D., Vanderbilt University, Nashville, Tennessee:
Statistical analysis of two-dimensional DIGE gels.
Kelleher, N., University of Illinois, Urbana: Top-down
proteomics.
Peterman, S., Thermo Fisher Scientific, Grimes, Iowa: 
Analysis of MRM data. Multiple reaction monitoring. 
Zhu, H., Johns Hopkins University, Baltimore, Maryland:
Design and application of protein microarrays.
Eukaryotic Gene Expression
July 21–August 10
INSTRUCTORS J. Espinosa, University of Colorado, Boulder
W.L. Kraus, Cornell University, Ithaca, New York
T. Oelgeschläger, Marie Curie Research Institute, Oxted, United Kingdom
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS V. Caputo, Marie Curie Research Institute, Oxted, United Kingdom
R. Henry, University of Colorado, Boulder
C. Lin, Stowers Institute for Medical Research, Kansas City, Missouri
D. Ruhl, Cornell University, Ithaca, New York
This course was designed for students, postdocs, and principal investigators who have recently ventured
into the exciting area of gene regulation. The course focused on state-of-the-art strategies and techniques
used in the field. Emphasis was placed both on in vitro and in vivo protein–DNA interactions and on
novel methodologies to study gene regulation. Students made nuclear extracts, performed in vitro tran-
scription reactions, and measured RNA levels using primer extension. Characterizations of the DNA-
binding properties of site-specific transcription factors were carried out using electrophoretic
mobility-shift and DNase I footprinting assays. In addition, students learned techniques for the as-
sembly and analysis of chromatin in vitro. These included transcription assays, chromatin footprinting,
and chromatin remodeling assays. 
During the past few years, the gene regulation field has developed in vivo approaches to study
gene regulation. Students were exposed to the chromatin immunoprecipitation technique. They
also used RNA interference (RNAi) for specific knockdown experiments in mammalian cells. The
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Alendar, A., Ms.C., Netherlands Cancer Institute, Amsterdam,
The Netherlands
Gahura, O., M.S., Charles University, Prague, Czech Republic
Hondele, M., Dipl., EMBL Heidelberg, Germany
Mathew, R., Ph.D., University of Chicago, Illinois
Morgan, M., Ph.D., University of Oxford, United Kingdom
Muramoto, H., M.A., The University of Tokyo, Japan
Pinheiro, A., Licentiate, University of Lisbon, Lisboa, Portugal 
Riising, E., M.S., University of Copenhagen, Denmark
Rossmann, M., M.D., Cold Spring Harbor Laboratory
Sankar, S., M.S., University of Utah, Salt Lake City
Sengupta, S., Ph.D., Michigan State University, East Lansing
Shiau, C., B.A., University of California, San Francisco
Tang, C., Ph.D., Cold Spring Harbor Laboratory
Varodayan, F., B.A., Columbia University, New York
Wenzel, S., M.S., University of Bayreuth, Germany
Yang, Y., B.S., University of Helsinki, Finland 
determination of cellular gene expression profiles has been accelerated tremendously by DNA mi-
croarray technology, and thus, students received hands-on training in performing and interpreting
results from DNA microarrays. Experience with basic recombinant DNA techniques was a prereq-
uisite for admission to this course. Lectures by the instructors covered the current status of the gene
expression field, theoretical aspects of the methodology, and broader issues regarding strategies for
investigating the regulation of gene expression in eukaryotes. Guest lecturers discussed contemporary
problems in eukaryotic gene regulation and technical approaches to their solution.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
SEMINARS
Bartolomei, M., University of Pennsylvania School of
Medicine, Philadelphia: Epigenetic regulation of genomic
imprinting.
Bernstein, E., Mount Sinai School of Medicine, New York:
Epigenetic cross-talk.
Brown, M., Dana-Farber Cancer Institute, Boston,
Massachusetts: Mining steroid receptor cistromes.
Dent, S., University of Texas M.D. Anderson Cancer Center,
Houston: The importance of a good HAT.
Dermitzakis, M., University of Geneva, Switzerland:
Population genetics and genomics of gene expression
regulation.
Gingeras, T., Cold Spring Harbor Laboratory: New classes of
functional short RNAs and chromosome-wide
transcriptional networks.
Kingston, R., Massachusetts General Hospital/Harvard
Medical School, Boston: Identification of regulatory
mechanisms using high-throughput nucleosome mapping
technologies.
Lees, J., Massachusetts Institute of Technology Center for
Cancer Research, Cambridge: The RB tumor suppressor–
Proliferation, apoptosis, and differentiation regulator.
Levine, M., University of California, Berkeley: Mechanisms 
of transcriptional precision in the Drosophila embryo.
Manley, J., Columbia University, New York: mRNA
processing and links to transcription.
Meyer, B., HHMI/University of Berkeley, California:
Chromosome-wide control of gene expression.
Nogales, E., HHMI/University of California, Berkeley:
Visualizing human protein complexes essential in gene
transcription and regulation.
Prives, C., Columbia University, New York: Target gene
selection by the p53 tumor suppressor protein.
Pugh, F., Penn State University, University Park, 
Pennsylvania: Interactions of the transcription regulatory
machinery with chromatin on a genomic scale.
Reinberg, D., HHMI/New York University School of
Medicine, New York: Transcription and how to be a factor 
in a crowded field.
Taatjes, D., University of Colorado, Boulder: Molecular
mechanisms that regulate mediator coactivator function.
Washburn, M., Stowers Institute for Medical Research, 
Kansas City, Missouri: Quantitative proteomic analysis 
of RNA polymerase II and the discovery of a novel Ser-5
CTD phosphatase.
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Imaging Structure and Function in the Nervous System
July 21–August 10
INSTRUCTORS S. Thompson, University of Maryland School of Medicine, Baltimore
W. Tyler, Arizona State University, Tempe
J. Waters, Northwestern University, Chicago, Illinois
ASSISTANTS T. Hedick, Northwestern University, Chicago, Illinois
A. Nimmerjahn, Stanford University, Stanford, California
D. Popovkina, University of Maryland, Baltimore
Y. Tufail, Arizona State University, Tempe
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light mi-
croscopy, as well as use of different types of electronic cameras, laser-scanning systems, functional
fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of
cell function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated (“caged”)
compounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophys-
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Ade, K., Ph.D., Duke University, Durham, North Carolina
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iological methods were covered. Particular weight was given to multiphoton laser-scanning mi-
croscopy and to newly available biological fluorophores, especially green fluorescent protein (GFP)
and its variants. The course used a spectrum of neural and cell biological systems, including living
animals, brain slices, and cultured cells. 
This course was supported with funds provided by the National Institute of Mental Health, the
National Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
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SEMINARS
Bruchez, M., Carnegie Mellon University, Pittsburgh,
Pennsylvania: New and future indicators.
Cohen-Cory, S., University of California, Los Angeles:
Imaging developmental plasticity.
Deisseroth, K., Stanford University, Stanford, California:
Light-triggered activation/silencing.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Extended 2P imaging and block-face
EM.
DiGregorio, D., Université Paris V, Paris, France: Flash
photolysis.
Engert, F., Harvard University, Cambridge, Massachusetts:
Light sources and detectors. Shot noise. Basics of 2P
imaging.
Frostig, R., University of California, Irvine: Intrinsic imaging.
George, N., Olympus America, Inc., Center Valley,
Pennsylvania: Objectives. BX51 optics Kohler illumination
on commercial.
Griesbeck, O., Max-Planck Institute of Neurobiology,
Martinsried, Bayern, Germany: XFPs and genetically
encoded sensors.
Halpain, S., University of California, San Diego, La Jolla:
Imaging neuronal morphogenesis. Time lapse and FRAP.
Hess, S., University of Maine, Orono: STORM, PALM,
FPALM.
Huebener, M., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Intrinsic imaging.
Kilborn, K., Intelligent Imaging Innovations, Inc., Santa
Monica, California: Deconvolution.
Kilborn, K., Intelligent Imaging Innovations, Inc., Santa
Monica, California and Redford, G., Intelligent Imaging
Innovations, Denver, Colorado: Frequency-domain FLIM.
Lanni, F., Carnegie Mellon University, Pittsburgh,
Pennsylvania: Basic microscopy.
Mrsic-Flogel, T., University College London, United
Kingdom: Organic calcium indicators in bulk loading.
Analysis of Ca bulk loading in vivo.
Murthy, V., Harvard University, Cambridge, Massachusetts:
Synaptofluorins and vesicle imaging.
Overstreet-Wadische, L., University of Alabama, Birmingham:
Imaging adult-generated neurons.
Smith, S., Stanford Medical School, Stanford, California:
Confocal microscopy. 
Tanter, M., National Institute for Health and Medical
Research, Paris, France: Ultrasound imaging. Analysis.
Tsai, P., University of California, San Diego, La Jolla: Optics
bench lab exercises–Basics Koehler. Scanning and
fluorescence. Optics bench lab exercises–Scanning. Optics
bench lab exercises–Confocal.
Tsai, P., University of California, San Diego, La Jolla and
George, N., Olympus America, Inc., Center Valley,
Pennsylvania: Optics bench lab exercises–Basics Koehler.
Tyler, J., Arizona State University, Tempe: Image J. 
Ultrasound imaging.
Waters, J., Northwestern University, Chicago, Illinois: 
Organic calcium indicators. Single-cell Ca imaging in vivo.
Home-brew microscope including laser safety.
Witkowski, J., Cold Spring Harbor Laboratory: Ethics.
Yasuda, R., Duke University Medical Center, Durham, North
Carolina: FRET and FLIM.
Yeast Genetics and Genomics
July 21–August 10
INSTRUCTORS B. Errede, University of North Carolina, Chapel Hill
J. Vogel, McGill University, Montreal, Canada
M. Whiteway, National Research Council of Canada, Montreal, Canada
ASSISTANTS E. Elias, McGill University, Montreal, Canada
E. Nazarova, McGill University, Montreal, Canada
J. Verdassdonk, University of North Carolina, Chapel Hill
This course is a modern, state-of-the-art laboratory course designed to teach the students the full
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cere-
visiae. Combinations of classical genetic approaches are emphasized, including the isolation and
characterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molec-
ular genetic techniques, including various types of yeast transformation, gene replacement with plas-
mids and polymerase chain reaction (PCR), construction and analysis of gene fusions, and
generation of mutations in cloned genes, were also emphasized. Students used classical and molecular
approaches to gain experience in identifying and interpreting various kinds of genetic interactions
including suppression and synthetic lethality. They were immersed in yeast genomics and performed
and interpreted experiments with DNA arrays. Students gained first-hand experience in modern
cytological approaches such as epitope tagging and imaging yeast cells using indirect immunofluo-
324
Erbil, W., Ph.D., University of California, Berkeley
Gary, L., Ph.D., GeoSynFuels, Golden, Colorado
Hsu, P.-h., M.S., The Scripps Research Institute, La Jolla,
California
Kaur, J., Ph.D., Marquette University, Milwaukee, Wisconsin
Kijanska, M., M.S., ETH Zurich, Switzerland
Kim, S., B.S., University of Oklahoma Health Science Center,
Oklahoma City
Kinney, J., Ph.D., Princeton University, Princeton, New 
Jersey
Li, L., Ph.D., University of Michigan, Ann Arbor
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Ren, X., Ph.D., National Institutes of Health, Bethesda,
Maryland
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rescence, green fluorescent protein (GFP)–protein fusions and a variety of fluorescent indicators for
various subcellular organelles. Lectures on fundamental aspects of yeast genetics were presented
along with seminars given by outside speakers on topics of current interest. 
This course was supported with funds provided by National Human Genome Research Institute
and the Howard Hughes Medical Institute.
PARTICIPANTS
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Burke, D., University of Virginia, Charlottesville: Mitotic
regulation by checkpoints.
Clarke, D., University of Minnesota, Minneapolis: Mitotic
checkpoints and chromosome segregation.
Fink, G., Whitehead Institute for Biomedical Research/MIT,
Cambridge, Massachusetts: Evolution of fungal surface
proteins and pathogenesis.
Fox, T., Cornell University, Ithaca, New York: Expression of
mitochondrial genes in yeast: Localized translation and
assembly feedback regulation.
Hughes, T., University of Toronto, Canada: How yeast know
where things are in the genome.
Kolfoil, M., McGill University, Montreal, Quebec, Canada:
Combining genetic manipulation and sophisticated imaging
techniques for studies in yeast.
Lindquist, S., Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: The surprising biology of 
protein conformational change unraveled with yeast.
Luca, F., University of Pennsylvania, Philadelphia: Yeast cell
cycle and growth control.
Michnick, S., University of Montreal, Montreal, Canada:
Structure and dynamics of protein interaction networks in
living cells.
Smith, J., University of Virginia, Charlottesville: The genetics
of aging in yeast.
Thorner, J., University of California, Berkeley: From signaling
to cell biology: Tales of two scaffolds (Ste5 and septins).
Warner, J., Albert Einstein College of Medicine, Bronx, New
York: Yeast and their ribosomes: Key to life, key to growth.
Zakian, V., Princeton University, Princeton, New Jersey:
Maintaining the end.
Cellular Biology of Addiction
August 4–10
INSTRUCTORS C. Evans, University of California, Los Angeles
M. von Zastrow, University of California, San Francisco
ASSISTANTS C. Culbertson, University of California, Los Angeles
V.C. Dang, University of California, San Francisco
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated
exposure to drugs produces neuroadaption and long-term memory of the experience, but the cellular
and molecular processes involved are only partially understood. The primary objective of the pro-
posed workshop was to provide an intense dialogue of the fundamentals, state-of-the-art advances,
and major gaps in the cell and molecular biology of drug addiction. Targeted to new or experienced
investigators, the workshop combined formal presentations and informal discussions to convey the
merits and excitement of cellular and molecular approaches to drug addiction research. 
With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop
comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving,
and relapse to drug use and to brain function, in general. A range of disciplines and topics were
represented, including noninvasive brain imaging to identify drug targets and adaptive processes;
neuroadaptative processes at the molecular and cellular level; neural networks and their modulation;
the relevance of genotype to susceptibility and drug response; tolerance and adaptation at the cellular
level; and approaches to exploit the daunting volume generated by neuroinformatics. This workshop
provided an integrated view of current and novel research on neuroadaptive responses to addiction,
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Seasholtz, A., Ph.D., University of Michigan, Ann Arbor 
Thompson, R., Ph.D., University of Michigan, Ann Arbor
Tomasiewicz, H., B.S., Mount Sinai School of Medicine, 
New York
Wood, D., Ph.D., Beth Israel Deaconess Medical School,
Boston, Massachusetts
fostered discussion on collaboration and integration, provided critical information needed to con-
struct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond
the plane of scientific endeavor, the information is vital for formulating public policy and for en-
lightening the public on the neurobiological consequences of drug use and addiction. The proposed
workshop was designed to generate interest in this level of analysis, open conduits for collaborations,
and present novel routes to investigating the neurobiology of addictive drugs. 
This course was supported with funds provided by the National Institute of Drug Abuse.
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Augustine, G., Duke University, Durham, North Carolina:
Synaptic function and addictive drug action.
Bierut, L., Washington University, St. Louis, Missouri: Human
genetics of nicotine dependence.
Blendy, J., University of Pennsylvania, Philadelphia: Functional
characterization of gene variants in addiction: Of mice and men.
Bonci, A., University of California, San Francisco: Synaptic
plasticity and addiction. 
Edwards, R., University of California, San Francisco:
Monoamine transporters and their regulation.
Heberlein, U., University of California, San Francisco: Genetic
approaches and model organisms in addiction research.
Kalivas, P., Medical University of South Carolina, Columbia:
Can we forget to be addicted?
Kieffer, B., Institute of Genetics and Molecular and Cellular
Biology, Illkirch, France: Animal models of opioid receptor
function and regulation.
Koob, G., Scripps Research Institute, La Jolla, California:
Neurocircuitry of addiction: From reward to antireward. 
Kreek, M.-J., The Rockefeller University, New York:
Endorphins, gene polymorphisms, stress responsivity, and
specific addictions: Selected topics.
Mackie, K., University of Indiana, Bloomington: Molecular
mechanisms of cannabinoids.
Madras, B., Harvard Medical School, Cambridge,
Massachusetts: The public health burden of substance abuse.
Nairn, A., Yale University, New Haven, Connecticut:
Dopamine-regulated signal transduction mechanisms and
psychostimulant action.
Nestler, E., Mt. Sinai School of Medicine, New York:
Molecular mechanisms of drug addiction.
O’Brien, C., University of Pennsylvania, Philadelphia:
Translational research in addiction medicine.
Picciotto, M., Yale University, New Haven, Connecticut:
Molecular mechanisms underlying nicotine addition.
Pollock, J., National Institute on Drug Abuse/NIH/DHHS,
Bethesda, Maryland: NIH/NIDA: Funding and other
important resources.
Sulzer, D., Columbia University, New York: Amphetamines
and synaptic selection.
von Zastrow, M., University of California, San Francisco and
Evans, C., University of California, Los Angeles: Welcome
and introduction to addiction as a cell biological problem. 
Wightman, M., University of North Carolina, Chapel Hill:
Regulation of dopamine release by natural and drug rewards.
Williams, J., Oregon Health & Science Institute, Portland:
Dopamine and opioid signaling in single neurons and
synaptic connections.
C. elegans
August 14–29
INSTRUCTORS S. Ahmed, University of North Carolina, Chapel Hill
E. Miska, University of Cambridge, United Kingdom
M. Zhen, Samuel Lunenfeld Research Institute, Toronto, Canada
ASSISTANTS A. Clark, University of Cambridge, United Kingdom
C. Mok, Samuel Lunenfeld Research Institute, Toronto, Canada
M. Simon, University of North Carolina, Chapel Hill
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome project.
The course was suited both for those investigators who have a current training in molecular biology
and some knowledge of genetics, but have no experience with C. elegans, and for students with some
prior worm experience who wished to expand their repertoire of expertise. The following topics were
covered both in the laboratory and by lectures from experts in the field: worm pushing, C. elegans
databases and worm bioinformatics, anatomy and development, forward genetics, chemical and trans-
poson mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics,
construction and screening of deletion libraries, and RNA inactivation. The course was designed to
impart sufficient training to students in the most important attributes of the C. elegans system to en-
able students to embark on their own research projects after returning to their home institutions.
This course was supported with funds provided by the National Institute of Child Health and
Human Development.
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C. elegans 329
SEMINARS
Ahmed, S., University of North Carolina, Chapel Hill:
Telomeres and telomerase.
Ahringer, J., University of Cambridge, United Kingdom: Cell
polarity and chomatin.
Alkema, M., University of Massachusetts Medical School,
Cambridge: Behavioral genetics.
Blumenthal, T., University of Colorado, Boulder: RNA
processing.
Culotti, J., Samuel Lunenfeld Research Institute, Toronto,
Canada: Axonal pathfinding.
Fang-Yen, C., Harvard University, Cambridge, Massachusetts:
Calcium imaging in C. elegans. 
Felix, M.-A., Institut Jacob Monod, CNRS, Paris, France: C.
elegans evolution.
Hall, D., Albert Einstein College of Medicine, Bronx, New
York: Ultrastructural analysis.
Kim, D., Massachusetts Institute of Technology, Cambridge:
Pathogenesis.
Miska, E., University of Cambridge, United Kingdom:
microRNAs.
Moerman, D., University of British Columbia, Vancouver,
Canada: Toward a mutation in every gene: The knockout
facility and application of new technologies.
Murphy, C., Princeton University, Princeton, New Jersey:
Mechanisms of aging.
Piano, F., New York University, New York: Genomics and
systems biology approaches in C. elegans. 
Richmond, J., University of Illinois, Chicago: Pre- and post-
synaptic regulation of C. elegans synaptic transmission.
Zhen, M., Samuel Lunenfeld Research Institute, Mt. Sinai
Hospital, Toronto, Canada: Nervous system development.
Programming for Biology
October 12–27
INSTRUCTORS S. Prochnik, DOE–Joint Genome Institute/University of California, Berkeley
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS J. Aerts, Roslin Institute, Scotland, United Kingdom
J. Babayev, Pioneer Hi-Bred, Johnston, Iowa
E. Lee, Lawrence Berkeley National Laboratory, Berkeley, California
J. Leipzig, DuPont Experimental Station, Wilmington, Delaware
D. Messina, Washington University School of Medicine, St. Louis, Missouri
S. Robb, University of Utah, Salt Lake City
The computer is already an indispensable tool for database searches, but the use of  Web-based tools
alone is not enough for today’s biologist who needs to access and work with data from myriad
sources in disparate formats. This need became even more important as new technologies increased
the already exponential rate at which biological data are generated. Designed for students and re-
searchers with little or no prior programming experience, this 2-week course gave biologists the
bioinformatics skills necessary to exploit this abundance of biological data. 
The course was based around the Perl scripting language, because of its ease of learning and its
incredible wealth of ready-built code modules (e.g., bioperl) designed to solve common biological
problems. Starting with introductory coding and continuing with a survey of available biological
libraries and practical topics in bioinformatics, students ended by learning how to construct and
run powerful and extensible analysis pipelines in a straightforward manner. The course combined
formal lectures with hands-on sessions in which students worked to solve problem sets covering
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Simon, S., M.S., Stiftung Tieraerztliche Hochschule
Hannover, Germany
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common scenarios in the acquisition, validation, integration, analysis, and visualization of biological
data. For their final projects, which ran during the second week of the course, students were posed
with problems using their own data and worked with each other and the faculty to solve them. Final
projects formed the basis of publications as well as public biological Web sites (see, for example,
http://bio.perl.org/wiki/Deobfuscator).
The prerequisite for the course was a basic knowledge of UNIX. Lectures and problem sets covering
this background material were available online from previous years and students studied this material
before starting the course. Note that the primary focus of this course was to provide students with
practical programming experience, rather than to present a detailed description of the algorithms
used in computational biology. For the latter, we recommend the Computational Genomics course.
This course was supported by the National Human Genome Research Institute.
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Begovic, E., University of California, Berkeley: Molecular
evolution and population genetics. Molecular evolution and
phylogenetics.
Cain, S., Ontario Institute for Cancer Research, Medina,
Ohio: Gbrowse.
Deschamps, S., Dupont, Wilmington, Delaware: NextGen
sequencing 1.
Dos Santos, S., Smithsonian Tropical Research Institute,
Panama City, Panama: Bioinformatics in tropical field
research sequencing samples. 
Hide, W., Harvard University/SANBI, Boston, Massachusetts:
EST assembly and analysis.
Lee, E., University of California, Berkeley: Perl III–Arrays and
hashes.
Leipzig, J., Dupont, Philadelphia, Pennsylvania: HTML.
NextGen sequence assembly III.
McKay, S., Cold Spring Harbor Laboratory: Database design.
DBI. CGI.
Messina, D., Stockholm University, Sweded: Perl VI–
Subroutines and modules. 
Pearson, W., University of Virginia, Charlottesville: Sequence
similarity searches and blast I. Sequence similarity searches
and blast II.
Prochnik, S., DOE Joint Genome Institute, Walnut Creek,
California: Perl IV–References. Perl VII–Object-oriented
Perl. Perl pipelines.
Robb, S., University of Utah, Salt Lake City: Bioperl I. Bioperl
II. Using UNIX. Perl II–Conditionals, logicals operators,
loops, and filehandles. Perl V–Regular expressions.
Thomas, P., SRI International, Menlo Park, California:
Predicting protein function.
Tisdall, J., DuPont Experimental Station, Wilmington,
Delaware: Scientific computing. Perl I–Program structure,
statements, variables.
Vaugh, M., Cold Spring Harbor Laboratory: NextGen
sequencing II.
X-ray Methods in Structural Biology
October 12–27
INSTRUCTORS W. Furey, V.A. Medical Center/University of Pittsburgh, Pittsburgh, Pennsylvania
G. Gilliland, Centorcor R&D, Inc., Radnor, Pennsylvania
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT R. Kettering, University of Pittsburgh, Pittsburgh, Pennsylvania
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through
other methods. This intensified laboratory/computational course focused on the major techniques
used to determine the three-dimensional structures of macromolecules. It was designed for scientists
with a working knowledge of protein structure and function, but who are new to macromolecular
crystallography. Topics to be covered include basic diffraction theory, crystallization (proteins, nucleic
acids, and complexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freez-
ing, data collection, data reduction, multiple isomorphous replacement, multiwavelength anomalous
diffraction, molecular replacement, solvent flattening, noncrystallographic symmetry averaging,
electron density interpretation, molecular graphics, structure refinement, structure validation, co-
ordinate deposition, and structure presentation. Participants learned through extensive hands-on
experiments. One or more proteins were crystallized and the structure(s) determined by several
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VanOs, L., B.S., University of Oregon, Eugene
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methods, in parallel with lectures on the theory and informal discussions behind the techniques.
Applicants should be familiar with the creation and editing of simple text files on Linux workstations
using a screen based editor (either vi or emacs).
This course was supported with funds provided by the National Cancer Institute and the Howard
Hughes Medical Institute.
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Adams, P., Lawrence Berkeley Laboratory, Berkeley, 
California: Introduction to PHENIX (and CNS). 
Structure refinement.
Cohen, A., Stanford Synchrotron Radiation Laboratory,
Stanford, California: Remote synchrotron data collection.
Emsley, P., University of York, United Kingdom: Model-
building tools in coot.
Furey, W., V.A. Medical Center/University of Pittsburgh,
Pittsburgh, Pennsylvania: Anomalous data collection
consideration. Patterson group therapy. Isomorphous
replacement and anomalous scattering. Solvent
flattening/phase combination. Noncrystallographic
symmetry averaging. MAD Phasing: A classical approach.
Solving structures with BnP.
Gilliland, G., Centorcor Inc., Radnor, Pennsylvania: 
Course overview: The structure determination of 
biological macromolecules. Maximizing crystallization
success through seeding. Review/discussion and fill out
evaluations.
Joshua-Tor, L., Cold Spring Harbor Laboratory: DNA
translocation in a replicative hexameric helicase.
Kleywegt, G., EMBL-EBI, Cambridge, United Kingdom: Just
because it’s in Nature, doesn’t mean it’s true… .
Kumar, P.R., Cold Spring Harbor Laboratory: Pymol
animation.
McPherson, A., University of California, Irvine: 
Crystallization of macromolecules I. Crystallization of
macromolecules II. Symmetry, periodicity, unit cells, 
space groups, Miller planes, and lattices. Waves, vectors, 
and complex numbers. Fundamental diffraction
relationships and Bragg’s law. Diffraction patterns, 
reciprocal space and Ewald’s sphere. Fourier transforms 
and the electron density equation. Patterson methods.
Crystallization review. Heavy atoms and anomalous
scatterers. Mechanisms of crystal growth.
Perrakis, A., Netherlands Cancer Institute, Amsterdam, The
Netherlands: Automated model building and refinement
with ARP/WARP.
Pflugrath, J., Rigaku Americas Corporation, The Woodlands,
Texas: Data dollection: Design and  setup.
Cryocrystallography. d*Trek/HKL2000 tutorial. Scaling and
merging synchroton data.
Read, R., University of Cambridge, United Kingdom:
Molecular replacement: New structures from old. Using
SAD data in phaser.
Richardson, J., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using
MolProbity.
Sweet, R., Brookhaven National Laboratory, Upton, New
York: Fundamentals of crystallography. X-ray sources and
optics.
Terwilliger, T., Los Alamos National Laboratory, Los Alamos,
New Mexico: Automated structure solution and model
building.
Tronrud, D., Oregon State University, Corvallis:
Macromolecular refinement I. Macromolecular refinement
II. Difference electron density maps.
Westbrook, J., Rutgers, The State University of New Jersey,
Piscataway: Automating PDB deposition.
Yeh, J., University of Pittsburgh, Pittsburgh, Pennsylvania:
Approaches for membrane protein crystallization. Assessing
crystallizability via biophysical characterization.
Workshop on Cereal Genomics
October 13–19
INSTRUCTORS S. Hake, Plant Gene Expression Center, Albany, California
D. Jackson, Cold Spring Harbor Laboratory
D. Ware, Cold Spring Harbor Laboratory/USDA-ARS
ASSISTANTS A. Eveland, Cold Spring Harbor Laboratory
D. O’Connor, University of California, Berkeley
S. Pasternak, Cold Spring Harbor Laboratory
P. Van Buren, Cold Spring Harbor Laboratory
This 1-week workshop enabled participants to take advantage of emerging genetic tools and the
completed cereal genome sequences of rice and maize, and emerging sequences of other species.
The workshop featured morning and evening lectures with afternoon computer lab exercises. It also
provided hands-on lab work in comparative anatomy, phenotype, and QTL sections in which par-
ticipants examined samples and made measurements for statistical analysis to illustrate the power
of maize genetics and its relation to genomics. The faculty (instructors and invited lecturers) are ac-
tive researchers in cereal genetics and genomics who have made significant contributions to the
field, ensuring that the latest techniques and ideas were presented. The course was structured to
provide time for informal discussions and exchange with leaders in the field.
This workshop was supported with funds provided by the National Science Foundation. 
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Bennetzen, J., University of Georgia, Athens: Orphan cereal
genomics: Comparative power and the search for novelty.
Buckler, E., Cornell University, New York and Rocheford, T.,
Purdue University, Indiana: QTL analyses.
Devos, K., University of Georgia, Athens: Genomics in
nonmodel grass species: Challenges and strategies.
Harper, L., Maize GDB/University of Berkeley, California:
Genomes, chromosomes, genes, and how maize GDB and
other cereal databases can help you.
Kellogg, E., University of Missouri, St. Louis: Diversity of the
cereals and other grasses.
Koch, K., University of Florida, Gainesville: Transposons for
reverse genetics in maize.
Meyers, B., University of Delaware, Newark: New 
technologies for RNA analysis.
Rafalski, A., DuPont/Pioneer, Wilmington, Delaware:
Association analyses.
Vielle-Calzada, J.P., National Laboratory of Genomics for
Biodiversity, Irapuato, Mexico: Genomics and maize land
races.
Wessler, S., University of Georgia, Athens: How transposable
elements amplify throughout genomes.
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PARTICIPANTS
Aquino, G., M.S., International Rice Research Institute, Metro
Manila, Philippines
Cruz, G., B.S., University of São Paulo, Brazil
DeRose-Wilson, L., Ph.D., Colorado State
University/University of California, Irvine, Fort Collins
Dorweiler, J., Ph.D., Marquette University, Milwaukee,
Wisconsin 
Gasperini, D., M.Sc., John Innes Centre, Norwich, United
Kingdom
Guo, X., B.S., University of Nebraska, Lincoln
Gutierrez-Nava, L., Ph.D., DuPont, Wilmington, Delaware
Gutijahr, C., Ph.D., University of Lausanne, Switzerland
Herath, V., B.Sc., University of Maine, Orono
Hill, D., B.S., University of Wyoming, Laramie
Madzima, T., Ph.D., Florida State University, Tallahassee
Oono, Y., Ph.D., National Institute of Agrobiological
Sciences, Tsukuba, Japan
Petsch, K., Ph.D., Cold Spring Harbor Laboratory 
Rijavec, T., Ph.D., National Institute of Biology, Ljubljana,
Slovenia
Santa Cruz Hidalgo, J., B.S., North Carolina State University,
Raleigh
Sosso, Davide, M.S., Ecole Normale Superieure de Lyon,
France
Advanced Sequencing Technologies and Applications
November 3–16
INSTRUCTORS E. Mardis, Washington University School of Medicine, St. Louis, Missouri
G. Marth, Boston College, Chestnut Hill, Massachusetts
W. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Ontario Institute for Cancer Research, Toronto, Canada
M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS D. Barnett, Boston College, Chestnut Hill, Massachusetts
M. Busby, Boston College, Chestnut Hill, Massachusetts
L. Cardone, Cold Spring Harbor Laboratory
Y. Erlich, Cold Spring Harbor Laboratory
E. Hodges, Cold Spring Harbor Laboratory
A. Indap, Boston College, Chestnut Hill, Massachusetts
M. Kramer, Cold Spring Harbor Laboratory
V. Magrini, Washington University School of Medicine, St. Louis, Missouri
S. McGrath, Washington University School of Medicine, St. Louis, Missouri
N. Navin, Cold Spring Harbor Laboratory
J. Parla, Cold Spring Harbor Laboratory
A. Quinlan, University of Virginia, Charlottesville
C. Stewart, Boston College, Chestnut Hill, Massachusetts
C. Teiling, Roche Diagnostics/454, Indianapolis, Indiana
J. Yao, Cold Spring Harbor Laboratory
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Bebek, G., Ph.D., Case Western Reserve University, Cleveland,
Ohio
Clark, L., Ph.D., Columbia University, New York 
Cohen, H., Ph.D., Bar-IIan University, Ramat Gan, Israel 
Cox, M., Ph.D., Massey University, Palmerston North, New
Zealand
Doktor, T., M.S., University of Southern Denmark, Odense,
Denmark
Elferink, M., M.S., Wageningen University, The Netherlands
Grosso, A., Ph.D., Institute of Molecular Medicine, Lisboa,
Portugal 
Hon, C.C., Ph.D., Institut Pasteur, Paris, France
Kao-Kniffin, J., Ph.D., University of Wisconsin, Madison
Konopka, G., Ph.D., University of California, Los Angeles
Kwon, S.Y., Ph.D., University of Birmingham, Edgbaston,
United Kingdom
Paisan-Ruiz, C., Ph.D., University College London Institute 
of Neurology, London, United Kingdom
Pluvinet, R., Ph.D., IMPPC, Barcelona, Spain
Schlegel, S., Dipl., Stockholm University, Stockholm, Sweden
Simoes, B., Lic., University College Dublin, Republic of
Ireland
Velichutina, I., Albert Einstein College of Medicine, Bronx,
New York
During the last decade, large-scale DNA sequencing has markedly impacted the practice of modern
biology and is beginning to affect the practice of medicine. With the recent introduction of several
advanced sequencing technologies, costs and timelines have been reduced by orders of magnitude,
facilitating investigators to conceptualize and perform sequencing-based projects that heretofore
were prohibitive. Furthermore, the application of these technologies to answer questions previously
not experimentally approachable is broadening their impact and application.
This intensive 2-week course explored applications of next-generation sequencing technologies,
with a focus on commercially available methods. Students were instructed in the detailed operation
of several revolutionary sequencing platforms, including sample preparation procedures, general
data handling through pipelines, and in-depth data analysis. A diverse range of biological questions
was  explored including DNA resequencing of human genomic regions (using cancer samples as a
test case), de novo DNA sequencing of bacterial genomes, and the use of these technologies in study-
ing small RNAs, among others. Guest lecturers highlighted their own applications of these revolu-
tionary technologies. 
We encouraged applicants from a diversity of scientific backgrounds including molecular evolu-
tion, development, neuroscience, cancer, plant biology, and microbiology.
This course was sponsored by Applied Biosystems, Illumina, and 454 Life Sciences.
PARTICIPANTS
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SEMINARS
Angly, F., San Diego State University, San Diego, California:
Metagenomics.
Brayer, J., RainDance Technologies, Inc., Lexington,
Massachusetts: Targeted enrichment by emulsion PCR and
the RainDance RDT 1000.
Dooling, D., The Genome Center at Washington University,
St. Louis, Missouri: IT infrastructure for NGS.
Eichler, E., The University of Washington, Seattle: Human
genome structural variation discovery by next-generation
sequencing.
Gnirke, A., Broad Institute, Cambridge, Massachusetts:
Solution-phase capture of DNA or RNA with SureSelect.
Maher, C., University of Michigan, Ann Arbor: Discovery of
fusion transcripts in RNA-Seq data.
Mardis, E., The Genome Center at Washington University, St.
Louis, Missouri: Whole-genome sequencing, variant
detection, and structural variation in cancer genomes.
McPherson, J., The Ontario Institute for Cancer Research,
Toronto, Canada: Next-generation sequencing of cancer
genomes at the OICR.
Mikkelson, T., Broad Institute, Cambridge, Massachusetts:
Comparative epigenomics of human and murine adipogenesis.
Overduin, B., EBI-European Bioinformatics Institute,
Hinxton, Cambridge, United Kingdom: Short-read archive.
Russ, C., Broad Institute, Cambridge, Massachusetts: Helicos
sequencer.
Schroth, G., Illumina, Inc., Hayward, California: RNA-Seq on
the Illumina GAIIx.
Stuart, J., Life Technologies, Inc., Carlsbad, California: cDNA
sequencing by SOLiD. 
Turner, S., Pacific Biosciences, Menlo Park, California: Real-
time single-molecule (SMRT) sequencing.
Watson, J., Cold Spring Harbor Laboratory: My genome
sequencing.
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
November 3–16
INSTRUCTORS V. Allan, University of Manchester, United Kingdom
K. Hu, Indiana University, Bloomington
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
COINSTRUCTOR J. Peng, Stanford University, Stanford, California
ASSISTANTS A. Heaslip, University of Indiana, Bloomington
P. March, University of Manchester, United Kingdom
A. McEvoy, University of California, Berkeley
Y.-C. Wang, University of California, Riverside
This course focused on specialized techniques in microscopy, in situ hybridization, immunocyto-
chemistry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well
as protein and RNA dynamics in living cells. The course emphasized the use of the latest equipment
and techniques in fluorescence microscopy, including confocal laser-scanning microscopy, decon-
volution methods, and several superresolution methods including structured illumination, STORM
and PALM digital image processing, and time-lapse imaging of living specimens. It was designed to
present students with state-of-the-art technology and scientific expertise in the use of light mi-
croscopy to address basic questions in cellular and molecular biology. The course was designed for
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Barry, J., B.A., Columbia University, New York
Bergmann, J., Dipl., The University of Edinburgh, United
Kingdom
Campbell, E., Ph.D., Loyola University, Maywood, Illinois 
Chen E.-S., Ph.D., National University Singapore, Singapore
Duquette, A., Ph.D., McGill University, Montreal, Canada
Estévez-Salmerón, L., Ph.D., University of California, San
Francisco
Keim, C., B.S., Columbia University, New York
Konings, I., B.A., Wageningen University and Research
Centre, The Netherlands
Lauks, J., M.Sc., Center for Neurogenomics & Cognitive
Research, Amsterdam, The Netherlands
Mesentier-Lourc, L., B.A., UFRJ, Rio de Janeiro, Brazil
Oguro, A., Ph.D., University of California, Los Angeles
Paul, S., B.S., Uniformed Services University of the Health
Sciences, Bethesda, Maryland
Perez, O., Ph.D., SDB-LASDB, Quito, Ecuador
Schosserer, M., M.Sc., University of Applied Life Sciences,
Vienna, Austria
Siddiqui, T., Ph.D., University of British Columbia,
Vancouver, Canada
von der Chevallerie, K., M.S., Tierärztliche Hochschule
Hannover, Germany
the molecular biologist who is in need of microscopic approaches and for the cell biologist who is
not familiar with the practical application of the advanced techniques presented in the course.
Among the methods presented were the preparation of tagged nucleic acid probes, fixation methods,
detection of multiple DNA sequences in single nuclei or chromosome spreads, comparative genomic
hybridization, cellular localization of RNA, localization of nucleic acids and proteins in the same
cells, use of a variety of reporter molecules and nonantibody fluorescent tags, indirect antibody la-
beling, detection of multiple proteins in a single cell labeling antibodies with two fluorophores for
STORM, and the use of green fluorescent protein (GFP) variants to study protein expression, by
wide field on PALM, localization, and dynamics. In each method, several experimental protocols
were presented allowing the students to assess the relative merits of each and to relate them to their
own research. Students were encouraged to bring their own nucleic acid, protein, or antibody probes
to the course, which were used in addition to those provided by the instructors. The laboratory ex-
ercises were supplemented with lectures given by invited distinguished scientists, who presented up-
to-the-minute reports on current methods and research using the techniques being presented.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
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SEMINARS
Allan, V., University of Manchester, United Kingdom:
Immunocytochemistry.
Davidson, M., The Florida State University, Tallahassee: A
library of fluorescent proteins for live-cell imaging.
Goodwin, P., Applied Precision, Inc., Issaquah, Washington:
Introduction to structured illumination methods.
Hu, K., Indiana University, Bloomington and Murray, J.,
University of Pennsylvania School of Medicine, Philadelphia:
Introduction to light and fluorescence microscopy.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Digital detectors and digital imaging
fundamentals.
North, A., The Rockefeller University, New York: Immuno-
cytochemistry on tissue sections: Principles and practice.
Ried, T., National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberrations
in cancer cells.
Shroff, H., National Institutes of Health, Bethesda, Maryland
and Bates, M., Harvard University, Cambridge,
Massachusetts: Pointlist imaging: PALM, STORM, and
similar methods.
Spector, D., Cold Spring Harbor Laboratory: Visualizing gene
expression/silencing in living cells.
Computational and  Comparative Genomics
November 4–10
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
L. Stubbs, University of Illinois, Urbana
ASSISTANT D. Triant, Louisana State University, Baton Rouge
Beyond BLAST and FASTA—This course presented a comprehensive overview of the theory and
practice of computational methods for gene identification and characterization from DNA sequence
data. The course focused on approaches for extracting the maximum amount of information from
protein and DNA sequence similarity through sequence database searches, statistical analysis, and
multiple sequence alignment. Additional topics included gene recognition (exon/intron prediction),
identifying signals in unaligned sequences, and integration of genetic and sequence information in
biological databases. The course combined lectures with hands-on exercises; students were encour-
aged to pose challenging sequence analysis problems using their own data. The course made extensive
use of local WWW pages to present problem sets and the computing tools to solve them. Students
used Windows and Mac workstations attached to a UNIX server; participants were comfortable
using the Unix operating system and a Unix text editor. The course was designed for biologists seek-
ing advanced training in biological sequence analysis, computational biology core resource directors
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Barski, A., Ph.D., National Heart, Lung and Blood Institute/
NIH, Bethesda, Maryland
Bratcher, H., M.Sc., University of Oxford, United Kingdom
Buza, T., Ph.D., Mississippi State University, Mississippi State
Crowgey, E., M.S., Pioneer Hi-Bred, Wilmington, Delaware
Doucet, J., Ph.D., Nicholls State University, Thiboaux,
Louisiana
Gallach, M., M.S., University of Texas, Arlington
Harrison, O., Ph.D., Oxford University, United Kingdom
Hnath, J., M.S., National Bioforensic Analysis Center,
Frederick, Maryland
Kabara, E., B.S., Michigan State University, East Lansing
Kamir, D., M.Sc., The Jackson Laboratory, Bar Harbor, Maine
Kienle, N., M.S., Max-Planck Institute for Biophysical
Chemistry, Goettingen, Germany
Lewis, S., B.S., University of California, Riverside
Lin, Y., M.D., RIKEN, Kobe, Japan
Lopes, A., B.Sc., IPATIMUP, Porto, Portugal
Low, L., Ph.D., Malaysian Palm Oil Board, Bandar Baru,
Bangi, Malaysia
Matthiesen, R., Ph.D., IPATIMUP, Porto, Portugal
Muhammad, A., D.Sc., Tuskegee University, Tuskegee,
Alabama
Schwarzbach, A., Ph.D., University of Texas, Brownsville
Seiler, M., Ph.D., University of Chicago, Chicago, Illinois
Stanton, J.-A., Ph.D., University of Otago, Dunedin, New
Zealand
Zweifel, E., B.S., St. Olaf College, Northfield, Minnesota
and staff, and for scientists in other disciplines, such as computer science, who wish to survey current
research problems in biological sequence analysis. The primary focus of this course was the theory
and practice of algorithms used in computational biology, with the goal of using current methods
more effectively and developing new algorithms. 
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
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SEMINARS
Altschul, S., National Library of Medicine, Bethesda,
Maryland: Statistics of sequence similarity scores. Iterated
protein database searches with PSI-BLAST. 
Cooper, P., National Center for Biotechnology
Information/National Library of Medicine, Bethesda,
Maryland: NCBI resources for bioinformatics and
computational biology. MCBO genome resources.
Overduin, B., EMBL–European Bioinformatics Institute,
Hinxton, Cambridge, United Kingdom: The ENSEMBL
database of genomes I: ENSEMBL II. Compara.
Pearson, W., University of Virginia, Charlottesville: Protein
evolution and sequence similarity searching. Similarity
searching II–strategies. Suboptimal global alignments.
Hidden Markov models and proteins profiles. Alignment
algorithms–Large-scale alignment I. Consensus sites.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment/multiple
alignment resources. Multiple alignment resources.
Stubbs, L., University of Illinois, Urbana: Genome 
comparison biology.
Thomas, P., SRI International, Menlo Park, California:
Interfering function/orthology. 
Phage Display of Proteins and Peptides
November 9–16
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego, La Jolla
ASSISTANTS S. Kacir, University of Pennsylvania, Philadelphia
L. Yunk, University of Pennsylvania, Philadelphia
Recent advances in the generation and selection of antibodies from combinatorial libraries allow
for the rapid production of antibodies from immune and nonimmune sources. This intensive lab-
oratory/lecture course focused on the construction of combinatorial antibody libraries expressed on
the surface of phage and selection of desired antibodies from the library. Students learned the the-
oretical and practical aspects of constructing combinatorial libraries from immune and nonimmune
sources as well as the construction of synthetic antibody libraries. ScFu antibodies were selected
from the library by panning. Production, purification, and characterization of Fab fragments ex-
pressed in Escherichia coli were also covered. Antibody epitopes were selected from peptide libraries
and characterized. The lecture series, presented by a number of invited speakers, emphasized poly-
merase chain reaction (PCR) of immunoglobulin genes, the biology of filamentous phage, and the
utility of surface expression libraries, expression of antibodies in E. coli and mammalian cells, anti-
body structure and function, catalytic antibodies, directed protein evolution, cell display libraries,
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Alexis, F., Ph.D., Clemson University, Clemson, South Carolina
Andersson, O., M.S., Karolinska Institutet, Stockholm, Sweden
Dunn, R., B.A., Biogen Idec, San Diego, California
Felizzola, O., B.S., Institution of Advanced Studies, Caracas,
Venezuela
Gadermaier, E., M.Sc., Center for Physiology and
Pathophysiology, Vienna, Austria
Jung, J., Ph.D., Korea Research Institute of Bioscience and
Biotechnology, Daejeon, South Korea
Madala, S., M.Sc., National Institutes of Health/NIAID,
Bethesda, Maryland 
Malm, M., M.Sc., Royal Institute of Technology, Stockholm,
Sweden
Martinez-Barnetche, J., B.S., Instituto Nacional De Salud
Publica, Cuernavaca, Mexico
Matsuo, A., Ph.D., Universidade Federal de São Paulo, Brazil 
Moreland, N., Ph.D., Duke NUS Graduate Medical School,
Singapore
Nilsson, O., M.Sc., Karolinska Institutet, Stockholm, Sweden
Ong, Y.T., B.S., University of Missouri, Columbia
Puffer, B., Ph.D., Integral Molecular, Philadelphia,
Pennsylvania 
Stambolsky, P., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Trilling, A.K., M.S., Plant Research International,
Wageningen, The Netherlands
the immunobiology of the antibody response, and recent results on the use of antibodies in therapy.
The theory and practical implications for selection from phage displayed libraries of random pep-
tides, cDNA products, and semisynthetic proteins were also explored.
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Phage Display of Proteins and Peptides      343
SEMINARS
Almagro, J.C., Johnson & Johnson, Radnor, Pennsylvania:
Antibody humanization.
Barbas, C., The Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The Ph.D. for peptides.
Rader, C., National Cancer Institute/NIH, Bethesda,
Maryland: Monoclonal antibody drug and target discovery
for cancer therapy.
Sidhu, S., Genetech, Inc., S. San Francisco, California:
Antibody phage display and chemical diversity in antigen
recognition.
Siegel, D., University of Pennsylvania Medical Center,
Philadelphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego, La Jolla:
Repertoire cloning of SLE autoantibodies.
Smith, G., University of Missouri, Columbia: Phage display 
of peptides.
Stanfield, R., The Scripps Research Institute, La Jolla,
California: Structural biology of the immune system.
Wittrup, K.D., Massachusetts Institute of Technology,
Cambridge: Yeast display libraries.
The Genome Access Course
April 20–21, November 17–18
TRAINERS G. Howell, The Jackson Laboratory
B. King, The Jackson Laboratory
L. Reinholdt, The Jackson Laboratory
R. Sachidanandam, Cold Spring Harbor Laboratory
This course was an intensive 2-day introduction to bioinformatics that was held twice in 2009 and
trained almost 43 participants in total. The core of the course was designed to cover the manipulation
and analysis of sequence information. The course was broken into modules designed to give a broad
overview of a given topic, with ample time for examples chosen by the instructors. Each module in-
cluded three parts consisting of a discussion of theory and methods, coverage of software and web
resources, and use of selected tools with examples (including those supplied by the students). The
modular design allowed the instructors to tailor the presentation to the interests of the students.
Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple Se-
quence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the course were
open to all on a first-come–first-served basis, subject to basic eligibility requirements. The course
was held at the Laboratory’s Genome Research Center at Woodbury located seven miles south of
the main Laboratory campus. Each student was provided with a PC laptop with wireless modem
for the duration of the course. Students were encouraged to supply problem sets and sequences of
interest to the trainers for possible incorporation as examples in the modules. Materials were made
available on the web and students continued to ask questions of the trainers as they applied what
they had learned in their individual endeavors. 
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November 15–18
Chellani, M., Translational Research, Melville, New York
Choi, G., University of Chicago, Surgery, Chicago, Illinois
Glaser, R., Stevenson University, Biology, Stevenson, Maryland
Hartung, A., GNF, Oncology Drug Discovery, San Diego,
California
Imumorin, I., Cornell University, Department of Animal
Science, Ithaca, New York
Lau, F., Harvard Stem Cell Institute, Cowan Lab, Boston,
Massachusetts
Lenert, G., University of Iowa Library, Hardin Library for the
Health Sciences, Iowa City
Levin, M., University of Pennsylvania, Pediatrics, Division of
Cardiology, Philadelphia
Lin, C.-Y., Albert Einstein College of Medicine, Epidemiology
and Public Health, Bronx, New York
MacKinnon, C., University of the Incarnate Word, Biology,
San Antonio, Texas
Meiss, S., California University of Pennsylvania, Biological and
Environmental Sciences, California, Pennsylvania
Mendoza, O., Stella Maris College (Autonomous),
Bioinformatics, Chennai, India
Owens, E., University of Alabama, Microbiology, 
Birmingham
Parker, J., Columbia University, Genetics and Development,
New York
Paul, J., DuPont, CR&D, Wilmington, Delaware
Rosner, M., University of Chicago, Ben May Department for
Cancer Research, Chicago, Illinois
Sellors, J., United Kingdom Biobank, Operations/Legal,
London, United Kingdom
Sun, S., Cold Spring Harbor Laboratory
Taylor, K., University of Missouri, Pathology and Anatomical
Sciences, Columbia
Tran, S., Amgen, Inc., Investigative Toxicology, Thousand
Oaks, California
Zhang, W., Roswell Park Cancer Institute, Molecular
Pharmacology and Cancer Therapeutics, Buffalo, New York
April 20–21
Alonso, A., Mount Sinai School of Medicine, Genetics and
Genomic Sciences, New York
Backman, C., NIH/NIDA Intramural Research Program,
Cellular Neurobiology Research Branch, Baltimore,
Maryland
Basso, M., Burke-Cornell Medical Research Institute,
Neurology and Neurosciences, White Plains, New York
Belmonte Mahon, P., Johns Hopkins University, Psychiatry,
Baltimore, Maryland
Chandra, D., Roswell Park Cancer Institute, Pharmacology
and Therapeutics, Buffalo, New York
DiLaura, R., Cleveland Clinic and Case Western Reserve
University, Clinical and Translational Research Informatics,
Brecksville, Ohio
Forslund, A., Albert Einstein College of Medicine, Genetics,
Bronx, New York
Gravina, S., Albert Einstein College of Medicine, Genetics,
Bronx, New York
Jensen, M., Harvard School of Public Health,
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Nutrition/Epidemiology, Boston, Massachusetts
Ma, T., Burke Medical Research Institute, Research–
Neurology and Neuroscience, White Plains, New York
Majovski, R., Genome Research, Cold Spring Harbor
Laboratory
Mayeux, R., Columbia University College of Physicians &
Surgeons, Taub Institute, New York
Parla, J., Cold Spring Harbor Laboratory, Genome Research
Center, Woodbury, New York
Qin, W., James J. Peters VA Medical Center, RR&D Center 
of Excellence, Bronx, New York
Rogers, J., Baylor College of Medicine, Human Genome
Sequencing Center, Houston, Texas
Stowe, A., Washington University in St. Louis, Neurosurgery,
St. Louis, Missouri
Willour, V., Johns Hopkins University, Psychiatry and
Behavioral Sciences, Baltimore, Maryland
Wray, C., MDIBL, Education, Salisbury Cove Maine
Cold Spring Harbor Laboratory acknowledges the generosity of the following companies that loaned equipment and reagents to
the various courses:
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454 Life Sciences
Accuri Cytometers Inc. 
Affymetrix
Agilent Technologies Inc.
Andor Technology
Applied Biosystems
Astro-Med Inc.
Berthold Technologies USA,
LLC
Bioptechs Inc.
Bio-Rad Laboratories
Bruker Daltonics Inc.
Carl Zeiss Inc.
Charles River Laboratories
Chroma Technology
Corporation
Coherent Laser
ConOptics
Corning Inc.
CrystaLaser
David Kopf Instruments
Doric Lenses
Drummond Scientific
Company
Epicentre Technologies
Eppendorf North America
Fotodyne Inc.
GE Healthcare
Hamamatsu Photonic Systems
Hamilton Thorne Biosciences
Hampton Research
Harvard Apparatus Inc.
Heka
Hill Instruments
Illumina Inc.
Intelligent Imaging
Innovations Inc.
Invitrogen Corporation
Jackson Immunoresearch
Laboratories
James A. Hill Instrument
Services
Kinetic Systems Inc.
Leica Microsystems Inc.
LI-COR
Lonza Rockland Inc.
Luigs & Neumann
MDS Analytical Technologies
Nalge Nunc International
Nanodrop Technologies
Narishige International USA
Inc.
Nasco
New England Biolabs Inc.
Nikon Inc.
Olympus America Inc.
Pel-Freez Biologicals
PerkinElmer Life and
Analytical Sciences
Photometrics
Photonic Instruments Inc.
Prairie Technologies
Promega Corporation
Qiagen Inc.
Q-Imaging Inc.
Roche Applied Science
SciGene
Sigma-Aldrich
Singer Instruments
Siskiyou Corporation
Spectra-Physics Lasers Inc.
Stanford Research Systems
Stratagene
Sutter Instruments
Tecan
The Gel Company
The Jackson Laboratory
Thermo Electron Corporation
Thermo Fisher Scientific
Torrey Pines Scientific
Varian Inc., Consumable
Products
VDS Vosskuhler GmbH
Warner Instruments
Waters Corporation
World Precision Instruments
Zeitz-Instrumente Vertriebs
GmbH
SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present
their findings. These weekly seminars keep the CSHL staff current on the latest scientific developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas
in an informal setting. 
Title Host
January
Dr. Jeff Lichtman, Harvard University Connectomics in the developing nervous system. Josh Huang
Dr. Li-Heui Tsai, Massachusetts Institute of Chromatin remodeling in neurodegeneration and Josh Huang 
Technology neuronal repair.
Dr. Titia de Lange, The Rockefeller University How telomeres protect chromosome ends. David Spector
Dr. Lisa Miller, Brookhaven National Ex situ imaging of amyloid structure and metal Leemor Joshua-Tor
Laboratory binding in a mouse model of Alzheimer’s 
disease.
February
Dr. Michael Ehlers, Duke University Protein machinery for postsynaptic plasticity. Hiro Furukawa
Dr. Robin Lovell-Badge, National Institute for How the decision to be male or female is made and Leemor Joshua-Tor
Medical Research, London maintained in mammals.
Dr. Caroline Dean, John Innes Centre, United Chromatin silencing in flowering time control. Rob Martienssen
Kingdom
March
Dr. David Glover, University of Cambridge Organizing centrosomes and assembling centrioles: David Spector
Roles of the polo-like kinases 1 and 4.
Dr. Ronald DePinho, Harvard University/ FoxOs in cancer and aging. Terri Grodzicker
Dana Farber Cancer Institute
Dr. David Porteous, The University of Genetics and biology of psychosis: Learning from Dick McCombie
Edinburgh DISC1.
Dr. Robert Desimone, Massachusetts Institute Neural synchrony and selective attention. Tony Zador
of Technology
April
Dr. John Kuriyan, University of California, Allosteric mechanisms in the activation of the EGF Bruce Stillman
Berkeley receptor.
Dr. Lewis Cantley, Harvard University PI3 kinase, cell growth regulation, and disease. Scott Powers
Dr. Thomas Sudhof, Stanford University Neurexins and neuroligins: Synapses to autism. Tony Zador
September
Dr. Luis Parada, University of Texas Modeling neural cancers in mice: Cell of origin and Scott Lowe
Southwestern Medical Center and other insights.
Dr. Peter Sarnow, Stanford University Subversion of a liver-specific microRNA by hepatitis Adrian Krainer
C virus.
October
Dr. Ihor Lemischka, Mount Sinai School of Dissecting cell-fate regulation in stem cells. Grigori Enikolopov
Medicine
Dr. Mitchell Lazar, University of Pennsylvania Nuclear receptors, epigenetics, and metabolism. Terri Grodzicker
School of Medicine
Dr. Carla Shatz, Stanford University Moonlighting MHCI and brain circuit tuning. Sydney Gary
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Title Host
November
Dr. James Lupski, Baylor College of Medicine Genomic disorders: Mechanisms and assays for Dick McCombie
CNV associated with neuropsychiatric and 
other disease traits.
December
Dr. John Diffley, Cancer Research, United Mechanism and regulation of DNA replication Leemor Joshua-Tor
Kingdom during the cell cycle and in response to DNA 
damage.
Dr. Kim Orth, University of Texas,  Black death, black spot, black pearl: Tales of  Leemor Joshua-Tor
Southwestern Medical Center bacterial effectors.
Dr. Bruce Spiegelman, Dana Farber Cancer Transcriptional control of adipogenesis and Terri Grodzicker
Institute/Harvard Medical School energy homeostasis.
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal avenue
for communication between the various research groups at the Laboratory. The seminars also afford
a necessary opportunity for the graduate students and postgraduate staff to develop their skills in
organizing, presenting, and defending their research.
Title
January
Zhenyu Xuan (Zhang Lab) Data mining through the Bioinformatics Shared Resource.
Dan Chitwood (Timmermans Lab) Pattern formation via small RNA movement.
Jeffrey Rosenfeld (Zhang Lab) The enigmatic nature of the “repressive” histone modification H3K9me3.
February
Clint Whipple (Jackson Lab) Evolution of convergent morphologies: Bract suppression in the grass 
family.
Prakash Kumar (Joshua-Tor Lab) Turning ON transcription: A sugary tale revisited.
Johannes Zuber (Lowe Lab) A path toward identifying the Achilles heel of chemoresistant leukemia.
Alexey Aravin (Hannon Lab) Small RNA pathways in mouse germ line.
March
Senthil Muthuswamy Cell polarity: The nexus between morphogenesis and cancer.
Jason Bohland (Mitra Lab) Neuroanatomy 2.0: Large-scale approaches to understanding brain 
organization.
Anirban Paul (Huang Lab) When DNA is not enough: New targets for Rett syndrome protein.
April
Santiago Jaramillo (Zador Lab) What can auditory cortex tell about our expectations?
Agustin Chicas (Lowe Lab) Dissecting the role of tumor suppressor pathways in cellular senescence.
Shilpi Paul (Mills Lab) What makes CHD5 tick? Insights into its mechanism and partners.
October
Alexei Aravin (Hannon Lab) Arginine methylation of Piwi proteins and assembly of ribonucleoprotein 
granules in germ line.
Yimin Hua (Krainer Lab) Antisense correction of SMN2 splicing in the CNS as a therapy for spinal 
muscular atrophy.
Eric Sawey (Powers Lab) An oncogenomics-based in vivo cDNA screen pinpints novel therapeutic 
targets for liver cancer.
Nael Nadif Kasri (Van Aelst Lab) Mind the gap: Rho GTPase signaling in X-linked mental retardation.
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November
Rafael Pagani (Zhong Lab) Spacing effect in long-term memory induction.
Aftabul Haque (Tonks Lab) Novel approaches to signal transduction-based therapy suggested by redox 
regulation of PTP1B.
Josh Dubnau Memories of a fly: The rutabaga and the pack of dogs.
December
Michael Feigin (Muthuswamy Lab) Regulation of mammary gland morphogenesis and tumorigenesis by the 
polarity protein Scribble.
Alexei Koulakov Olfactory space: Myth or reality?
Dick McCombie Finding a needle in a haystack.
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This was a busy year for the Banbury Center, with 20 science-related meetings and 555 participants.
The proportion of U.S. participants was 79.7%, a number that has remained remarkably constant
over the years. The U.S. participants came from 32 states, with the usual suspects leading the way
(New York, Massachusetts, and Maryland). Foreign participants came from 22 countries, the ma-
jority from the United Kingdom. There tends to be a significant gender imbalance in Banbury Cen-
ter meetings, but we did rather better in 2009 with more than 30% of participants being female.
Looking back at the decade just ended, there were 212 meetings at Banbury, with 6277 partici-
pants, an average of 31 participants per meeting. (These participants represent 4839 individuals;
many came more than once in the period.) Seventy-seven percent of participants came from the
U.S., and the percentage of female participants was 26%. The number of meetings each year ranged
from a low of 17 in 2006 to a high of 26 in 2001.
To return to 2009, the year was characterized by a larger than usual number of meetings dealing
with policy or the planning of research or promotion of a research area. Perhaps the most notable
of these meetings was one held in December, on Promoting Research on Severe Mental Illness. The
themes of the meeting were that finding the genes involved in severe mental disease is the most
promising line of research and that the new generation of tools for large-scale genomics provides
new opportunities for research on mental illness. Led by Jim Watson, Ed Scolnick, and Herb Pardes,
participants reviewed the current state of genetic and genomics research and discussed how to ad-
vance this research. Participants prepared a “call to arms” that was published in the Policy Forum
of Science (327: 1580–1581). Fittingly, support for the meeting was provided by foundations at the
forefront of research on mental illnesses, including NARSAD–The Brain & Behavior Research
Fund, World Heritage Foundation–Prechter Family Fund, and the Simons Foundation.
BANBURY CENTER
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Robertson House
Aquatic Plants: Environment, Energy, and Evolution is another example of a meeting that combined
research and policy. Duckweeds are familiar to us as the green “scum” floating on the surface of still
bodies of water, such as ponds. They are tiny plants, without leaves or stems, and may or may not
have rootlets. Duckweeds reproduce vegetatively as well as sexually and have the fastest known dou-
bling time of flowering plants. Their advantages as experimental organisms are that they are easy to
culture, have relatively small genomes, and can be transformed. Duckweeds are already used as food
and in bioremediation, but participants in this meeting believe that the full potential of duckweed
has yet to be realized. As a consequence, participants critically reviewed the biological and genetic
properties of duckweed and examined the ways in which these properties could be exploited, and
duckweed promoted, for biomass, biofuels, metabolic engineering, and bioremediation.
Continuing with this theme of meetings promoting policy, Banbury Center hosted a meeting of
the International Steering Committee for Plant Genomics, an informal group comprised of funding
organizations with a special interest in promoting genomic techniques for improving crops. The Com-
mittee, which includes scientists from Australia, Canada, France, Japan, Korea, the United Kingdom,
and the United States, came to Banbury to develop a first draft of “a vision paper for the future of
plant biology.” Michael Gale, from the John Innes Institute in Norwich, England, was one of the par-
ticipants, and we were saddened to learn of his death in July, 2009. Mike was one of the world’s
leading authorities on cereal genetics, and his research career was devoted to relieving world hunger
through the improvement of cereal crops.
A notable scientific meeting was Structural Variation in the Human Genome. Structural changes
in genomes have been known for many years. Studies of chromosomes revealed major rearrange-
ments such as translocations, inversions, and insertions. The introduction of chromosome-banding
stains in the 1960s revealed much smaller, intrachromosomal insertions and deletions. There was a
further increase in resolution with the use of DNA probes and microarray techniques, and it became
clear that changes could be as small as a few kilobases and were far more common in the human
genome than had been thought. Indeed, copy-number variants (CNVs) are now recognized as one
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of the most common forms of genetic variation in human beings. CNVs have been associated with
a range of human developmental disorders, including psychiatric disorders such as schizophrenia.
Participants in this meeting discussed the mechanisms by which CNVs arise, their clinical conse-
quences, and the development of diagnostics tests.
The Human Genome Project (HGP) was one of the great scientific enterprises of the 20th cen-
tury, ranking with the Manhattan and Apollo Projects. The latter have been exhaustively docu-
mented, by the Department of Energy and by NASA, and we believe that the HGP warrants the
same historical attention. We have initiated a program to document the history of the HGP and re-
lated sequencing projects. The first goal of this project is to create a comprehensive database of the
locations, nature, and a description of materials relating to the HGP, whether held by scientists, ac-
ademic institutions, foundations, or government departments. The discussion meeting International
Catalog for the History of the Human Genome Project was held to examine how other organizations
have assembled such databases, to review the proposed project, and to suggest amendments and
modifications in the light of other experience. Participants included key players in the early devel-
opment of the HGP, historians of science, and archivists working on similar projects. The discussions
were most helpful for planning the next steps in our project.
The Boehringer Ingelheim Foundation promotes biomedical research by providing fellowships
for graduate students performing research for a Ph.D. Each year, the Foundation holds a meeting in
North America for their fellows, and 2009 marked the third occasion on which the Foundation has
come to Banbury. It is always a pleasure to have scientists-in-training here, especially because the
Foundation generously funds a special lecture, open to CSHL scientists. We were delighted to have
Beth Shapiro (Pennsylvania State University) as our speaker. Beth had just been awarded a MacArthur
Fellowship and, having heard her fascinating research, it was clear to see why she had been chosen.
Meetings participants and students taking 2009 summer courses have enjoyed the fruits of the
refurbishment of Robertson House, which was carried out during the winter 2008–2009. The
Robertson family has continued to help us in preserving Robertson House, and in particular, I
would like to thank Victoria Linnartz, the granddaughter of Charles and Marie Robertson, for all
of her hard work in enhancing the beauty of the house.
When I came to the Banbury Center, Bea Toliver was already here as assistant to the Banbury di-
rector and Katya Davey was hostess in Robertson House. It was immediately clear that we needed
help and so, early in 1988, Ellie Sidorenko joined us in the Banbury office. Ellie was the first and
only change in the Banbury Center staff for almost 20 years, and now, in the space of just a few
years, Katya, Bea, and, in 2009, Ellie retired. Banbury has been very fortunate in recruiting three
people who have immediately understood the Banbury style. Basia Polakowski took on the role of
hostess in Robertson House in 2005, and, in 2009, Janice Tozzo became the Banbury Center assis-
tant and was joined by Susanne Igneri later in the year. 
As always, the operations of the Banbury Center depend on many people: Janice, Susanne, and
Basia have already earned the thanks of meetings participants; Mike Peluso and the grounds crew
continue to keep the Banbury grounds looking beautiful; Jon Parsons is indispensable in handling
our AV needs; Connie Brukin takes interesting and artistic photographs of participants; and the
staff of the Laboratory’s Food Services and Housekeeping cope admirably with the very full schedule
of Banbury meetings.
Jan Witkowski
Executive Director
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NSF Workshop: A Vision for Plant Biology
March 1–4
FUNDED BY             Biotechnology and Biological Sciences Research Council (BBSRC), 
                                Deutsche Forschungsgemeinschaft (DFG), National Science Foundation, 
                                The Salk Institute for Biological Studies
ARRANGED BY        J. Ecker, The Salk Institute for Biological Studies
                                A. Millar, University of Edinburgh
The International Steering Committee on Plant Genomics is an informal group made up of funding
organizations with a special interest in promoting genomic techniques in improving crops. Among
other goals, the Committee is intended to facilitate communications between funding agencies in
this area and promoting research collaborations. A small group of scientists drawn from participating
countries (including Australia, Canada, France, Japan, Korea, the United Kingdom, and the United
States) came to Banbury to discuss their perspectives of current and future challenges in the plant
sciences and to develop an International Model for the Future of Plant Science. A draft report was
prepared by the scientists at the conclusion of the meeting and presented at widely attended com-
munity meetings for comment during 2009. The final report will be published in 2010.
Orientation:    J. Ecker, The Salk Institute for Biological Studies, San Diego, California
                     A. Millar, University of Edinburgh, Edinburgh, United Kingdom
356
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SESSION 1
Scientists’ presentations.
SESSION 2
Summarize speaker recommendations. 
Draft outline.
Finalize writing assignments.
SESSION 3
Writing groups to draft sections.
M. Bevan S.-H. Lee, E. Dennis
J. Silverthorne, R. Bastow, K. Kistner, R. McKibbin
SESSION 4
Writing groups to draft sections.
Progress review.
SESSION 5
Editing and compilation of draft document by cochairs.
SESSION 6
Wrap-up and development of powerpoint presentation for
Cold Spring Harbor Laboratory meeting.
Neurobiology of Depression: From Molecules to Mood
March 22–25
FUNDED BY AstraZeneca Pharmaceuticals, Hoffmann-LaRoche, Inc., Hope for Depression 
Research Foundation, Johnson & Johnson Pharmaceuticals Research, Lilly Research 
Laboratories, NIMH, Wyeth Pharmaceuticals
ARRANGED BY R. Hen, Columbia University
B. McEwen, The Rockefeller University
R. Duman, Yale University
H. Manji, Johnson & Johnson Pharmaceutical Research
Depression is a devastating illness that affects 15%–20% of the population, resulting in enormous
personal suffering and economic loss to society. Despite intensive research, the neurobiological
mechanisms underlying the etiology and treatment of major depressive disorders have not been
identified. The aim of this meeting was to bring together basic and clinical investigators to provide
a comprehensive and integrated assessment of the current state of knowledge of depression research.
Discussions covered the genetic, molecular, and cellular determinants of mood and depression in
animal models and in humans, as well as the latest information from clinical studies on the circuitry,
imaging and the treatment of mood disorders. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcoming Remarks, 
Overview of the Agenda/
Schedule, and Objectives: R. Hen, Columbia University, College of Physicians & 
            Surgeons, New York, New York
SESSION 1: Treatments and Models
Chairperson: R. Duman, Yale University School of Medicine, New Haven, Connecticut
H. Koenigsberg, Mount Sinai School of Medicine, New York:
Does a psychosocial perspective have something to offer
neurobiological research in depression and vice versa?
D. Charney, Mount Sinai School of Medicine, New York:
Therapeutic effects of ketamine in treatment-resistant
depression.
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SESSION 3: Genes and Development
Chairperson: R. Hen, Columbia University, College of Physicians & Surgeons, New York
K. Kendler, Virginia Commonwealth University, Richmond:
The genetic epidemiology of major depression.
J. Gingrich, Columbia University, New York: Role of develop-
mental serotonin signaling in adult affective function.
K. Ressler, Emory University, Atlanta, Georgia: BDNF in
prefrontal cortex, amygdala, and hippocampus required for
extinction of aversive memories.
M. Meaney, McGill University, Montreal, Canada: Epigenetic
mechanisms for the environmental programming of gene
expression.
E. Nestler, Mount Sinai School of Medicine, New York:
Epigenetic mechanisms of depression.
SESSION 4: Stress and Sex
Chairperson: H. Akil, University of Michigan, Ann Arbor
R. Duman, Yale University School of Medicine, New Haven,
Connecticut: Neurotrophic factors in the pathophysiology
and treatment of depression.
N. Sousa, University of Minho, Braga, Portugal: Role of
neurogenesis in depression.
W. Carlezon, Harvard Medical School–McLean Hospital,
Belmont, Massachusetts: Stress, behavior, and hippocampal
neurogenesis.
A. Miller, Emory University School of Medicine, Atlanta,
Georgia: Inflammation and its discontents: Role of cytokines
in the pathophysiology of depression.
P. Schmidt, National Institutes of Health/NIMH, Bethesda,
Maryland: Reproductive endocrinology and mood disorders
in women.
T. Schors, Rutgers University, Piscataway, New Jersey: Why are
females so smart and yet so susceptible to stress?
A. Lewy, Oregon Health Sciences University, Portland:
Circadian misalignment component of sleep and mood
disorders.
R. Hen, Columbia University, College of Physicians &
Surgeons, New York: Mechanisms underlying the response to
antidepressants: Responders versus nonresponders.
H. Akil, University of Michigan, Ann Arbor: Novel molecular
targets in mood disorders.
Z. Nahas, Medical University of South Carolina, Charleston:
Oxytocin for depression.
M. Solms, University of Cape Town, Roundebosch, South
Africa: Depression and separation distress.
L. Brady and R. Nakamura, National Institutes of
Health/NIMH, Bethesda, Maryland: NIH initiatives.
SESSION 5: New Directions
Chairperson: B. McEwen, The Rockefeller University, New York
H. Manji, Johnson & Johnson Pharmaceutical Research &
Development, Titusville, New Jersey: Targeting synaptic and
cellular plasticity cascades to develop improved therapeutics.
C. Nemeroff, Emory University School of Medicine, Atlanta,
Georgia: Early life trauma in major depression: A distinct
endophenotype.
B. McEwen, The Rockefeller University, New York: Depression,
adaptive plasticity, and resilience: Insights from animal models.
SESSION 2: Imaging/Circuitry
Chairperson: H. Manji, Johnson & Johnson Pharmaceutical Research & Development, Titusville, New Jersey
Y. Sheline, Washington University School of Medicine, St. Louis,
Missouri: Resting state connectivity studies in major depression.
S. Maier, University of Colorado, Boulder, Colorado: Role of
the medial prefrontal cortex in resilience and vulnerability.
M. George, Medical University of South Carolina, Charleston:
Noninvasively modulating prefrontal cortical–subcortical
networks to treat depression: The current evidence for TMS
and future directions.
H. Mayberg, Emory University School of Medicine, Atlanta,
Georgia: Deep brain stimulation for treatment-resistant
depression.
K. Disseroth, Stanford University, Stanford, California:
Development and application of optical technologies for
probing depression.
B. McEwen, R. Hen
New Developments in Fragile X Syndrome: From Basic
Mechanisms to Therapeutics
April 5–8
FUNDED BY             NIHM grant to the University of Illinois
ARRANGED BY        K. Huber, University of Texas Southwestern Medical Center
                                F. Gasparini, Novartis Pharma AG
                                W.T. Greenough, University of Illinois
                                E. Berry-Kravis, Rush University Medical Center
                                K. Clapp, FRAXA Research Foundation
There has been much progress in the past years in several areas of research on Fragile X, but there
is still much to be learned. This meeting focused on the basic mechanisms of FMRP function, the
consequences of its loss on synaptic and circuit function, and therapies for treatment. Some questions
that were examined included: How does FMRP regulate translation and processing of its associated
mRNAs? How is neuronal circuit function altered in Fragile X Syndrome and can this explain the
behavioral symptoms of the disease? 
Introductory Remarks: J.A. Witkowski, Banbury Center
Opening Comments: K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
SESSION 1: Molecular Functions of FMRP and Related Proteins
Chairperson: D. Nelson, Baylor College of Medicine, Houston, Texas
H. Moine, Institute de Genetique, Illkirch, France: FMRP in
mRNA metabolism: From RISC to dendritic mRNA
control.
C. Bagni, K.U. Leuven University, Belgium: Developmental
changes of the FMRP-BC1 interaction alter the regulation 
of synaptic translation.
360
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SESSION 2: Synaptic Mechanisms of FMRP Function and Alterations in Fragile X Syndrome
Chairperson: W.T. Greenough, University of Illinois, Urbana
G. Bassell, Emory University, Atlanta, Georgia: FMRP and
miRNA-mediated translation regulation at synapses.
P. Vanderklish, Scripps Research Institute, La Jolla, California:
Kinase and phosphatase regulatory protein abnormalities in
the Fmr1 KO.
K. Huber, University of Texas Southwestern Medical Center,
Dallas: FMRP regulation of mGluR-dependent long-term
depression.
S. Zukin, Albert Einstein College of Medicine, Bronx, New 
York: Dysregulation of mTOR signaling in a mouse model of
Fragile X.
I. Weiler, University of Illinois, Urbana Champaign: A novel
presynaptic defect in FXS.
T. Price, University of Arizona, Tucson: Axonal plasticity,
FMRP, and pain.
M. Zhuo, University of Toronto, Ontario, Canada: Regulation
of FMRP in prefrontal cortex.
M. Bear, Massachusetts Institute of Technology, Cambridge:
Hypersensitivity to, not hyperactivity of, mGluR5 in Fragile X.
S. Chattarji, Tata Institute of Fundamental Research, Bangalore,
India: Characterization and reversal of synaptic defects in the
amygdala in a mouse model of Fragile X syndrome.
B. Oostra, Erasmus University, Rotterdam, The Netherlands:
Effects of mGluR antagonists on neurons.
SESSION 3: Circuit Function and Development in Fragile X Syndrome
Chairperson: K. Huber, University of Texas Southwestern Medical Center, Dallas
K. Broadie, Vanderbilt University & Medical School,
Nashville, Tennessee: Drosophila model of Fragile X: Brain
circuit function.
D. Nelson, Baylor College of Medicine, Houston, Texas:
Developmental requirements of FMRP.
P. Kind, University of Edinburgh, United Kingdom: Role of
FMRP in early postnatal development of the cerebral cortex.
J. Gibson, University of Texas Southwestern Medical Center,
Dallas: Alterations in neocortical connectivity and circuit
function in the Fmr1 KO mouse.
M. Avoli, McGill University, Montreal, Canada: Tonic
inhibition and Fragile X syndrome.
R. Wong, SUNY–Downstate Health Science Center,
Brooklyn, New York: Plasticity mechanisms for mGluR-
mediated epileptiform activity in Fragile X mice.
L. Kaczmarek, Yale University School of Medicine, New
Haven, Connecticut: FMRP and sodium-activated
potassium channels.
SESSION 4: Therapeutics in Animal Models of Fragile X Syndrome and Patients
Chairperson: M. Tranfaglia, FRAXA Research Institute, Newburyport, Massachusetts
F. Bolduc, University of Alberta, Edmonton, Canada: Fragile
X flies and memory: Therapeutic approaches.
W. Spooren, F. Hoffmann-LaRoche Ltd., Basel, Switzerland:
Translational aspects of Fragile X.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
MGluR5 antagonists as antihyperalgesic in models for
inflammatory pain.
R. Hagerman, University of California Davis Health System,
Sacramento: Minocycline treatment in Fragile X syndrome.
E. Berry-Kravis, Rush University Medical Center, Chicago,
Illinois: Pilot measures of inhibition and executive function
for clinical trials in FXS.
S. Jacquemont, University Hospital, Lausanne, Switzerland:
Phase-2 clinical trials of a specific mGluR5 antagonist in
Fragile X syndrome.
C.B. Smith, National Institutes of Health/NIMH, Bethesda,
Maryland: Fragile X permutation: Morphological,
behavioral, and neurochemical effects in a mouse model.
S. Vasudevan, Yale University, New Haven, Connecticut:
Translational regulation by microRNPs.
J. Darnell, The Rockefeller University, New York:
Identification of neuronal RNA ligands of FMRP by cross-
linking–IP analysis.
J. Richter, University of Massachusetts Medical School,
Worcester: RNA processing and synaptic plasticity.
P. Lombroso, Yale University School of Medicine, New Haven,
Connecticut: Taking STEPs to improve cognition: Role of
STEP in Fragile X syndrome.
W. Spooren
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Searching for Principles Underlying Memory in Biological Systems
April 12–15
FUNDED BY The Swartz Foundation
ARRANGED BY W.A. Suzuki, New York University
S. Fusi, Columbia University
This workshop brought together experimentalists and theoreticians studying both medial temporal
lobe functions and prefrontal functions, as well as their interactions. Participants included experi-
mentalists working on questions of synaptic plasticity and systems-level behavioral neurophysiology,
as well as human neuropsychologists. The goal was to encourage interaction and discussion between
theoreticians and experimentalists working at all of these different levels of analysis. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: Why this meeting? W.A. Suzuki, New York University, New York
S. Fusi, Columbia University, New York
SESSION 1: Functional Organization of the Medial Temporal Lobe: Views From Across Different Experimental
Systems
Chairperson: L. Davachi, New York University, New York
H. Eichenbaum, Boston University, Boston, Massachusetts:
How does the hippocampus integrate “what” and “where”
information?
J.T. Wixted, University of California, San Diego, La Jolla: Inter-
preting memory-related activity in the medical temporal lobe.
Y. Dudai, Weizmann Institute of Science, Rehovot, Israel:
Predicting not to predict too much: How the cellular
machinery of memory anticipates the uncertain future.
W.A. Suzuki, New York University, New York: Task-dependent
patterns of medial temporal lobe activity.
P. Dayan, University College London, United Kingdom:
Episodic control: Singular recall and optimal actions.
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SESSION 4: Working Memory
Chairperson: S. Grant, Wellcome Trust Sanger Institute, Hinxton, United Kingdom
SESSION 2: Functional Organization of the Medial Temporal Lobe: Views from Across 
Different Experimental Systems
Chairperson: H. Eichenbaum, Boston University, Boston, Massachusetts
D.L. Shachter, Harvard University, Cambridge, Massachu-
setts: Episodic simulation of future events and the medial
temporal lobe.
D. Shohamy, Columbia University, New York: Striatal and
hippocampal contributions to different forms of learning.
L. Davachi, New York University, New York: Memory signals
in the human medial temporal lobe.
G. Buzsaki, Rutgers, The State University of New Jersey,
Newark: Cell assembly sequences in the service of memory.
C. Stark, University of California, Irvine: Pattern separation in
the human hippocampus.
N. Burgess, University College London, United Kingdom:
Neural mechanisms of spatial memory.
L. Colgin, Kavli Institute for Systems Neuroscience, Trond-
heim, Norway: High and low frequencies of γ oscillations serve
as discrete communication channels in the hippocampus.
J.J. Knierim, Johns Hopkins University, Baltimore, Maryland:
Medial and lateral entorhinal inputs to the hippocampus.
M.A. Wilson, Massachusetts Institute of Technology,
Cambridge: Memory reactivation in the hippocampus.
S. Fusi, Columbia University, New York: Memories on
multiple timescales: The importance of heterogeneity and
memory transfer.
SESSION 3: Hippocampal Functions: Theoretical and Experimental Views
Chairperson: G. Buzsaki, Rutgers, The State University of New Jersey, Newark
E.K. Miller, Massachusetts Institute of Technology,
Cambridge: Brain rhythms and short-term memory.
X.J. Wang, Yale University School of Medicine, New Haven,
Connecticut: Slow reverberation mechanism of working
memory.
S. Ganguli, University of California, San Franciso: Short-term
sequence memory in neuronal networks.
A. Treves, SISSA–Cognitive Neuroscience, Trieste, Italy:
Creative latching dynamics in simplified cortical networks.
M.V. Tosodyks, Weizmann Institute of Science, Rehovot,
Israel: Synaptic theory of working memory.
SESSION 5: Synaptic Plasticity: Theory and Experiments
Chairperson: W.A. Suzuki, New York University, New York
L.F. Abbott, Columbia University, New York: Chemical
kinetics and memory.
S. Grant, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom: Synapse complexity.
A. Maffei, SUNY, Stony Brook, New York: Plasticity of
inhibition in visual cortex.
S. Wang, Princeton University, Princeton, New Jersey:
Elements of synaptic learning rules.
M.A. Hauser, University College London, United Kingdom:
How do the properties of dendrites influence synaptic
plasticity and memory storage? Y. Dudai
G. Buzsaki
N. Burgess, C. Stark
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Molecular Biology of Sirtuins 
April 26–29
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY L.P. Guarente, Massachusetts Institute of Technology
D.A. Sinclair, Harvard Medical School
In the 1990s, the Sir2 protein was identified as a key regulator of lifespan in budding yeast. Since
then, it has become increasingly clear that the Sir2 family proteins are highly conserved enzymes
that mediate many of the health benefits of calorie restriction. Sirtuins are becoming increasingly
appreciated for their potential in treating diverse diseases, from neurodegeneration to Type II dia-
betes. The modulation of sirtuins by metabolites such as NAD+ and nicotinamide, by environmental
changes such as DNA damage, diet and exercise, and most recently by small drug-like molecules,
has further increased interest in sirtuins. Participants in this meeting discussed new directions for
research on sirtuins and identified how sirtuins can be used for improving human health. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Metabolism 1
Chairperson: D.A. Sinclair, Harvard Medical School, Boston, Massachusetts
D. Accili, Columbia University, New York: Metabolic actions
of Sirt1.
J. Auwerx, Ecole Polytechnique Federal de Lausanne,
Switzerland: A cofactor network to control metabolism.
N. Barzilai, Albert Einstein College of Medicine, Bronx, New
York: Central effects of Sirt1 on peripheral glucose
homeostasis.
R. de Cabo, National Institutes of Health/NIA, Baltimore,
Maryland: Health and longevity consequences of activating
SIRT1.
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M.Y. Donath, University Hospital Zurich, Switzerland: SIRT1
in type-1 diabetes and autoimmune/autoinflam-matory
diseases.
S.-I. Imai, Washington University School of Medicine, St.
Louis, Missouri: Systemic regulation of metabolism and
aging by SIRT1 and Nampt-mediated NAD biosynthesis.
C. Deng, National Institutes of Health/NIDD, Bethesda,
Maryland: Sirt6 in glucose and fat metabolism.
SESSION 2: Neuro-Cancer
Chairperson: D. Accili, Columbia University, New York
A. Brunet, Stanford University, Stanford, California: Sirt1 and
Fox03 in adult neural stem cells.
R. Coppari, University of Texas Southwestern Medical Center,
Dallas: Brain SIRT1: A novel target to treat diet-induced
metabolic dysfunctions?
L.P. Guarante, Massachusetts Institute of Technology,
Cambridge: Sirtuins and disease.
L.-H. Tsai, Massachusetts Institute of Technology, Cambridge:
Role of SIRT1 in neuroprotections and cognition.
E.N. Chini, Mayo Clinic, Rochester, Minnesota: Role of the
NADase CD38 and the nuclear protein DBC1 as regulators
of SIRT1 and metabolism.
Z. Lou, Mayo Clinic, Rochester, Minnesota: A c-Myc/SIRT 1
feedback loop regulates cell growth and transformation.
S.-J. Lin, University of California, Davis: Sirtuins, NAD
metabolism, and calorie restriction: Insight from S. cerevisiae.
M.W. McBurney, Ottawa Health Research Institute, Ontario,
Canada: Roles of FMRP in neuronal architecture develop-
ment and synaptogenesis.
T. Nystrom, CMB Gothenborg University, Gothenborg,
Sweden: Global genetic interaction network of Sir2 
and damage segregation.
V. Sartorelli, National Institutes of Health/NIAMS, IRP,
Bethesda, Maryland: Roles of SIRT1 in skeletal muscle.
K. Irani, University of Pittsburgh Medical Center, Pittsburgh,
Pennsylvania: Nitroso-redox regulation of SIRT1.
P. Sassone-Corsi, University of California, Irvine: SIRT and
circadian clock.
SESSION 3: Metabolism 2
Chairperson: A. Brunet, Stanford University, Stanford, California
SESSION 4: Metabolism 3 and Drugs
Chairperson: S.-J. Lin, University of California, Davis
D.A. Sinclair, Harvard Medical School, Boston, Massachusetts:
Genes and small molecules that modulate sirtuins.
Y. Suh, Albert Einstein College of Medicine, Bronx, New York:
Genetic variation in sirtuins and disease.
L. Bordone, Novartis Institute for Biomedical Research,
Cambridge, Massachusetts: Therapeutic opportunities for
sirtuins.
G.P. Vlasuk and C. Westphal, Sirtris, Cambridge, Massachu-
setts: New therapeutic opportunities for pharmacological
modulators of sirtuin activity.
SESSION 5: SIRT2–7
Chairperson: L.P. Guarante, Massachusetts Institute of
Technology, Cambridge
M. Haigis, Harvard Medical School, Boston, Massachusetts:
Understanding the impact of sirtuins on mitochondrial
metabolism.
A.A. Sauve, Weill Cornell Medical College, New York: 
Enzymology and chemical reactivity of SIRT5 and 
SIRT6.
Q. Tong, Baylor College of Medicine, Houston, Texas:
Functions of SIRT2 and SIRT3.
A. Brunet, S.-I. Imai, P. Sassone-Corsi
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The First NIMH-sponsored Brain Camp
April 29–May 2 
FUNDED BY           National Institute of Mental Health
ARRANGED BY M. Akil, National Institute of Mental Health
T.R. Insel, National Institute of Mental Health
There is a need to link psychiatry training to neuroscience. Although psychiatric disorders such as
schizophrenia and depression are regarded as brain disorders, current training programs in psychiatry
include very little of the findings of modern neuroscience. This NIMH-sponsored “brain camp”
was a first attempt to see whether this situation can be rectified by providing psychiatry residents
with an intense exposure to the world of cognitive neuroscience. To this end, more than 20 psychi-
atry residents and 17 speakers participated in in-depth discussions of a variety of topics.
Introduction and Charge: T.R. Insel, National Institute of Mental Health, Bethesda, Maryland
SESSION 1: Genetics
F. McMahon, National Institute of Mental Health, Bethesda,
Maryland  
M.W. State, Yale University School of Medicine, New Haven,
Connecticut  
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SESSION 2: Social Neuroscience: The social brain
R. Adolphs, California Institute of Technology, Pasadena
T.R. Insel, National Institute of Mental Health, Bethesda,
Maryland
SESSION 3: Developmental Neurobiology/Schizophrenia
S.A. Anderson, Weill Medical College of Cornell University,
New York 
D.A. Lewis, University of Pittsburgh Medical Center,
Pittsburgh, Pennsylvania 
Discussion with the organizers: Teaching neuroscience in
medical school and during psychiatry training; what’s
missing?
SESSION 4: The Neurobiology of Affect, Emotion, and
Affective Disorders
M. Davis, Emory University, Atlanta, Georgia  
H. Akil, University of Michigan, Ann Arbor 
K. J. Ressler, Emory University, Atlanta, Georgia
SESSION 5: Cognitive Neuroscience
C. Carter, University of California Davis, Sacramento 
J.D. Cohen, Princeton University, Princeton, New Jersey 
D. Barch, Washington University, St. Louis, Missouri
Special Presentation: Molecular and Cellular Tools for
Studying and Perturbing Brain Circuits
K. Deisseroth, Stanford University, Stanford 
SESSION 6: Cognitive Neuroscience II
J. Wallis, University of California, Berkeley 
M. Frank, Brown University, Providence, Rhode Island  
SESSION 7: Effects of Pre- and Postnatal
Experiences on Adult Stress Response and 
Disease Vulnerability
E.J. Nestler, Mount Sinai School of Medicine, 
New York 
F. Champagne, Columbia University, New York 
R. Caceda
J. Coughlin, M. Nakic
S. Wang
D. Ross
T. Insel, A. Yusim
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International Catalog for the History of the Human Genome Project
June 16–17
FUNDED BY The Wellcome Trust
ARRANGED BY L. Pollock, Library and Archives, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
The Human Genome Project (HGP) was one of the great scientific enterprises of the 20th century,
and we have initiated a program to document the history of the HGP and related sequencing proj-
ects. The first goal of this project is to create a comprehensive database of the locations, nature, and
description of materials relating to the HGP, whether held by scientists, academic institutions, foun-
dations, or government departments. This discussion meeting was held to examine how other or-
ganizations have assembled such databases, to review the proposed project, and to suggest
amendments and modifications in the light of other experience.
Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: L. Pollock, Library and Archives, Cold Spring Harbor Laboratory
SESSION 1: Case Studies
J. Anderson, Niels Bohr Library and Archives, American
Institute of Physics, College Park, Maryland: Center for
History of Physics at the American Institute of Physics.
P. Theerman, NLM History of Medicine, Bethesda, Maryland:
National Library of Medicine’s Profiles in Science.
J. Van Oudenaren, World Digital Library, Library of Congress,
Washington, D.C.: World Digital Library.
R. Moore, Data Intensive Cyber Environments, Renaissance
Computing Institute, Chapel Hill, North Carolina:
Managing and integrating diverse data sets.
M. Olson, J.D. Watson
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SESSION 2: About the Project
M. Pollock, Library and Archives, Cold Spring Harbor Laboratory: Immediate
and future goals.
SESSION 3: Planning the Next Steps: What Should We Consider?
Types and Sources of Materials
What period should be covered?
What should be collected?
Where is it?
How Much is There?
Organization—How to do it?
Project plan
Phases
Collaborations
Funding: How Can We Fund the Project?
Where from?
What about long-term support?
What working groups would be useful?
Group I: Technical issues relating to managing and
integrating data.
Group II: Identifying collections and owners of relevant 
materials.
Group III: Finance.
SESSION 4: Summary and Conclusions
Personal Remarks: J.D. Watson, Cold Spring Harbor Laboratory
E. Carlson
A. Patrinos, C. DeLisi J. Weissenbach
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Arbuscular Mycorrhizal Symbioses and Their Impact on Plant Nutrition
September 8–11
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M. Harrison, Cornell University
U. Paszkowski, Université de Lausanne
The arbuscular mycorrhizal (AM) symbiosis is a widespread plant–fungal interaction that occurs
between roots of terrestrial plants and Glomeromycotan fungi. This association has received con-
siderable scientific attention because of (1) the nutritional benefit it confers on the plant by im-
proving access to otherwise limiting sources of nutrients, (2) its widespread occurrence among extant
plants and significance in terrestrial ecosystems, and (3) its ancestral role in the evolution of symbiosis
signaling pathways. This discussion meeting focused on AM symbioses and their impact on plant
nutrition and brought together key researchers from the AM symbiosis, plant mineral nutrition,
and root architecture fields.
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M. Harrison, Boyce Thompson Institute, Cornell University, Ithaca, New York
U. Paszkowski, Université de Lausanne, Lausanne, Switzerland
SESSION 1: Signaling and Development of Arbuscular Mycorrhizal Symbiosis
Chairperson: M. Parniske, University of Munich, Munich, Germany
P. Young, University of York, United Kingdom: The glomus
genome: What we have learnt so far?
G. Becard, University of Toulouse, France: Early signaling in
the AM symbiosis from the lab to the field.
M. Parniske, University of Munich, Germany: Signal
transduction in symbiosis.
G. Oldroyd, John Innes Center, BBSRC, United Kingdom:
Early signaling events during the establishment of the
mycorrhizal association.
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SESSION 2: Phosphorus and Nitrogen Sensing and Signaling
Chairperson: S. Abel, University of California, Davis
M. Udvardi, Samuel Roberts Nobleel Foundation, Ardmore,
Oklahoma: HERMES: A Medicago gene required for both
AM and nitrogen-fixing/rhizobial symbioses.
S. Abel, University of California, Davis: Phosphate sensing in
root development.
J. Paz-Ares, Centro National de Biotechnologia, Madrid,
Spain: Phosphate starvation signaling in Arabidopsis.
B. Forde, Lancaster University, United Kingdom: Nitrogen
signaling and the modulation of root architecture.
SESSION 3: Root Architecture and Mineral Nutrient Acquisition
Chairperson: D. Schachtman, Donald Danforth Plant Science Center, 
St. Louis, Missouri
E. Nielsen, University of Michigan, Ann Arbor: Polarized
membrane trafficking during root hair growth.
C. Hardtke, Université de Lausanne, Lausanne, Switzerland:
Natural genetic variation.
J. Lynch, Pennsylvania State University, University Park: Root
architecture and AMs.
SESSION 4: Mineral Nutrient Acquisition in AM Symbiosis
Chairperson: M. Harrison, Boyce Thompson Institute,
Cornell University, Ithaca, New York
I. Jakobsen, Technical University of Denmark, Roskilde,
Denmark: Functional analysis of Pi uptake pathways by
means of VIGS.
D. Schachtman, Donald Danforth Plant Science Center, St.
Louis, Missouri: Response of mycorrhizal and
nonmycorrhizal tomato roots to nutrient enriched soil
patches.
E. Neumann, Institute of Vegetable and Ornamental Crops,
Grossbeeren, Germany: Exploitation of different soil
nitrogen resources by the extraradial mycelium of arbuscular
mycorrhizal fungi.
Y. Shachar-Hill, Michigan State University, East Lansing:
Movement and metabolism of carbon, nitrogen, and sulfur
in the AM symbiosis.
D. Reinhardt, University of Fribourg, Fribourg, Switzerland:
Regulation of AM symbiosis by nutrients.
M. Harrison, Boyce Thompson Institute, Cornell University,
Ithaca, New York: Phosphate transport in AM symbiosis.
U. Paszkowski
SESSION 5: Functional Diversity in AM Symbiosis
Chairperson: U. Paszkowski, Université de Lausanne, 
Lausanne, Switzerland
J. Bever, Indiana University, Bloomington: Preferential
allocation of plant photosynthate and the maintenance of the
AM mutualism.
D. Janos, University of Miami, Coral Gables, Florida:
Evolution of dependence upon, responsiveness to, and
effectiveness of AM.
S. Kaeppler, University of Wisconsin, Madison: Variation
among maize lines for mycorrhizal responsiveness under P
stress.
U. Paszkowski, Université de Lausanne, Lausanne,
Switzerland: Molecular genetics of the AM symbiosis in
cereals.
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From Infection to Neurometabolism: A Nexus for CFS
September 13–16
FUNDED BY National Institutes of Health and the CFIDS Association of America
ARRANGED BY S. Vernon, CFIDS Association of America
E. Hanna, NIH, Office of Research on Women’s Health
Chronic fatigue and widespread pain are common physical symptoms and unfortunately are the
most likely to remain unexplained. Chief among illnesses characterized by medically unexplained
chronic fatigue and pain is chronic fatigue syndrome (CFS), afflicting at least 4 million American
adults. Despite more than 20 years of CFS research and more than 5000 peer-reviewed biomedical
publications detailing infection, genetic polymorphisms, and brain metabolism in CFS, there is still
no evidence-based diagnosis and treatment. The objective of this workshop was to lay the foundation
for an expanded CFS research network that will work toward evidence-based objective diagnosis
and treatment of CFS. 
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Gathering and Integration of Information to Identify Biomarkers for CFS Diagnosis and Treatment
Chairpersons: S. Vernon, CFIDS Association of America, Charlotte, North Carolina, and 
E. Hanna, NIH, Office of Research on Women’s Health, Bethesda, Maryland
K. McCleary, CFIDS Association of America, Charlotte,
North Carolina: Supporting CFS research through advocacy.
E. Hanna, NIH, Office of Research on Women’s Health,
Bethesda, Maryland: Establishing and supporting a CFS
research network.
L. Bateman, The Fatigue Consultation Clinic, Salt Lake City,
Utah: The minimal clinical information required in a
research network.
L. Jason, DePaul University, Chicago, Illinois: Importance of
defining CFS for research studies.
S. Vernon, CFIDS Association of America, Charlotte, North
Carolina: The minimal laboratory information required in a
research network.
B. Mishra, New York University, New York: Computational
possibilities of a research network.
S. Srivastava, National Cancer Institute, Bethesda, Maryland:
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Establishing an evidence-based biomarker research network.
K. Helmer, Massachusetts General Hospital, Charleston:
Creating a research network using BIRN resources.
SESSION 2: Infectious and Immunologic Biomarkers of CFS
Chairpersons: S. Vernon, CFIDS Association of America, Charlotte, North Carolina, and
E. Hanna, NIH, Office of Research on Women’s Health, Bethesda, Maryland
M. Hornig, Columbia University, New York: Chronic viruses
as biomarkers.
B. Katz, Children’s Memorial Hospital, Chicago, Illinois:
EBV: Cause, trigger, or sustain CFS.
B. Huber, Tufts University School of Medicine, Boston,
Massachusetts: Endogenous retroviruses: Cause, trigger, or
sustain CFS.
R. Engler, Walter Reed Army Medical Center, Washington,
D.C.: Vaccines and CFS.
T. Theoharides, Tufts University School of Medicine, Boston,
Massachusetts: Mast cells and CFS.
K. Light, University of Utah Health Sciences Center, Salt Lake
City: Peripheral blood biomarkers in CFS.
M. Fletcher, University of Miami School of Medicine, Miami,
Florida: Neuroimmune biomarkers in CFS.
P. Rowe, Johns Hopkins University, Baltimore, Maryland:
Orthostatic stability and instability.
I. Biaggioni, Vanderbilt University, Nashville, Tennessee:
Biomarkers of blood pressure regulation.
M. Medow, New York Medical College, Valhalla: Cerebral
blood flow and autoregulation.
J. Stewart, New York Medical College, Hawthorne: Blood flow
biomarkers in CFS.
D. Shungu, Weill Medical College of Cornell University, New
York: Brain metabolic correlates of CFS.
D. Cook, University of Wisconsin, Madison: Brain function as
indicated by fMRI in CFS.
B. Natelson, Beth Israel Medical Center, New York:
Neurologic biomarkers in CFS.
Evidence evaluation and summary sessions of infection and immunity presentations
S. Raj, A. Vincent, N. Klimas, T. Komaroff, L. Royster, C. Bausch, S. Vernon, E. Hanna, K. McCleary, S. Yale, E.
Aslakson, B. Evengard 
SESSION 3: ANS and CNS Biomarkers of CFS  
Chairpersons: S. Vernon, CFIDS Association of America, Charlotte, North Carolina, and
E. Hanna, NIH, Office of Research on Women’s Health, Bethesda, Maryland
SESSION 4: Future Directions
Chairpersons: K. McCleary, CFIDS Association of America, Charlotte, North Carolina, and
L. Royster, DePaul University, Chicago, Illinois
A. Kogelnik, Open Medicine Institute, Mount View,
California: Electronic medical record and genetics as
biomarkers of CFS.
J. Baraniuk, Georgetown University, Washington, D.C.:
Proteomic biomarkers of CFS.
G. Broderick, University of Alberta, Edmonton, Canada:
Genomic identification of dysfunctional cell subsets as
biomarkers.
S. Shukla, Marshfield Clinic Research Foundation, Marshfield,
Wisconsin: Metagenomic approach to investigate
microbiological markers.
Workgroup meets to evaluate evidence and summarize sessions of ANS, CNS, and omic presentations
S. Raj, A. Vincent, N. Klimas, T. Komaroff, L. Royster, C. Bausch, S. Vernon, E. Hanna, K. McCleary, S. Yale, E.
Aslakson, B. Evengard
SESSION 5: Evaluation and Summary Reports
Chairpersons: S. Vernon, CFIDS Association of America, Charlotte, North Carolina, and
E. Hanna, NIH, Office of Research on Women’s Health, Bethesda, Maryland
Y. Setty, Microsoft Research Cambridge, Cambridge, United
Kingdom: Can a research network help realistic modeling of
CFS?
A. Komaroff, Harvard Medical School, Boston, Massachusetts:
Infectious agents as CFS biomarkers.
N. Klimas, University of Miami, Miami, Florida: Immuno-
logic and omic biomarkers of CFS.
S. Raj, Vanderbilt University, Nashville, Tennessee: ANS and
CNS biomarkers of CFS.
Research Network Next Steps: 
E. Hanna, NIH, Office of Research on Women’s Health,
Bethesda, Maryland
S. Vernon, CFIDS Association of America, Charlotte, North
Carolina
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Epigenetic Inheritance, Gene Regulation, and Plant Development
September 20–23 
FUNDED BY The Cold Spring Harbor–Pioneer Collaborative Research Program
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
S. Tingey, DuPont Experimental Station
This meeting fulfilled two functions. The first was that it provided an opportunity for participants
in the Cold Spring Harbor Laboratory–DuPont-Pioneer collaboration to meet one another and to
exchange data, information, and ideas, and to review progress. Second, epigenetics is of special in-
terest in plant science, and one day of the meeting was devoted to a minisymposium on the topic
with invited speakers drawn from outside the collaboration.
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Epigenetics and Functional Genomics
Chairperson: J.A. Rafalski, DuPont Experimental Station, Delaware
R. Martienssen (R. Schwab), Cold Spring Harbor Laboratory:
Efficiency of artificial miRNA.
M. Aukerman, DuPont Experimental Station, Wilmington,
Delaware: miRNAs for translational silencing.
B. Meeley, Pioneer Hi-Bred International, Johnston, Iowa:
Activation tagging in maize and other updates.
M. Tanurdzic, Cold Spring Harbor Laboratory: Epigenetic
variation.
W. McCombie, Cold Spring Harbor Laboratory: Next-
generation sequencing.
J. Hicks and J. Kendall, Cold Spring Harbor Laboratory:
Hybrid capture bisulfite sequencing.
M. Regulski, Cold Spring Harbor Laboratory:  Hybrid capture
of maize DNA/discussion.
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SESSION 4: Epigenetic Inheritance
Chairperson: M. Auckerman, DuPont Experimental Station, Delaware
V. Colot, CNRS–École Normale Supérieure, Paris, France:
The other side of genetics: Epigenetics across generations.
J. Paszkowski, Unversity of Geneva, Geneva, Switzerland: Role
of methylation in transgenerational inheritance.
E. Richards, Cornell University, Ithaca, New York: Epigenetic
variation or resistance gene variation/instability.
R. Martienssen, Cold Spring Harbor Laboratory:
Reprogramming of transposons in pollen.
J.P. Vielle-Calzada, National Laboratory of Genomics for
Biodiversity, Carretera Irapuato-Leon, Mexico: Control of
gamete formation by a small RNA pathway in Arabidopsis.
SESSION 5: The Maize Genome and General Discussion
Chairperson: S. Tingey, Dupont Experimental Station, Delaware
D. Ware Laboratory, Cold Spring Harbor Laboratory
J. Stein: Genome fractionation/evoluntionary analysis.
J.-M. Chia: Diversity/HapMap.
C. Liang: Gene building and incorporation of RNA-Seq
data. 
SESSION 2: Gene Expression and Development
Chairperson: D. Jackson, Cold Spring Harbor Laboratory
J. Tisdall, DuPont Experimental Station, Wilmington,
Delaware: Whole transcriptome work.
A. Eveland, Cold Spring Harbor Laboratory: Analysis of solexa
transcriptome data.
V. Llaca, Pioneer Hi-Bred International, Johnston, Iowa and S.
DesChamps, Dupont Experimental Station, Wilmington,
Delaware: SBS technology. 
P. Bommert, Cold Spring Harbor Laboratory: Positional
cloning of fasciated ear genes.
M. Guo, Pioneer Hi-Bred International, Johnston, Iowa:
Regulation of organ size in maize.
D. Jackson, Cold Spring Harbor Laboratory: Fluorescent
reporter lines in maize.
M. Dotto, Cold Spring Harbor Laboratory: Leaf patterning by
laxmidrib and tasiRNA pathways.
D. Ware, Cold Spring Harbor Laboratory: Sequencing the
maize genome.
A. Rafalski, DuPont Experimental Station, Wilmington,
Delaware: Genome technologies.
N. Springer, University of Minnesota, St. Paul: Links between
genomic structure variation and epigenetic variation in
maize.
M. Timmermans, Cold Spring Harbor Laboratory: Mutations
in the maize tasiRNA pathway affect multiple developmental
processes.
Z. Lippman, Cold Spring Harbor Laboratory: Inflorescence
architecture, flowering, and heterosis.
V. Chandler, Gordon and Betty Moore Foundation, Palo Alto,
California: Paramutation.
SESSION 3: Genomes and Epigenomes in Plant Development
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
D. Ware, M. TimmermansJ. Paszkowski, J. Rafalski
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Psychiatric Genetics: Current Progress and Future Directions
September 23–24 
FUNDED BY The Stanley Research Foundation
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
S.C. Gary, Cold Spring Harbor Laboratory
E. Scolnick, Broad Institute, Massachusetts Institute of Technology
Ted and Veda Stanley and the Stanley Medical Research Institute are most generous supporters of
research on schizophrenia and bipolar disorder. Among their initiatives are the Stanley Center for
Psychiatric Research at the Broad Institute, and the Stanley Institute for Cognitive Genomics at
Cold Spring Harbor Laboratory (CSHL). Both groups are using the latest genome technologies to
search for genetic alterations that contribute to schizophrenia and bipolar disorder. This meeting
brought Stanley-funded investigators from the Broad Institute and CSHL together, with the goals
of providing an update on the research and reviewing topics that may be the basis for future projects
and collaborations.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: J.D. Watson, Cold Spring Harbor Laboratory
SESSION 1: Genetics Update
Chairperson: T. Schulze, National Institutes of Health/NIMH, Bethesda, Maryland 
J. Sebat, Cold Spring Harbor Laboratory
W.R. McCombie, Cold Spring Harbor Laboratory
P. Sklar, Broad Institute, MIT, Harvard University, 
Boston, Massachusetts
N. Craddock, Cardiff University School of Medicine, 
Cardiff, United Kingdom
Coffee break
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SESSION 2: Genetics: Next Steps
Chairperson: P. Sklar, Broad Institute, MIT, Harvard University, Boston, Massachusetts
E. Leibenluft, National Institutes of Health/NIMH, Bethesda,
Maryland
T. Schulze, National Institutes of Health/NIMH, Bethesda,
Maryland
SESSION 3: Neuroscience
Chairperson: L. Tsai, Massachusetts Institute of Technology, Cambridge
K. Singh, Broad Institute, Boston, Massachusetts
A. Sawa, Johns Hopkins School of Medicine, Baltimore,
Maryland
P. Osten, Cold Spring Harbor Laboratory
B. Li, Cold Spring Harbor Laboratory
T. Petryshen, Broad Institute, MIT, Boston, Massachusetts
H. Song, Johns Hopkins University School of Medicine,
Baltimore, Maryland
J. Madison, Broad Institute, MIT, Boston, Massachusetts
K. Brennand, The Salk Institute, La Jolla, California
SESSION 4: iPS
Chairperson: A. Malhotra, The Zucker Hillside Hospital, Glen Oaks, New York
SESSION 5: Drug Discovery
Chairperson: M. Moyer, Broad Institute, Cambridge, Massachusetts
S. Haggarty, Broad Institute, Harvard University, Boston,
Massachusetts
J. Pan, Broad Institute, MIT, Boston, Massachusetts
SESSION 6: Stanley Medical Research Institute
Chairperson: B. Yolken, Johns Hopkins University, Baltimore, Maryland
S. Kim, Stanley Medical Research Institute
S. Sabunciyan, Stanley Medical Research Institute
L. Brando, Stanley Medical Research Institute
SESSION 7: Future Directions
Chairperson: E. Scolnick, Broad Institute, MIT, Cambridge, Massachusetts
Meeting Summary and Discusssion on Future Directions
SESSION 8: Special Session
Introduction: J.D. Watson, Cold Spring Harbor Laboratory
N. Craddock, Cardiff University School of Medicine, Cardiff,
United Kingdom
R. Perlis, Broad Institute, Massachusetts General Hospital,
Boston
E. Scolnick, Broad Institute, MIT, Cambridge, Massachusetts,
and J.D. Watson, Cold Spring Harbor Laboratory
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Science: Get It Across!
October 1–8
FUNDED BY Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine
ARRANGED BY C. Walther, Boehringer Ingelheim Fonds
S. Schedler, Boehringer Ingelheim Fonds
The Boehringer Ingelheim Fonds Foundation returned to the Banbury Center for their biannual
fellows meeting in North America. In addition to providing training for their fellows, the Foundation
very generously supported a special lecture by a visiting young scientist, given in Grace Auditorium
and open to all CSHL scientists. This year’s lecture, “Measuring evolution through space and time”
was given by Beth Shapiro, Shaffer Assistant Professor from the Department of Biology at Pennsyl-
vania State University. 
Opening Remarks: C. Walther, Boehringer Ingelheim Fonds, Heidesheim, Germany
Speakers
W. Wells, Global Alliance for TB Drug Development, New
York: Writing techniques and how to structure papers.
W. Tansey, Cold Spring Harbor Laboratory: Presentation of
graphic information and how to prepare and deliver a
scientific talk.
W. Tansey, Cold Spring Harbor Laboratory: Powerpoint
presentations and review of videotaped presentations.
Writing assignments. Review and critique of videotaped
presentations.
H. Ploegh, Whitehead Institute, Cambridge, Massachusetts:
What makes success in science?
C. Walther, Boehringer Ingelheim Fonds, Heidesheim,
Germany: All about Boehringer Ingelheim Fonds.
B. Shapiro, Pennsylvania State University, University Park:
Measuring evolution through space and time at Grace
Auditorium. 
M. Hansen and M. Corral, Nature Publishing Group, New
York: Graphic assignments and presentations.
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Aquatic Plants: Environment, Energy, and Evolution
October 18–21 
FUNDED BY The Gordon and Betty Moore Foundation
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
J. Shanklin, Brookhaven National Laboratories
T. Michael, Rutgers University
The aquatic plant duckweed (Lemna spp.) has been proposed as an aquatic plant “model” system.
They are easy to culture and some species have relatively compact genomes. They propagate vege-
tatively as well as sexually, have the fastest known doubling time of flowering plants, and are
amenable for transient transformation. The Joint Genome Institute recently embarked on sequenc-
ing the Spirodela polyrhiza genome. Participants in this workshop critically reviewed the biological
and genetic properties of duckweed, which may lead to its use in many fields, including plant biol-
ogy, aquatic biology, biomass, biofuels, metabolic engineering, and bioremediation. 
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: R. Martienssen, Cold Spring Harbor Laboratory
SESSION 1: Genetics and Genomics
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
I. Sussex, Yale University, New Haven, Connecticut, and E.
Landolt, ETH, Zurich, Switzerland: Comments to the
morphological systematic and to the genotypic variability of
Lemnaceae (read by M. Eberius, LemnaTec GmbH,
Würselen, Germany).
M. Edelman, Weizmann Institute of Science, Rehovot, Israel:
Lemnaceae: Model plants for in vivo studies.
R. McCombie, Cold Spring Harbor Laboratory: Sequencing
Lemna and other plant genomes using next-generation
sequencing.
T. Michael, Rutgers University, Piscataway, New Jersey: The
Duckweed Genome Project.
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SESSION 2: Biofuels, Bioremediation, and Other Opportunities
Chairperson: J. Shanklin, Brookhaven National Laboratory, Upton, New York
A. Stomp, North Carolina State University, Raleigh: The
Lemnaceae: Tantalizing opportunities and significant
challenges.
R. Kerstetter, Rutgers University, Piscataway, New Jersey: The
remarkable potential of duckweed as a biofuel feed stock.
C. Xu, Brookhaven National Laboratory, Upton, New York:
Regulatory mechanisms controlling biosyntheses and storage
in plants and microalgae.
K. Appenroth, University of Jena, Jena, Germany: The affair
between duckweeds and heavy metals.
J. Cheng, North Carolina State University, Raleigh: Growing
duckweed for nutrient recovery from wastewater.
SESSION 3: Evolution, Ecology, and Education
Chairperson: J. Messing, Rutgers University, Piscataway, New Jersey
C. De Pamphilis, Pennsylvania State University, University
Park: Tribe analyses, ancestral genes, and ancient polyploidy.
D. Les, University of Connecticut, Storrs: Phylogenetics and
genome evaluation in duckweeds and other aquatic plants.
V. de Miranda, Universidade de Mogi das Cruzes: Aspects of
biology, ecology, and evolution of Utricularia (Lentibulari-
aceae).
B. Greenburg, University of Waterloo, Waterloo, Canada: Use
of Lemna in environmental toxicology: An ideal system to
study mechanisms of phytotoxicology.
T. Oyama, Kyoto University, Kyoto, Japan: Genetic
manipulation of Lemna in the study of circadian rhythm.
D. Micklos, Dolan DNA Learning Center, Cold Spring
Harbor Laboratory: Discussion.
S. Tresch, BASF Agricultural Center, Limburgerhof, Germany:
Lemna paucicostata: A plant test organism in herbicide mode
of action research.
E. Lam, Rutgers University, New Brunswick, New Jersey:
Engineering of duckweed: Plastid transformation.
O. Babourina, University of Western Australia, Perth: Ion
transport in aquatic plants.
J. Schwender, Brookhaven National Laboratory, Upton, New
York: Duckweeds and metabolic studies using stable isotope
tracers.
J. Slovin, U.S. Department of Agriculture, Beltsville,
Maryland: Lemnacea as ideal organisms for metabolic
pathway research.
J. Cohen, University of Minnesota, St. Paul: Discussion.
SESSION 4: Physiology and Biochemistry
Chairperson: T. Michael, Rutgers University, Piscataway, New Jersey
SESSION 5: Aquatic Plants and Other Model Systems
Chairperson: T. Michael, Rutgers University, Piscataway, New Jersey
V. Citovsky, SUNY, Stony Brook, New York: Discussion.
T. Mockler, Oregon State University, Corvallis: Application of
next-generation sequencing to transcriptome annotation.
M. Eberius, LemnaTec GmbH, Würselen, Germany: High-
throughput screening for phenotype and growth to identify
and characterize genotype phenotype relation of duckweed.
R. Martienssen, Cold Spring Harbor Laboratory:
Developmental challenges and genetic solutions in biofuel
crop design.
SESSION 6: Strategies for Future Developments
Discussion moderated by
R. Martienssen, Cold Spring Harbor Laboratory
J. Shanklin, Brookhaven National Laboratories, Upton, New York
T. Michael, Rutgers University, Piscataway, New Jersey
A. Stomp
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Feedback Networks in the Intersection of Metabolism 
and Receptor Tyrosine Kinase Signaling
November 8–10
FUNDED BY OSI Pharmaceuticals, Inc.
ARRANGED BY J. Haley, OSI Pharmaceuticals
In recent years, it has become clear that proliferative and survival signaling pathways can be made
redundant by compensatory signaling through alternative pathways. Many of receptor tyrosine ki-
nase networks are subject to dynamic feedback controls through other pathways that impact the ef-
ficacy of single-agent targeted therapies. Similarly, many of the pathways specifically targeted by
recent cancer therapeutics are intersected by metabolic control networks that can dynamically alter
pathway inhibition and efficacy. This discussion meeting reviewed what is known of signaling net-
works affecting feedback control of energy utilization, receptor tyrosine kinase signaling, and their
intersection nodes and the modeling and imaging of networks and nodes. The goal was to develop
a better understanding of how combinations of targeted antitumor agents can overcome the com-
pensatory and feedback control that limits their use as single therapies.
Welcome and Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Background to Meeting: J. Haley, OSI Pharmaceuticals, Farmingdale, New York
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SESSION 3: Metabolic Controls in the Ras-Raf-Erk and Jnk/p38 Pathways
Chairperson: C. Thompson, University of Pennsylvania, Philadelphia
R. Marais, Institute of Cancer Research, London, England:
BRAF therapeutic opportunities.
S. Benkovic, Pennsylvania State University, University Park:
De novo purine biosyntheses: The “purinosome.”
R. Davis, University of Massachusetts Medical School/HHMI,
Worcester: Stress-activated MAP kinase regulation of insulin
signaling.
SESSION 4: Network Control of and by Protein Phosphatases
Chairperson: L. Cantley, Harvard Medical Center, Boston, Massachusetts
J. den Hertog, Hubrecht Institute, Utrecht, The Netherlands:
Protein tyrosine phosphatases in development and disease.
S. Keyse, University of Dundee, Dundee, Scotland: Regulation
of MAPK signaling by protein phosphatases.
T. Tiganis, Monash University, Victoria, Australia: Reactive
oxygen species, protein tyrosine phosphatases, and type 2
diabetes.
N. Tonks, Cold Spring Harbor Laboratory: Redox regulation
of PTP1B: Novel avenues for therapeutic intervention in
diabetes and obesity.
M. Comb, Cell Signaling Technology, Beverly, Massachusetts:
A new view on Akt signaling downstream from RTKs.
K. Janes, University of Virginia, Charlottesville: Identifying
feedback networks in single cells.
W. Hahn, Harvard Medical Center, Boston, Massachusetts:
Genetic approaches to dissect feedback and signaling in
cancer.
SESSION 5: Global Approaches to Interrogating Networks and
Systems
Chairperson: N. Tonks, Cold Spring Harbor Laboratory
SESSION 1: Metabolism-PI3K-Tor
Chairperson: J. Haley, OSI Pharmaceuticals, Farmingdale, New York 
C. Thompson, University of Pennsylvania, Philadelphia:
Metabolic intermediates amplify phosphotyrosine signaling.
M. Simon, University of Pennsylvania, Philadelphia: Oxygen
availability and tumor cell metabolism.
L. Cantley, Harvard Medical Center, Boston, Massachusetts:
PI3 kinase and cancer metabolism.
D. Sabatini, Whitehead Institute, Massachusetts Institute of
Technology, Cambridge: mTOR and the control of cell
growth.
P. Dennis, National Cancer Institute, Bethesda, Maryland:
Tissue-specific modulation of cancer signaling by metformin
in a model of chemoprevention.
W. Weiss, University of California, San Francisco: Akt and
autophagy cooperate to promote therapeutic resistance in
glioma.
N. Rosen, Memorial Sloan-Kettering Cancer Center, New
York: Octogene-induced feedback: Implications for therapy.
SESSION 2: Regulation of RTK Signaling Systems
Chairperson: C. Thompson, University of Pennsylvania, Philadelphia
Y. Yarden, Weizmann Institute of Science, Rehovot, Israel: The
ErbB/Her network.
N. Hynes, Friedrich Miescher Institute, Basel, Switzerland:
Targeting RTKs in breast cancer: ErbB, Ret, and FGFRs.
P. Carmeliet, Katholieke Universiteit, Leuven, Belgium:
Angiogenic strategies by targeting RTK or metabolism.
R. Davis
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Structural Variation in the Human Genome
November 15–18
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Lupski, Baylor College of Medicine
E. Eichler, University of Washington
Chromosomal rearrangements were the first genome-scale variations to be discovered in human be-
ings. They were detected by light microscopy of chromosomes stained with simple dyes and later at
higher resolution when Giemsa banding was introduced. Fifty years later, extraordinary resolution
is being provided by genomic microarrays and sequencing, and new classes of genomic variations
are being revealed. Copy-number variants (CNVs) are, perhaps, the most important of these. Rang-
ing in size from kilobases to megabases, CNVs have been associated with a number of human de-
velopmental disorders. However, much remains to be done before CNVs can be used routinely as
diagnostic markers. The goals of this meeting were to review the occurrence and generation of CNVs
in the human genome, discuss approaches for their discovery, examine their relationship with disease,
discuss their use for genetic diagnoses, and explore how to develop cost-effective tests.
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: E. Eichler, University of Washington, Seattle
J. Lupski, Baylor College of Medicine, Houston, Texas
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SESSION 1: CNVs: The Clinical Perspective
Chairperson: J. Lupski, Baylor College of Medicine, Houston, Texas
B. Bejjani, Signature Genomics Laboratories, Spokane,
Washington: Managing CNVs in the diagnostic laboratory.
P. Stankiewicz, Baylor College of Medicine, Houston, Texas:
Design of clinical arrays.
H. Firth, Addenbrooke’s Hospital, Cambridge, England:
Decipher/deciphering developmental disorders.
D. Ledbetter, Emory University School of Medicine, Atlanta,
Georgia: CNV atlas of human development.
SESSION 2: Mechanism and Evolution
Chairperson: M. Snyder, Stanford University School of Medicine, Stanford, California
J. Lupski, Baylor College of Medicine, Houston, Texas:
Genomic disorders: Mechanisms upstream and downstream
from CNV.
E. Hollox, University of Leicester, Leicester, England:
Evolution and variation of β-defensin copy number.
J. Sikela, University of Colorado, Aurora: Linking genome
instability, evolutionary adaptation, and disease.
P. Hastings, Baylor College of Medicine, Houston, Texas:
Mechanisms of structural change.
M. Gerstein, Yale University, New Haven, Connecticut:
Detection and analysis of structural variants in personal
genome sequencing data.
J. Korbel, EMBL Heidelberg, Heidelberg, Germany: Next-
generation analysis of structural variation in humans with a
breakpoint library.
H. Peckham, Life Technologies, Beverly, Massachusetts: CNV
detection with short-read sequencing.
M. Snyder, Stanford University School of Medicine, Stanford,
California: Variation and transcription factor binding in
humans.
E. Klopocki, Charité Universitätsmedizin Berlin, Berlin,
Germany: CNVs of conserved noncoding sequence elements:
A novel mechanism in the pathogenesis of congenital
malformations.
X. Zhang, Chinese Academy of Medical Sciences, Beijing,
China: Variable phenotypes associated with CNVs of the
same chromosomal regions.
SESSION 3: Next-generation Detection and Interpretation
Chairperson: E. Eichler, University of Washington, Seattle
SESSION 4: Neuropsychiatric Traits and CNV
Chairperson: H. Mefford, University of Washington, Seattle
S. Scherer, The Hospital for Sick Children, Toronto, Canada:
CNV in autism spectrum and related neurodevelopmental
disorders: Genome to outcome.
E. Eichler, University of Washington, Seattle: Genome
structural variation and disease.
A. Beaudet, Baylor College of Medicine, Houston, Texas:
Genotype/phenotype correlations for CHRNA7 to antisocial
behaviors.
J. Sebat, Cold Spring Harbor Laboratory: Looking for rare
variants of large effect in schizophrenia and bipolar disorder.
SESSION 5: CNV and Common Complex Traits
Chairperson: A. Beaudet, Baylor College of Medicine, Houston, Texas
H. Mefford, University of Washington, Seattle: CNVs in
epilepsy: Expanding the phenotypic spectrum of genomic
disorders.
T. Aitman, Imperial College, London, England: 
CNV and autoimmunity.
S. McCarroll, Harvard Medical School, Boston,
Massachusetts: Genome structural polymorphism in
common diseases.
SESSION 6: Interpretation of Phenotypic Consequences of CNV
Chairperson: A. Beaudet, Baylor College of Medicine, Houston, Texas
L. Pérez Jurado, University of Washington, Seattle: The hidden
variation: Common CNVs/PSVs in autism spectrum
disorders.
B. de Vries, University Medical Center Nijmegen, Nijmegan,
The Netherlands: Interpretation of CNVs in a clinical
setting; benign versus pathogenic.
N. Spinner, The Children’s Hospital of Philadelphia,
Philadelphia, Pennsylvania: Genomic alterations and
phenotype: Determining pathogenicity is NOT SO
SIMPLE.
Concluding Remarks: J. Lupski, Baylor College of Medicine, Houston, Texas
E. Eichler, University of Washington
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Promoting Research on Severe Mental Illness
December 3–5
FUNDED BY NARSAD, The Brain & Behavior Research Fund, World Heritage 
Foundation–Prechter Family Fund, Simons Foundation
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
E. Scolnick, Broad Institute
H. Pardes, New York Presbyterian Hospital
H. Heimer, Schizophrenia Research Forum
A. Moran, NARSAD
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Mental disorders place a terrible burden on society, and there is an urgent need to encourage Con-
gress to promote research on these disorders. A major effort to find the genes involved in mental
disorders began in the 1980s, but the then available tools were not suitable for the analysis of dis-
orders caused by many mutations. Continuing technical developments, many arising from the
Human Genome Project, have revitalized genetic analysis of complex disorders, and these new tech-
niques are being applied to mental disorders. Participants in this meeting included eminent scientists
and psychiatrists, as well as individuals familiar with promoting research, in this case, genomics-
based research, an approach offering the best path to treatments or prevention of mental disorders.
Welcome and Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcome and Introductory Remarks: C. Lieber and S. Lieber, NARSAD, Great Neck, New York
The Need for Research: J.D. Watson, Cold Spring Harbor Laboratory
386 Banbury Center
SESSION 1: Genetics and Genomics
Chairperson: E. Kandel, Columbia University, New York
K. Kendler, Virginia Commonwealth University, Richmond:
Challenges in genetics research in mental illness.
E. Scolnick and P. Sklar, Broad Institute, Cambridge,
Massachusetts: Genomic approaches to mental illness.
W. McCombie, Cold Spring Harbor Laboratory: Fourth-
generation DNA sequencing and human genetic disorders.
D. Goldstein, Duke University, North Carolina: Rare and
common genetic variants contributing to risk of
schizophrenia. 
M. Daly, Harvard University, Cambridge, Massachusetts:
General discussion.
SESSION 2: Promoting Genomic Research in Mental Illness
Chairperson: T. Insel, National Institutes of Health/NIMH, Bethesda, Maryland
Views of Genetic and Genomic Research
T. Lehner, National Institute for Mental Health
E. Green, National Human Genome Research Institute, Bethesda, 
Maryland
A. Malhotra, The Zucker Hillside Hospital, Glen Oaks, New York
C. Gilliam, University of Chicago, Chicago, Illinois
F. Henn, Brookhaven National Laboratory, New York
R. DePaulo, Johns Hopkins University School of Medicine, Baltimore, 
Maryland
H. Akil, University of Michigan, Ann Arbor
W. Bunney, University of California, Irvine
Input from Groups Engaged in Promoting Research
NARSAD: H. Pardes, New York Presbyterian Hospital, New York
Prechter Fund: W. Prechter, Heinz C. Prechter Bipolar Research Fund, 
Ann Arbor, Michigan 
Simons Foundation: G. Fischbach, Simons Foundation, New York
General Discussion and Points Arising
SESSION 3: What to Do?
Chairperson: H. Pardes, New York Presbyterian Hospital, New York
M. Woolley, Research!America, Alexandria, Virginia: Promoting 
research.
Is Washington D.C. Receptive to This Message?
G. Weiblinger, National Institutes of Health/NIMH, Bethesda, Maryland: 
Determining the NIH Annual Budget.
How to Do It?
M.-C. King, University of Washington, Seattle: Scientists joining the 
advocacy for mental health research.
B. Metheny, South Dartmouth, Massachusetts: Delegation model.
J. Greden, University of Michigan, Ann Arbor: National networks of
depression centers.
B. Gill, The Charles A. Dana Foundation, New York: Dana Alliance for 
Brain Research.
What Do We Need? Summation and Action Points: Open 
Discussion
Moderator: H. Pardes, New York Presbyterian Hospital, New York
A. Moran, B. Shobe
E. Green, J.D. Watson
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Coinfections in Lyme Disease
December 14–15
FUNDED BY Time for Lyme, Inc.
ARRANGED BY S. Schutzer, UMDNJ–New Jersey Medical School
Since the 1990s, the Banbury Center has been the venue for a series of very influential meetings on
Lyme disease. A benefit of such meetings has been collaborations into research on coinfections
carried by the same tick vector that transmits Lyme disease. This meeting reviewed what is known
of coinfections in Lyme disease and provided an opportunity for planning a Lyme disease meeting
at Banbury in 2010.
Introductory and Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: S. Schutzer, UMDNJ–New Jersey Medical School, Newark
SESSION 1
Chairperson: S. Schutzer, UMDNJ–New Jersey Medical School, Newark
D. Fish, Yale University, New Haven, Connecticut: Ticks and
the environment.
M. Eshoo, IBIS Biosciences, Inc., Carlsbad, California: Summary
of polymicrobial detection studies in tick-borne diseases.
A. Hohenhaus, Animal Medical Center, New York: The dog as
a sentinel of tick-borne diseases.
S. Schutzer, UMDNJ–New Jersey Medical School, Newark:
Continued and future studies and discussion.
SESSION 2
Chairperson: P. Fox, Animal Medical Center, New York
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On November 20, research teams from the United States and Mexico published the complete maize
genome—the entire set of genetic information belonging to the plant better known to us as corn.
Anticipating this event for the launch of a new Internet site, Weed to Wonder, a videography team
from the DNALC went to Mexico to get the story behind the research and put the genome se-
quence into the context of the history of maize cultivation. First, we traveled 70 miles south of Mex-
ico City to the Balsas River Valley, where an old man led us up a shock-breaking road and along an
obscure path to a rock shelter from the dawn of maize cultivation. Eight months previously, mi-
croscopic analysis of grinding stones from this site revealed traces of cultivated maize that date back
8700 years. This is almost as old as the earliest evidence of wheat cultivation in the Fertile Crescent.
The grinding stones found in the shelter were nothing fancy—just rounded river stones—but they
would have been effective enough at making a rough corn meal. Combined with water, this would
have made a simple porridge or a dough from which to fashion the quintessential Mexican staple,
the tortilla. 
An elderly guide leads Jason Williams, Eun-sook Jeong, and Dave Micklos—with cameras and tripods in tow—to the site of the
shelter where maize grinding stones were discovered. Dave then speaks on camera about the location.
Just below the shelter, we passed a tiny, unkempt corn field very much like the field, or perhaps
even the same field, from which the ancient agronomists had harvested their maize. Somewhere
nearby, teosinte, the wild ancestor of modern maize, would have been brought under cultivation.
Genetic analysis has placed the Balsas River subspecies of teosinte at the root of the “tree” leading
to all modern maize. However, the food potential of teosinte would not have been immediately ob-
vious, because its kernels are covered with a flinty, inedible outer covering. In the 1930s, Nobel lau-
reate George Beadle demonstrated how Mesoamericans could have first exploited teosinte as food.
He showed that its kernels explode when heated, casting off their flinty coats and leaving behind ed-
ible little puffballs. Teosinte was almost certainly eaten as popcorn, making it the world’s first and
most enduring junk food.
The ancient farmers would have identified stands of teosinte that made the biggest and best-tast-
ing popcorn. Eventually, they would have had the idea to plant seeds from some of the best plants
in fertile soil on the banks of tributaries of the Balsas. In watching the cultivated teosinte year after
year, they would have selected odd plants—less bushy ones that made harvest easier and, of course,
those with larger cobs and less-flinty kernels. For some time, they would have continued to eat the
cultivated maize as popcorn, but eventually, they would have discovered the varied uses of ground
maize meal. This is the evidence provided by millstones from the humble shelter in the Balsas River
Valley.
At the International Maize and Wheat Improvement Center (CIMMYT), we visited Suketoshi
Taba, who leads the effort to conserve as many types of cultivated and wild corn as possible. The cold
storage vaults of his germplasm bank contain 26,000 varieties of maize seed, the products of thou-
sands of years of human-directed evolution. Represented in this germplasm bank are ~60 indigenous
races of Mexican maize—each as genetically distinct from one another as humans are from chim-
panzees. Frequent exchange of genes with wild teosinte, which grows as a “weed” in cultivated maize
fields, has been a major source of this fantastic genetic diversity.
In Irapuato, 200 miles northwest of Mexico City, we visited the National Laboratory of Ge-
nomics for Biodiversity, an immaculately modern facility designed to take Mexico into the genome-
sequencing club. There, we interviewed Luis Herrara-Estrella, its director, and Jean-Philippe
Vielle-Calzada, who headed their effort to sequence the genome of the
maize race called Palomero. They used so-called next-generation sequenc-
ing to rapidly generate data on millions of short genome pieces. Then, they
“scaffolded” their fragmentary data onto a genome completed by tradi-
tional methods by a U.S. team that included CSHL researchers. Vielle-
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(Above) Teosinte
seed, (right) Suke-
toshi Taba discusses
one example of
maize seed stored in
the germplasm bank. 
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Calzada, who spent his postdoctoral period at CSHL, explained that the sequencing of the Palom-
ero genome was simplified because it is ~20% smaller than the B73 cultivar sequenced by the Amer-
ican team. Palomero, with its miniature cob, is one of most ancient of Mexican maize races cultivated
as popcorn. A comparison by the Mexican team turned up long stretches of identical DNA se-
quences shared by the Palomero and B73 genomes. Contrary to the overall sequence differences
that arose as maize diversified into different races, these regions must have been strongly selected early
in the domestication process and then passed on to all maize races. Close examination revealed that
several of these regions contain genes that detoxify heavy metals from the environment, such as cad-
mium and copper.
With this knowledge, we set off on a jarring 15-mile trip on an unsurfaced road and then a lung-
aching hike that took us to pass at 14,000 feet on Nevado de Toluca, a volcanic caldera southwest of
Mexico City. One of its Aztec names, Lord of the Cornstalks, is appropriate to this story because it looks
down on the fields of the Balsas River and is only ~50 miles away from the shelter where we started
our exploration. The Toluca volcano erupted most recently ~10,500 years ago, carpeting the region with
ash and debris. This coincides closely with the early cultivation of maize and provides a context for in-
terpreting the conserved metal decontamination genes found by Vielle-Calzada. Prior to industrial-
ization, volcanic eruptions were the major source of heavy metals in the soil, and it appears that the
cultivation of maize selected for plants that were tolerant to the metallic soils in this region. 
Maize gods and goddesses are central icons of every pre-Columbian culture of Mexico, includ-
ing Mayan, Toltec, Zapotec, Mixtec, and Aztec. There was good reason for this veneration and for
the widespread notion that they were “children of the corn.” The large-scale cultivation of maize
made possible the numerous and vast pre-Columbian cities and the cultures that flourished around
them. North of Mexico City, Teotihuacan was a city of 100,000 residents that rose to greatness
2000 years ago. Ears of Palomero maize have been found in graves there. To the east, Cacaxtla was
a ceremonial center founded by Mayan settlers. Set atop a towering pyramid, archeologists are still
busy excavating one of the most extensive troves of polychrome murals in the ancient world. There,
we saw a mural that is perhaps most emblematic of the Native American view of maize and human
life, a corn plant in which human heads burst forth from ears of corn along the axis of the stalk. In
Mexico, the cultivation of maize is so wrapped up in human history that it is difficult to draw a line
between the plant and the people who brought it under domestication.
The Weed to Wonder Internet site grew out of a collaboration between CSHL’s Dick McCombie
and Doreen Ware, and Rick Myers of Washington University in St. Louis, to develop a mini-web-
site describing the National Science Foundation (NSF)-funded Maize Genome Sequencing Project.
New funding through an NSF project on maize meristem, run by CSHL researcher Marja Tim-
mermans and Mike Scanlon at Cornell University, is allowing us to build a substantial website that
explores how humans transformed the common weed, teosinte, into the modern agricultural won-
der we know as corn. In addition to a podcast on our Mexican journey, we developed two additional
Pyramid of the Moon, Teotihuacan (left). Eun-sook Jeong, Jason Williams, Dave Micklos, and Jaime Padilla (the guide for the trip)
pose in front of Nevado de Toluca.
podcasts with scientists describing CSHL’s special connection to the project. Another production
was an historical recreation of CSHL in 1909, with George Shull explaining his experiment on hy-
brid vigor that is the foundation of all hybrid corn grown today. The website includes animations
describing the different DNA-sequencing approaches used by the American and Mexican teams
and a video tour of the Genome Sequencing Center at Washington University in St. Louis. A vir-
tual exhibit on the life of Nobel Prize–winner Barbara McClintock includes many artifacts from
her lab at CSHL, where she discovered transposons (so-called “jumping genes”). An online lab note-
book allows students to do experiments in maize genetics and to detect one of McClintock’s trans-
posons in corn.
iPlant Collaborative
In 2009 we continued to contribute to the iPlant Collaborative (iPlant), a consortium headed by
the University of Arizona and CSHL to develop a computer (cyber) infrastructure to support plant
research. Funded by the NSF’s National Plant Genome Initiative, iPlant aims to develop tools and
interfaces that will provide scientists with easy access to large-scale plant data sets and high-powered
informatics tools. Following a year of input from the plant science community, iPlant announced
in April that it will build “discovery environments” to help plant scientists solve two “grand chal-
lenges”: (1) to produce an iPlant tree of life (iPTOL) encompassing ~500,000 plant species and (2)
to explore the genotype-to-phenotype continuum in plants (iPG2P). 
As a member of the iPlant Education, Outreach, and Training (EOT) component, the DNALC
is working with the grand challenge teams to create educational interfaces for the computing tools
and data sets available in each discovery environment. In this way, students and teachers can work
with the same data and use the same tools at the same time as high-level plant researchers. Students
may literally look over the shoulders of plant re-
searchers as they, for example, understand the
mechanisms that could enable crop plants to rap-
idly respond to global climate changes.
In advance of setting the two grand challenges,
the DNALC embarked on an EOT demonstration
project to construct a DNA Subway—an educa-
tional platform for gene annotation and compari-
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son. This effort leverages the DNALC’s previous experience in developing community workspaces
and simple bioinformatics interfaces, such as Sequence Server (www.bioservers.org) and Gene Boy
(www.dnai.org/geneboy/index.html). The project coordinated contributions from 25 scientists,
computer programmers, and bioinformaticians at 12 institutions including Scott Cain (Ontario In-
stitute for Cancer Research), Tuajuanda Jordan (Howard Hughes Medical Institute), Zhenyuan Lu
and Anthony Biondo (CSHL), Sally Elgin (Washington University in St. Louis), Susan Singer (Carl-
ton College), Ann Stapleton (University of North Carolina, Wilmington), and Sue Wessler (Uni-
versity of Georgia).
We used the metaphor of a subway map as an intuitive and appealing interface to sophisticated
informatics tools. “Riding” on any of three different “lines” of the DNA Subway, users can analyze
up to 100 kb of DNA—predicting and annotating genes (Red Line), prospecting for related genes
(Yellow Line), and analyzing next-generation transcriptome data (Blue Line). The first line installed,
the Red Line, allows users to (1) predict repeat DNA, genes, and tRNAs, (2) gather supporting
RNA and protein evidence, (3) make and edit gene models in a graphical annotation editor (Apollo),
(4) view the assembled data in stand-alone browser, and (5) export to a community browser to view
their assembled data in the context of a completed genome (Phytozome). Work can be saved to a per-
sonal profile for later use or to share with other users.
In June, we co-organized a meeting at Washington University, St. Louis, to inform our develop-
ment efforts. The 3-day workshop, Genomics in Education: Gene Annotation and Comparison,
brought together 44 participants representing three worlds (genome research, education, and com-
puter science) working in three biological systems (microbes, plants, and animals). Presentations
emphasized the importance of research partnerships in which students are welcomed as co-investi-
gators. They also highlighted students’ desire for a wet-bench hook to anchor abstract bioinfor-
matics investigations. A clear message was that biology educators need to scale up from local
experiments that involve a single class to distributed experiments in which classes around the coun-
try contribute to and analyze common data sets.
Informed by the consensus developed at the Genomics in Education meeting, by year’s end, we
began organizing two distributed research projects for iPlant: Chloroplast Gene Sequencing and the
Orphan Data Project. The Chloroplast Gene Sequencing Project will allow students to analyze se-
quences to determine phylogenetic relationships between plant groups or to show regional variation
within a species (ecotypes). Analyses will be based on so-called DNA “bar codes,” short regions of
DNA sequence that uniquely identify different plants. Although sequence from the mitochondrial
gene cox1 (cytochrome c oxidase subunit 1) is universally used to bar code animals, the plant world
has settled on sequences from two chloroplast genes, rbcL (ribulose-bisphosphate carboxylase) and
matK (maturase K). 
Students first work with a plant taxonomist or ecologist to identify interesting local plants whose
sequences have not yet been submitted to major bar-code databases. In the classroom, students iso-
late plant DNA and use polymerase chain reaction (PCR) to amplify the bar-code region from their
selected plants. The student DNA samples are shipped to a sequencing center, where the finished
sequences are uploaded into a database at the iPlant Internet site. Students access their sequences and
use them as a starting point in a study of plant phylogenetics or diversity using alignment and tree-
drawing tools on the DNA Subway. Ultimately, they can submit high-quality sequences to the Bar
Code of Life or other scientific databases. This effort will be informed by our existing DNA Se-
quencing Service and BioServers Internet site, which provides sequencing and analysis tools for human
mitochondrial DNA.
The Orphan Data Project will support distributed research projects in the data-rich world created
by next-generation sequencing and high-throughput phenotyping. The objective is to create an on-
line “marketplace” to connect faculty and students with researchers who have novel data sets to be
analyzed. The site will provide an index of projects with descriptions of available data and sugges-
tions for how they can be used for class or independent research projects. The site will also include
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networking tools—analogous to a Facebook “wall”—to allow collaborators to coalesce around each
data set. Partnership Coordinator Jason Williams will facilitate data submissions and “matches” be-
tween researchers and interested parties. 
Many types of orphan data can be analyzed using the tools available at the DNA Subway and
iPlant discovery environments. Notably, gene mutation and expression data will readily articulate
with the genotype-to-phenotype grand challenge. We expect that college faculty will seek out data
related to their doctoral or postdoctoral studies, potentially providing projects with additional high-
level co-investigators. The Internet is an ideal instrument to identify small communities of interest
in a given data set, which would function autonomously from iPlant. We expect that some larger
communities will reach a threshold at which they might be adopted as formal iPlant education proj-
ects, and regional workshops will provide venues to share collaborative results.
Landeau Multimedia Studio
In December 2008, Cable Network News (CNN) eliminated its entire science, technology, and en-
vironmental news staff. In March 2009, The Boston Globe eliminated its 25-year-old science section.
Only 35 of 95 weekly science newspaper sections have survived since their heyday in the late 1980s.
In a recent survey of science journalists by Nature magazine, 29% said their publications had cut sci-
ence-writing staff in the past five years. A 2009 survey by the Pew Research Center found that only
20% of adult Americans read science magazines; this is about the same proportion that are consid-
ered sufficiently scientifically literate to be able to understand the science section of The New York
Times. Despite the grim statistics for print science journalism, 67% of respondents in the Pew study
said they regularly watch science channels and programs, such as the Discovery Channel and NOVA.
According to Nielsen, the Discovery Channel is among the most-watched cable channels. 
Somewhere between the waning reach of “hard science” news and the appeal of popular “science
lite” lies a niche for informed and entertaining television coverage. With its strong background in
Internet multimedia, proximity to CSHL’s high-caliber research, and ready access to the flow of
8000 thought leaders in biology who annually attend CSHL meetings, the DNALC is well posi-
tioned to occupy this middle ground of television science. We believe that locating a television pro-
duction team within a prestigious scientific community can provide a general model for how science
organizations can leverage local expert knowledge to produce high-quality science programming. In
this way, universities, research institutes, and science centers can help fill the vacuum created as the
mainstream mass media retreat from science coverage.
The completion of the Laurie J. Landeau Multimedia Studio has provided us with the physical re-
sources needed for high-level video production. During the year, we demonstrated capabilities of the
studio’s theatrical lighting and sets by producing video in a number of different formats. In addition
to interviews for our Genes to Cognition Online and Weed to Wonder Internet sites, we completed news
podcasts on several topics: an anthropology series on ancient hominid fossils “Ida,” “Ardi,” and Ne-
anderthal; the Nobel Prize in Physiology or
Medicine; and the completion of the maize
genome.
We are now working to come up with
concepts and funding mechanisms that will
enable the DNALC to partner with PBS
and cable channels to produce high-quality
television programs. Talks with Robert
Krulwich of ABC News and WNYC’s
Radio Lab, and Laura Savini, of WNET.org,
helped crystallize one concept for an in-
quiry-based program that shows how DNA
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For a Weed to Wonder podcast, James Watson (left) provides perspec-
tive on the role maize has had in CSHL’s history.
solves real problems in modern life. Equal parts talk show, cooking show, and investigative report,
each episode will take the audience inside an interesting “detective case.” Although it will build on
popular interest in Crime Scene Investigations (CSI), the show will explore how modern science can
solve a range of interesting, everyday problems. The program will employ a young, “perky-quirky”
host who begins each exploration at the studio coffee table brainstorming with CSHL scientists
about how to solve a real-world problem. (The host and scientists are “the DNA detectives.”) Tak-
ing to the field, the host personalizes the problem by interviewing people and gets experimental
ideas by visiting the lab of a scientific expert. Then, it’s back to the studio lab, to “cook up” a real
experiment with the help of the detectives. The experiment will answer the question at hand and
also point to solutions for similar problems.
For example, a recent exposé found that many restaurants substitute tilapia and other inexpensive
fish for premium fish, such as red snapper, white tuna sushi, and Chilean sea bass. In this case, the
DNA detectives would follow several New York families into restaurants and interview them while
they order a premium fish. The detectives then take samples back to the studio to run DNA tests to
determine exactly what sorts of fish are on the menus. Other questions the DNA detectives might
tackle include: Do perfume testers smell better than me? Is my certified organic food genetically mod-
ified? Which top chef has the best sense of taste? How can DNA set free a convict on death row?
Where did that illegal elephant tusk come from? Is it safe for me to take that drug? Am I related to a
Neanderthal? How do they find a good mate for a zoo animal? Is my all-beef hotdog all beef?
Genes to Cognition (G2C) Online
Our latest, largest, and most interactive website, Genes to Cognition (G2C) Online (www.g2conline.
org), launched on March 15, coinciding with the beginning of the Dana Foundation’s Brain Aware-
ness Week. G2C Online, which is supported by the Dana Foundation and Hewlett Foundation,
features a rich library of more than 750 animations, articles, demonstrations, and interactive ex-
periments about neuroscience in the 21st century. It is modeled as a small world network, where each
content item is a node in a web of interactive media. By exploring nodes at any of six levels of analy-
sis—genes, biochemicals, cells, brain, cognition (behavior), and the environment—students can
understand that thinking and disorders of thinking can be approached on multiple levels. Six major
psychiatric disorders form the hub of the G2C Online network: ADHD, autism, Alzheimer’s dis-
ease, bipolar disorder depression, and schizophrenia. Students can learn the fundamentals of neu-
roscience through a series of narrated animations, conduct interactive experiments using real-world
experimental data, and browse a library of video
interviews with leading researchers, including
Nobel laureates Eric Kandel and James Watson.
The most searched-for feature is the 3D Brain,
an interactive brain map that allows users to ro-
tate the brain in three-dimensional space. Created
in collaboration with AXS-3D, a Toronto-based
animation studio, 3D Brain includes individual
maps of 29 substructures with information on
brain damage, case studies, and links to modern
research. We collaborated with Jens Egeblad,
brother of CSHL’s Dr. Mikala Egeblad, to create
3D Brain, the DNALC’s first iPhone application.
Launched on September 20, the 3D Brain app has
become a staple in Apple’s Education Top-10, peaking at some 20,000 weekly downloads. By year’s
end, it had been downloaded 159,380 times to users in 70 countries and was the highest-rated app
in the Education Top-25. 3D Brain is free to download from Apple’s iTunes and the App Store. 
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The G2C Online project will culminate in 2010, with a large-scale study of how the site is used
in classroom settings. Twelve high school and college educators and their 700 students will partici-
pate in a quasi-experiment, which uses matched experiment and control groups. Each teacher will
use the site with two classes they teach. One class will use G2C Online to learn about a selected
topic (e.g., autism) and use traditional resources to learn about another topic (e.g., schizophrenia).
A second class will do the reverse: Use traditional sources to learn about autism and G2C Online to
learn about schizophrenia. Using classes taught by the same teachers, controls for the level of back-
ground and “scaffolding” that accompanies each topic, while “flipping” the assignments controls for
class differences. As well as completing teacher-authored assessments, students will also complete a
number of instruments designed to assess science literacy and general knowledge of neuroscience.
In this way, we hope to find out if G2C Online, and its unique network structure, helps students con-
ceptualize “ideas” in science.
Internet Visitation and Development 
Although the number of visits to the DNALC’s family of Internet sites in 2009 held constant at six mil-
lion, visitors consumed 23% more information than in 2008. Nearly 5 terabytes (5000 gigabytes, GB)
of data were served, with DNA Interactive reaching 1365 GB for the year. Two new sites were added in
2009. Genes to Cognition (G2C) Online launched in March, and Weed to Wonder launched on No-
vember 20 to coincide with the publication of the maize genome sequence in the journal Science.
We continued with a series of interventions to
update our websites and to drive visitation. This
included search engine optimization to make our
sites more visible to Google and other search ar-
biters. We devoted considerable effort to redevelop
the DNALC home page, which provides informa-
tion about our educational programs and is a por-
tal to our 14 content sites. The former home page
was built in the media integration program Flash,
which provided a sleek design but hid some con-
tent from search engines. The new design uses
HTML pages formatted with cascading style sheets
(CSS). The HTML pages are readily searched, and
CSS enables us to rapidly update the site.
Periodically “freshening” sites with new content
encourages visits from search engines indexers,
which can improve page rank in search results. No-
tably, we added blogs to six of our major content
sites: Genes to Cognition Online, Inside Cancer,
DNA Interactive, Eugenics Archive, DNA from the
Beginning, and Your Genes, Your Health. On a regular basis, DNALC staff members provide their own
perspectives on current news and discoveries that connect with website content. Blog visits totaled
32,066 in 2009. We have also broadened DNALC exposure by creating Twitter and Facebook pages.
We increased access to our high-quality video content under our own DNA Today banner and
through the YouTube channel. We posted 82 videos on YouTube over the course of 2009 resulting
in nearly 42,000 video views, more than half of the total views (76,213) since we started YouTube
postings in May 2007. The majority of viewers found our videos by searching YouTube (29%) or by
following a link from another video page (30%); perhaps surprisingly, only 5% of YouTube views
were initiated by Google searches. Cell Signals, a three-dimensional tour through a cell, comprised
57% of YouTube views, followed by The Neanderthal Genome Project, an interview with Svante
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Pääbo, at 10%. YouTube reports that our audience is largely male (62%) and between 45 and 64
years of age (53%), highlighting a need to attract female and younger viewers.
As part of the National Science Digital Library Project, we completed a 4-year project to develop
a database of virtually all of the DNALC’s proprietary multimedia content. This content management
system constitutes a digital card catalog that allows any item to be readily searched using a large set
of fields. Indexing 727 items from our first site, DNA from the Beginning, brought to 5380 the total
number of animations, videos, images, photographs, and other items in our content management sys-
tem. All of these items were “harvested” to the BioScieEdNet (BEN) digital library, composing more
than one-third of the 15,319 resources available at this NSF-supported portal (www.biosciednet.org).
The DNALC home page incorporates a new search interface that searches all of these items, an in-
creasing number of which can be downloaded to personal computers. 
We continue to get a visitation boost from Google AdWords, a grant program that provides free
“sponsored” links in the right-hand-side “advertising gutter” on Google’s search results page. The Ad-
Words account contains a set of keywords for each DNALC website. When someone searches for one
of the keywords, an ad for the site is displayed and logged as an “impression.” A “click-through” is
logged when the link is followed, resulting in a visit to one of our sites. DNA from the Beginning is
our most successful site on AdWords, with 57,254 visits from 3,557,433 impressions. Not surpris-
ingly, 86.6% of click-throughs resulted from a search for “DNA.” Genes to Cognition Online reaped
55,025 visits from 4,949,401 impressions—73% were searches for “brain.” All DNALC sites re-
ceived a total of 140,201 visits from 13,128,457 AdWord impressions. The relatively low conversion
rate (from impression to click-through) is probably due to the fact that users of free content, such
as teachers and students, generally concentrate on free listing rather than sponsored ads. The rank-
ings of free listings also give a measure of the authority of the link, and DNALC sites are frequently
among the top five returns for many key search terms.
Average
monthly Change
Average Change bandwidth Change Visits in from 2008
visit length from 2008 (GB) over 2008 2009 (%)
Content sites
Blogs (G2C 3/09, others 8/09) 10:21 n.a. 1.86 n.a. 32,066 n.a.
DNA from the Beginning 12:49 +3:17 29.74 –7.35 1,180,507 –9.34
DNA Interactive & myDNAi 10:26 0 113.73 +2.17 1,046,656 –9.07
Dolan DNALC Home 10:05 +0:52 134.27 +39.5 1,623,778 –0.34
Genes to Cognition Online (3/15) 8:34 n.a. 44.39 n.a. 186,574 n.a.
Image Archive on the American
Eugenics Movement 14:04 –3:42 17.57 +6.02 687,515 +13.08
Inside Cancer 9:48 +2:30 29.30 –2.05 187,311 –21.93
Inside Cancer Teacher Center 10:53 –3:08 0.54 –0.49 86,707 +289.68
Your Genes, Your Health 7:55 –0:17 37.99 –3.46 691,320 –14.19
Weed to Wonder (11/20) 18:46 n.a. 37.55 n.a. 16,277 n.a.
Laboratory/bioinformatics sites
BioServers 20:11 –3:56 2.57 + 0.01 100,929 –25.76
DNALC Kits/Carolina
Collaboration 9:11 –6:07 0.66 –1.68 8,910 +64.24
Dynamic Gene 9:45 +2:27 0.34 15,514 +37.57
Genetic Origins 6:38 –0:50 1.53 –0.04 102,163 –0.66
Greenomes 3:34 +0:19 0.47 –0.07 17,317 +30.09
Silencing Genomes 11:01 –1:44 0.54 –0.01 38,913 +32.08
All sites 10:54 +1:27 6,022,457 –0.62
Faculty Training
During the year, more than 1200 educators participated in a range of professional development ac-
tivities conducted at Harlem DNA Lab and at 19 sites around the United States and Asia. Through
our collaboration with the New York City Department of Education, sponsored by the Howard
Hughes Medical Institute, 312 teachers participated in workshops at Harlem DNA Lab, including
37% underrepresented minorities. With funding from the NSF, National Institutes of Health (NIH),
and the Hewlett Foundation, we collaborated with host institutions to conduct 37 workshops on
cancer biology, RNA interference (RNAi), and neurobiology. Seven workshops were conducted at
institutions with high proportions of underrepresented minorities, where 20% of participants were
African American or Hispanic. Overall, 12% of the 590 participants at off-site workshops were un-
derrepresented minorities. An additional 319 educators attended workshops or presentations at pro-
fessional meetings, which covered topics including neurobiology, bioinformatics, detecting GM
foods by PCR, DNALC online tools for education, and DNA forensics. One workshop was held at
Ho Yu College in Hong Kong as part of the inauguration of MobileLab, an impressive biotechnol-
ogy bus developed by our friend William Mak. 
With Phase II funding from NSF’s Course, Curriculum, and Laboratory Improvement (CCLI)
program, we continued our efforts to bring compelling RNAi experiments into college classrooms.
A total of 126 college faculty participated in week-long workshops and weekend follow-ups that
cover a range of RNAi experiments in Caenorhabditis elegans, a simple roundworm that is a model
eukaryotic system. After observing mutant phenotypes and learning basic worm “husbandry,” fac-
ulty learned simple methods to induce RNAi and then learned “single-worm PCR” to examine the
mechanism of RNAi, comparing the DNA of worms with identical phenotypes induced by either
RNAi or a mutation. They also learned methods to support student projects, such as using bioin-
formatics to identify a target gene and developing their own RNAi reagents “from scratch.” The Si-
lencing Genomes Internet site (www.silencinggenomes.org), which has received more than 80,000
visits, includes all experiments and reagent recipes. A free-strain library includes all needed bacter-
ial and C. elegans strains, as well as more than 100 vectors developed by workshop participants to
silence worm homologs to human genes. To date, more than 1300 strain orders have been filled
and used with a reported 6000 students. Three stand-alone kits derived from the program will be
released by Carolina Biological Supply Company in 2010.
With Phase II funding from an NIH Science Education Partnership Award (SEPA), we contin-
ued to improve and disseminate Inside Cancer (www.insidecancer.org), a multimedia Internet re-
source for understanding the molecular genetic basis of cancer. By focusing on how researchers gain
insights into the unseen world of genes and signaling molecules, Inside Cancer provides examples of
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Faculty Workshop Sites 2009
Silencing Genomes, Inside Cancer, and G2C Online:
Virginia Tech, Blacksburg
Inside Cancer and G2C Online: Arizona State Univer-
sity, Tempe; Contra Costa Office of Education,
Pleasant Hill, California; Great Bay Community
College, Portsmouth, New Hampshire
Harlem DNA Lab, New York: John Jay College of
Criminal Justice, New York; Madison Area Tech-
nical College, Madison, Wisconsin; Oxnard Col-
lege, Oxnard, California; Raritan Valley Com-
munity College, Somerville, New Jersey; Tulsa
Community College, Tulsa, Oklahoma; Univer-
sity of Colorado, Denver
Silencing Genomes and Inside Cancer: Houston Com-
munity College Northwest, Houston, Texas;
Howard University, Washington, D.C.; North Car-
olina A&T University, Greensboro; St. Louis Sci-
ence Center, Missouri
Silencing Genomes: Austin Community College,
Austin, Texas; California State University, Domin-
guez Hills
Inside Cancer: Bossier Parish Community College,
Bossier, Louisiana; Illinois Institute of Technology,
Chicago; Minneapolis Community & Technical
College, Minneapolis
the science process while engaging students with this relevant topic. A total of 314 high school and
college faculty attended 1-day workshops at 18 sites around the nation, learning how to use Inside
Cancer to enhance teaching of cancer cell biology in health, general biology, and advanced biology
classes. Responding to feedback from workshop participants, five Faculty Fellows spent 3 weeks in
residence at CSHL creating lessons and improving Inside Cancer content: Margaret Witecki (Mount
Vernon High School, Washington), Wendy Wooten (High Tech Los Angeles High School, Cali-
fornia), Lisa Orenstein (The Overlake School, Redmond, Washington), Robin Cochran-Dirksen
(Lead-Deadwood High School, South Dakota), and Greg Ballog (South Whidbey School District,
Langley, Washington). With funding from the Hewlett Foundation, we continued to disseminate
G2C Online. One-day workshops conducted at 11 sites drew 150 high school and college educators
to learn how to use this unique learning resource.
We continued our long-term collaboration with the Singapore Ministry of Education when in
December we hosted an attachment of four Singaporean primary teachers (grades 3–6). The visit-
ing educators spent 2 weeks in Cold Spring Harbor, immersed in student programs and in small
workshop sessions with DNALC middle school instructors. Over the course of their stay, the teach-
ers focused on the Fun with DNA and World of Enzymes curricula and will share what they learned
with colleagues in their respective schools. 
Harlem DNA Lab
With the official opening of Harlem DNA Lab in fall 2008, we fulfilled our long-held goal of de-
veloping a base of operations from which to provide underserved schools in New York City (NYC)
the same enrichment opportunities that we offer Long Island’s schools. The NYC Department of
Education renovated the 1200-square-foot facility, located in the John S. Roberts Educational Com-
plex to our specifications and the Jerome L. Greene Foundation provided $100,000 of state-of-the-
art equipment.
Core support from the Dana Foundation allowed us to aggressively ramp-up our student en-
richment program to reach our target audience of underserved and disadvantaged students. In 2009,
we provided lab field trips to 3183 middle and high school students, 78% of whom were African
American or Hispanic. Eighty percent of students were provided scholarships courtesy of the William
Townsend Porter Foundation, based primarily on Title One status (at least 40% of a school’s stu-
dent population is on free/reduced lunch program). Students came from 45 zoned, charter, magnet,
and independent schools from throughout New York City.
We provided intensive enrichment to students
from two schools housed with us in the John S.
Roberts Educational Complex: the Coalition
School for Social Justice and MS 45. Sixty Coali-
tion students (grade 12) participated in a series of
three biotechnology laboratories, and 375 MS 45
students (grades 6–8), participated in three ge-
netics laboratories. A Coalition senior was re-
cruited as our first student intern. In the spring,
we participated in several programs for the World
Science Festival (WSF), “a tribute to imagination,
ingenuity and inventiveness that takes science out
of the laboratory and into the streets, theaters,
museums, and public halls of New York City.”
For Pioneers in Science, we worked intensively
with immigrant students from Brooklyn Interna-
tional High School to prepare for one-on-one in-
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Following a bacterial transformation, participants “painted” with E. coli in collabo-
ration with artist Amy Chase Gulden at the World Science Festival.
terviews with Nobel laureate Harold Varmus during the Festival. At our booth at the Street Fair in
Washington Square Park, Ileana Rios did DNA extractions with passersby.
In late fall, we announced a Charter Membership Program to provide intensive support to several
independent schools as they develop a sequenced program of accelerated science opportunities for
their teachers and students. An exclusive package of benefits includes in-school and laboratory field
trips, summer camp programs, and professional development for teachers, all designed to bring sci-
ence instruction up to par with the most advanced schools in the country. By year’s end, Trinity
School, one of the oldest independent schools in Manhattan, had made a 2-year commitment. We
expect that the remaining membership will be filled early in 2010. 
HHMI Training Program
Harlem DNA Lab is also the site of a professional development collaboration with the NYC De-
partment of Education (DOE). Sponsored by the Howard Hughes Medical Institute (HHMI), the
program aims to develop a strong base of teachers who can competently introduce six “targeted” ex-
periments in genetics and biotechnology at identified points in required science courses. We worked
intensively with DOE staff members and project advisors to introduce the training program to key
opinion leaders in the educational system. During the second year of the project, we provided 612
training sessions (one teacher x 3–4 hours of lab training), fulfilling 77% of our ambitious 800-ses-
sion goal. Fifty-eight teachers completed four sessions required for Certificate Training, and 378
teachers had taken one or more labs. Almost two thirds of training sessions were within our primary
audience of 8th-grade Scope and Sequence teachers and 9th–10th-grade Living Environment teach-
ers and included 35% African American and Hispanic teachers.
We also continued to work on two key project components that support classroom implemen-
tation: online Lab Center and experiment footlockers that support each of the targeted labs. Lab Cen-
402 Dolan DNA Learning Center
DNALC educators
provide video intro-
ductions to each Lab
Center activity.
Teachers can use Lab
Center to prepare
students before their
visit and for follow-
up afterward.
ter (www.dnalc.org/labcenter/harlemdnalab) provides multimedia guides for each lab, including
video introduction, online lab notebook, animations, scientist interviews, teacher lesson plans, and
prelab and postlab student work sheets. Teacher Fellows from around the New York metropolitan
area continued to help the website evolve: Greg Borman (City University of New York), Caren
Gough (New York State Science Mentor), Dr. Dahlia McGregor (South Shore High School), Adri-
enne Rubin (Eleanor Roosevelt School), Kathleen Rucker (Brooklyn International High School), and
Jerry Watkins (Central Islip). The final phase will be to add a series of “New York Stories,” video pod-
casts that link each experiment to notable work, past and present, done by researchers in New York
area institutions.
Our original proposal envisioned regional consortia of indi-
vidual schools that would contribute funds to purchase shared
footlockers. The recession had effectively ended this source of
local funds, putting the footlockers in jeopardy. However, a grant
of $75,000 from the Richard M. Lounsbery Foundation jump-
started the program in October with the purchase of 14 foot-
lockers made to our specifications. For a small restocking fee,
teachers who have participated in professional development
training or who have accompanied students on a field trip to the
Harlem DNA Lab are invited to rent footlockers. Kits contain all equipment
and materials needed for labs on DNA models, fruit fly mutations, DNA ex-
traction, bacterial transformation, protein isolation, DNA restriction analy-
sis, and human DNA variations. 
Student Instruction and Family Science
Annual visitation reached 47,798 in 2009. This included 21,031 students who conducted experi-
ments at the DNALC, DNALC West or the Harlem DNA Lab, and 9450 students who received in-
school instruction by DNALC staff members. About two-thirds of student visitors participated in
Genetics as a Model for Whole Learning (GMWL), a program that is used to introduce genetics at 70
public and private schools. Bank of America and TD Bank provided scholarships for 2032 students
from underserved Long Island schools.
Despite difficult economic circumstances, hard work by DNALC administrators and educators
made the 2009 summer camps a great success. A record 932 students attended camps at the DNALC,
DNALC West, Harlem DNA Lab, and in Wyandanch. A new online system simplified registration and
saved administrative time by enabling parents to register and pay for camps, switch sessions, and can-
cel registrations on their own. Frequent ads in local papers, including Nassau, Suffolk, and Big Apple
Parent, and large e-mail campaigns also contributed to the successful summer season. With the help
of Jerry Watkins, a retired Central Islip science teacher and long-time friend of the DNALC, 12 stu-
dents from Wyandanch High School participated in a 1-week DNA Science camp held in the most
unlikely of places: the Wyandanch Public Library! Brookhaven National Laboratory provided stipends
for all students, and the DNALC provided materials and reagents. In addition, Bank of America and
the William Townsend Porter Foundation provided scholarships to 19 underrepresented minority or
disadvantaged students who attended camps at the DNALC and DNALC West. 
We continued the spring tradition, begun in 1985, of hosting Great Moments in DNA Science, a
seminar series that honors the brightest local students. Three in-depth talks covered the gamut of
research at CSHL and drew 271 participants: Dr. Eric Sawey, “Of Mice and Men: Using a Mouse
Model to Identify Human Oncogenes”; Dr. Emily Hodges, “Using Massively Parallel Sequencing
Technology and Genome Sequencing to Study Cancer Genomes”; and Dr. Stacy DeBlasio, “Illu-
minating Biology—The Science of Fluorescent-tagged Maize.” Saturday DNA! continued its popu-
lar monthly run, with hands-on sessions for parents and children that feature the latest developments
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Images of student and gel taken by a
teacher using a Footlocker kit elec-
trophoresis digital camera.
in the biological sciences. DNALC instructional, scientific, and BioMedia staff led 408 participants
in programs on diverse explorations, including “Life up Close: Microscopic Worlds,” “Personalized
Medicine,” and “Composting 101.”
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CSH High School Partnership
In the spring, we graduated our third class of students from Genome Science, our partnership with
Cold Spring Harbor High School (CSHHS). The year-long “capstone” course was co-instructed by
DNALC staff and CSHHS biology teacher Martin Glynn, with students coming on alternate days
to the DNALC for their final two class periods. The course emphasized critical thinking and included
experiments and independent projects across a range of biological systems: A plant unit analyzed
transgenes in genetically modified food and newly sequenced genes in rice; human-based experiments
used molecular tools to examine human origins and genetic variation; and work with C. elegans in-
troduced the cutting-edge RNAi technique.
The fourth class of Genome Science commenced in the fall with the added benefit of students
coming to the DNALC 5 days a week. The basic units on plants, RNAi, and human variation are
being supplemented with new research projects. As advance work on our Chloroplast Gene Sequenc-
ing Project, the students tested primers and produced a DNA bar code to identify local plants. In
collaboration with Tim Herman at the Center for BioMolecular Modeling at the Milwaukee School
of Engineering, and Joan Kiely at the Biotechnology Teaching Center at Stony Brook University, we
have added a new module on protein modeling. As part of the bioinformatics unit, the students re-
searched proteins involved in cell signaling and used three-dimensional software to highlight im-
portant parts of their structures. Coordinates from their modified structures were then used to con-
struct physical models of the proteins. The students presented their models and created posters
describing their proteins to scientists at a CSHL meeting on “Rat Genomics and Models.” We are
also pioneering a new section on metagenomics, which uses high-throughput sequencing to survey
genes and organisms present in an ecosystem. In this case, students will use bioinformatics tools to
search sequences from microbes in rotting wood, with the aim of identifying novel enzymes that
break down plant cellulose into sugars that can be used for biofuel production. This collaboration
involves former DNALC instructor Scott Bronson and researchers Niels Van der Lelie and Safiyh
Taghavi at Brookhaven National Laboratory. 
Watson School of Biological Sciences
Each January, students from the Watson School of Biological Sciences take a required teaching ro-
tation, during which they work at the DNALC to learn effective skills for communicating with
nonscientists. In the first phase of training, Watson School students observe DNALC instructors as
they teach middle and high school labs. Students then work in pairs to develop lesson plans that will
guide their own instruction. In the second phase of training, each graduate pair coteaches their pre-
pared lab alongside a DNALC instructor. Detailed feedback on their teaching—including pace,
knowledge, and engagement—prepares each pair for the final training phase: independently teach-
ing the practiced lab (with DNALC staff available for support). After completing middle school
and high school rotations, students select three additional lessons to demonstrate their new teach-
ing skills or travel with DNA staff to provide off-site instruction at a local middle school.
At the annual Watson School commencement on April 26, DNALC Executive Director David
Micklos was among four people whose contributions to science education were recognized with an
honorary Doctor of Science. Accepting the degree, he highlighted the unique opportunity that the
DNALC presented to him, to CSHL, and to Long Island:
“Jim Watson is fond of saying that one should never
be the brightest person in the room. I was acutely
aware that this applied to me when I first came to
Cold Spring Harbor 26 years ago. Whatever success
I have had here was in large part motivated by my
desire to fit in amongst the fabulous minds at Cold
Spring Harbor, and the honor of this degree makes me feel that I have found a small niche in
this great institution. I am very proud of what we have been able to accomplish at the Dolan
DNA Learning Center. When I first came to Long Island, most students remembered Cold
Spring Harbor for its Fish Hatchery. Now we have a generation of students who remember
Cold Spring Harbor for its DNA—and fifth and sixth graders are getting the grounding in
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he receives his degree.
Below, Dave Micklos (left),
David Spector (center), and
Bruce Stillman (right).
the genetics they will need to flourish in the genome age. I want to make it clear that I really
don’t believe that the unlikely success of the DNA Learning Center could have been repeated
at another institution. The DNA Learning Center arose from unique brew of high-level sci-
entists and engaged philanthropists, reaching out to include young students in the seamless
flow of the Laboratory’s history and march into the future.”
DNA Sequencing Service
The DNALC provided another year of free DNA sequencing to students and teachers worldwide.
The DNA Sequencing Service allows users to analyze and compare their own mitochondrial (mt)
DNA sequence with populations from around the world to explore human diversity. The mito-
chondrion is the cellular organelle responsible for providing energy in higher cells. A remnant of its
ancient life as a free-living bacterium, the mitochondrion has its own chromosome (genome). De-
pending on energy demands, there are hundreds to thousands of mitochondria per cell, and each
carries several copies of mitochondrial chromosome. Thus, mitochondrial DNA is highly amplified
compared to nuclear DNA, which has only two copies. This makes mitochondrial DNA the ideal
target for sequencing from tissue samples that are very old, very small, or badly degraded by the en-
vironment. The hypervariable region of the mitochondrial chromosome accumulates mutations
quickly, providing a means to study genetic changes that have occurred during human evolution.
The DNALC popularized methods to use mitochondrial mutation analysis in education, focusing
on the same DNA region used by National Geographic’s Genographic Project and featured in the pop-
ular book The Seven Daughters of Eve. Using DNALC protocols or ready-to-use kits, students isolate
a 440-nucleotide sequence of their mitochondrial genome and send the amplified samples to the
DNALC by overnight mail. Sequencing reactions are prepared by DNALC interns and sent to the
CSHL Sequencing Shared Resource Facility in Woodbury for sequencing on an Applied Biosystems
3730xi Genetic Analyzer. The finished sequences are uploaded to an online DNA database at the
DNALC’s BioServers Internet site (www.bioservers.org), which provides tools to compare mitochon-
drial DNA sequences of individuals across the globe. Additionally, mitochondrial DNA sequences
from Neanderthals (~50,000 years old) and Otzi “the ice man” (5000 years old) allow students to con-
sider the question “how ancient is ancient?” In 2009, we sequenced 7057 student DNA samples sub-
mitted from 121 high schools, 39 community colleges, and 39 universities. The free sequencing
service, which is now in its 11th year, is made possible by sequencing reagents donated by Applied
Biosystems of Foster City, California.
Staff and Interns
In the fall, we said goodbye for a second time to Malissa Greif (formerly Hewitt). Malissa helped
found and then managed our successful GMWL program for middle schools in the mid 1990s,
leaving in 1998 to become a full-time mom. She returned in 2006 as a middle school instructor, re-
cruiting a number of new schools into the GMWL program and developing new labs on bioreme-
diation. We wish her the best of luck in her new home in Nissequogue.
As development of the Genes to Cognition Online website wound down, multimedia designer
Stephen Blue left to concentrate on his teaching at City University of New York and Parsons School
of Design. In addition to his work on G2C Online, Stephen, who joined us in 2007, designed the
multimedia Lab Centers (www.dnalc.org/labcenter/) that accompany six of our most popular lab
field trips. During the year, he continued to collaborate with CSHL Press, developing illustrations
for our forthcoming textbook, Genome Science.
In December, high school instructor Jason Williams was promoted to the newly created position
of partnership coordinator for the iPlant Collaborative. Jason will have a key role in developing large-
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scale, distributed experiments that allow faculty and students to participate directly in modern plant
research. He will work with the plant research community to identify available tools and data sets
and then foster ongoing collaborations among scientists, teachers, and students. One project will pro-
vide online tools and databases to allow students to sequence and analyze genes used to study plant
phylogenetics and diversity. 
After graduating Magna Cum Laude from Long Island University with a bachelor’s
degree in forensic science and a minor in chemistry, Jennifer Aiello joined the DNALC
staff as a middle school instructor. Jen started here in 2002 as a high school intern from
Kings Park High School, continuing to work at the DNALC through her years at C.W.
Post, when she managed our free DNA Sequencing Service and our C. elegans strain
bank. Jen has already brought new experiences in forensic science to our Saturday DNA!
Program, which we anticipate will grow into a new summer camp offering.
The internship program continues to draw some of Long Island’s most talented high
school and college students, engaging them in science research and providing practical lab-
oratory experience. We were pleased to accept a large group of new high school interns
this year: Laura Bergsten (Cold Spring Harbor), George Economou (Syosset), Lindsay
Hochberg (Oyster Bay), Anouva Kalra-Iall (Roslyn), Anastasia Minkin (Oyster Bay), Nate
Rahimzada (North Shore Hebrew Academy), Jaylin Sasson (Jericho), Max Vaysman
(Commack), Pamela Wax (Harborfields), and Sara Wienclaw (Kellenberg). We also welcomed Annie
Laurie Benzie (Adelphi) as a college intern to help with DNA Sequencing Service and C. elegans strain
requests. Returning interns were Emily Troge (Our Lady of Mercy) and Kevin Wu (Jericho). Many of
our interns continued to invest their DNALC experience in their own research. Arielle Scardino (City
College) worked with Jermel Watkins to explore how a decreased expression of certain mitochondrial
genes can be used as a biomarker for neuromuscular dysfunction. 
The BioMedia Group continues to rely on Chris Weidler (Farmingdale State College) and his
range of computer skills. Chris created all of the themes for our new blogs and has stepped in to help
with video processing. Tony Biondo (Stony Brook University) provided vital programming support
on our iPlant DNA Subway, as well as video encoding for hundreds of online clips. 
We bid farewell to a number of interns when they began their college careers: Charmaine Brown
(St. John’s University), Nancy Desai (Boston University), Rachel Gellerman (Binghamton Univer-
sity), Yasmina Macer (Wellesley College), Stephanie Parascandalo (Queens College), Arielle Scardino
(City College of New York), and Kaitlin Watrud (Gettysburg College). A number returned to assist
with summer camps: Nick Wilkens (Ithaca College), Seth Schortz (Emory University), Lauren
Thompson (Barnard College), Matthew Woo (Vassar College), and Janice Yong (Boston University). 
Expert Advisors and Corporate Support
We are lucky to have high-level support from two advisory bodies: the Dolan DNA Learning Cen-
ter Committee and the Corporate Advisory Board (CAB). The DNALC Committee consists of
community leaders and members of the CSHL senior management and Board of Trustees, who
oversee strategic development, including capital funding and the evolution of satellite locations in
North America and beyond. The CAB provides liaison to the Long Island and New York City
business communities; its annual fund campaign and golf tournament contributed $225,000 in
2009.
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2009 Workshops, Meetings, and Collaborations
January 8 iPlant Collaborative Cyberinfrastructure Workshop, Biosphere 2, University of Arizona, Tucson, Arizona
January 8 National Genographic Presentation, Nassau BOCES, Garden City, New York
January 10 HHMI Professional Development Workshop, “PCR and Human DNA Variations, Part 2,” Harlem DNA Lab
January 12 Site visit by G2C Online Fellow Caren Gough, Education Consultant
January 23 NIH Inside Cancer Workshop, Illinois Institute of Technology, Chicago, Illinois
January 24 Saturday DNA! “Murder at the Museum,” DNALC
January 27 Meeting with Scott Bronson, Brookhaven National Laboratory, Upton, New York
February 3 Site visit by Robin Hood Foundation, Harlem DNA Lab
February 6 Site visit by Marc Nivet, Josiah Macy, Jr. Foundation, New York
February 9 Site visit by Wanda Wakal, Executive Officer, Research & Development in Gifted & Enrichment, Learning 
Support Organization, Harlem DNA Lab
February 9 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
February 14 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
February 17–18 G2C Online Workshop, Contra Costa County School District, Pleasant Hill, California
February 19 NIH Inside Cancer Workshop, Contra Costa County School District, Pleasant Hill, California
February 19 Site visit by G2C Online Fellows Caren Gough, Education Consultant, and Laura Maitland, Advanced 
Placement Psychology Consultant
February 21 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
February 24 Site visit by Zoraya Victory, World Science Festival Planning Committee, Harlem DNA Lab
February 26 Science Supervisors’ Meeting with Alan Ascher, Harlem DNA Lab
February 27 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
February 28 Saturday DNA! “Dust Away Crime,” DNALC
March 5 Site visit by Dale Cole with OSI Pharmaceuticals Inc. members and students from Wyandanch schools
March 6–7 HHMI Peer Cluster Meeting, University of Wisconsin, Milwaukee, Wisconsin
March 6–7 G2C Online Workshop, Harlem DNA Lab
March 9–10 G2C Online Workshop, Fralin Biotechnology Center, Blacksburg, Virginia
March 10 Site visit by Abby Kirschner, Curriculum and Content Coordinator, NYC Teaching Fellows Program, 
Harlem DNA Lab
March 12 HHMI Professional Development Workshop, “Transformation and Protein Isolation,” Harlem DNA Lab
March 12 NIH Inside Cancer Workshop, Virginia Tech, Blacksburg, Virginia
March 13 Site visit by Orla Dolan, Cork Cancer Research Center, Cork, Ireland
March 13 Site visit by Ryan Goble, Curriculum Coordinator, Literacy and New Teacher Coach, Banana Kelly High School,
Harlem DNA Lab
March 13–14 NSF Silencing Genomes Follow-up Workshop, Virginia Tech, Blacksburg, Virginia
March 19–21 National Science Teachers Association National Conference Presentations: “Bioinformatics in Your Classroom,” 
“Sense in Molecules: A Polymorphic Analysis,” and “G2C Online,” New Orleans, Louisiana 
March 20 Site visit by David Porteous, University of Edinburgh Centre for Molecular Medicine and Institute of Genetics 
and Molecular Medicine, Edinburgh, Scotland
March 20 Women in Science Conference, Suffolk Community College, Brentwood, New York
March 21 HHMI Professional Development Workshop, “Transformation and Protein Isolation,” Harlem DNA Lab
March 28 Saturday DNA! “Mitochondrial DNA,” DNALC
March 28 Site visit by College of New Rochelle alumni, New Rochelle, New York
March 28 NIH Inside Cancer Workshop, Harlem DNA Lab
April 4 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
April 17 Interview with Sue Wessler, University of Georgia, Athens, Georgia, DNALC
April 17 NIH Inside Cancer Workshop, University of Colorado Anschutz Medical Campus, Denver, Colorado
April 18 G2C Online Workshop, University of Colorado Anschutz Medical Campus, Denver, Colorado
April 20–23 Site visit to Carolina Biological Supply Company, Burlington, North Carolina
April 22–24 Seminar, workshop, and dedication of MobileLab, Ho Yu College and Primary School, Hong Kong
April 25 NIH Inside Cancer Workshop, Arizona State University, Tempe, Arizona
April 25 Science Council of New York City Workshop, Stuyvesant High School, New York
May 1 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
May 1–2 G2C Online Workshop, Arizona Biodesign Institute, Arizona State University, Tempe, Arizona
May 5 Site visit by Jan Kang, Trinity School, Harlem DNA Lab
May 7 Great Moments in DNA Science Honors Seminar: “Of Mice and Men: Using a Mouse Model to Identify New 
Targets for Cancer Therapy,” Eric Sawey, CSHL
May 8 Interview with Svante Pääbo, Max-Planck Institute for Evolutionary Anthropology, Leipzig, Germany, DNALC
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May 9 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part One,” Harlem DNA Lab
May 14 Great Moments in DNA Science Honors Seminar: “Using High-throughput Sequencing to Study Cancer 
Genomes,” Emily Hodges, CSHL
May 15 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part One,” Harlem DNA Lab
May 16 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part Two,” Harlem DNA Lab
May 16 Saturday DNA! “Who’s the Suspect?” DNALC
May 18–20 NIH SEPA Principal Investigators Meeting, Science Museum of Minnesota, St. Paul, Minnesota
May 21 Great Moments in DNA Science Honors Seminar: “Illuminating Biology—The Science of Fluorescent-tagged 
Proteins in Corn,” Stacy DiBlasio, CSHL
May 21–22 NSF Silencing Genomes Follow-up Workshop, Austin Community College, Austin, Texas
May 22 NIH Inside Cancer Workshop, Minneapolis Community & Technical College, Minneapolis, Minnesota
May 22 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part Two,” Harlem DNA Lab
May 26 North Carolina Life Science and Bioinformatics Education Symposium, North Carolina Biotech Center, Raleigh,
North Carolina
May 28 Interviews with Russell Doolittle, Harvard University, Cambridge, Massachusetts; Craig Venter, J. Craig Venter 
Institute, San Diego, California; and Tim White, University of California, Berkeley, DNALC
May 29 Interviews with Seth Grant, Wellcome Trust Sanger Institute, Cambridge, England; Nicole King, University of 
California, Berkeley; and Sue Wessler, University of Georgia, Athens, DNALC
May 30–31 NSF Silencing Genomes and G2C Online Seminars, Bossier Parish Community College, Bossier Parish, Louisiana
May 31 NIH Inside Cancer Workshop, Bossier Parish Community College, Bossier Parish, Louisiana
June 1 Interviews with John Doebley, University of Wisconsin, Madison, and Eugenie Scott, National Center for 
Science Education, Oakland, California, DNALC
June 1–5 NSF Silencing Genomes Workshop, California State University, Dominguez Hills, California
June 6 NIH Inside Cancer Workshop, St. Louis Science Center, St. Louis, Missouri
June 8–12 NSF Silencing Genomes Workshop, St. Louis Science Center, St. Louis, Missouri
June 9 16th Annual Golf Outing, Piping Rock Club, Locust Valley, New York
June 9 Site visit by Kristin Baldwin and Amy Chase, E. coli Art Project for World Science Festival, Harlem DNA Lab
June 10 NIH Inside Cancer Workshop, Tulsa Community College, Tulsa, Oklahoma
June 10 Site visit by Kidgie Williams, Hospitality Committee for United Nations Delegations, Inc., and United Nations 
delegates’ family members, New York
June 11 Site visit by Maxmillian Angerholzer III, Executive Director and Secretary, Lounsbery Foundation, Harlem DNA Lab
June 11 World Science Festival, New York University, New York
June 11–12 G2C Online Workshop, Tulsa Community College, Tulsa, Oklahoma
June 12 Site visit by Kristin Baldwin and Amy Chase, E. coli Art Project for World Science Festival, Harlem DNA Lab
June 13 Saturday DNA! “Oil Eating Bacteria,” DNALC
June 15–19 DNA Science Workshop, Harlem DNA Lab
June 17–19 Genomics in Education Symposium, St. Louis, Missouri
June 20 NIH Inside Cancer Workshop, North Carolina Agricultural & Technical University, Greensboro
June 22–26 Fun with DNA Workshop, Harlem DNA Lab
June 22–26 NSF Silencing Genomes Workshop, North Carolina Agricultural & Technical University, Greensboro
June 29 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
June 29–July 2 Fun with DNA Workshop, DNALC
Fun with DNA Workshop, DNALC West
Plant Genomics Workshop, DNALC
World of Enzymes Workshop, DNALC
June 30 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
July 1 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part One,” Harlem DNA Lab
July 2 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part Two,” Harlem DNA Lab
July 6 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
July 6–10 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC West
July 7 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
July 8 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part One,” Harlem DNA Lab
July 9 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part Two,” Harlem DNA Lab
July 9 Site visit by New York State Biology Professional Development Network with Caren Gough, Education Consultant
July 10 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
July 13 Site visit by Tuan Chiong Chew, Executive Director, Singapore Science Center, Singapore
July 13–17 DNA Science Workshop, DNALC West
Genetic Horizons Workshop, DNALC
World of Enzymes Workshop, DNALC
July 13–24 Site visit by Inside Cancer Faculty Fellows Wendy Wooten, Robin Cochran-Dirksen, and Greg Ballog
July 13–24 HHMI New York Leadership Symposium, DNALC
July 15 Site visit by Rod Miller, Mark Greenburg, Donna Murasko, and Patricia Austin, Drexel University, Philadelphia, 
Pennsylvania
July 15–17 American Association for the Advancement of Science Meeting, “Transforming Undergraduate Biology 
Education,” Washington, D.C.
July 16 Site visit by NYS Assembly member Deborah J. Glick, Greenwich Village, New York
July 17 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
July 20–24 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC West
Human Genomics Workshop, DNALC
July 20–31 Site visit by Inside Cancer Fellows Lisa Orenstein and Maggy Witecki
July 21 Site visit by Lawrence Kobilinsky, Albert Harpe, and Linda Rourke, John Jay College of Criminal Justice, New York
July 22 Site visit by Rick Acritelli and 10 teachers, The New York Center for Teacher Development, Port Jefferson, New York
July 24 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
July 24 Site visit by 15 STEP program students, SUNY, Old Westbury, New York
July 27–31 DNA Science Workshop, Harlem DNA Lab
Genetic Horizons Workshop, DNALC West
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
Human Genomics Workshop, DNALC
July 31 NIH Inside Cancer Workshop, Howard University, Washington, D.C.
August 3 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
August 3–7 NSF Silencing Genomes Workshop, Howard University, Washington, D.C.
August 3–7 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Fun with DNA Workshop, DNALC West
Genetic Horizons Workshop, DNALC
August 4 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
August 5 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
August 6 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
August 7 G2C Online Workshop, Madison Area Technical College, Madison, Wisconsin
August 8 NIH Inside Cancer Workshop, Madison Area Technical College, Madison, Wisconsin
August 10–14 DNA Science Workshop, DNALC
Green Genes Workshop, DNALC
Human Genomics Workshop, Harlem DNA Lab
World of Enzymes Workshop, DNALC
World of Enzymes Workshop, DNALC West
August 12–14 Professional Development Workshop, Hauppauge UFSD, New York
August 14 NIH Inside Cancer Workshop, Houston Community College Northwest, Houston, Texas
August 17 Site visit by Jill Hirsch, Kathy Tompkins, and Lacey Tompkins, The Chapin School, New York
August 17–20 HHMI Peer Cluster Meeting, Great Falls, Montana
August 17–21 DNA Science Workshop, DNALC
DNA Science Workshop, DNALC West
Fun with DNA Workshop, DNALC
Fun with DNA Workshop, Harlem DNA Lab
Genetic Horizons Workshop, DNALC
August 17–21 NSF Silencing Genomes Workshop, Houston Community College Northwest, Houston, Texas
August 24 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
August 24–28 DNA Science Workshop, DNALC
DNA Science Workshop, Wyandanch Public Library, Wyandanch, New York
Green Genes Workshop, DNALC
Human Genomics Workshop, DNALC West
World of Enzymes Workshop, DNALC
August 25 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
August 26 Site visit by HHMI Fellow Caren Gough, Executive Consultant, and Kathleen Rucker, Brooklyn International 
High School, Brooklyn, New York
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August 26 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
August 27 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
August 28 G2C Online Workshop, John Jay College of Criminal Justice, New York
August 29 NIH Inside Cancer Workshop, John Jay College of Criminal Justice, New York
Aug. 31–Sept. 4 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC West
World of Enzymes Workshop, DNALC
September 1 Site visit by Hilleary Osheroff, Samara Rubinstein, and Monique Scott, American Museum of Natural History, 
New York
September 8 Site visit by Scott Bronson, Safiyh Taghavi, and Daniel van der Lelie, Brookhaven National Laboratory, Upton, 
New York
September 9 Site visit by Joan Kiely, Stony Brook University, Stony Brook, New York
September 11–18 JGI Metagenomics Course, Walnut Creek, California
September 16 Site visit by 10 scientists, Tsinghua University, Beijing, China
September 21 Interview with Jean-Philippe Vielle Calzada, Laboratorio Nacional de Genomica para LaBiodiversidad, Irapuato, 
Mexico, DNALC
September 21 Meeting with Bhuma Krishnamachari, C.W. Post Genetic Counseling Program, C.W. Post University, Brookville,
New York
September 24 Interview with Janet Rossant, The Hospital for Sick Children, Toronto, Canada, DNALC
September 24 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
September 25 Site visit by Hilleary Osheroff, American Museum of Natural History, New York, New York, Harlem DNA Lab
September 26 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
October 3–9 Weed to Wonder Videography, Balsas River Valley region of Mexico, documenting the history of maize cultivation 
October 5 Interview with Suketoshi Taba, International Maize and Wheat Improvement Center, Texcoco, Mexico
October 7 Interviews with Jean-Philippe Vielle Calzada and Luis R. Herrera Estrella, Laboratorio Nacional de Genomica 
para La Biodiversidad, Irapuato, Mexico
October 9 NIH Inside Cancer Workshop, Oxnard College, Oxnard, California
October 10 G2C Online Workshop, Oxnard College, Oxnard, California
October 16 Interview with Ed Buckler, Cornell University, Ithaca, New York, and Torbert Rocheford, Purdue University, 
West Lafayette, Indiana, DNALC
October 17 Saturday DNA! “Disease Detectives,” DNALC
October 17 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
November 2 Weed to Wonder videography of George Shull Recreation, Uplands Farm, CSHL
November 2–4 Site visit by Maria Halaschek-Weiner and Jochen Stadler, Vienna Open Lab, Vienna, Austria
November 3 HHMI Professional Development, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
November 5 NIH Inside Cancer Workshop, Raritan Community College, Somerville, New Jersey
November 6 G2C Online Workshop, Raritan Community College, Somerville, New Jersey
November 7 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem 
DNA Lab
November 9–10 HHMI Precollege Programs Meeting, Bethesda, Maryland
November 10–13 NSF Research Coordination Networks–Undergraduate Biology Education Grant Review, Arlington, Virginia
November 14 Saturday DNA! “Personalized Medicine,” DNALC
November 14 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
November 20 Site visit by Richard Thompson, Melanie Harasym, and alumni, College of New Rochelle, New Rochelle, New 
York, with Barbara Candee, CSHL Association Board Director
November 20 G2C Online Workshop, Great Bay Community College, Portsmouth, New Hampshire
November 21 NIH Inside Cancer Workshop, Great Bay Community College, Portsmouth, New Hampshire
November 30 Meeting with middle and high school science faculty, Trinity School, Harlem DNA Lab
Nov. 30–Dec. 11 Singapore Primary Teachers Attachment, DNALC 
December 2–4 NSF ATE Grant Review Panel, National Science Foundation, Arlington, Virginia
December 3 Site visit by Barbara Gill, Barbara Rich, and Janet Eilber, The Dana Foundation, New York
December 4 Meeting with Robert Krulwich, National Public Radio, New York
December 5 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
December 12 Saturday DNA! “Life Up Close: Microscopic Worlds,” DNALC
December 14 Site visit by Theresa Regnante, United Way of Long Island, and Teresa Kemp-Zielenski, DNALC Corporate 
Advisory Board member
December 19 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part One,” Harlem DNA Lab
December 30 Site visit by Andrea and Sabrina Gallego, The Simons Foundation, New York
Sites of Major Faculty Workshops 1985–2009
Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Arizona State University, Tempe 2009
Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA California State University, Dominguez Hills 2009
California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Canada College, Redwood City 1997
City College of San Francisco 2006
Contra Costa County Office of Education, Pleasant Hill 2002, 2009
Foothill College, Los Altos Hills 1997
Harbor–UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA Biomed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Oxnard Community College, Oxnard 2009
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001, 2008
San Francisco State University 1991
San Jose State University 2005
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998, 2009
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007–2008
North Miami Beach Senior High School 1991
University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Morehouse College, Atlanta 1991, 1996–1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986–1987
Illinois Institute of Technology, Chicago 2009
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Bossier Parish Community College 2009
Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
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St. John’s College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
The Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA Minneapolis Community and Technical College 2009
University of Minnesota, St. Paul 2005
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2008
MISSOURI St. Louis Science Center, St. Louis 2008–2009
Stowers Institute for Medical Research, Kansas City 2002, 2008
Washington University, St. Louis 1989, 1997
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE Great Bay Community College, Portsmouth 2009
New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986–1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
Raritan Valley Community College, Somerville 2009
NEW MEXICO Biolink Southwest Regional Meeting, Albuquerque 2008
NEW YORK Albany High School 1987
American Museum of Natural History, New York 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Cold Spring Harbor High School 1985, 1987
Columbia University, New York 1993
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988–1995, 2001–
2004, 2006–2009
DNA Learning Center 1990, 1992, 1995, 2000
DNA Learning Center 1990–1992
DNA Learning Center West 2005
Fostertown School, Newburgh 1991
Harlem DNA Lab, East Harlem 2008–2009
Huntington High School 1986
Irvington High School 1986
John Jay College of Criminal Justice 2009
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
New York City Department of Education 2007
New York Institute of Technology, New York 2006
New York Institute of Technology, New York 2006
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987–1990
Stuyvesant High School, New York 1998–1999
The Rockefeller University, New York 2003
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Lake Saranac 2001
Union College, Schenectady 2004
United States Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina Agricultural & Technical State University, Greensboro 2006–2007, 2009
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
Langston University, Langston 2008
North Westerville High School 1990
OKLAHOMA Tulsa Community College, Tulsa 2009
Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
Kimmel Cancer Center, Philadelphia 2008
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TENNESSEE NABT Professional Development Conference, Memphis 2008
TEXAS Austin Community College-Rio Grande Campus 2000
Austin Community College–Eastview Campus 2007–2009
Houston Community College Northwest, Houston 2009
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Midland College, Midland 2008
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M, AG Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005, 2008–2009
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001, 2008
University of Washington, Seattle 1993, 1998
WASHINGTON, D.C Howard University 1992, 1996, 2009
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999, 2009
Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab 2007
CANADA Red River Community College, Winnipeg, Manitoba 1989
CHINA Ho Yu College, Hong Kong 2009
GERMANY Urania Science Center, Berlin 2008
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
MEXICO ASPB Plant Biology, Merida 2008
PANAMA University of Panama, Panama City 1994
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PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil
Uppsala University, Uppsala 2000
THE NETHERLANDS International Chromosome Conference, Amsterdam 2007
COLD SPRING HARBOR 
LABORATORY PRESS
SERIALS
Genes & Development, Vol. 23 (www.genesdev.org)
Genome Research, Vol. 19 (www.genome.org)
Learning & Memory, Vol. 16 (www.learnmem.org)
RNA, Vol. 15 (www.rnajournal.org)
Cold Spring Harbor Symposia on Quantitative Biology, Vol. 73: Con-
trol and Regulation of Stem Cells, edited by Bruce Stillman, David
Stewart, and Terri Grodzicker
Cold Spring Harbor Protocols (www.cshprotocols.org)
Cold Spring Harbor Perspectives in Biology (www.cshperspectives.org)
LABORATORY MANUALS
Genetics of Complex Human Diseases: A Laboratory Manual, edited
by Ammar Al-Chalabi and Laura Almasy
Live Cell Imaging, 2nd ed.: A Laboratory Manual, edited by Robert
D. Goldman, Jason R. Swedlow, and David L. Spector
Mouse Hematology: A Laboratory Manual, by Michael P. McGarry,
Cheryl A. Protheroe, and James J. Lee
HANDBOOKS
Statistics at the Bench: A Step-by-Step Handbook for Biologists, by
Martina Bremer and Rebecca W. Doerge
TEXTBOOKS
Untangling the Double Helix: DNA Entanglement and the Action 
of the DNA Topoisomerases, by James C. Wang
MONOGRAPH
The Skeletal System, edited by Olivier Pourquié
SCIENCE AND SOCIETY
What a Time I Am Having: Selected Letters of Max Perutz, by
Vivien Perutz
Francis Crick: Hunter of Life’s Secrets, by Robert Olby
OTHER
CSHL Annual Report 2008; Yearbook Edition
CSHL Annual Report 2008
Banbury Center Annual Report 2008
Watson School of Biological Sciences Annual Report 2008
WEBSITES
http://cshmonographs.org/index.php/monographs; Cold Spring
Harbor Monographs Archive Online 
http://www.cshl.symposium.org; Symposia, Vol. 73 added to
online Symposia website
2009 PUBLICATIONS
The journal publishing programA selection of recently published books
CSHL Press’ new online journal, Perspectives in Biology
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COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR’S REPORT
Cold Spring Harbor Laboratory’s outstanding research activities are complemented by a renowned
program of professional and public education in biomedicine that is transmitted worldwide by Cold
Spring Harbor Laboratory Press. Its evolution into a well-known and respected professional pub-
lisher has produced six research journals, two of them among the most highly ranked in science;
the world’s most widely used laboratory manuals; prestigious monographs; an outstanding series of
conference proceedings; and best-selling primers on professional skill development for scientists.
These activities enhance the work of other educational divisions, produce revenue that supports the
Laboratory’s work as a whole, and strengthen Cold Spring Harbor’s association with excellence.
In 2009, for the sixth consecutive year, the Press generated a substantial operating excess, with a
margin of $516,000 that exceeded budget by $100,000, on revenues of $9.1 million. The Press’
total contribution to the Laboratory, including support for institutional overhead, was $1.1 million. 
Journals
Revenue from journal publishing remains vital to the financial health of the Press. In 2009, economic
recession overtook most of the countries that provide the lion’s share of that revenue. Nevertheless,
gratifyingly, the year proved to be a solid one for journal subscriptions, with four of our five titles
meeting or exceeding their sales targets. The exception was our newest journal Cold Spring Harbor
Protocols, which fell short of a notably aggressive projection but nonetheless advanced strongly. Journal
purchasing decisions are made in the third quarter of the year preceding the subscription year, so the
full impact of recession on library budgets may not be seen until subscriptions are renewed for 2011.
To assist struggling institutions, and as a protective measure, price increases for journals in 2010 were
restricted to less than 4%. Initiatives to support retention and growth include new subscription pack-
ages offering discounts to libraries subscribing to all Press titles. Proactive promotions of subscription
renewals, including journal packages with our newest titles, began earlier than usual, with promising
results. Proposals for multilibrary subscription packages in the most recent quarter include offers to
groups in India, Hong Kong, Australia, Brazil, Korea, Japan, and France. Although such proposals
usually take many months or years to conclude, we have recently signed agreements in India and
France and anticipate more success in 2010.
Advertising sales in the journals also proved pleasingly robust despite general market gloom and
mergers in the laboratory equipment and reagents market that continued to reduce the client base.
Print remains the main driver of advertising sales, but there is a gradual and persistent climb in rev-
enue from electronic placement.
Subscription growth and advertising sales performance are highly dependent on the journals’ ed-
itorial value to the community. The metrics of value are under scrutiny and the long-established “im-
pact factor” is no longer either the sole, or unassailable, arbiter of quality. But by all available measures,
our journals Genes & Development and Genome Research continue to rank at the peak of distinction
in the fields of genetics and developmental and cell biology. Learning & Memory, a specialized journal
in the vast field of neuroscience, continues to attract a substantial number of submissions and appears
to have made an untroubled transition to an “online-only” condition with only a minimal loss of
subscriptions. RNA, the journal published for The RNA Society, also continued to be editorially vig-
orous, assisted by the revitalization of RNA biology, and as the year ended, we were delighted by the
Society’s declaration of its wish to continue a publishing relationship with the Press beyond the end
of the current contract in December 2010. The excellence of our production, marketing, and editorial
services and sound strategic guidance were cited by the Society as the reasons for their decision, and
a plan is being devised to bring further improvements to the journal. 
Toward the year’s end, Cold Spring Harbor Protocols, our methods journal, achieved acceptance
for indexing in Medline, the premier reference source in the life sciences, recognition that will enable
this still-growing journal to gain additional traffic and exposure. 
In December, the long-standing European editorial office of Genes & Development began winding
down, in order to consolidate all manuscript review and selection in the Cold Spring Harbor office.
This decision, taken with intent to increase efficiency and cost effectiveness in full consultation with
co-owner The Genetics Society of Great Britain, alters an editorial structure put in place at the jour-
nal’s launch 22 years ago, when the scientific community was more circumscribed and the tech-
nologies underlying journal publishing were dramatically different. Now that papers have global
origins and the entire editorial process can be conducted electronically, from manuscript submission
through the review of proofs, there is no longer the same need for a regional office. Since the journal
began, five scientists have been European Editor: Graham Bulfield, Nicholas Hastie, Davor Solter,
Rudi Grosschedl, and Winship Herr. They have been important to the journal’s emergence as one
of the most significant in biological science and we are most grateful for their service. With the in-
crease in activity required at Cold Spring Harbor in 2010, the editorial team will be expanded. 
The globalization of bioscience is underscored by the Laboratory’s ambitious new conference
center at Dushu Lake, Suzhou, China. Methods of promoting our publications there are being ex-
plored and local printing of sample issues, regional advertising partnerships, and subject-specific
content collections are some of the possibilities under consideration.
The launch in July of our newest serial, the review journal Cold Spring Harbor Perspectives in Biology,
after an 18-month development period, showcased the exceptional quality to be expected from this
journal. Its unique feature is its publication of collections of articles that have each been commissioned
to provide an in-depth, coherent survey of a single topic. More than 20 subject collections from cell
and molecular biology are in the publication pipeline, and each collection has commissioning editors
with outstanding international reputations. Each article is being published individually in an issue of
the journal, but when complete, the collections will be available in print or as downloadable electronic
books. The journal is available free of charge for a year before fees are imposed for access.
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Mark Beavers (left), conference coordinator for CSHL’s Meeting and Courses department, and David Crotty (right), executive editor
of CSH Protocols, at the Cold Spring Harbor booth at the October 2009 Society for Neuroscience meeting in Chicago.
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The response from scientists to the Perspectives concept has been so positive that recruiting has
begun for Cold Spring Harbor Perspectives in Medicine, a source of research information for physicians
and scientists working in cancer, neuropathies, psychiatric disorders, infectious disease, metabolic
syndrome, and other disorders. This publication will appear first as a supplement, becoming a sep-
arate publication and additional source of revenue later.
Other Online Publications
A CSHL Press Monograph online archive was launched in October and features the series’ entire
collection of titles from 1972 to 2009. The archive’s 59 full-text volumes will be sold to institutions
as a complete collection and to individuals on a pay-per-chapter basis. Online development and
publication were accomplished with modest investment, in collaboration with The Public Knowl-
edge Project at Vancouver’s Simon Fraser University. This is the second archive of classic publications
from the Laboratory to be made available, following last year’s release of the complete electronic
archive from 1933 of the Annual Symposia.
In trade publishing, 2009 was the year that the e-book became a commercial reality. The mass
media were abuzz with the explosion in sales of handheld reading devices such as the Kindle and
Sony Reader. iPhone users made book readers their favorite applications, and sales of e-books rose
sharply at Amazon.com. Amid the frenzy, it was necessary to remember that only about 2% of all
book sales were e-books, that fewer than 3 million Kindles had been sold, and that Amazon was
controlling what purchasers paid for an e-book, regardless of the publisher’s price. Sales of Cold
Spring Harbor’s six Kindle editions were low, as expected, because the device is too expensive for
most scientists, and the most popular title, unsurprisingly, was our single work of fiction, Experi-
mental Heart. But the experience of producing and marketing books in this form was valuable, be-
cause the demand and technologies for electronic books are certain to evolve rapidly in 2010. The
Press is responding with several new initiatives. These include the sale of e-books directly from the
Press website, the creation of content applications for mobile devices including the iPad and iPhone,
Google Editions as a possible sales partner, changes in the business model of sales to the Kindle
platform, the creation of device-readable editions of our journals, and the design of dedicated, brows-
able multimedia sites for certain key book titles. Our goal is to cost effectively make our content
available in as many ways as readers require. 
Press Marketing Manager Ingrid Benirschke (left) overseeing the Cold Spring Harbor booth at the October 2009 Society for Neuro-
science meeting in Chicago.
Books
Nine new books were published in 2009 and 17 new contracts were signed with editors and authors.
As the list below indicates, the newly published titles included technical manuals, a monograph, an
advanced textbook, two volumes of biography, and a handbook on statistical methods that already
promises to be one of the strongest book titles the Press has published in recent years. The appearance
of the long-awaited scientific biography of Francis Crick by the distinguished historian Robert Olby
was a notable event and reviews of the book have been warm and appreciative. 
The year’s best-selling book titles were Molecular Cloning, At the Bench, Essentials of Glycobiology,
Evolution, and Epigenetics. Evolution, the textbook published in July 2007, continues to capture
adoptions for classes at universities around the world. The book has been critically acclaimed as the
first to successfully integrate evolutionary biology with molecular biology and genomics. Work is
now beginning on a second edition and a shorter, nonmajors edition, and the book is being trans-
lated into Chinese, Japanese, and Greek languages.
Other translation contracts included a Russian edition of Epigenetics, Arabic translation of The
Eighth Day of Creation, German translation of Proteomics, Japanese translation of Essentials of Gly-
cobiology, and Indonesian translation for our children’s books series Enjoy Your Cells.
The decade-long digital transition in the distribution and purchase of scientific information con-
tinues to drive the evolution of our marketing and sales strategies. A monthly electronic newsletter
is sent to more than 45,000 individuals worldwide each month, promoting new titles, journal arti-
cles, and the work of the other educational divisions of the Laboratory. A new quarterly e-newsletter
to librarians has also proved useful. The addition of features and functions to our website continues
to enhance its value as the cornerstone of our presence in the information landscape. 
Our publishing program benefits greatly from the local expertise of commission-based sales agents
in China, Japan, India, and South America. In recent years, European book sales and marketing
have been managed in the same way, but from 2010, these functions will return to the direct control
of the Press. Warehousing, order processing, and book distribution will be handled by a U.K. com-
pany, and a part-time marketing manager has been appointed to complement and enhance the ac-
tivities of the Cold Spring Harbor sales and marketing team. This reorganization saves significant
expense, allows expansion of our marketing activities, and connects us more directly with customers
in our largest non-U.S. market.
Staff
Two promotions were announced during the year: Laureen Connell from Assistant to Associate Ed-
itor of Genes & Development, and Christina Lo to the additional position of Contracts and Rights
Manager. We also said farewell to Lauren Schmidt and welcomed Ann Smith as her replacement.
Dr. Nicholas Oswald was appointed European Marketing and Sales Manager, based in Edinburgh
U.K. 
A complete list of staff members of the Press as of December 2009 is printed elsewhere in this
volume. The Laboratory is fortunate to have the service of such capable and dedicated professionals.
Special thanks are due to those with the added responsibility of leadership in the diverse departments
and projects of the Press: Jan Argentine, David Crotty, Alex Gann, Terri Grodzicker, Christina Lo,
Geraldine Jaitin, Bill Keen, Wayne Manos, Richard Sever, Marcie Siconolfi, Hillary Sussman, Linda
Sussman, and Denise Weiss.
John R. Inglis
Executive Director
and Publisher
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FINANCE
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2009
(with comparative financial information as of December 31, 2008)
  2009 2008
Assets:
Cash and cash equivalents $   65,950,558 52,226,592
Grants receivable 6,200,398 8,597,399
Contributions receivable, net 119,740,185 104,681,657
Publications inventory 4,570,278 3,925,967
Investments 241,595,564 213,424,159
Restricted use assets 2,111,090 20,947,929
Deposits with bond trustee – 11,886,744
Other assets 10,398,213 10,227,962
Land, buildings and equipment, net 237,791,406 198,684,203
Total assets $ 688,357,692 624,602,612
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $   26,475,011 50,563,503
Deferred revenue 5,640,029 3,962,000
Bonds payable 97,200,000 97,200,000
Total liabilities 129,315,040 151,725,503
Net assets:
Unrestricted 235,125,827 126,126,561
Temporarily restricted 142,357,714 179,988,153
Permanently restricted 181,559,111 166,762,395
Total net assets 559,042,652 472,877,109
Total liabilities and net assets $ 688,357,692 624,602,612
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2009
(with summarized financial information for the year ended December 31, 2008)
                                                                                                      Temporarily       Permanently              2009                    2008
                                                                        Unrestricted            Restricted          Restricted                Total                     Total
Revenue and other support:
Public support–contributions and 
non-Federal grant awards $   10,276,866 54,571,890 2,255,040 67,103,796 102,678,072 
Federal grant awards 29,648,968 –   – 29,648,968 27,728,155 
Indirect cost allowances 21,016,585 – –  21,016,585 22,079,594 
Investment return utilized 18,216,748 –  – 18,216,748 16,956,184 
Program fees 5,484,810 – – 5,484,810 4,634,167 
Publications sales 9,136,188 –   –   9,136,188 10,998,768 
Dining services 4,103,820 – – 4,103,820 4,074,984 
Rooms and apartments 3,255,480 – – 3,255,480 3,088,435 
Miscellaneous 1,962,873 – – 1,962,873 2,300,014 
Net assets released from restrictions 48,880,350 (48,880,350) –   – –
Total revenue and other support 151,982,688 5,691,540 2,255,040 159,929,268 194,538,373 
Expenses:
Research 73,046,245 – – 73,046,245 69,062,315 
Educational programs 15,319,175 – – 15,319,175 15,259,681 
Publications 9,075,715 – – 9,075,715 10,764,090 
Banbury Center conferences 1,069,044 – – 1,069,044 1,309,337 
Dolan DNA Learning Center programs 1,467,947 – – 1,467,947 1,476,222 
Watson School of Biological Sciences 
programs 3,595,810 – – 3,595,810 3,138,774 
General and administrative 14,293,070 – – 14,293,070 14,545,349 
Dining services 4,885,369 – – 4,885,369 5,345,228 
Total expenses 122,752,375 – – 122,752,375 120,900,996 
Excess of revenue and other support 
over expenses 29,230,313 5,691,540 2,255,040 37,176,893 73,637,377 
Other changes in net assets:
Investment return/(loss) excluding amount 
utilized 7,475,070 4,447,005 12,541,676 24,463,751 (93,289,813)
Change in fair value of interest-rate swap 24,524,899 – – 24,524,899 (29,526,602)
Write-off of terminated bond insurance – – – – (961,438)
Release of temporarily restricted capital 
funds 47,768,984 (47,768,984) – – –
Increase (decrease) in net assets 108,999,266 (37,630,439) 14,796,716 86,165,543 (50,140,476)
Net assets at beginning of year 126,126,561 179,988,153 166,762,395 472,877,109 523,017,585 
Net assets at end of year $ 235,125,827 142,357,714 181,559,111 559,042,652 472,877,109 
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CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2009
(with comparative financial information for the year ended December 31, 2008)
     2009 2008
Cash flows from operating activities:
Increase (decrease) in net assets $    86,165,543 (50,140,476)
Adjustments to reconcile increase (decrease) in net assets
to net cash provided by operating activities:
Change in fair value of interest rate swap (24,524,897) 29,526,602  
Depreciation and amortization 9,282,371 7,056,947  
Net (appreciation) depreciation in fair value of investments (36,992,017) 83,339,568  
Contributions restricted for long-term investment (9,121,400) (28,230,901)
Changes in assets and liabilities:
Grants receivable 2,397,001  439,731  
Contributions receivable, net of financing activities (18,458,455) (30,956,222)
Publications inventory (644,311) 107,133  
Other assets (611,026) 267,791  
Restricted use assets 1,456,592 423,656
Accounts payable and accrued expenses, net of financing activities 32,680  4,152,607  
Deferred revenue 1,678,029  (41,091)
Net cash provided by operating activities 10,660,110  15,945,345  
Cash flows from investing activities:
Capital expenditures (48,389,574) (46,536,698)
Proceeds from sales and maturities of investments 140,454,706  159,193,212  
Purchases of investments (131,634,094) (122,321,887)
Net change in investment in employee residences 440,775 1,208,853  
Net cash used in investing activities (39,128,187) (8,456,520)
Cash flows from financing activities:
Permanently restricted contributions 2,255,040  12,906,255  
Contributions restricted for investment in land, buildings
and equipment 6,866,360  15,324,644  
Decrease (increase) in contributions receivable 3,399,927  (6,632,433)
Decrease in deposits with bond trustee 11,886,744  17,596,724  
Increase (decrease) in accounts payable relating to capital
expenditures 403,725  (3,114,384)
Decrease (increase) in deposits with swap counterparty 17,380,247  (17,380,247)
Payment of conversion costs on bonds payable – (500,700)
Write-off of terminated bond insurance – 961,438  
Net cash provided by financing activities 42,192,043  19,161,297  
Net increase in cash and cash equivalents 13,723,966  26,650,122  
Cash and cash equivalents at beginning of year 52,226,592  25,576,470  
Cash and cash equivalents at end of year $    65,950,558  52,226,592  
Supplemental disclosure:
Interest paid $      3,180,748  4,153,373  
Noncash investing and financing activities:
Contributed property $           98,085  –
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a
substantial portion of their funding through grants from the Federal Government and through
grants, capital gifts, and annual contributions from New York State, private foundations, corpora-
tions, and individuals. The following section summarizes funding that occurred during 2009.
GRANTS January 1–December 31, 2009
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2009 Funding1
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Support Drs. Martienssen/McCombie 05/14/09 05/13/10 $      474,500 *2
Dr. Hannon 08/01/09 12/31/09 99,310 *2
Dr. D. Spector 12/17/09 11/30/10 95,137 *2
Program Project and Center Support Drs. Hannon/Krainer/Lowe/Spector/ 01/01/07 12/31/11 4,501,160
Stillman/Tansey
Dr. Stillman–Cancer Center Core 08/15/05 07/31/10 4,126,879 
Dr. Stillman–Cancer Center Core 09/30/09 03/31/11 199,292 *2
Dr. Zador 09/30/09 08/31/11 719,000 *2
Cooperative Research Agreement Support3 Drs. Gingeras/Hannon 09/27/07 06/30/11 3,600,584 
Dr. Huang 09/08/06 08/31/11 127,814 
Drs. Lowe/Hannon/Hicks/Powers 09/01/09 08/31/14 821,775 *
Contract Support Drs. Hannon/Lowe 12/31/09 12/31/11 999,980 *
Research Support Dr. Dubnau 09/15/09 08/31/14 431,667 *
Drs. Gingeras/Hannon/McCombie 09/30/09 08/31/11 1,473,081 *2
Drs. Gingeras/Hannon/McCombie 09/30/09 08/31/11 1,401,903 *2
Drs. Gingeras/Hannon/McCombie 09/30/09 08/31/11 1,428,205 *2
Dr. Hannon 09/01/09 08/31/13 344,400 *
Dr. Huang 09/30/09 08/31/11 498,790 *2
Dr. Huang 04/16/09 03/31/11 252,000 *
Dr. Joshua-Tor 07/01/07 06/30/12 299,954 
Dr. Joshua-Tor 02/01/06 01/31/10 308,597 
Dr. Koulakov 02/01/08 01/31/12 420,000 
Dr. Krainer 09/21/07 08/31/11 638,359 
Dr. Lowe 09/15/09 08/31/14 344,400 *
Dr. Martienssen 09/29/09 08/31/11 336,000 *2
Dr. Martienssen 08/01/07 07/31/11 412,000 
Dr. Mills 12/26/07 11/30/12 348,600 
Dr. Mitra 02/01/08 12/31/10 189,000 
Dr. Mitra 09/30/09 05/31/14 1,048,290 *
Dr. Mitra 09/30/09 08/31/11 498,858 *2
Dr. Muthuswamy 02/01/09 12/31/13 375,966 *
Drs. Powers/Lowe/Krasnitz/Sordella 09/29/09 08/31/11 2,363,922 *2
1Includes direct and indirect costs
2Award issued under the American Recovery and Reinvestment Act of 2009
3Cooperative research agreement funding amounts include only CSHL portion of award
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Grantor Program/Principal Investigator Duration of Grant 2009 Funding1
Dr. Powers 12/02/06 11/30/11 439,016 
Dr. Sebat 04/01/07 03/31/10 729,402 
Dr. Sebat 09/30/05 07/31/10 415,639 
Dr. Skowronski 09/26/09 08/31/11 9,869 *2
Dr. Skowronski 05/01/08 04/30/13 420,000 
Dr. D. Spector 04/01/90 03/31/11 652,580 
Dr. Stenlund 02/01/08 01/31/12 420,000 
Dr. Stillman 06/01/08 05/31/12 610,717 
Dr. Tansey 05/01/07 05/31/09 29,423 
Dr. Tonks 07/21/06 05/31/10 289,553 
Dr. Van Aelst 07/01/08 03/31/13 378,000 
Dr. Van Aelst 01/01/09 12/31/13 348,600 *
Drs. Wigler/McCombie 09/30/09 08/31/11 1,384,503 *2
Dr. Zador 09/24/09 08/31/11 90,236 *2
Dr. Zador 09/18/08 07/31/13 357,000 
Dr. Zhang 05/01/08 02/28/11 650,000 
Drs. Zhang/Krainer/McCombie 08/13/07 07/31/11 470,400 
Research Subcontracts
NIH/Allen Institute for Brain Science Dr. Mitra 09/15/09 08/31/10 201,600 *
Consortium Agreement
NIH/Angion Biomedica Corp. Dr. Enikolopov 09/30/09 08/31/11 271,759 *
Consortium Agreement
NIH/Brookhaven National Laboratory Dr. Stillman 09/01/06 08/31/11 38,854 
Consortium Agreement
NIH/Columbia University Consortium Dr. Wigler 09/01/06 05/31/10 303,489 
Agreement
NIH/Columbia University Consortium Dr. Lowe 08/18/06 07/31/11 407,069 
Agreement
NIH/Georgia Institute of Technology Dr. D. Spector 09/30/06 09/29/11 427,000 
Consortium Agreement
NIH/Ludwig Institute for Cancer Dr. Zhang 09/29/08 06/30/13 227,961 
Research Consortium Agreement
NIH/Northwestern University Dr. Osten 09/15/09 08/31/11 42,000 *
Consortium Agreement 
NIH/Ontario Institute for Cancer Dr. Stein 03/01/09 03/31/10 62,609 *
Research Consortium Agreement 
NIH/Paratek Pharmaceuticals, Inc., Dr. Krainer 01/05/09 12/31/10 166,025 *
Consortium Agreement
NIH/Rutgers University Consortium Dr. Mitra 12/08/04 11/30/10 185,940
Agreement 
NIH/University of California, San Dr. Egeblad 09/01/09 08/31/14 163,501 *
Francisco, Consortium Agreement
NIH/University of California, Berkeley, Dr. Gingeras 01/01/09 03/31/11 999,423 *
National Laboratory Consortium 
Agreement
NIH/University of Southern California Drs. Lowe/Sordella 09/28/09 07/31/14 371,637 *
Consortium Agreement
NIH/Vanderbilt University Consortium Dr. Tansey 06/01/09 04/30/10 58,152 *
Agreement
Fellowship Support Dr. Borges 08/16/09 08/15/12 50,054 *
Dr. Lazarus 07/15/09 07/14/11 25,176 *
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1Includes direct and indirect costs
2Award issued under the American Recovery and Reinvestment Act of 2009
*New grants awarded in 2009
Grantor Program/Principal Investigator Duration of Grant 2009 Funding1
Graduate Training Support Dr. Joshua-Tor, Watson School of Biological 07/01/07 06/30/12 206,330 
Sciences
Dr. Joshua-Tor, Watson School of Biological 09/01/09 08/31/11 41,266 *2
Sciences–Supplement
Course Support Advanced Immunocytochemistry, In Situ 07/01/98 08/31/10 86,250 
Hybridization, and Live Cell Imaging
Advanced Techniques in Molecular Neuroscience 07/01/01 06/30/12 96,512 
C. elegans 08/01/98 08/31/11 80,420 
Cell and Developmental Biology of Xenopus 04/01/09 03/31/14 59,900 *
Computational and Comparative Genomics 06/06/91 07/31/13 48,818 
Eukaryotic Gene Expression 01/01/83 03/31/11 112,154 
Imaging Structure and Function in the 07/01/01 06/30/12 46,740 
Nervous System
Integrated Data Analysis for High-throughput 09/01/07 04/30/12 59,464 
Biology
Molecular Embryology of the Mouse 01/01/83 03/31/11 113,305 
Neurobiology of Drosophila 07/01/01 06/30/12 78,326 
Programming for Biology 09/25/09 08/31/14 60,000 *
Protein Purification and Characterization 01/01/83 03/31/11 69,977 
Proteomics 07/01/03 06/30/11 78,059 
X-ray Methods in Structural Biology 07/01/07 06/30/12 74,812 
Yeast Genetics and Genomics 07/01/07 05/31/10 50,393 
Meeting Support The Ubiquitin Family 04/11/07 03/31/12 5,000 
The Biology of Genomes 04/01/08 03/31/13 37,080 
Channels, Receptors, and Synapses 04/01/06 03/31/11 23,271 
Cell Death 09/14/07 08/31/12 5,000 
74th Symposium: Evolution: The Molecular 01/01/09 12/31/09 13,000 *
Landscape
Molecular and Cellular Biology of Plasminogen 04/01/09 03/31/10 4,000 *
Activation
Telomeres and Telomerase 03/01/09 02/28/10 10,000 *
Retroviruses 04/01/09 03/31/10 12,000 *
Network Biology 04/21/09 02/28/14 7,500 *
Neurobiology of Drosophila 07/01/09 06/30/10 23,000 *
Genome Informatics 07/01/09 06/30/10 22,000 *
Mechanisms of Eukaryotic Transcription 08/15/09 07/31/10 5,000 *
Microbial Pathogenesis and Host Response 08/01/09 07/31/10 21,025 *
Harnessing Immunity to Prevent and Treat 11/06/09 10/31/10 8,000 *
Disease
HEALTH RESOURCES AND SERVICES ADMINISTRATION
Equipment Dr. D. Spector 09/01/09 08/31/11 706,860 *
NATIONAL SCIENCE FOUNDATION
Equipment Drs. Martienssen/McCombie 09/01/09 08/31/12 999,253 *2
Multiple Project Award Support Dr. Jackson 07/01/05 06/30/10 1,069,628 
Dr. Ware 10/01/07 09/30/11 1,669,733 
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1Includes direct and indirect costs
2Award issued under the American Recovery and Reinvestment Act of 2009
*New grants awarded in 2009
Grantor Program/Principal Investigator Duration of Grant 2009 Funding1
Research Support Dr. Jackson 04/01/07 03/31/10 150,000 
Dr. Lippman 09/15/09 08/31/12 159,324 *
Dr. Ware 06/15/08 05/31/11 243,954 
Research Subcontracts
NSF/Cornell University Consortium Drs. Timmermans/Micklos 09/01/08 08/31/12 591,378 
Agreement
NSF/Marquette University Consortium Dr. Jackson 08/01/09 07/31/10 54,800 *
Agreement
NSF/University of Arizona Consortium Drs. Stein/Martienssen/Micklos/Vaughn/Ware 02/01/08 01/31/13 1,204,131
Agreement 
NSF/University of California, Berkeley, Dr. Jackson 08/31/06 07/31/11 221,856 
Consortium Agreement
NSF/University of California, Davis, Dr. Martienssen 09/01/06 08/31/10 271,715 
Consortium Agreement
NSF/University of California, Davis, Dr. Ware 09/01/08 08/31/11 205,976 
Consortium Agreement
NSF/Washington University Consortium Drs. McCombie/Martienssen/Ware 11/15/05 10/31/09 436,710
Agreement 
Fellowship Support C. Malone 06/01/07 05/31/10 40,500 
Dr. Eveland 10/01/08 09/30/10 72,000 
Undergraduate Training Support Dr. Jackson, Watson School of Biological Sciences 03/01/09 02/29/12 66,750 *
Course Support Molecular Techniques in Plant Science 07/01/07 06/30/10 45,540 
Advanced Bacterial Genetics 07/01/09 06/30/14 88,713 *
Cell and Developmental Biology of Xenopus 05/01/07 04/30/10 20,000 
Computational Cell Biology 04/15/08 03/31/11 94,221 
Meeting Support Engineering Principles for Biological Sciences 02/01/09 01/31/10 15,000 *
Neurobiology of Drosophila 05/01/09 04/30/10 15,000 *
International Workshop on Rapid Release of 05/01/09 04/30/10 18,500 *
Prepublication Data
Plant Genomes 06/15/09 05/31/10 5,000 *
Yeast Cell Biology 07/01/09 06/30/10 29,845 *
Eukaryotic DNA Replication 09/01/09 08/31/10 7,000 *
Eukaryotic mRNA Processing 09/01/09 08/31/10 7,000 *
EC-US Plant Biotechnology Workshop on Plant 12/01/09 11/30/10 47,922 *
Bioinformatics and Databases
Mechanisms of Eukaryotic Transcription 09/01/09 08/31/10 7,000 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. McCombie 09/11/09 09/10/14 213,052 *
Dr. Jackson 09/01/08 08/31/11 128,873 
Meeting Support Bovine Genome 09/01/09 08/31/10 2,000 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 09/01/08 08/31/13 635,946 
Dr. Muthuswamy 06/01/08 05/31/13 762,629 
Dr. Powers 07/01/07 06/30/10 168,000 
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Dr. Trotman 08/15/09 08/14/12 127,292 *
Dr. Wigler 09/01/09 08/31/11 2,441,000 *
Fellowship Support Dr. He 12/15/08 12/14/11 32,400 
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
New York State Department of Health Dr. D. Spector 01/01/09 12/31/09 481,738 *
Eleanor Schwartz Charitable Foundation Dr. Osten 03/01/09 02/28/10 200,000 *
Program Project Support
The Leukemia and Lymphoma Society Dr. Lowe 10/01/08 09/30/13 1,250,000 
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lippman/Martienssen/ 07/01/07 06/30/12 1,600,000 
Timmermans/Ware
The Simons Foundation/Autism Dr. Wigler 07/01/08 06/30/11 6,586,312 
The Simons Foundation/Center for Dr. Wigler 09/01/08 08/31/11 1,500,000 
Quantitative Biology
Theodore R. and Vada S. Stanley Drs. Watson/McCombie/Sebat 07/01/07 06/30/12 5,000,000 
Research Support
Alpern Family Foundation Inc. Dr. Egeblad 12/15/09 12/14/10 1,000 *
American Cancer Society Dr. Wigler 01/01/05 12/31/10 10,000 
Dr. Wigler 01/01/06 12/31/10 60,000 
Dr. Mills 07/01/06 06/30/10 240,000 
American Heart Association Dr. Furukawa 07/01/09 06/30/13 77,000 *
Anonymous Gift Dr. Osten 09/01/09 08/31/11 262,088 *
Autism Speaks, Inc. Dr. Zador 07/01/07 06/30/10 127,500 
Mr. Donald E. Axinn Drs. Hannon/Lowe 01/01/09 12/31/09 250,000 *
Geoffrey Beene Cancer Center/Sloan- Dr. Hicks 08/01/08 07/31/10 42,654 
Kettering Institute for Cancer Research
Breast Cancer Help, Inc./Sons of Italy Dr. Sordella 04/01/09 03/31/10 10,000 *
in America
The Breast Cancer Research Foundation Dr. Wigler 10/01/09 09/30/10 200,000 *
Clear Channel Worldwide (WALK 97.5 Dr. Egeblad 04/01/09 03/31/10 5,000 *
FM) Breast Cancer Research Walk
Coleman Fung Foundation Inc. Dr. Zador 02/01/07 01/31/10 50,000 
The Dana Foundation Dr. Li 10/01/09 09/30/12 67,000 *
Dr. Li 01/01/09 12/31/11 200,000 *
Dart Neuroscience LLC Dr. Zhong 06/01/09 05/31/10 125,000 *
The Kathryn W. Davis Foundation Dr. Hannon 01/15/07 01/14/11 1,019,655 
The Ellison Medical Foundation Dr. Enikolopov 09/09/09 09/08/13 252,000 *
Entertainment Industry Foundation Dr. Hannon 11/01/09 10/31/10 250,000 *
The Eppley Foundation for Research, Inc. Dr. Zhong 12/22/09 12/21/10 50,000 *
Find a Cure Today (F.A.C.T.) Dr. Egeblad 12/01/09 11/30/10 25,000 *
Douglas and Christine Fox Dr. Furukawa 12/15/09 12/14/10 1,000 *
The Joni Gladowsky Breast Cancer Dr. Egeblad 12/01/09 11/30/10 35,000 *
Foundation
GlaxoSmithKline Dr. Powers 10/01/08 09/30/10 1,099,802 
Richard and Mindy Gordon Dr. Egeblad 01/01/09 12/31/09 5,000 *
The Irving A. Hansen Memorial Dr. Tonks 07/01/09 06/30/10 10,000 *
Foundation
Jo-Ellen and Ira Hazan Dr. Enikolopov 12/01/09 11/30/10 200,000 *
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Hearts for Cancer Dr. Muthuswamy 12/01/07 11/30/09 1,000 
Dr. Egeblad 04/01/09 03/31/10 1,710 *
The International Human Frontier Dr. Lippman 07/01/09 06/30/12 100,000 *
Science Program Organization
Isis Pharmaceuticals, Inc. Dr. D. Spector 01/01/09 12/31/09 10,000 *
V. Kann Rasmussen Foundation Dr. Trotman 09/01/07 08/31/12 50,000 
The Karches Foundation Dr. Wigler 07/01/05 06/30/10 494,535 
Mara and Thomas Lehrman Charitable Dr. Mitra 01/01/09 12/31/09 55,000 *
Fund
The Long Island 2-Day Walk to Fight Dr. Egeblad 11/01/08 10/31/10 20,000 
Breast Cancer
Manhasset Women’s Coalition Against Dr. Muthuswamy 01/01/09 12/31/09 50,000 *
Breast Cancer
Carol Marcincuk Fund Dr. Lucito 01/01/09 12/31/09 4,690 *
In Honor of Carissa Maringo Dr. Egeblad 10/01/09 09/30/10 4,300 *
The G. Harold and Leila Y. Mathers Dr. Huang 07/01/07 06/30/10 205,913  
Charitable Foundation
The Elizabeth McFarland Breast Cancer Dr. Wigler 01/01/09 12/31/09 61,801 *
Fund
Roni and Charles McGuffog Dr. Furukawa 03/01/09 02/28/10 1,000 *
The McKnight Endowment Fund for Dr. Osten 08/01/09 07/31/11 100,000 *
Neuroscience
The Don Monti Memorial Research Dr. Lowe 03/01/09 02/28/10 500,000 *
Foundation
Louis Morin Charitable Trust Dr. Kepecs 12/01/09 11/30/10 70,000 *
MSC Biotarget LLC Dr. Tonks 11/01/09 10/31/10 60,000 *
Muscular Dystrophy Association, Inc. Dr. Krainer 07/01/07 06/30/10 241,300 
The Neuberger Berman Foundation Dr. Trotman 11/01/09 10/31/10 20,000 *
New York State Department of Health– Drs. Enikolopov/Koulakov 01/01/09 12/31/11 359,996 *
New York Stem Cell Science (NYSTEM) Dr. Timmermans 01/01/09 12/31/10 119,234 *
Philips Research North America Dr. Zhang 01/01/09 12/31/10 180,000 *
Drs. Lucito/Hicks 04/01/09 03/31/10 565,671 *
Rahn & Bodmer Co. Dr. Trotman 12/15/09 12/14/10 400 *
Christina Renna Foundation, Inc. Dr. Van Aelst 01/01/08 12/31/09 17,300 
Diane Emdin Sachs Memorial Fund Dr. Sordella 06/01/09 05/31/10 23,947 *
In Honor of Jacob T. Schwartz Dr. Wigler 04/01/09 03/31/10 600 *
Judi Shesh Memorial Foundation Dr. Hannon 07/01/09 06/30/10 10,000 *
The Simons Foundation Dr. Mills 01/01/07 12/31/09 544,373 
Dr. Huang 10/01/07 09/30/10 440,805 
Dr. Mitra 09/01/09 08/31/11 150,000 *
Dr. Osten 07/01/09 06/30/11 149,838 *
Mary F. Smith Family Foundation Dr. Egeblad 11/01/09 10/31/10 2,000 *
Starr Cancer Consortium Dr. Egeblad 08/01/09 07/31/11 150,000 *
Dr. Hannon 07/01/08 06/30/10 452,316 
Dr. Lazebnik 08/01/09 07/31/11 180,000 *
Dr. Lowe 07/01/08 06/30/10 60,000 
Drs. Lowe/Hannon 11/01/09 10/31/10 480,000 *
Drs. Lucito/Tonks 08/01/09 07/31/11 473,780 *
Dr. McCombie 07/01/08 06/30/10 300,000 
Dr. McCombie 08/01/09 07/31/11 180,000 *
Dr. Powers   08/01/09 07/31/11 120,000 *
Dr. Trotman 08/01/09 07/31/11 150,000 *
Dr. Wigler 08/01/09 07/31/11 399,900 *
Dr. Zhang 08/01/09 07/31/11 240,000 *
Swim Across America Dr. Sordella 11/01/09 10/31/10 50,000 *
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The V Foundation Dr. Trotman 11/01/08 10/31/10 50,000 
Drs. Powers/Sordella 11/01/08 10/31/11 200,000 
Waldbaum Foundation Dr. Egeblad 09/01/08 08/31/09 8,000 
West Islip Breast Cancer Coalition for Dr. Egeblad 11/01/09 10/31/10 10,000 *
Long Island Inc.
West Islip Youth Enrichment Services Dr. Egeblad 10/01/09 09/30/10 5,660 *
Whitehall Foundation, Inc. Dr. Kepecs 06/01/08 05/31/11 75,000 
Wodecroft Foundation Dr. Li 09/01/09 08/31/10 25,000 *
Women in Science Dr. Timmermans 01/01/09 12/31/09 48,296 *
Women’s Insurance Network of Long Island Dr. Egeblad 06/01/09 05/31/10 3,000 *
Fellowship Support
The Abrams Charitable Trust Dr. Joshua-Tor 05/01/09 04/30/10 1,500 *
The Rita Allen Foundation Dr. Trotman 09/01/07 08/31/10 100,000 
American Association for Cancer Research Dr. Miething 07/01/09 06/30/10 30,000 *
American Cancer Society Dr. Karginov                     01/01/07 12/31/09 48,000 
Australian Government National Health Dr. Dow 02/01/09 01/31/11 51,875 *
and Medical Research Council
Autism Speaks, Inc. Dr. Xiong 10/01/08 09/30/10 44,000 
Arnold and Mabel Beckman Foundation Watson School of Biological Sciences 09/01/05 08/31/10 350,000 
Terri Brodeur Breast Cancer Foundation Dr. Bialucha 01/01/09 12/31/10 50,000 *
Canadian Institutes of Health Research Dr. Aznarez 07/01/09 12/31/11 21,768 *
Carnegie Institution Dr. Lippman 09/01/09 08/31/10 17,539 *
The Mary K. Chapman Foundation Dr. Xu 04/01/08 03/31/10 85,000 
The Jane Coffin Childs Memorial Fund Dr. Kuhn 07/01/08 06/30/11 46,500 
for Medical Research
CSHL Association Fellowship New Investigator Support 01/01/09 12/31/09 280,000 *
Danish Cancer Society Dr. Jensen 01/01/07 03/10/10 75,000 
Englehorn Scholarship Program Watson School of Biological Sciences 01/01/09 12/31/09 49,980 *
Genentech Foundation Dr. Joshua-Tor, Watson School of Biological 07/01/09 06/30/12 55,017 *
Sciences
The Allen and Lola Goldring Foundation Dr. Stillman 09/01/09 08/31/10 75,000 *
Lita Annenberg Hazen Foundation Watson School of Biological Sciences 05/01/08 04/30/18 10,000 
Hope Funds for Cancer Research Dr. Sawey 07/01/09 06/30/11 42,500 *
Human Frontier Science Program Dr. Canela 05/01/09 04/30/11 47,400 *
Dr. Kvitsiani 09/01/08 08/31/11 46,400 
Dr. Skopelitis 04/01/09 03/31/11 46,400 *
International Rett Syndrome Foundation Dr. A. Paul 10/01/09 09/30/11 50,000 *
Dr. Lin 01/01/09 12/31/10 50,000 *
The Japan Society for the Promotion of Dr. Hige 07/01/08 06/30/10 48,000
Science Dr. Kawakami 04/01/08 03/31/10 52,000 
Annette Kade Charitable Trust Watson School of Biological Sciences 04/01/09 03/31/10 60,000 *
The Esther A. and Joseph Klingenstein Dr. Kepecs 07/01/09 06/30/12 50,000 *
Fund Inc.
The Susan G. Komen Breast Cancer Dr. Anczukow 06/04/09 06/03/12 60,000 *
Foundation, Inc.
Life Sciences Research Foundation Dr. Xu 11/01/09 10/31/12 56,000 *
NARSAD Dr. Park 07/01/08 06/30/10 30,000 
The Robert Leet and Clara Guthrie Dr. Demir 07/01/08 06/30/10 44,500 
Patterson Trust Dr. Oviedo 01/15/08 01/14/10 50,000 
Dr. Lu 01/15/09 01/14/11 46,000 *
The Sass Foundation for Medical Dr. S. Paul 04/01/08 03/31/10 75,000 
Research, Inc.
The Seligson Foundation Dr. Zuber 01/01/09 12/31/09 75,000 *
Alfred P. Sloan Foundation Dr. Kepecs 09/16/09 09/15/11 25,000 *
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Lauri Strauss Leukemia Foundation Dr. Miething 04/01/09 03/31/10 15,000 *
The Swartz Foundation Dr. Zador 01/01/09 12/31/09 165,000 *
Drs. Koulakov/Kolterman 01/01/09 12/31/09 55,000 *
Drs. Zador/Reid 01/01/09 12/31/09 55,000 *
Dr. Zador 01/01/09 12/31/09 15,000 *
Vanderbilt University Medical Center A. Leung 09/01/09 08/31/10 37,760 *
Vietnam Education Foundation Dr. Nguyen 08/01/09 07/31/10 31,200 *
Training Support
Howard Hughes Medical Institute Undergraduate Research Program 06/01/09 05/31/10 7,600 *
Steamboat Foundation Undergraduate Research Program 05/01/09 04/30/10 12,000 *
William Townsend Porter Foundation Undergraduate Research Program 04/01/09 03/31/10 9,100 *
Course Support
The Autism Speaks Foundation Workshop on Autism Spectrum Disorders 05/01/07 04/30/11 15,000 
Howard Hughes Medical Institute Neurobiology Course Support 01/01/07 12/31/11 750,000 
IAC-USNC/IBRO Student Support Course Scholarships 04/01/09 03/31/10 6,395 
Illumina, Inc. Advanced Sequencing Technologies and 03/01/09 02/28/10 30,000 *
Applications
Nancy Lurie Marks Family Foundation Workshop on Autism Spectrum Disorders 05/01/07 04/30/11 15,000 
Roche Diagnostics Corporation Advanced Sequencing Technologies and 03/01/09 02/28/10 30,000 *
Applications
The Simons Foundation Workshop on Autism Spectrum Disorders 05/01/07 04/30/11 15,000 
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 10/01/09 09/30/10 3,000 *
Immune System
The Company of Biologists Limited Vertebrate Organogenesis 09/01/09 08/31/10 4,738 *
Dow AgroSciences, LLC Plant Genomes: Genes, Networks, and 04/01/09 03/31/10 5,000 *
Applications
Illumina, Inc. Personal Genomes 09/14/09 09/13/10 4,250 *
The Biology of Genomes 04/01/09 03/31/10 3,750 *
Merial Limited Bovine Genome 04/01/09 03/31/10 4,000 *
Novartis Institutes for BioMedical Vertebrate Organogenesis 09/01/09 08/31/10 5,000 *
Research, Inc.
Pfizer Inc. Bovine Genome 04/01/09 03/31/10 5,000 *
Research and Diagnostic Systems, Inc. Gene Expression and Signaling in the 10/01/09 09/30/10 2,500 *
Immune System
Roche Diagnostics Corporation Personal Genomes 03/01/09 02/28/10 35,000 *
Bovine Genome 03/01/09 02/28/10 10,000 *
The Biology of Genomes 03/01/09 02/28/10 35,000 *
University of Illinois Molecular and Cellular Biology of Plasminogen 05/01/09 04/30/10 2,500 *
Activation
University of Missouri Bovine Genome 04/01/09 03/31/10 9,600 *
University of Pennsylvania Single-cell Techniques 04/01/09 03/31/10 5,000 *
Dr. Charles Weissmann 2010 CSHL Symposium Premeeting to 12/01/09 11/30/10 10,000 *
Celebrate the 75th Symposium
The Wellcome Trust History of the Human Genome Project 04/01/09 03/31/10 14,500 *
Carl Zeiss MicroImaging, Inc. Single-cell Techniques 04/01/09 03/31/10 3,500 *
Library Support
James R. Hudson, Jr. 09/16/09 09/15/10 75,000 *
Ellen Brenner Memorial Fund 12/22/09 12/21/10 2,000 
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Amityville Union Free School District $  1,200
Bay Shore Union Free School District 6,000
Bellmore Union Free School District 4,000
Bellmore–Merrick Central HS District 16,000
Bethpage Union Free School District 2,250
Commack Union Free School District 5600
Deer Park Union Free School District 1,600
Eastern Middle School, Greenwich, CT 2,900
East Meadow Union Free School District 2,550
East Williston Union Free School District 5,600
Elmont Union Free School District 1,800
Floral Park–Bellerose Union Free School District 6,500
Friends Academy, Locust Valley 2,350
Garden City Union Free School District 10,950
Great Neck Union Free School District 11,800
Half Hollow Hills Central School District 7,625
Hauppauge Union Free School District 3,000
Herricks Union Free School District 2,700
Huntington Union Free School District 4,350
Jericho Union Free School District 8,125
Lawrence Union Free School District 6,700
Lindenhurst Union Free School District 1,400
Locust Valley Central School District $  7,750
Merrick Union Free School District 2,250
Mott Hall V, NYC 1,200
MS 181, NYC 1,000
MS 447 The Math and Science Exploratory School, NYC 2,480
North Bellmore Union Free School District 4,300
North Shore Central School District 1,500
North Shore Hebrew Academy 1,000
Oceanside Union Free School District 1,500
Old Westbury School of the Holy Child 3,250
Oyster Bay–East Norwich Central School District 2,475
Rockville Centre Union Free School District 2,400
Roslyn Union Free School District 3,600
St. Dominic Elementary School, Oyster Bay 4,050
St. Edward the Confessor School, Syosset 2,025
Syosset Central School District 32,500
Three Village Central School District 2,200
Trinity Regional School 1,100
Valley Stream 13 Union Free School District 1,200
Yeshiva Darchei Torah 1,400
Yeshiva of North Jersey, NJ 2,100
The following schools each contributed $1000 or more for participation in the Genetics as a Model for Whole Learning Program:
Manhasset Union Free School District $  2,500
Massapequa Union Free School District 3,000
Northport–East Northport 2,500
North Shore Central School District 3,000
North Shore Hebrew Academy 3,000
Oceanside Union Free School District 3,000
Oyster Bay–East Norwich School District 1,500
Plainedge Union Free School District 3,000
Plainview–Old Bethpage Central School District 3,000
Port Washington Union Free School District 1,500
Ramaz School 1,500
Roslyn Union Free School District 3,000
Sachem Central School District 3,000
South Huntington Union Free School District 1,500
Syosset Central School District 1,500
West Hempstead Union Free School District 3,000
Yeshiva University High School for Girls 1,500
DOLAN DNA LEARNING CENTER GRANTS
Duration 2009 
Grantor Program of Grant Funding†
FEDERAL GRANTS
National Institutes of Health Science Education Partnership Award (SEPA): Nationwide 08/07–07/10 $ 97,358
Dissemination of Inside Cancer Internet Site
National Science Foundation Course, Curriculum, and Laboratory Instruction (CCLI) Program: 9/07–8/10 165,361
Nationwide Dissemination of RNAi Curriculum
National Science Foundation, National Science Digital Library: Meta-tagging DNALC Internet 10/05–9/09 65,240
American Association for Content for BiosciEdNet
the Advancement of Science
National Science Foundation, Educational Outreach for iPlant: A Cyberinfrastructure for Plant Sciences 2/08–1/13 409,411
University of Arizona
National Science Foundation, Weed to Wonder Internet Site Development: Educational Outreach for 9/08–8/10 190,156
Cornell University Functional Genomics of the Maize Shoot Apical Meristem
NONFEDERAL GRANTS
Bank of America Scholarships for Minority and Underserved Students on Long Island 2009 25,000
Dana Foundation Genes to Cognition (G2C) Online Internet Site Development 10/04–3/09 $14,725
Dana Foundation Harlem DNA Lab Operating Support 3/09–2/12 118,298
Dialog Gentechnik DNALC Licensing 2009 62,400
Hewlett Foundation Genes to Cognition (G2C) Online Internet Site Dissemination and Evaluation 10/05–4/10 107,387
HHMI Foundation Pre-College Science Education Initiative: NYC Teacher Professional Development 9/07–8/12 136,126
Lounsbery Foundation Biotechnology Footlocker Program: Harlem DNA Lab 11/09–8/10 51,916
National Grid Foundation Scholarships for Minority and Underserved Students in the Brentwood 5/09–5/10 10,000
Union Free School District
North Shore-LIJ Health System DNALC West Operating Support 2009 50,000
Porter Foundation Scholarships for Minority and Underserved Students at Harlem DNA Lab 3/08–3/10 31,850
The following schools each contributed $1000 or more for participation in the Curriculum Study Program:
Bethpage Union Free School District $  1,500
East Meadow Union Free School District 3,000
Elwood Union Free School District 3,000
Garden City Union Free School District 1,500
Great Neck Union Free School District 3,000
Green Vale School 3,000
Half Hollow Hills Central School District 1,500
Harborfields Central School District 1,500
Herricks Union Free School District 1,500
Huntington Union Free School District 3,000
Island Trees Union Free School District 1,500
Jericho Union Free School District 1,500
Kings Park Central School District 1,500
Lawrence Union Free School District 3,000
Levittown UFSD 3,000
Locust Valley Central School District 1,500
Long Beach City School District 3,000
†Includes direct and indirect costs
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FEDERAL SUPPORT
NIH–National Institute of The 1st Annual NIMH-Sponsored Brain Camp 2009 $ 37,177
Mental Health 
NIH–National Institute on Neurobiology of Depression: From Molecules 2009 5,580
Drug Abuse to Mood
NIH–National Institute of From Infection to Neurometabolism: A Nexus for CFS 2009 35,000
Neurological Disorders and Stroke
NIH–National Institute of New Developments in Fragile X Syndrome: From 2009 51,273
Mental Health (through a Basic Mechanisms to Therapeutics
grant to University of Illinois)
National Science Foundation NSF Workshop: A Vision for Plant Biology 2009 915
NONFEDERAL SUPPORT
Meeting Support
AstraZeneca Pharmaceuticals Neurobiology of Depression: From Molecules 2009 7,000
to Mood
Biotechnology and Biological NSF Workshop: A Vision for Plant Biology 2009 2,745
Sciences Research Council
(BBSRC)
Boehringer Ingelheim Fonds Science: Get it Across! 2009 67,991
CFIDS Association of America From Infection to Neurometabolism: A Nexus 2009 15,753
for CFS
Cold Spring Harbor–Pioneer Epigenetic Inheritance, Gene Regulation, and 2009 47,049
Collaborative Research Program Plant Development
Deutsche Forschungsgemeinschaft NSF Workshop: A Vision for Plant Biology 2009 915
(DFG)
The Gordon and Betty Moore Aquatic Plants: Environment, Energy, and Evolution 2009 50,000
Foundation
Hoffmann-LaRoche, Inc. Neurobiology of Depression: From Molecules to Mood 2009 10,000
Hope for Depression Research Neurobiology of Depression: From Molecules to Mood 2009 4,593
Foundation
Johnson & Johnson Neurobiology of Depression: From Molecules to Mood 2009 10,000
Lilly Research Laboratories Neurobiology of Depression: From Molecules to Mood 2009 6,600
NARSAD, The Brain and Promoting Research on Severe Mental llness 2009 15,000
Behavior Research Fund
OSI Pharmaceuticals, Inc. Feedback Networks in the Intersection of Metabolism 2009 32,132
and Receptor Tyrosine Kinase Signaling
The Salk Institute NSF Workshop: A Vision for Plant Biology 2009 8,235
Simons Foundation Promoting Research on Severe Mental Illness 2009 5,000
The Stanley Research Foundation Psychiatric Genetics: Current Progress and 2009 17,823
Future Directions
The Swartz Foundation Searching for Principles Underlying Memory in 2009 44,355
Biological Systems
Time for Lyme, Inc. Coinfections in Lyme Disease 2009 5,070
University of Arizona iPlant Collaborative 2009 23,078
The Wellcome Trust International Catalog for the History of the Human 2009 12,369
Genome Project
World Heritage Foundation– Promoting Research on Severe Mental Illness 2009 5,000
Prechter Family Fund
Wyeth Pharmaceuticals Neurobiology of Depression: From Molecules to Mood 2009 5,000
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year’s meetings nor introduce new and unusual topics. 
We are especially grateful to the companies that joined us in 2009 as the economic difficulties
began to take effect. The year 2010 is going to be especially challenging as the number of companies
shrinks through takeovers, and companies and foundations adopt austerity measures.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives
of the Corporate Sponsors at our meetings. Six and three scientists, respectively, from Benefactors
and Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by
invitation of the organizers. Member companies receive gratis copies of Cold Spring Harbor Labo-
ratory Press publications, including the journals Genes & Development, Learning & Memory, Protein
Science, Genome Research, and RNA.
We acknowledge our Sponsors in all relevant publications, including the books of abstracts given
to each of the 7000 participants who come to the meetings each year. The names of the sponsoring
companies are listed on the poster describing the meetings, and this is mailed to approximately 30,000
scientists throughout the world. In addition, the companies are listed on the Cold Spring Harbor
Laboratory website on the Meetings Office and Banbury Center pages. Members in 2009 were
CORPORATE SPONSORS
Agilent Technologies, Inc.
AstraZeneca UK Ltd.
BioVentures, Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
Hoffmann-La Roche Inc.
Life Technologies (Applied Biosystems 
& Invitrogen)
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Sanofi-Aventis
Schering-Plough Research Institute
CORPORATE BENEFACTOR
GlaxoSmithKline
PLANT CORPORATE SPONSORS
Monsanto Company
Pioneer Hi-Bred International, Inc.
FOUNDATION
HudsonAlpha Institute for Biotechnology
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DEVELOPMENT
June 12, 2009 was an important day in the history of Cold Spring Harbor Laboratory as we dedicated
six new buildings to expand our research programs in cancer, autism, and schizophrenia, and to house
a new program in quantitative biology. At the dedication were many of our long-time friends who
participated in the $200 million capital campaign and helped to make the blueprints from 2000 into
such a beautiful reality. One of the highlights from the ceremony for me was the presence of 17 mem-
bers of the Quick family. Jean and Les Quick, whose names grace one of the new buildings for cancer
research, would be so proud to know that their legacy of philanthropy and family continues. Brothers
Tom and Peter Quick both served on the Laboratory's campaign cabinet and provided much help and
support.
Our summer jubilation was dampened later in the fall with the passing of Don Axinn, one of
the staunchest advocates for this building project. Not only did Don name the last building in the
complex, but he also lent his real-estate development expertise chairing the Laboratory's building
committee. His advice and attention to our facilities team were quite remarkable and unprecedented.
Don's boundless energy was thwarted in the last months by his esophageal cancer which metasta-
sized, but he left this world knowing that these buildings will be home to the breakthrough work
of young scientists like Dr. Mikala Egebald who has developed a technology to determine why and
how tumors metastasize. Don taught me many life lessons that I am just beginning to appreciate,
and all of us here at the Laboratory will miss him terribly. 
As 2009 draws to a conclusion, I would like to thank all of you who care and support the growth
of Cold Spring Harbor Laboratory as we approach this new decade of discovery.
Charles V. Prizzi, Vice President for Development
The Quick family at the Hillside Campus dedication ceremony
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Mr. and Mrs. Edward Chernoff
Mrs. John P. Clearly
Mr. and Mrs. Norris Darrell
Mrs. Kathryn Wasserman Davis
Mr. and Mrs. Yves C. de Balmann
Mr. Michael Eisenbud and Dr. Marcia
Kramer Mayer
Mr. and Mrs. John H. Friedman
Mrs. Allen A. Goldring
Dr. Leo A. Guthart
Mr. Matthew Haines
Mr. and Mrs. Ira Hazan
Mr. Francis Kirschner
Drs. Marsha and Henry Laufer
Dr. Betsy and Mr. Bryan H. Lawrence
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mrs. Nancy Abeles Marks
Dr. Gillian and Mr. Eduardo Mestre
Mr. and Mrs. Douglas P. Morris
Mr. and Mrs. Frank T. O’Keefe
Mr. and Mrs. John C. Phelan
Mr. and Mrs. Alan Seligson
Drs. Marilyn and James Simons
Mr. and Mrs. Erwin P. Staller
Mrs. Cynthia R. Stebbins
Mr. Paul J. Taubman
Mrs. Robert W. Tilney
Mr. and Mrs. Howard J. Tytel
Dr. and Mrs. James D. Watson
President’s Council
Members of the President’s Council contribute at least $25,000 annually to support CSHL Fellows, unusually tal-
ented young scientists who embark on independent research directly after graduate school. Each year, members
gather for a spring reception and a fall retreat to explore a chosen topic of broad public interest that relates to
CSHL research.
The April reception hosted by CSHL Chairman Eduardo Mestre and his wife Gillian featured a presentation
by 23andMe by cofounders Linda Avey and Anne Wojcicki (wife of Google cofounder Sergey Brin). Companies
such as 23andMe encourage individuals to access and learn about their own genetic information, and they compile
data to create common, standardized resources of genetic profiles with the hope of accelerating personalized med-
icine. The October retreat included talks about personal genomes related to health, privacy, the criminal justice
system, human origins, and advancements in genome sequencing technology.
President
Dr. Bruce Stillman
Chairpersons
Mr. and Mrs. Thomas D. Lehrman
Mr. George F. Ohrstrom
Dr. and Mrs. James M. Stone
Members
Mr. and Mrs. Donald Everett Axinn
Mr. Daniel Berlin
Mr. and Mrs. Hans E.R. Bosch
Dr. Gerald Chan
2009 Fall President’s Council attendees listen as a Cold Spring Harbor Laboratory scientist
Doreen Ware discusses her research.
23andme founders (left to right) Linda Avey and Anne Wojci-
cki with Connie de Balmann, CSHL Trustee Kristina Davison
and Silda Wall Spitzer at the 2009 Spring President’s Council
Reception.
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Cold Spring Harbor Laboratory Association (CSHLA)
Once again, the CSHL Association annual fund goal was exceeded, and we raised $1,153,616. We
were proud to have CSHL alumni and new President of the Howard Hughes Medical Institute Bob
Tjian give a lively overview of CSHL’s impact on the world of biology at our annual meeting in
January. For the first time in years, we took a break from our annual spring benefit, but supporters
responded generously to our “noninvitation” and donated more than $80,000. The annual Sym-
posium this year was on Evolution, and neighbors and friends at nearly 20 different dinner parties
especially enjoyed meeting paleontologists, anthropologists, and philosophers along with geneticists
and molecular biologists from around the world. Fife and Heather Whitman warmly welcomed
CSHL’s major donors to their meticulously restored historic Jones family home, Hill House, on a
memorably balmy Sunday evening in early October. We are grateful to Laboratory Association Pres-
ident Tim Broadbent for his energetic leadership of our board and look forward to another eventful
year of friend raising and fund raising in 2010.
Honorary Directors
George W. Cutting, Jr.
Mary D. Lindsay
Anne R. Meier
Maureen G. Leness
Frank T. O’Keefe
Lauryl Palatnick
David Peikon
Scott J. Ratner, M.D. 
Raymond G. Schuville
Debbie Parmet Sondock
Cathy Cyphers Soref
Pearl F. Staller
W. Fifield Whitman
James A. Woods
Joseph V. Amella
Joyce Bertoldo
Maria L. Brisbane
Barbara Candee
Michele Munn Celestino
Katie Charlston Colgate, Ph.D.
Linda Ferrante
John S. Friedman
Charles B. Goodwin, M.D.
Nancy Lippmann Israeli, M.D.
Virginia Knott
Directors
Executive Committee
Timothy S. Broadbent, 
President
Pien Bosch, Vice President
Lynn M. Gray, Vice
President
Sandy Tytel, Treasurer
Suzanne DiMaio, 
Secretary
2009 CSHLA Hike
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Dolan DNA Learning Center Advisory Boards
We are lucky to have high-level support from two advisory bodies: the Education Committee and the
Corporate Advisory Board (CAB). The Education Committee formulates policy and assists with strate-
gic planning, whereas the CAB provides liaison to the Long Island and New York City business com-
munity. The CAB also conducts an annual golf tournament and the annual fund campaign. These are
the DNALC’s major sources of unrestricted funding. In 2009, more than $200,000 was raised through
these events. 
Edward Chernoff
Lola Grace
Lori Homer
Suzanne Kleinknecht
Suzanne Leeds
Peter Quick
Lawrence Scherr, M.D.
Adele Smithers
DNALC Education Committee
Chairperson: Laurie Landeau,VMD
Arthur Spiro 
Peter Tilles
Edward Travaglianti
Marianne Dolan Weber
Corporate Advisory Board
Chairman: Edward A. Chernoff, Motors & Armatures Inc.
CSHL Trustee Liaison: Laurie Landeau, VMD
Nikon Instruments group at the June 2009 Golf Tournament held at Piping Rock Country
Club, benefiting the Dolan DNA Learning Center
DNA Learning Center Corporate Advisory Board Chairman
Edward Chernoff and DNA Learning Center Executive 
Michael Aboff, Aboff’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale Sothebys
International Realty
Jeffrey Carstens, Sovereign Bank
Richard A. Catalano, KPMG, LLP
Marian Conway, Roslyn Savings
Foundation
James Chinitz, Population Diagnostics
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
David Epstein, Ph.D., OSI Pharmaceu-
ticals, Inc.
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis, Mallet-
Prevost, Colt & Mosle LLP
Mary Jane Helenek, Luitpold Pharma-
ceuticals
Arthur D. Herman, Herman Develop-
ment Corporation
Diana Hoadley, JP Morgan
Robert Isaksen, Bank of America
Neil M. Kaufman, Davidoff, Malito &
Hutcher
John C. Kean III, Kean Development
Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, National Grid Foundation
James E. Mattutat, Ingleside Investors, Inc.
John Molloy, H2M
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sothebys
Real Estate
Christiaan B. Reynolds
William D. Roche
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of
New York
Robert Van Nostrand
Hans Zobel, Ziehm Medical LLC
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Jim Watson and 2009 Nobel Prize winner 
Dr. Carol Greider at the Double Helix Medals
Dinner held at the Mandarin Oriental hotel in
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CSHL President Bruce Stillman (left) with CSHL
Trustee Marilyn Simons and Jim Simons at the
2009 Double Helix Medals Dinner
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(Left to right) Peter Guida, Corinne Greenberg, 2009
Double Helix Medal recipient Hank Greenberg, and
Bernadette Castro at the Double Helix Medals Dinner
*Multiyear pledge or gift/pledge of $100,000+ made to the Hillside Campus Campaign
**Deceased in 2009
(Left to right) Linda Viertel, Lulu Wang, 2009
Double Helix Medal recipient Kathryn Davis,
and Starr Foundation President Florence Davis
(Left to right) 2009 Double Helix Medal recipients Stanley Cohen and Her-
bert Boyer with CSHL President Bruce Stillman
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(Left to right) Donald Schaeffer, Jonathan Serko, CSHLA Director Tracey DeMatteis Serko, Nancy
DeMatteis, and CSHL President Bruce Stillman at the Hillside Campus dedication ceremony
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at the Spring President’s Council reception
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(Left to right) CSHL Trustee Louise Parent, Watson
School Dean Leemor Joshua-Tor, Mara Lehrman,
CSHL Trustee Kristina Davison, Kinga Lampert,
Lara Trafelet, and Mary Snow at the 2009
Women’s Partnership in Science Luncheon
*Multiyear pledge or gift/pledge of $100,000+ made to the Hillside Campus Campaign
**Deceased in 2009
Michael J. Fox with CSHL President Bruce Stillman
during a visit to the Laboratory
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